"","regCodeExt","tumorType","metaCondition","condition","conditionCode","context","contextCode","regName","continuous","noCycles_Original","regString","shortString"
"1","1.126.100.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Cyclophosphamide & Non-pegylated liposomal doxorubicin (MC)",TRUE,"Cont.","21.Cyclophosphamide;0.Non-pegylatedliposomaldoxorubicin;21.Cyclophosphamide;0.Non-pegylatedliposomaldoxorubicin;","21.Cyclophosphamide;0.Non-pegylatedliposomaldoxorubicin;"
"2","1.126.101.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Paclitaxel monotherapy, weekly",TRUE,"Cont.","7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;","7.Paclitaxel;7.Paclitaxel;"
"3","1.126.101.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Paclitaxel monotherapy, weekly",TRUE,"Cont.","14.Paclitaxel;7.Paclitaxel;7.Paclitaxel;14.Paclitaxel;7.Paclitaxel;7.Paclitaxel;","14.Paclitaxel;7.Paclitaxel;7.Paclitaxel;"
"4","1.126.101.3","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Paclitaxel monotherapy, weekly",TRUE,"Cont.","7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;","7.Paclitaxel;7.Paclitaxel;"
"5","1.126.102.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Paclitaxel monotherapy, q3wk",TRUE,"Cont.","21.Paclitaxel;21.Paclitaxel;","21.Paclitaxel;21.Paclitaxel;"
"6","1.126.102.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Paclitaxel monotherapy, q3wk",TRUE,"Cont.","28.Paclitaxel;28.Paclitaxel;","28.Paclitaxel;28.Paclitaxel;"
"7","1.126.103.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Paclitaxel & Bevacizumab",TRUE,"Cont.","14.Bevacizumab;0.Paclitaxel;7.Paclitaxel;7.Bevacizumab;0.Paclitaxel;14.Bevacizumab;0.Paclitaxel;7.Paclitaxel;7.Bevacizumab;0.Paclitaxel;","14.Bevacizumab;0.Paclitaxel;7.Paclitaxel;7.Bevacizumab;0.Paclitaxel;"
"8","1.126.104.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Paclitaxel & Vinorelbine",TRUE,"Cont.","21.Paclitaxel;0.Vinorelbine;7.Vinorelbine;21.Paclitaxel;0.Vinorelbine;7.Vinorelbine;","21.Paclitaxel;0.Vinorelbine;7.Vinorelbine;"
"9","1.126.105.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"nab-Paclitaxel monotherapy",TRUE,"Cont.","14.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);7.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);7.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);14.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);7.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);7.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);","14.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);7.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);7.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);"
"10","1.126.105.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"nab-Paclitaxel monotherapy",TRUE,"Cont.","21.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);21.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);","21.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);"
"11","1.126.106.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Paclitaxel, nanoparticle albumin-bound & Bevacizumab",TRUE,"Cont.","14.Bevacizumab;0.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);7.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);7.Bevacizumab;0.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);14.Bevacizumab;0.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);7.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);7.Bevacizumab;0.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);","14.Bevacizumab;0.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);7.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);7.Bevacizumab;0.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);"
"12","1.126.106.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Paclitaxel, nanoparticle albumin-bound & Bevacizumab",TRUE,"Cont.","21.Bevacizumab;0.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);21.Bevacizumab;0.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);","21.Bevacizumab;0.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);"
"13","1.126.107.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Pemetrexed monotherapy",TRUE,"Cont.","21.Pemetrexted;21.Pemetrexted;","21.Pemetrexted;21.Pemetrexted;"
"14","1.126.107.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Pemetrexed monotherapy",TRUE,"Cont.","14.Pemetrexted;14.Pemetrexted;","14.Pemetrexted;14.Pemetrexted;"
"15","1.126.108.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"S-1 monotherapy",TRUE,"Cont.","15.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;15.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;","15.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;"
"16","1.126.109.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Capecitabine & Docetaxel (TX)",TRUE,"Cont.","8.Capecitabine;0.Docetaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Capecitabine;0.Docetaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Capecitabine;0.Docetaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"17","1.126.110.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Epirubicin & Vinorelbine (VE)",TRUE,"Cont.","14.Epirubicin;0.Vinorelbine;7.Vinorelbine;14.Epirubicin;0.Vinorelbine;7.Vinorelbine;","14.Epirubicin;0.Vinorelbine;7.Vinorelbine;"
"18","1.126.75.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Cyclophosphamide & Doxorubicin (AC)",FALSE,"6","21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;","21.Cyclophosphamide;0.Doxorubicin;"
"19","1.126.75.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Cyclophosphamide & Doxorubicin (AC)",FALSE,"6","28.Cyclophosphamide;0.Doxorubicin;28.Cyclophosphamide;0.Doxorubicin;","28.Cyclophosphamide;0.Doxorubicin;"
"20","1.126.75.3","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Cyclophosphamide & Doxorubicin (AC)",FALSE,"9","21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;","21.Cyclophosphamide;0.Doxorubicin;"
"21","1.126.75.4","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Cyclophosphamide & Doxorubicin (AC)",FALSE,"7","21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;","21.Cyclophosphamide;0.Doxorubicin;"
"22","1.126.75.5","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Cyclophosphamide & Doxorubicin (AC)",FALSE,"8","21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;","21.Cyclophosphamide;0.Doxorubicin;"
"23","1.126.75.6","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Cyclophosphamide & Doxorubicin (AC)",FALSE,"9","21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;","21.Cyclophosphamide;0.Doxorubicin;"
"24","1.126.76.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Cyclophosphamide & Doxorubicin (AC) & Bevacizumab",FALSE,"8","21.Bevacizumab;0.Cyclophosphamide;0.Doxorubicin;21.Bevacizumab;0.Cyclophosphamide;0.Doxorubicin;","21.Bevacizumab;0.Cyclophosphamide;0.Doxorubicin;"
"25","1.126.76.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Cyclophosphamide & Doxorubicin (AC) & Bevacizumab",FALSE,"4","21.Bevacizumab;0.Cyclophosphamide;0.Doxorubicin;21.Bevacizumab;0.Cyclophosphamide;0.Doxorubicin;","21.Bevacizumab;0.Cyclophosphamide;0.Doxorubicin;"
"26","1.126.77.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Capecitabine monotherapy",TRUE,"Cont.","1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","1.Capecitabine;1.Capecitabine;"
"27","1.126.77.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Capecitabine monotherapy",FALSE,"8","1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","1.Capecitabine;1.Capecitabine;"
"28","1.126.77.3","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Capecitabine monotherapy",TRUE,"Cont.","8.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"29","1.126.78.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Capecitabine & Bevacizumab",TRUE,"Cont.","8.Bevacizumab;0.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Bevacizumab;0.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Bevacizumab;0.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"30","1.126.79.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Capecitabine & Paclitaxel",TRUE,"Cont.","8.Capecitabine;0.Paclitaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Paclitaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Capecitabine;0.Paclitaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Paclitaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Capecitabine;0.Paclitaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Paclitaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"31","1.126.80.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Capecitabine & Paclitaxel, nanoparticle albumin-bound",TRUE,"Cont.","7.Capecitabine;0.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;7.Capecitabine;0.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","7.Capecitabine;0.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"32","1.126.81.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"CMF",TRUE,"Cont.","21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;","21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;"
"33","1.126.81.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"CMF",TRUE,"Cont.","15.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;15.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;","15.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;"
"34","1.126.82.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Docetaxel monotherapy",TRUE,"Cont.","14.Docetaxel;7.Docetaxel;7.Docetaxel;14.Docetaxel;7.Docetaxel;7.Docetaxel;","14.Docetaxel;7.Docetaxel;7.Docetaxel;"
"35","1.126.82.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Docetaxel monotherapy",TRUE,"Cont.","21.Docetaxel;7.Docetaxel;7.Docetaxel;7.Docetaxel;7.Docetaxel;7.Docetaxel;21.Docetaxel;7.Docetaxel;7.Docetaxel;7.Docetaxel;7.Docetaxel;7.Docetaxel;","21.Docetaxel;7.Docetaxel;7.Docetaxel;7.Docetaxel;7.Docetaxel;7.Docetaxel;"
"36","1.126.82.3","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Docetaxel monotherapy",TRUE,"Cont.","21.Docetaxel;21.Docetaxel;","21.Docetaxel;21.Docetaxel;"
"37","1.126.82.4","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Docetaxel monotherapy",TRUE,"Cont.","28.Docetaxel;28.Docetaxel;","28.Docetaxel;28.Docetaxel;"
"38","1.126.83.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Docetaxel & Bevacizumab",TRUE,"Cont.","21.Bevacizumab;0.Docetaxel;21.Bevacizumab;0.Docetaxel;","21.Bevacizumab;0.Docetaxel;"
"39","1.126.84.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Docetaxel & Doxorubicin (AT)",FALSE,"6","21.Docetaxel;0.Doxorubicin;21.Docetaxel;0.Doxorubicin;","21.Docetaxel;0.Doxorubicin;"
"40","1.126.84.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Docetaxel & Doxorubicin (AT)",FALSE,"8","21.Docetaxel;0.Doxorubicin;21.Docetaxel;0.Doxorubicin;","21.Docetaxel;0.Doxorubicin;"
"41","1.126.85.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Docetaxel & Epirubicin (DE)",FALSE,"8","21.Docetaxel;0.Epirubicin;21.Docetaxel;0.Epirubicin;","21.Docetaxel;0.Epirubicin;"
"42","1.126.85.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Docetaxel & Epirubicin (DE)",TRUE,"Cont.","21.Docetaxel;0.Epirubicin;21.Docetaxel;0.Epirubicin;","21.Docetaxel;0.Epirubicin;"
"43","1.126.86.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Docetaxel & Gemcitabine",TRUE,"Cont.","14.Doxorubicin;0.Gemcitabine;7.Gemcitabine;14.Doxorubicin;0.Gemcitabine;7.Gemcitabine;","14.Doxorubicin;0.Gemcitabine;7.Gemcitabine;"
"44","1.126.86.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Docetaxel & Gemcitabine",TRUE,"Cont.","14.Gemcitabine;7.Doxorubicin;0.Gemcitabine;14.Gemcitabine;7.Doxorubicin;0.Gemcitabine;","14.Gemcitabine;7.Doxorubicin;0.Gemcitabine;"
"45","1.126.87.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Doxorubicin monotherapy",TRUE,"Cont.","7.Doxorubicin;7.Doxorubicin;","7.Doxorubicin;7.Doxorubicin;"
"46","1.126.87.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Doxorubicin monotherapy",TRUE,"Cont.","21.Doxorubicin;21.Doxorubicin;","21.Doxorubicin;21.Doxorubicin;"
"47","1.126.87.3","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Doxorubicin monotherapy",FALSE,"7","21.Doxorubicin;21.Doxorubicin;","21.Doxorubicin;21.Doxorubicin;"
"48","1.126.88.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Doxorubicin & Paclitaxel (AT)",TRUE,"Cont.","21.Doxorubicin;0.Paclitaxel;21.Doxorubicin;0.Paclitaxel;","21.Doxorubicin;0.Paclitaxel;"
"49","1.126.88.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Doxorubicin & Paclitaxel (AT)",FALSE,"8","21.Doxorubicin;0.Paclitaxel;21.Doxorubicin;0.Paclitaxel;","21.Doxorubicin;0.Paclitaxel;"
"50","1.126.88.3","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Doxorubicin & Paclitaxel (AT)",FALSE,"8","20.Doxorubicin;1.Paclitaxel;20.Doxorubicin;1.Paclitaxel;","20.Doxorubicin;1.Paclitaxel;"
"51","1.126.88.4","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Doxorubicin & Paclitaxel (AT)",TRUE,"Cont.","20.Doxorubicin;0.Paclitaxel;1.Paclitaxel;20.Doxorubicin;0.Paclitaxel;1.Paclitaxel;","20.Doxorubicin;0.Paclitaxel;1.Paclitaxel;"
"52","1.126.89.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Pegylated liposomal doxorubicin monotherapy",FALSE,"6","28.Pegylatedliposomaldoxorubicin;28.Pegylatedliposomaldoxorubicin;","28.Pegylatedliposomaldoxorubicin;28.Pegylatedliposomaldoxorubicin;"
"53","1.126.89.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Pegylated liposomal doxorubicin monotherapy",TRUE,"Cont.","28.Pegylatedliposomaldoxorubicin;28.Pegylatedliposomaldoxorubicin;","28.Pegylatedliposomaldoxorubicin;28.Pegylatedliposomaldoxorubicin;"
"54","1.126.90.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Cyclophosphamide & Epirubicin (EC)",FALSE,"6","21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;","21.Cyclophosphamide;0.Epirubicin;"
"55","1.126.90.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Cyclophosphamide & Epirubicin (EC)",FALSE,"7","21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;","21.Cyclophosphamide;0.Epirubicin;"
"56","1.126.90.3","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Cyclophosphamide & Epirubicin (EC)",FALSE,"8","21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;","21.Cyclophosphamide;0.Epirubicin;"
"57","1.126.91.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Cyclophosphamide & Epirubicin (EC) & Bevacizumab",FALSE,"8","21.Bevacizumab;0.Cyclophosphamide;0.Epirubicin;21.Bevacizumab;0.Cyclophosphamide;0.Epirubicin;","21.Bevacizumab;0.Cyclophosphamide;0.Epirubicin;"
"58","1.126.92.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Epirubicin & Paclitaxel (EP)",TRUE,"Cont.","21.Epirubicin;0.Paclitaxel;21.Epirubicin;0.Paclitaxel;","21.Epirubicin;0.Paclitaxel;"
"59","1.126.93.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Epirubicin Monotherapy",TRUE,"Cont.","14.Epirubicin;7.Epirubicin;7.Epirubicin;14.Epirubicin;7.Epirubicin;7.Epirubicin;","14.Epirubicin;7.Epirubicin;7.Epirubicin;"
"60","1.126.93.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Epirubicin Monotherapy",TRUE,"Cont.","21.Epirubicin;21.Epirubicin;","21.Epirubicin;21.Epirubicin;"
"61","1.126.93.3","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Epirubicin Monotherapy",TRUE,"Cont.","14.Epirubicin;14.Epirubicin;","14.Epirubicin;14.Epirubicin;"
"62","1.126.93.4","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Epirubicin Monotherapy",TRUE,"Cont.","21.Epirubicin;7.Epirubicin;21.Epirubicin;7.Epirubicin;","21.Epirubicin;7.Epirubicin;"
"63","1.126.93.5","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Epirubicin Monotherapy",TRUE,"Cont.","20.Epirubicin;1.Epirubicin;20.Epirubicin;1.Epirubicin;","20.Epirubicin;1.Epirubicin;"
"64","1.126.94.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"FAC",FALSE,"6","21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;","21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;"
"65","1.126.94.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"FAC",FALSE,"7","21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;","21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;"
"66","1.126.94.3","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"FAC",FALSE,"8","21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;","21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;"
"67","1.126.94.4","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"FAC",TRUE,"Cont.","21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;","21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;"
"68","1.126.94.5","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"FAC",TRUE,"Cont.","14.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;7.Fluorouracil;14.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;7.Fluorouracil;","14.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;7.Fluorouracil;"
"69","1.126.94.6","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"FAC",TRUE,"Cont.","17.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;17.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","17.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"70","1.126.94.7","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"FAC",TRUE,"Cont.","18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;3.Fluorouracil;18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;3.Fluorouracil;","18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;3.Fluorouracil;"
"71","1.126.94.8","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"FAC",TRUE,"Cont.","15.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;15.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;","15.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;"
"72","1.126.95.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"FAC & Bevacizumab",TRUE,"Cont.","21.Bevacizumab;0.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Bevacizumab;0.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;","21.Bevacizumab;0.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;"
"73","1.126.96.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"FEC",TRUE,"Cont.","21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;","21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;"
"74","1.126.96.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"FEC",TRUE,"Cont.","28.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;28.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;","28.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;"
"75","1.126.96.3","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"FEC",TRUE,"Cont.","14.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;7.Fluorouracil;14.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;7.Fluorouracil;","14.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;7.Fluorouracil;"
"76","1.126.96.4","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"FEC",TRUE,"Cont.","15.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;15.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;","15.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;"
"77","1.126.96.5","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"FEC",TRUE,"Cont.","21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;7.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;7.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;","21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;7.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;"
"78","1.126.97.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"FEC & Bevacizumab",TRUE,"Cont.","21.Bevacizumab;0.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Bevacizumab;0.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;","21.Bevacizumab;0.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;"
"79","1.126.98.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Gemcitabine monotherapy",TRUE,"Cont.","14.Gemcitabine;7.Gemcitabine;7.Gemcitabine;14.Gemcitabine;7.Gemcitabine;7.Gemcitabine;","14.Gemcitabine;7.Gemcitabine;7.Gemcitabine;"
"80","1.126.99.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Gemcitabine & Paclitaxel",FALSE,"6","14.Gemcitabine;0.Paclitaxel;7.Gemcitabine;14.Gemcitabine;0.Paclitaxel;7.Gemcitabine;","14.Gemcitabine;0.Paclitaxel;7.Gemcitabine;"
"81","1.126.99.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, first-line chemotherapy",126,"Gemcitabine & Paclitaxel",TRUE,"Cont.","14.Gemcitabine;0.Paclitaxel;7.Gemcitabine;14.Gemcitabine;0.Paclitaxel;7.Gemcitabine;","14.Gemcitabine;0.Paclitaxel;7.Gemcitabine;"
"82","1.129.111.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, maintenance after first-line therapy",129,"Bevacizumab monotherapy",TRUE,"Cont.","21.Bevacizumab;21.Bevacizumab;","21.Bevacizumab;21.Bevacizumab;"
"83","1.129.112.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, maintenance after first-line therapy",129,"Capecitabine & Bevacizumab",TRUE,"Cont.","8.Bevacizumab;0.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Bevacizumab;0.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Bevacizumab;0.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"84","1.129.113.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, maintenance after first-line therapy",129,"Gemcitabine & Paclitaxel",TRUE,"Cont.","14.Gemcitabine;0.Paclitaxel;7.Gemcitabine;14.Gemcitabine;0.Paclitaxel;7.Gemcitabine;","14.Gemcitabine;0.Paclitaxel;7.Gemcitabine;"
"85","1.132.114.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, subsequent lines of chemotherapy",132,"Capecitabine monotherapy",TRUE,"Cont.","8.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"86","1.132.115.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, subsequent lines of chemotherapy",132,"Capecitabine & Bevacizumab",TRUE,"Cont.","8.Bevacizumab;0.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Bevacizumab;0.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Bevacizumab;0.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"87","1.132.116.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, subsequent lines of chemotherapy",132,"Capecitabine & Docetaxel (TX)",TRUE,"Cont.","8.Capecitabine;0.Docetaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Capecitabine;0.Docetaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Capecitabine;0.Docetaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"88","1.132.117.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, subsequent lines of chemotherapy",132,"Capecitabine & Ixabepilone",TRUE,"Cont.","8.Capecitabine;0.Ixabepilone;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Capecitabine;0.Ixabepilone;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Capecitabine;0.Ixabepilone;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"89","1.132.118.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, subsequent lines of chemotherapy",132,"Capecitabine & Vinflunine",TRUE,"Cont.","8.Capecitabine;0.Vinflunine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Capecitabine;0.Vinflunine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Capecitabine;0.Vinflunine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"90","1.132.119.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, subsequent lines of chemotherapy",132,"Carboplatin & Gemcitabine (GCb)",TRUE,"Cont.","14.Carboplatin;0.Gemcitabine;7.Carboplatin;0.Gemcitabine;14.Carboplatin;0.Gemcitabine;7.Carboplatin;0.Gemcitabine;","14.Carboplatin;0.Gemcitabine;7.Carboplatin;0.Gemcitabine;"
"91","1.132.120.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, subsequent lines of chemotherapy",132,"Cisplatin & Vinorelbine (CVb)",TRUE,"Cont.","14.Cisplatin;0.Vinorelbine;7.Vinorelbine;14.Cisplatin;0.Vinorelbine;7.Vinorelbine;","14.Cisplatin;0.Vinorelbine;7.Vinorelbine;"
"92","1.132.121.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, subsequent lines of chemotherapy",132,"Cyclophosphamide & Methotrexate (CM)",TRUE,"Cont.","1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;","1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;"
"93","1.132.121.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, subsequent lines of chemotherapy",132,"Cyclophosphamide & Methotrexate (CM)",TRUE,"Cont.","1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;","1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;"
"94","1.132.122.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, subsequent lines of chemotherapy",132,"Cyclophosphamide monotherapy",TRUE,"Cont.","14.Cyclophosphamide;14.Cyclophosphamide;","14.Cyclophosphamide;14.Cyclophosphamide;"
"95","1.132.123.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, subsequent lines of chemotherapy",132,"Docetaxel monotherapy",TRUE,"Cont.","14.Docetaxel;7.Docetaxel;7.Docetaxel;14.Docetaxel;7.Docetaxel;7.Docetaxel;","14.Docetaxel;7.Docetaxel;7.Docetaxel;"
"96","1.132.123.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, subsequent lines of chemotherapy",132,"Docetaxel monotherapy",TRUE,"Cont.","21.Docetaxel;7.Docetaxel;7.Docetaxel;7.Docetaxel;7.Docetaxel;7.Docetaxel;21.Docetaxel;7.Docetaxel;7.Docetaxel;7.Docetaxel;7.Docetaxel;7.Docetaxel;","21.Docetaxel;7.Docetaxel;7.Docetaxel;7.Docetaxel;7.Docetaxel;7.Docetaxel;"
"97","1.132.123.3","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, subsequent lines of chemotherapy",132,"Docetaxel monotherapy",TRUE,"Cont.","21.Docetaxel;21.Docetaxel;","21.Docetaxel;21.Docetaxel;"
"98","1.132.124.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, subsequent lines of chemotherapy",132,"Docetaxel & Bevacizumab",TRUE,"Cont.","21.Bevacizumab;0.Docetaxel;21.Bevacizumab;0.Docetaxel;","21.Bevacizumab;0.Docetaxel;"
"99","1.132.125.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, subsequent lines of chemotherapy",132,"Docetaxel & Gemcitabine",FALSE,"8","14.Gemcitabine;7.Docetaxel;0.Gemcitabine;14.Gemcitabine;7.Docetaxel;0.Gemcitabine;","14.Gemcitabine;7.Docetaxel;0.Gemcitabine;"
"100","1.132.126.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, subsequent lines of chemotherapy",132,"Doxorubicin monotherapy",TRUE,"Cont.","7.Doxorubicin;7.Doxorubicin;","7.Doxorubicin;7.Doxorubicin;"
"101","1.132.126.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, subsequent lines of chemotherapy",132,"Doxorubicin monotherapy",TRUE,"Cont.","21.Doxorubicin;21.Doxorubicin;","21.Doxorubicin;21.Doxorubicin;"
"102","1.132.127.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, subsequent lines of chemotherapy",132,"Doxorubicin & Bevacizumab",TRUE,"Cont.","7.Bevacizumab;0.Doxorubicin;7.Doxorubicin;7.Bevacizumab;0.Doxorubicin;7.Doxorubicin;7.Bevacizumab;0.Doxorubicin;7.Doxorubicin;7.Bevacizumab;0.Doxorubicin;7.Doxorubicin;","7.Bevacizumab;0.Doxorubicin;7.Doxorubicin;"
"103","1.132.127.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, subsequent lines of chemotherapy",132,"Doxorubicin & Bevacizumab",TRUE,"Cont.","21.Bevacizumab;0.Doxorubicin;21.Bevacizumab;0.Doxorubicin;","21.Bevacizumab;0.Doxorubicin;"
"104","1.132.128.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, subsequent lines of chemotherapy",132,"Eribulin monotherapy",TRUE,"Cont.","14.Eribulin;7.Eribulin;14.Eribulin;7.Eribulin;","14.Eribulin;7.Eribulin;"
"105","1.132.129.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, subsequent lines of chemotherapy",132,"Gemcitabine monotherapy",TRUE,"Cont.","14.Gemcitabine;7.Gemcitabine;7.Gemcitabine;14.Gemcitabine;7.Gemcitabine;7.Gemcitabine;","14.Gemcitabine;7.Gemcitabine;7.Gemcitabine;"
"106","1.132.129.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, subsequent lines of chemotherapy",132,"Gemcitabine monotherapy",TRUE,"Cont.","14.Gemcitabine;7.Gemcitabine;14.Gemcitabine;7.Gemcitabine;","14.Gemcitabine;7.Gemcitabine;"
"107","1.132.130.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, subsequent lines of chemotherapy",132,"Gemcitabine & Bevacizumab",TRUE,"Cont.","14.Bevacizumab;0.Gemcitabine;7.Gemcitabine;7.Bevacizumab;0.Gemcitabine;14.Bevacizumab;0.Gemcitabine;7.Gemcitabine;7.Bevacizumab;0.Gemcitabine;","14.Bevacizumab;0.Gemcitabine;7.Gemcitabine;7.Bevacizumab;0.Gemcitabine;"
"108","1.132.130.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, subsequent lines of chemotherapy",132,"Gemcitabine & Bevacizumab",TRUE,"Cont.","14.Bevacizumab;0.Gemcitabine;7.Gemcitabine;14.Bevacizumab;0.Gemcitabine;7.Gemcitabine;","14.Bevacizumab;0.Gemcitabine;7.Gemcitabine;"
"109","1.132.131.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, subsequent lines of chemotherapy",132,"Ixabepilone monotherapy",TRUE,"Cont.","21.Ixabepilone;21.Ixabepilone;","21.Ixabepilone;21.Ixabepilone;"
"110","1.132.132.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, subsequent lines of chemotherapy",132,"Non-pegylated liposomal doxorubicin monotherapy",TRUE,"Cont.","21.Non-pegylatedliposomaldoxorubicin;21.Non-pegylatedliposomaldoxorubicin;","21.Non-pegylatedliposomaldoxorubicin;21.Non-pegylatedliposomaldoxorubicin;"
"111","1.132.133.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, subsequent lines of chemotherapy",132,"Non-pegylated liposomal doxorubicin & Bevacizumab",TRUE,"Cont.","21.Bevacizumab;0.Non-pegylatedliposomaldoxorubicin;21.Bevacizumab;0.Non-pegylatedliposomaldoxorubicin;","21.Bevacizumab;0.Non-pegylatedliposomaldoxorubicin;"
"112","1.132.134.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, subsequent lines of chemotherapy",132,"Paclitaxel monotherapy, weekly",TRUE,"Cont.","7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;","7.Paclitaxel;7.Paclitaxel;"
"113","1.132.134.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, subsequent lines of chemotherapy",132,"Paclitaxel monotherapy, weekly",TRUE,"Cont.","14.Paclitaxel;7.Paclitaxel;7.Paclitaxel;14.Paclitaxel;7.Paclitaxel;7.Paclitaxel;","14.Paclitaxel;7.Paclitaxel;7.Paclitaxel;"
"114","1.132.135.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, subsequent lines of chemotherapy",132,"Paclitaxel monotherapy, q3wk",TRUE,"Cont.","21.Paclitaxel;21.Paclitaxel;","21.Paclitaxel;21.Paclitaxel;"
"115","1.132.136.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, subsequent lines of chemotherapy",132,"Paclitaxel & Bevacizumab",TRUE,"Cont.","14.Bevacizumab;0.Paclitaxel;7.Paclitaxel;7.Bevacizumab;0.Paclitaxel;14.Bevacizumab;0.Paclitaxel;7.Paclitaxel;7.Bevacizumab;0.Paclitaxel;","14.Bevacizumab;0.Paclitaxel;7.Paclitaxel;7.Bevacizumab;0.Paclitaxel;"
"116","1.132.136.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, subsequent lines of chemotherapy",132,"Paclitaxel & Bevacizumab",TRUE,"Cont.","21.Bevacizumab;0.Paclitaxel;21.Bevacizumab;0.Paclitaxel;","21.Bevacizumab;0.Paclitaxel;"
"117","1.132.137.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, subsequent lines of chemotherapy",132,"nab-Paclitaxel monotherapy",TRUE,"Cont.","14.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);7.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);7.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);14.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);7.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);7.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);","14.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);7.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);7.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);"
"118","1.132.137.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, subsequent lines of chemotherapy",132,"nab-Paclitaxel monotherapy",TRUE,"Cont.","21.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);21.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);","21.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);"
"119","1.132.138.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, subsequent lines of chemotherapy",132,"Paclitaxel, nanoparticle albumin-bound & Bevacizumab",TRUE,"Cont.","7.Bevacizumab;0.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);7.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);7.Bevacizumab;0.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);7.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);7.Bevacizumab;0.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);7.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);7.Bevacizumab;0.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);7.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);","7.Bevacizumab;0.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);7.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);"
"120","1.132.138.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, subsequent lines of chemotherapy",132,"Paclitaxel, nanoparticle albumin-bound & Bevacizumab",TRUE,"Cont.","21.Bevacizumab;0.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);21.Bevacizumab;0.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);","21.Bevacizumab;0.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);"
"121","1.132.139.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, subsequent lines of chemotherapy",132,"Pegylated liposomal doxorubicin monotherapy",TRUE,"Cont.","28.Pegylatedliposomaldoxorubicin;28.Pegylatedliposomaldoxorubicin;","28.Pegylatedliposomaldoxorubicin;28.Pegylatedliposomaldoxorubicin;"
"122","1.132.140.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, subsequent lines of chemotherapy",132,"Pegylated liposomal doxorubicin & Bevacizumab",TRUE,"Cont.","14.Bevacizumab;0.Pegylatedliposomaldoxorubicin;14.Bevacizumab;14.Bevacizumab;0.Pegylatedliposomaldoxorubicin;14.Bevacizumab;","14.Bevacizumab;0.Pegylatedliposomaldoxorubicin;14.Bevacizumab;"
"123","1.132.141.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, subsequent lines of chemotherapy",132,"Trastuzumab deruxtecan monotherapy",TRUE,"Cont.","21.Trastuzumab;21.Trastuzumab;","21.Trastuzumab;21.Trastuzumab;"
"124","1.132.142.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, subsequent lines of chemotherapy",132,"Vinorelbine monotherapy",TRUE,"Cont.","7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;","7.Vinorelbine;7.Vinorelbine;"
"125","1.132.142.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, subsequent lines of chemotherapy",132,"Vinorelbine monotherapy",TRUE,"Cont.","21.Vinorelbine;21.Vinorelbine;","21.Vinorelbine;21.Vinorelbine;"
"126","1.132.142.3","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, subsequent lines of chemotherapy",132,"Vinorelbine monotherapy",TRUE,"Cont.","14.Vinorelbine;7.Vinorelbine;14.Vinorelbine;7.Vinorelbine;","14.Vinorelbine;7.Vinorelbine;"
"127","1.132.143.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, subsequent lines of chemotherapy",132,"Vinorelbine & Bevacizumab",TRUE,"Cont.","7.Bevacizumab;0.Vinorelbine;7.Vinorelbine;7.Bevacizumab;0.Vinorelbine;7.Vinorelbine;","7.Bevacizumab;0.Vinorelbine;7.Vinorelbine;"
"128","1.132.143.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Metastatic disease, subsequent lines of chemotherapy",132,"Vinorelbine & Bevacizumab",TRUE,"Cont.","21.Bevacizumab;0.Vinorelbine;21.Bevacizumab;0.Vinorelbine;","21.Bevacizumab;0.Vinorelbine;"
"129","1.147.16.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Neoadjuvant chemotherapy",147,"Capecitabine & Docetaxel (TX)",FALSE,"4","8.Capecitabine;0.Docetaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Capecitabine;0.Docetaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Capecitabine;0.Docetaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"130","1.147.17.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Neoadjuvant chemotherapy",147,"Cyclophosphamide & Doxorubicin (AC)",FALSE,"4","21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;","21.Cyclophosphamide;0.Doxorubicin;"
"131","1.147.17.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Neoadjuvant chemotherapy",147,"Cyclophosphamide & Doxorubicin (AC)",FALSE,"6","21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;","21.Cyclophosphamide;0.Doxorubicin;"
"132","1.147.18.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Neoadjuvant chemotherapy",147,"Dose-dense Cyclophosphamide & Doxorubicin (ddAC)",FALSE,"4","14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;","14.Cyclophosphamide;0.Doxorubicin;"
"133","1.147.19.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Neoadjuvant chemotherapy",147,"DI EC",FALSE,"4","21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;","21.Cyclophosphamide;0.Epirubicin;"
"134","1.147.20.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Neoadjuvant chemotherapy",147,"Docetaxel & Epirubicin (DE)",FALSE,"3","21.Docetaxel;0.Epirubicin;21.Docetaxel;0.Epirubicin;","21.Docetaxel;0.Epirubicin;"
"135","1.147.20.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Neoadjuvant chemotherapy",147,"Docetaxel & Epirubicin (DE)",FALSE,"6","21.Docetaxel;0.Epirubicin;21.Docetaxel;0.Epirubicin;","21.Docetaxel;0.Epirubicin;"
"136","1.147.21.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Neoadjuvant chemotherapy",147,"EDC",FALSE,"6","8.Capecitabine;0.Docetaxel;0.Epirubicin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Capecitabine;0.Docetaxel;0.Epirubicin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Capecitabine;0.Docetaxel;0.Epirubicin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"137","1.147.22.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Neoadjuvant chemotherapy",147,"Epirubicin monotherapy",FALSE,"3","20.Epirubicin;1.Epirubicin;20.Epirubicin;1.Epirubicin;","20.Epirubicin;1.Epirubicin;"
"138","1.147.22.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Neoadjuvant chemotherapy",147,"Epirubicin monotherapy",FALSE,"4","20.Epirubicin;1.Epirubicin;20.Epirubicin;1.Epirubicin;","20.Epirubicin;1.Epirubicin;"
"139","1.147.23.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Neoadjuvant chemotherapy",147,"Epirubicin & Paclitaxel (EP)",FALSE,"4","21.Epirubicin;0.Paclitaxel;21.Epirubicin;0.Paclitaxel;","21.Epirubicin;0.Paclitaxel;"
"140","1.147.24.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Neoadjuvant chemotherapy",147,"FAC",FALSE,"4","21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;","21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;"
"141","1.147.24.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Neoadjuvant chemotherapy",147,"FAC",FALSE,"3","21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;","21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;"
"142","1.147.24.3","Solid Tumor","Breast Oncology","Breast cancer",1,"Neoadjuvant chemotherapy",147,"FAC",FALSE,"4","18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;3.Fluorouracil;18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;3.Fluorouracil;","18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;3.Fluorouracil;"
"143","1.147.24.4","Solid Tumor","Breast Oncology","Breast cancer",1,"Neoadjuvant chemotherapy",147,"FAC",FALSE,"4","21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;2.Fluorouracil;2.Cyclophosphamide;0.Fluorouracil;3.Doxorubicin;0.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;2.Fluorouracil;2.Cyclophosphamide;0.Fluorouracil;3.Doxorubicin;0.Fluorouracil;","21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;2.Fluorouracil;2.Cyclophosphamide;0.Fluorouracil;3.Doxorubicin;0.Fluorouracil;"
"144","1.147.24.5","Solid Tumor","Breast Oncology","Breast cancer",1,"Neoadjuvant chemotherapy",147,"FAC",FALSE,"4","18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Doxorubicin;1.Doxorubicin;1.Doxorubicin;0.Fluorouracil;18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Doxorubicin;1.Doxorubicin;1.Doxorubicin;0.Fluorouracil;","18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Doxorubicin;1.Doxorubicin;1.Doxorubicin;0.Fluorouracil;"
"145","1.147.25.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Neoadjuvant chemotherapy",147,"FEC",FALSE,"3","21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;","21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;"
"146","1.147.25.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Neoadjuvant chemotherapy",147,"FEC",FALSE,"4","21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;","21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;"
"147","1.147.25.3","Solid Tumor","Breast Oncology","Breast cancer",1,"Neoadjuvant chemotherapy",147,"FEC",FALSE,"6","15.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;15.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;","15.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;"
"148","1.147.26.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Neoadjuvant chemotherapy",147,"iddEPC",NA,NA,"0.Epirubicin;14.Epirubicin;14.Epirubicin;14.Paclitaxel;14.Paclitaxel;14.Paclitaxel;14.Cyclophosphamide;14.Cyclophosphamide;14.Cyclophosphamide;","0.Epirubicin;14.Epirubicin;14.Epirubicin;14.Paclitaxel;14.Paclitaxel;14.Paclitaxel;14.Cyclophosphamide;14.Cyclophosphamide;14.Cyclophosphamide;"
"149","1.147.27.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Neoadjuvant chemotherapy",147,"Paclitaxel monotherapy, dose-dense (q2wk)",FALSE,"4","14.Paclitaxel;14.Paclitaxel;","14.Paclitaxel;14.Paclitaxel;"
"150","1.147.28.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Neoadjuvant chemotherapy",147,"PET",FALSE,"4","7.Cisplatin;0.Epirubicin;0.Paclitaxel;7.Cisplatin;0.Epirubicin;0.Paclitaxel;7.Cisplatin;0.Epirubicin;0.Paclitaxel;7.Cisplatin;0.Epirubicin;0.Paclitaxel;7.Cisplatin;0.Epirubicin;0.Paclitaxel;7.Cisplatin;0.Epirubicin;0.Paclitaxel;","7.Cisplatin;0.Epirubicin;0.Paclitaxel;"
"151","1.147.29.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Neoadjuvant chemotherapy",147,"TAC",FALSE,"6","21.Cyclophosphamide;0.Docetaxel;0.Doxorubicin;21.Cyclophosphamide;0.Docetaxel;0.Doxorubicin;","21.Cyclophosphamide;0.Docetaxel;0.Doxorubicin;"
"152","1.148.1.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Neoadjuvant chemotherapy, sequential protocols",148,"AC-D",FALSE,"8","21.Cyclophosphamide;0.Docetaxel;0.Doxorubicin;21.Cyclophosphamide;0.Docetaxel;0.Doxorubicin;","21.Cyclophosphamide;0.Docetaxel;0.Doxorubicin;"
"153","1.148.10.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Neoadjuvant chemotherapy, sequential protocols",148,"nab-Paclitaxel-EC",NA,NA,"0.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);21.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);21.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);21.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;","0.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);21.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);21.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);21.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;"
"154","1.148.11.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Neoadjuvant chemotherapy, sequential protocols",148,"T-AC",NA,NA,"0.Paclitaxel;28.Paclitaxel;28.Paclitaxel;28.Paclitaxel;28.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;","0.Paclitaxel;28.Paclitaxel;28.Paclitaxel;28.Paclitaxel;28.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;"
"155","1.148.12.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Neoadjuvant chemotherapy, sequential protocols",148,"T-EC",NA,NA,"0.Paclitaxel;21.Paclitaxel;21.Paclitaxel;21.Paclitaxel;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;","0.Paclitaxel;21.Paclitaxel;21.Paclitaxel;21.Paclitaxel;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;"
"156","1.148.13.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Neoadjuvant chemotherapy, sequential protocols",148,"ddT-EC",NA,NA,"0.Paclitaxel;14.Paclitaxel;14.Paclitaxel;14.Paclitaxel;14.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;","0.Paclitaxel;14.Paclitaxel;14.Paclitaxel;14.Paclitaxel;14.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;"
"157","1.148.14.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Neoadjuvant chemotherapy, sequential protocols",148,"T-FAC",NA,NA,"0.Paclitaxel;21.Paclitaxel;21.Paclitaxel;21.Paclitaxel;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;3.Fluorouracil;18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;3.Fluorouracil;18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;3.Fluorouracil;18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;3.Fluorouracil;","0.Paclitaxel;21.Paclitaxel;21.Paclitaxel;21.Paclitaxel;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;3.Fluorouracil;18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;3.Fluorouracil;18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;3.Fluorouracil;18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;3.Fluorouracil;"
"158","1.148.14.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Neoadjuvant chemotherapy, sequential protocols",148,"T-FAC",NA,NA,"0.Paclitaxel;28.Paclitaxel;28.Paclitaxel;28.Paclitaxel;28.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;3.Fluorouracil;18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;3.Fluorouracil;18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;3.Fluorouracil;18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;3.Fluorouracil;","0.Paclitaxel;28.Paclitaxel;28.Paclitaxel;28.Paclitaxel;28.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;3.Fluorouracil;18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;3.Fluorouracil;18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;3.Fluorouracil;18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;3.Fluorouracil;"
"159","1.148.14.3","Solid Tumor","Breast Oncology","Breast cancer",1,"Neoadjuvant chemotherapy, sequential protocols",148,"T-FAC",NA,NA,"0.Paclitaxel;21.Paclitaxel;21.Paclitaxel;21.Paclitaxel;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;3.Fluorouracil;18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;3.Fluorouracil;18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;3.Fluorouracil;18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;3.Fluorouracil;","0.Paclitaxel;21.Paclitaxel;21.Paclitaxel;21.Paclitaxel;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;3.Fluorouracil;18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;3.Fluorouracil;18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;3.Fluorouracil;18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;3.Fluorouracil;"
"160","1.148.14.4","Solid Tumor","Breast Oncology","Breast cancer",1,"Neoadjuvant chemotherapy, sequential protocols",148,"T-FAC",NA,NA,"0.Paclitaxel;21.Paclitaxel;21.Paclitaxel;21.Paclitaxel;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Doxorubicin;1.Doxorubicin;1.Doxorubicin;0.Fluorouracil;18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Doxorubicin;1.Doxorubicin;1.Doxorubicin;0.Fluorouracil;18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Doxorubicin;1.Doxorubicin;1.Doxorubicin;0.Fluorouracil;18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Doxorubicin;1.Doxorubicin;1.Doxorubicin;0.Fluorouracil;","0.Paclitaxel;21.Paclitaxel;21.Paclitaxel;21.Paclitaxel;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Doxorubicin;1.Doxorubicin;1.Doxorubicin;0.Fluorouracil;18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Doxorubicin;1.Doxorubicin;1.Doxorubicin;0.Fluorouracil;18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Doxorubicin;1.Doxorubicin;1.Doxorubicin;0.Fluorouracil;18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Doxorubicin;1.Doxorubicin;1.Doxorubicin;0.Fluorouracil;"
"161","1.148.14.5","Solid Tumor","Breast Oncology","Breast cancer",1,"Neoadjuvant chemotherapy, sequential protocols",148,"T-FAC",NA,NA,"0.Paclitaxel;28.Paclitaxel;28.Paclitaxel;28.Paclitaxel;28.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Doxorubicin;1.Doxorubicin;1.Doxorubicin;0.Fluorouracil;18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Doxorubicin;1.Doxorubicin;1.Doxorubicin;0.Fluorouracil;18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Doxorubicin;1.Doxorubicin;1.Doxorubicin;0.Fluorouracil;18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Doxorubicin;1.Doxorubicin;1.Doxorubicin;0.Fluorouracil;","0.Paclitaxel;28.Paclitaxel;28.Paclitaxel;28.Paclitaxel;28.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Doxorubicin;1.Doxorubicin;1.Doxorubicin;0.Fluorouracil;18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Doxorubicin;1.Doxorubicin;1.Doxorubicin;0.Fluorouracil;18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Doxorubicin;1.Doxorubicin;1.Doxorubicin;0.Fluorouracil;18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Doxorubicin;1.Doxorubicin;1.Doxorubicin;0.Fluorouracil;"
"162","1.148.14.6","Solid Tumor","Breast Oncology","Breast cancer",1,"Neoadjuvant chemotherapy, sequential protocols",148,"T-FAC",NA,NA,"0.Paclitaxel;21.Paclitaxel;21.Paclitaxel;21.Paclitaxel;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Doxorubicin;1.Doxorubicin;1.Doxorubicin;0.Fluorouracil;18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Doxorubicin;1.Doxorubicin;1.Doxorubicin;0.Fluorouracil;18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Doxorubicin;1.Doxorubicin;1.Doxorubicin;0.Fluorouracil;18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Doxorubicin;1.Doxorubicin;1.Doxorubicin;0.Fluorouracil;","0.Paclitaxel;21.Paclitaxel;21.Paclitaxel;21.Paclitaxel;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Doxorubicin;1.Doxorubicin;1.Doxorubicin;0.Fluorouracil;18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Doxorubicin;1.Doxorubicin;1.Doxorubicin;0.Fluorouracil;18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Doxorubicin;1.Doxorubicin;1.Doxorubicin;0.Fluorouracil;18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Doxorubicin;1.Doxorubicin;1.Doxorubicin;0.Fluorouracil;"
"163","1.148.15.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Neoadjuvant chemotherapy, sequential protocols",148,"T-FEC",NA,NA,"0.Paclitaxel;21.Paclitaxel;21.Paclitaxel;21.Paclitaxel;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;","0.Paclitaxel;21.Paclitaxel;21.Paclitaxel;21.Paclitaxel;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;"
"164","1.148.15.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Neoadjuvant chemotherapy, sequential protocols",148,"T-FEC",NA,NA,"0.Paclitaxel;28.Paclitaxel;28.Paclitaxel;28.Paclitaxel;28.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;","0.Paclitaxel;28.Paclitaxel;28.Paclitaxel;28.Paclitaxel;28.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;"
"165","1.148.2.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Neoadjuvant chemotherapy, sequential protocols",148,"AC-T",FALSE,"9","7.Cyclophosphamide;0.Doxorubicin;0.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Cyclophosphamide;0.Doxorubicin;0.Paclitaxel;7.Paclitaxel;7.Paclitaxel;","7.Cyclophosphamide;0.Doxorubicin;0.Paclitaxel;7.Paclitaxel;7.Paclitaxel;"
"166","1.148.3.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Neoadjuvant chemotherapy, sequential protocols",148,"D-AC",FALSE,"8","21.Cyclophosphamide;0.Docetaxel;0.Doxorubicin;21.Cyclophosphamide;0.Docetaxel;0.Doxorubicin;","21.Cyclophosphamide;0.Docetaxel;0.Doxorubicin;"
"167","1.148.4.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Neoadjuvant chemotherapy, sequential protocols",148,"D-AC+Bev",NA,NA,"0.Bevacizumab;0.Docetaxel;21.Bevacizumab;0.Docetaxel;21.Bevacizumab;0.Docetaxel;21.Bevacizumab;0.Docetaxel;21.Bevacizumab;0.Cyclophosphamide;0.Doxorubicin;21.Bevacizumab;0.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;","0.Bevacizumab;0.Docetaxel;21.Bevacizumab;0.Docetaxel;21.Bevacizumab;0.Docetaxel;21.Bevacizumab;0.Docetaxel;21.Bevacizumab;0.Cyclophosphamide;0.Doxorubicin;21.Bevacizumab;0.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;"
"168","1.148.5.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Neoadjuvant chemotherapy, sequential protocols",148,"D-FEC",NA,NA,"0.Docetaxel;21.Docetaxel;21.Docetaxel;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;","0.Docetaxel;21.Docetaxel;21.Docetaxel;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;"
"169","1.148.6.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Neoadjuvant chemotherapy, sequential protocols",148,"D-FEC+Bev",NA,NA,"0.Bevacizumab;0.Docetaxel;21.Bevacizumab;0.Docetaxel;21.Bevacizumab;0.Docetaxel;21.Bevacizumab;0.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;","0.Bevacizumab;0.Docetaxel;21.Bevacizumab;0.Docetaxel;21.Bevacizumab;0.Docetaxel;21.Bevacizumab;0.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;"
"170","1.148.7.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Neoadjuvant chemotherapy, sequential protocols",148,"EC-D",NA,NA,"0.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Docetaxel;21.Docetaxel;21.Docetaxel;21.Docetaxel;","0.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Docetaxel;21.Docetaxel;21.Docetaxel;21.Docetaxel;"
"171","1.148.8.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Neoadjuvant chemotherapy, sequential protocols",148,"EC-T",NA,NA,"0.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Paclitaxel;21.Paclitaxel;21.Paclitaxel;21.Paclitaxel;","0.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Paclitaxel;21.Paclitaxel;21.Paclitaxel;21.Paclitaxel;"
"172","1.148.9.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Neoadjuvant chemotherapy, sequential protocols",148,"EC-ddT",NA,NA,"0.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Paclitaxel;14.Paclitaxel;14.Paclitaxel;14.Paclitaxel;","0.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Paclitaxel;14.Paclitaxel;14.Paclitaxel;14.Paclitaxel;"
"173","1.2.48.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"Bevacizumab monotherapy",FALSE,"10","21.Bevacizumab;21.Bevacizumab;","21.Bevacizumab;21.Bevacizumab;"
"174","1.2.49.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"Capecitabine monotherapy",FALSE,"4","8.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"175","1.2.49.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"Capecitabine monotherapy",FALSE,"6","8.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"176","1.2.49.3","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"Capecitabine monotherapy",FALSE,"7","8.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"177","1.2.49.4","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"Capecitabine monotherapy",FALSE,"8","8.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"178","1.2.50.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"CMF",FALSE,"6","21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;","21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;"
"179","1.2.50.10","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"CMF",FALSE,"4","21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;7.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;7.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;","21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;7.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;"
"180","1.2.50.11","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"CMF",FALSE,"6","15.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;15.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;","15.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;"
"181","1.2.50.12","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"CMF",FALSE,"3","15.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;15.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;","15.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;"
"182","1.2.50.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"CMF",FALSE,"8","28.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;28.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;","28.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;"
"183","1.2.50.3","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"CMF",FALSE,"24","15.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;15.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;","15.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;"
"184","1.2.50.4","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"CMF",FALSE,"6","21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;","21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;"
"185","1.2.50.5","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"CMF",FALSE,"7","21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;","21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;"
"186","1.2.50.6","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"CMF",FALSE,"8","21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;","21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;"
"187","1.2.50.7","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"CMF",FALSE,"12","15.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;15.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;","15.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;"
"188","1.2.50.8","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"CMF",FALSE,"6","21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;7.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;7.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;","21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;7.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;"
"189","1.2.50.9","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"CMF",FALSE,"3","21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;7.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;7.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;","21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;7.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;"
"190","1.2.51.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"CMFT",FALSE,"26","1.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;","1.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;"
"191","1.2.51.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"CMFT",FALSE,"12","1.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;","1.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Cyclophosphamide;0.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;"
"192","1.2.52.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"Dose-dense Cyclophosphamide monotherapy",FALSE,"4","14.Cyclophosphamide;14.Cyclophosphamide;","14.Cyclophosphamide;14.Cyclophosphamide;"
"193","1.2.53.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"Cyclophosphamide & Docetaxel (TC)",FALSE,"4","21.Cyclophosphamide;0.Docetaxel;21.Cyclophosphamide;0.Docetaxel;","21.Cyclophosphamide;0.Docetaxel;"
"194","1.2.53.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"Cyclophosphamide & Docetaxel (TC)",FALSE,"6","21.Cyclophosphamide;0.Docetaxel;21.Cyclophosphamide;0.Docetaxel;","21.Cyclophosphamide;0.Docetaxel;"
"195","1.2.54.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"Cyclophosphamide & Doxorubicin (AC)",FALSE,"6","21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;","21.Cyclophosphamide;0.Doxorubicin;"
"196","1.2.54.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"Cyclophosphamide & Doxorubicin (AC)",FALSE,"4","21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;","21.Cyclophosphamide;0.Doxorubicin;"
"197","1.2.55.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"Dose-dense Cyclophosphamide & Doxorubicin (ddAC)",FALSE,"4","14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;","14.Cyclophosphamide;0.Doxorubicin;"
"198","1.2.55.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"Dose-dense Cyclophosphamide & Doxorubicin (ddAC)",FALSE,"6","14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;","14.Cyclophosphamide;0.Doxorubicin;"
"199","1.2.56.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"Cyclophosphamide & Epirubicin (EC)",FALSE,"8","21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;","21.Cyclophosphamide;0.Epirubicin;"
"200","1.2.56.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"Cyclophosphamide & Epirubicin (EC)",FALSE,"4","21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;","21.Cyclophosphamide;0.Epirubicin;"
"201","1.2.57.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"Dose-dense Cyclophosphamide & Epirubicin (ddEC)",FALSE,"4","14.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;","14.Cyclophosphamide;0.Epirubicin;"
"202","1.2.58.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"Docetaxel monotherapy",FALSE,"3","21.Docetaxel;21.Docetaxel;","21.Docetaxel;21.Docetaxel;"
"203","1.2.58.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"Docetaxel monotherapy",FALSE,"4","21.Docetaxel;21.Docetaxel;","21.Docetaxel;21.Docetaxel;"
"204","1.2.59.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"Dose-dense Docetaxel monotherapy",FALSE,"4","14.Docetaxel;14.Docetaxel;","14.Docetaxel;14.Docetaxel;"
"205","1.2.60.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"Doxorubicin monotherapy",FALSE,"4","21.Doxorubicin;21.Doxorubicin;","21.Doxorubicin;21.Doxorubicin;"
"206","1.2.61.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"Dose-dense Doxorubicin monotherapy",FALSE,"4","14.Doxorubicin;14.Doxorubicin;","14.Doxorubicin;14.Doxorubicin;"
"207","1.2.62.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"Doxorubicin & Paclitaxel (AT)",FALSE,"4","21.Doxorubicin;0.Paclitaxel;21.Doxorubicin;0.Paclitaxel;","21.Doxorubicin;0.Paclitaxel;"
"208","1.2.63.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"Epirubicin & Paclitaxel (EP)",FALSE,"4","21.Epirubicin;0.Paclitaxel;21.Epirubicin;0.Paclitaxel;","21.Epirubicin;0.Paclitaxel;"
"209","1.2.64.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"iddEnPC",NA,NA,"0.Epirubicin;14.Epirubicin;14.Epirubicin;14.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);14.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);14.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);14.Cyclophosphamide;14.Cyclophosphamide;14.Cyclophosphamide;","0.Epirubicin;14.Epirubicin;14.Epirubicin;14.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);14.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);14.Paclitaxel;0.nanoparticlealbumin-bound(Abraxane);14.Cyclophosphamide;14.Cyclophosphamide;14.Cyclophosphamide;"
"210","1.2.65.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"iddEPC",NA,NA,"0.Epirubicin;14.Epirubicin;14.Epirubicin;14.Paclitaxel;14.Paclitaxel;14.Paclitaxel;14.Cyclophosphamide;14.Cyclophosphamide;14.Cyclophosphamide;","0.Epirubicin;14.Epirubicin;14.Epirubicin;14.Paclitaxel;14.Paclitaxel;14.Paclitaxel;14.Cyclophosphamide;14.Cyclophosphamide;14.Cyclophosphamide;"
"211","1.2.66.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"Epirubicin monotherapy",FALSE,"4","21.Epirubicin;21.Epirubicin;","21.Epirubicin;21.Epirubicin;"
"212","1.2.66.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"Epirubicin monotherapy",FALSE,"6","21.Epirubicin;7.Epirubicin;21.Epirubicin;7.Epirubicin;","21.Epirubicin;7.Epirubicin;"
"213","1.2.67.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"Dose-dense Epirubicin monotherapy",FALSE,"3","14.Epirubicin;14.Epirubicin;","14.Epirubicin;14.Epirubicin;"
"214","1.2.67.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"3",FALSE,"4","14.Epirubicin;14.Epirubicin;","14.Epirubicin;14.Epirubicin;"
"215","1.2.68.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"FAC",FALSE,"6","21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;","21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;"
"216","1.2.68.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"FAC",FALSE,"4","21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;","21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;"
"217","1.2.68.3","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"FAC",FALSE,"6","21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;7.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;7.Fluorouracil;","21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;7.Fluorouracil;"
"218","1.2.68.4","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"FAC",FALSE,"3","14.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;7.Fluorouracil;14.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;7.Fluorouracil;","14.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;7.Fluorouracil;"
"219","1.2.68.5","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"FAC",FALSE,"8","18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;3.Fluorouracil;18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;3.Fluorouracil;","18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;3.Fluorouracil;"
"220","1.2.68.6","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"FAC",FALSE,"6","15.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;15.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;","15.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;"
"221","1.2.68.7","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"FAC",FALSE,"4","21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;7.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;7.Fluorouracil;","21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;7.Fluorouracil;"
"222","1.2.68.8","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"FAC",FALSE,"6","21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;7.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;7.Fluorouracil;","21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;7.Fluorouracil;"
"223","1.2.68.9","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"FAC",FALSE,"8","18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Doxorubicin;1.Doxorubicin;1.Doxorubicin;0.Fluorouracil;18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Doxorubicin;1.Doxorubicin;1.Doxorubicin;0.Fluorouracil;","18.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Doxorubicin;1.Doxorubicin;1.Doxorubicin;0.Fluorouracil;"
"224","1.2.69.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"FEC",FALSE,"6","21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;","21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;"
"225","1.2.69.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"FEC",FALSE,"4","21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;","21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;"
"226","1.2.69.3","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"FEC",FALSE,"8","21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;","21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;"
"227","1.2.69.4","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"FEC",FALSE,"3","21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;","21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;"
"228","1.2.69.5","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"FEC",FALSE,"9","21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;","21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;"
"229","1.2.69.6","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"FEC",FALSE,"6","21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;7.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;7.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;","21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;7.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;"
"230","1.2.69.7","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"FEC",FALSE,"6","21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;7.Cyclophosphamide;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;7.Cyclophosphamide;0.Fluorouracil;","21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;7.Cyclophosphamide;0.Fluorouracil;"
"231","1.2.70.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"MMM",FALSE,"6","21.Methotrexate;0.Mitomycin;0.Mitoxantrone;21.Methotrexate;0.Mitomycin;0.Mitoxantrone;","21.Methotrexate;0.Mitomycin;0.Mitoxantrone;"
"232","1.2.71.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"Paclitaxel monotherapy, weekly",FALSE,"4","7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;","7.Paclitaxel;7.Paclitaxel;"
"233","1.2.71.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"Paclitaxel monotherapy, weekly",FALSE,"2","7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;","7.Paclitaxel;7.Paclitaxel;"
"234","1.2.72.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"Paclitaxel monotherapy, dose-dense (q2wk)",FALSE,"4","14.Paclitaxel;14.Paclitaxel;","14.Paclitaxel;14.Paclitaxel;"
"235","1.2.72.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"Paclitaxel monotherapy, dose-dense (q2wk)",FALSE,"6","14.Paclitaxel;14.Paclitaxel;","14.Paclitaxel;14.Paclitaxel;"
"236","1.2.73.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"TAC (Docetaxel)",FALSE,"4","21.Cyclophosphamide;0.Docetaxel;0.Doxorubicin;21.Cyclophosphamide;0.Docetaxel;0.Doxorubicin;","21.Cyclophosphamide;0.Docetaxel;0.Doxorubicin;"
"237","1.2.73.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"TAC (Docetaxel)",FALSE,"6","21.Cyclophosphamide;0.Docetaxel;0.Doxorubicin;21.Cyclophosphamide;0.Docetaxel;0.Doxorubicin;","21.Cyclophosphamide;0.Docetaxel;0.Doxorubicin;"
"238","1.2.74.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy",2,"Vinorelbine monotherapy",NA,NA,"0.Vinorelbine;21.Vinorelbine;21.Vinorelbine;","0.Vinorelbine;21.Vinorelbine;21.Vinorelbine;"
"239","1.3.30.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy, sequential protocols",3,"A-CMF",NA,NA,"0.Doxorubicin;21.Doxorubicin;21.Doxorubicin;21.Doxorubicin;21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;28.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;28.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;28.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;","0.Doxorubicin;21.Doxorubicin;21.Doxorubicin;21.Doxorubicin;21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;28.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;28.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;28.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;"
"240","1.3.30.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy, sequential protocols",3,"A-CMF",NA,NA,"0.Doxorubicin;21.Doxorubicin;21.Doxorubicin;21.Doxorubicin;21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;22.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;22.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;22.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;","0.Doxorubicin;21.Doxorubicin;21.Doxorubicin;21.Doxorubicin;21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;22.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;22.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;22.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;"
"241","1.3.31.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy, sequential protocols",3,"AC-CMF",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;22.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;22.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;","0.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;22.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;22.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;"
"242","1.3.32.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy, sequential protocols",3,"AC-D",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Docetaxel;21.Docetaxel;21.Docetaxel;21.Docetaxel;","0.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Docetaxel;21.Docetaxel;21.Docetaxel;21.Docetaxel;"
"243","1.3.32.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy, sequential protocols",3,"AC-D",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Docetaxel;7.Docetaxel;7.Docetaxel;7.Docetaxel;7.Docetaxel;","0.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Docetaxel;7.Docetaxel;7.Docetaxel;7.Docetaxel;7.Docetaxel;"
"244","1.3.33.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy, sequential protocols",3,"AC-T",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Paclitaxel;21.Paclitaxel;21.Paclitaxel;21.Paclitaxel;","0.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Paclitaxel;21.Paclitaxel;21.Paclitaxel;21.Paclitaxel;"
"245","1.3.33.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy, sequential protocols",3,"AC-T",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Paclitaxel;21.Paclitaxel;21.Paclitaxel;21.Paclitaxel;","0.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Paclitaxel;21.Paclitaxel;21.Paclitaxel;21.Paclitaxel;"
"246","1.3.34.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy, sequential protocols",3,"Dose-dense AC-T",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Paclitaxel;14.Paclitaxel;14.Paclitaxel;14.Paclitaxel;","0.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Paclitaxel;14.Paclitaxel;14.Paclitaxel;14.Paclitaxel;"
"247","1.3.34.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy, sequential protocols",3,"Dose-dense AC-T",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;","0.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;"
"248","1.3.35.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy, sequential protocols",3,"D-EC",NA,NA,"0.Docetaxel;21.Docetaxel;21.Docetaxel;21.Docetaxel;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;","0.Docetaxel;21.Docetaxel;21.Docetaxel;21.Docetaxel;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;"
"249","1.3.36.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy, sequential protocols",3,"D-FEC",NA,NA,"0.Docetaxel;21.Docetaxel;21.Docetaxel;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;","0.Docetaxel;21.Docetaxel;21.Docetaxel;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;"
"250","1.3.37.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy, sequential protocols",3,"E-CMF",NA,NA,"0.Epirubicin;21.Epirubicin;21.Epirubicin;21.Epirubicin;21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;","0.Epirubicin;21.Epirubicin;21.Epirubicin;21.Epirubicin;21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;"
"251","1.3.37.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy, sequential protocols",3,"E-CMF",NA,NA,"0.Epirubicin;21.Epirubicin;21.Epirubicin;21.Epirubicin;21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;28.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;28.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;28.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;","0.Epirubicin;21.Epirubicin;21.Epirubicin;21.Epirubicin;21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;28.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;28.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;28.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;"
"252","1.3.37.3","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy, sequential protocols",3,"E-CMF",NA,NA,"0.Epirubicin;21.Epirubicin;21.Epirubicin;21.Epirubicin;21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;22.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;22.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;22.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;","0.Epirubicin;21.Epirubicin;21.Epirubicin;21.Epirubicin;21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;22.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;22.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;22.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;"
"253","1.3.38.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy, sequential protocols",3,"E-D",NA,NA,"0.Epirubicin;28.Epirubicin;28.Epirubicin;28.Docetaxel;21.Docetaxel;21.Docetaxel;","0.Epirubicin;28.Epirubicin;28.Epirubicin;28.Docetaxel;21.Docetaxel;21.Docetaxel;"
"254","1.3.38.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy, sequential protocols",3,"E-D",NA,NA,"0.Epirubicin;21.Epirubicin;21.Epirubicin;21.Epirubicin;21.Docetaxel;21.Docetaxel;21.Docetaxel;21.Docetaxel;","0.Epirubicin;21.Epirubicin;21.Epirubicin;21.Epirubicin;21.Docetaxel;21.Docetaxel;21.Docetaxel;21.Docetaxel;"
"255","1.3.39.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy, sequential protocols",3,"EC-CMF",NA,NA,"0.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;22.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;22.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;","0.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;22.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;22.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;"
"256","1.3.40.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy, sequential protocols",3,"EC-D",NA,NA,"0.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Docetaxel;21.Docetaxel;21.Docetaxel;","0.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Docetaxel;21.Docetaxel;21.Docetaxel;"
"257","1.3.40.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy, sequential protocols",3,"EC-D",NA,NA,"0.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Docetaxel;21.Docetaxel;21.Docetaxel;21.Docetaxel;","0.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Docetaxel;21.Docetaxel;21.Docetaxel;21.Docetaxel;"
"258","1.3.41.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy, sequential protocols",3,"EC-T",NA,NA,"0.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Paclitaxel;21.Paclitaxel;21.Paclitaxel;21.Paclitaxel;","0.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Paclitaxel;21.Paclitaxel;21.Paclitaxel;21.Paclitaxel;"
"259","1.3.41.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy, sequential protocols",3,"EC-T",NA,NA,"0.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Paclitaxel;21.Paclitaxel;21.Paclitaxel;21.Paclitaxel;","0.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Paclitaxel;21.Paclitaxel;21.Paclitaxel;21.Paclitaxel;"
"260","1.3.42.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy, sequential protocols",3,"ddEC-T",NA,NA,"0.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;14.Paclitaxel;14.Paclitaxel;14.Paclitaxel;","0.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;14.Paclitaxel;14.Paclitaxel;14.Paclitaxel;"
"261","1.3.43.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy, sequential protocols",3,"FEC-D",NA,NA,"0.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Docetaxel;21.Docetaxel;21.Docetaxel;","0.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Docetaxel;21.Docetaxel;21.Docetaxel;"
"262","1.3.43.2","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy, sequential protocols",3,"FEC-D",NA,NA,"0.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Docetaxel;21.Docetaxel;21.Docetaxel;21.Docetaxel;","0.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Docetaxel;21.Docetaxel;21.Docetaxel;21.Docetaxel;"
"263","1.3.44.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy, sequential protocols",3,"Dose-dense FEC-D",NA,NA,"0.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;14.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;14.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;14.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;14.Docetaxel;14.Docetaxel;14.Docetaxel;14.Docetaxel;","0.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;14.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;14.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;14.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;14.Docetaxel;14.Docetaxel;14.Docetaxel;14.Docetaxel;"
"264","1.3.45.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy, sequential protocols",3,"FEC-P",NA,NA,"0.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;","0.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;"
"265","1.3.46.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy, sequential protocols",3,"T-FEC",NA,NA,"0.Paclitaxel;21.Paclitaxel;21.Paclitaxel;21.Paclitaxel;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;","0.Paclitaxel;21.Paclitaxel;21.Paclitaxel;21.Paclitaxel;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;"
"266","1.3.47.1","Solid Tumor","Breast Oncology","Breast cancer",1,"Adjuvant chemotherapy, sequential protocols",3,"TX-CEX",NA,NA,"0.Capecitabine;0.Docetaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;15.Capecitabine;0.Docetaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;15.Capecitabine;0.Docetaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;15.Capecitabine;0.Cyclophosphamide;0.Epirubicin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;15.Capecitabine;0.Cyclophosphamide;0.Epirubicin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;15.Capecitabine;0.Cyclophosphamide;0.Epirubicin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","0.Capecitabine;0.Docetaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;15.Capecitabine;0.Docetaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;15.Capecitabine;0.Docetaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;15.Capecitabine;0.Cyclophosphamide;0.Epirubicin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;15.Capecitabine;0.Cyclophosphamide;0.Epirubicin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;15.Capecitabine;0.Cyclophosphamide;0.Epirubicin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"267","10.121.384.1","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Maintenance immunotherapy for metastatic or unresectable disease",121,"IL-2 monotherapy",FALSE,"12","3.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;3.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;3.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;3.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;3.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;3.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;3.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;3.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;","3.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;"
"268","10.137.375.1","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Metastatic or unresectable disease",137,"Dacarbazine monotherapy",FALSE,"8","21.Dacarbazine;21.Dacarbazine;","21.Dacarbazine;21.Dacarbazine;"
"269","10.137.375.2","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Metastatic or unresectable disease",137,"Dacarbazine monotherapy",TRUE,"Cont.","19.Dacarbazine;1.Dacarbazine;1.Dacarbazine;1.Dacarbazine;1.Dacarbazine;1.Dacarbazine;1.Dacarbazine;1.Dacarbazine;1.Dacarbazine;1.Dacarbazine;19.Dacarbazine;1.Dacarbazine;1.Dacarbazine;1.Dacarbazine;1.Dacarbazine;1.Dacarbazine;1.Dacarbazine;1.Dacarbazine;1.Dacarbazine;1.Dacarbazine;","19.Dacarbazine;1.Dacarbazine;1.Dacarbazine;1.Dacarbazine;1.Dacarbazine;1.Dacarbazine;1.Dacarbazine;1.Dacarbazine;1.Dacarbazine;1.Dacarbazine;"
"270","10.137.376.1","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Metastatic or unresectable disease",137,"High-dose Interleukin-2",TRUE,"Cont.","66.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;10.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;66.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;10.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;","66.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;10.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;"
"271","10.137.376.2","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Metastatic or unresectable disease",137,"High-dose Interleukin-2",TRUE,"Cont.","38.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;38.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;","38.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;"
"272","10.137.376.3","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Metastatic or unresectable disease",137,"High-dose Interleukin-2",TRUE,"Cont.","38.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;10.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;38.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;10.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;","38.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;10.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;"
"273","10.137.376.4","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Metastatic or unresectable disease",137,"High-dose Interleukin-2",TRUE,"Cont.","25.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;17.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;25.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;17.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;","25.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;17.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;"
"274","10.137.378.1","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Metastatic or unresectable disease",137,"Ipilimumab monotherapy",TRUE,"Cont.","84.Ipilimumab;84.Ipilimumab;","84.Ipilimumab;84.Ipilimumab;"
"275","10.139.358.1","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Metastatic or unresectable disease, first-line",139,"ABC",TRUE,"Cont.","14.Bevacizumab;0.Carboplatin;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Bevacizumab;0.Paclitaxel;0.nanoparticlealbumin-bound;14.Bevacizumab;0.Carboplatin;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Bevacizumab;0.Paclitaxel;0.nanoparticlealbumin-bound;","14.Bevacizumab;0.Carboplatin;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Bevacizumab;0.Paclitaxel;0.nanoparticlealbumin-bound;"
"276","10.139.359.1","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Metastatic or unresectable disease, first-line",139,"Carboplatin & Paclitaxel (CP)",TRUE,"Cont.","28.Carboplatin;0.Paclitaxel;28.Carboplatin;0.Paclitaxel;","28.Carboplatin;0.Paclitaxel;"
"277","10.139.359.2","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Metastatic or unresectable disease, first-line",139,"Carboplatin & Paclitaxel (CP)",TRUE,"Cont.","21.Carboplatin;0.Paclitaxel;21.Carboplatin;0.Paclitaxel;","21.Carboplatin;0.Paclitaxel;"
"278","10.139.360.1","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Metastatic or unresectable disease, first-line",139,"Carboplatin & Paclitaxel (CP) & Bevacizumab",TRUE,"Cont.","14.Bevacizumab;0.Carboplatin;0.Paclitaxel;14.Bevacizumab;14.Bevacizumab;0.Carboplatin;0.Paclitaxel;14.Bevacizumab;","14.Bevacizumab;0.Carboplatin;0.Paclitaxel;14.Bevacizumab;"
"279","10.139.361.1","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Metastatic or unresectable disease, first-line",139,"Carboplatin & nab-Paclitaxel",TRUE,"Cont.","14.Carboplatin;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Carboplatin;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Carboplatin;0.Paclitaxel;0.nanoparticlealbumin-bound;14.Carboplatin;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Carboplatin;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Carboplatin;0.Paclitaxel;0.nanoparticlealbumin-bound;","14.Carboplatin;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Carboplatin;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Carboplatin;0.Paclitaxel;0.nanoparticlealbumin-bound;"
"280","10.139.362.1","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Metastatic or unresectable disease, first-line",139,"Cisplatin & Dacarbazine",FALSE,"6","21.Cisplatin;0.Dacarbazine;21.Cisplatin;0.Dacarbazine;","21.Cisplatin;0.Dacarbazine;"
"281","10.139.363.1","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Metastatic or unresectable disease, first-line",139,"Cisplatin, Dacarbazine, Paclitaxel",TRUE,"Cont.","18.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;18.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;","18.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;"
"282","10.141.373.1","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Metastatic or unresectable disease, second-line",141,"Lifileucel & IL-2",TRUE,"Cont.","28.IL-2-Aldesleukin;0.Lifileuecel;28.IL-2-Aldesleukin;0.Lifileuecel;","28.IL-2-Aldesleukin;0.Lifileuecel;"
"283","10.141.373.2","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Metastatic or unresectable disease, second-line",141,"Lifileucel & IL-2",TRUE,"Cont.","27.Lifileuecel;1.IL-2-Aldesleukin;27.Lifileuecel;1.IL-2-Aldesleukin;","27.Lifileuecel;1.IL-2-Aldesleukin;"
"284","10.141.374.1","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Metastatic or unresectable disease, second-line",141,"Toripalimab monotherapy",TRUE,"Cont.","14.Toripalimab;14.Toripalimab;","14.Toripalimab;14.Toripalimab;"
"285","10.141.383.1","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Metastatic or unresectable disease, second-line",141,"Docetaxel monotherapy",TRUE,"Cont.","17.Docetaxel;0.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;17.Docetaxel;0.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;","17.Docetaxel;0.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;"
"286","10.141.384.1","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Metastatic or unresectable disease, second-line",141,"Paclitaxel monotherapy",TRUE,"Cont.","14.Paclitaxel;7.Paclitaxel;7.Paclitaxel;14.Paclitaxel;7.Paclitaxel;7.Paclitaxel;","14.Paclitaxel;7.Paclitaxel;7.Paclitaxel;"
"287","10.141.384.2","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Metastatic or unresectable disease, second-line",141,"Paclitaxel monotherapy",TRUE,"Cont.","21.Paclitaxel;21.Paclitaxel;","21.Paclitaxel;21.Paclitaxel;"
"288","10.141.384.3","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Metastatic or unresectable disease, second-line",141,"Paclitaxel monotherapy",TRUE,"Cont.","20.Paclitaxel;1.Paclitaxel;20.Paclitaxel;1.Paclitaxel;","20.Paclitaxel;1.Paclitaxel;"
"289","10.141.385.1","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Metastatic or unresectable disease, second-line",141,"nab-Paclitaxel monotherapy",TRUE,"Cont.","14.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;14.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;","14.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;"
"290","10.147.369.3","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Neoadjuvant chemotherapy",147,"Ipilimumab & Nivolumab",TRUE,"Cont.","21.Ipilimumab;21.Ipilimumab;","21.Ipilimumab;21.Ipilimumab;"
"291","10.147.369.4","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Neoadjuvant chemotherapy",147,"Ipilimumab & Nivolumab",TRUE,"Cont.","28.Ipilimumab;0.Nivolumab;28.Ipilimumab;0.Nivolumab;","28.Ipilimumab;0.Nivolumab;"
"292","10.147.370.1","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Neoadjuvant chemotherapy",147,"Nivolumab monotherapy",TRUE,"Cont.","14.Nivolumab;14.Nivolumab;","14.Nivolumab;14.Nivolumab;"
"293","10.147.370.2","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Neoadjuvant chemotherapy",147,"Nivolumab monotherapy",TRUE,"Cont.","28.Nivolumab;28.Nivolumab;","28.Nivolumab;28.Nivolumab;"
"294","10.147.371.1","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Neoadjuvant chemotherapy",147,"Nivolumab & Relatlimab",TRUE,"Cont.","28.Nivolumabandrelatlimab;28.Nivolumabandrelatlimab;","28.Nivolumabandrelatlimab;28.Nivolumabandrelatlimab;"
"295","10.147.372.1","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Neoadjuvant chemotherapy",147,"Temozolomide & Bevacizumab",TRUE,"Cont.","14.Bevacizumab;0.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;10.Bevacizumab;14.Bevacizumab;0.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;10.Bevacizumab;","14.Bevacizumab;0.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;10.Bevacizumab;"
"296","10.147.379.1","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Neoadjuvant chemotherapy",147,"Ipilimumab & Nivolumab",FALSE,"8","21.Nivolumab;21.Nivolumab;","21.Nivolumab;21.Nivolumab;"
"297","10.147.380.1","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Neoadjuvant chemotherapy",147,"Ipilimumab, then Nivolumab",NA,NA,"0.Ipilimumab;21.Ipilimumab;21.Ipilimumab;21.Ipilimumab;21.Nivolumab;14.Nivolumab;14.Nivolumab;14.Nivolumab;","0.Ipilimumab;21.Ipilimumab;21.Ipilimumab;21.Ipilimumab;21.Nivolumab;14.Nivolumab;14.Nivolumab;14.Nivolumab;"
"298","10.147.381.1","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Neoadjuvant chemotherapy",147,"Nivolumab monotherapy",NA,NA,"0.Nivolumab;14.Nivolumab;14.Nivolumab;14.Nivolumab;14.Nivolumab;14.Nivolumab;14.Nivolumab;14.Nivolumab;14.Nivolumab;","0.Nivolumab;14.Nivolumab;14.Nivolumab;14.Nivolumab;14.Nivolumab;14.Nivolumab;14.Nivolumab;14.Nivolumab;14.Nivolumab;"
"299","10.147.382.1","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Neoadjuvant chemotherapy",147,"Nivolumab, then Ipilimumab",NA,NA,"0.Nivolumab;14.Nivolumab;14.Nivolumab;14.Nivolumab;14.Nivolumab;14.Nivolumab;14.Ipilimumab;21.Ipilimumab;21.Ipilimumab;","0.Nivolumab;14.Nivolumab;14.Nivolumab;14.Nivolumab;14.Nivolumab;14.Nivolumab;14.Ipilimumab;21.Ipilimumab;21.Ipilimumab;"
"300","10.151.352.1","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Neoadjuvant immunotherapy",151,"Pembrolizumab monotherapy",FALSE,"3","21.Pembrolizumab;21.Pembrolizumab;","21.Pembrolizumab;21.Pembrolizumab;"
"301","10.4.353.1","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Adjuvant therapy",4,"Cisplatin & Temozolomide",FALSE,"6","17.Cisplatin;0.Temozolomide;1.Cisplatin;0.Temozolomide;1.Cisplatin;0.Temozolomide;1.Temozolomide;1.Temozolomide;17.Cisplatin;0.Temozolomide;1.Cisplatin;0.Temozolomide;1.Cisplatin;0.Temozolomide;1.Temozolomide;1.Temozolomide;","17.Cisplatin;0.Temozolomide;1.Cisplatin;0.Temozolomide;1.Cisplatin;0.Temozolomide;1.Temozolomide;1.Temozolomide;"
"302","10.4.354.1","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Adjuvant therapy",4,"Ipilimumab monotherapy",NA,NA,"0.Ipilimumab;21.Ipilimumab;21.Ipilimumab;21.Ipilimumab;84.Ipilimumab;84.Ipilimumab;","0.Ipilimumab;21.Ipilimumab;21.Ipilimumab;21.Ipilimumab;84.Ipilimumab;84.Ipilimumab;"
"303","10.4.354.2","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Adjuvant therapy",4,"Ipilimumab monotherapy",NA,NA,"0.Ipilimumab;21.Ipilimumab;21.Ipilimumab;21.Ipilimumab;84.Ipilimumab;84.Ipilimumab;84.Ipilimumab;","0.Ipilimumab;21.Ipilimumab;21.Ipilimumab;21.Ipilimumab;84.Ipilimumab;84.Ipilimumab;84.Ipilimumab;"
"304","10.4.355.1","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Adjuvant therapy",4,"Ipilimumab & Nivolumab",NA,NA,"0.Ipilimumab;0.Nivolumab;21.Ipilimumab;0.Nivolumab;21.Ipilimumab;0.Nivolumab;21.Ipilimumab;0.Nivolumab;21.Nivolumab;14.Nivolumab;14.Nivolumab;14.Nivolumab;14.Nivolumab;","0.Ipilimumab;0.Nivolumab;21.Ipilimumab;0.Nivolumab;21.Ipilimumab;0.Nivolumab;21.Ipilimumab;0.Nivolumab;21.Nivolumab;14.Nivolumab;14.Nivolumab;14.Nivolumab;14.Nivolumab;"
"305","10.4.355.2","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Adjuvant therapy",4,"Ipilimumab & Nivolumab",FALSE,"9","14.Ipilimumab;0.Nivolumab;14.Nivolumab;14.Nivolumab;14.Ipilimumab;0.Nivolumab;14.Nivolumab;14.Nivolumab;","14.Ipilimumab;0.Nivolumab;14.Nivolumab;14.Nivolumab;"
"306","10.4.356.1","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Adjuvant therapy",4,"Nivolumab monotherapy",TRUE,"Cont.","14.Nivolumab;14.Nivolumab;","14.Nivolumab;14.Nivolumab;"
"307","10.4.365.3","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Adjuvant therapy",4,"Dacarbazine monotherapy",TRUE,"Cont.","24.Dacarbazine;1.Dacarbazine;1.Dacarbazine;1.Dacarbazine;1.Dacarbazine;24.Dacarbazine;1.Dacarbazine;1.Dacarbazine;1.Dacarbazine;1.Dacarbazine;","24.Dacarbazine;1.Dacarbazine;1.Dacarbazine;1.Dacarbazine;1.Dacarbazine;"
"308","10.4.365.4","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Adjuvant therapy",4,"Dacarbazine monotherapy",TRUE,"Cont.","17.Dacarbazine;1.Dacarbazine;1.Dacarbazine;1.Dacarbazine;1.Dacarbazine;17.Dacarbazine;1.Dacarbazine;1.Dacarbazine;1.Dacarbazine;1.Dacarbazine;","17.Dacarbazine;1.Dacarbazine;1.Dacarbazine;1.Dacarbazine;1.Dacarbazine;"
"309","10.4.366.1","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Adjuvant therapy",4,"Dacarbazine & Ipilimumab",NA,NA,"0.Dacarbazine;0.Ipilimumab;21.Dacarbazine;0.Ipilimumab;21.Dacarbazine;0.Ipilimumab;21.Dacarbazine;0.Ipilimumab;21.Dacarbazine;21.Dacarbazine;21.Dacarbazine;21.Dacarbazine;","0.Dacarbazine;0.Ipilimumab;21.Dacarbazine;0.Ipilimumab;21.Dacarbazine;0.Ipilimumab;21.Dacarbazine;0.Ipilimumab;21.Dacarbazine;21.Dacarbazine;21.Dacarbazine;21.Dacarbazine;"
"310","10.4.366.2","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Adjuvant therapy",4,"Dacarbazine & Ipilimumab",TRUE,"Cont.","84.Ipilimumab;84.Ipilimumab;","84.Ipilimumab;84.Ipilimumab;"
"311","10.4.367.1","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Adjuvant therapy",4,"Fotemustine monotherapy",FALSE,"3","42.Fotemustine;7.Fotemustine;7.Fotemustine;42.Fotemustine;7.Fotemustine;7.Fotemustine;","42.Fotemustine;7.Fotemustine;7.Fotemustine;"
"312","10.4.367.2","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Adjuvant therapy",4,"Fotemustine monotherapy",TRUE,"Cont.","21.Fotemustine;21.Fotemustine;","21.Fotemustine;21.Fotemustine;"
"313","10.4.368.1","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Adjuvant therapy",4,"Ipilimumab monotherapy",FALSE,"4","21.Ipilimumab;21.Ipilimumab;","21.Ipilimumab;21.Ipilimumab;"
"314","10.4.369.1","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Adjuvant therapy",4,"Ipilimumab & Nivolumab",NA,NA,"0.Ipilimumab;0.Nivolumab;21.Ipilimumab;0.Nivolumab;21.Ipilimumab;0.Nivolumab;21.Ipilimumab;0.Nivolumab;","0.Ipilimumab;0.Nivolumab;21.Ipilimumab;0.Nivolumab;21.Ipilimumab;0.Nivolumab;21.Ipilimumab;0.Nivolumab;"
"315","10.4.369.2","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Adjuvant therapy",4,"Ipilimumab & Nivolumab",TRUE,"Cont.","14.Ipilimumab;0.Nivolumab;14.Ipilimumab;0.Nivolumab;","14.Ipilimumab;0.Nivolumab;"
"316","10.4.369.3","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Adjuvant therapy",4,"Ipilimumab & Nivolumab",TRUE,"Cont.","21.Nivolumab;21.Nivolumab;","21.Nivolumab;21.Nivolumab;"
"317","10.4.379.1","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Adjuvant therapy",4,"Ipilimumab & Nivolumab",FALSE,"8","21.Ipilimumab;21.Ipilimumab;","21.Ipilimumab;21.Ipilimumab;"
"318","10.98.357.1","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Local therapy",98,"Talimogene laherparepvec monotherapy",TRUE,"Cont.","21.Talimogenelaherparepvec;21.Talimogenelaherparepvec;","21.Talimogenelaherparepvec;21.Talimogenelaherparepvec;"
"319","10.98.357.2","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Local therapy",98,"Talimogene laherparepvec monotherapy",TRUE,"Cont.","14.Talimogenelaherparepvec;14.Talimogenelaherparepvec;","14.Talimogenelaherparepvec;14.Talimogenelaherparepvec;"
"320","10.98.363.1","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Local therapy",98,"Cisplatin, Dacarbazine, Paclitaxel",TRUE,"Cont.","14.Dacarbazine;0.Paclitaxel;7.Paclitaxel;14.Dacarbazine;0.Paclitaxel;7.Paclitaxel;","14.Dacarbazine;0.Paclitaxel;7.Paclitaxel;"
"321","10.98.364.1","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Local therapy",98,"CVD (Vindesine)",TRUE,"Cont.","19.Cisplatin;0.Dacarbazine;0.Vindesine;1.Cisplatin;0.Dacarbazine;1.Cisplatin;0.Dacarbazine;19.Cisplatin;0.Dacarbazine;0.Vindesine;1.Cisplatin;0.Dacarbazine;1.Cisplatin;0.Dacarbazine;","19.Cisplatin;0.Dacarbazine;0.Vindesine;1.Cisplatin;0.Dacarbazine;1.Cisplatin;0.Dacarbazine;"
"322","10.98.365.1","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Local therapy",98,"Dacarbazine monotherapy",TRUE,"Cont.","21.Dacarbazine;21.Dacarbazine;","21.Dacarbazine;21.Dacarbazine;"
"323","10.98.365.2","Solid Tumor","Dermatologic Oncology","Melanoma",10,"Local therapy",98,"Dacarbazine monotherapy",TRUE,"Cont.","28.Dacarbazine;28.Dacarbazine;","28.Dacarbazine;28.Dacarbazine;"
"324","100.124.1412.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, MET-mutated",100,"Metastatic disease, all lines of therapy",124,"Capmatinib monotherapy",TRUE,"Cont.","1.Capmatinib;1.Capmatinib;1.Capmatinib;1.Capmatinib;1.Capmatinib;1.Capmatinib;1.Capmatinib;1.Capmatinib;1.Capmatinib;1.Capmatinib;1.Capmatinib;1.Capmatinib;1.Capmatinib;1.Capmatinib;","1.Capmatinib;1.Capmatinib;"
"325","100.124.1413.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, MET-mutated",100,"Metastatic disease, all lines of therapy",124,"Tepotinib monotherapy",TRUE,"Cont.","1.Tepotinib;1.Tepotinib;1.Tepotinib;1.Tepotinib;1.Tepotinib;1.Tepotinib;1.Tepotinib;1.Tepotinib;1.Tepotinib;1.Tepotinib;1.Tepotinib;1.Tepotinib;1.Tepotinib;1.Tepotinib;","1.Tepotinib;1.Tepotinib;"
"326","101.124.1414.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, RET-positive",101,"Metastatic disease, all lines of therapy",124,"Pralsetinib monotherapy",TRUE,"Cont.","1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;","1.Pralsetinib;1.Pralsetinib;"
"327","101.124.1415.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, RET-positive",101,"Metastatic disease, all lines of therapy",124,"Selpercatinib monotherapy",TRUE,"Cont.","1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;","1.Selpercatinib;1.Selpercatinib;"
"328","102.124.1416.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, ROS1-positive",102,"Metastatic disease, all lines of therapy",124,"Entrectinib monotherapy",TRUE,"Cont.","1.Entrectinib;1.Entrectinib;1.Entrectinib;1.Entrectinib;1.Entrectinib;1.Entrectinib;1.Entrectinib;1.Entrectinib;1.Entrectinib;1.Entrectinib;1.Entrectinib;1.Entrectinib;1.Entrectinib;1.Entrectinib;","1.Entrectinib;1.Entrectinib;"
"329","102.30.1418.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, CNS metastases",102,"ALK-mutated, all lines of therapy",30,"Cisplatin, Gefitinib, Pemetrexed",TRUE,"Cont.","1.Cisplatin;0.Gefitinib;0.Pemetrexed;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Cisplatin;0.Gefitinib;0.Pemetrexed;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;","1.Cisplatin;0.Gefitinib;0.Pemetrexed;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;"
"330","102.30.1419.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, CNS metastases",102,"ALK-mutated, all lines of therapy",30,"Gefitinib, Nedaplatin, Pemetrexed",TRUE,"Cont.","1.Gefitinib;0.Nedaplatin;0.Pemetrexed;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;0.Nedaplatin;0.Pemetrexed;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;","1.Gefitinib;0.Nedaplatin;0.Pemetrexed;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;"
"331","102.31.1417.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, CNS metastases",102,"All lines of therapy",31,"Teniposide & WBRT",TRUE,"Cont.","14.Teniposide;14.Teniposide;","14.Teniposide;14.Teniposide;"
"332","103.173.1437.1","Solid Tumor","Thoraic Oncology","Small cell lung cancer",103,"Relapsed or refractory disease, second-line",173,"Cisplatin, Etoposide, Irinotecan",FALSE,"5","7.Carboplatin;0.Etoposide;1.Etoposide;1.Etoposide;5.Carboplatin;0.Irinotecan;7.Carboplatin;0.Etoposide;1.Etoposide;1.Etoposide;5.Carboplatin;0.Irinotecan;","7.Carboplatin;0.Etoposide;1.Etoposide;1.Etoposide;5.Carboplatin;0.Irinotecan;"
"333","103.173.1438.1","Solid Tumor","Thoraic Oncology","Small cell lung cancer",103,"Relapsed or refractory disease, second-line",173,"Lurbinectedin monotherapy",TRUE,"Cont.","21.Lurbinectedin;21.Lurbinectedin;","21.Lurbinectedin;21.Lurbinectedin;"
"334","103.174.1439.1","Solid Tumor","Thoraic Oncology","Small cell lung cancer",103,"Relapsed or refractory disease, subsequent lines",174,"Bendamustine monotherapy",TRUE,"Cont.","20.Bendamustine;1.Bendamustine;20.Bendamustine;1.Bendamustine;","20.Bendamustine;1.Bendamustine;"
"335","103.174.1440.1","Solid Tumor","Thoraic Oncology","Small cell lung cancer",103,"Relapsed or refractory disease, subsequent lines",174,"CAV",TRUE,"Cont.","21.Cyclophosphamide;0.Doxorubicin;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Vincristine;","21.Cyclophosphamide;0.Doxorubicin;0.Vincristine;"
"336","103.174.1441.1","Solid Tumor","Thoraic Oncology","Small cell lung cancer",103,"Relapsed or refractory disease, subsequent lines",174,"Epirubicin & Ifosfamide",TRUE,"Cont.","27.Epirubicin;0.Ifosfamide;1.Ifosfamide;27.Epirubicin;0.Ifosfamide;1.Ifosfamide;","27.Epirubicin;0.Ifosfamide;1.Ifosfamide;"
"337","103.174.1442.1","Solid Tumor","Thoraic Oncology","Small cell lung cancer",103,"Relapsed or refractory disease, subsequent lines",174,"Etoposide monotherapy",TRUE,"Cont.","1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;","1.Etoposide;1.Etoposide;"
"338","103.174.1443.1","Solid Tumor","Thoraic Oncology","Small cell lung cancer",103,"Relapsed or refractory disease, subsequent lines",174,"Ifosfamide monotherapy",TRUE,"Cont.","21.Ifosfamide;21.Ifosfamide;","21.Ifosfamide;21.Ifosfamide;"
"339","103.174.1444.1","Solid Tumor","Thoraic Oncology","Small cell lung cancer",103,"Relapsed or refractory disease, subsequent lines",174,"Ifosfamide & Paclitaxel",TRUE,"Cont.","20.Ifosfamide;0.Paclitaxel;1.Ifosfamide;20.Ifosfamide;0.Paclitaxel;1.Ifosfamide;","20.Ifosfamide;0.Paclitaxel;1.Ifosfamide;"
"340","103.174.1445.1","Solid Tumor","Thoraic Oncology","Small cell lung cancer",103,"Relapsed or refractory disease, subsequent lines",174,"Irinotecan monotherapy",TRUE,"Cont.","7.Irinotecan;7.Irinotecan;7.Irinotecan;7.Irinotecan;7.Irinotecan;7.Irinotecan;","7.Irinotecan;7.Irinotecan;"
"341","103.174.1445.2","Solid Tumor","Thoraic Oncology","Small cell lung cancer",103,"Relapsed or refractory disease, subsequent lines",174,"Irinotecan monotherapy",TRUE,"Cont.","21.Irinotecan;21.Irinotecan;","21.Irinotecan;21.Irinotecan;"
"342","103.174.1446.1","Solid Tumor","Thoraic Oncology","Small cell lung cancer",103,"Relapsed or refractory disease, subsequent lines",174,"Paclitaxel monotherapy",TRUE,"Cont.","21.Paclitaxel;21.Paclitaxel;","21.Paclitaxel;21.Paclitaxel;"
"343","103.174.1446.2","Solid Tumor","Thoraic Oncology","Small cell lung cancer",103,"Relapsed or refractory disease, subsequent lines",174,"Paclitaxel monotherapy",TRUE,"Cont.","21.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;21.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;","21.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;"
"344","103.174.1447.1","Solid Tumor","Thoraic Oncology","Small cell lung cancer",103,"Relapsed or refractory disease, subsequent lines",174,"Temozolomide monotherapy",TRUE,"Cont.","8.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;8.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;","8.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;"
"345","103.174.1447.2","Solid Tumor","Thoraic Oncology","Small cell lung cancer",103,"Relapsed or refractory disease, subsequent lines",174,"Temozolomide monotherapy",TRUE,"Cont.","24.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;24.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;","24.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;"
"346","103.174.1448.1","Solid Tumor","Thoraic Oncology","Small cell lung cancer",103,"Relapsed or refractory disease, subsequent lines",174,"Topotecan monotherapy",TRUE,"Cont.","17.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;17.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;","17.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;"
"347","103.174.1449.1","Solid Tumor","Thoraic Oncology","Small cell lung cancer",103,"Relapsed or refractory disease, subsequent lines",174,"Vinorelbine monotherapy",TRUE,"Cont.","7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;","7.Vinorelbine;7.Vinorelbine;"
"348","103.61.1422.1","Solid Tumor","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, induction",61,"Belotecan & Cisplatin",TRUE,"Cont.","18.Belotecan;0.Cisplatin;1.Belotecan;1.Belotecan;1.Belotecan;18.Belotecan;0.Cisplatin;1.Belotecan;1.Belotecan;1.Belotecan;","18.Belotecan;0.Cisplatin;1.Belotecan;1.Belotecan;1.Belotecan;"
"349","103.61.1423.1","Solid Tumor","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, induction",61,"Carboplatin & Etoposide (CE)",TRUE,"Cont.","17.Carboplatin;0.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;17.Carboplatin;0.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;","17.Carboplatin;0.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;"
"350","103.61.1424.1","Solid Tumor","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, induction",61,"Carboplatin & Etoposide (CE) & Atezolizumab",TRUE,"Cont.","19.Atezolizumab;0.Carboplatin;0.Etoposide;1.Etoposide;1.Etoposide;19.Atezolizumab;0.Carboplatin;0.Etoposide;1.Etoposide;1.Etoposide;","19.Atezolizumab;0.Carboplatin;0.Etoposide;1.Etoposide;1.Etoposide;"
"351","103.61.1425.1","Solid Tumor","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, induction",61,"Carboplatin & Etoposide (CE) & Bevacizumab",FALSE,"4","19.Bevacizumab;0.Carboplatin;0.Etoposide;1.Etoposide;1.Etoposide;19.Bevacizumab;0.Carboplatin;0.Etoposide;1.Etoposide;1.Etoposide;","19.Bevacizumab;0.Carboplatin;0.Etoposide;1.Etoposide;1.Etoposide;"
"352","103.61.1426.1","Solid Tumor","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, induction",61,"Carboplatin & Etoposide (CE) & Durvalumab",FALSE,"4","19.Carboplatin;0.Durvalumab;0.Etoposide;1.Etoposide;1.Etoposide;19.Carboplatin;0.Durvalumab;0.Etoposide;1.Etoposide;1.Etoposide;","19.Carboplatin;0.Durvalumab;0.Etoposide;1.Etoposide;1.Etoposide;"
"353","103.61.1426.2","Solid Tumor","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, induction",61,"Carboplatin & Etoposide (CE) & Durvalumab",TRUE,"Cont.","26.Carboplatin;0.Durvalumab;0.Etoposide;1.Etoposide;1.Etoposide;26.Carboplatin;0.Durvalumab;0.Etoposide;1.Etoposide;1.Etoposide;","26.Carboplatin;0.Durvalumab;0.Etoposide;1.Etoposide;1.Etoposide;"
"354","103.61.1427.1","Solid Tumor","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, induction",61,"Carboplatin & Etoposide (CE) & Serplulimab",TRUE,"Cont.","19.Carboplatin;0.Etoposide;0.Serplulimab;1.Etoposide;1.Etoposide;19.Carboplatin;0.Etoposide;0.Serplulimab;1.Etoposide;1.Etoposide;","19.Carboplatin;0.Etoposide;0.Serplulimab;1.Etoposide;1.Etoposide;"
"355","103.61.1428.1","Solid Tumor","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, induction",61,"Carboplatin & Irinotecan",FALSE,"4","21.Carboplatin;0.Irinotecan;21.Carboplatin;0.Irinotecan;","21.Carboplatin;0.Irinotecan;"
"356","103.61.1428.2","Solid Tumor","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, induction",61,"Carboplatin & Irinotecan",TRUE,"Cont.","14.Carboplatin;0.Irinotecan;7.Irinotecan;7.Irinotecan;14.Carboplatin;0.Irinotecan;7.Irinotecan;7.Irinotecan;","14.Carboplatin;0.Irinotecan;7.Irinotecan;7.Irinotecan;"
"357","103.61.1429.1","Solid Tumor","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, induction",61,"Cisplatin & Etoposide (EP)",TRUE,"Cont.","26.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;26.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;","26.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;"
"358","103.61.1429.2","Solid Tumor","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, induction",61,"Cisplatin & Etoposide (EP)",TRUE,"Cont.","18.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Etoposide;18.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Etoposide;","18.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Etoposide;"
"359","103.61.1429.3","Solid Tumor","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, induction",61,"Cisplatin & Etoposide (EP)",FALSE,"4","18.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;18.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;","18.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;"
"360","103.61.1429.4","Solid Tumor","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, induction",61,"Cisplatin & Etoposide (EP)",FALSE,"6","19.Etoposide;1.Cisplatin;0.Etoposide;1.Etoposide;19.Etoposide;1.Cisplatin;0.Etoposide;1.Etoposide;","19.Etoposide;1.Cisplatin;0.Etoposide;1.Etoposide;"
"361","103.61.1429.5","Solid Tumor","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, induction",61,"Cisplatin & Etoposide (EP)",FALSE,"4","17.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;17.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;","17.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;"
"362","103.61.1430.1","Solid Tumor","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, induction",61,"Cisplatin & Etoposide (EP) & Bevacizumab",TRUE,"Cont.","19.Bevacizumab;0.Cisplatin;0.Etoposide;1.Etoposide;1.Etoposide;19.Bevacizumab;0.Cisplatin;0.Etoposide;1.Etoposide;1.Etoposide;","19.Bevacizumab;0.Cisplatin;0.Etoposide;1.Etoposide;1.Etoposide;"
"363","103.61.1431.1","Solid Tumor","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, induction",61,"Cisplatin & Etoposide (EP) & Durvalumab",TRUE,"Cont.","19.Cisplatin;0.Durvalumab;0.Etoposide;1.Etoposide;1.Etoposide;19.Cisplatin;0.Durvalumab;0.Etoposide;1.Etoposide;1.Etoposide;","19.Cisplatin;0.Durvalumab;0.Etoposide;1.Etoposide;1.Etoposide;"
"364","103.61.1431.2","Solid Tumor","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, induction",61,"Cisplatin & Etoposide (EP) & Durvalumab",TRUE,"Cont.","26.Cisplatin;0.Durvalumab;0.Etoposide;1.Etoposide;1.Etoposide;26.Cisplatin;0.Durvalumab;0.Etoposide;1.Etoposide;1.Etoposide;","26.Cisplatin;0.Durvalumab;0.Etoposide;1.Etoposide;1.Etoposide;"
"365","103.61.1432.1","Solid Tumor","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, induction",61,"Cisplatin & Irinotecan (IC)",TRUE,"Cont.","14.Cisplatin;0.Irinotecan;7.Cisplatin;0.Irinotecan;14.Cisplatin;0.Irinotecan;7.Cisplatin;0.Irinotecan;","14.Cisplatin;0.Irinotecan;7.Cisplatin;0.Irinotecan;"
"366","103.61.1432.2","Solid Tumor","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, induction",61,"Cisplatin & Irinotecan (IC)",TRUE,"Cont.","14.Cisplatin;0.Irinotecan;7.Irinotecan;14.Cisplatin;0.Irinotecan;7.Irinotecan;","14.Cisplatin;0.Irinotecan;7.Irinotecan;"
"367","103.61.1433.1","Solid Tumor","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, induction",61,"Ifosfamide monotherapy",TRUE,"Cont.","17.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;17.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;","17.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;"
"368","103.61.1434.1","Solid Tumor","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, induction",61,"IVE",TRUE,"Cont.","19.Epirubicin;0.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;19.Epirubicin;0.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;","19.Epirubicin;0.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;"
"369","103.61.1435.1","Solid Tumor","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, induction",61,"Teniposide monotherapy",TRUE,"Cont.","17.Teniposide;1.Teniposide;1.Teniposide;1.Teniposide;1.Teniposide;17.Teniposide;1.Teniposide;1.Teniposide;1.Teniposide;1.Teniposide;","17.Teniposide;1.Teniposide;1.Teniposide;1.Teniposide;1.Teniposide;"
"370","103.62.1436.1","Solid Tumor","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, maintenance after first-line therapy",62,"Sunitinib monotherapy",TRUE,"Cont.","1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;","1.Sunitinib;1.Sunitinib;"
"371","103.97.1420.1","Solid Tumor","Thoraic Oncology","Small cell lung cancer",103,"Limited stage, definitive chemoradiotherapy",97,"Carboplatin, Etoposide, RT",TRUE,"Cont.","19.Carboplatin;0.Etoposide;1.Etoposide;1.Etoposide;19.Carboplatin;0.Etoposide;1.Etoposide;1.Etoposide;","19.Carboplatin;0.Etoposide;1.Etoposide;1.Etoposide;"
"372","103.97.1421.1","Solid Tumor","Thoraic Oncology","Small cell lung cancer",103,"Limited stage, definitive chemoradiotherapy",97,"Cisplatin, Etoposide, RT",TRUE,"Cont.","19.Cisplatin;0.Etoposide;1.Etoposide;1.Etoposide;19.Cisplatin;0.Etoposide;1.Etoposide;1.Etoposide;","19.Cisplatin;0.Etoposide;1.Etoposide;1.Etoposide;"
"373","103.97.1421.2","Solid Tumor","Thoraic Oncology","Small cell lung cancer",103,"Limited stage, definitive chemoradiotherapy",97,"Cisplatin, Etoposide, RT",TRUE,"Cont.","26.Cisplatin;0.Etoposide;1.Etoposide;1.Etoposide;26.Cisplatin;0.Etoposide;1.Etoposide;1.Etoposide;","26.Cisplatin;0.Etoposide;1.Etoposide;1.Etoposide;"
"374","104.154.1450.1","Solid Tumor","Thoraic Oncology","Thymoma",104,"Neoadjuvant therapy for borderline resectable disease",154,"PAC",FALSE,"3","19.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;1.Cisplatin;1.Cisplatin;19.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;1.Cisplatin;1.Cisplatin;","19.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;1.Cisplatin;1.Cisplatin;"
"375","104.154.1450.2","Solid Tumor","Thoraic Oncology","Thymoma",104,"Neoadjuvant therapy for borderline resectable disease",154,"PAC",FALSE,"3","26.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;1.Cisplatin;1.Cisplatin;26.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;1.Cisplatin;1.Cisplatin;","26.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;1.Cisplatin;1.Cisplatin;"
"376","104.154.1450.3","Solid Tumor","Thoraic Oncology","Thymoma",104,"Neoadjuvant therapy for borderline resectable disease",154,"PAC",FALSE,"3","18.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;1.Cisplatin;0.Doxorubicin;1.Cisplatin;0.Doxorubicin;1.Doxorubicin;18.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;1.Cisplatin;0.Doxorubicin;1.Cisplatin;0.Doxorubicin;1.Doxorubicin;","18.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;1.Cisplatin;0.Doxorubicin;1.Cisplatin;0.Doxorubicin;1.Doxorubicin;"
"377","104.154.1450.4","Solid Tumor","Thoraic Oncology","Thymoma",104,"Neoadjuvant therapy for borderline resectable disease",154,"PAC",FALSE,"3","25.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;1.Cisplatin;0.Doxorubicin;1.Cisplatin;0.Doxorubicin;1.Doxorubicin;25.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;1.Cisplatin;0.Doxorubicin;1.Cisplatin;0.Doxorubicin;1.Doxorubicin;","25.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;1.Cisplatin;0.Doxorubicin;1.Cisplatin;0.Doxorubicin;1.Doxorubicin;"
"378","104.20.1451.1","Solid Tumor","Thoraic Oncology","Thymoma",104,"Advanced or metastatic disease, first-line therapy",20,"ADOC",TRUE,"Cont.","18.Cisplatin;0.Doxorubicin;2.Vincristine;1.Cyclophosphamide;18.Cisplatin;0.Doxorubicin;2.Vincristine;1.Cyclophosphamide;","18.Cisplatin;0.Doxorubicin;2.Vincristine;1.Cyclophosphamide;"
"379","104.20.1451.2","Solid Tumor","Thoraic Oncology","Thymoma",104,"Advanced or metastatic disease, first-line therapy",20,"ADOC",TRUE,"Cont.","25.Cisplatin;0.Doxorubicin;2.Vincristine;1.Cyclophosphamide;25.Cisplatin;0.Doxorubicin;2.Vincristine;1.Cyclophosphamide;","25.Cisplatin;0.Doxorubicin;2.Vincristine;1.Cyclophosphamide;"
"380","104.20.1452.1","Solid Tumor","Thoraic Oncology","Thymoma",104,"Advanced or metastatic disease, first-line therapy",20,"PAC",TRUE,"Cont.","21.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;21.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;","21.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;"
"381","104.20.1453.1","Solid Tumor","Thoraic Oncology","Thymoma",104,"Advanced or metastatic disease, first-line therapy",20,"VIP",FALSE,"4","18.Cisplatin;0.Etoposide;0.Ifosfamide;1.Cisplatin;0.Etoposide;0.Ifosfamide;1.Cisplatin;0.Etoposide;0.Ifosfamide;1.Cisplatin;0.Etoposide;0.Ifosfamide;18.Cisplatin;0.Etoposide;0.Ifosfamide;1.Cisplatin;0.Etoposide;0.Ifosfamide;1.Cisplatin;0.Etoposide;0.Ifosfamide;1.Cisplatin;0.Etoposide;0.Ifosfamide;","18.Cisplatin;0.Etoposide;0.Ifosfamide;1.Cisplatin;0.Etoposide;0.Ifosfamide;1.Cisplatin;0.Etoposide;0.Ifosfamide;1.Cisplatin;0.Etoposide;0.Ifosfamide;"
"382","104.26.1454.1","Solid Tumor","Thoraic Oncology","Thymoma",104,"Advanced or metastatic disease, subsequent lines of therapy",26,"Capecitabine & Gemcitabine",TRUE,"Cont.","8.Capecitabine;0.Gemcitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Gemcitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Capecitabine;0.Gemcitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Gemcitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Capecitabine;0.Gemcitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Gemcitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"383","104.26.1455.1","Solid Tumor","Thoraic Oncology","Thymoma",104,"Advanced or metastatic disease, subsequent lines of therapy",26,"Everolimus monotherapy",TRUE,"Cont.","1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;","1.Everolimus;1.Everolimus;"
"384","104.26.1456.1","Solid Tumor","Thoraic Oncology","Thymoma",104,"Advanced or metastatic disease, subsequent lines of therapy",26,"Octreotide monotherapy",TRUE,"Cont.","1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;","1.Ocreotide;1.Ocreotide;"
"385","104.26.1457.1","Solid Tumor","Thoraic Oncology","Thymoma",104,"Advanced or metastatic disease, subsequent lines of therapy",26,"Sunitinib monotherapy",TRUE,"Cont.","15.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;15.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;","15.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;"
"386","105.31.1458.1","Solid Tumor","Site-agnostic","BRAF",105,"All lines of therapy",31,"Dabrafenib & Trametinib",TRUE,"Cont.","1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;","1.Dabrafenib;0.Trametinib;"
"387","105.31.1459.1","Solid Tumor","Site-agnostic","BRAF",105,"All lines of therapy",31,"Vemurafenib monotherapy",TRUE,"Cont.","1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;","1.Vemurafenib;1.Vemurafenib;"
"388","106.31.1460.1","Solid Tumor","Site-agnostic","EGFR",106,"All lines of therapy",31,"Erlotinib monotherapy",TRUE,"Cont.","1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;","1.Erlotinib;1.Erlotinib;"
"389","107.31.1461.1","Solid Tumor","Site-agnostic","ERBB2 (HER2)",107,"All lines of therapy",31,"Neratinib monotherapy",TRUE,"Cont.","1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;","1.Neratinib;1.Neratinib;"
"390","107.31.1462.1","Solid Tumor","Site-agnostic","ERBB2 (HER2)",107,"All lines of therapy",31,"Pertuzumab & Trastuzumab",TRUE,"Cont.","21.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;","21.Pertuzumab;0.Trastuzumab;"
"391","107.31.1463.1","Solid Tumor","Site-agnostic","ERBB2 (HER2)",107,"All lines of therapy",31,"Trastuzumab emtansine monotherapy",TRUE,"Cont.","21.Trastuzumabemtansine;21.Trastuzumabemtansine;","21.Trastuzumabemtansine;21.Trastuzumabemtansine;"
"392","109.31.1464.1","Solid Tumor","Site-agnostic","MSI-H or dMMR",109,"All lines of therapy",31,"Dostarlimab monotherapy",TRUE,"Cont.","21.Dostarlimab;21.Dostarlimab;","21.Dostarlimab;21.Dostarlimab;"
"393","109.31.1464.2","Solid Tumor","Site-agnostic","MSI-H or dMMR",109,"All lines of therapy",31,"Dostarlimab monotherapy",TRUE,"Cont.","42.Dostarlimab;42.Dostarlimab;","42.Dostarlimab;42.Dostarlimab;"
"394","109.31.1465.1","Solid Tumor","Site-agnostic","MSI-H or dMMR",109,"All lines of therapy",31,"Envafolimab monotherapy",TRUE,"Cont.","7.Envafolimab;7.Envafolimab;7.Envafolimab;7.Envafolimab;7.Envafolimab;7.Envafolimab;7.Envafolimab;7.Envafolimab;","7.Envafolimab;7.Envafolimab;"
"395","109.31.1466.1","Solid Tumor","Site-agnostic","MSI-H or dMMR",109,"All lines of therapy",31,"Pembrolizumab monotherapy",TRUE,"Cont.","14.Pembrolizumab;14.Pembrolizumab;","14.Pembrolizumab;14.Pembrolizumab;"
"396","109.31.1466.2","Solid Tumor","Site-agnostic","MSI-H or dMMR",109,"All lines of therapy",31,"Pembrolizumab monotherapy",TRUE,"Cont.","21.Pembrolizumab;21.Pembrolizumab;","21.Pembrolizumab;21.Pembrolizumab;"
"397","11.16.375.1","Solid Tumor","Dermatologic Oncology","Melanoma, BRAF-mutated",11,"Advanced or metastatic disease, BRAF inhibitor-naive",16,"Dacarbazine monotherapy",TRUE,"Cont.","21.Dacarbazine;21.Dacarbazine;","21.Dacarbazine;21.Dacarbazine;"
"398","11.16.376.1","Solid Tumor","Dermatologic Oncology","Melanoma, BRAF-mutated",11,"Advanced or metastatic disease, BRAF inhibitor-naive",16,"Ipilimumab & Nivolumab",FALSE,"4","21.Ipilimumab;0.Nivolumab;21.Ipilimumab;0.Nivolumab;","21.Ipilimumab;0.Nivolumab;"
"399","11.16.376.2","Solid Tumor","Dermatologic Oncology","Melanoma, BRAF-mutated",11,"Advanced or metastatic disease, BRAF inhibitor-naive",16,"Ipilimumab & Nivolumab",TRUE,"Cont.","14.Ipilimumab;0.Nivolumab;14.Ipilimumab;0.Nivolumab;","14.Ipilimumab;0.Nivolumab;"
"400","11.16.377.1","Solid Tumor","Dermatologic Oncology","Melanoma, BRAF-mutated",11,"Advanced or metastatic disease, BRAF inhibitor-naive",16,"Trametinib monotherapy",TRUE,"Cont.","1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;","1.Trametinib;1.Trametinib;"
"401","11.16.387.1","Solid Tumor","Dermatologic Oncology","Melanoma, BRAF-mutated",11,"Advanced or metastatic disease, BRAF inhibitor-naive",16,"Binimetinib & Encorafenib",TRUE,"Cont.","1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;","1.Binimetinib;0.Encorafenib;"
"402","11.16.388.1","Solid Tumor","Dermatologic Oncology","Melanoma, BRAF-mutated",11,"Advanced or metastatic disease, BRAF inhibitor-naive",16,"Cobimetinib & Vemurafenib",TRUE,"Cont.","1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;","1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;"
"403","11.16.389.1","Solid Tumor","Dermatologic Oncology","Melanoma, BRAF-mutated",11,"Advanced or metastatic disease, BRAF inhibitor-naive",16,"Cobimetinib, Vemurafenib, Atezolizumab",TRUE,"Cont.","1.Atezolizumab;0.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Atezolizumab;0.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Atezolizumab;0.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Atezolizumab;0.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;","1.Atezolizumab;0.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Atezolizumab;0.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Cobimetinib;0.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;"
"404","11.16.390.1","Solid Tumor","Dermatologic Oncology","Melanoma, BRAF-mutated",11,"Advanced or metastatic disease, BRAF inhibitor-naive",16,"Dabrafenib monotherapy",TRUE,"Cont.","1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;","1.Dabrafenib;1.Dabrafenib;"
"405","11.4.385.1","Solid Tumor","Dermatologic Oncology","Melanoma, BRAF-mutated",11,"Adjuvant therapy",4,"Dabrafenib & Trametinib",TRUE,"Cont.","1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;","1.Dabrafenib;0.Trametinib;"
"406","11.4.386.1","Solid Tumor","Dermatologic Oncology","Melanoma, BRAF-mutated",11,"Adjuvant therapy",4,"Vemurafenib monotherapy",TRUE,"Cont.","1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;","1.Vemurafenib;1.Vemurafenib;"
"407","110.31.1467.1","Solid Tumor","Site-agnostic","NTRK",110,"All lines of therapy",31,"Entrectinib monotherapy",TRUE,"Cont.","1.Entrectinib;1.Entrectinib;1.Entrectinib;1.Entrectinib;1.Entrectinib;1.Entrectinib;1.Entrectinib;1.Entrectinib;1.Entrectinib;1.Entrectinib;1.Entrectinib;1.Entrectinib;1.Entrectinib;1.Entrectinib;","1.Entrectinib;1.Entrectinib;"
"408","110.31.1468.1","Solid Tumor","Site-agnostic","NTRK",110,"All lines of therapy",31,"Larotrectinib monotherapy",TRUE,"Cont.","1.Larotrectinib;1.Larotrectinib;1.Larotrectinib;1.Larotrectinib;1.Larotrectinib;1.Larotrectinib;1.Larotrectinib;1.Larotrectinib;1.Larotrectinib;1.Larotrectinib;1.Larotrectinib;1.Larotrectinib;1.Larotrectinib;1.Larotrectinib;","1.Larotrectinib;1.Larotrectinib;"
"409","111.31.1469.1","Solid Tumor","Site-agnostic","SMO or PTCH-1 (Hedgehog)",111,"All lines of therapy",31,"Vismodegib monotherapy",TRUE,"Cont.","1.Vismodegib;1.Vismodegib;1.Vismodegib;1.Vismodegib;1.Vismodegib;1.Vismodegib;1.Vismodegib;1.Vismodegib;1.Vismodegib;1.Vismodegib;1.Vismodegib;1.Vismodegib;1.Vismodegib;1.Vismodegib;","1.Vismodegib;1.Vismodegib;"
"410","113.31.1470.1","Solid Tumor","Site-agnostic","Carcinoma of unknown primary",113,"All lines of therapy",31,"BEP",TRUE,"Cont.","7.Bleomycin;0.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;3.Bleomycin;7.Bleomycin;7.Bleomycin;0.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;3.Bleomycin;7.Bleomycin;","7.Bleomycin;0.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;3.Bleomycin;7.Bleomycin;"
"411","113.31.1471.1","Solid Tumor","Site-agnostic","Carcinoma of unknown primary",113,"All lines of therapy",31,"Carboplatin & Docetaxel",TRUE,"Cont.","21.Carboplatin;0.Docetaxel;21.Carboplatin;0.Docetaxel;","21.Carboplatin;0.Docetaxel;"
"412","113.31.1472.1","Solid Tumor","Site-agnostic","Carcinoma of unknown primary",113,"All lines of therapy",31,"Carboplatin & Paclitaxel (CP)",TRUE,"Cont.","21.Carboplatin;0.Paclitaxel;21.Carboplatin;0.Paclitaxel;","21.Carboplatin;0.Paclitaxel;"
"413","113.31.1473.1","Solid Tumor","Site-agnostic","Carcinoma of unknown primary",113,"All lines of therapy",31,"Cisplatin monotherapy",TRUE,"Cont.","21.Cisplatin;21.Cisplatin;","21.Cisplatin;21.Cisplatin;"
"414","113.31.1474.1","Solid Tumor","Site-agnostic","Carcinoma of unknown primary",113,"All lines of therapy",31,"Cisplatin & Docetaxel (DC)",TRUE,"Cont.","21.Cisplatin;0.Docetaxel;21.Cisplatin;0.Docetaxel;","21.Cisplatin;0.Docetaxel;"
"415","113.31.1475.1","Solid Tumor","Site-agnostic","Carcinoma of unknown primary",113,"All lines of therapy",31,"Cisplatin & Gemcitabine (GC)",TRUE,"Cont.","14.Cisplatin;0.Gemcitabine;7.Gemcitabine;14.Cisplatin;0.Gemcitabine;7.Gemcitabine;","14.Cisplatin;0.Gemcitabine;7.Gemcitabine;"
"416","113.31.1476.1","Solid Tumor","Site-agnostic","Carcinoma of unknown primary",113,"All lines of therapy",31,"Cisplatin & Irinotecan (IC)",TRUE,"Cont.","21.Cisplatin;0.Irinotecan;21.Cisplatin;0.Irinotecan;","21.Cisplatin;0.Irinotecan;"
"417","113.31.1477.1","Solid Tumor","Site-agnostic","Carcinoma of unknown primary",113,"All lines of therapy",31,"DCF",FALSE,"3","21.Cisplatin;0.Docetaxel;0.Fluorouracil;21.Cisplatin;0.Docetaxel;0.Fluorouracil;","21.Cisplatin;0.Docetaxel;0.Fluorouracil;"
"418","113.31.1477.2","Solid Tumor","Site-agnostic","Carcinoma of unknown primary",113,"All lines of therapy",31,"DCF",FALSE,"3","16.Cisplatin;0.Docetaxel;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;16.Cisplatin;0.Docetaxel;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","16.Cisplatin;0.Docetaxel;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"419","113.31.1478.1","Solid Tumor","Site-agnostic","Carcinoma of unknown primary",113,"All lines of therapy",31,"Docetaxel & Gemcitabine",TRUE,"Cont.","14.Gemcitabine;7.Docetaxel;0.Gemcitabine;14.Gemcitabine;7.Docetaxel;0.Gemcitabine;","14.Gemcitabine;7.Docetaxel;0.Gemcitabine;"
"420","113.31.1479.1","Solid Tumor","Site-agnostic","Carcinoma of unknown primary",113,"All lines of therapy",31,"Erlotinib & Bevacizumab",TRUE,"Cont.","1.Bevacizumab;0.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Bevacizumab;0.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Bevacizumab;0.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Bevacizumab;0.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;","1.Bevacizumab;0.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;"
"421","113.31.1480.1","Solid Tumor","Site-agnostic","Carcinoma of unknown primary",113,"All lines of therapy",31,"GCP",TRUE,"Cont.","14.Carboplatin;0.Gemcitabine;0.Paclitaxel;7.Gemcitabine;14.Carboplatin;0.Gemcitabine;0.Paclitaxel;7.Gemcitabine;","14.Carboplatin;0.Gemcitabine;0.Paclitaxel;7.Gemcitabine;"
"422","113.31.1481.1","Solid Tumor","Site-agnostic","Carcinoma of unknown primary",113,"All lines of therapy",31,"Gemcitabine & Irinotecan",TRUE,"Cont.","14.Gemcitabine;0.Irinotecan;7.Gemcitabine;0.Irinotecan;14.Gemcitabine;0.Irinotecan;7.Gemcitabine;0.Irinotecan;","14.Gemcitabine;0.Irinotecan;7.Gemcitabine;0.Irinotecan;"
"423","113.31.1482.1","Solid Tumor","Site-agnostic","Carcinoma of unknown primary",113,"All lines of therapy",31,"PCE",TRUE,"Cont.","1.Carboplatin;0.Etoposide;0.Paclitaxel;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Carboplatin;0.Etoposide;0.Paclitaxel;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;","1.Carboplatin;0.Etoposide;0.Paclitaxel;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;"
"424","113.31.1483.1","Solid Tumor","Site-agnostic","Carcinoma of unknown primary",113,"All lines of therapy",31,"PCF",FALSE,"3","20.Fluorouracil;0.Paclitaxel;1.Cisplatin;20.Fluorouracil;0.Paclitaxel;1.Cisplatin;","20.Fluorouracil;0.Paclitaxel;1.Cisplatin;"
"425","113.31.1483.2","Solid Tumor","Site-agnostic","Carcinoma of unknown primary",113,"All lines of therapy",31,"PCF",FALSE,"3","16.Fluorouracil;0.Paclitaxel;1.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;16.Fluorouracil;0.Paclitaxel;1.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","16.Fluorouracil;0.Paclitaxel;1.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"426","114.114.1537.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Maintenance after first-line therapy",114,"Azacitidine monotherapy",TRUE,"Cont.","24.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;24.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;","24.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;"
"427","114.114.1538.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Maintenance after first-line therapy",114,"Azacitidine oral monotherapy",TRUE,"Cont.","15.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;15.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;","15.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;"
"428","114.114.1539.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Maintenance after first-line therapy",114,"Gemtuzumab ozogamicin monotherapy",TRUE,"Cont.","28.Gemtuzumabozogamicin;28.Gemtuzumabozogamicin;","28.Gemtuzumabozogamicin;28.Gemtuzumabozogamicin;"
"429","114.114.1540.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Maintenance after first-line therapy",114,"Low-dose Cytarabine monotherapy (LoDAC)",TRUE,"Cont.","36.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;36.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;","36.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"430","114.114.1541.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Maintenance after first-line therapy",114,"Sorafenib monotherapy",TRUE,"Cont.","1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;","1.Sorafenib;1.Sorafenib;"
"431","114.184.1542.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Relapsed or refractory, salvage therapy",184,"5+2d",FALSE,"1","0.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;","0.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"432","114.184.1543.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Relapsed or refractory, salvage therapy",184,"ADE (standard-dose Ara-C)",FALSE,"1","0.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;","0.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"433","114.184.1543.2","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Relapsed or refractory, salvage therapy",184,"ADE (standard-dose Ara-C)",FALSE,"1","0.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;1.Cytarabine;1.Cytarabine;","0.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"434","114.184.1544.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Relapsed or refractory, salvage therapy",184,"CLAG",FALSE,"1","0.Cladribine;0.Cytarabine;1.Cladribine;0.Cytarabine;1.Cladribine;0.Cytarabine;1.Cladribine;0.Cytarabine;1.Cladribine;0.Cytarabine;","0.Cladribine;0.Cytarabine;1.Cladribine;0.Cytarabine;1.Cladribine;0.Cytarabine;1.Cladribine;0.Cytarabine;1.Cladribine;0.Cytarabine;"
"435","114.184.1545.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Relapsed or refractory, salvage therapy",184,"CLAG-M",FALSE,"1","0.Cladribine;0.Cytarabine;0.Mitoxantrone;1.Cladribine;0.Cytarabine;0.Mitoxantrone;1.Cladribine;0.Cytarabine;0.Mitoxantrone;1.Cladribine;0.Cytarabine;1.Cladribine;0.Cytarabine;","0.Cladribine;0.Cytarabine;0.Mitoxantrone;1.Cladribine;0.Cytarabine;0.Mitoxantrone;1.Cladribine;0.Cytarabine;0.Mitoxantrone;1.Cladribine;0.Cytarabine;1.Cladribine;0.Cytarabine;"
"436","114.184.1546.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Relapsed or refractory, salvage therapy",184,"CLARA",FALSE,"1","0.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;","0.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;"
"437","114.184.1547.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Relapsed or refractory, salvage therapy",184,"Clofarabine & Cytarabine",TRUE,"Cont.","19.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;19.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;","19.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"438","114.184.1547.2","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Relapsed or refractory, salvage therapy",184,"Clofarabine & Cytarabine",TRUE,"Cont.","15.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;15.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;","15.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"439","114.184.1547.3","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Relapsed or refractory, salvage therapy",184,"Clofarabine & Cytarabine",TRUE,"Cont.","24.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;24.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;","24.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;"
"440","114.184.1548.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Relapsed or refractory, salvage therapy",184,"FLAG",FALSE,"1","0.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;","0.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;"
"441","114.184.1549.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Relapsed or refractory, salvage therapy",184,"FLAG-Ida",FALSE,"1","0.Cytarabine;0.Fludarabine;0.Idarubicin;1.Cytarabine;0.Fludarabine;0.Idarubicin;1.Cytarabine;0.Fludarabine;0.Idarubicin;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;","0.Cytarabine;0.Fludarabine;0.Idarubicin;1.Cytarabine;0.Fludarabine;0.Idarubicin;1.Cytarabine;0.Fludarabine;0.Idarubicin;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;"
"442","114.184.1550.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Relapsed or refractory, salvage therapy",184,"F-SHAI",FALSE,"1","0.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;1.Idarubicin;1.Idarubicin;4.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;1.Idarubicin;1.Idarubicin;","0.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;1.Idarubicin;1.Idarubicin;4.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;1.Idarubicin;1.Idarubicin;"
"443","114.184.1551.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Relapsed or refractory, salvage therapy",184,"Gemtuzumab ozogamicin monotherapy",FALSE,"1","0.Gemtuzumabozogamicin;3.Gemtuzumabozogamicin;3.Gemtuzumabozogamicin;","0.Gemtuzumabozogamicin;3.Gemtuzumabozogamicin;3.Gemtuzumabozogamicin;"
"444","114.184.1551.2","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Relapsed or refractory, salvage therapy",184,"Gemtuzumab ozogamicin monotherapy",FALSE,"1","0.Gemtuzumabozogamicin;","0.Gemtuzumabozogamicin;0.Gemtuzumabozogamicin;"
"445","114.184.1552.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Relapsed or refractory, salvage therapy",184,"High-dose Cytarabine monotherapy (HiDAC)",FALSE,"1","0.Cytarabine;0.Cytarabine;1.Cytarabine;0.Cytarabine;1.Cytarabine;0.Cytarabine;","0.Cytarabine;0.Cytarabine;1.Cytarabine;0.Cytarabine;1.Cytarabine;0.Cytarabine;"
"446","114.184.1553.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Relapsed or refractory, salvage therapy",184,"Intermediate-dose Cytarabine monotherapy (IDAC)",TRUE,"Cont.","24.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;24.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;","24.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"447","114.184.1554.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Relapsed or refractory, salvage therapy",184,"MAC",FALSE,"1","0.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Mitoxantrone;","0.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Mitoxantrone;"
"448","114.184.1554.2","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Relapsed or refractory, salvage therapy",184,"MAC",FALSE,"1","0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;","0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;"
"449","114.184.1555.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Relapsed or refractory, salvage therapy",184,"MEC",FALSE,"1","0.Cytarabine;0.Etoposide;0.Mitoxantrone;1.Cytarabine;0.Etoposide;0.Mitoxantrone;1.Cytarabine;0.Etoposide;0.Mitoxantrone;1.Cytarabine;0.Etoposide;0.Mitoxantrone;1.Cytarabine;0.Etoposide;0.Mitoxantrone;1.Cytarabine;0.Etoposide;0.Mitoxantrone;","0.Cytarabine;0.Etoposide;0.Mitoxantrone;1.Cytarabine;0.Etoposide;0.Mitoxantrone;1.Cytarabine;0.Etoposide;0.Mitoxantrone;1.Cytarabine;0.Etoposide;0.Mitoxantrone;1.Cytarabine;0.Etoposide;0.Mitoxantrone;1.Cytarabine;0.Etoposide;0.Mitoxantrone;"
"450","114.184.1555.2","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Relapsed or refractory, salvage therapy",184,"MEC",TRUE,"Cont.","24.Cytarabine;0.Etoposide;0.Mitoxantrone;1.Cytarabine;0.Etoposide;0.Mitoxantrone;1.Cytarabine;0.Etoposide;0.Mitoxantrone;1.Cytarabine;0.Etoposide;0.Mitoxantrone;1.Cytarabine;0.Etoposide;0.Mitoxantrone;24.Cytarabine;0.Etoposide;0.Mitoxantrone;1.Cytarabine;0.Etoposide;0.Mitoxantrone;1.Cytarabine;0.Etoposide;0.Mitoxantrone;1.Cytarabine;0.Etoposide;0.Mitoxantrone;1.Cytarabine;0.Etoposide;0.Mitoxantrone;","24.Cytarabine;0.Etoposide;0.Mitoxantrone;1.Cytarabine;0.Etoposide;0.Mitoxantrone;1.Cytarabine;0.Etoposide;0.Mitoxantrone;1.Cytarabine;0.Etoposide;0.Mitoxantrone;1.Cytarabine;0.Etoposide;0.Mitoxantrone;"
"451","114.186.1559.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Relapsed or refractory, subsequent lines of therapy",186,"Ruxolitinib monotherapy",TRUE,"Cont.","1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;","1.Ruxolitinib;1.Ruxolitinib;"
"452","114.192.1501.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Subsequent induction therapy, standard and older ""fit"" patients",192,"DA 3+8",FALSE,"1","0.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;","0.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"453","114.192.1502.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Subsequent induction therapy, standard and older ""fit"" patients",192,"DA 3+8 & GO",FALSE,"1","0.Cytarabine;0.Daunorubicin;0.Gemtuzumabozogamicin;1.Cytarabine;1.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;","0.Cytarabine;0.Daunorubicin;0.Gemtuzumabozogamicin;1.Cytarabine;1.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"454","114.192.1508.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Subsequent induction therapy, standard and older ""fit"" patients",192,"CPX-351 monotherapy",FALSE,"1","0.CPX-351;2.CPX-351;2.CPX-351;","0.CPX-351;2.CPX-351;2.CPX-351;"
"455","114.192.1508.2","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Subsequent induction therapy, standard and older ""fit"" patients",192,"CPX-351 monotherapy",TRUE,"Cont.","17.CPX-351;2.CPX-351;2.CPX-351;17.CPX-351;2.CPX-351;2.CPX-351;","17.CPX-351;2.CPX-351;2.CPX-351;"
"456","114.192.1509.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Subsequent induction therapy, standard and older ""fit"" patients",192,"Decitabine monotherapy",TRUE,"Cont.","24.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;24.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;","24.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;"
"457","114.192.1509.2","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Subsequent induction therapy, standard and older ""fit"" patients",192,"Decitabine monotherapy",TRUE,"Cont.","31.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;31.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;","31.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;"
"458","114.192.1509.3","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Subsequent induction therapy, standard and older ""fit"" patients",192,"Decitabine monotherapy",TRUE,"Cont.","38.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;38.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;","38.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;"
"459","114.205.1484.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Upfront induction therapy, standard and older ""fit"" patients",205,"7+3d",FALSE,"1","0.Cytarabine;0.Daunorubicin;1.Daunorubicin;1.Daunorubicin;","0.Cytarabine;0.Daunorubicin;1.Daunorubicin;1.Daunorubicin;"
"460","114.205.1484.2","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Upfront induction therapy, standard and older ""fit"" patients",205,"7+3d",FALSE,"1","0.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;","0.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"461","114.205.1484.3","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Upfront induction therapy, standard and older ""fit"" patients",205,"7+3d",FALSE,"1","0.Cytarabine;2.Daunorubicin;1.Daunorubicin;1.Daunorubicin;","0.Cytarabine;2.Daunorubicin;1.Daunorubicin;1.Daunorubicin;"
"462","114.205.1484.4","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Upfront induction therapy, standard and older ""fit"" patients",205,"7+3d",FALSE,"1","0.Cytarabine;1.Cytarabine;1.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;","0.Cytarabine;1.Cytarabine;1.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;"
"463","114.205.1485.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Upfront induction therapy, standard and older ""fit"" patients",205,"7+3d & GO",FALSE,"1","0.Cytarabine;0.Daunorubicin;0.Gemtuzumabozogamicin;1.Daunorubicin;1.Daunorubicin;1.Gemtuzumabozogamicin;3.Gemtuzumabozogamicin;","0.Cytarabine;0.Daunorubicin;0.Gemtuzumabozogamicin;1.Daunorubicin;1.Daunorubicin;1.Gemtuzumabozogamicin;3.Gemtuzumabozogamicin;"
"464","114.205.1485.2","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Upfront induction therapy, standard and older ""fit"" patients",205,"7+3d & GO",FALSE,"1","0.Cytarabine;0.Daunorubicin;0.Gemtuzumabozogamicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Gemtuzumabozogamicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;0.Gemtuzumabozogamicin;","0.Cytarabine;0.Daunorubicin;0.Gemtuzumabozogamicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Gemtuzumabozogamicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;0.Gemtuzumabozogamicin;"
"465","114.205.1485.3","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Upfront induction therapy, standard and older ""fit"" patients",205,"7+3d & GO",FALSE,"1","0.Cytarabine;0.Daunorubicin;1.Daunorubicin;1.Daunorubicin;1.Gemtuzumabozogamicin;","0.Cytarabine;0.Daunorubicin;1.Daunorubicin;1.Daunorubicin;1.Gemtuzumabozogamicin;"
"466","114.205.1485.4","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Upfront induction therapy, standard and older ""fit"" patients",205,"7+3d & GO",FALSE,"1","0.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Gemtuzumabozogamicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;","0.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Gemtuzumabozogamicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"467","114.205.1486.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Upfront induction therapy, standard and older ""fit"" patients",205,"7+3i",FALSE,"1","0.Cytarabine;0.Idarubicin;1.Idarubicin;1.Idarubicin;","0.Cytarabine;0.Idarubicin;1.Idarubicin;1.Idarubicin;"
"468","114.205.1486.2","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Upfront induction therapy, standard and older ""fit"" patients",205,"7+3i",FALSE,"1","0.Cytarabine;0.Idarubicin;1.Cytarabine;0.Idarubicin;1.Cytarabine;0.Idarubicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;","0.Cytarabine;0.Idarubicin;1.Cytarabine;0.Idarubicin;1.Cytarabine;0.Idarubicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"469","114.205.1486.3","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Upfront induction therapy, standard and older ""fit"" patients",205,"7+3i",FALSE,"1","0.Cytarabine;4.Idarubicin;1.Idarubicin;1.Idarubicin;","0.Cytarabine;4.Idarubicin;1.Idarubicin;1.Idarubicin;"
"470","114.205.1486.4","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Upfront induction therapy, standard and older ""fit"" patients",205,"7+3i",FALSE,"1","0.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;0.Idarubicin;1.Cytarabine;0.Idarubicin;1.Cytarabine;0.Idarubicin;","0.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;0.Idarubicin;1.Cytarabine;0.Idarubicin;1.Cytarabine;0.Idarubicin;"
"471","114.205.1487.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Upfront induction therapy, standard and older ""fit"" patients",205,"7+3i & Sorafenib",FALSE,"1","0.Cytarabine;0.Idarubicin;0.Sorafenib;1.Idarubicin;0.Sorafenib;1.Idarubicin;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;","0.Cytarabine;0.Idarubicin;0.Sorafenib;1.Idarubicin;0.Sorafenib;1.Idarubicin;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;"
"472","114.205.1487.2","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Upfront induction therapy, standard and older ""fit"" patients",205,"7+3i & Sorafenib",FALSE,"1","0.Cytarabine;0.Idarubicin;0.Sorafenib;1.Cytarabine;0.Idarubicin;0.Sorafenib;1.Cytarabine;0.Idarubicin;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Cytarabine;0.Sorafenib;","0.Cytarabine;0.Idarubicin;0.Sorafenib;1.Cytarabine;0.Idarubicin;0.Sorafenib;1.Cytarabine;0.Idarubicin;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Cytarabine;0.Sorafenib;"
"473","114.205.1488.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Upfront induction therapy, standard and older ""fit"" patients",205,"7+3d & Glasdegib",FALSE,"1","0.Glasdegib;4.Cytarabine;0.Daunorubicin;1.Daunorubicin;1.Daunorubicin;","0.Glasdegib;4.Cytarabine;0.Daunorubicin;1.Daunorubicin;1.Daunorubicin;"
"474","114.205.1488.2","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Upfront induction therapy, standard and older ""fit"" patients",205,"7+3d & Glasdegib",FALSE,"1","0.Glasdegib;4.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;","0.Glasdegib;4.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"475","114.205.1489.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Upfront induction therapy, standard and older ""fit"" patients",205,"7+3m",FALSE,"1","0.Cytarabine;0.Mitoxantrone;1.Mitoxantrone;1.Mitoxantrone;","0.Cytarabine;0.Mitoxantrone;1.Mitoxantrone;1.Mitoxantrone;"
"476","114.205.1489.2","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Upfront induction therapy, standard and older ""fit"" patients",205,"7+3m",FALSE,"1","0.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;","0.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"477","114.205.1490.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Upfront induction therapy, standard and older ""fit"" patients",205,"ADE (standard-dose Ara-C)",TRUE,"Cont.","1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Daunorubicin;0.Etoposide;1.Daunorubicin;0.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Daunorubicin;0.Etoposide;1.Daunorubicin;0.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;","1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Daunorubicin;0.Etoposide;1.Daunorubicin;0.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;"
"478","114.205.1490.2","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Upfront induction therapy, standard and older ""fit"" patients",205,"ADE (standard-dose Ara-C)",TRUE,"Cont.","1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;","1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;"
"479","114.205.1490.3","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Upfront induction therapy, standard and older ""fit"" patients",205,"ADE (standard-dose Ara-C)",TRUE,"Cont.","5.Cytarabine;0.Daunorubicin;0.Etoposide;1.Daunorubicin;0.Etoposide;1.Daunorubicin;0.Etoposide;5.Cytarabine;0.Daunorubicin;0.Etoposide;1.Daunorubicin;0.Etoposide;1.Daunorubicin;0.Etoposide;","5.Cytarabine;0.Daunorubicin;0.Etoposide;1.Daunorubicin;0.Etoposide;1.Daunorubicin;0.Etoposide;"
"480","114.205.1490.4","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Upfront induction therapy, standard and older ""fit"" patients",205,"ADE (standard-dose Ara-C)",TRUE,"Cont.","1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;","1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"481","114.205.1490.5","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Upfront induction therapy, standard and older ""fit"" patients",205,"ADE (standard-dose Ara-C)",TRUE,"Cont.","6.Cytarabine;0.Daunorubicin;0.Etoposide;1.Etoposide;1.Daunorubicin;0.Etoposide;1.Etoposide;1.Daunorubicin;0.Etoposide;6.Cytarabine;0.Daunorubicin;0.Etoposide;1.Etoposide;1.Daunorubicin;0.Etoposide;1.Etoposide;1.Daunorubicin;0.Etoposide;","6.Cytarabine;0.Daunorubicin;0.Etoposide;1.Etoposide;1.Daunorubicin;0.Etoposide;1.Etoposide;1.Daunorubicin;0.Etoposide;"
"482","114.205.1490.6","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Upfront induction therapy, standard and older ""fit"" patients",205,"ADE (standard-dose Ara-C)",TRUE,"Cont.","1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;","1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"483","114.205.1490.7","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Upfront induction therapy, standard and older ""fit"" patients",205,"ADE (standard-dose Ara-C)",TRUE,"Cont.","4.Cytarabine;0.Daunorubicin;0.Etoposide;1.Etoposide;1.Daunorubicin;0.Etoposide;1.Etoposide;1.Daunorubicin;0.Etoposide;4.Cytarabine;0.Daunorubicin;0.Etoposide;1.Etoposide;1.Daunorubicin;0.Etoposide;1.Etoposide;1.Daunorubicin;0.Etoposide;","4.Cytarabine;0.Daunorubicin;0.Etoposide;1.Etoposide;1.Daunorubicin;0.Etoposide;1.Etoposide;1.Daunorubicin;0.Etoposide;"
"484","114.205.1490.8","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Upfront induction therapy, standard and older ""fit"" patients",205,"ADE (standard-dose Ara-C)",TRUE,"Cont.","1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;1.Cytarabine;1.Cytarabine;","1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"485","114.205.1491.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Upfront induction therapy, standard and older ""fit"" patients",205,"ADE (high-dose Ara-C)",FALSE,"1","0.Cytarabine;0.Daunorubicin;0.Etoposide;1.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;2.Cytarabine;","0.Cytarabine;0.Daunorubicin;0.Etoposide;1.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;2.Cytarabine;"
"486","114.205.1491.2","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Upfront induction therapy, standard and older ""fit"" patients",205,"ADE (high-dose Ara-C)",FALSE,"1","0.Cytarabine;0.Daunorubicin;0.Etoposide;1.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Etoposide;1.Cytarabine;0.Etoposide;","0.Cytarabine;0.Daunorubicin;0.Etoposide;1.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Etoposide;1.Cytarabine;0.Etoposide;"
"487","114.205.1492.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Upfront induction therapy, standard and older ""fit"" patients",205,"AIE",FALSE,"1","0.Cytarabine;0.Etoposide;0.Idarubicin;1.Cytarabine;0.Etoposide;0.Idarubicin;1.Cytarabine;0.Etoposide;0.Idarubicin;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;1.Cytarabine;","0.Cytarabine;0.Etoposide;0.Idarubicin;1.Cytarabine;0.Etoposide;0.Idarubicin;1.Cytarabine;0.Etoposide;0.Idarubicin;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;1.Cytarabine;"
"488","114.205.1493.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Upfront induction therapy, standard and older ""fit"" patients",205,"CIA",FALSE,"1","0.Clofarabine;0.Cytarabine;0.Idarubicin;1.Clofarabine;0.Cytarabine;0.Idarubicin;1.Clofarabine;0.Cytarabine;0.Idarubicin;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;","0.Clofarabine;0.Cytarabine;0.Idarubicin;1.Clofarabine;0.Cytarabine;0.Idarubicin;1.Clofarabine;0.Cytarabine;0.Idarubicin;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;"
"489","114.205.1494.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Upfront induction therapy, standard and older ""fit"" patients",205,"DA 3 + 10",FALSE,"1","0.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;","0.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"490","114.205.1495.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Upfront induction therapy, standard and older ""fit"" patients",205,"DA 3 + 10, GO",FALSE,"1","0.Cytarabine;0.Daunorubicin;0.Gemtuzumabozogamicin;1.Cytarabine;1.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;","0.Cytarabine;0.Daunorubicin;0.Gemtuzumabozogamicin;1.Cytarabine;1.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"491","114.205.1496.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Upfront induction therapy, standard and older ""fit"" patients",205,"DAC",FALSE,"1","0.Cladribine;0.Cytarabine;0.Daunorubicin;1.Cladribine;0.Daunorubicin;1.Cladribine;0.Daunorubicin;1.Cladribine;1.Cladribine;","0.Cladribine;0.Cytarabine;0.Daunorubicin;1.Cladribine;0.Daunorubicin;1.Cladribine;0.Daunorubicin;1.Cladribine;1.Cladribine;"
"492","114.205.1496.2","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Upfront induction therapy, standard and older ""fit"" patients",205,"DAC",FALSE,"1","0.Cladribine;0.Cytarabine;0.Daunorubicin;1.Cladribine;0.Cytarabine;0.Daunorubicin;1.Cladribine;0.Cytarabine;0.Daunorubicin;1.Cladribine;0.Cytarabine;1.Cladribine;0.Cytarabine;1.Cytarabine;1.Cytarabine;","0.Cladribine;0.Cytarabine;0.Daunorubicin;1.Cladribine;0.Cytarabine;0.Daunorubicin;1.Cladribine;0.Cytarabine;0.Daunorubicin;1.Cladribine;0.Cytarabine;1.Cladribine;0.Cytarabine;1.Cytarabine;1.Cytarabine;"
"493","114.205.1497.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Upfront induction therapy, standard and older ""fit"" patients",205,"FLAG-Ida",FALSE,"1","0.Lenograstim;1.Cytarabine;0.Fludarabine;0.Lenograstim;1.Cytarabine;0.Fludarabine;0.Lenograstim;1.Cytarabine;0.Fludarabine;0.Idarubicin;0.Lenograstim;1.Cytarabine;0.Fludarabine;0.Idarubicin;0.Lenograstim;1.Cytarabine;0.Fludarabine;0.Idarubicin;0.Lenograstim;1.Lenograstim;","0.Lenograstim;1.Cytarabine;0.Fludarabine;0.Lenograstim;1.Cytarabine;0.Fludarabine;0.Lenograstim;1.Cytarabine;0.Fludarabine;0.Idarubicin;0.Lenograstim;1.Cytarabine;0.Fludarabine;0.Idarubicin;0.Lenograstim;1.Cytarabine;0.Fludarabine;0.Idarubicin;0.Lenograstim;1.Lenograstim;"
"494","114.205.1498.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Upfront induction therapy, standard and older ""fit"" patients",205,"HAA",FALSE,"1","0.Aclarubicin;0.Cytarabine;0.Omacetaxine;1.Aclarubicin;0.Cytarabine;0.Omacetaxine;1.Aclarubicin;0.Cytarabine;0.Omacetaxine;1.Aclarubicin;0.Cytarabine;0.Omacetaxine;1.Aclarubicin;0.Cytarabine;0.Omacetaxine;1.Aclarubicin;0.Cytarabine;0.Omacetaxine;1.Aclarubicin;0.Cytarabine;0.Omacetaxine;","0.Aclarubicin;0.Cytarabine;0.Omacetaxine;1.Aclarubicin;0.Cytarabine;0.Omacetaxine;1.Aclarubicin;0.Cytarabine;0.Omacetaxine;1.Aclarubicin;0.Cytarabine;0.Omacetaxine;1.Aclarubicin;0.Cytarabine;0.Omacetaxine;1.Aclarubicin;0.Cytarabine;0.Omacetaxine;1.Aclarubicin;0.Cytarabine;0.Omacetaxine;"
"495","114.205.1499.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Upfront induction therapy, standard and older ""fit"" patients",205,"ICL",FALSE,"1","0.Cytarabine;0.Idarubicin;0.Lomustine;1.Idarubicin;1.Idarubicin;1.Idarubicin;1.Idarubicin;","0.Cytarabine;0.Idarubicin;0.Lomustine;1.Idarubicin;1.Idarubicin;1.Idarubicin;1.Idarubicin;"
"496","114.205.1499.2","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Upfront induction therapy, standard and older ""fit"" patients",205,"ICL",FALSE,"1","0.Cytarabine;0.Idarubicin;0.Lomustine;1.Cytarabine;0.Idarubicin;1.Cytarabine;0.Idarubicin;1.Cytarabine;0.Idarubicin;1.Cytarabine;0.Idarubicin;1.Cytarabine;1.Cytarabine;","0.Cytarabine;0.Idarubicin;0.Lomustine;1.Cytarabine;0.Idarubicin;1.Cytarabine;0.Idarubicin;1.Cytarabine;0.Idarubicin;1.Cytarabine;0.Idarubicin;1.Cytarabine;1.Cytarabine;"
"497","114.205.1500.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Upfront induction therapy, standard and older ""fit"" patients",205,"MEC",FALSE,"1","0.Cytarabine;0.Etoposide;0.Mitoxantrone;1.Etoposide;1.Etoposide;0.Mitoxantrone;2.Mitoxantrone;","0.Cytarabine;0.Etoposide;0.Mitoxantrone;1.Etoposide;1.Etoposide;0.Mitoxantrone;2.Mitoxantrone;"
"498","114.205.1500.2","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Upfront induction therapy, standard and older ""fit"" patients",205,"MEC",FALSE,"1","0.Cytarabine;0.Etoposide;0.Mitoxantrone;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;0.Mitoxantrone;1.Cytarabine;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;1.Cytarabine;","0.Cytarabine;0.Etoposide;0.Mitoxantrone;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;0.Mitoxantrone;1.Cytarabine;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;1.Cytarabine;"
"499","114.205.1507.5","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Upfront induction therapy, standard and older ""fit"" patients",205,"Clofarabine & LoDAC",FALSE,"1","0.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;","0.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"500","114.41.1556.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after salvage therapy",41,"BuCy, then allo HSCT",FALSE,"1","0.Busulfan;1.Busulfan;1.Busulfan;1.Busulfan;1.Cyclophosphamide;1.Cyclophosphamide;","0.Busulfan;1.Busulfan;1.Busulfan;1.Busulfan;1.Cyclophosphamide;1.Cyclophosphamide;"
"501","114.41.1556.2","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after salvage therapy",41,"BuCy, then allo HSCT",FALSE,"1","0.Busulfan;1.Busulfan;1.Busulfan;1.Busulfan;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;","0.Busulfan;1.Busulfan;1.Busulfan;1.Busulfan;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;"
"502","114.41.1557.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after salvage therapy",41,"BuFlu, then allo HSCT",FALSE,"1","0.Busulfan;0.Fludarabine;1.Busulfan;0.Fludarabine;1.Busulfan;0.Fludarabine;1.Busulfan;0.Fludarabine;","0.Busulfan;0.Fludarabine;1.Busulfan;0.Fludarabine;1.Busulfan;0.Fludarabine;1.Busulfan;0.Fludarabine;"
"503","114.41.1557.2","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after salvage therapy",41,"BuFlu, then allo HSCT",FALSE,"1","0.Busulfan;1.Busulfan;0.Fludarabine;1.Busulfan;0.Fludarabine;1.Busulfan;0.Fludarabine;1.Fludarabine;1.Fludarabine;","0.Busulfan;1.Busulfan;0.Fludarabine;1.Busulfan;0.Fludarabine;1.Busulfan;0.Fludarabine;1.Fludarabine;1.Fludarabine;"
"504","114.41.1558.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after salvage therapy",41,"Clofarabine & Melphalan, then allo HSCT",FALSE,"1","0.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Melphalan;","0.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Melphalan;"
"505","114.44.1516.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after upfront therapy",44,"5+2d",FALSE,"1","0.Cytarabine;0.Daunorubicin;1.Daunorubicin;","0.Cytarabine;0.Daunorubicin;1.Daunorubicin;"
"506","114.44.1516.2","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after upfront therapy",44,"5+2d",FALSE,"1","0.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;","0.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"507","114.44.1517.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after upfront therapy",44,"High-dose Cytarabine monotherapy (HiDAC)",FALSE,"1","0.Cytarabine;2.Cytarabine;2.Cytarabine;","0.Cytarabine;2.Cytarabine;2.Cytarabine;"
"508","114.44.1517.2","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after upfront therapy",44,"High-dose Cytarabine monotherapy (HiDAC)",TRUE,"Cont.","24.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;24.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;","24.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"509","114.44.1517.3","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after upfront therapy",44,"High-dose Cytarabine monotherapy (HiDAC)",FALSE,"1","0.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;","0.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"510","114.44.1517.4","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after upfront therapy",44,"High-dose Cytarabine monotherapy (HiDAC)",FALSE,"1","0.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;","0.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"511","114.44.1517.5","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after upfront therapy",44,"High-dose Cytarabine monotherapy (HiDAC)",TRUE,"Cont.","24.Cytarabine;2.Cytarabine;2.Cytarabine;24.Cytarabine;2.Cytarabine;2.Cytarabine;","24.Cytarabine;2.Cytarabine;2.Cytarabine;"
"512","114.44.1518.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after upfront therapy",44,"HiDAC & G-CSF",FALSE,"3","31.Cytarabine;2.Cytarabine;2.Cytarabine;31.Cytarabine;2.Cytarabine;2.Cytarabine;","31.Cytarabine;2.Cytarabine;2.Cytarabine;"
"513","114.44.1519.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after upfront therapy",44,"Azacitidine monotherapy",FALSE,"4","28.Azacitidine;28.Azacitidine;","28.Azacitidine;28.Azacitidine;"
"514","114.44.1520.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after upfront therapy",44,"BuCy, then auto HSCT",FALSE,"1","0.Busulfan;1.Busulfan;1.Busulfan;1.Busulfan;1.Cyclophosphamide;1.Cyclophosphamide;","0.Busulfan;1.Busulfan;1.Busulfan;1.Busulfan;1.Cyclophosphamide;1.Cyclophosphamide;"
"515","114.44.1521.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after upfront therapy",44,"BuFlu, then allo HSCT",FALSE,"1","0.Fludarabine;1.Fludarabine;1.Fludarabine;1.Busulfan;0.Fludarabine;1.Busulfan;0.Fludarabine;","0.Fludarabine;1.Fludarabine;1.Fludarabine;1.Busulfan;0.Fludarabine;1.Busulfan;0.Fludarabine;"
"516","114.44.1522.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after upfront therapy",44,"CIA",TRUE,"Cont.","19.Clofarabine;0.Cytarabine;0.Idarubicin;1.Clofarabine;0.Cytarabine;0.Idarubicin;1.Clofarabine;0.Cytarabine;19.Clofarabine;0.Cytarabine;0.Idarubicin;1.Clofarabine;0.Cytarabine;0.Idarubicin;1.Clofarabine;0.Cytarabine;","19.Clofarabine;0.Cytarabine;0.Idarubicin;1.Clofarabine;0.Cytarabine;0.Idarubicin;1.Clofarabine;0.Cytarabine;"
"517","114.44.1522.2","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after upfront therapy",44,"CIA",TRUE,"Cont.","26.Clofarabine;0.Cytarabine;0.Idarubicin;1.Clofarabine;0.Cytarabine;0.Idarubicin;1.Clofarabine;0.Cytarabine;26.Clofarabine;0.Cytarabine;0.Idarubicin;1.Clofarabine;0.Cytarabine;0.Idarubicin;1.Clofarabine;0.Cytarabine;","26.Clofarabine;0.Cytarabine;0.Idarubicin;1.Clofarabine;0.Cytarabine;0.Idarubicin;1.Clofarabine;0.Cytarabine;"
"518","114.44.1523.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after upfront therapy",44,"CLARA",FALSE,"3","30.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;30.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;","30.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;"
"519","114.44.1524.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after upfront therapy",44,"Clofarabine & LoDAC/Decitabine",TRUE,"Cont.","22.Clofarabine;0.Cytarabine;0.Decitabine;1.Clofarabine;0.Cytarabine;0.Decitabine;1.Clofarabine;0.Cytarabine;0.Decitabine;1.Cytarabine;0.Decitabine;1.Cytarabine;0.Decitabine;1.Cytarabine;1.Cytarabine;22.Clofarabine;0.Cytarabine;0.Decitabine;1.Clofarabine;0.Cytarabine;0.Decitabine;1.Clofarabine;0.Cytarabine;0.Decitabine;1.Cytarabine;0.Decitabine;1.Cytarabine;0.Decitabine;1.Cytarabine;1.Cytarabine;","22.Clofarabine;0.Cytarabine;0.Decitabine;1.Clofarabine;0.Cytarabine;0.Decitabine;1.Clofarabine;0.Cytarabine;0.Decitabine;1.Cytarabine;0.Decitabine;1.Cytarabine;0.Decitabine;1.Cytarabine;1.Cytarabine;"
"520","114.44.1524.2","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after upfront therapy",44,"Clofarabine & LoDAC/Decitabine",TRUE,"Cont.","29.Clofarabine;0.Cytarabine;0.Decitabine;1.Clofarabine;0.Cytarabine;0.Decitabine;1.Clofarabine;0.Cytarabine;0.Decitabine;1.Cytarabine;0.Decitabine;1.Cytarabine;0.Decitabine;1.Cytarabine;1.Cytarabine;29.Clofarabine;0.Cytarabine;0.Decitabine;1.Clofarabine;0.Cytarabine;0.Decitabine;1.Clofarabine;0.Cytarabine;0.Decitabine;1.Cytarabine;0.Decitabine;1.Cytarabine;0.Decitabine;1.Cytarabine;1.Cytarabine;","29.Clofarabine;0.Cytarabine;0.Decitabine;1.Clofarabine;0.Cytarabine;0.Decitabine;1.Clofarabine;0.Cytarabine;0.Decitabine;1.Cytarabine;0.Decitabine;1.Cytarabine;0.Decitabine;1.Cytarabine;1.Cytarabine;"
"521","114.44.1524.3","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after upfront therapy",44,"Clofarabine & LoDAC/Decitabine",TRUE,"Cont.","36.Clofarabine;0.Cytarabine;0.Decitabine;1.Clofarabine;0.Cytarabine;0.Decitabine;1.Clofarabine;0.Cytarabine;0.Decitabine;1.Cytarabine;0.Decitabine;1.Cytarabine;0.Decitabine;1.Cytarabine;1.Cytarabine;36.Clofarabine;0.Cytarabine;0.Decitabine;1.Clofarabine;0.Cytarabine;0.Decitabine;1.Clofarabine;0.Cytarabine;0.Decitabine;1.Cytarabine;0.Decitabine;1.Cytarabine;0.Decitabine;1.Cytarabine;1.Cytarabine;","36.Clofarabine;0.Cytarabine;0.Decitabine;1.Clofarabine;0.Cytarabine;0.Decitabine;1.Clofarabine;0.Cytarabine;0.Decitabine;1.Cytarabine;0.Decitabine;1.Cytarabine;0.Decitabine;1.Cytarabine;1.Cytarabine;"
"522","114.44.1524.4","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after upfront therapy",44,"Clofarabine & LoDAC/Decitabine",TRUE,"Cont.","43.Clofarabine;0.Cytarabine;0.Decitabine;1.Clofarabine;0.Cytarabine;0.Decitabine;1.Clofarabine;0.Cytarabine;0.Decitabine;1.Cytarabine;0.Decitabine;1.Cytarabine;0.Decitabine;1.Cytarabine;1.Cytarabine;43.Clofarabine;0.Cytarabine;0.Decitabine;1.Clofarabine;0.Cytarabine;0.Decitabine;1.Clofarabine;0.Cytarabine;0.Decitabine;1.Cytarabine;0.Decitabine;1.Cytarabine;0.Decitabine;1.Cytarabine;1.Cytarabine;","43.Clofarabine;0.Cytarabine;0.Decitabine;1.Clofarabine;0.Cytarabine;0.Decitabine;1.Clofarabine;0.Cytarabine;0.Decitabine;1.Cytarabine;0.Decitabine;1.Cytarabine;0.Decitabine;1.Cytarabine;1.Cytarabine;"
"523","114.44.1525.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after upfront therapy",44,"CPX-351 monotherapy",TRUE,"Cont.","33.CPX-351;2.CPX-351;33.CPX-351;2.CPX-351;","33.CPX-351;2.CPX-351;"
"524","114.44.1525.2","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after upfront therapy",44,"CPX-351 monotherapy",TRUE,"Cont.","40.CPX-351;2.CPX-351;40.CPX-351;2.CPX-351;","40.CPX-351;2.CPX-351;"
"525","114.44.1525.3","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after upfront therapy",44,"CPX-351 monotherapy",TRUE,"Cont.","47.CPX-351;2.CPX-351;47.CPX-351;2.CPX-351;","47.CPX-351;2.CPX-351;"
"526","114.44.1525.4","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after upfront therapy",44,"CPX-351 monotherapy",TRUE,"Cont.","54.CPX-351;2.CPX-351;54.CPX-351;2.CPX-351;","54.CPX-351;2.CPX-351;"
"527","114.44.1526.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after upfront therapy",44,"Cytarabine & Daunorubicin",TRUE,"Cont.","25.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;25.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;","25.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"528","114.44.1526.2","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after upfront therapy",44,"Cytarabine & Daunorubicin",TRUE,"Cont.","25.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;25.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;","25.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;"
"529","114.44.1526.3","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after upfront therapy",44,"Cytarabine & Daunorubicin",TRUE,"Cont.","24.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;24.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;","24.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"530","114.44.1527.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after upfront therapy",44,"Cytarabine, Daunorubicin, Gemtuzumab ozogamicin",TRUE,"Cont.","25.Cytarabine;0.Daunorubicin;0.Gemtuzumabozogamicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;25.Cytarabine;0.Daunorubicin;0.Gemtuzumabozogamicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;","25.Cytarabine;0.Daunorubicin;0.Gemtuzumabozogamicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"531","114.44.1527.2","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after upfront therapy",44,"Cytarabine, Daunorubicin, Gemtuzumab ozogamicin",TRUE,"Cont.","25.Cytarabine;0.Daunorubicin;0.Gemtuzumabozogamicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;25.Cytarabine;0.Daunorubicin;0.Gemtuzumabozogamicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;","25.Cytarabine;0.Daunorubicin;0.Gemtuzumabozogamicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;"
"532","114.44.1528.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after upfront therapy",44,"CYVE",TRUE,"Cont.","2.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;1.Cytarabine;1.Cytarabine;2.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;1.Cytarabine;1.Cytarabine;","2.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"533","114.44.1529.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after upfront therapy",44,"Cytarabine & Idarubicin",TRUE,"Cont.","24.Cytarabine;0.Idarubicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;24.Cytarabine;0.Idarubicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;","24.Cytarabine;0.Idarubicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"534","114.44.1530.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after upfront therapy",44,"Cytarabine, Idarubicin, Sorafenib",TRUE,"Cont.","1.Cytarabine;0.Idarubicin;0.Sorafenib;1.Idarubicin;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Cytarabine;0.Idarubicin;0.Sorafenib;1.Idarubicin;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;","1.Cytarabine;0.Idarubicin;0.Sorafenib;1.Idarubicin;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;"
"535","114.44.1530.2","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after upfront therapy",44,"Cytarabine, Idarubicin, Sorafenib",TRUE,"Cont.","8.Cytarabine;0.Idarubicin;0.Sorafenib;1.Idarubicin;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;8.Cytarabine;0.Idarubicin;0.Sorafenib;1.Idarubicin;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;","8.Cytarabine;0.Idarubicin;0.Sorafenib;1.Idarubicin;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;"
"536","114.44.1530.3","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after upfront therapy",44,"Cytarabine, Idarubicin, Sorafenib",TRUE,"Cont.","15.Cytarabine;0.Idarubicin;0.Sorafenib;1.Idarubicin;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;15.Cytarabine;0.Idarubicin;0.Sorafenib;1.Idarubicin;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;","15.Cytarabine;0.Idarubicin;0.Sorafenib;1.Idarubicin;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;"
"537","114.44.1530.4","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after upfront therapy",44,"Cytarabine, Idarubicin, Sorafenib",TRUE,"Cont.","1.Cytarabine;0.Idarubicin;0.Sorafenib;1.Cytarabine;0.Idarubicin;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Cytarabine;0.Idarubicin;0.Sorafenib;1.Cytarabine;0.Idarubicin;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;","1.Cytarabine;0.Idarubicin;0.Sorafenib;1.Cytarabine;0.Idarubicin;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;"
"538","114.44.1530.5","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after upfront therapy",44,"Cytarabine, Idarubicin, Sorafenib",TRUE,"Cont.","8.Cytarabine;0.Idarubicin;0.Sorafenib;1.Cytarabine;0.Idarubicin;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;8.Cytarabine;0.Idarubicin;0.Sorafenib;1.Cytarabine;0.Idarubicin;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;","8.Cytarabine;0.Idarubicin;0.Sorafenib;1.Cytarabine;0.Idarubicin;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;"
"539","114.44.1530.6","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after upfront therapy",44,"Cytarabine, Idarubicin, Sorafenib",TRUE,"Cont.","15.Cytarabine;0.Idarubicin;0.Sorafenib;1.Cytarabine;0.Idarubicin;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;15.Cytarabine;0.Idarubicin;0.Sorafenib;1.Cytarabine;0.Idarubicin;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;","15.Cytarabine;0.Idarubicin;0.Sorafenib;1.Cytarabine;0.Idarubicin;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;"
"540","114.44.1531.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after upfront therapy",44,"Cyclophosphamide & TBI, then allo HSCT",FALSE,"1","0.Cyclophosphamide;1.Cyclophosphamide;","0.Cyclophosphamide;1.Cyclophosphamide;"
"541","114.44.1532.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after upfront therapy",44,"Etoposide & Mitoxantrone",FALSE,"1","0.Etoposide;0.Mitoxantrone;1.Etoposide;0.Mitoxantrone;1.Etoposide;0.Mitoxantrone;","0.Etoposide;0.Mitoxantrone;1.Etoposide;0.Mitoxantrone;1.Etoposide;0.Mitoxantrone;"
"542","114.44.1532.2","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after upfront therapy",44,"Etoposide & Mitoxantrone",FALSE,"1","0.Etoposide;0.Mitoxantrone;1.Etoposide;0.Mitoxantrone;1.Etoposide;0.Mitoxantrone;1.Etoposide;0.Mitoxantrone;1.Etoposide;0.Mitoxantrone;","0.Etoposide;0.Mitoxantrone;1.Etoposide;0.Mitoxantrone;1.Etoposide;0.Mitoxantrone;1.Etoposide;0.Mitoxantrone;1.Etoposide;0.Mitoxantrone;"
"543","114.44.1533.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after upfront therapy",44,"Fludarabine & TBI, then allo HSCT",FALSE,"1","0.Fludarabine;1.Fludarabine;1.Fludarabine;1.Fludarabine;","0.Fludarabine;1.Fludarabine;1.Fludarabine;1.Fludarabine;"
"544","114.44.1533.2","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after upfront therapy",44,"Fludarabine & TBI, then allo HSCT",FALSE,"1","0.Fludarabine;1.Fludarabine;1.Fludarabine;","0.Fludarabine;1.Fludarabine;1.Fludarabine;"
"545","114.44.1534.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after upfront therapy",44,"Fludarabine, Busulfan, ATG, then allo HSCT",FALSE,"1","0.Fludarabine;1.Fludarabine;1.Fludarabine;1.ATG(Rabbit);0.Busulfan;0.Fludarabine;1.ATG(Rabbit);0.Busulfan;0.Fludarabine;1.ATG(Rabbit);","0.Fludarabine;1.Fludarabine;1.Fludarabine;1.ATG(Rabbit);0.Busulfan;0.Fludarabine;1.ATG(Rabbit);0.Busulfan;0.Fludarabine;1.ATG(Rabbit);"
"546","114.44.1535.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after upfront therapy",44,"HAM",FALSE,"1","0.Cytarabine;1.Cytarabine;1.Cytarabine;0.Mitoxantrone;1.Mitoxantrone;1.Mitoxantrone;","0.Cytarabine;1.Cytarabine;1.Cytarabine;0.Mitoxantrone;1.Mitoxantrone;1.Mitoxantrone;"
"547","114.44.1536.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after upfront therapy",44,"IC & Norethandrolone/6-MP, MTX, Norethandrolone",NA,NA,"0.Cytarabine;0.Idarubicin;0.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Norethandrolone;78.Methotrexate;0.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Methotrexate;0.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Norethandrolone;78.Cytarabine;0.Idarubicin;0.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Norethandrolone;78.Methotrexate;0.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Methotrexate;0.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Norethandrolone;78.Cytarabine;0.Idarubicin;0.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Norethandrolone;78.Methotrexate;0.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Methotrexate;0.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Norethandrolone;","0.Cytarabine;0.Idarubicin;0.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Norethandrolone;78.Methotrexate;0.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Methotrexate;0.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Norethandrolone;78.Cytarabine;0.Idarubicin;0.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Norethandrolone;78.Methotrexate;0.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Methotrexate;0.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Norethandrolone;78.Cytarabine;0.Idarubicin;0.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Norethandrolone;78.Methotrexate;0.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Methotrexate;0.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Norethandrolone;"
"548","114.44.1536.2","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"Consolidation after upfront therapy",44,"IC & Norethandrolone/6-MP, MTX, Norethandrolone",NA,NA,"0.Cytarabine;0.Idarubicin;0.Norethandrolone;1.Cytarabine;0.Norethandrolone;1.Cytarabine;0.Norethandrolone;1.Cytarabine;0.Norethandrolone;1.Cytarabine;0.Norethandrolone;1.Cytarabine;0.Norethandrolone;1.Norethandrolone;78.Methotrexate;0.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Methotrexate;0.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Norethandrolone;78.Cytarabine;0.Idarubicin;0.Norethandrolone;1.Cytarabine;0.Norethandrolone;1.Cytarabine;0.Norethandrolone;1.Cytarabine;0.Norethandrolone;1.Cytarabine;0.Norethandrolone;1.Cytarabine;0.Norethandrolone;1.Norethandrolone;78.Methotrexate;0.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Methotrexate;0.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Norethandrolone;78.Cytarabine;0.Idarubicin;0.Norethandrolone;1.Cytarabine;0.Norethandrolone;1.Cytarabine;0.Norethandrolone;1.Cytarabine;0.Norethandrolone;1.Cytarabine;0.Norethandrolone;1.Cytarabine;0.Norethandrolone;1.Norethandrolone;78.Methotrexate;0.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Methotrexate;0.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Norethandrolone;","0.Cytarabine;0.Idarubicin;0.Norethandrolone;1.Cytarabine;0.Norethandrolone;1.Cytarabine;0.Norethandrolone;1.Cytarabine;0.Norethandrolone;1.Cytarabine;0.Norethandrolone;1.Cytarabine;0.Norethandrolone;1.Norethandrolone;78.Methotrexate;0.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Methotrexate;0.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Norethandrolone;78.Cytarabine;0.Idarubicin;0.Norethandrolone;1.Cytarabine;0.Norethandrolone;1.Cytarabine;0.Norethandrolone;1.Cytarabine;0.Norethandrolone;1.Cytarabine;0.Norethandrolone;1.Cytarabine;0.Norethandrolone;1.Norethandrolone;78.Methotrexate;0.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Methotrexate;0.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Norethandrolone;78.Cytarabine;0.Idarubicin;0.Norethandrolone;1.Cytarabine;0.Norethandrolone;1.Cytarabine;0.Norethandrolone;1.Cytarabine;0.Norethandrolone;1.Cytarabine;0.Norethandrolone;1.Cytarabine;0.Norethandrolone;1.Norethandrolone;78.Methotrexate;0.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Methotrexate;0.Norethandrolone;1.Norethandrolone;1.Norethandrolone;1.Norethandrolone;"
"549","114.65.1503.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"First-line induction therapy, older or ""unfit"" patients",65,"Azacitidine monotherapy",TRUE,"Cont.","22.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;22.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;","22.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;"
"550","114.65.1504.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"First-line induction therapy, older or ""unfit"" patients",65,"Azacitidine & Venetoclax",TRUE,"Cont.","1.Azacitidine;0.Venetoclax;1.Azacitidine;0.Venetoclax;1.Azacitidine;0.Venetoclax;1.Azacitidine;0.Venetoclax;1.Azacitidine;0.Venetoclax;1.Azacitidine;0.Venetoclax;1.Azacitidine;0.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Azacitidine;0.Venetoclax;1.Azacitidine;0.Venetoclax;1.Azacitidine;0.Venetoclax;1.Azacitidine;0.Venetoclax;1.Azacitidine;0.Venetoclax;1.Azacitidine;0.Venetoclax;1.Azacitidine;0.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;","1.Azacitidine;0.Venetoclax;1.Azacitidine;0.Venetoclax;1.Azacitidine;0.Venetoclax;1.Azacitidine;0.Venetoclax;1.Azacitidine;0.Venetoclax;1.Azacitidine;0.Venetoclax;1.Azacitidine;0.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;"
"551","114.65.1505.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"First-line induction therapy, older or ""unfit"" patients",65,"Azacitidine & Gemtuzumab ozogamicin",FALSE,"1","0.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;1.Gemtuzumabozogamicin;","0.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;1.Gemtuzumabozogamicin;"
"552","114.65.1506.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"First-line induction therapy, older or ""unfit"" patients",65,"Clofarabine monotherapy",FALSE,"4","24.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;24.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;","24.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;"
"553","114.65.1506.2","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"First-line induction therapy, older or ""unfit"" patients",65,"Clofarabine monotherapy",FALSE,"4","38.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;38.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;","38.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;"
"554","114.65.1506.3","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"First-line induction therapy, older or ""unfit"" patients",65,"Clofarabine monotherapy",FALSE,"4","31.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;31.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;","31.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;"
"555","114.65.1506.4","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"First-line induction therapy, older or ""unfit"" patients",65,"Clofarabine monotherapy",FALSE,"1","0.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;","0.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;"
"556","114.65.1507.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"First-line induction therapy, older or ""unfit"" patients",65,"Clofarabine & LoDAC",TRUE,"Cont.","15.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;15.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;","15.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"557","114.65.1507.2","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"First-line induction therapy, older or ""unfit"" patients",65,"Clofarabine & LoDAC",TRUE,"Cont.","22.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;22.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;","22.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"558","114.65.1507.3","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"First-line induction therapy, older or ""unfit"" patients",65,"Clofarabine & LoDAC",TRUE,"Cont.","29.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;29.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;","29.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"559","114.65.1507.4","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"First-line induction therapy, older or ""unfit"" patients",65,"Clofarabine & LoDAC",TRUE,"Cont.","36.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;36.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;","36.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Clofarabine;0.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"560","114.65.1509.4","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"First-line induction therapy, older or ""unfit"" patients",65,"Decitabine monotherapy",TRUE,"Cont.","19.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;19.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;","19.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;"
"561","114.65.1510.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"First-line induction therapy, older or ""unfit"" patients",65,"Decitabine & Venetoclax",TRUE,"Cont.","1.Decitabine;0.Venetoclax;1.Decitabine;0.Venetoclax;1.Decitabine;0.Venetoclax;1.Decitabine;0.Venetoclax;1.Decitabine;0.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Decitabine;0.Venetoclax;1.Decitabine;0.Venetoclax;1.Decitabine;0.Venetoclax;1.Decitabine;0.Venetoclax;1.Decitabine;0.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;","1.Decitabine;0.Venetoclax;1.Decitabine;0.Venetoclax;1.Decitabine;0.Venetoclax;1.Decitabine;0.Venetoclax;1.Decitabine;0.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;"
"562","114.65.1510.2","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"First-line induction therapy, older or ""unfit"" patients",65,"Decitabine & Venetoclax",TRUE,"Cont.","8.Decitabine;0.Venetoclax;1.Decitabine;0.Venetoclax;1.Decitabine;0.Venetoclax;1.Decitabine;0.Venetoclax;1.Decitabine;0.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;8.Decitabine;0.Venetoclax;1.Decitabine;0.Venetoclax;1.Decitabine;0.Venetoclax;1.Decitabine;0.Venetoclax;1.Decitabine;0.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;","8.Decitabine;0.Venetoclax;1.Decitabine;0.Venetoclax;1.Decitabine;0.Venetoclax;1.Decitabine;0.Venetoclax;1.Decitabine;0.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;"
"563","114.65.1511.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"First-line induction therapy, older or ""unfit"" patients",65,"Gemtuzumab ozogamicin monotherapy",FALSE,"1","0.Gemtuzumabozogamicin;7.Gemtuzumabozogamicin;","0.Gemtuzumabozogamicin;7.Gemtuzumabozogamicin;"
"564","114.65.1512.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"First-line induction therapy, older or ""unfit"" patients",65,"Glasdegib & LoDAC",TRUE,"Cont.","1.Cytarabine;0.Glasdegib;1.Cytarabine;0.Glasdegib;1.Cytarabine;0.Glasdegib;1.Cytarabine;0.Glasdegib;1.Cytarabine;0.Glasdegib;1.Cytarabine;0.Glasdegib;1.Cytarabine;0.Glasdegib;1.Cytarabine;0.Glasdegib;1.Cytarabine;0.Glasdegib;1.Cytarabine;0.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;1.Cytarabine;0.Glasdegib;1.Cytarabine;0.Glasdegib;1.Cytarabine;0.Glasdegib;1.Cytarabine;0.Glasdegib;1.Cytarabine;0.Glasdegib;1.Cytarabine;0.Glasdegib;1.Cytarabine;0.Glasdegib;1.Cytarabine;0.Glasdegib;1.Cytarabine;0.Glasdegib;1.Cytarabine;0.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;","1.Cytarabine;0.Glasdegib;1.Cytarabine;0.Glasdegib;1.Cytarabine;0.Glasdegib;1.Cytarabine;0.Glasdegib;1.Cytarabine;0.Glasdegib;1.Cytarabine;0.Glasdegib;1.Cytarabine;0.Glasdegib;1.Cytarabine;0.Glasdegib;1.Cytarabine;0.Glasdegib;1.Cytarabine;0.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;1.Glasdegib;"
"565","114.65.1513.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"First-line induction therapy, older or ""unfit"" patients",65,"Low-dose Cytarabine monotherapy (LoDAC)",TRUE,"Cont.","19.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;19.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;","19.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"566","114.65.1513.2","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"First-line induction therapy, older or ""unfit"" patients",65,"Low-dose Cytarabine monotherapy (LoDAC)",TRUE,"Cont.","26.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;26.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;","26.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"567","114.65.1513.3","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"First-line induction therapy, older or ""unfit"" patients",65,"Low-dose Cytarabine monotherapy (LoDAC)",TRUE,"Cont.","33.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;33.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;","33.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"568","114.65.1513.4","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"First-line induction therapy, older or ""unfit"" patients",65,"Low-dose Cytarabine monotherapy (LoDAC)",TRUE,"Cont.","15.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;15.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;","15.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"569","114.65.1514.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"First-line induction therapy, older or ""unfit"" patients",65,"LoDAC & Venetoclax",TRUE,"Cont.","1.Cytarabine;0.Venetoclax;1.Cytarabine;0.Venetoclax;1.Cytarabine;0.Venetoclax;1.Cytarabine;0.Venetoclax;1.Cytarabine;0.Venetoclax;1.Cytarabine;0.Venetoclax;1.Cytarabine;0.Venetoclax;1.Cytarabine;0.Venetoclax;1.Cytarabine;0.Venetoclax;1.Cytarabine;0.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Cytarabine;0.Venetoclax;1.Cytarabine;0.Venetoclax;1.Cytarabine;0.Venetoclax;1.Cytarabine;0.Venetoclax;1.Cytarabine;0.Venetoclax;1.Cytarabine;0.Venetoclax;1.Cytarabine;0.Venetoclax;1.Cytarabine;0.Venetoclax;1.Cytarabine;0.Venetoclax;1.Cytarabine;0.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;","1.Cytarabine;0.Venetoclax;1.Cytarabine;0.Venetoclax;1.Cytarabine;0.Venetoclax;1.Cytarabine;0.Venetoclax;1.Cytarabine;0.Venetoclax;1.Cytarabine;0.Venetoclax;1.Cytarabine;0.Venetoclax;1.Cytarabine;0.Venetoclax;1.Cytarabine;0.Venetoclax;1.Cytarabine;0.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;"
"570","114.65.1515.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"First-line induction therapy, older or ""unfit"" patients",65,"Temozolomide monotherapy",TRUE,"Cont.","22.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;22.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;","22.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;"
"571","114.65.1515.2","Malignant Hematology","Acute leukemias","Acute myeloid leukemia",114,"First-line induction therapy, older or ""unfit"" patients",65,"Temozolomide monotherapy",TRUE,"Cont.","24.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;24.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;","24.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;"
"572","115.119.1566.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia, FLT3-positive",115,"Maintenance after upfront therapy, including allogeneic HSCT",119,"Midostaurin monotherapy",TRUE,"Cont.","1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;","1.Midostaurin;1.Midostaurin;"
"573","115.178.1567.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia, FLT3-positive",115,"Relapsed or refractory, further lines of therapy",178,"Azacitidine & Sorafenib",TRUE,"Cont.","1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;","1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;"
"574","115.178.1567.2","Malignant Hematology","Acute leukemias","Acute myeloid leukemia, FLT3-positive",115,"Relapsed or refractory, further lines of therapy",178,"Azacitidine & Sorafenib",TRUE,"Cont.","8.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;8.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;","8.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;"
"575","115.178.1567.3","Malignant Hematology","Acute leukemias","Acute myeloid leukemia, FLT3-positive",115,"Relapsed or refractory, further lines of therapy",178,"Azacitidine & Sorafenib",TRUE,"Cont.","15.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;15.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;","15.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;"
"576","115.178.1567.4","Malignant Hematology","Acute leukemias","Acute myeloid leukemia, FLT3-positive",115,"Relapsed or refractory, further lines of therapy",178,"Azacitidine & Sorafenib",TRUE,"Cont.","22.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;22.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;","22.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;"
"577","115.178.1567.5","Malignant Hematology","Acute leukemias","Acute myeloid leukemia, FLT3-positive",115,"Relapsed or refractory, further lines of therapy",178,"Azacitidine & Sorafenib",TRUE,"Cont.","29.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;29.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;","29.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Azacitidine;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;"
"578","115.178.1568.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia, FLT3-positive",115,"Relapsed or refractory, further lines of therapy",178,"FLAG-Ida",TRUE,"Cont.","24.Cytarabine;0.Fludarabine;0.Idarubicin;1.Cytarabine;0.Fludarabine;0.Idarubicin;1.Cytarabine;0.Fludarabine;0.Idarubicin;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;24.Cytarabine;0.Fludarabine;0.Idarubicin;1.Cytarabine;0.Fludarabine;0.Idarubicin;1.Cytarabine;0.Fludarabine;0.Idarubicin;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;","24.Cytarabine;0.Fludarabine;0.Idarubicin;1.Cytarabine;0.Fludarabine;0.Idarubicin;1.Cytarabine;0.Fludarabine;0.Idarubicin;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;"
"579","115.178.1569.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia, FLT3-positive",115,"Relapsed or refractory, further lines of therapy",178,"Gilteritinib monotherapy",TRUE,"Cont.","1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;1.Gilteritinib;","1.Gilteritinib;1.Gilteritinib;"
"580","115.178.1570.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia, FLT3-positive",115,"Relapsed or refractory, further lines of therapy",178,"Quizartinib monotherapy",TRUE,"Cont.","1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;","1.Quizartinib;1.Quizartinib;"
"581","115.206.1560.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia, FLT3-positive",115,"Upfront induction therapy, standard patients",206,"7+3d & Midostaurin",FALSE,"1","0.Cytarabine;0.Daunorubicin;1.Daunorubicin;1.Daunorubicin;5.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;","0.Cytarabine;0.Daunorubicin;1.Daunorubicin;1.Daunorubicin;5.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;"
"582","115.206.1560.2","Malignant Hematology","Acute leukemias","Acute myeloid leukemia, FLT3-positive",115,"Upfront induction therapy, standard patients",206,"7+3d & Midostaurin",FALSE,"1","0.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;","0.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;"
"583","115.206.1561.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia, FLT3-positive",115,"Upfront induction therapy, standard patients",206,"7+3d & Quizartinib",FALSE,"1","0.Cytarabine;0.Daunorubicin;1.Daunorubicin;1.Daunorubicin;5.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;","0.Cytarabine;0.Daunorubicin;1.Daunorubicin;1.Daunorubicin;5.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;"
"584","115.206.1561.2","Malignant Hematology","Acute leukemias","Acute myeloid leukemia, FLT3-positive",115,"Upfront induction therapy, standard patients",206,"7+3d & Quizartinib",FALSE,"1","0.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;","0.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;"
"585","115.206.1562.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia, FLT3-positive",115,"Upfront induction therapy, standard patients",206,"7+3i & Quizartinib",FALSE,"1","0.Cytarabine;0.Idarubicin;1.Idarubicin;1.Idarubicin;5.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;","0.Cytarabine;0.Idarubicin;1.Idarubicin;1.Idarubicin;5.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;"
"586","115.206.1562.2","Malignant Hematology","Acute leukemias","Acute myeloid leukemia, FLT3-positive",115,"Upfront induction therapy, standard patients",206,"7+3i & Quizartinib",FALSE,"1","0.Cytarabine;0.Idarubicin;1.Cytarabine;0.Idarubicin;1.Cytarabine;0.Idarubicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;","0.Cytarabine;0.Idarubicin;1.Cytarabine;0.Idarubicin;1.Cytarabine;0.Idarubicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;1.Quizartinib;"
"587","115.44.1564.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia, FLT3-positive",115,"Consolidation after upfront therapy",44,"HiDAC & Midostaurin",FALSE,"4","8.Cytarabine;2.Cytarabine;2.Cytarabine;3.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;8.Cytarabine;2.Cytarabine;2.Cytarabine;3.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;","8.Cytarabine;2.Cytarabine;2.Cytarabine;3.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;"
"588","115.44.1565.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia, FLT3-positive",115,"Consolidation after upfront therapy",44,"IDAC & Sorafenib",FALSE,"2","1.Cytarabine;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;","1.Cytarabine;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;"
"589","115.44.1565.2","Malignant Hematology","Acute leukemias","Acute myeloid leukemia, FLT3-positive",115,"Consolidation after upfront therapy",44,"IDAC & Sorafenib",FALSE,"2","8.Cytarabine;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;","8.Cytarabine;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;"
"590","115.44.1565.3","Malignant Hematology","Acute leukemias","Acute myeloid leukemia, FLT3-positive",115,"Consolidation after upfront therapy",44,"IDAC & Sorafenib",FALSE,"2","15.Cytarabine;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;","15.Cytarabine;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;"
"591","115.66.1563.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia, FLT3-positive",115,"First-line induction therapy, older patients or ""unfit"" patients",66,"7+3d & Sorafenib",FALSE,"1","0.Cytarabine;0.Daunorubicin;0.Sorafenib;1.Daunorubicin;0.Sorafenib;1.Daunorubicin;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;","0.Cytarabine;0.Daunorubicin;0.Sorafenib;1.Daunorubicin;0.Sorafenib;1.Daunorubicin;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;"
"592","115.66.1563.2","Malignant Hematology","Acute leukemias","Acute myeloid leukemia, FLT3-positive",115,"First-line induction therapy, older patients or ""unfit"" patients",66,"7+3d & Sorafenib",FALSE,"1","0.Cytarabine;0.Daunorubicin;0.Sorafenib;1.Cytarabine;0.Daunorubicin;0.Sorafenib;1.Cytarabine;0.Daunorubicin;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Cytarabine;0.Sorafenib;","0.Cytarabine;0.Daunorubicin;0.Sorafenib;1.Cytarabine;0.Daunorubicin;0.Sorafenib;1.Cytarabine;0.Daunorubicin;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Cytarabine;0.Sorafenib;1.Cytarabine;0.Sorafenib;"
"593","116.84.1571.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia, IDH-mutated",116,"IDH1 first-line therapy, older or 'unfit' patients",84,"Azacitidine & Ivosidenib",TRUE,"Cont.","1.Azacitidine;0.Ivosidenib;1.Azacitidine;0.Ivosidenib;1.Azacitidine;0.Ivosidenib;1.Azacitidine;0.Ivosidenib;1.Azacitidine;0.Ivosidenib;1.Azacitidine;0.Ivosidenib;1.Azacitidine;0.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Azacitidine;0.Ivosidenib;1.Azacitidine;0.Ivosidenib;1.Azacitidine;0.Ivosidenib;1.Azacitidine;0.Ivosidenib;1.Azacitidine;0.Ivosidenib;1.Azacitidine;0.Ivosidenib;1.Azacitidine;0.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;","1.Azacitidine;0.Ivosidenib;1.Azacitidine;0.Ivosidenib;1.Azacitidine;0.Ivosidenib;1.Azacitidine;0.Ivosidenib;1.Azacitidine;0.Ivosidenib;1.Azacitidine;0.Ivosidenib;1.Azacitidine;0.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;"
"594","116.84.1572.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia, IDH-mutated",116,"IDH1 first-line therapy, older or 'unfit' patients",84,"Ivosidenib monotherapy",TRUE,"Cont.","1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;","1.Ivosidenib;1.Ivosidenib;"
"595","116.85.1573.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia, IDH-mutated",116,"IDH1 relapsed or refractory, salvage therapy",85,"Olutasidenib monotherapy",TRUE,"Cont.","1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;1.Olutasidenib;","1.Olutasidenib;1.Olutasidenib;"
"596","116.86.1574.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia, IDH-mutated",116,"IDH2 first-line therapy, older or 'unfit' patients",86,"Enasidenib monotherapy",TRUE,"Cont.","1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;1.Enasidenib;","1.Enasidenib;1.Enasidenib;"
"597","117.85.1575.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia, NPM1-mutated",117,"IDH1 relapsed or refractory, salvage therapy",85,"ICE & ATRA",NA,NA,"0.NA;","0.NA;"
"598","117.85.1575.2","Malignant Hematology","Acute leukemias","Acute myeloid leukemia, NPM1-mutated",117,"IDH1 relapsed or refractory, salvage therapy",85,"ICE & ATRA",NA,NA,"0.NA;","0.NA;"
"599","117.86.1575.1","Malignant Hematology","Acute leukemias","Acute myeloid leukemia, NPM1-mutated",117,"IDH2 first-line therapy, older or 'unfit' patients",86,"ICE & ATRA",NA,NA,"0.Cytarabine;0.Etoposide;0.Idarubicin;1.Etoposide;1.Etoposide;0.Idarubicin;2.Idarubicin;17.Cytarabine;0.Etoposide;0.Idarubicin;2.Etoposide;0.Idarubicin;","0.Cytarabine;0.Etoposide;0.Idarubicin;1.Etoposide;1.Etoposide;0.Idarubicin;2.Idarubicin;17.Cytarabine;0.Etoposide;0.Idarubicin;2.Etoposide;0.Idarubicin;"
"600","117.86.1575.2","Malignant Hematology","Acute leukemias","Acute myeloid leukemia, NPM1-mutated",117,"IDH2 first-line therapy, older or 'unfit' patients",86,"ICE & ATRA",NA,NA,"0.Cytarabine;0.Etoposide;0.Idarubicin;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;0.Idarubicin;1.Cytarabine;1.Cytarabine;0.Idarubicin;1.Cytarabine;1.Cytarabine;15.Cytarabine;0.Etoposide;0.Idarubicin;1.Cytarabine;1.Cytarabine;0.Etoposide;0.Idarubicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;","0.Cytarabine;0.Etoposide;0.Idarubicin;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;0.Idarubicin;1.Cytarabine;1.Cytarabine;0.Idarubicin;1.Cytarabine;1.Cytarabine;15.Cytarabine;0.Etoposide;0.Idarubicin;1.Cytarabine;1.Cytarabine;0.Etoposide;0.Idarubicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"601","117.86.1575.3","Malignant Hematology","Acute leukemias","Acute myeloid leukemia, NPM1-mutated",117,"IDH2 first-line therapy, older or 'unfit' patients",86,"ICE & ATRA",FALSE,"2","1.Cytarabine;0.Etoposide;0.Idarubicin;2.Etoposide;0.Idarubicin;6.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;","1.Cytarabine;0.Etoposide;0.Idarubicin;2.Etoposide;0.Idarubicin;6.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;"
"602","117.86.1575.4","Malignant Hematology","Acute leukemias","Acute myeloid leukemia, NPM1-mutated",117,"IDH2 first-line therapy, older or 'unfit' patients",86,"ICE & ATRA",FALSE,"2","1.Cytarabine;0.Etoposide;0.Idarubicin;1.Cytarabine;1.Cytarabine;0.Etoposide;0.Idarubicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;2.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;","1.Cytarabine;0.Etoposide;0.Idarubicin;1.Cytarabine;1.Cytarabine;0.Etoposide;0.Idarubicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;2.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;"
"603","118.118.1597.1","Malignant Hematology","Acute leukemias","Acute promyelocytic leukemia",118,"Maintenance after upfront therapy",118,"Arsenic trioxide monotherapy",FALSE,"6","19.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;19.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;","19.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;"
"604","118.118.1598.1","Malignant Hematology","Acute leukemias","Acute promyelocytic leukemia",118,"Maintenance after upfront therapy",118,"ATRA monotherapy",TRUE,"Cont.","8.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;8.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;","8.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;"
"605","118.118.1598.2","Malignant Hematology","Acute leukemias","Acute promyelocytic leukemia",118,"Maintenance after upfront therapy",118,"ATRA monotherapy",TRUE,"Cont.","70.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;70.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;","70.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;"
"606","118.118.1599.1","Malignant Hematology","Acute leukemias","Acute promyelocytic leukemia",118,"Maintenance after upfront therapy",118,"ATRA, Mercaptopurine, Methotrexate",TRUE,"Cont.","1.ATRA;0.Mercaptopurine;0.Methotrexate;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;0.Methotrexate;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.ATRA;0.Mercaptopurine;0.Methotrexate;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;0.Methotrexate;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;","1.ATRA;0.Mercaptopurine;0.Methotrexate;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;0.Methotrexate;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;"
"607","118.118.1599.2","Malignant Hematology","Acute leukemias","Acute promyelocytic leukemia",118,"Maintenance after upfront therapy",118,"ATRA, Mercaptopurine, Methotrexate",NA,NA,"0.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;78.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;78.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;78.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;78.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;78.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;78.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;78.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;","0.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;78.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;78.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;78.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;78.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;78.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;78.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;78.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;"
"608","118.118.1599.3","Malignant Hematology","Acute leukemias","Acute promyelocytic leukemia",118,"Maintenance after upfront therapy",118,"ATRA, Mercaptopurine, Methotrexate",TRUE,"Cont.","1.ATRA;0.Mercaptopurine;0.Methotrexate;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.ATRA;0.Mercaptopurine;0.Methotrexate;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;","1.ATRA;0.Mercaptopurine;0.Methotrexate;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;"
"609","118.118.1599.4","Malignant Hematology","Acute leukemias","Acute promyelocytic leukemia",118,"Maintenance after upfront therapy",118,"ATRA, Mercaptopurine, Methotrexate",TRUE,"Cont.","1.ATRA;0.Mercaptopurine;0.Methotrexate;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;0.Methotrexate;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.ATRA;0.Mercaptopurine;0.Methotrexate;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;0.Methotrexate;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;","1.ATRA;0.Mercaptopurine;0.Methotrexate;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;0.Methotrexate;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;1.ATRA;0.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;"
"610","118.118.1599.5","Malignant Hematology","Acute leukemias","Acute promyelocytic leukemia",118,"Maintenance after upfront therapy",118,"ATRA, Mercaptopurine, Methotrexate",TRUE,"Cont.","1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;","1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;"
"611","118.118.1600.1","Malignant Hematology","Acute leukemias","Acute promyelocytic leukemia",118,"Maintenance after upfront therapy",118,"Mercaptopurine & Methotrexate",TRUE,"Cont.","1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;","1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;"
"612","118.183.1601.1","Malignant Hematology","Acute leukemias","Acute promyelocytic leukemia",118,"Relapsed or refractory, salvage induction therapy",183,"Arsenic trioxide & Idarubicin",FALSE,"1","0.Arsenictrioxide;0.Idarubicin;1.Arsenictrioxide;0.Idarubicin;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;","0.Arsenictrioxide;0.Idarubicin;1.Arsenictrioxide;0.Idarubicin;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;"
"613","118.183.1601.2","Malignant Hematology","Acute leukemias","Acute promyelocytic leukemia",118,"Relapsed or refractory, salvage induction therapy",183,"Arsenic trioxide & Idarubicin",NA,NA,"0.Arsenictrioxide;0.Idarubicin;1.Arsenictrioxide;0.Idarubicin;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;54.Cytarabine;0.Methotrexate;","0.Arsenictrioxide;0.Idarubicin;1.Arsenictrioxide;0.Idarubicin;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;54.Cytarabine;0.Methotrexate;"
"614","118.183.1602.1","Malignant Hematology","Acute leukemias","Acute promyelocytic leukemia",118,"Relapsed or refractory, salvage induction therapy",183,"Tamibarotene monotherapy",TRUE,"Cont.","1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;1.Tamibarotene;","1.Tamibarotene;1.Tamibarotene;"
"615","118.204.1576.1","Malignant Hematology","Acute leukemias","Acute promyelocytic leukemia",118,"Upfront induction therapy",204,"ADE & ATRA",FALSE,"1","0.ATRA;0.Cytarabine;0.Daunorubicin;0.Etoposide;1.ATRA;0.Cytarabine;0.Etoposide;1.ATRA;0.Cytarabine;0.Daunorubicin;0.Etoposide;1.ATRA;0.Cytarabine;0.Etoposide;1.ATRA;0.Cytarabine;0.Daunorubicin;0.Etoposide;1.ATRA;0.Cytarabine;1.ATRA;0.Cytarabine;1.ATRA;0.Cytarabine;1.ATRA;0.Cytarabine;1.ATRA;0.Cytarabine;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;","0.ATRA;0.Cytarabine;0.Daunorubicin;0.Etoposide;1.ATRA;0.Cytarabine;0.Etoposide;1.ATRA;0.Cytarabine;0.Daunorubicin;0.Etoposide;1.ATRA;0.Cytarabine;0.Etoposide;1.ATRA;0.Cytarabine;0.Daunorubicin;0.Etoposide;1.ATRA;0.Cytarabine;1.ATRA;0.Cytarabine;1.ATRA;0.Cytarabine;1.ATRA;0.Cytarabine;1.ATRA;0.Cytarabine;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;"
"616","118.204.1577.1","Malignant Hematology","Acute leukemias","Acute promyelocytic leukemia",118,"Upfront induction therapy",204,"Arsenic trioxide monotherapy",TRUE,"Cont.","1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;","1.Arsenictrioxide;1.Arsenictrioxide;"
"617","118.204.1578.1","Malignant Hematology","Acute leukemias","Acute promyelocytic leukemia",118,"Upfront induction therapy",204,"Arsenic trioxide & ATRA",FALSE,"1","0.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;","0.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;"
"618","118.204.1578.2","Malignant Hematology","Acute leukemias","Acute promyelocytic leukemia",118,"Upfront induction therapy",204,"Arsenic trioxide & ATRA",FALSE,"1","0.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;","0.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;"
"619","118.204.1578.3","Malignant Hematology","Acute leukemias","Acute promyelocytic leukemia",118,"Upfront induction therapy",204,"Arsenic trioxide & ATRA",TRUE,"Cont.","1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;","1.ATRA;0.Arsenictrioxide;"
"620","118.204.1579.1","Malignant Hematology","Acute leukemias","Acute promyelocytic leukemia",118,"Upfront induction therapy",204,"Arsenic trioxide, ATRA, Gemtuzumab ozogamicin",NA,NA,"0.ATRA;0.Arsenictrioxide;0.Gemtuzumabozogamicin;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;1.ATRA;1.ATRA;0.Arsenictrioxide;1.ATRA;1.ATRA;1.ATRA;0.Arsenictrioxide;1.ATRA;1.ATRA;1.ATRA;","0.ATRA;0.Arsenictrioxide;0.Gemtuzumabozogamicin;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;1.ATRA;1.ATRA;0.Arsenictrioxide;1.ATRA;1.ATRA;1.ATRA;0.Arsenictrioxide;1.ATRA;1.ATRA;1.ATRA;"
"621","118.204.1579.2","Malignant Hematology","Acute leukemias","Acute promyelocytic leukemia",118,"Upfront induction therapy",204,"Arsenic trioxide, ATRA, Gemtuzumab ozogamicin",FALSE,"1","0.ATRA;0.Arsenictrioxide;0.Gemtuzumabozogamicin;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;","0.ATRA;0.Arsenictrioxide;0.Gemtuzumabozogamicin;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;"
"622","118.204.1580.1","Malignant Hematology","Acute leukemias","Acute promyelocytic leukemia",118,"Upfront induction therapy",204,"Arsenic trioxide, ATRA, Idarubicin",FALSE,"1","0.ATRA;1.ATRA;0.Idarubicin;1.ATRA;1.ATRA;0.Idarubicin;1.ATRA;1.ATRA;0.Idarubicin;1.ATRA;1.ATRA;0.Idarubicin;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;","0.ATRA;1.ATRA;0.Idarubicin;1.ATRA;1.ATRA;0.Idarubicin;1.ATRA;1.ATRA;0.Idarubicin;1.ATRA;1.ATRA;0.Idarubicin;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;"
"623","118.204.1581.1","Malignant Hematology","Acute leukemias","Acute promyelocytic leukemia",118,"Upfront induction therapy",204,"ATRA monotherapy",TRUE,"Cont.","1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;","1.ATRA;1.ATRA;"
"624","118.204.1582.1","Malignant Hematology","Acute leukemias","Acute promyelocytic leukemia",118,"Upfront induction therapy",204,"ATRA, Cytarabine, Daunorubicin",FALSE,"1","0.ATRA;1.ATRA;1.ATRA;0.Cytarabine;0.Daunorubicin;1.ATRA;0.Daunorubicin;1.ATRA;0.Daunorubicin;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;","0.ATRA;1.ATRA;1.ATRA;0.Cytarabine;0.Daunorubicin;1.ATRA;0.Daunorubicin;1.ATRA;0.Daunorubicin;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;"
"625","118.204.1582.2","Malignant Hematology","Acute leukemias","Acute promyelocytic leukemia",118,"Upfront induction therapy",204,"ATRA, Cytarabine, Daunorubicin",FALSE,"1","0.ATRA;1.ATRA;1.ATRA;0.Cytarabine;0.Daunorubicin;1.ATRA;0.Cytarabine;0.Daunorubicin;1.ATRA;0.Cytarabine;0.Daunorubicin;1.ATRA;0.Cytarabine;1.ATRA;0.Cytarabine;1.ATRA;0.Cytarabine;1.ATRA;0.Cytarabine;1.ATRA;0.Cytarabine;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;","0.ATRA;1.ATRA;1.ATRA;0.Cytarabine;0.Daunorubicin;1.ATRA;0.Cytarabine;0.Daunorubicin;1.ATRA;0.Cytarabine;0.Daunorubicin;1.ATRA;0.Cytarabine;1.ATRA;0.Cytarabine;1.ATRA;0.Cytarabine;1.ATRA;0.Cytarabine;1.ATRA;0.Cytarabine;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;"
"626","118.204.1583.1","Malignant Hematology","Acute leukemias","Acute promyelocytic leukemia",118,"Upfront induction therapy",204,"ATRA, Cytarabine, Idarubicin",FALSE,"1","0.ATRA;1.ATRA;1.ATRA;0.Cytarabine;0.Idarubicin;1.ATRA;0.Idarubicin;1.ATRA;0.Idarubicin;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;","0.ATRA;1.ATRA;1.ATRA;0.Cytarabine;0.Idarubicin;1.ATRA;0.Idarubicin;1.ATRA;0.Idarubicin;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;"
"627","118.204.1583.2","Malignant Hematology","Acute leukemias","Acute promyelocytic leukemia",118,"Upfront induction therapy",204,"ATRA, Cytarabine, Idarubicin",FALSE,"1","0.ATRA;1.ATRA;1.ATRA;0.Cytarabine;0.Idarubicin;1.ATRA;0.Cytarabine;0.Idarubicin;1.ATRA;0.Cytarabine;0.Idarubicin;1.ATRA;0.Cytarabine;1.ATRA;0.Cytarabine;1.ATRA;0.Cytarabine;1.ATRA;0.Cytarabine;1.ATRA;0.Cytarabine;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;","0.ATRA;1.ATRA;1.ATRA;0.Cytarabine;0.Idarubicin;1.ATRA;0.Cytarabine;0.Idarubicin;1.ATRA;0.Cytarabine;0.Idarubicin;1.ATRA;0.Cytarabine;1.ATRA;0.Cytarabine;1.ATRA;0.Cytarabine;1.ATRA;0.Cytarabine;1.ATRA;0.Cytarabine;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;"
"628","118.204.1584.1","Malignant Hematology","Acute leukemias","Acute promyelocytic leukemia",118,"Upfront induction therapy",204,"ATRA & Daunorubicin",FALSE,"1","0.ATRA;1.ATRA;1.ATRA;0.Daunorubicin;1.ATRA;0.Daunorubicin;1.ATRA;0.Daunorubicin;1.ATRA;1.ATRA;","0.ATRA;1.ATRA;1.ATRA;0.Daunorubicin;1.ATRA;0.Daunorubicin;1.ATRA;0.Daunorubicin;1.ATRA;1.ATRA;"
"629","118.204.1585.1","Malignant Hematology","Acute leukemias","Acute promyelocytic leukemia",118,"Upfront induction therapy",204,"ATRA & Idarubicin",FALSE,"1","0.ATRA;1.ATRA;0.Idarubicin;1.ATRA;1.ATRA;0.Idarubicin;1.ATRA;1.ATRA;0.Idarubicin;1.ATRA;1.ATRA;0.Idarubicin;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;","0.ATRA;1.ATRA;0.Idarubicin;1.ATRA;1.ATRA;0.Idarubicin;1.ATRA;1.ATRA;0.Idarubicin;1.ATRA;1.ATRA;0.Idarubicin;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;"
"630","118.204.1585.2","Malignant Hematology","Acute leukemias","Acute promyelocytic leukemia",118,"Upfront induction therapy",204,"ATRA & Idarubicin",FALSE,"1","0.ATRA;1.ATRA;0.Idarubicin;1.ATRA;1.ATRA;0.Idarubicin;1.ATRA;1.ATRA;0.Idarubicin;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;","0.ATRA;1.ATRA;0.Idarubicin;1.ATRA;1.ATRA;0.Idarubicin;1.ATRA;1.ATRA;0.Idarubicin;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;"
"631","118.41.1603.1","Malignant Hematology","Acute leukemias","Acute promyelocytic leukemia",118,"Consolidation after salvage therapy",41,"Arsenic trioxide monotherapy",FALSE,"2","3.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Cytarabine;0.Methotrexate;","3.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Cytarabine;0.Methotrexate;"
"632","118.41.1604.1","Malignant Hematology","Acute leukemias","Acute promyelocytic leukemia",118,"Consolidation after salvage therapy",41,"Busulfan & Melphalan, then auto HSCT",FALSE,"1","0.Busulfan;1.Busulfan;1.Busulfan;1.Melphalan;1.Melphalan;","0.Busulfan;1.Busulfan;1.Busulfan;1.Melphalan;1.Melphalan;"
"633","118.44.1586.1","Malignant Hematology","Acute leukemias","Acute promyelocytic leukemia",118,"Consolidation after upfront therapy",44,"Arsenic trioxide, then ATRA & Daunorubicin",NA,NA,"0.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;59.ATRA;0.Daunorubicin;1.ATRA;0.Daunorubicin;1.ATRA;0.Daunorubicin;1.ATRA;1.ATRA;1.ATRA;1.ATRA;33.ATRA;0.Daunorubicin;1.ATRA;0.Daunorubicin;1.ATRA;0.Daunorubicin;1.ATRA;1.ATRA;1.ATRA;1.ATRA;","0.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;59.ATRA;0.Daunorubicin;1.ATRA;0.Daunorubicin;1.ATRA;0.Daunorubicin;1.ATRA;1.ATRA;1.ATRA;1.ATRA;33.ATRA;0.Daunorubicin;1.ATRA;0.Daunorubicin;1.ATRA;0.Daunorubicin;1.ATRA;1.ATRA;1.ATRA;1.ATRA;"
"634","118.44.1587.1","Malignant Hematology","Acute leukemias","Acute promyelocytic leukemia",118,"Consolidation after upfront therapy",44,"Arsenic trioxide & ATRA",NA,NA,"0.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;1.ATRA;22.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;22.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;1.ATRA;22.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;22.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;1.ATRA;22.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;22.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;1.ATRA;","0.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;1.ATRA;22.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;22.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;1.ATRA;22.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;22.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;1.ATRA;22.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;22.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;1.ATRA;"
"635","118.44.1587.2","Malignant Hematology","Acute leukemias","Acute promyelocytic leukemia",118,"Consolidation after upfront therapy",44,"Arsenic trioxide & ATRA",NA,NA,"0.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;22.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;","0.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;22.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.ATRA;0.Arsenictrioxide;1.Arsenictrioxide;1.Arsenictrioxide;"
"636","118.44.1588.1","Malignant Hematology","Acute leukemias","Acute promyelocytic leukemia",118,"Consolidation after upfront therapy",44,"ATRA & Daunorubicin",FALSE,"2","33.ATRA;0.Daunorubicin;1.ATRA;0.Daunorubicin;1.ATRA;0.Daunorubicin;1.ATRA;1.ATRA;1.ATRA;1.ATRA;","33.ATRA;0.Daunorubicin;1.ATRA;0.Daunorubicin;1.ATRA;0.Daunorubicin;1.ATRA;1.ATRA;1.ATRA;1.ATRA;"
"637","118.44.1589.1","Malignant Hematology","Acute leukemias","Acute promyelocytic leukemia",118,"Consolidation after upfront therapy",44,"Cytarabine & Daunorubicin",NA,NA,"0.Cytarabine;0.Daunorubicin;1.Daunorubicin;1.Daunorubicin;26.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;","0.Cytarabine;0.Daunorubicin;1.Daunorubicin;1.Daunorubicin;26.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;"
"638","118.44.1589.2","Malignant Hematology","Acute leukemias","Acute promyelocytic leukemia",118,"Consolidation after upfront therapy",44,"Cytarabine & Daunorubicin",NA,NA,"0.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;22.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;","0.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;22.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;0.Daunorubicin;1.Cytarabine;"
"639","118.44.1590.1","Malignant Hematology","Acute leukemias","Acute promyelocytic leukemia",118,"Consolidation after upfront therapy",44,"Cytarabine & Idarubicin",FALSE,"1","0.Cytarabine;0.Idarubicin;1.Cytarabine;0.Idarubicin;1.Cytarabine;0.Idarubicin;1.Cytarabine;0.Idarubicin;","0.Cytarabine;0.Idarubicin;1.Cytarabine;0.Idarubicin;1.Cytarabine;0.Idarubicin;1.Cytarabine;0.Idarubicin;"
"640","118.44.1591.1","Malignant Hematology","Acute leukemias","Acute promyelocytic leukemia",118,"Consolidation after upfront therapy",44,"Cytarabine & Idarubicin, then Etoposide & Mitoxantrone, then Cytarabine, Idarubicin, Thioguanine",NA,NA,"0.Cytarabine;0.Idarubicin;1.Cytarabine;0.Idarubicin;1.Cytarabine;0.Idarubicin;1.Cytarabine;0.Idarubicin;1.Etoposide;0.Mitoxantrone;1.Etoposide;0.Mitoxantrone;1.Etoposide;0.Mitoxantrone;1.Etoposide;0.Mitoxantrone;1.Etoposide;0.Mitoxantrone;1.Cytarabine;0.Idarubicin;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;","0.Cytarabine;0.Idarubicin;1.Cytarabine;0.Idarubicin;1.Cytarabine;0.Idarubicin;1.Cytarabine;0.Idarubicin;1.Etoposide;0.Mitoxantrone;1.Etoposide;0.Mitoxantrone;1.Etoposide;0.Mitoxantrone;1.Etoposide;0.Mitoxantrone;1.Etoposide;0.Mitoxantrone;1.Cytarabine;0.Idarubicin;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;"
"641","118.44.1592.1","Malignant Hematology","Acute leukemias","Acute promyelocytic leukemia",118,"Consolidation after upfront therapy",44,"Cytarabine & Idarubicin, then Etoposide & Mitoxantrone, then Cytarabine, Idarubicin, Thioguanine, with ATRA",NA,NA,"0.ATRA;0.Cytarabine;0.Idarubicin;0.Methotrexate;1.ATRA;0.Cytarabine;0.Idarubicin;1.ATRA;0.Cytarabine;0.Idarubicin;1.ATRA;0.Cytarabine;0.Idarubicin;1.ATRA;1.ATRA;1.ATRA;22.ATRA;0.Etoposide;0.Methotrexate;0.Mitoxantrone;1.ATRA;0.Etoposide;0.Mitoxantrone;1.ATRA;0.Etoposide;0.Mitoxantrone;1.ATRA;0.Etoposide;0.Mitoxantrone;1.ATRA;0.Etoposide;0.Mitoxantrone;1.ATRA;1.ATRA;22.ATRA;0.Cytarabine;0.Idarubicin;0.Methotrexate;0.Thioguanine;1.ATRA;0.Cytarabine;0.Thioguanine;1.ATRA;0.Cytarabine;0.Thioguanine;1.ATRA;0.Cytarabine;0.Thioguanine;1.ATRA;0.Cytarabine;0.Thioguanine;1.ATRA;1.ATRA;","0.ATRA;0.Cytarabine;0.Idarubicin;0.Methotrexate;1.ATRA;0.Cytarabine;0.Idarubicin;1.ATRA;0.Cytarabine;0.Idarubicin;1.ATRA;0.Cytarabine;0.Idarubicin;1.ATRA;1.ATRA;1.ATRA;22.ATRA;0.Etoposide;0.Methotrexate;0.Mitoxantrone;1.ATRA;0.Etoposide;0.Mitoxantrone;1.ATRA;0.Etoposide;0.Mitoxantrone;1.ATRA;0.Etoposide;0.Mitoxantrone;1.ATRA;0.Etoposide;0.Mitoxantrone;1.ATRA;1.ATRA;22.ATRA;0.Cytarabine;0.Idarubicin;0.Methotrexate;0.Thioguanine;1.ATRA;0.Cytarabine;0.Thioguanine;1.ATRA;0.Cytarabine;0.Thioguanine;1.ATRA;0.Cytarabine;0.Thioguanine;1.ATRA;0.Cytarabine;0.Thioguanine;1.ATRA;1.ATRA;"
"642","118.44.1593.1","Malignant Hematology","Acute leukemias","Acute promyelocytic leukemia",118,"Consolidation after upfront therapy",44,"Cytarabine & Idarubicin, then Mitoxantrone, then Cytarabine & Idarubicin, with ATRA",NA,NA,"0.ATRA;0.Cytarabine;0.Idarubicin;1.ATRA;0.Cytarabine;0.Idarubicin;1.ATRA;0.Cytarabine;0.Idarubicin;1.ATRA;0.Cytarabine;0.Idarubicin;1.ATRA;1.ATRA;1.ATRA;22.ATRA;0.Mitoxantrone;1.ATRA;0.Mitoxantrone;1.ATRA;0.Mitoxantrone;1.ATRA;0.Mitoxantrone;1.ATRA;0.Mitoxantrone;1.ATRA;1.ATRA;22.ATRA;0.Cytarabine;0.Idarubicin;1.ATRA;0.Cytarabine;1.ATRA;0.Cytarabine;1.ATRA;0.Cytarabine;1.ATRA;1.ATRA;1.ATRA;","0.ATRA;0.Cytarabine;0.Idarubicin;1.ATRA;0.Cytarabine;0.Idarubicin;1.ATRA;0.Cytarabine;0.Idarubicin;1.ATRA;0.Cytarabine;0.Idarubicin;1.ATRA;1.ATRA;1.ATRA;22.ATRA;0.Mitoxantrone;1.ATRA;0.Mitoxantrone;1.ATRA;0.Mitoxantrone;1.ATRA;0.Mitoxantrone;1.ATRA;0.Mitoxantrone;1.ATRA;1.ATRA;22.ATRA;0.Cytarabine;0.Idarubicin;1.ATRA;0.Cytarabine;1.ATRA;0.Cytarabine;1.ATRA;0.Cytarabine;1.ATRA;1.ATRA;1.ATRA;"
"643","118.44.1594.1","Malignant Hematology","Acute leukemias","Acute promyelocytic leukemia",118,"Consolidation after upfront therapy",44,"Daunorubicin monotherapy",NA,NA,"0.Daunorubicin;NA.Daunorubicin;NA.Daunorubicin;","0.Daunorubicin;NA.Daunorubicin;NA.Daunorubicin;"
"644","118.44.1595.1","Malignant Hematology","Acute leukemias","Acute promyelocytic leukemia",118,"Consolidation after upfront therapy",44,"Idarubicin, then Mitoxantrone, then Idarubicin",NA,NA,"0.Idarubicin;1.Idarubicin;1.Idarubicin;1.Idarubicin;25.Mitoxantrone;1.Mitoxantrone;1.Mitoxantrone;1.Mitoxantrone;1.Mitoxantrone;24.Idarubicin;","0.Idarubicin;1.Idarubicin;1.Idarubicin;1.Idarubicin;25.Mitoxantrone;1.Mitoxantrone;1.Mitoxantrone;1.Mitoxantrone;1.Mitoxantrone;24.Idarubicin;"
"645","118.44.1596.1","Malignant Hematology","Acute leukemias","Acute promyelocytic leukemia",118,"Consolidation after upfront therapy",44,"Idarubicin, then Mitoxantrone, then Idarubicin, with ATRA",NA,NA,"0.ATRA;0.Idarubicin;1.ATRA;0.Idarubicin;1.ATRA;0.Idarubicin;1.ATRA;0.Idarubicin;1.ATRA;1.ATRA;1.ATRA;22.ATRA;0.Mitoxantrone;1.ATRA;0.Mitoxantrone;1.ATRA;0.Mitoxantrone;1.ATRA;0.Mitoxantrone;1.ATRA;0.Mitoxantrone;1.ATRA;1.ATRA;22.ATRA;0.Idarubicin;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;","0.ATRA;0.Idarubicin;1.ATRA;0.Idarubicin;1.ATRA;0.Idarubicin;1.ATRA;0.Idarubicin;1.ATRA;1.ATRA;1.ATRA;22.ATRA;0.Mitoxantrone;1.ATRA;0.Mitoxantrone;1.ATRA;0.Mitoxantrone;1.ATRA;0.Mitoxantrone;1.ATRA;0.Mitoxantrone;1.ATRA;1.ATRA;22.ATRA;0.Idarubicin;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;"
"646","118.44.1596.2","Malignant Hematology","Acute leukemias","Acute promyelocytic leukemia",118,"Consolidation after upfront therapy",44,"Idarubicin, then Mitoxantrone, then Idarubicin, with ATRA",NA,NA,"0.ATRA;0.Idarubicin;1.ATRA;0.Idarubicin;1.ATRA;0.Idarubicin;1.ATRA;0.Idarubicin;1.ATRA;1.ATRA;1.ATRA;22.ATRA;0.Mitoxantrone;1.ATRA;0.Mitoxantrone;1.ATRA;0.Mitoxantrone;1.ATRA;1.ATRA;1.ATRA;1.ATRA;22.ATRA;0.Idarubicin;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;","0.ATRA;0.Idarubicin;1.ATRA;0.Idarubicin;1.ATRA;0.Idarubicin;1.ATRA;0.Idarubicin;1.ATRA;1.ATRA;1.ATRA;22.ATRA;0.Mitoxantrone;1.ATRA;0.Mitoxantrone;1.ATRA;0.Mitoxantrone;1.ATRA;1.ATRA;1.ATRA;1.ATRA;22.ATRA;0.Idarubicin;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;"
"647","118.44.1596.3","Malignant Hematology","Acute leukemias","Acute promyelocytic leukemia",118,"Consolidation after upfront therapy",44,"Idarubicin, then Mitoxantrone, then Idarubicin, with ATRA",NA,NA,"0.ATRA;0.Idarubicin;1.ATRA;0.Idarubicin;1.ATRA;0.Idarubicin;1.ATRA;0.Idarubicin;1.ATRA;1.ATRA;1.ATRA;22.ATRA;0.Mitoxantrone;1.ATRA;0.Mitoxantrone;1.ATRA;0.Mitoxantrone;1.ATRA;1.ATRA;1.ATRA;1.ATRA;22.ATRA;0.Idarubicin;1.ATRA;0.Idarubicin;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;","0.ATRA;0.Idarubicin;1.ATRA;0.Idarubicin;1.ATRA;0.Idarubicin;1.ATRA;0.Idarubicin;1.ATRA;1.ATRA;1.ATRA;22.ATRA;0.Mitoxantrone;1.ATRA;0.Mitoxantrone;1.ATRA;0.Mitoxantrone;1.ATRA;1.ATRA;1.ATRA;1.ATRA;22.ATRA;0.Idarubicin;1.ATRA;0.Idarubicin;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;"
"648","118.44.1596.4","Malignant Hematology","Acute leukemias","Acute promyelocytic leukemia",118,"Consolidation after upfront therapy",44,"Idarubicin, then Mitoxantrone, then Idarubicin, with ATRA",NA,NA,"0.ATRA;0.Idarubicin;1.ATRA;0.Idarubicin;1.ATRA;0.Idarubicin;1.ATRA;0.Idarubicin;1.ATRA;1.ATRA;1.ATRA;22.ATRA;0.Mitoxantrone;1.ATRA;0.Mitoxantrone;1.ATRA;0.Mitoxantrone;1.ATRA;0.Mitoxantrone;1.ATRA;0.Mitoxantrone;1.ATRA;1.ATRA;22.ATRA;0.Idarubicin;1.ATRA;0.Idarubicin;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;","0.ATRA;0.Idarubicin;1.ATRA;0.Idarubicin;1.ATRA;0.Idarubicin;1.ATRA;0.Idarubicin;1.ATRA;1.ATRA;1.ATRA;22.ATRA;0.Mitoxantrone;1.ATRA;0.Mitoxantrone;1.ATRA;0.Mitoxantrone;1.ATRA;0.Mitoxantrone;1.ATRA;0.Mitoxantrone;1.ATRA;1.ATRA;22.ATRA;0.Idarubicin;1.ATRA;0.Idarubicin;1.ATRA;1.ATRA;1.ATRA;1.ATRA;1.ATRA;"
"649","119.117.1649.2","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Maintenance after subsequent lines of therapy",117,"Blinatumomab monotherapy",TRUE,"Cont.","57.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;57.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;","57.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;"
"650","119.118.1636.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Maintenance after upfront therapy",118,"Mercaptopurine, Methotrexate, Vincristine, Dexamethasone",TRUE,"Cont.","1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;","1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;"
"651","119.118.1637.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Maintenance after upfront therapy",118,"Mercaptopurine & Methotrexate",TRUE,"Cont.","1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;","1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;"
"652","119.118.1638.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Maintenance after upfront therapy",118,"POMP",TRUE,"Cont.","1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;","1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;"
"653","119.118.1638.2","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Maintenance after upfront therapy",118,"POMP",TRUE,"Cont.","1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;","1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;"
"654","119.118.1638.3","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Maintenance after upfront therapy",118,"POMP",TRUE,"Cont.","1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;","1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;"
"655","119.118.1638.4","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Maintenance after upfront therapy",118,"POMP",TRUE,"Cont.","24.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;0.Methotrexate;24.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;0.Methotrexate;","24.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;0.Methotrexate;"
"656","119.160.1605.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Pre-phase",160,"Methotrexate monotherapy",FALSE,"1","0.Methotrexate;","0.Methotrexate;0.Methotrexate;"
"657","119.160.1606.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Pre-phase",160,"Vincristine monotherapy",FALSE,"1","0.Vincristine;","0.Vincristine;0.Vincristine;"
"658","119.172.1639.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Relapsed or refractory",172,"Augmented Hyper-CVAD & Asparaginase",NA,NA,"0.Asparaginase;0.Cyclophosphamide;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;18.Asparaginase;0.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;19.Asparaginase;0.Cyclophosphamide;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;18.Asparaginase;0.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;19.Asparaginase;0.Cyclophosphamide;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;18.Asparaginase;0.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;19.Asparaginase;0.Cyclophosphamide;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;18.Asparaginase;0.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;","0.Asparaginase;0.Cyclophosphamide;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;18.Asparaginase;0.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;19.Asparaginase;0.Cyclophosphamide;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;18.Asparaginase;0.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;19.Asparaginase;0.Cyclophosphamide;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;18.Asparaginase;0.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;19.Asparaginase;0.Cyclophosphamide;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;18.Asparaginase;0.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;"
"659","119.172.1639.2","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Relapsed or refractory",172,"Augmented Hyper-CVAD & Asparaginase",NA,NA,"0.Asparaginase;0.Cyclophosphamide;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;25.Asparaginase;0.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;26.Asparaginase;0.Cyclophosphamide;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;25.Asparaginase;0.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;26.Asparaginase;0.Cyclophosphamide;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;25.Asparaginase;0.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;26.Asparaginase;0.Cyclophosphamide;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;25.Asparaginase;0.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;","0.Asparaginase;0.Cyclophosphamide;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;25.Asparaginase;0.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;26.Asparaginase;0.Cyclophosphamide;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;25.Asparaginase;0.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;26.Asparaginase;0.Cyclophosphamide;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;25.Asparaginase;0.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;26.Asparaginase;0.Cyclophosphamide;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;25.Asparaginase;0.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;"
"660","119.172.1639.3","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Relapsed or refractory",172,"Augmented Hyper-CVAD & Asparaginase",NA,NA,"0.Asparaginase;0.Cyclophosphamide;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;32.Asparaginase;0.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;33.Asparaginase;0.Cyclophosphamide;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;32.Asparaginase;0.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;33.Asparaginase;0.Cyclophosphamide;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;32.Asparaginase;0.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;33.Asparaginase;0.Cyclophosphamide;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;32.Asparaginase;0.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;","0.Asparaginase;0.Cyclophosphamide;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;32.Asparaginase;0.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;33.Asparaginase;0.Cyclophosphamide;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;32.Asparaginase;0.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;33.Asparaginase;0.Cyclophosphamide;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;32.Asparaginase;0.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;33.Asparaginase;0.Cyclophosphamide;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;32.Asparaginase;0.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;"
"661","119.172.1639.4","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Relapsed or refractory",172,"Augmented Hyper-CVAD & Asparaginase",NA,NA,"0.Cyclophosphamide;0.Pegaspargase;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;18.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;2.Pegaspargase;17.Cyclophosphamide;0.Pegaspargase;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;18.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;2.Pegaspargase;17.Cyclophosphamide;0.Pegaspargase;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;18.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;2.Pegaspargase;17.Cyclophosphamide;0.Pegaspargase;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;18.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;2.Pegaspargase;","0.Cyclophosphamide;0.Pegaspargase;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;18.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;2.Pegaspargase;17.Cyclophosphamide;0.Pegaspargase;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;18.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;2.Pegaspargase;17.Cyclophosphamide;0.Pegaspargase;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;18.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;2.Pegaspargase;17.Cyclophosphamide;0.Pegaspargase;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;18.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;2.Pegaspargase;"
"662","119.172.1639.5","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Relapsed or refractory",172,"Augmented Hyper-CVAD & Asparaginase",NA,NA,"0.Cyclophosphamide;0.Pegaspargase;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;25.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;2.Pegaspargase;24.Cyclophosphamide;0.Pegaspargase;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;25.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;2.Pegaspargase;24.Cyclophosphamide;0.Pegaspargase;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;25.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;2.Pegaspargase;24.Cyclophosphamide;0.Pegaspargase;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;25.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;2.Pegaspargase;","0.Cyclophosphamide;0.Pegaspargase;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;25.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;2.Pegaspargase;24.Cyclophosphamide;0.Pegaspargase;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;25.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;2.Pegaspargase;24.Cyclophosphamide;0.Pegaspargase;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;25.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;2.Pegaspargase;24.Cyclophosphamide;0.Pegaspargase;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;25.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;2.Pegaspargase;"
"663","119.172.1639.6","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Relapsed or refractory",172,"Augmented Hyper-CVAD & Asparaginase",NA,NA,"0.Cyclophosphamide;0.Pegaspargase;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;32.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;2.Pegaspargase;31.Cyclophosphamide;0.Pegaspargase;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;32.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;2.Pegaspargase;31.Cyclophosphamide;0.Pegaspargase;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;32.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;2.Pegaspargase;31.Cyclophosphamide;0.Pegaspargase;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;32.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;2.Pegaspargase;","0.Cyclophosphamide;0.Pegaspargase;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;32.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;2.Pegaspargase;31.Cyclophosphamide;0.Pegaspargase;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;32.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;2.Pegaspargase;31.Cyclophosphamide;0.Pegaspargase;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;32.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;2.Pegaspargase;31.Cyclophosphamide;0.Pegaspargase;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;32.Methotrexate;0.Vincristine;1.Cytarabine;1.Cytarabine;2.Pegaspargase;"
"664","119.172.1640.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Relapsed or refractory",172,"Brexucabtagene autoleucel monotherapy",FALSE,"1","0.Brexucabtageneautoleucel;","0.Brexucabtageneautoleucel;0.Brexucabtageneautoleucel;"
"665","119.172.1641.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Relapsed or refractory",172,"Clofarabine monotherapy",TRUE,"Cont.","17.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;17.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;","17.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;"
"666","119.172.1641.2","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Relapsed or refractory",172,"Clofarabine monotherapy",TRUE,"Cont.","24.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;24.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;","24.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;"
"667","119.172.1641.3","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Relapsed or refractory",172,"Clofarabine monotherapy",TRUE,"Cont.","31.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;31.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;","31.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;"
"668","119.172.1641.4","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Relapsed or refractory",172,"Clofarabine monotherapy",TRUE,"Cont.","38.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;38.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;","38.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;"
"669","119.172.1642.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Relapsed or refractory",172,"Cytarabine monotherapy",FALSE,"1","0.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;","0.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"670","119.172.1643.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Relapsed or refractory",172,"Cytarabine, Idarubicin, Rituximab",FALSE,"1","0.Cytarabine;0.Idarubicin;0.Rituximab;1.Cytarabine;0.Idarubicin;1.Cytarabine;0.Idarubicin;1.Cytarabine;3.Rituximab;","0.Cytarabine;0.Idarubicin;0.Rituximab;1.Cytarabine;0.Idarubicin;1.Cytarabine;0.Idarubicin;1.Cytarabine;3.Rituximab;"
"671","119.172.1644.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Relapsed or refractory",172,"Cytarabine & Mitoxantrone (MC)",TRUE,"Cont.","9.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;9.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;","9.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"672","119.172.1644.2","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Relapsed or refractory",172,"Cytarabine & Mitoxantrone (MC)",TRUE,"Cont.","14.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;14.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;","14.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"673","119.172.1645.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Relapsed or refractory",172,"FLAG",TRUE,"Cont.","23.Cytarabine;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;23.Cytarabine;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;","23.Cytarabine;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;"
"674","119.172.1646.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Relapsed or refractory",172,"Hyper-CVAD/MA & Everolimus",NA,NA,"0.Cyclophosphamide;0.Everolimus;1.Cyclophosphamide;0.Everolimus;1.Cyclophosphamide;0.Everolimus;1.Doxorubicin;0.Everolimus;0.Vincristine;1.Everolimus;1.Everolimus;1.Everolimus;22.Everolimus;0.Methotrexate;1.Cytarabine;0.Everolimus;0.Methotrexate;1.Cytarabine;0.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;22.Cyclophosphamide;0.Everolimus;1.Cyclophosphamide;0.Everolimus;1.Cyclophosphamide;0.Everolimus;1.Doxorubicin;0.Everolimus;0.Vincristine;1.Everolimus;1.Everolimus;1.Everolimus;22.Everolimus;0.Methotrexate;1.Cytarabine;0.Everolimus;0.Methotrexate;1.Cytarabine;0.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;22.Cyclophosphamide;0.Everolimus;1.Cyclophosphamide;0.Everolimus;1.Cyclophosphamide;0.Everolimus;1.Doxorubicin;0.Everolimus;0.Vincristine;1.Everolimus;1.Everolimus;1.Everolimus;22.Everolimus;0.Methotrexate;1.Cytarabine;0.Everolimus;0.Methotrexate;1.Cytarabine;0.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;22.Cyclophosphamide;0.Everolimus;1.Cyclophosphamide;0.Everolimus;1.Cyclophosphamide;0.Everolimus;1.Doxorubicin;0.Everolimus;0.Vincristine;1.Everolimus;1.Everolimus;1.Everolimus;22.Everolimus;0.Methotrexate;1.Cytarabine;0.Everolimus;0.Methotrexate;1.Cytarabine;0.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;","0.Cyclophosphamide;0.Everolimus;1.Cyclophosphamide;0.Everolimus;1.Cyclophosphamide;0.Everolimus;1.Doxorubicin;0.Everolimus;0.Vincristine;1.Everolimus;1.Everolimus;1.Everolimus;22.Everolimus;0.Methotrexate;1.Cytarabine;0.Everolimus;0.Methotrexate;1.Cytarabine;0.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;22.Cyclophosphamide;0.Everolimus;1.Cyclophosphamide;0.Everolimus;1.Cyclophosphamide;0.Everolimus;1.Doxorubicin;0.Everolimus;0.Vincristine;1.Everolimus;1.Everolimus;1.Everolimus;22.Everolimus;0.Methotrexate;1.Cytarabine;0.Everolimus;0.Methotrexate;1.Cytarabine;0.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;22.Cyclophosphamide;0.Everolimus;1.Cyclophosphamide;0.Everolimus;1.Cyclophosphamide;0.Everolimus;1.Doxorubicin;0.Everolimus;0.Vincristine;1.Everolimus;1.Everolimus;1.Everolimus;22.Everolimus;0.Methotrexate;1.Cytarabine;0.Everolimus;0.Methotrexate;1.Cytarabine;0.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;22.Cyclophosphamide;0.Everolimus;1.Cyclophosphamide;0.Everolimus;1.Cyclophosphamide;0.Everolimus;1.Doxorubicin;0.Everolimus;0.Vincristine;1.Everolimus;1.Everolimus;1.Everolimus;22.Everolimus;0.Methotrexate;1.Cytarabine;0.Everolimus;0.Methotrexate;1.Cytarabine;0.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;"
"675","119.172.1647.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Relapsed or refractory",172,"Inotuzumab ozogamicin monotherapy",FALSE,"1","0.Inotuzumabozogamicin;7.Inotuzumabozogamicin;7.Inotuzumabozogamicin;","0.Inotuzumabozogamicin;7.Inotuzumabozogamicin;7.Inotuzumabozogamicin;"
"676","119.172.1647.2","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Relapsed or refractory",172,"Inotuzumab ozogamicin monotherapy",TRUE,"Cont.","14.Inotuzumabozogamicin;7.Inotuzumabozogamicin;7.Inotuzumabozogamicin;14.Inotuzumabozogamicin;7.Inotuzumabozogamicin;7.Inotuzumabozogamicin;","14.Inotuzumabozogamicin;7.Inotuzumabozogamicin;7.Inotuzumabozogamicin;"
"677","119.172.1648.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Relapsed or refractory",172,"Tisagenlecleucel monotherapy",FALSE,"1","0.Tisagenlecleucel;","0.Tisagenlecleucel;0.Tisagenlecleucel;"
"678","119.204.1607.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Upfront induction therapy",204,"Blinatumomab monotherapy",FALSE,"2","1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;","1.Blinatumomab;1.Blinatumomab;"
"679","119.204.1608.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Upfront induction therapy",204,"Cyclophosphamide, Cytarabine, Mercaptopurine",FALSE,"1","0.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cyclophosphamide;","0.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cyclophosphamide;"
"680","119.204.1609.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Upfront induction therapy",204,"Cyclophosphamide, Daunorubicin, Vincristine, Prednisone",FALSE,"1","0.Cyclophosphamide;0.Daunorubicin;0.Vincristine;1.Daunorubicin;1.Daunorubicin;5.Cyclophosphamide;0.Vincristine;7.Daunorubicin;0.Vincristine;1.Daunorubicin;6.Vincristine;","0.Cyclophosphamide;0.Daunorubicin;0.Vincristine;1.Daunorubicin;1.Daunorubicin;5.Cyclophosphamide;0.Vincristine;7.Daunorubicin;0.Vincristine;1.Daunorubicin;6.Vincristine;"
"681","119.204.1610.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Upfront induction therapy",204,"Cyclophosphamide, Daunorubicin, L-Asparaginase, Vincristine, Prednisone",FALSE,"1","0.Cyclophosphamide;0.Cytarabine;0.Methotrexate;0.Vincristine;7.Asparaginase;0.Cytarabine;0.Methotrexate;0.Vincristine;2.Asparaginase;2.Asparaginase;3.Cyclophosphamide;0.Daunorubicin;0.Vincristine;1.Daunorubicin;1.Lenograstim;1.Lenograstim;1.Lenograstim;1.Asparaginase;0.Lenograstim;1.Lenograstim;1.Asparaginase;0.Lenograstim;0.Vincristine;1.Lenograstim;1.Asparaginase;0.Lenograstim;1.Lenograstim;1.Asparaginase;0.Lenograstim;1.Lenograstim;1.Asparaginase;0.Lenograstim;","0.Cyclophosphamide;0.Cytarabine;0.Methotrexate;0.Vincristine;7.Asparaginase;0.Cytarabine;0.Methotrexate;0.Vincristine;2.Asparaginase;2.Asparaginase;3.Cyclophosphamide;0.Daunorubicin;0.Vincristine;1.Daunorubicin;1.Lenograstim;1.Lenograstim;1.Lenograstim;1.Asparaginase;0.Lenograstim;1.Lenograstim;1.Asparaginase;0.Lenograstim;0.Vincristine;1.Lenograstim;1.Asparaginase;0.Lenograstim;1.Lenograstim;1.Asparaginase;0.Lenograstim;1.Lenograstim;1.Asparaginase;0.Lenograstim;"
"682","119.204.1610.2","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Upfront induction therapy",204,"Cyclophosphamide, Daunorubicin, L-Asparaginase, Vincristine, Prednisone",FALSE,"1","0.Cyclophosphamide;0.Cytarabine;0.Methotrexate;0.Vincristine;7.Asparaginase;0.Cytarabine;0.Methotrexate;0.Vincristine;2.Asparaginase;2.Asparaginase;3.Cyclophosphamide;0.Daunorubicin;0.Vincristine;1.Cyclophosphamide;0.Daunorubicin;1.Lenograstim;1.Lenograstim;1.Lenograstim;1.Asparaginase;0.Lenograstim;1.Lenograstim;1.Asparaginase;0.Lenograstim;0.Vincristine;1.Lenograstim;1.Asparaginase;0.Lenograstim;1.Lenograstim;1.Asparaginase;0.Lenograstim;1.Lenograstim;1.Asparaginase;0.Lenograstim;","0.Cyclophosphamide;0.Cytarabine;0.Methotrexate;0.Vincristine;7.Asparaginase;0.Cytarabine;0.Methotrexate;0.Vincristine;2.Asparaginase;2.Asparaginase;3.Cyclophosphamide;0.Daunorubicin;0.Vincristine;1.Cyclophosphamide;0.Daunorubicin;1.Lenograstim;1.Lenograstim;1.Lenograstim;1.Asparaginase;0.Lenograstim;1.Lenograstim;1.Asparaginase;0.Lenograstim;0.Vincristine;1.Lenograstim;1.Asparaginase;0.Lenograstim;1.Lenograstim;1.Asparaginase;0.Lenograstim;1.Lenograstim;1.Asparaginase;0.Lenograstim;"
"683","119.204.1610.3","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Upfront induction therapy",204,"Cyclophosphamide, Daunorubicin, L-Asparaginase, Vincristine, Prednisone",FALSE,"1","0.Cyclophosphamide;0.Cytarabine;0.Methotrexate;0.Vincristine;7.Asparaginase;0.Cytarabine;0.Methotrexate;0.Vincristine;2.Asparaginase;2.Asparaginase;3.Cyclophosphamide;0.Daunorubicin;0.Vincristine;1.Cyclophosphamide;0.Daunorubicin;1.Cyclophosphamide;1.Lenograstim;1.Lenograstim;1.Asparaginase;0.Lenograstim;1.Lenograstim;1.Asparaginase;0.Lenograstim;0.Vincristine;1.Lenograstim;1.Asparaginase;0.Lenograstim;1.Lenograstim;1.Asparaginase;0.Lenograstim;1.Lenograstim;1.Asparaginase;0.Lenograstim;","0.Cyclophosphamide;0.Cytarabine;0.Methotrexate;0.Vincristine;7.Asparaginase;0.Cytarabine;0.Methotrexate;0.Vincristine;2.Asparaginase;2.Asparaginase;3.Cyclophosphamide;0.Daunorubicin;0.Vincristine;1.Cyclophosphamide;0.Daunorubicin;1.Cyclophosphamide;1.Lenograstim;1.Lenograstim;1.Asparaginase;0.Lenograstim;1.Lenograstim;1.Asparaginase;0.Lenograstim;0.Vincristine;1.Lenograstim;1.Asparaginase;0.Lenograstim;1.Lenograstim;1.Asparaginase;0.Lenograstim;1.Lenograstim;1.Asparaginase;0.Lenograstim;"
"684","119.204.1610.4","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Upfront induction therapy",204,"Cyclophosphamide, Daunorubicin, L-Asparaginase, Vincristine, Prednisone",FALSE,"1","0.Cyclophosphamide;0.Daunorubicin;0.Vincristine;1.Cyclophosphamide;6.Daunorubicin;0.Vincristine;7.Daunorubicin;0.Vincristine;7.Asparaginase;0.Daunorubicin;0.Vincristine;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;","0.Cyclophosphamide;0.Daunorubicin;0.Vincristine;1.Cyclophosphamide;6.Daunorubicin;0.Vincristine;7.Daunorubicin;0.Vincristine;7.Asparaginase;0.Daunorubicin;0.Vincristine;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;"
"685","119.204.1610.5","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Upfront induction therapy",204,"Cyclophosphamide, Daunorubicin, L-Asparaginase, Vincristine, Prednisone",FALSE,"1","0.Cyclophosphamide;0.Daunorubicin;0.Vincristine;1.Daunorubicin;1.Daunorubicin;2.Asparaginase;3.Asparaginase;0.Vincristine;3.Asparaginase;4.Asparaginase;0.Vincristine;3.Asparaginase;4.Asparaginase;0.Vincristine;","0.Cyclophosphamide;0.Daunorubicin;0.Vincristine;1.Daunorubicin;1.Daunorubicin;2.Asparaginase;3.Asparaginase;0.Vincristine;3.Asparaginase;4.Asparaginase;0.Vincristine;3.Asparaginase;4.Asparaginase;0.Vincristine;"
"686","119.204.1611.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Upfront induction therapy",204,"Cyclophosphamide, Daunorubicin, L-Asparaginase, Vincristine, Prednisone, Rituximab",FALSE,"1","0.Cyclophosphamide;0.Cytarabine;0.Methotrexate;0.Rituximab;0.Vincristine;6.Rituximab;1.Asparaginase;0.Cytarabine;0.Methotrexate;0.Vincristine;2.Asparaginase;2.Asparaginase;3.Cyclophosphamide;0.Daunorubicin;0.Vincristine;1.Daunorubicin;1.Lenograstim;1.Lenograstim;1.Lenograstim;1.Asparaginase;0.Lenograstim;1.Lenograstim;1.Asparaginase;0.Lenograstim;0.Vincristine;1.Lenograstim;1.Asparaginase;0.Lenograstim;1.Lenograstim;1.Asparaginase;0.Lenograstim;1.Lenograstim;1.Asparaginase;0.Lenograstim;","0.Cyclophosphamide;0.Cytarabine;0.Methotrexate;0.Rituximab;0.Vincristine;6.Rituximab;1.Asparaginase;0.Cytarabine;0.Methotrexate;0.Vincristine;2.Asparaginase;2.Asparaginase;3.Cyclophosphamide;0.Daunorubicin;0.Vincristine;1.Daunorubicin;1.Lenograstim;1.Lenograstim;1.Lenograstim;1.Asparaginase;0.Lenograstim;1.Lenograstim;1.Asparaginase;0.Lenograstim;0.Vincristine;1.Lenograstim;1.Asparaginase;0.Lenograstim;1.Lenograstim;1.Asparaginase;0.Lenograstim;1.Lenograstim;1.Asparaginase;0.Lenograstim;"
"687","119.204.1612.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Upfront induction therapy",204,"Cyclophosphamide, Idarubicin, Vincristine, Prednisone",FALSE,"1","0.Cyclophosphamide;0.Idarubicin;0.Vincristine;1.Idarubicin;1.Idarubicin;5.Cyclophosphamide;0.Idarubicin;0.Vincristine;7.Vincristine;7.Vincristine;","0.Cyclophosphamide;0.Idarubicin;0.Vincristine;1.Idarubicin;1.Idarubicin;5.Cyclophosphamide;0.Idarubicin;0.Vincristine;7.Vincristine;7.Vincristine;"
"688","119.204.1613.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Upfront induction therapy",204,"DOLP",FALSE,"1","0.Asparaginase;0.Daunorubicin;0.Vincristine;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;0.Daunorubicin;0.Vincristine;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Daunorubicin;0.Vincristine;7.Daunorubicin;0.Vincristine;","0.Asparaginase;0.Daunorubicin;0.Vincristine;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;0.Daunorubicin;0.Vincristine;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Daunorubicin;0.Vincristine;7.Daunorubicin;0.Vincristine;"
"689","119.204.1613.2","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Upfront induction therapy",204,"DOLP",FALSE,"1","0.Daunorubicin;0.Vincristine;7.Daunorubicin;0.Vincristine;7.Daunorubicin;0.Vincristine;7.Asparaginase;0.Daunorubicin;0.Vincristine;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;","0.Daunorubicin;0.Vincristine;7.Daunorubicin;0.Vincristine;7.Daunorubicin;0.Vincristine;7.Asparaginase;0.Daunorubicin;0.Vincristine;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;"
"690","119.204.1613.3","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Upfront induction therapy",204,"DOLP",FALSE,"1","0.Daunorubicin;0.Vincristine;1.Daunorubicin;1.Daunorubicin;5.Vincristine;7.Vincristine;7.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;","0.Daunorubicin;0.Vincristine;1.Daunorubicin;1.Daunorubicin;5.Vincristine;7.Vincristine;7.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;"
"691","119.204.1613.4","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Upfront induction therapy",204,"DOLP",FALSE,"1","0.Daunorubicin;0.Vincristine;1.Daunorubicin;6.Vincristine;7.Vincristine;2.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;0.Vincristine;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;","0.Daunorubicin;0.Vincristine;1.Daunorubicin;6.Vincristine;7.Vincristine;2.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;0.Vincristine;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;"
"692","119.204.1613.5","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Upfront induction therapy",204,"DOLP",FALSE,"1","0.Daunorubicin;0.Vincristine;1.Daunorubicin;1.Daunorubicin;5.Vincristine;7.Daunorubicin;0.Vincristine;2.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;0.Vincristine;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;0.Daunorubicin;0.Vincristine;1.Asparaginase;0.Daunorubicin;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Vincristine;","0.Daunorubicin;0.Vincristine;1.Daunorubicin;1.Daunorubicin;5.Vincristine;7.Daunorubicin;0.Vincristine;2.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;0.Vincristine;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;0.Daunorubicin;0.Vincristine;1.Asparaginase;0.Daunorubicin;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Vincristine;"
"693","119.204.1613.6","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Upfront induction therapy",204,"DOLP",FALSE,"1","0.Daunorubicin;0.Vincristine;1.Daunorubicin;1.Daunorubicin;5.Vincristine;7.Asparaginase;0.Vincristine;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;0.Daunorubicin;0.Vincristine;1.Asparaginase;0.Daunorubicin;1.Asparaginase;5.Vincristine;7.Vincristine;","0.Daunorubicin;0.Vincristine;1.Daunorubicin;1.Daunorubicin;5.Vincristine;7.Asparaginase;0.Vincristine;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;0.Daunorubicin;0.Vincristine;1.Asparaginase;0.Daunorubicin;1.Asparaginase;5.Vincristine;7.Vincristine;"
"694","119.204.1613.7","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Upfront induction therapy",204,"DOLP",FALSE,"1","0.Daunorubicin;0.Vincristine;7.Daunorubicin;0.Vincristine;7.Daunorubicin;0.Vincristine;2.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;0.Daunorubicin;0.Vincristine;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;","0.Daunorubicin;0.Vincristine;7.Daunorubicin;0.Vincristine;7.Daunorubicin;0.Vincristine;2.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;0.Daunorubicin;0.Vincristine;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;"
"695","119.204.1614.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Upfront induction therapy",204,"Daunorubicin, Pegaspargase, Vincristine, Dexamethasone",FALSE,"1","0.Daunorubicin;0.Vincristine;3.Pegaspargase;4.Daunorubicin;0.Vincristine;6.Methotrexate;1.Daunorubicin;0.Vincristine;3.Pegaspargase;4.Daunorubicin;0.Vincristine;","0.Daunorubicin;0.Vincristine;3.Pegaspargase;4.Daunorubicin;0.Vincristine;6.Methotrexate;1.Daunorubicin;0.Vincristine;3.Pegaspargase;4.Daunorubicin;0.Vincristine;"
"696","119.204.1614.2","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Upfront induction therapy",204,"Daunorubicin, Pegaspargase, Vincristine, Dexamethasone",FALSE,"1","0.Daunorubicin;0.Vincristine;7.Daunorubicin;0.Vincristine;6.Methotrexate;1.Daunorubicin;0.Vincristine;3.Pegaspargase;4.Daunorubicin;0.Vincristine;","0.Daunorubicin;0.Vincristine;7.Daunorubicin;0.Vincristine;6.Methotrexate;1.Daunorubicin;0.Vincristine;3.Pegaspargase;4.Daunorubicin;0.Vincristine;"
"697","119.204.1615.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Upfront induction therapy",204,"Daunorubicin, Pegaspargase, Vincristine, Prednisone",FALSE,"1","0.Cytarabine;0.Daunorubicin;0.Vincristine;3.Pegaspargase;4.Daunorubicin;0.Methotrexate;0.Vincristine;7.Daunorubicin;0.Vincristine;7.Daunorubicin;0.Vincristine;","0.Cytarabine;0.Daunorubicin;0.Vincristine;3.Pegaspargase;4.Daunorubicin;0.Methotrexate;0.Vincristine;7.Daunorubicin;0.Vincristine;7.Daunorubicin;0.Vincristine;"
"698","119.204.1615.2","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Upfront induction therapy",204,"Daunorubicin, Pegaspargase, Vincristine, Prednisone",FALSE,"1","0.Daunorubicin;0.Vincristine;1.Daunorubicin;1.Daunorubicin;5.Vincristine;7.Pegaspargase;0.Vincristine;7.Vincristine;","0.Daunorubicin;0.Vincristine;1.Daunorubicin;1.Daunorubicin;5.Vincristine;7.Pegaspargase;0.Vincristine;7.Vincristine;"
"699","119.204.1615.3","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Upfront induction therapy",204,"Daunorubicin, Pegaspargase, Vincristine, Prednisone",FALSE,"1","0.Daunorubicin;0.Vincristine;1.Daunorubicin;1.Daunorubicin;5.Vincristine;7.Pegaspargase;0.Vincristine;7.Daunorubicin;0.Vincristine;1.Daunorubicin;6.Vincristine;7.Vincristine;2.Pegaspargase;","0.Daunorubicin;0.Vincristine;1.Daunorubicin;1.Daunorubicin;5.Vincristine;7.Pegaspargase;0.Vincristine;7.Daunorubicin;0.Vincristine;1.Daunorubicin;6.Vincristine;7.Vincristine;2.Pegaspargase;"
"700","119.204.1616.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Upfront induction therapy",204,"Hyper-CVAD/MA",NA,NA,"0.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;1.Doxorubicin;24.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;26.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;1.Doxorubicin;24.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;26.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;1.Doxorubicin;24.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;26.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;1.Doxorubicin;24.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;","0.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;1.Doxorubicin;24.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;26.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;1.Doxorubicin;24.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;26.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;1.Doxorubicin;24.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;26.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;1.Doxorubicin;24.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;"
"701","119.204.1616.2","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Upfront induction therapy",204,"Hyper-CVAD/MA",NA,NA,"0.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;1.Doxorubicin;2.Cytarabine;22.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;4.Cytarabine;22.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;1.Doxorubicin;2.Cytarabine;22.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;4.Cytarabine;22.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;1.Doxorubicin;2.Cytarabine;22.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;4.Cytarabine;22.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;1.Doxorubicin;2.Cytarabine;22.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;4.Cytarabine;","0.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;1.Doxorubicin;2.Cytarabine;22.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;4.Cytarabine;22.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;1.Doxorubicin;2.Cytarabine;22.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;4.Cytarabine;22.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;1.Doxorubicin;2.Cytarabine;22.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;4.Cytarabine;22.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;1.Doxorubicin;2.Cytarabine;22.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;4.Cytarabine;"
"702","119.204.1617.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Upfront induction therapy",204,"Mini-Hyper-CVD/MA & Inotuzumab ozogamicin",NA,NA,"0.Cyclophosphamide;0.Inotuzumabozogamicin;0.Vincristine;1.Cyclophosphamide;0.Inotuzumabozogamicin;1.Cyclophosphamide;0.Inotuzumabozogamicin;1.Inotuzumabozogamicin;25.Methotrexate;1.Cytarabine;1.Cytarabine;0.Inotuzumabozogamicin;26.Cyclophosphamide;0.Inotuzumabozogamicin;0.Vincristine;1.Cyclophosphamide;0.Inotuzumabozogamicin;1.Cyclophosphamide;0.Inotuzumabozogamicin;1.Inotuzumabozogamicin;25.Methotrexate;1.Cytarabine;1.Cytarabine;0.Inotuzumabozogamicin;26.Cyclophosphamide;0.Inotuzumabozogamicin;0.Vincristine;1.Cyclophosphamide;0.Inotuzumabozogamicin;1.Cyclophosphamide;0.Inotuzumabozogamicin;1.Inotuzumabozogamicin;25.Methotrexate;1.Cytarabine;1.Cytarabine;0.Inotuzumabozogamicin;26.Cyclophosphamide;0.Inotuzumabozogamicin;0.Vincristine;1.Cyclophosphamide;0.Inotuzumabozogamicin;1.Cyclophosphamide;0.Inotuzumabozogamicin;1.Inotuzumabozogamicin;25.Methotrexate;1.Cytarabine;1.Cytarabine;0.Inotuzumabozogamicin;","0.Cyclophosphamide;0.Inotuzumabozogamicin;0.Vincristine;1.Cyclophosphamide;0.Inotuzumabozogamicin;1.Cyclophosphamide;0.Inotuzumabozogamicin;1.Inotuzumabozogamicin;25.Methotrexate;1.Cytarabine;1.Cytarabine;0.Inotuzumabozogamicin;26.Cyclophosphamide;0.Inotuzumabozogamicin;0.Vincristine;1.Cyclophosphamide;0.Inotuzumabozogamicin;1.Cyclophosphamide;0.Inotuzumabozogamicin;1.Inotuzumabozogamicin;25.Methotrexate;1.Cytarabine;1.Cytarabine;0.Inotuzumabozogamicin;26.Cyclophosphamide;0.Inotuzumabozogamicin;0.Vincristine;1.Cyclophosphamide;0.Inotuzumabozogamicin;1.Cyclophosphamide;0.Inotuzumabozogamicin;1.Inotuzumabozogamicin;25.Methotrexate;1.Cytarabine;1.Cytarabine;0.Inotuzumabozogamicin;26.Cyclophosphamide;0.Inotuzumabozogamicin;0.Vincristine;1.Cyclophosphamide;0.Inotuzumabozogamicin;1.Cyclophosphamide;0.Inotuzumabozogamicin;1.Inotuzumabozogamicin;25.Methotrexate;1.Cytarabine;1.Cytarabine;0.Inotuzumabozogamicin;"
"703","119.204.1618.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Upfront induction therapy",204,"R-Hyper-CVAD/R-MA",NA,NA,"0.Cyclophosphamide;0.Rituximab;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;25.Methotrexate;1.Cytarabine;0.Rituximab;1.Cytarabine;26.Cyclophosphamide;0.Rituximab;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;25.Methotrexate;1.Cytarabine;0.Rituximab;1.Cytarabine;26.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;25.Methotrexate;1.Cytarabine;1.Cytarabine;26.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;25.Methotrexate;1.Cytarabine;1.Cytarabine;","0.Cyclophosphamide;0.Rituximab;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;25.Methotrexate;1.Cytarabine;0.Rituximab;1.Cytarabine;26.Cyclophosphamide;0.Rituximab;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;25.Methotrexate;1.Cytarabine;0.Rituximab;1.Cytarabine;26.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;25.Methotrexate;1.Cytarabine;1.Cytarabine;26.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;25.Methotrexate;1.Cytarabine;1.Cytarabine;"
"704","119.204.1618.2","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Upfront induction therapy",204,"R-Hyper-CVAD/R-MA",NA,NA,"0.Cyclophosphamide;0.Rituximab;1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;3.Cytarabine;22.Methotrexate;1.Cytarabine;0.Methotrexate;0.Rituximab;1.Cytarabine;4.Cytarabine;22.Cyclophosphamide;0.Rituximab;1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;3.Cytarabine;22.Methotrexate;1.Cytarabine;0.Methotrexate;0.Rituximab;1.Cytarabine;4.Cytarabine;22.Cyclophosphamide;1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;3.Cytarabine;22.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;4.Cytarabine;22.Cyclophosphamide;1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;3.Cytarabine;22.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;4.Cytarabine;","0.Cyclophosphamide;0.Rituximab;1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;3.Cytarabine;22.Methotrexate;1.Cytarabine;0.Methotrexate;0.Rituximab;1.Cytarabine;4.Cytarabine;22.Cyclophosphamide;0.Rituximab;1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;3.Cytarabine;22.Methotrexate;1.Cytarabine;0.Methotrexate;0.Rituximab;1.Cytarabine;4.Cytarabine;22.Cyclophosphamide;1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;3.Cytarabine;22.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;4.Cytarabine;22.Cyclophosphamide;1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;3.Cytarabine;22.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;4.Cytarabine;"
"705","119.41.1649.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Consolidation after salvage therapy",41,"Blinatumomab monotherapy",FALSE,"2","8.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;","8.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;"
"706","119.45.1622.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Consolidation after upfront therapy (including post-remission therapy)",45,"AALL0232 consolidation",FALSE,"1","0.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Pegaspargase;0.Vincristine;7.Vincristine;7.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Pegaspargase;0.Vincristine;7.Vincristine;","0.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Pegaspargase;0.Vincristine;7.Vincristine;7.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Pegaspargase;0.Vincristine;7.Vincristine;"
"707","119.45.1623.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Consolidation after upfront therapy (including post-remission therapy)",45,"Blinatumomab monotherapy",TRUE,"Cont.","15.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;15.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;","15.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;"
"708","119.45.1625.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Consolidation after upfront therapy (including post-remission therapy)",45,"Etoposide & TBI, then allo HSCT",FALSE,"1","0.Etoposide;","0.Etoposide;0.Etoposide;"
"709","119.45.1626.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Consolidation after upfront therapy (including post-remission therapy)",45,"International ALL Trial",NA,NA,"0.Cytarabine;0.Etoposide;0.Vincristine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;24.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;24.Daunorubicin;56.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;","0.Cytarabine;0.Etoposide;0.Vincristine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;24.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;24.Daunorubicin;56.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;"
"710","119.45.1626.2","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Consolidation after upfront therapy (including post-remission therapy)",45,"International ALL Trial",NA,NA,"0.Cytarabine;0.Cytarabine;0.Etoposide;0.Vincristine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;24.Cytarabine;0.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;24.Cytarabine;0.Daunorubicin;56.Cytarabine;0.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;","0.Cytarabine;0.Cytarabine;0.Etoposide;0.Vincristine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;24.Cytarabine;0.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;24.Cytarabine;0.Daunorubicin;56.Cytarabine;0.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;"
"711","119.45.1627.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Consolidation after upfront therapy (including post-remission therapy)",45,"Mercaptopurine, Methotrexate, Vincristine",TRUE,"Cont.","8.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;8.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;","8.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;"
"712","119.45.1627.2","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Consolidation after upfront therapy (including post-remission therapy)",45,"Mercaptopurine, Methotrexate, Vincristine",TRUE,"Cont.","8.Mercaptopurine;0.Methotrexate;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;8.Mercaptopurine;0.Methotrexate;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;","8.Mercaptopurine;0.Methotrexate;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;"
"713","119.45.1628.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Consolidation after upfront therapy (including post-remission therapy)",45,"Linker regimen (consolidation)",NA,NA,"0.Daunorubicin;0.Vincristine;1.Asparaginase;0.Daunorubicin;2.Asparaginase;3.Asparaginase;22.Cytarabine;0.Teniposide;3.Cytarabine;0.Teniposide;25.Daunorubicin;0.Vincristine;1.Asparaginase;0.Daunorubicin;2.Asparaginase;3.Asparaginase;22.Cytarabine;0.Teniposide;3.Cytarabine;0.Teniposide;25.Daunorubicin;0.Vincristine;1.Asparaginase;0.Daunorubicin;2.Asparaginase;3.Asparaginase;22.Cytarabine;0.Teniposide;3.Cytarabine;0.Teniposide;25.Daunorubicin;0.Vincristine;1.Asparaginase;0.Daunorubicin;2.Asparaginase;3.Asparaginase;22.Cytarabine;0.Teniposide;3.Cytarabine;0.Teniposide;25.Methotrexate;1.Asparaginase;0.Methotrexate;1.Methotrexate;1.Asparaginase;3.Asparaginase;","0.Daunorubicin;0.Vincristine;1.Asparaginase;0.Daunorubicin;2.Asparaginase;3.Asparaginase;22.Cytarabine;0.Teniposide;3.Cytarabine;0.Teniposide;25.Daunorubicin;0.Vincristine;1.Asparaginase;0.Daunorubicin;2.Asparaginase;3.Asparaginase;22.Cytarabine;0.Teniposide;3.Cytarabine;0.Teniposide;25.Daunorubicin;0.Vincristine;1.Asparaginase;0.Daunorubicin;2.Asparaginase;3.Asparaginase;22.Cytarabine;0.Teniposide;3.Cytarabine;0.Teniposide;25.Daunorubicin;0.Vincristine;1.Asparaginase;0.Daunorubicin;2.Asparaginase;3.Asparaginase;22.Cytarabine;0.Teniposide;3.Cytarabine;0.Teniposide;25.Methotrexate;1.Asparaginase;0.Methotrexate;1.Methotrexate;1.Asparaginase;3.Asparaginase;"
"714","119.45.1629.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Consolidation after upfront therapy (including post-remission therapy)",45,"Pediatric-like GRAALL consolidation",NA,NA,"0.Cytarabine;1.Cytarabine;1.Asparaginase;88.Cytarabine;1.Cytarabine;1.Asparaginase;88.Cytarabine;1.Cytarabine;1.Asparaginase;","0.Cytarabine;1.Cytarabine;1.Asparaginase;88.Cytarabine;1.Cytarabine;1.Asparaginase;88.Cytarabine;1.Cytarabine;1.Asparaginase;"
"715","119.58.1620.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Early intensification therapy",58,"CALGB 8811 early intensification",FALSE,"2","4.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Asparaginase;0.Vincristine;3.Asparaginase;4.Asparaginase;0.Vincristine;3.Asparaginase;","4.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Asparaginase;0.Vincristine;3.Asparaginase;4.Asparaginase;0.Vincristine;3.Asparaginase;"
"716","119.58.1621.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Early intensification therapy",58,"L-Asparaginase & Methotrexate",FALSE,"3","6.Methotrexate;1.Asparaginase;6.Methotrexate;1.Asparaginase;13.Methotrexate;1.Asparaginase;6.Methotrexate;1.Asparaginase;6.Methotrexate;1.Asparaginase;13.Methotrexate;1.Asparaginase;","6.Methotrexate;1.Asparaginase;6.Methotrexate;1.Asparaginase;13.Methotrexate;1.Asparaginase;"
"717","119.60.1619.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Extended induction therapy",60,"Daunorubicin, Pegaspargase, Vincristine, Prednisone",FALSE,"1","0.Daunorubicin;0.Vincristine;3.Pegaspargase;4.Vincristine;","0.Daunorubicin;0.Vincristine;3.Pegaspargase;4.Vincristine;"
"718","119.94.1630.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Interim maintenance",94,"Mercaptopurine, Methotrexate, WB-XRT",FALSE,"1","0.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;","0.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;"
"719","119.94.1631.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Interim maintenance",94,"Methotrexate & Pegaspargase",FALSE,"1","0.Methotrexate;0.Pegaspargase;1.Pegaspargase;9.Methotrexate;10.Methotrexate;1.Pegaspargase;9.Methotrexate;0.Pegaspargase;10.Methotrexate;","0.Methotrexate;0.Pegaspargase;1.Pegaspargase;9.Methotrexate;10.Methotrexate;1.Pegaspargase;9.Methotrexate;0.Pegaspargase;10.Methotrexate;"
"720","119.96.1632.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Late intensification",96,"Cyclophosphamide, Cytarabine, Pegaspargase, Thioguanine, Vincristine, Dexamethasone",FALSE,"1","0.Methotrexate;0.Vincristine;3.Pegaspargase;4.Vincristine;21.Cyclophosphamide;0.Cytarabine;0.Methotrexate;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Cytarabine;0.Methotrexate;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Pegaspargase;0.Vincristine;7.Vincristine;","0.Methotrexate;0.Vincristine;3.Pegaspargase;4.Vincristine;21.Cyclophosphamide;0.Cytarabine;0.Methotrexate;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Cytarabine;0.Methotrexate;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Pegaspargase;0.Vincristine;7.Vincristine;"
"721","119.96.1633.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Late intensification",96,"Cyclophosphamide, Daunorubicin, L-Asparaginase, Vincristine, Prednisone",FALSE,"1","0.Daunorubicin;0.Vincristine;1.Daunorubicin;1.Daunorubicin;5.Asparaginase;0.Vincristine;2.Asparaginase;2.Asparaginase;3.Cyclophosphamide;0.Vincristine;3.Asparaginase;2.Asparaginase;2.Asparaginase;","0.Daunorubicin;0.Vincristine;1.Daunorubicin;1.Daunorubicin;5.Asparaginase;0.Vincristine;2.Asparaginase;2.Asparaginase;3.Cyclophosphamide;0.Vincristine;3.Asparaginase;2.Asparaginase;2.Asparaginase;"
"722","119.96.1634.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Late intensification",96,"Cytarabine & Idarubicin",FALSE,"1","0.Cytarabine;0.Idarubicin;1.Cytarabine;0.Idarubicin;1.Cytarabine;0.Idarubicin;1.Cytarabine;","0.Cytarabine;0.Idarubicin;1.Cytarabine;0.Idarubicin;1.Cytarabine;0.Idarubicin;1.Cytarabine;"
"723","119.96.1635.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia",119,"Late intensification",96,"CALGB 8811 late intensification",FALSE,"1","0.Doxorubicin;0.Vincristine;7.Doxorubicin;0.Vincristine;7.Doxorubicin;0.Vincristine;14.Cyclophosphamide;0.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;","0.Doxorubicin;0.Vincristine;7.Doxorubicin;0.Vincristine;7.Doxorubicin;0.Vincristine;14.Cyclophosphamide;0.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;"
"724","12.29.378.1","Solid Tumor","Dermatologic Oncology","Melanoma, KIT-mutated",12,"Advanced or metastatic disease, TKI-naive",29,"Imatinib monotherapy",TRUE,"Cont.","1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;","1.Imatinib;1.Imatinib;"
"725","120.118.1666.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia, Ph-positive",120,"Maintenance after upfront therapy",118,"Dasatinib monotherapy",TRUE,"Cont.","1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;","1.Dasatinib;1.Dasatinib;"
"726","120.118.1667.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia, Ph-positive",120,"Maintenance after upfront therapy",118,"Dasatinib, Vincristine, Prednisone",TRUE,"Cont.","1.Dasatinib;0.Vincristine;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;0.Vincristine;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;","1.Dasatinib;0.Vincristine;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;"
"727","120.118.1668.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia, Ph-positive",120,"Maintenance after upfront therapy",118,"Imatinib, Vincristine, Prednisone",TRUE,"Cont.","1.Imatinib;0.Vincristine;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;0.Vincristine;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;","1.Imatinib;0.Vincristine;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;"
"728","120.118.1669.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia, Ph-positive",120,"Maintenance after upfront therapy",118,"Nilotinib monotherapy",TRUE,"Cont.","1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;","1.Nilotinib;1.Nilotinib;"
"729","120.172.1670.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia, Ph-positive",120,"Relapsed or refractory",172,"Bosutinib monotherapy",TRUE,"Cont.","1.Bosutinib;1.Bosutinib;1.Bosutinib;1.Bosutinib;1.Bosutinib;1.Bosutinib;1.Bosutinib;1.Bosutinib;1.Bosutinib;1.Bosutinib;1.Bosutinib;1.Bosutinib;1.Bosutinib;1.Bosutinib;","1.Bosutinib;1.Bosutinib;"
"730","120.204.1650.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia, Ph-positive",120,"Upfront induction therapy",204,"Dasatinib & Prednisone",FALSE,"1","0.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;","0.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;"
"731","120.204.1651.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia, Ph-positive",120,"Upfront induction therapy",204,"Daunorubicin, L-Asparaginase, Vincristine, Prednisone, Imatinib",FALSE,"1","0.Daunorubicin;0.Imatinib;0.Vincristine;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Daunorubicin;0.Imatinib;0.Vincristine;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Daunorubicin;0.Imatinib;0.Vincristine;1.Imatinib;1.Asparaginase;0.Imatinib;1.Asparaginase;0.Imatinib;1.Asparaginase;0.Imatinib;1.Asparaginase;0.Imatinib;1.Asparaginase;0.Imatinib;1.Asparaginase;0.Daunorubicin;0.Imatinib;0.Vincristine;1.Asparaginase;0.Imatinib;1.Asparaginase;0.Imatinib;1.Asparaginase;0.Imatinib;1.Asparaginase;0.Imatinib;1.Asparaginase;0.Imatinib;1.Asparaginase;0.Imatinib;","0.Daunorubicin;0.Imatinib;0.Vincristine;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Daunorubicin;0.Imatinib;0.Vincristine;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Daunorubicin;0.Imatinib;0.Vincristine;1.Imatinib;1.Asparaginase;0.Imatinib;1.Asparaginase;0.Imatinib;1.Asparaginase;0.Imatinib;1.Asparaginase;0.Imatinib;1.Asparaginase;0.Imatinib;1.Asparaginase;0.Daunorubicin;0.Imatinib;0.Vincristine;1.Asparaginase;0.Imatinib;1.Asparaginase;0.Imatinib;1.Asparaginase;0.Imatinib;1.Asparaginase;0.Imatinib;1.Asparaginase;0.Imatinib;1.Asparaginase;0.Imatinib;"
"732","120.204.1652.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia, Ph-positive",120,"Upfront induction therapy",204,"Daunorubicin, Vincristine, Prednisolone, Nilotinib",TRUE,"Cont.","1.Daunorubicin;0.Methotrexate;0.Vincristine;1.Daunorubicin;1.Daunorubicin;5.Nilotinib;0.Vincristine;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Daunorubicin;0.Methotrexate;0.Vincristine;1.Daunorubicin;1.Daunorubicin;5.Nilotinib;0.Vincristine;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;","1.Daunorubicin;0.Methotrexate;0.Vincristine;1.Daunorubicin;1.Daunorubicin;5.Nilotinib;0.Vincristine;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;"
"733","120.204.1652.2","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia, Ph-positive",120,"Upfront induction therapy",204,"Daunorubicin, Vincristine, Prednisolone, Nilotinib",TRUE,"Cont.","1.Daunorubicin;0.Vincristine;1.Daunorubicin;1.Daunorubicin;5.Nilotinib;0.Vincristine;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Daunorubicin;0.Vincristine;1.Daunorubicin;1.Daunorubicin;5.Nilotinib;0.Vincristine;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;","1.Daunorubicin;0.Vincristine;1.Daunorubicin;1.Daunorubicin;5.Nilotinib;0.Vincristine;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;"
"734","120.204.1653.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia, Ph-positive",120,"Upfront induction therapy",204,"Hyper-CVAD/MA & Dasatinib",NA,NA,"0.Cyclophosphamide;0.Dasatinib;1.Cyclophosphamide;0.Dasatinib;1.Cyclophosphamide;0.Dasatinib;1.Dasatinib;0.Doxorubicin;0.Vincristine;1.Dasatinib;0.Doxorubicin;1.Dasatinib;1.Dasatinib;22.Dasatinib;0.Methotrexate;1.Cytarabine;0.Dasatinib;1.Cytarabine;0.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;22.Cyclophosphamide;0.Dasatinib;1.Cyclophosphamide;0.Dasatinib;1.Cyclophosphamide;0.Dasatinib;1.Dasatinib;0.Doxorubicin;0.Vincristine;1.Dasatinib;0.Doxorubicin;1.Dasatinib;1.Dasatinib;22.Dasatinib;0.Methotrexate;1.Cytarabine;0.Dasatinib;1.Cytarabine;0.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;22.Cyclophosphamide;0.Dasatinib;1.Cyclophosphamide;0.Dasatinib;1.Cyclophosphamide;0.Dasatinib;1.Dasatinib;0.Doxorubicin;0.Vincristine;1.Dasatinib;0.Doxorubicin;1.Dasatinib;1.Dasatinib;22.Dasatinib;0.Methotrexate;1.Cytarabine;0.Dasatinib;1.Cytarabine;0.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;22.Cyclophosphamide;0.Dasatinib;1.Cyclophosphamide;0.Dasatinib;1.Cyclophosphamide;0.Dasatinib;1.Dasatinib;0.Doxorubicin;0.Vincristine;1.Dasatinib;0.Doxorubicin;1.Dasatinib;1.Dasatinib;22.Dasatinib;0.Methotrexate;1.Cytarabine;0.Dasatinib;1.Cytarabine;0.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;","0.Cyclophosphamide;0.Dasatinib;1.Cyclophosphamide;0.Dasatinib;1.Cyclophosphamide;0.Dasatinib;1.Dasatinib;0.Doxorubicin;0.Vincristine;1.Dasatinib;0.Doxorubicin;1.Dasatinib;1.Dasatinib;22.Dasatinib;0.Methotrexate;1.Cytarabine;0.Dasatinib;1.Cytarabine;0.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;22.Cyclophosphamide;0.Dasatinib;1.Cyclophosphamide;0.Dasatinib;1.Cyclophosphamide;0.Dasatinib;1.Dasatinib;0.Doxorubicin;0.Vincristine;1.Dasatinib;0.Doxorubicin;1.Dasatinib;1.Dasatinib;22.Dasatinib;0.Methotrexate;1.Cytarabine;0.Dasatinib;1.Cytarabine;0.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;22.Cyclophosphamide;0.Dasatinib;1.Cyclophosphamide;0.Dasatinib;1.Cyclophosphamide;0.Dasatinib;1.Dasatinib;0.Doxorubicin;0.Vincristine;1.Dasatinib;0.Doxorubicin;1.Dasatinib;1.Dasatinib;22.Dasatinib;0.Methotrexate;1.Cytarabine;0.Dasatinib;1.Cytarabine;0.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;22.Cyclophosphamide;0.Dasatinib;1.Cyclophosphamide;0.Dasatinib;1.Cyclophosphamide;0.Dasatinib;1.Dasatinib;0.Doxorubicin;0.Vincristine;1.Dasatinib;0.Doxorubicin;1.Dasatinib;1.Dasatinib;22.Dasatinib;0.Methotrexate;1.Cytarabine;0.Dasatinib;1.Cytarabine;0.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;"
"735","120.204.1653.2","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia, Ph-positive",120,"Upfront induction therapy",204,"Hyper-CVAD/MA & Dasatinib",NA,NA,"0.Cyclophosphamide;0.Dasatinib;1.Cyclophosphamide;0.Dasatinib;0.Methotrexate;1.Cyclophosphamide;0.Dasatinib;1.Dasatinib;0.Doxorubicin;0.Vincristine;1.Dasatinib;0.Doxorubicin;1.Dasatinib;1.Cytarabine;0.Dasatinib;22.Dasatinib;0.Methotrexate;1.Cytarabine;0.Dasatinib;0.Methotrexate;1.Cytarabine;0.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Cytarabine;0.Dasatinib;22.Cyclophosphamide;0.Dasatinib;1.Cyclophosphamide;0.Dasatinib;0.Methotrexate;1.Cyclophosphamide;0.Dasatinib;1.Dasatinib;0.Doxorubicin;0.Vincristine;1.Dasatinib;0.Doxorubicin;1.Dasatinib;1.Cytarabine;0.Dasatinib;22.Dasatinib;0.Methotrexate;1.Cytarabine;0.Dasatinib;0.Methotrexate;1.Cytarabine;0.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Cytarabine;0.Dasatinib;22.Cyclophosphamide;0.Dasatinib;1.Cyclophosphamide;0.Dasatinib;0.Methotrexate;1.Cyclophosphamide;0.Dasatinib;1.Dasatinib;0.Doxorubicin;0.Vincristine;1.Dasatinib;0.Doxorubicin;1.Dasatinib;1.Cytarabine;0.Dasatinib;22.Dasatinib;0.Methotrexate;1.Cytarabine;0.Dasatinib;0.Methotrexate;1.Cytarabine;0.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Cytarabine;0.Dasatinib;22.Cyclophosphamide;0.Dasatinib;1.Cyclophosphamide;0.Dasatinib;0.Methotrexate;1.Cyclophosphamide;0.Dasatinib;1.Dasatinib;0.Doxorubicin;0.Vincristine;1.Dasatinib;0.Doxorubicin;1.Dasatinib;1.Cytarabine;0.Dasatinib;22.Dasatinib;0.Methotrexate;1.Cytarabine;0.Dasatinib;0.Methotrexate;1.Cytarabine;0.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Cytarabine;0.Dasatinib;","0.Cyclophosphamide;0.Dasatinib;1.Cyclophosphamide;0.Dasatinib;0.Methotrexate;1.Cyclophosphamide;0.Dasatinib;1.Dasatinib;0.Doxorubicin;0.Vincristine;1.Dasatinib;0.Doxorubicin;1.Dasatinib;1.Cytarabine;0.Dasatinib;22.Dasatinib;0.Methotrexate;1.Cytarabine;0.Dasatinib;0.Methotrexate;1.Cytarabine;0.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Cytarabine;0.Dasatinib;22.Cyclophosphamide;0.Dasatinib;1.Cyclophosphamide;0.Dasatinib;0.Methotrexate;1.Cyclophosphamide;0.Dasatinib;1.Dasatinib;0.Doxorubicin;0.Vincristine;1.Dasatinib;0.Doxorubicin;1.Dasatinib;1.Cytarabine;0.Dasatinib;22.Dasatinib;0.Methotrexate;1.Cytarabine;0.Dasatinib;0.Methotrexate;1.Cytarabine;0.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Cytarabine;0.Dasatinib;22.Cyclophosphamide;0.Dasatinib;1.Cyclophosphamide;0.Dasatinib;0.Methotrexate;1.Cyclophosphamide;0.Dasatinib;1.Dasatinib;0.Doxorubicin;0.Vincristine;1.Dasatinib;0.Doxorubicin;1.Dasatinib;1.Cytarabine;0.Dasatinib;22.Dasatinib;0.Methotrexate;1.Cytarabine;0.Dasatinib;0.Methotrexate;1.Cytarabine;0.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Cytarabine;0.Dasatinib;22.Cyclophosphamide;0.Dasatinib;1.Cyclophosphamide;0.Dasatinib;0.Methotrexate;1.Cyclophosphamide;0.Dasatinib;1.Dasatinib;0.Doxorubicin;0.Vincristine;1.Dasatinib;0.Doxorubicin;1.Dasatinib;1.Cytarabine;0.Dasatinib;22.Dasatinib;0.Methotrexate;1.Cytarabine;0.Dasatinib;0.Methotrexate;1.Cytarabine;0.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Cytarabine;0.Dasatinib;"
"736","120.204.1653.3","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia, Ph-positive",120,"Upfront induction therapy",204,"Hyper-CVAD/MA & Dasatinib",NA,NA,"0.Cyclophosphamide;0.Dasatinib;0.Methotrexate;1.Cyclophosphamide;0.Dasatinib;1.Cyclophosphamide;0.Dasatinib;1.Dasatinib;0.Doxorubicin;0.Vincristine;1.Dasatinib;0.Doxorubicin;1.Dasatinib;1.Dasatinib;22.Dasatinib;0.Methotrexate;0.Methotrexate;1.Cytarabine;0.Dasatinib;1.Cytarabine;0.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;22.Cyclophosphamide;0.Dasatinib;0.Methotrexate;1.Cyclophosphamide;0.Dasatinib;1.Cyclophosphamide;0.Dasatinib;1.Dasatinib;0.Doxorubicin;0.Vincristine;1.Dasatinib;0.Doxorubicin;1.Dasatinib;1.Dasatinib;22.Dasatinib;0.Methotrexate;0.Methotrexate;1.Cytarabine;0.Dasatinib;1.Cytarabine;0.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;22.Cyclophosphamide;0.Dasatinib;0.Methotrexate;1.Cyclophosphamide;0.Dasatinib;1.Cyclophosphamide;0.Dasatinib;1.Dasatinib;0.Doxorubicin;0.Vincristine;1.Dasatinib;0.Doxorubicin;1.Dasatinib;1.Dasatinib;22.Dasatinib;0.Methotrexate;0.Methotrexate;1.Cytarabine;0.Dasatinib;1.Cytarabine;0.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;22.Cyclophosphamide;0.Dasatinib;0.Methotrexate;1.Cyclophosphamide;0.Dasatinib;1.Cyclophosphamide;0.Dasatinib;1.Dasatinib;0.Doxorubicin;0.Vincristine;1.Dasatinib;0.Doxorubicin;1.Dasatinib;1.Dasatinib;22.Dasatinib;0.Methotrexate;0.Methotrexate;1.Cytarabine;0.Dasatinib;1.Cytarabine;0.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;","0.Cyclophosphamide;0.Dasatinib;0.Methotrexate;1.Cyclophosphamide;0.Dasatinib;1.Cyclophosphamide;0.Dasatinib;1.Dasatinib;0.Doxorubicin;0.Vincristine;1.Dasatinib;0.Doxorubicin;1.Dasatinib;1.Dasatinib;22.Dasatinib;0.Methotrexate;0.Methotrexate;1.Cytarabine;0.Dasatinib;1.Cytarabine;0.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;22.Cyclophosphamide;0.Dasatinib;0.Methotrexate;1.Cyclophosphamide;0.Dasatinib;1.Cyclophosphamide;0.Dasatinib;1.Dasatinib;0.Doxorubicin;0.Vincristine;1.Dasatinib;0.Doxorubicin;1.Dasatinib;1.Dasatinib;22.Dasatinib;0.Methotrexate;0.Methotrexate;1.Cytarabine;0.Dasatinib;1.Cytarabine;0.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;22.Cyclophosphamide;0.Dasatinib;0.Methotrexate;1.Cyclophosphamide;0.Dasatinib;1.Cyclophosphamide;0.Dasatinib;1.Dasatinib;0.Doxorubicin;0.Vincristine;1.Dasatinib;0.Doxorubicin;1.Dasatinib;1.Dasatinib;22.Dasatinib;0.Methotrexate;0.Methotrexate;1.Cytarabine;0.Dasatinib;1.Cytarabine;0.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;22.Cyclophosphamide;0.Dasatinib;0.Methotrexate;1.Cyclophosphamide;0.Dasatinib;1.Cyclophosphamide;0.Dasatinib;1.Dasatinib;0.Doxorubicin;0.Vincristine;1.Dasatinib;0.Doxorubicin;1.Dasatinib;1.Dasatinib;22.Dasatinib;0.Methotrexate;0.Methotrexate;1.Cytarabine;0.Dasatinib;1.Cytarabine;0.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;"
"737","120.204.1654.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia, Ph-positive",120,"Upfront induction therapy",204,"Hyper-CVAD/induction",TRUE,"Cont.","11.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;7.Vincristine;11.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;7.Vincristine;","11.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;7.Vincristine;"
"738","120.204.1654.2","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia, Ph-positive",120,"Upfront induction therapy",204,"Hyper-CVAD/induction",TRUE,"Cont.","18.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;7.Vincristine;18.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;7.Vincristine;","18.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;7.Vincristine;"
"739","120.204.1654.3","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia, Ph-positive",120,"Upfront induction therapy",204,"Hyper-CVAD/induction",TRUE,"Cont.","25.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;7.Vincristine;25.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;7.Vincristine;","25.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;7.Vincristine;"
"740","120.204.1654.4","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia, Ph-positive",120,"Upfront induction therapy",204,"Hyper-CVAD/induction",TRUE,"Cont.","32.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;7.Vincristine;32.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;7.Vincristine;","32.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;7.Vincristine;"
"741","120.204.1655.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia, Ph-positive",120,"Upfront induction therapy",204,"MA/consolidation",TRUE,"Cont.","15.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;4.Cytarabine;15.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;4.Cytarabine;","15.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;4.Cytarabine;"
"742","120.204.1655.2","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia, Ph-positive",120,"Upfront induction therapy",204,"MA/consolidation",TRUE,"Cont.","14.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;5.Cytarabine;14.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;5.Cytarabine;","14.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;5.Cytarabine;"
"743","120.204.1655.3","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia, Ph-positive",120,"Upfront induction therapy",204,"MA/consolidation",TRUE,"Cont.","22.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;4.Cytarabine;22.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;4.Cytarabine;","22.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;4.Cytarabine;"
"744","120.204.1655.4","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia, Ph-positive",120,"Upfront induction therapy",204,"MA/consolidation",TRUE,"Cont.","21.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;5.Cytarabine;21.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;5.Cytarabine;","21.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;5.Cytarabine;"
"745","120.204.1655.5","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia, Ph-positive",120,"Upfront induction therapy",204,"MA/consolidation",TRUE,"Cont.","29.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;4.Cytarabine;29.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;4.Cytarabine;","29.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;4.Cytarabine;"
"746","120.204.1655.6","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia, Ph-positive",120,"Upfront induction therapy",204,"MA/consolidation",TRUE,"Cont.","28.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;5.Cytarabine;28.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;5.Cytarabine;","28.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;5.Cytarabine;"
"747","120.204.1655.7","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia, Ph-positive",120,"Upfront induction therapy",204,"MA/consolidation",TRUE,"Cont.","36.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;4.Cytarabine;36.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;4.Cytarabine;","36.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;4.Cytarabine;"
"748","120.204.1655.8","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia, Ph-positive",120,"Upfront induction therapy",204,"MA/consolidation",TRUE,"Cont.","35.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;5.Cytarabine;35.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;5.Cytarabine;","35.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;5.Cytarabine;"
"749","120.204.1656.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia, Ph-positive",120,"Upfront induction therapy",204,"Hyper-CVAD/MA & Imatinib",NA,NA,"0.Cyclophosphamide;0.Imatinib;1.Cyclophosphamide;0.Imatinib;1.Cyclophosphamide;0.Imatinib;1.Doxorubicin;0.Imatinib;0.Vincristine;1.Imatinib;1.Imatinib;1.Imatinib;22.Imatinib;0.Methotrexate;1.Cytarabine;0.Imatinib;0.Methotrexate;1.Cytarabine;0.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Cytarabine;0.Imatinib;22.Cyclophosphamide;0.Imatinib;1.Cyclophosphamide;0.Imatinib;1.Cyclophosphamide;0.Imatinib;1.Doxorubicin;0.Imatinib;0.Vincristine;1.Imatinib;1.Imatinib;1.Imatinib;22.Imatinib;0.Methotrexate;1.Cytarabine;0.Imatinib;0.Methotrexate;1.Cytarabine;0.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Cytarabine;0.Imatinib;22.Cyclophosphamide;0.Imatinib;1.Cyclophosphamide;0.Imatinib;1.Cyclophosphamide;0.Imatinib;1.Doxorubicin;0.Imatinib;0.Vincristine;1.Imatinib;1.Imatinib;1.Imatinib;22.Imatinib;0.Methotrexate;1.Cytarabine;0.Imatinib;0.Methotrexate;1.Cytarabine;0.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Cytarabine;0.Imatinib;22.Cyclophosphamide;0.Imatinib;1.Cyclophosphamide;0.Imatinib;1.Cyclophosphamide;0.Imatinib;1.Doxorubicin;0.Imatinib;0.Vincristine;1.Imatinib;1.Imatinib;1.Imatinib;22.Imatinib;0.Methotrexate;1.Cytarabine;0.Imatinib;0.Methotrexate;1.Cytarabine;0.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Cytarabine;0.Imatinib;","0.Cyclophosphamide;0.Imatinib;1.Cyclophosphamide;0.Imatinib;1.Cyclophosphamide;0.Imatinib;1.Doxorubicin;0.Imatinib;0.Vincristine;1.Imatinib;1.Imatinib;1.Imatinib;22.Imatinib;0.Methotrexate;1.Cytarabine;0.Imatinib;0.Methotrexate;1.Cytarabine;0.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Cytarabine;0.Imatinib;22.Cyclophosphamide;0.Imatinib;1.Cyclophosphamide;0.Imatinib;1.Cyclophosphamide;0.Imatinib;1.Doxorubicin;0.Imatinib;0.Vincristine;1.Imatinib;1.Imatinib;1.Imatinib;22.Imatinib;0.Methotrexate;1.Cytarabine;0.Imatinib;0.Methotrexate;1.Cytarabine;0.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Cytarabine;0.Imatinib;22.Cyclophosphamide;0.Imatinib;1.Cyclophosphamide;0.Imatinib;1.Cyclophosphamide;0.Imatinib;1.Doxorubicin;0.Imatinib;0.Vincristine;1.Imatinib;1.Imatinib;1.Imatinib;22.Imatinib;0.Methotrexate;1.Cytarabine;0.Imatinib;0.Methotrexate;1.Cytarabine;0.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Cytarabine;0.Imatinib;22.Cyclophosphamide;0.Imatinib;1.Cyclophosphamide;0.Imatinib;1.Cyclophosphamide;0.Imatinib;1.Doxorubicin;0.Imatinib;0.Vincristine;1.Imatinib;1.Imatinib;1.Imatinib;22.Imatinib;0.Methotrexate;1.Cytarabine;0.Imatinib;0.Methotrexate;1.Cytarabine;0.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Cytarabine;0.Imatinib;"
"750","120.204.1657.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia, Ph-positive",120,"Upfront induction therapy",204,"Hyper-CVAD/MA & Ponatinib",NA,NA,"0.Cyclophosphamide;0.Ponatinib;1.Cyclophosphamide;0.Ponatinib;1.Cyclophosphamide;0.Ponatinib;1.Doxorubicin;0.Ponatinib;0.Vincristine;1.Ponatinib;1.Ponatinib;1.Ponatinib;22.Methotrexate;0.Ponatinib;1.Cytarabine;0.Methotrexate;0.Ponatinib;1.Cytarabine;0.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Cytarabine;0.Ponatinib;22.Cyclophosphamide;0.Ponatinib;1.Cyclophosphamide;0.Ponatinib;1.Cyclophosphamide;0.Ponatinib;1.Doxorubicin;0.Ponatinib;0.Vincristine;1.Ponatinib;1.Ponatinib;1.Ponatinib;22.Methotrexate;0.Ponatinib;1.Cytarabine;0.Methotrexate;0.Ponatinib;1.Cytarabine;0.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Cytarabine;0.Ponatinib;22.Cyclophosphamide;0.Ponatinib;1.Cyclophosphamide;0.Ponatinib;1.Cyclophosphamide;0.Ponatinib;1.Doxorubicin;0.Ponatinib;0.Vincristine;1.Ponatinib;1.Ponatinib;1.Ponatinib;22.Methotrexate;0.Ponatinib;1.Cytarabine;0.Methotrexate;0.Ponatinib;1.Cytarabine;0.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Cytarabine;0.Ponatinib;22.Cyclophosphamide;0.Ponatinib;1.Cyclophosphamide;0.Ponatinib;1.Cyclophosphamide;0.Ponatinib;1.Doxorubicin;0.Ponatinib;0.Vincristine;1.Ponatinib;1.Ponatinib;1.Ponatinib;22.Methotrexate;0.Ponatinib;1.Cytarabine;0.Methotrexate;0.Ponatinib;1.Cytarabine;0.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Cytarabine;0.Ponatinib;","0.Cyclophosphamide;0.Ponatinib;1.Cyclophosphamide;0.Ponatinib;1.Cyclophosphamide;0.Ponatinib;1.Doxorubicin;0.Ponatinib;0.Vincristine;1.Ponatinib;1.Ponatinib;1.Ponatinib;22.Methotrexate;0.Ponatinib;1.Cytarabine;0.Methotrexate;0.Ponatinib;1.Cytarabine;0.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Cytarabine;0.Ponatinib;22.Cyclophosphamide;0.Ponatinib;1.Cyclophosphamide;0.Ponatinib;1.Cyclophosphamide;0.Ponatinib;1.Doxorubicin;0.Ponatinib;0.Vincristine;1.Ponatinib;1.Ponatinib;1.Ponatinib;22.Methotrexate;0.Ponatinib;1.Cytarabine;0.Methotrexate;0.Ponatinib;1.Cytarabine;0.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Cytarabine;0.Ponatinib;22.Cyclophosphamide;0.Ponatinib;1.Cyclophosphamide;0.Ponatinib;1.Cyclophosphamide;0.Ponatinib;1.Doxorubicin;0.Ponatinib;0.Vincristine;1.Ponatinib;1.Ponatinib;1.Ponatinib;22.Methotrexate;0.Ponatinib;1.Cytarabine;0.Methotrexate;0.Ponatinib;1.Cytarabine;0.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Cytarabine;0.Ponatinib;22.Cyclophosphamide;0.Ponatinib;1.Cyclophosphamide;0.Ponatinib;1.Cyclophosphamide;0.Ponatinib;1.Doxorubicin;0.Ponatinib;0.Vincristine;1.Ponatinib;1.Ponatinib;1.Ponatinib;22.Methotrexate;0.Ponatinib;1.Cytarabine;0.Methotrexate;0.Ponatinib;1.Cytarabine;0.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Cytarabine;0.Ponatinib;"
"751","120.204.1658.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia, Ph-positive",120,"Upfront induction therapy",204,"Imatinib & Prednisone",FALSE,"1","0.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;0.Methotrexate;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;0.Methotrexate;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;","0.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;0.Methotrexate;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;0.Methotrexate;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;"
"752","120.204.1659.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia, Ph-positive",120,"Upfront induction therapy",204,"Imatinib, Vincristine, Dexamethasone",FALSE,"1","0.Imatinib;0.Vincristine;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;0.Vincristine;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;0.Vincristine;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;0.Vincristine;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;","0.Imatinib;0.Vincristine;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;0.Vincristine;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;0.Vincristine;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;0.Vincristine;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;"
"753","120.204.1660.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia, Ph-positive",120,"Upfront induction therapy",204,"Ponatinib & Blinatumomab",TRUE,"Cont.","1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;","1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Blinatumomab;0.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;"
"754","120.204.1661.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia, Ph-positive",120,"Upfront induction therapy",204,"Ponatinib monotherapy",TRUE,"Cont.","1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;","1.Ponatinib;1.Ponatinib;"
"755","120.45.1662.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia, Ph-positive",120,"Consolidation after upfront therapy (including post-remission therapy)",45,"Dasatinib & Blinatumomab",TRUE,"Cont.","1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;","1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Blinatumomab;0.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;"
"756","120.45.1663.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia, Ph-positive",120,"Consolidation after upfront therapy (including post-remission therapy)",45,"HAM & Imatinib",FALSE,"1","0.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;0.Methotrexate;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;0.Methotrexate;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;","0.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;0.Methotrexate;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;0.Methotrexate;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;"
"757","120.45.1664.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia, Ph-positive",120,"Consolidation after upfront therapy (including post-remission therapy)",45,"Nilotinib-based consolidation",NA,NA,"0.Daunorubicin;0.Nilotinib;0.Vincristine;1.Daunorubicin;0.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;22.Cytarabine;0.Etoposide;0.Nilotinib;1.Cytarabine;0.Etoposide;0.Nilotinib;1.Cytarabine;0.Etoposide;0.Nilotinib;1.Cytarabine;0.Etoposide;0.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;22.Methotrexate;0.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;22.Cytarabine;0.Etoposide;0.Nilotinib;1.Cytarabine;0.Etoposide;0.Nilotinib;1.Cytarabine;0.Etoposide;0.Nilotinib;1.Cytarabine;0.Etoposide;0.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;22.Methotrexate;0.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;","0.Daunorubicin;0.Nilotinib;0.Vincristine;1.Daunorubicin;0.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;22.Cytarabine;0.Etoposide;0.Nilotinib;1.Cytarabine;0.Etoposide;0.Nilotinib;1.Cytarabine;0.Etoposide;0.Nilotinib;1.Cytarabine;0.Etoposide;0.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;22.Methotrexate;0.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;22.Cytarabine;0.Etoposide;0.Nilotinib;1.Cytarabine;0.Etoposide;0.Nilotinib;1.Cytarabine;0.Etoposide;0.Nilotinib;1.Cytarabine;0.Etoposide;0.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;22.Methotrexate;0.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;"
"758","120.96.1665.1","Malignant Hematology","Acute leukemias","B-cell acute lymphoblastic leukemia, Ph-positive",120,"Late intensification",96,"Cytarabine, Idarubicin, Imatinib",FALSE,"1","0.Cytarabine;1.Cytarabine;1.Cytarabine;0.Idarubicin;1.Cytarabine;1.Cytarabine;0.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;0.Methotrexate;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;0.Methotrexate;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;","0.Cytarabine;1.Cytarabine;1.Cytarabine;0.Idarubicin;1.Cytarabine;1.Cytarabine;0.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;0.Methotrexate;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;0.Methotrexate;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;"
"759","121.172.1671.1","Malignant Hematology","Acute leukemias","T-cell acute lymphoblastic leukemia",121,"Relapsed or refractory",172,"Nelarabine monotherapy",TRUE,"Cont.","17.Nelarabine;1.Nelarabine;1.Nelarabine;1.Nelarabine;1.Nelarabine;17.Nelarabine;1.Nelarabine;1.Nelarabine;1.Nelarabine;1.Nelarabine;","17.Nelarabine;1.Nelarabine;1.Nelarabine;1.Nelarabine;1.Nelarabine;"
"760","121.172.1671.2","Malignant Hematology","Acute leukemias","T-cell acute lymphoblastic leukemia",121,"Relapsed or refractory",172,"Nelarabine monotherapy",TRUE,"Cont.","17.Nelarabine;2.Nelarabine;2.Nelarabine;17.Nelarabine;2.Nelarabine;2.Nelarabine;","17.Nelarabine;2.Nelarabine;2.Nelarabine;"
"761","122.172.1672.1","Malignant Hematology","Acute leukemias","Blastic plasmacytoid dendritic cell neoplasm",122,"Relapsed or refractory",172,"Tagraxofusp monotherapy",TRUE,"Cont.","17.Tagraxofusp;1.Tagraxofusp;1.Tagraxofusp;1.Tagraxofusp;1.Tagraxofusp;17.Tagraxofusp;1.Tagraxofusp;1.Tagraxofusp;1.Tagraxofusp;1.Tagraxofusp;","17.Tagraxofusp;1.Tagraxofusp;1.Tagraxofusp;1.Tagraxofusp;1.Tagraxofusp;"
"762","123.36.1673.1","Malignant Hematology","Acute leukemias","CNS leukemia",123,"CNS prophylaxis, local therapy",36,"IT Cytarabine & Methotrexate",FALSE,"1","0.Methotrexate;5.Cytarabine;","0.Methotrexate;5.Cytarabine;"
"763","123.36.1673.2","Malignant Hematology","Acute leukemias","CNS leukemia",123,"CNS prophylaxis, local therapy",36,"IT Cytarabine & Methotrexate",FALSE,"1","0.Methotrexate;6.Cytarabine;","0.Methotrexate;6.Cytarabine;"
"764","123.36.1674.1","Malignant Hematology","Acute leukemias","CNS leukemia",123,"CNS prophylaxis, local therapy",36,"IT Cytarabine & WBRT",TRUE,"Cont.","7.Cytarabine;0.Cytarabine;7.Cytarabine;0.Cytarabine;","7.Cytarabine;0.Cytarabine;"
"765","123.36.1675.1","Malignant Hematology","Acute leukemias","CNS leukemia",123,"CNS prophylaxis, local therapy",36,"IT Methotrexate monotherapy",TRUE,"Cont.","28.Methotrexate;28.Methotrexate;","28.Methotrexate;28.Methotrexate;"
"766","123.36.1675.2","Malignant Hematology","Acute leukemias","CNS leukemia",123,"CNS prophylaxis, local therapy",36,"IT Methotrexate monotherapy",TRUE,"Cont.","7.Methotrexate;7.Methotrexate;7.Methotrexate;7.Methotrexate;7.Methotrexate;7.Methotrexate;7.Methotrexate;7.Methotrexate;","7.Methotrexate;7.Methotrexate;"
"767","123.36.1675.3","Malignant Hematology","Acute leukemias","CNS leukemia",123,"CNS prophylaxis, local therapy",36,"IT Methotrexate monotherapy",TRUE,"Cont.","7.Methotrexate;7.Methotrexate;","7.Methotrexate;7.Methotrexate;"
"768","123.37.1676.1","Malignant Hematology","Acute leukemias","CNS leukemia",123,"CNS prophylaxis, systemic therapy",37,"Mercaptopurine & WBRT",TRUE,"Cont.","1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;","1.Mercaptopurine;1.Mercaptopurine;"
"769","123.38.1677.1","Malignant Hematology","Acute leukemias","CNS leukemia",123,"CNS treatment, local therapy",38,"IT Cytarabine & Methotrexate",TRUE,"Cont.","7.Cytarabine;0.Methotrexate;7.Cytarabine;0.Methotrexate;","7.Cytarabine;0.Methotrexate;"
"770","124.34.1678.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Chronic myeloid leukemia (CML)",124,"Chronic phase, first-line therapy",34,"Bosutinib monotherapy",TRUE,"Cont.","1.Bosutinib;1.Bosutinib;1.Bosutinib;1.Bosutinib;1.Bosutinib;1.Bosutinib;1.Bosutinib;1.Bosutinib;1.Bosutinib;1.Bosutinib;1.Bosutinib;1.Bosutinib;1.Bosutinib;1.Bosutinib;","1.Bosutinib;1.Bosutinib;"
"771","124.34.1679.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Chronic myeloid leukemia (CML)",124,"Chronic phase, first-line therapy",34,"Cytarabine & Interferon alfa-2b",TRUE,"Cont.","1.Cytarabine;0.Interferonalfa-2b;1.Cytarabine;0.Interferonalfa-2b;1.Cytarabine;0.Interferonalfa-2b;1.Cytarabine;0.Interferonalfa-2b;1.Cytarabine;0.Interferonalfa-2b;1.Cytarabine;0.Interferonalfa-2b;1.Cytarabine;0.Interferonalfa-2b;1.Cytarabine;0.Interferonalfa-2b;1.Cytarabine;0.Interferonalfa-2b;1.Cytarabine;0.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Cytarabine;0.Interferonalfa-2b;1.Cytarabine;0.Interferonalfa-2b;1.Cytarabine;0.Interferonalfa-2b;1.Cytarabine;0.Interferonalfa-2b;1.Cytarabine;0.Interferonalfa-2b;1.Cytarabine;0.Interferonalfa-2b;1.Cytarabine;0.Interferonalfa-2b;1.Cytarabine;0.Interferonalfa-2b;1.Cytarabine;0.Interferonalfa-2b;1.Cytarabine;0.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;","1.Cytarabine;0.Interferonalfa-2b;1.Cytarabine;0.Interferonalfa-2b;1.Cytarabine;0.Interferonalfa-2b;1.Cytarabine;0.Interferonalfa-2b;1.Cytarabine;0.Interferonalfa-2b;1.Cytarabine;0.Interferonalfa-2b;1.Cytarabine;0.Interferonalfa-2b;1.Cytarabine;0.Interferonalfa-2b;1.Cytarabine;0.Interferonalfa-2b;1.Cytarabine;0.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;"
"772","124.34.1680.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Chronic myeloid leukemia (CML)",124,"Chronic phase, first-line therapy",34,"Dasatinib monotherapy",TRUE,"Cont.","1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;","1.Dasatinib;1.Dasatinib;"
"773","124.34.1681.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Chronic myeloid leukemia (CML)",124,"Chronic phase, first-line therapy",34,"Imatinib monotherapy",TRUE,"Cont.","1.Imatinib;0.Imatinib;1.Imatinib;0.Imatinib;1.Imatinib;0.Imatinib;1.Imatinib;0.Imatinib;1.Imatinib;0.Imatinib;1.Imatinib;0.Imatinib;1.Imatinib;0.Imatinib;1.Imatinib;0.Imatinib;1.Imatinib;0.Imatinib;1.Imatinib;0.Imatinib;1.Imatinib;0.Imatinib;1.Imatinib;0.Imatinib;1.Imatinib;0.Imatinib;1.Imatinib;0.Imatinib;","1.Imatinib;0.Imatinib;"
"774","124.34.1681.2","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Chronic myeloid leukemia (CML)",124,"Chronic phase, first-line therapy",34,"Imatinib monotherapy, intermittent",TRUE,"Cont.","15.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;15.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;","15.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;"
"775","124.34.1681.3","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Chronic myeloid leukemia (CML)",124,"Chronic phase, first-line therapy",34,"Imatinib monotherapy, intermittent",TRUE,"Cont.","29.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;29.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;","29.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;"
"776","124.34.1682.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Chronic myeloid leukemia (CML)",124,"Chronic phase, first-line therapy",34,"Imatinib & LoDAC",TRUE,"Cont.","1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Cytarabine;0.Imatinib;1.Cytarabine;0.Imatinib;1.Cytarabine;0.Imatinib;1.Cytarabine;0.Imatinib;1.Cytarabine;0.Imatinib;1.Cytarabine;0.Imatinib;1.Cytarabine;0.Imatinib;1.Cytarabine;0.Imatinib;1.Cytarabine;0.Imatinib;1.Cytarabine;0.Imatinib;1.Cytarabine;0.Imatinib;1.Cytarabine;0.Imatinib;1.Cytarabine;0.Imatinib;1.Cytarabine;0.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Cytarabine;0.Imatinib;1.Cytarabine;0.Imatinib;1.Cytarabine;0.Imatinib;1.Cytarabine;0.Imatinib;1.Cytarabine;0.Imatinib;1.Cytarabine;0.Imatinib;1.Cytarabine;0.Imatinib;1.Cytarabine;0.Imatinib;1.Cytarabine;0.Imatinib;1.Cytarabine;0.Imatinib;1.Cytarabine;0.Imatinib;1.Cytarabine;0.Imatinib;1.Cytarabine;0.Imatinib;1.Cytarabine;0.Imatinib;","1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Cytarabine;0.Imatinib;1.Cytarabine;0.Imatinib;1.Cytarabine;0.Imatinib;1.Cytarabine;0.Imatinib;1.Cytarabine;0.Imatinib;1.Cytarabine;0.Imatinib;1.Cytarabine;0.Imatinib;1.Cytarabine;0.Imatinib;1.Cytarabine;0.Imatinib;1.Cytarabine;0.Imatinib;1.Cytarabine;0.Imatinib;1.Cytarabine;0.Imatinib;1.Cytarabine;0.Imatinib;1.Cytarabine;0.Imatinib;"
"777","124.34.1683.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Chronic myeloid leukemia (CML)",124,"Chronic phase, first-line therapy",34,"Imatinib & Interferon alfa",TRUE,"Cont.","1.Imatinib;0.Interferonalfa;1.Imatinib;1.Imatinib;0.Interferonalfa;1.Imatinib;1.Imatinib;0.Interferonalfa;1.Imatinib;1.Imatinib;1.Imatinib;0.Interferonalfa;1.Imatinib;1.Imatinib;0.Interferonalfa;1.Imatinib;1.Imatinib;0.Interferonalfa;1.Imatinib;1.Imatinib;","1.Imatinib;0.Interferonalfa;1.Imatinib;1.Imatinib;0.Interferonalfa;1.Imatinib;1.Imatinib;0.Interferonalfa;1.Imatinib;1.Imatinib;"
"778","124.34.1684.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Chronic myeloid leukemia (CML)",124,"Chronic phase, first-line therapy",34,"Imatinib & Peginterferon alfa-2a",TRUE,"Cont.","1.Imatinib;0.Peginterferonalfa-2a;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;0.Peginterferonalfa-2a;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;0.Peginterferonalfa-2a;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;0.Peginterferonalfa-2a;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;0.Peginterferonalfa-2a;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;0.Peginterferonalfa-2a;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;0.Peginterferonalfa-2a;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;0.Peginterferonalfa-2a;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;","1.Imatinib;0.Peginterferonalfa-2a;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;"
"779","124.34.1685.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Chronic myeloid leukemia (CML)",124,"Chronic phase, first-line therapy",34,"Interferon alfa-2a monotherapy",TRUE,"Cont.","1.Interferonalfa-2a;1.Interferonalfa-2a;1.Interferonalfa-2a;1.Interferonalfa-2a;1.Interferonalfa-2a;1.Interferonalfa-2a;1.Interferonalfa-2a;1.Interferonalfa-2a;1.Interferonalfa-2a;1.Interferonalfa-2a;1.Interferonalfa-2a;1.Interferonalfa-2a;1.Interferonalfa-2a;1.Interferonalfa-2a;","1.Interferonalfa-2a;1.Interferonalfa-2a;"
"780","124.34.1686.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Chronic myeloid leukemia (CML)",124,"Chronic phase, first-line therapy",34,"Interferon alfa-2b monotherapy",TRUE,"Cont.","1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;","1.Interferonalfa-2b;1.Interferonalfa-2b;"
"781","124.34.1687.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Chronic myeloid leukemia (CML)",124,"Chronic phase, first-line therapy",34,"Interferon alfa-n1 monotherapy",TRUE,"Cont.","1.Interferonalfa-n1;1.Interferonalfa-n1;1.Interferonalfa-n1;1.Interferonalfa-n1;1.Interferonalfa-n1;1.Interferonalfa-n1;1.Interferonalfa-n1;1.Interferonalfa-n1;1.Interferonalfa-n1;1.Interferonalfa-n1;1.Interferonalfa-n1;1.Interferonalfa-n1;1.Interferonalfa-n1;1.Interferonalfa-n1;","1.Interferonalfa-n1;1.Interferonalfa-n1;"
"782","124.34.1688.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Chronic myeloid leukemia (CML)",124,"Chronic phase, first-line therapy",34,"Nilotinib monotherapy",TRUE,"Cont.","1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;","1.Nilotinib;1.Nilotinib;"
"783","124.34.1689.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Chronic myeloid leukemia (CML)",124,"Chronic phase, first-line therapy",34,"Radotinib monotherapy",TRUE,"Cont.","1.Radotinib;1.Radotinib;1.Radotinib;1.Radotinib;1.Radotinib;1.Radotinib;1.Radotinib;1.Radotinib;1.Radotinib;1.Radotinib;1.Radotinib;1.Radotinib;1.Radotinib;1.Radotinib;","1.Radotinib;1.Radotinib;"
"784","124.35.1690.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Chronic myeloid leukemia (CML)",124,"Chronic phase, relapsed or refractory",35,"Asciminib monotherapy",TRUE,"Cont.","1.Asciminib;1.Asciminib;1.Asciminib;1.Asciminib;1.Asciminib;1.Asciminib;1.Asciminib;1.Asciminib;1.Asciminib;1.Asciminib;1.Asciminib;1.Asciminib;1.Asciminib;1.Asciminib;","1.Asciminib;1.Asciminib;"
"785","124.35.1691.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Chronic myeloid leukemia (CML)",124,"Chronic phase, relapsed or refractory",35,"BuCyTBI, then allo HSCT",FALSE,"1","0.Busulfan;1.Cyclophosphamide;1.Cyclophosphamide;","0.Busulfan;1.Cyclophosphamide;1.Cyclophosphamide;"
"786","124.35.1692.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Chronic myeloid leukemia (CML)",124,"Chronic phase, relapsed or refractory",35,"Cyclophosphamide & TBI, then allo HSCT",FALSE,"1","0.Cyclophosphamide;1.Cyclophosphamide;","0.Cyclophosphamide;1.Cyclophosphamide;"
"787","124.35.1693.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Chronic myeloid leukemia (CML)",124,"Chronic phase, relapsed or refractory",35,"Omacetaxine monotherapy",TRUE,"Cont.","15.Omacetaxine;1.Omacetaxine;1.Omacetaxine;1.Omacetaxine;1.Omacetaxine;1.Omacetaxine;1.Omacetaxine;1.Omacetaxine;1.Omacetaxine;1.Omacetaxine;1.Omacetaxine;1.Omacetaxine;1.Omacetaxine;1.Omacetaxine;15.Omacetaxine;1.Omacetaxine;1.Omacetaxine;1.Omacetaxine;1.Omacetaxine;1.Omacetaxine;1.Omacetaxine;1.Omacetaxine;1.Omacetaxine;1.Omacetaxine;1.Omacetaxine;1.Omacetaxine;1.Omacetaxine;1.Omacetaxine;","15.Omacetaxine;1.Omacetaxine;1.Omacetaxine;1.Omacetaxine;1.Omacetaxine;1.Omacetaxine;1.Omacetaxine;1.Omacetaxine;1.Omacetaxine;1.Omacetaxine;1.Omacetaxine;1.Omacetaxine;1.Omacetaxine;1.Omacetaxine;"
"788","124.35.1693.2","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Chronic myeloid leukemia (CML)",124,"Chronic phase, relapsed or refractory",35,"Omacetaxine monotherapy",TRUE,"Cont.","22.Omacetaxine;1.Omacetaxine;1.Omacetaxine;1.Omacetaxine;1.Omacetaxine;1.Omacetaxine;1.Omacetaxine;22.Omacetaxine;1.Omacetaxine;1.Omacetaxine;1.Omacetaxine;1.Omacetaxine;1.Omacetaxine;1.Omacetaxine;","22.Omacetaxine;1.Omacetaxine;1.Omacetaxine;1.Omacetaxine;1.Omacetaxine;1.Omacetaxine;1.Omacetaxine;"
"789","124.35.1694.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Chronic myeloid leukemia (CML)",124,"Chronic phase, relapsed or refractory",35,"Ponatinib monotherapy",TRUE,"Cont.","1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;1.Ponatinib;","1.Ponatinib;1.Ponatinib;"
"790","125.114.1699.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Chronic myelomonocytic leukemia",125,"Maintenance after first-line therapy",114,"Decitabine and cedazuridine monotherapy",TRUE,"Cont.","24.Decitabineandcedazuridine;1.Decitabineandcedazuridine;1.Decitabineandcedazuridine;1.Decitabineandcedazuridine;1.Decitabineandcedazuridine;24.Decitabineandcedazuridine;1.Decitabineandcedazuridine;1.Decitabineandcedazuridine;1.Decitabineandcedazuridine;1.Decitabineandcedazuridine;","24.Decitabineandcedazuridine;1.Decitabineandcedazuridine;1.Decitabineandcedazuridine;1.Decitabineandcedazuridine;1.Decitabineandcedazuridine;"
"791","125.67.1695.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Chronic myelomonocytic leukemia",125,"First-line therapy",67,"Azacitidine monotherapy",TRUE,"Cont.","22.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;22.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;","22.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;"
"792","125.67.1695.2","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Chronic myelomonocytic leukemia",125,"First-line therapy",67,"Azacitidine monotherapy",TRUE,"Cont.","20.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;3.Azacitidine;1.Azacitidine;20.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;3.Azacitidine;1.Azacitidine;","20.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;3.Azacitidine;1.Azacitidine;"
"793","125.67.1696.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Chronic myelomonocytic leukemia",125,"First-line therapy",67,"Azacitidine & Lenalidomide",TRUE,"Cont.","8.Azacitidine;0.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;8.Azacitidine;0.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","8.Azacitidine;0.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"794","125.67.1696.2","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Chronic myelomonocytic leukemia",125,"First-line therapy",67,"Azacitidine & Lenalidomide",TRUE,"Cont.","8.Azacitidine;0.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;8.Azacitidine;0.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","8.Azacitidine;0.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"795","125.67.1697.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Chronic myelomonocytic leukemia",125,"First-line therapy",67,"Azacitidine & Vorinostat",TRUE,"Cont.","20.Azacitidine;1.Azacitidine;1.Azacitidine;0.Vorinostat;1.Azacitidine;0.Vorinostat;1.Azacitidine;0.Vorinostat;1.Azacitidine;0.Vorinostat;1.Azacitidine;0.Vorinostat;1.Vorinostat;1.Vorinostat;20.Azacitidine;1.Azacitidine;1.Azacitidine;0.Vorinostat;1.Azacitidine;0.Vorinostat;1.Azacitidine;0.Vorinostat;1.Azacitidine;0.Vorinostat;1.Azacitidine;0.Vorinostat;1.Vorinostat;1.Vorinostat;","20.Azacitidine;1.Azacitidine;1.Azacitidine;0.Vorinostat;1.Azacitidine;0.Vorinostat;1.Azacitidine;0.Vorinostat;1.Azacitidine;0.Vorinostat;1.Azacitidine;0.Vorinostat;1.Vorinostat;1.Vorinostat;"
"796","125.67.1697.2","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Chronic myelomonocytic leukemia",125,"First-line therapy",67,"Azacitidine & Vorinostat",TRUE,"Cont.","20.Azacitidine;1.Azacitidine;1.Azacitidine;0.Vorinostat;1.Azacitidine;0.Vorinostat;1.Azacitidine;0.Vorinostat;1.Vorinostat;1.Vorinostat;1.Azacitidine;0.Vorinostat;1.Azacitidine;0.Vorinostat;20.Azacitidine;1.Azacitidine;1.Azacitidine;0.Vorinostat;1.Azacitidine;0.Vorinostat;1.Azacitidine;0.Vorinostat;1.Vorinostat;1.Vorinostat;1.Azacitidine;0.Vorinostat;1.Azacitidine;0.Vorinostat;","20.Azacitidine;1.Azacitidine;1.Azacitidine;0.Vorinostat;1.Azacitidine;0.Vorinostat;1.Azacitidine;0.Vorinostat;1.Vorinostat;1.Vorinostat;1.Azacitidine;0.Vorinostat;1.Azacitidine;0.Vorinostat;"
"797","125.67.1698.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Chronic myelomonocytic leukemia",125,"First-line therapy",67,"Decitabine monotherapy",TRUE,"Cont.","24.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;24.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;","24.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;"
"798","126.189.1703.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Essential thrombocythemia",126,"Relapsed, refractory, or intolerant to initial therapy",189,"Ruxolitinib monotherapy",TRUE,"Cont.","1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;","1.Ruxolitinib;1.Ruxolitinib;"
"799","126.67.1700.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Essential thrombocythemia",126,"First-line therapy",67,"Anagrelide monotherapy",TRUE,"Cont.","1.Anagrelide;1.Anagrelide;1.Anagrelide;1.Anagrelide;1.Anagrelide;1.Anagrelide;1.Anagrelide;1.Anagrelide;1.Anagrelide;1.Anagrelide;1.Anagrelide;1.Anagrelide;1.Anagrelide;1.Anagrelide;","1.Anagrelide;1.Anagrelide;"
"800","126.67.1701.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Essential thrombocythemia",126,"First-line therapy",67,"Hydroxyurea monotherapy",TRUE,"Cont.","1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;","1.Hydroxyurea;1.Hydroxyurea;"
"801","126.67.1702.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Essential thrombocythemia",126,"First-line therapy",67,"Peginterferon alfa-2a monotherapy",TRUE,"Cont.","7.Peginterferonalfa-2a;7.Peginterferonalfa-2a;7.Peginterferonalfa-2a;7.Peginterferonalfa-2a;7.Peginterferonalfa-2a;7.Peginterferonalfa-2a;7.Peginterferonalfa-2a;7.Peginterferonalfa-2a;","7.Peginterferonalfa-2a;7.Peginterferonalfa-2a;"
"802","127.31.1704.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Hypereosinophilic syndrome",127,"All lines of therapy",31,"Alemtuzumab monotherapy",TRUE,"Cont.","4.Alemtuzumab;3.Alemtuzumab;4.Alemtuzumab;3.Alemtuzumab;","4.Alemtuzumab;3.Alemtuzumab;"
"803","127.31.1705.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Hypereosinophilic syndrome",127,"All lines of therapy",31,"Benralizumab monotherapy",TRUE,"Cont.","28.Benralizumab;28.Benralizumab;","28.Benralizumab;28.Benralizumab;"
"804","127.31.1706.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Hypereosinophilic syndrome",127,"All lines of therapy",31,"Cladribine & Cytarabine",TRUE,"Cont.","16.Cytarabine;1.Cladribine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;16.Cytarabine;1.Cladribine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;","16.Cytarabine;1.Cladribine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"805","127.31.1706.2","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Hypereosinophilic syndrome",127,"All lines of therapy",31,"Cladribine & Cytarabine",TRUE,"Cont.","16.Cytarabine;1.Cladribine;1.Cladribine;0.Cytarabine;1.Cladribine;0.Cytarabine;1.Cladribine;0.Cytarabine;1.Cladribine;0.Cytarabine;16.Cytarabine;1.Cladribine;1.Cladribine;0.Cytarabine;1.Cladribine;0.Cytarabine;1.Cladribine;0.Cytarabine;1.Cladribine;0.Cytarabine;","16.Cytarabine;1.Cladribine;1.Cladribine;0.Cytarabine;1.Cladribine;0.Cytarabine;1.Cladribine;0.Cytarabine;1.Cladribine;0.Cytarabine;"
"806","127.31.1707.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Hypereosinophilic syndrome",127,"All lines of therapy",31,"Mepolizumab monotherapy",TRUE,"Cont.","21.Mepolizumab;21.Mepolizumab;","21.Mepolizumab;21.Mepolizumab;"
"807","128.113.1708.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Myelodysplastic syndrome",128,"Lower-risk MDS, all lines of therapy",113,"Azacitidine oral monotherapy",TRUE,"Cont.","8.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;8.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;","8.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;1.Azacitidineoral;"
"808","128.113.1709.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Myelodysplastic syndrome",128,"Lower-risk MDS, all lines of therapy",113,"Erythropoietin monotherapy",TRUE,"Cont.","7.Erythropoietinalfa;7.Erythropoietinalfa;","7.Erythropoietinalfa;7.Erythropoietinalfa;"
"809","128.113.1710.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Myelodysplastic syndrome",128,"Lower-risk MDS, all lines of therapy",113,"Erythropoetin & Lenalidomide",TRUE,"Cont.","7.Epoetinbeta;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Epoetinbeta;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Epoetinbeta;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Epoetinbeta;7.Epoetinbeta;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Epoetinbeta;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Epoetinbeta;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Epoetinbeta;","7.Epoetinbeta;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Epoetinbeta;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Epoetinbeta;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Epoetinbeta;"
"810","128.113.1710.2","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Myelodysplastic syndrome",128,"Lower-risk MDS, all lines of therapy",113,"Erythropoetin & Lenalidomide",TRUE,"Cont.","1.Epoetinbeta;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Epoetinbeta;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Epoetinbeta;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Epoetinbeta;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Epoetinbeta;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Epoetinbeta;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Epoetinbeta;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Epoetinbeta;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","1.Epoetinbeta;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"811","128.113.1711.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Myelodysplastic syndrome",128,"Lower-risk MDS, all lines of therapy",113,"Lenalidomide monotherapy",TRUE,"Cont.","1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","1.Lenalidomide;1.Lenalidomide;"
"812","128.113.1711.2","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Myelodysplastic syndrome",128,"Lower-risk MDS, all lines of therapy",113,"Lenalidomide monotherapy",TRUE,"Cont.","8.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;8.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","8.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"813","128.113.1712.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Myelodysplastic syndrome",128,"Lower-risk MDS, all lines of therapy",113,"Luspatercept monotherapy",TRUE,"Cont.","21.Luspatercept;21.Luspatercept;","21.Luspatercept;21.Luspatercept;"
"814","128.172.1725.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Myelodysplastic syndrome",128,"Relapsed or refractory",172,"Erlotinib monotherapy",TRUE,"Cont.","1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;","1.Erlotinib;1.Erlotinib;"
"815","128.172.1726.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Myelodysplastic syndrome",128,"Relapsed or refractory",172,"Midostaurin monotherapy",TRUE,"Cont.","1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;1.Midostaurin;","1.Midostaurin;1.Midostaurin;"
"816","128.40.1724.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Myelodysplastic syndrome",128,"Consolidation after first-line therapy",40,"Busulfan & Cyclophosphamide, then allo HSCT",FALSE,"1","0.Busulfan;1.Busulfan;1.Busulfan;1.Busulfan;1.Cyclophosphamide;1.Cyclophosphamide;","0.Busulfan;1.Busulfan;1.Busulfan;1.Busulfan;1.Cyclophosphamide;1.Cyclophosphamide;"
"817","128.67.1713.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Myelodysplastic syndrome",128,"First-line therapy",67,"Alemtuzumab monotherapy",FALSE,"1","0.Alemtuzumab;1.Alemtuzumab;1.Alemtuzumab;1.Alemtuzumab;1.Alemtuzumab;1.Alemtuzumab;1.Alemtuzumab;1.Alemtuzumab;1.Alemtuzumab;1.Alemtuzumab;1.Alemtuzumab;","0.Alemtuzumab;1.Alemtuzumab;1.Alemtuzumab;1.Alemtuzumab;1.Alemtuzumab;1.Alemtuzumab;1.Alemtuzumab;1.Alemtuzumab;1.Alemtuzumab;1.Alemtuzumab;1.Alemtuzumab;"
"818","128.67.1714.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Myelodysplastic syndrome",128,"First-line therapy",67,"ATG (Horse) monotherapy",FALSE,"1","0.Antithymocyteglobulin;0.horseATG;1.Antithymocyteglobulin;0.horseATG;1.Antithymocyteglobulin;0.horseATG;1.Antithymocyteglobulin;0.horseATG;","0.Antithymocyteglobulin;0.horseATG;1.Antithymocyteglobulin;0.horseATG;1.Antithymocyteglobulin;0.horseATG;1.Antithymocyteglobulin;0.horseATG;"
"819","128.67.1715.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Myelodysplastic syndrome",128,"First-line therapy",67,"ATG (Rabbit) monotherapy",FALSE,"1","0.Antithymocyteglobulin;0.rabbitATG;1.Antithymocyteglobulin;0.rabbitATG;1.Antithymocyteglobulin;0.rabbitATG;1.Antithymocyteglobulin;0.rabbitATG;","0.Antithymocyteglobulin;0.rabbitATG;1.Antithymocyteglobulin;0.rabbitATG;1.Antithymocyteglobulin;0.rabbitATG;1.Antithymocyteglobulin;0.rabbitATG;"
"820","128.67.1716.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Myelodysplastic syndrome",128,"First-line therapy",67,"ATG (Horse) & Cyclosporine",FALSE,"1","0.Antithymocyteglobulin;0.horseATG;0.Cyclosporine;1.Antithymocyteglobulin;0.horseATG;0.Cyclosporine;1.Antithymocyteglobulin;0.horseATG;0.Cyclosporine;1.Antithymocyteglobulin;0.horseATG;0.Cyclosporine;1.Antithymocyteglobulin;0.horseATG;0.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;","0.Antithymocyteglobulin;0.horseATG;0.Cyclosporine;1.Antithymocyteglobulin;0.horseATG;0.Cyclosporine;1.Antithymocyteglobulin;0.horseATG;0.Cyclosporine;1.Antithymocyteglobulin;0.horseATG;0.Cyclosporine;1.Antithymocyteglobulin;0.horseATG;0.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;"
"821","128.67.1717.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Myelodysplastic syndrome",128,"First-line therapy",67,"Azacitidine monotherapy",TRUE,"Cont.","24.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;24.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;","24.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;"
"822","128.67.1717.2","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Myelodysplastic syndrome",128,"First-line therapy",67,"Azacitidine monotherapy",TRUE,"Cont.","26.Azacitidine;1.Azacitidine;1.Azacitidine;26.Azacitidine;1.Azacitidine;1.Azacitidine;","26.Azacitidine;1.Azacitidine;1.Azacitidine;"
"823","128.67.1718.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Myelodysplastic syndrome",128,"First-line therapy",67,"Azacitidine & Lenalidomide",TRUE,"Cont.","8.Azacitidine;0.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;8.Azacitidine;0.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","8.Azacitidine;0.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Azacitidine;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"824","128.67.1719.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Myelodysplastic syndrome",128,"First-line therapy",67,"Clofarabine monotherapy",TRUE,"Cont.","24.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;24.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;","24.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;"
"825","128.67.1719.2","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Myelodysplastic syndrome",128,"First-line therapy",67,"Clofarabine monotherapy",TRUE,"Cont.","31.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;31.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;","31.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;"
"826","128.67.1719.3","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Myelodysplastic syndrome",128,"First-line therapy",67,"Clofarabine monotherapy",TRUE,"Cont.","38.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;38.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;","38.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;"
"827","128.67.1719.4","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Myelodysplastic syndrome",128,"First-line therapy",67,"Clofarabine monotherapy",TRUE,"Cont.","45.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;45.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;","45.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;"
"828","128.67.1719.5","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Myelodysplastic syndrome",128,"First-line therapy",67,"Clofarabine monotherapy",TRUE,"Cont.","52.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;52.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;","52.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;"
"829","128.67.1720.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Myelodysplastic syndrome",128,"First-line therapy",67,"Cyclosporine monotherapy",TRUE,"Cont.","1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;1.Cyclosporine;","1.Cyclosporine;1.Cyclosporine;"
"830","128.67.1721.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Myelodysplastic syndrome",128,"First-line therapy",67,"Decitabine monotherapy",TRUE,"Cont.","19.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;19.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;","19.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;1.Decitabine;"
"831","128.67.1721.2","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Myelodysplastic syndrome",128,"First-line therapy",67,"Decitabine monotherapy",TRUE,"Cont.","26.Decitabine;1.Decitabine;1.Decitabine;26.Decitabine;1.Decitabine;1.Decitabine;","26.Decitabine;1.Decitabine;1.Decitabine;"
"832","128.67.1721.3","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Myelodysplastic syndrome",128,"First-line therapy",67,"Decitabine monotherapy",TRUE,"Cont.","14.Decitabine;7.Decitabine;7.Decitabine;14.Decitabine;7.Decitabine;7.Decitabine;","14.Decitabine;7.Decitabine;7.Decitabine;"
"833","128.67.1721.4","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Myelodysplastic syndrome",128,"First-line therapy",67,"Decitabine monotherapy",TRUE,"Cont.","40.Decitabine;1.Decitabine;1.Decitabine;40.Decitabine;1.Decitabine;1.Decitabine;","40.Decitabine;1.Decitabine;1.Decitabine;"
"834","128.67.1722.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Myelodysplastic syndrome",128,"First-line therapy",67,"Low-dose Cytarabine monotherapy (LoDAC)",TRUE,"Cont.","15.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;15.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;","15.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"835","128.67.1722.2","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Myelodysplastic syndrome",128,"First-line therapy",67,"Low-dose Cytarabine monotherapy (LoDAC)",TRUE,"Cont.","8.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;8.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;","8.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"836","128.67.1722.3","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Myelodysplastic syndrome",128,"First-line therapy",67,"Low-dose Cytarabine monotherapy (LoDAC)",TRUE,"Cont.","1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;","1.Cytarabine;1.Cytarabine;"
"837","128.67.1723.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Myelodysplastic syndrome",128,"First-line therapy",67,"Temozolomide monotherapy",TRUE,"Cont.","24.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;24.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;","24.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;"
"838","128.67.1723.2","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Myelodysplastic syndrome",128,"First-line therapy",67,"Temozolomide monotherapy",TRUE,"Cont.","22.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;22.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;","22.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;"
"839","129.31.1727.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Myelofibrosis",129,"All lines of therapy",31,"Danazol monotherapy",TRUE,"Cont.","1.Danazol;1.Danazol;1.Danazol;1.Danazol;1.Danazol;1.Danazol;1.Danazol;1.Danazol;1.Danazol;1.Danazol;1.Danazol;1.Danazol;1.Danazol;1.Danazol;","1.Danazol;1.Danazol;"
"840","129.31.1728.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Myelofibrosis",129,"All lines of therapy",31,"Fedratinib monotherapy",TRUE,"Cont.","1.Fedratinib;1.Fedratinib;1.Fedratinib;1.Fedratinib;1.Fedratinib;1.Fedratinib;1.Fedratinib;1.Fedratinib;1.Fedratinib;1.Fedratinib;1.Fedratinib;1.Fedratinib;1.Fedratinib;1.Fedratinib;","1.Fedratinib;1.Fedratinib;"
"841","129.31.1729.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Myelofibrosis",129,"All lines of therapy",31,"Lenalidomide monotherapy",TRUE,"Cont.","1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","1.Lenalidomide;1.Lenalidomide;"
"842","129.31.1730.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Myelofibrosis",129,"All lines of therapy",31,"Pacritinib monotherapy",TRUE,"Cont.","1.Pacritinib;1.Pacritinib;1.Pacritinib;1.Pacritinib;1.Pacritinib;1.Pacritinib;1.Pacritinib;1.Pacritinib;1.Pacritinib;1.Pacritinib;1.Pacritinib;1.Pacritinib;1.Pacritinib;1.Pacritinib;","1.Pacritinib;1.Pacritinib;"
"843","129.31.1731.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Myelofibrosis",129,"All lines of therapy",31,"Pomalidomide monotherapy",TRUE,"Cont.","1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;","1.Pomalidomide;1.Pomalidomide;"
"844","13.29.379.1","Solid Tumor","Dermatologic Oncology","Melanoma, NRAS-mutated",13,"Advanced or metastatic disease, TKI-naive",29,"Binimetinib monotherapy",TRUE,"Cont.","1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;1.Binimetinib;","1.Binimetinib;1.Binimetinib;"
"845","130.188.1733.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Polycythemia vera",130,"Relapsed, refractory, or intolerant",188,"Pipobroman monotherapy",TRUE,"Cont.","1.Pipobroman;1.Pipobroman;1.Pipobroman;1.Pipobroman;1.Pipobroman;1.Pipobroman;1.Pipobroman;1.Pipobroman;1.Pipobroman;1.Pipobroman;1.Pipobroman;1.Pipobroman;1.Pipobroman;1.Pipobroman;","1.Pipobroman;1.Pipobroman;"
"846","130.188.1734.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Polycythemia vera",130,"Relapsed, refractory, or intolerant",188,"Thalidomide monotherapy",TRUE,"Cont.","1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;","1.Thalidomide;1.Thalidomide;"
"847","130.67.1732.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Polycythemia vera",130,"First-line therapy",67,"Ropeginterferon alfa-2b monotherapy",TRUE,"Cont.","14.Ropeginterferonalfa-2b;14.Ropeginterferonalfa-2b;","14.Ropeginterferonalfa-2b;14.Ropeginterferonalfa-2b;"
"848","131.31.1735.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Systemic mastocytosis",131,"All lines of therapy",31,"Avapritinib monotherapy",TRUE,"Cont.","1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;","1.Avapritinib;1.Avapritinib;"
"849","131.31.1736.1","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Systemic mastocytosis",131,"All lines of therapy",31,"Cladribine monotherapy",TRUE,"Cont.","24.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;24.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;","24.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;"
"850","131.31.1736.2","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Systemic mastocytosis",131,"All lines of therapy",31,"Cladribine monotherapy",TRUE,"Cont.","31.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;31.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;","31.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;"
"851","131.31.1736.3","Malignant Hematology","Myeloproliferative neoplasms and myelodysplastic syndromes","Systemic mastocytosis",131,"All lines of therapy",31,"Cladribine monotherapy",TRUE,"Cont.","38.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;38.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;","38.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;"
"852","132.122.1760.1","Malignant Hematology","Aggressive lymphomas","Burkitt lymphoma",132,"Maintenance therapy",122,"COPAD/CYVE",FALSE,"2","6.Cyclophosphamide;0.Vincristine;1.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Methotrexate;26.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;","6.Cyclophosphamide;0.Vincristine;1.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Methotrexate;26.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;"
"853","132.122.1761.1","Malignant Hematology","Aggressive lymphomas","Burkitt lymphoma",132,"Maintenance therapy",122,"COPADM",FALSE,"1","0.Cyclophosphamide;0.Methotrexate;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Methotrexate;","0.Cyclophosphamide;0.Methotrexate;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Methotrexate;"
"854","132.195.1740.1","Malignant Hematology","Aggressive lymphomas","Burkitt lymphoma",132,"Untreated",195,"BASIC",FALSE,"2","4.Cyclophosphamide;0.Cytarabine;0.Rituximab;0.Vincristine;3.Cytarabine;4.Methotrexate;0.Rituximab;3.Cytarabine;","4.Cyclophosphamide;0.Cytarabine;0.Rituximab;0.Vincristine;3.Cytarabine;4.Methotrexate;0.Rituximab;3.Cytarabine;"
"855","132.195.1741.1","Malignant Hematology","Aggressive lymphomas","Burkitt lymphoma",132,"Untreated",195,"CALGB 10-002 regimen",NA,NA,"0.Cytarabine;0.Ifosfamide;0.Methotrexate;0.Vincristine;1.Ifosfamide;0.Methotrexate;1.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Cytarabine;0.Methotrexate;0.Vincristine;1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;0.Doxorubicin;1.Cyclophosphamide;0.Doxorubicin;17.Cytarabine;0.Ifosfamide;0.Methotrexate;0.Vincristine;1.Ifosfamide;0.Methotrexate;1.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Cytarabine;0.Methotrexate;0.Vincristine;1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;0.Doxorubicin;1.Cyclophosphamide;0.Doxorubicin;17.Cytarabine;0.Ifosfamide;0.Methotrexate;0.Vincristine;1.Ifosfamide;0.Methotrexate;1.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Cytarabine;0.Methotrexate;0.Vincristine;1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;0.Doxorubicin;1.Cyclophosphamide;0.Doxorubicin;","0.Cytarabine;0.Ifosfamide;0.Methotrexate;0.Vincristine;1.Ifosfamide;0.Methotrexate;1.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Cytarabine;0.Methotrexate;0.Vincristine;1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;0.Doxorubicin;1.Cyclophosphamide;0.Doxorubicin;17.Cytarabine;0.Ifosfamide;0.Methotrexate;0.Vincristine;1.Ifosfamide;0.Methotrexate;1.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Cytarabine;0.Methotrexate;0.Vincristine;1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;0.Doxorubicin;1.Cyclophosphamide;0.Doxorubicin;17.Cytarabine;0.Ifosfamide;0.Methotrexate;0.Vincristine;1.Ifosfamide;0.Methotrexate;1.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Cytarabine;0.Methotrexate;0.Vincristine;1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;0.Doxorubicin;1.Cyclophosphamide;0.Doxorubicin;"
"856","132.195.1742.1","Malignant Hematology","Aggressive lymphomas","Burkitt lymphoma",132,"Untreated",195,"CODOX-M",FALSE,"3","7.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;0.Cytarabine;1.Cyclophosphamide;1.Cyclophosphamide;3.Vincristine;2.Methotrexate;5.Methotrexate;7.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;0.Cytarabine;1.Cyclophosphamide;1.Cyclophosphamide;3.Vincristine;2.Methotrexate;5.Methotrexate;","7.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;0.Cytarabine;1.Cyclophosphamide;1.Cyclophosphamide;3.Vincristine;2.Methotrexate;5.Methotrexate;"
"857","132.195.1742.2","Malignant Hematology","Aggressive lymphomas","Burkitt lymphoma",132,"Untreated",195,"CODOX-M",FALSE,"3","12.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Methotrexate;0.Vincristine;1.Cyclophosphamide;8.Methotrexate;0.Vincristine;12.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Methotrexate;0.Vincristine;1.Cyclophosphamide;8.Methotrexate;0.Vincristine;","12.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Methotrexate;0.Vincristine;1.Cyclophosphamide;8.Methotrexate;0.Vincristine;"
"858","132.195.1743.1","Malignant Hematology","Aggressive lymphomas","Burkitt lymphoma",132,"Untreated",195,"CODOX-M/IVAC",NA,NA,"0.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;0.Cytarabine;1.Cyclophosphamide;1.Cyclophosphamide;17.Cytarabine;0.Etoposide;0.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;0.Methotrexate;","0.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;0.Cytarabine;1.Cyclophosphamide;1.Cyclophosphamide;17.Cytarabine;0.Etoposide;0.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;0.Methotrexate;"
"859","132.195.1743.2","Malignant Hematology","Aggressive lymphomas","Burkitt lymphoma",132,"Untreated",195,"CODOX-M/IVAC",NA,NA,"0.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Methotrexate;0.Vincristine;1.Cyclophosphamide;1.Cytarabine;19.Cytarabine;0.Etoposide;0.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;0.Methotrexate;","0.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Methotrexate;0.Vincristine;1.Cyclophosphamide;1.Cytarabine;19.Cytarabine;0.Etoposide;0.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;0.Methotrexate;"
"860","132.195.1744.1","Malignant Hematology","Aggressive lymphomas","Burkitt lymphoma",132,"Untreated",195,"COPAD",TRUE,"Cont.","16.Vincristine;1.Cyclophosphamide;0.Doxorubicin;1.Cyclophosphamide;1.Cyclophosphamide;2.Vincristine;16.Vincristine;1.Cyclophosphamide;0.Doxorubicin;1.Cyclophosphamide;1.Cyclophosphamide;2.Vincristine;","16.Vincristine;1.Cyclophosphamide;0.Doxorubicin;1.Cyclophosphamide;1.Cyclophosphamide;2.Vincristine;"
"861","132.195.1745.1","Malignant Hematology","Aggressive lymphomas","Burkitt lymphoma",132,"Untreated",195,"COPADM_1B",FALSE,"1","0.Methotrexate;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;2.Methotrexate;","0.Methotrexate;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;2.Methotrexate;"
"862","132.195.1746.1","Malignant Hematology","Aggressive lymphomas","Burkitt lymphoma",132,"Untreated",195,"COPADM_1C",FALSE,"1","0.Methotrexate;0.Vincristine;1.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;0.Cytarabine;0.Methotrexate;2.Cytarabine;0.Methotrexate;","0.Methotrexate;0.Vincristine;1.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;0.Cytarabine;0.Methotrexate;2.Cytarabine;0.Methotrexate;"
"863","132.195.1747.1","Malignant Hematology","Aggressive lymphomas","Burkitt lymphoma",132,"Untreated",195,"COPAD_2B",FALSE,"1","0.Methotrexate;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;2.Methotrexate;0.Vincristine;","0.Methotrexate;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;2.Methotrexate;0.Vincristine;"
"864","132.195.1748.1","Malignant Hematology","Aggressive lymphomas","Burkitt lymphoma",132,"Untreated",195,"COPADM_2C",FALSE,"1","0.Methotrexate;0.Vincristine;1.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;0.Cytarabine;0.Methotrexate;2.Cytarabine;0.Methotrexate;0.Vincristine;","0.Methotrexate;0.Vincristine;1.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;0.Cytarabine;0.Methotrexate;2.Cytarabine;0.Methotrexate;0.Vincristine;"
"865","132.195.1749.1","Malignant Hematology","Aggressive lymphomas","Burkitt lymphoma",132,"Untreated",195,"DA-R-EPOCH",TRUE,"Cont.","17.Doxorubicin;0.Etoposide;0.Rituximab;0.Vincristine;4.Cyclophosphamide;17.Doxorubicin;0.Etoposide;0.Rituximab;0.Vincristine;4.Cyclophosphamide;","17.Doxorubicin;0.Etoposide;0.Rituximab;0.Vincristine;4.Cyclophosphamide;"
"866","132.195.1749.2","Malignant Hematology","Aggressive lymphomas","Burkitt lymphoma",132,"Untreated",195,"DA-R-EPOCH",TRUE,"Cont.","17.Doxorubicin;0.Etoposide;0.Methotrexate;0.Rituximab;0.Vincristine;4.Cyclophosphamide;0.Methotrexate;17.Doxorubicin;0.Etoposide;0.Methotrexate;0.Rituximab;0.Vincristine;4.Cyclophosphamide;0.Methotrexate;","17.Doxorubicin;0.Etoposide;0.Methotrexate;0.Rituximab;0.Vincristine;4.Cyclophosphamide;0.Methotrexate;"
"867","132.195.1749.3","Malignant Hematology","Aggressive lymphomas","Burkitt lymphoma",132,"Untreated",195,"DA-R-EPOCH",TRUE,"Cont.","17.Doxorubicin;0.Etoposide;0.Rituximab;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;17.Doxorubicin;0.Etoposide;0.Rituximab;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;","17.Doxorubicin;0.Etoposide;0.Rituximab;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;"
"868","132.195.1749.4","Malignant Hematology","Aggressive lymphomas","Burkitt lymphoma",132,"Untreated",195,"DA-R-EPOCH",TRUE,"Cont.","17.Doxorubicin;0.Etoposide;0.Methotrexate;0.Rituximab;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Methotrexate;0.Vincristine;17.Doxorubicin;0.Etoposide;0.Methotrexate;0.Rituximab;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Methotrexate;0.Vincristine;","17.Doxorubicin;0.Etoposide;0.Methotrexate;0.Rituximab;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Methotrexate;0.Vincristine;"
"869","132.195.1750.1","Malignant Hematology","Aggressive lymphomas","Burkitt lymphoma",132,"Untreated",195,"GMALL-R",TRUE,"Cont.","2.Cyclophosphamide;0.Cytarabine;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;2.Rituximab;1.Cytarabine;0.Ifosfamide;0.Methotrexate;0.Vincristine;1.Ifosfamide;1.Ifosfamide;1.Cytarabine;0.Ifosfamide;0.Teniposide;1.Cytarabine;0.Ifosfamide;0.Methotrexate;0.Teniposide;16.Rituximab;1.Cyclophosphamide;0.Cytarabine;0.Ifosfamide;0.Methotrexate;0.Vincristine;1.Cyclophosphamide;0.Ifosfamide;1.Cyclophosphamide;0.Ifosfamide;1.Cyclophosphamide;0.Doxorubicin;0.Ifosfamide;1.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Ifosfamide;0.Methotrexate;16.Rituximab;1.Methotrexate;0.Vindesine;3.Etoposide;1.Cytarabine;0.Etoposide;2.Cyclophosphamide;0.Cytarabine;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;2.Rituximab;1.Cytarabine;0.Ifosfamide;0.Methotrexate;0.Vincristine;1.Ifosfamide;1.Ifosfamide;1.Cytarabine;0.Ifosfamide;0.Teniposide;1.Cytarabine;0.Ifosfamide;0.Methotrexate;0.Teniposide;16.Rituximab;1.Cyclophosphamide;0.Cytarabine;0.Ifosfamide;0.Methotrexate;0.Vincristine;1.Cyclophosphamide;0.Ifosfamide;1.Cyclophosphamide;0.Ifosfamide;1.Cyclophosphamide;0.Doxorubicin;0.Ifosfamide;1.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Ifosfamide;0.Methotrexate;16.Rituximab;1.Methotrexate;0.Vindesine;3.Etoposide;1.Cytarabine;0.Etoposide;","2.Cyclophosphamide;0.Cytarabine;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;2.Rituximab;1.Cytarabine;0.Ifosfamide;0.Methotrexate;0.Vincristine;1.Ifosfamide;1.Ifosfamide;1.Cytarabine;0.Ifosfamide;0.Teniposide;1.Cytarabine;0.Ifosfamide;0.Methotrexate;0.Teniposide;16.Rituximab;1.Cyclophosphamide;0.Cytarabine;0.Ifosfamide;0.Methotrexate;0.Vincristine;1.Cyclophosphamide;0.Ifosfamide;1.Cyclophosphamide;0.Ifosfamide;1.Cyclophosphamide;0.Doxorubicin;0.Ifosfamide;1.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Ifosfamide;0.Methotrexate;16.Rituximab;1.Methotrexate;0.Vindesine;3.Etoposide;1.Cytarabine;0.Etoposide;"
"870","132.195.1751.1","Malignant Hematology","Aggressive lymphomas","Burkitt lymphoma",132,"Untreated",195,"R-CODOX-M",FALSE,"3","7.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Methotrexate;0.Rituximab;0.Vincristine;1.Cyclophosphamide;3.Cytarabine;10.Methotrexate;0.Vincristine;7.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Methotrexate;0.Rituximab;0.Vincristine;1.Cyclophosphamide;3.Cytarabine;10.Methotrexate;0.Vincristine;","7.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Methotrexate;0.Rituximab;0.Vincristine;1.Cyclophosphamide;3.Cytarabine;10.Methotrexate;0.Vincristine;"
"871","132.195.1752.1","Malignant Hematology","Aggressive lymphomas","Burkitt lymphoma",132,"Untreated",195,"R-CODOX-M/R-IVAC",NA,NA,"0.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Methotrexate;0.Rituximab;0.Vincristine;1.Cyclophosphamide;1.Cytarabine;2.Cytarabine;17.Cytarabine;0.Etoposide;0.Ifosfamide;0.Rituximab;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;0.Methotrexate;","0.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Methotrexate;0.Rituximab;0.Vincristine;1.Cyclophosphamide;1.Cytarabine;2.Cytarabine;17.Cytarabine;0.Etoposide;0.Ifosfamide;0.Rituximab;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;0.Methotrexate;"
"872","132.195.1753.1","Malignant Hematology","Aggressive lymphomas","Burkitt lymphoma",132,"Untreated",195,"R-CODOX-M (Pegylated liposomal doxorubicin substituted)",FALSE,"3","11.Rituximab;1.Cyclophosphamide;0.Cytarabine;0.Pegylatedliposomaldoxorubicin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;3.Rituximab;0.Vincristine;2.Methotrexate;11.Rituximab;1.Cyclophosphamide;0.Cytarabine;0.Pegylatedliposomaldoxorubicin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;3.Rituximab;0.Vincristine;2.Methotrexate;","11.Rituximab;1.Cyclophosphamide;0.Cytarabine;0.Pegylatedliposomaldoxorubicin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;3.Rituximab;0.Vincristine;2.Methotrexate;"
"873","132.195.1754.1","Malignant Hematology","Aggressive lymphomas","Burkitt lymphoma",132,"Untreated",195,"R-CODOX-M/R-IVAC (Pegylated liposomal doxorubicin substituted)",NA,NA,"0.Rituximab;1.Cyclophosphamide;0.Cytarabine;0.Pegylatedliposomaldoxorubicin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;0.Cytarabine;1.Cyclophosphamide;1.Cyclophosphamide;16.Rituximab;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;0.Methotrexate;1.Rituximab;","0.Rituximab;1.Cyclophosphamide;0.Cytarabine;0.Pegylatedliposomaldoxorubicin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;0.Cytarabine;1.Cyclophosphamide;1.Cyclophosphamide;16.Rituximab;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;0.Methotrexate;1.Rituximab;"
"874","132.195.1755.1","Malignant Hematology","Aggressive lymphomas","Burkitt lymphoma",132,"Untreated",195,"R-COPADM",FALSE,"2","15.Rituximab;1.Methotrexate;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;2.Methotrexate;0.Rituximab;","15.Rituximab;1.Methotrexate;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;2.Methotrexate;0.Rituximab;"
"875","132.195.1756.1","Malignant Hematology","Aggressive lymphomas","Burkitt lymphoma",132,"Untreated",195,"R-Hyper-CVAD/R-MA",NA,NA,"0.Cyclophosphamide;0.Rituximab;1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;3.Cytarabine;15.Methotrexate;1.Cytarabine;0.Methotrexate;0.Rituximab;1.Cytarabine;4.Cytarabine;15.Cyclophosphamide;0.Rituximab;1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;3.Cytarabine;15.Methotrexate;1.Cytarabine;0.Methotrexate;0.Rituximab;1.Cytarabine;4.Cytarabine;15.Cyclophosphamide;1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;3.Cytarabine;15.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;4.Cytarabine;15.Cyclophosphamide;1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;3.Cytarabine;15.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;4.Cytarabine;","0.Cyclophosphamide;0.Rituximab;1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;3.Cytarabine;15.Methotrexate;1.Cytarabine;0.Methotrexate;0.Rituximab;1.Cytarabine;4.Cytarabine;15.Cyclophosphamide;0.Rituximab;1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;3.Cytarabine;15.Methotrexate;1.Cytarabine;0.Methotrexate;0.Rituximab;1.Cytarabine;4.Cytarabine;15.Cyclophosphamide;1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;3.Cytarabine;15.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;4.Cytarabine;15.Cyclophosphamide;1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;3.Cytarabine;15.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;4.Cytarabine;"
"876","132.202.1737.1","Malignant Hematology","Aggressive lymphomas","Burkitt lymphoma",132,"Untreated, pre-phase",202,"CVP_A",FALSE,"1","0.Cyclophosphamide;0.Cytarabine;0.Methotrexate;0.Methotrexate;0.Vincristine;2.Cytarabine;0.Methotrexate;2.Cytarabine;0.Methotrexate;","0.Cyclophosphamide;0.Cytarabine;0.Methotrexate;0.Methotrexate;0.Vincristine;2.Cytarabine;0.Methotrexate;2.Cytarabine;0.Methotrexate;"
"877","132.202.1738.1","Malignant Hematology","Aggressive lymphomas","Burkitt lymphoma",132,"Untreated, pre-phase",202,"Cyclophosphamide monotherapy",FALSE,"1","0.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;","0.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;"
"878","132.202.1739.1","Malignant Hematology","Aggressive lymphomas","Burkitt lymphoma",132,"Untreated, pre-phase",202,"Cyclophosphamide monotherapy with prophylaxis",FALSE,"1","0.Cyclophosphamide;0.Cytarabine;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;","0.Cyclophosphamide;0.Cytarabine;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;"
"879","132.51.1757.1","Malignant Hematology","Aggressive lymphomas","Burkitt lymphoma",132,"Consolidation/Intensification therapy",51,"BASIC",NA,NA,"0.Rituximab;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;17.Cytarabine;0.Rituximab;","0.Rituximab;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;17.Cytarabine;0.Rituximab;"
"880","132.51.1758.1","Malignant Hematology","Aggressive lymphomas","Burkitt lymphoma",132,"Consolidation/Intensification therapy",51,"Cytarabine & Methotrexate (CYM)",FALSE,"1","0.Methotrexate;1.Cytarabine;0.Methotrexate;4.Cytarabine;","0.Methotrexate;1.Cytarabine;0.Methotrexate;4.Cytarabine;"
"881","132.51.1758.2","Malignant Hematology","Aggressive lymphomas","Burkitt lymphoma",132,"Consolidation/Intensification therapy",51,"Cytarabine & Methotrexate (CYM)",FALSE,"1","0.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;","0.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"882","132.51.1759.1","Malignant Hematology","Aggressive lymphomas","Burkitt lymphoma",132,"Consolidation/Intensification therapy",51,"CYVE",FALSE,"1","0.Cytarabine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;","0.Cytarabine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;"
"883","133.184.1792.1","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"Relapsed or refractory, salvage therapy",184,"CYVE",FALSE,"1","0.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;","0.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;"
"884","133.184.1792.2","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"Relapsed or refractory, salvage therapy",184,"CYVE",FALSE,"1","0.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;","0.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;"
"885","133.184.1793.1","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"Relapsed or refractory, salvage therapy",184,"Ifosfamide & Methotrexate",FALSE,"1","0.Methotrexate;2.Ifosfamide;1.Ifosfamide;1.Ifosfamide;","0.Methotrexate;2.Ifosfamide;1.Ifosfamide;1.Ifosfamide;"
"886","133.186.1794.1","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"Relapsed or refractory, subsequent lines of therapy",186,"Rituximab monotherapy",TRUE,"Cont.","7.Rituximab;7.Rituximab;7.Rituximab;7.Rituximab;7.Rituximab;7.Rituximab;7.Rituximab;7.Rituximab;","7.Rituximab;7.Rituximab;"
"887","133.186.1795.1","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"Relapsed or refractory, subsequent lines of therapy",186,"Temsirolimus monotherapy",TRUE,"Cont.","7.Temsirolimus;7.Temsirolimus;7.Temsirolimus;7.Temsirolimus;7.Temsirolimus;7.Temsirolimus;7.Temsirolimus;7.Temsirolimus;","7.Temsirolimus;7.Temsirolimus;"
"888","133.186.1796.1","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"Relapsed or refractory, subsequent lines of therapy",186,"Topotecan monotherapy",TRUE,"Cont.","17.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;17.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;","17.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;"
"889","133.213.1771.1","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"Upfront therapy, non-randomized or retrospective data",213,"Lomustine, Methotrexate, Procarbazine",TRUE,"Cont.","16.Lomustine;0.Methotrexate;0.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;5.Methotrexate;15.Methotrexate;16.Lomustine;0.Methotrexate;0.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;5.Methotrexate;15.Methotrexate;","16.Lomustine;0.Methotrexate;0.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;5.Methotrexate;15.Methotrexate;"
"890","133.213.1771.2","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"Upfront therapy, non-randomized or retrospective data",213,"Lomustine, Methotrexate, Procarbazine",FALSE,"1","0.Cytarabine;0.Lomustine;0.Methotrexate;0.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Cytarabine;0.Methotrexate;0.Procarbazine;1.Procarbazine;1.Procarbazine;3.Cytarabine;0.Methotrexate;5.Cytarabine;0.Methotrexate;5.Methotrexate;","0.Cytarabine;0.Lomustine;0.Methotrexate;0.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Cytarabine;0.Methotrexate;0.Procarbazine;1.Procarbazine;1.Procarbazine;3.Cytarabine;0.Methotrexate;5.Cytarabine;0.Methotrexate;5.Methotrexate;"
"891","133.213.1772.1","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"Upfront therapy, non-randomized or retrospective data",213,"Methotrexate, then Cytarabine",NA,NA,"0.Methotrexate;14.Methotrexate;14.Methotrexate;14.Methotrexate;14.Methotrexate;14.Cytarabine;1.Cytarabine;27.Cytarabine;1.Cytarabine;","0.Methotrexate;14.Methotrexate;14.Methotrexate;14.Methotrexate;14.Methotrexate;14.Cytarabine;1.Cytarabine;27.Cytarabine;1.Cytarabine;"
"892","133.213.1773.1","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"Upfront therapy, non-randomized or retrospective data",213,"Methotrexate, then Cytarabine & Thiotepa",NA,NA,"0.Methotrexate;29.Cytarabine;1.Cytarabine;0.Thiotepa;","0.Methotrexate;29.Cytarabine;1.Cytarabine;0.Thiotepa;"
"893","133.213.1773.2","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"Upfront therapy, non-randomized or retrospective data",213,"Methotrexate, then Cytarabine & Thiotepa",NA,NA,"0.Methotrexate;10.Methotrexate;10.Cytarabine;1.Cytarabine;0.Thiotepa;20.Cytarabine;1.Cytarabine;0.Thiotepa;","0.Methotrexate;10.Methotrexate;10.Cytarabine;1.Cytarabine;0.Thiotepa;20.Cytarabine;1.Cytarabine;0.Thiotepa;"
"894","133.213.1773.3","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"Upfront therapy, non-randomized or retrospective data",213,"Methotrexate, then Cytarabine & Thiotepa",NA,NA,"0.Methotrexate;10.Methotrexate;10.Methotrexate;10.Cytarabine;1.Cytarabine;0.Thiotepa;20.Cytarabine;1.Cytarabine;0.Thiotepa;","0.Methotrexate;10.Methotrexate;10.Methotrexate;10.Cytarabine;1.Cytarabine;0.Thiotepa;20.Cytarabine;1.Cytarabine;0.Thiotepa;"
"895","133.213.1773.4","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"Upfront therapy, non-randomized or retrospective data",213,"Methotrexate, then Cytarabine & Thiotepa",NA,NA,"0.Methotrexate;10.Methotrexate;10.Methotrexate;10.Methotrexate;10.Cytarabine;1.Cytarabine;0.Thiotepa;20.Cytarabine;1.Cytarabine;0.Thiotepa;","0.Methotrexate;10.Methotrexate;10.Methotrexate;10.Methotrexate;10.Cytarabine;1.Cytarabine;0.Thiotepa;20.Cytarabine;1.Cytarabine;0.Thiotepa;"
"896","133.213.1774.1","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"Upfront therapy, non-randomized or retrospective data",213,"Methotrexate & Rituximab",NA,NA,"0.Methotrexate;","0.Methotrexate;"
"897","133.213.1775.1","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"Upfront therapy, non-randomized or retrospective data",213,"MPV",NA,NA,"0.Methotrexate;NA.Procarbazine;NA.Vincristine;NA.Procarbazine;NA.Procarbazine;NA.Procarbazine;NA.Procarbazine;NA.Procarbazine;NA.Procarbazine;","0.Methotrexate;NA.Procarbazine;NA.Vincristine;NA.Procarbazine;NA.Procarbazine;NA.Procarbazine;NA.Procarbazine;NA.Procarbazine;NA.Procarbazine;"
"898","133.213.1776.1","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"Upfront therapy, non-randomized or retrospective data",213,"MT-R",NA,NA,"0.Methotrexate;0.Rituximab;3.Methotrexate;14.Methotrexate;14.Methotrexate;14.Methotrexate;14.Methotrexate;","0.Methotrexate;0.Rituximab;3.Methotrexate;14.Methotrexate;14.Methotrexate;14.Methotrexate;14.Methotrexate;"
"899","133.213.1776.2","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"Upfront therapy, non-randomized or retrospective data",213,"MT-R",NA,NA,"0.Methotrexate;2.Rituximab;4.Temozolomide;8.Methotrexate;2.Rituximab;12.Methotrexate;2.Rituximab;4.Temozolomide;8.Methotrexate;2.Rituximab;12.Methotrexate;2.Rituximab;4.Temozolomide;8.Methotrexate;2.Rituximab;12.Methotrexate;6.Temozolomide;","0.Methotrexate;2.Rituximab;4.Temozolomide;8.Methotrexate;2.Rituximab;12.Methotrexate;2.Rituximab;4.Temozolomide;8.Methotrexate;2.Rituximab;12.Methotrexate;2.Rituximab;4.Temozolomide;8.Methotrexate;2.Rituximab;12.Methotrexate;6.Temozolomide;"
"900","133.213.1777.1","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"Upfront therapy, non-randomized or retrospective data",213,"MVBP",FALSE,"1","0.Cytarabine;0.Methotrexate;1.Etoposide;1.Carmustine;12.Methotrexate;","0.Cytarabine;0.Methotrexate;1.Etoposide;1.Carmustine;12.Methotrexate;"
"901","133.213.1778.1","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"Upfront therapy, non-randomized or retrospective data",213,"Nordic Regimen, older patients",NA,NA,"0.Methotrexate;0.Rituximab;1.Ifosfamide;0.Liposomalcytarabine;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;17.Methotrexate;1.Cyclophosphamide;0.Liposomalcytarabine;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;16.Cytarabine;0.Vindesine;1.Cytarabine;20.Methotrexate;1.Liposomalcytarabine;20.Methotrexate;1.Cyclophosphamide;0.Liposomalcytarabine;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;16.Cytarabine;0.Vindesine;1.Cytarabine;","0.Methotrexate;0.Rituximab;1.Ifosfamide;0.Liposomalcytarabine;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;17.Methotrexate;1.Cyclophosphamide;0.Liposomalcytarabine;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;16.Cytarabine;0.Vindesine;1.Cytarabine;20.Methotrexate;1.Liposomalcytarabine;20.Methotrexate;1.Cyclophosphamide;0.Liposomalcytarabine;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;16.Cytarabine;0.Vindesine;1.Cytarabine;"
"902","133.213.1779.1","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"Upfront therapy, non-randomized or retrospective data",213,"Nordic Regimen, younger patients",NA,NA,"0.Methotrexate;0.Rituximab;0.Vincristine;1.Cyclophosphamide;0.Ifosfamide;0.Liposomalcytarabine;1.Cyclophosphamide;0.Ifosfamide;1.Cyclophosphamide;0.Ifosfamide;1.Cyclophosphamide;0.Ifosfamide;17.Methotrexate;1.Liposomalcytarabine;20.Cytarabine;0.Vindesine;1.Cytarabine;20.Methotrexate;0.Vincristine;1.Cyclophosphamide;0.Ifosfamide;0.Liposomalcytarabine;1.Cyclophosphamide;0.Ifosfamide;1.Cyclophosphamide;0.Ifosfamide;1.Cyclophosphamide;0.Ifosfamide;17.Methotrexate;1.Liposomalcytarabine;20.Cytarabine;0.Vindesine;1.Cytarabine;","0.Methotrexate;0.Rituximab;0.Vincristine;1.Cyclophosphamide;0.Ifosfamide;0.Liposomalcytarabine;1.Cyclophosphamide;0.Ifosfamide;1.Cyclophosphamide;0.Ifosfamide;1.Cyclophosphamide;0.Ifosfamide;17.Methotrexate;1.Liposomalcytarabine;20.Cytarabine;0.Vindesine;1.Cytarabine;20.Methotrexate;0.Vincristine;1.Cyclophosphamide;0.Ifosfamide;0.Liposomalcytarabine;1.Cyclophosphamide;0.Ifosfamide;1.Cyclophosphamide;0.Ifosfamide;1.Cyclophosphamide;0.Ifosfamide;17.Methotrexate;1.Liposomalcytarabine;20.Cytarabine;0.Vindesine;1.Cytarabine;"
"903","133.213.1780.1","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"Upfront therapy, non-randomized or retrospective data",213,"R-MCP (CCNU)",TRUE,"Cont.","14.Rituximab;7.Rituximab;1.Lomustine;0.Methotrexate;0.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;4.Rituximab;1.Methotrexate;13.Rituximab;1.Methotrexate;14.Rituximab;7.Rituximab;1.Lomustine;0.Methotrexate;0.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;4.Rituximab;1.Methotrexate;13.Rituximab;1.Methotrexate;","14.Rituximab;7.Rituximab;1.Lomustine;0.Methotrexate;0.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;4.Rituximab;1.Methotrexate;13.Rituximab;1.Methotrexate;"
"904","133.213.1781.1","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"Upfront therapy, non-randomized or retrospective data",213,"R-MP",NA,NA,"0.Rituximab;50.Rituximab;1.Methotrexate;0.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;36.Rituximab;1.Methotrexate;0.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;","0.Rituximab;50.Rituximab;1.Methotrexate;0.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;36.Rituximab;1.Methotrexate;0.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;"
"905","133.213.1782.1","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"Upfront therapy, non-randomized or retrospective data",213,"R-MPV",TRUE,"Cont.","7.Procarbazine;0.Rituximab;1.Methotrexate;0.Procarbazine;0.Vincristine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Methotrexate;7.Procarbazine;0.Rituximab;1.Methotrexate;0.Procarbazine;0.Vincristine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Methotrexate;","7.Procarbazine;0.Rituximab;1.Methotrexate;0.Procarbazine;0.Vincristine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Methotrexate;"
"906","133.214.1766.1","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"Upfront therapy, randomized data",214,"Cytarabine & Methotrexate (CYM)",FALSE,"4","19.Methotrexate;1.Cytarabine;1.Cytarabine;19.Methotrexate;1.Cytarabine;1.Cytarabine;","19.Methotrexate;1.Cytarabine;1.Cytarabine;"
"907","133.214.1767.1","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"Upfront therapy, randomized data",214,"Cytarabine, Methotrexate, Rituximab",FALSE,"4","19.Rituximab;5.Rituximab;1.Methotrexate;1.Cytarabine;1.Cytarabine;19.Rituximab;5.Rituximab;1.Methotrexate;1.Cytarabine;1.Cytarabine;","19.Rituximab;5.Rituximab;1.Methotrexate;1.Cytarabine;1.Cytarabine;"
"908","133.214.1768.1","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"Upfront therapy, randomized data",214,"MATRix",FALSE,"4","18.Rituximab;5.Rituximab;1.Methotrexate;1.Cytarabine;1.Cytarabine;1.Thiotepa;18.Rituximab;5.Rituximab;1.Methotrexate;1.Cytarabine;1.Cytarabine;1.Thiotepa;","18.Rituximab;5.Rituximab;1.Methotrexate;1.Cytarabine;1.Cytarabine;1.Thiotepa;"
"909","133.214.1769.1","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"Upfront therapy, randomized data",214,"MBVP",FALSE,"2","14.Methotrexate;1.Teniposide;1.Teniposide;1.Carmustine;11.Methotrexate;","14.Methotrexate;1.Teniposide;1.Teniposide;1.Carmustine;11.Methotrexate;"
"910","133.214.1770.1","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"Upfront therapy, randomized data",214,"Methotrexate monotherapy",FALSE,"4","21.Methotrexate;21.Methotrexate;","21.Methotrexate;21.Methotrexate;"
"911","133.214.1770.2","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"Upfront therapy, randomized data",214,"Methotrexate monotherapy",TRUE,"Cont.","14.Methotrexate;14.Methotrexate;","14.Methotrexate;14.Methotrexate;"
"912","133.214.1770.3","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"Upfront therapy, randomized data",214,"Methotrexate monotherapy",FALSE,"1","0.Methotrexate;9.Methotrexate;","0.Methotrexate;9.Methotrexate;"
"913","133.37.1762.1","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"CNS prophylaxis, systemic therapy",37,"High-dose Cytarabine monotherapy (HiDAC)",FALSE,"1","0.Cytarabine;1.Cytarabine;","0.Cytarabine;1.Cytarabine;"
"914","133.37.1763.1","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"CNS prophylaxis, systemic therapy",37,"Methotrexate monotherapy",FALSE,"1","0.Methotrexate;","0.Methotrexate;0.Methotrexate;"
"915","133.37.1763.2","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"CNS prophylaxis, systemic therapy",37,"Methotrexate monotherapy",FALSE,"1","0.Methotrexate;1.Methotrexate;","0.Methotrexate;1.Methotrexate;"
"916","133.38.1764.1","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"CNS treatment, local therapy",38,"IT Cytarabine monotherapy",FALSE,"1","0.Cytarabine;3.Cytarabine;4.Cytarabine;3.Cytarabine;4.Cytarabine;3.Cytarabine;4.Cytarabine;3.Cytarabine;","0.Cytarabine;3.Cytarabine;4.Cytarabine;3.Cytarabine;4.Cytarabine;3.Cytarabine;4.Cytarabine;3.Cytarabine;"
"917","133.38.1765.1","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"CNS treatment, local therapy",38,"IT Cytarabine liposomal monotherapy",FALSE,"2","14.Liposomalcytarabine;","14.Liposomalcytarabine;14.Liposomalcytarabine;"
"918","133.48.1783.1","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"Consolidation and/or maintenance after upfront therapy",48,"BCNU/TT, then auto HSCT",FALSE,"1","0.Carmustine;1.Thiotepa;1.Thiotepa;","0.Carmustine;1.Thiotepa;1.Thiotepa;"
"919","133.48.1784.1","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"Consolidation and/or maintenance after upfront therapy",48,"BEAM, then auto HSCT",FALSE,"1","0.Carmustine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Melphalan;","0.Carmustine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Melphalan;"
"920","133.48.1785.1","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"Consolidation and/or maintenance after upfront therapy",48,"Bu/TT, then auto HSCT",FALSE,"1","0.Busulfan;1.Busulfan;1.Busulfan;1.Busulfan;1.Thiotepa;1.Thiotepa;","0.Busulfan;1.Busulfan;1.Busulfan;1.Busulfan;1.Thiotepa;1.Thiotepa;"
"921","133.48.1786.1","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"Consolidation and/or maintenance after upfront therapy",48,"Bu/TT/Cy, then auto HSCT",FALSE,"1","0.Thiotepa;1.Thiotepa;1.Thiotepa;1.Busulfan;1.Busulfan;1.Busulfan;1.Cyclophosphamide;1.Cyclophosphamide;","0.Thiotepa;1.Thiotepa;1.Thiotepa;1.Busulfan;1.Busulfan;1.Busulfan;1.Cyclophosphamide;1.Cyclophosphamide;"
"922","133.48.1787.1","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"Consolidation and/or maintenance after upfront therapy",48,"CYVE",FALSE,"1","0.Cytarabine;0.Etoposide;1.Cytarabine;1.Cytarabine;1.Cytarabine;","0.Cytarabine;0.Etoposide;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"923","133.48.1787.2","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"Consolidation and/or maintenance after upfront therapy",48,"CYVE",FALSE,"1","0.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;","0.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;"
"924","133.48.1788.1","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"Consolidation and/or maintenance after upfront therapy",48,"Lomustine, Methotrexate, Procarbazine",FALSE,"5","36.Cytarabine;0.Lomustine;0.Methotrexate;0.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;36.Cytarabine;0.Lomustine;0.Methotrexate;0.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;","36.Cytarabine;0.Lomustine;0.Methotrexate;0.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;"
"925","133.48.1789.1","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"Consolidation and/or maintenance after upfront therapy",48,"Methotrexate monotherapy",FALSE,"4","28.Methotrexate;28.Methotrexate;","28.Methotrexate;28.Methotrexate;"
"926","133.48.1789.2","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"Consolidation and/or maintenance after upfront therapy",48,"Methotrexate monotherapy",FALSE,"11","28.Methotrexate;28.Methotrexate;","28.Methotrexate;28.Methotrexate;"
"927","133.48.1790.1","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"Consolidation and/or maintenance after upfront therapy",48,"Procarbazine monotherapy",FALSE,"6","24.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;24.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;","24.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;"
"928","133.48.1791.1","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"Consolidation and/or maintenance after upfront therapy",48,"Temozolomide monotherapy",TRUE,"Cont.","3.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;3.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;","3.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;"
"929","133.48.1791.2","Malignant Hematology","Aggressive lymphomas","CNS lymphoma",133,"Consolidation and/or maintenance after upfront therapy",48,"Temozolomide monotherapy",TRUE,"Cont.","24.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;24.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;","24.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;"
"930","134.118.1827.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Maintenance after upfront therapy",118,"Lenalidomide monotherapy",TRUE,"Cont.","8.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;8.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","8.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"931","134.118.1828.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Maintenance after upfront therapy",118,"Rituximab monotherapy",TRUE,"Cont.","56.Rituximab;56.Rituximab;","56.Rituximab;56.Rituximab;"
"932","134.118.1828.2","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Maintenance after upfront therapy",118,"Rituximab monotherapy",TRUE,"Cont.","84.Rituximab;84.Rituximab;","84.Rituximab;84.Rituximab;"
"933","134.178.1855.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, further lines of therapy",178,"Bendamustine monotherapy",TRUE,"Cont.","20.Bendamustine;1.Bendamustine;20.Bendamustine;1.Bendamustine;","20.Bendamustine;1.Bendamustine;"
"934","134.178.1856.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, further lines of therapy",178,"Blinatumomab monotherapy",TRUE,"Cont.","1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;","1.Blinatumomab;1.Blinatumomab;"
"935","134.178.1857.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, further lines of therapy",178,"Bendamustine & Rituximab (BR)",TRUE,"Cont.","19.Rituximab;1.Bendamustine;1.Bendamustine;19.Rituximab;1.Bendamustine;1.Bendamustine;","19.Rituximab;1.Bendamustine;1.Bendamustine;"
"936","134.178.1858.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, further lines of therapy",178,"Bendamustine & Rituximab (BR) & Polatuzumab vedotin",TRUE,"Cont.","19.Rituximab;1.Bendamustine;0.Polatuzumabvedotin;1.Bendamustine;19.Rituximab;1.Bendamustine;0.Polatuzumabvedotin;1.Bendamustine;","19.Rituximab;1.Bendamustine;0.Polatuzumabvedotin;1.Bendamustine;"
"937","134.178.1858.2","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, further lines of therapy",178,"Bendamustine & Rituximab (BR) & Polatuzumab vedotin",TRUE,"Cont.","20.Bendamustine;0.Polatuzumabvedotin;0.Rituximab;1.Bendamustine;20.Bendamustine;0.Polatuzumabvedotin;0.Rituximab;1.Bendamustine;","20.Bendamustine;0.Polatuzumabvedotin;0.Rituximab;1.Bendamustine;"
"938","134.178.1859.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, further lines of therapy",178,"Brentuximab vedotin monotherapy",TRUE,"Cont.","21.Brentuximabvedotin;21.Brentuximabvedotin;","21.Brentuximabvedotin;21.Brentuximabvedotin;"
"939","134.178.1860.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, further lines of therapy",178,"Etoposide monotherapy",TRUE,"Cont.","26.Etoposide;1.Etoposide;1.Etoposide;26.Etoposide;1.Etoposide;1.Etoposide;","26.Etoposide;1.Etoposide;1.Etoposide;"
"940","134.178.1860.2","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, further lines of therapy",178,"Etoposide monotherapy",TRUE,"Cont.","24.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;24.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;","24.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;"
"941","134.178.1860.3","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, further lines of therapy",178,"Etoposide monotherapy",TRUE,"Cont.","19.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;19.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;","19.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;"
"942","134.178.1860.4","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, further lines of therapy",178,"Etoposide monotherapy",TRUE,"Cont.","15.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;15.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;","15.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;"
"943","134.178.1860.5","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, further lines of therapy",178,"Etoposide monotherapy",TRUE,"Cont.","8.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;8.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;","8.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;"
"944","134.178.1861.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, further lines of therapy",178,"Everolimus monotherapy",TRUE,"Cont.","1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;","1.Everolimus;1.Everolimus;"
"945","134.178.1862.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, further lines of therapy",178,"Everolimus & Rituximab",TRUE,"Cont.","1.Everolimus;0.Rituximab;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;0.Rituximab;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;0.Rituximab;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;0.Rituximab;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;0.Rituximab;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;0.Rituximab;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;0.Rituximab;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;0.Rituximab;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;","1.Everolimus;0.Rituximab;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;"
"946","134.178.1863.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, further lines of therapy",178,"Gemcitabine monotherapy",TRUE,"Cont.","14.Gemcitabine;14.Gemcitabine;14.Gemcitabine;14.Gemcitabine;","14.Gemcitabine;14.Gemcitabine;"
"947","134.178.1863.2","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, further lines of therapy",178,"Gemcitabine monotherapy",TRUE,"Cont.","14.Gemcitabine;7.Gemcitabine;7.Gemcitabine;14.Gemcitabine;7.Gemcitabine;7.Gemcitabine;","14.Gemcitabine;7.Gemcitabine;7.Gemcitabine;"
"948","134.178.1864.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, further lines of therapy",178,"Gemcitabine & Rituximab",TRUE,"Cont.","14.Gemcitabine;0.Rituximab;7.Gemcitabine;7.Gemcitabine;14.Gemcitabine;0.Rituximab;7.Gemcitabine;7.Gemcitabine;","14.Gemcitabine;0.Rituximab;7.Gemcitabine;7.Gemcitabine;"
"949","134.178.1864.2","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, further lines of therapy",178,"Gemcitabine & Rituximab",TRUE,"Cont.","7.Gemcitabine;0.Rituximab;7.Gemcitabine;0.Rituximab;7.Gemcitabine;0.Rituximab;7.Rituximab;7.Gemcitabine;0.Rituximab;7.Gemcitabine;0.Rituximab;7.Gemcitabine;0.Rituximab;7.Rituximab;","7.Gemcitabine;0.Rituximab;7.Gemcitabine;0.Rituximab;7.Gemcitabine;0.Rituximab;7.Rituximab;"
"950","134.178.1865.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, further lines of therapy",178,"GVD",TRUE,"Cont.","14.Gemcitabine;0.Pegylatedliposomaldoxorubicin;0.Vinorelbine;14.Gemcitabine;0.Pegylatedliposomaldoxorubicin;0.Vinorelbine;","14.Gemcitabine;0.Pegylatedliposomaldoxorubicin;0.Vinorelbine;"
"951","134.178.1866.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, further lines of therapy",178,"Ibrutinib monotherapy",TRUE,"Cont.","1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;","1.Ibrutinib;1.Ibrutinib;"
"952","134.178.1867.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, further lines of therapy",178,"Ifosfamide monotherapy",TRUE,"Cont.","27.Ifosfamide;1.Ifosfamide;27.Ifosfamide;1.Ifosfamide;","27.Ifosfamide;1.Ifosfamide;"
"953","134.178.1868.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, further lines of therapy",178,"Lenalidomide & Rituximab (R2)",TRUE,"Cont.","7.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Rituximab;7.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Rituximab;","7.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Rituximab;"
"954","134.178.1868.2","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, further lines of therapy",178,"Lenalidomide & Rituximab (R2)",TRUE,"Cont.","8.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Rituximab;8.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Rituximab;","8.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Rituximab;"
"955","134.178.1869.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, further lines of therapy",178,"Lenalidomide & Tafasitamab",TRUE,"Cont.","7.Lenalidomide;0.Tafasitamab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Tafasitamab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Tafasitamab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Tafasitamab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Tafasitamab;7.Lenalidomide;0.Tafasitamab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Tafasitamab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Tafasitamab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Tafasitamab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Tafasitamab;","7.Lenalidomide;0.Tafasitamab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Tafasitamab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Tafasitamab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Tafasitamab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Tafasitamab;"
"956","134.178.1869.2","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, further lines of therapy",178,"Lenalidomide & Tafasitamab",TRUE,"Cont.","7.Lenalidomide;0.Tafasitamab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Tafasitamab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Tafasitamab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Tafasitamab;7.Lenalidomide;0.Tafasitamab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Tafasitamab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Tafasitamab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Tafasitamab;","7.Lenalidomide;0.Tafasitamab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Tafasitamab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Tafasitamab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Tafasitamab;"
"957","134.178.1869.3","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, further lines of therapy",178,"Lenalidomide & Tafasitamab",TRUE,"Cont.","8.Lenalidomide;0.Tafasitamab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Tafasitamab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;8.Lenalidomide;0.Tafasitamab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Tafasitamab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","8.Lenalidomide;0.Tafasitamab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Tafasitamab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"958","134.178.1870.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, further lines of therapy",178,"Loncastuximab tesirine monotherapy",TRUE,"Cont.","21.Loncastuximabtesirine;21.Loncastuximabtesirine;","21.Loncastuximabtesirine;21.Loncastuximabtesirine;"
"959","134.178.1871.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, further lines of therapy",178,"Mitoxantrone monotherapy",TRUE,"Cont.","21.Mitoxantrone;21.Mitoxantrone;","21.Mitoxantrone;21.Mitoxantrone;"
"960","134.178.1872.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, further lines of therapy",178,"Obinutuzumab monotherapy",TRUE,"Cont.","14.Obinutuzumab;7.Obinutuzumab;14.Obinutuzumab;7.Obinutuzumab;","14.Obinutuzumab;7.Obinutuzumab;"
"961","134.178.1872.2","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, further lines of therapy",178,"Obinutuzumab monotherapy",TRUE,"Cont.","21.Obinutuzumab;21.Obinutuzumab;","21.Obinutuzumab;21.Obinutuzumab;"
"962","134.178.1873.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, further lines of therapy",178,"Ofatumumab monotherapy",TRUE,"Cont.","7.Ofatumumab;7.Ofatumumab;7.Ofatumumab;7.Ofatumumab;7.Ofatumumab;7.Ofatumumab;7.Ofatumumab;7.Ofatumumab;","7.Ofatumumab;7.Ofatumumab;"
"963","134.178.1874.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, further lines of therapy",178,"Oxaliplatin monotherapy",TRUE,"Cont.","21.Oxaliplatin;21.Oxaliplatin;","21.Oxaliplatin;21.Oxaliplatin;"
"964","134.178.1875.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, further lines of therapy",178,"Panobinostat monotherapy",TRUE,"Cont.","3.Panobinostat;2.Panobinostat;2.Panobinostat;3.Panobinostat;2.Panobinostat;2.Panobinostat;","3.Panobinostat;2.Panobinostat;2.Panobinostat;"
"965","134.178.1876.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, further lines of therapy",178,"Panobinostat & Rituximab",TRUE,"Cont.","3.Panobinostat;0.Rituximab;2.Panobinostat;2.Panobinostat;3.Panobinostat;2.Panobinostat;2.Panobinostat;3.Panobinostat;2.Panobinostat;2.Panobinostat;3.Panobinostat;0.Rituximab;2.Panobinostat;2.Panobinostat;3.Panobinostat;2.Panobinostat;2.Panobinostat;3.Panobinostat;2.Panobinostat;2.Panobinostat;","3.Panobinostat;0.Rituximab;2.Panobinostat;2.Panobinostat;3.Panobinostat;2.Panobinostat;2.Panobinostat;3.Panobinostat;2.Panobinostat;2.Panobinostat;"
"966","134.178.1877.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, further lines of therapy",178,"Pixantrone monotherapy",TRUE,"Cont.","14.Pixantrone;7.Pixantrone;7.Pixantrone;14.Pixantrone;7.Pixantrone;7.Pixantrone;","14.Pixantrone;7.Pixantrone;7.Pixantrone;"
"967","134.178.1878.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, further lines of therapy",178,"R-BL",TRUE,"Cont.","8.Bendamustine;0.Lenalidomide;0.Rituximab;1.Bendamustine;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;8.Bendamustine;0.Lenalidomide;0.Rituximab;1.Bendamustine;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","8.Bendamustine;0.Lenalidomide;0.Rituximab;1.Bendamustine;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"968","134.178.1879.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, further lines of therapy",178,"R-CVEP",FALSE,"6","19.Cyclophosphamide;0.Etoposide;0.Rituximab;0.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Cyclophosphamide;0.Vorinostat;1.Vorinostat;1.Vorinostat;19.Cyclophosphamide;0.Etoposide;0.Rituximab;0.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Cyclophosphamide;0.Vorinostat;1.Vorinostat;1.Vorinostat;","19.Cyclophosphamide;0.Etoposide;0.Rituximab;0.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Cyclophosphamide;0.Vorinostat;1.Vorinostat;1.Vorinostat;"
"969","134.178.1880.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, further lines of therapy",178,"R-GemOx",TRUE,"Cont.","13.Rituximab;1.Gemcitabine;0.Oxaliplatin;13.Rituximab;1.Gemcitabine;0.Oxaliplatin;","13.Rituximab;1.Gemcitabine;0.Oxaliplatin;"
"970","134.178.1880.2","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, further lines of therapy",178,"R-GemOx",TRUE,"Cont.","21.Gemcitabine;0.Oxaliplatin;0.Rituximab;21.Gemcitabine;0.Oxaliplatin;0.Rituximab;","21.Gemcitabine;0.Oxaliplatin;0.Rituximab;"
"971","134.178.1881.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, further lines of therapy",178,"Selinexor monotherapy",TRUE,"Cont.","5.Selinexor;2.Selinexor;5.Selinexor;2.Selinexor;","5.Selinexor;2.Selinexor;"
"972","134.178.1882.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, further lines of therapy",178,"Tisagenlecleucel monotherapy",FALSE,"1","0.Tisagenlecleucel;","0.Tisagenlecleucel;0.Tisagenlecleucel;"
"973","134.178.1883.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, further lines of therapy",178,"TTR",TRUE,"Cont.","16.Rituximab;1.Paclitaxel;0.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;16.Rituximab;1.Paclitaxel;0.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;","16.Rituximab;1.Paclitaxel;0.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;"
"974","134.178.1884.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, further lines of therapy",178,"Vinorelbine monotherapy",TRUE,"Cont.","7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;","7.Vinorelbine;7.Vinorelbine;"
"975","134.184.1829.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, salvage therapy",184,"Axicabtagene ciloleucel monotherapy",FALSE,"1","0.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;3.Axicabtageneciloleucel;","0.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;3.Axicabtageneciloleucel;"
"976","134.184.1830.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, salvage therapy",184,"Lisocabtagene maraleucel monotherapy",FALSE,"1","0.Lisocabtagenemaraleucel;","0.Lisocabtagenemaraleucel;0.Lisocabtagenemaraleucel;"
"977","134.184.1831.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, salvage therapy",184,"O-DHAP",NA,NA,"0.Cisplatin;0.Ofatumumab;1.Cytarabine;20.Cisplatin;0.Ofatumumab;1.Cytarabine;20.Cisplatin;0.Ofatumumab;1.Cytarabine;","0.Cisplatin;0.Ofatumumab;1.Cytarabine;20.Cisplatin;0.Ofatumumab;1.Cytarabine;20.Cisplatin;0.Ofatumumab;1.Cytarabine;"
"978","134.184.1832.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, salvage therapy",184,"O-ICE",NA,NA,"0.Carboplatin;0.Etoposide;0.Ofatumumab;1.Etoposide;0.Ifosfamide;1.Etoposide;19.Carboplatin;0.Etoposide;0.Ofatumumab;1.Etoposide;0.Ifosfamide;1.Etoposide;19.Carboplatin;0.Etoposide;0.Ofatumumab;1.Etoposide;0.Ifosfamide;1.Etoposide;","0.Carboplatin;0.Etoposide;0.Ofatumumab;1.Etoposide;0.Ifosfamide;1.Etoposide;19.Carboplatin;0.Etoposide;0.Ofatumumab;1.Etoposide;0.Ifosfamide;1.Etoposide;19.Carboplatin;0.Etoposide;0.Ofatumumab;1.Etoposide;0.Ifosfamide;1.Etoposide;"
"979","134.184.1832.2","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, salvage therapy",184,"O-ICE",NA,NA,"0.Etoposide;0.Ofatumumab;1.Carboplatin;0.Etoposide;0.Ifosfamide;1.Etoposide;19.Etoposide;0.Ofatumumab;1.Carboplatin;0.Etoposide;0.Ifosfamide;1.Etoposide;19.Etoposide;0.Ofatumumab;1.Carboplatin;0.Etoposide;0.Ifosfamide;1.Etoposide;","0.Etoposide;0.Ofatumumab;1.Carboplatin;0.Etoposide;0.Ifosfamide;1.Etoposide;19.Etoposide;0.Ofatumumab;1.Carboplatin;0.Etoposide;0.Ifosfamide;1.Etoposide;19.Etoposide;0.Ofatumumab;1.Carboplatin;0.Etoposide;0.Ifosfamide;1.Etoposide;"
"980","134.184.1833.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, salvage therapy",184,"R-DexaBEAM",FALSE,"2","14.Rituximab;1.Melphalan;1.Carmustine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Rituximab;","14.Rituximab;1.Melphalan;1.Carmustine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Rituximab;"
"981","134.184.1833.2","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, salvage therapy",184,"R-DexaBEAM",FALSE,"2","21.Rituximab;1.Melphalan;1.Carmustine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Rituximab;","21.Rituximab;1.Melphalan;1.Carmustine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Rituximab;"
"982","134.184.1834.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, salvage therapy",184,"R-DHAOx",NA,NA,"0.Rituximab;22.Cytarabine;0.Oxaliplatin;1.Cytarabine;20.Cytarabine;0.Oxaliplatin;1.Cytarabine;","0.Rituximab;22.Cytarabine;0.Oxaliplatin;1.Cytarabine;20.Cytarabine;0.Oxaliplatin;1.Cytarabine;"
"983","134.184.1834.2","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, salvage therapy",184,"R-DHAOx",NA,NA,"0.Rituximab;22.Cytarabine;0.Oxaliplatin;1.Cytarabine;20.Cytarabine;0.Oxaliplatin;1.Cytarabine;20.Cytarabine;0.Oxaliplatin;1.Cytarabine;","0.Rituximab;22.Cytarabine;0.Oxaliplatin;1.Cytarabine;20.Cytarabine;0.Oxaliplatin;1.Cytarabine;20.Cytarabine;0.Oxaliplatin;1.Cytarabine;"
"984","134.184.1834.3","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, salvage therapy",184,"R-DHAOx",NA,NA,"0.Rituximab;22.Cytarabine;0.Oxaliplatin;1.Cytarabine;20.Cytarabine;0.Oxaliplatin;1.Cytarabine;20.Cytarabine;0.Oxaliplatin;1.Cytarabine;20.Cytarabine;0.Oxaliplatin;1.Cytarabine;","0.Rituximab;22.Cytarabine;0.Oxaliplatin;1.Cytarabine;20.Cytarabine;0.Oxaliplatin;1.Cytarabine;20.Cytarabine;0.Oxaliplatin;1.Cytarabine;20.Cytarabine;0.Oxaliplatin;1.Cytarabine;"
"985","134.184.1834.4","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, salvage therapy",184,"R-DHAOx",NA,NA,"0.Rituximab;22.Cytarabine;0.Oxaliplatin;1.Cytarabine;20.Cytarabine;0.Oxaliplatin;1.Cytarabine;20.Cytarabine;0.Oxaliplatin;1.Cytarabine;20.Cytarabine;0.Oxaliplatin;1.Cytarabine;20.Cytarabine;0.Oxaliplatin;1.Cytarabine;","0.Rituximab;22.Cytarabine;0.Oxaliplatin;1.Cytarabine;20.Cytarabine;0.Oxaliplatin;1.Cytarabine;20.Cytarabine;0.Oxaliplatin;1.Cytarabine;20.Cytarabine;0.Oxaliplatin;1.Cytarabine;20.Cytarabine;0.Oxaliplatin;1.Cytarabine;"
"986","134.184.1835.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, salvage therapy",184,"R-DHAP",NA,NA,"0.Cisplatin;0.Rituximab;1.Cytarabine;20.Cisplatin;0.Rituximab;1.Cytarabine;20.Cisplatin;1.Cytarabine;","0.Cisplatin;0.Rituximab;1.Cytarabine;20.Cisplatin;0.Rituximab;1.Cytarabine;20.Cisplatin;1.Cytarabine;"
"987","134.184.1835.2","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, salvage therapy",184,"R-DHAP",NA,NA,"0.Rituximab;1.Cisplatin;0.Rituximab;1.Cytarabine;19.Cisplatin;0.Rituximab;1.Cytarabine;20.Cisplatin;1.Cytarabine;","0.Rituximab;1.Cisplatin;0.Rituximab;1.Cytarabine;19.Cisplatin;0.Rituximab;1.Cytarabine;20.Cisplatin;1.Cytarabine;"
"988","134.184.1835.3","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, salvage therapy",184,"R-DHAP",TRUE,"Cont.","18.Cisplatin;0.Rituximab;0.Rituximab;1.Cytarabine;1.Cisplatin;1.Cytarabine;18.Cisplatin;0.Rituximab;0.Rituximab;1.Cytarabine;1.Cisplatin;1.Cytarabine;","18.Cisplatin;0.Rituximab;0.Rituximab;1.Cytarabine;1.Cisplatin;1.Cytarabine;"
"989","134.184.1835.4","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, salvage therapy",184,"R-DHAP",NA,NA,"0.Rituximab;2.Cisplatin;1.Cisplatin;0.Cytarabine;1.Cisplatin;17.Rituximab;2.Cisplatin;1.Cisplatin;0.Cytarabine;1.Cisplatin;1.Cisplatin;16.Rituximab;2.Cisplatin;1.Cisplatin;0.Cytarabine;1.Cisplatin;1.Cisplatin;16.Rituximab;2.Cisplatin;1.Cisplatin;0.Cytarabine;1.Cisplatin;1.Cisplatin;","0.Rituximab;2.Cisplatin;1.Cisplatin;0.Cytarabine;1.Cisplatin;17.Rituximab;2.Cisplatin;1.Cisplatin;0.Cytarabine;1.Cisplatin;1.Cisplatin;16.Rituximab;2.Cisplatin;1.Cisplatin;0.Cytarabine;1.Cisplatin;1.Cisplatin;16.Rituximab;2.Cisplatin;1.Cisplatin;0.Cytarabine;1.Cisplatin;1.Cisplatin;"
"990","134.184.1836.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, salvage therapy",184,"R-DHAP/R-VIM",NA,NA,"0.Cisplatin;1.Cytarabine;3.Rituximab;24.Etoposide;0.Ifosfamide;0.Methotrexate;1.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Ifosfamide;1.Etoposide;0.Ifosfamide;0.Methotrexate;1.Rituximab;23.Cisplatin;1.Cytarabine;3.Rituximab;","0.Cisplatin;1.Cytarabine;3.Rituximab;24.Etoposide;0.Ifosfamide;0.Methotrexate;1.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Ifosfamide;1.Etoposide;0.Ifosfamide;0.Methotrexate;1.Rituximab;23.Cisplatin;1.Cytarabine;3.Rituximab;"
"991","134.184.1837.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, salvage therapy",184,"R-EPOCH",TRUE,"Cont.","17.Rituximab;1.Doxorubicin;0.Etoposide;0.Vincristine;3.Cyclophosphamide;17.Rituximab;1.Doxorubicin;0.Etoposide;0.Vincristine;3.Cyclophosphamide;","17.Rituximab;1.Doxorubicin;0.Etoposide;0.Vincristine;3.Cyclophosphamide;"
"992","134.184.1837.2","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, salvage therapy",184,"R-EPOCH",TRUE,"Cont.","17.Rituximab;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;17.Rituximab;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;","17.Rituximab;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;"
"993","134.184.1838.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, salvage therapy",184,"R-ESHAP",TRUE,"Cont.","17.Cisplatin;0.Etoposide;0.Rituximab;1.Etoposide;1.Etoposide;1.Etoposide;1.Cytarabine;17.Cisplatin;0.Etoposide;0.Rituximab;1.Etoposide;1.Etoposide;1.Etoposide;1.Cytarabine;","17.Cisplatin;0.Etoposide;0.Rituximab;1.Etoposide;1.Etoposide;1.Etoposide;1.Cytarabine;"
"994","134.184.1838.2","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, salvage therapy",184,"R-ESHAP",TRUE,"Cont.","17.Cisplatin;0.Etoposide;0.Rituximab;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Cytarabine;17.Cisplatin;0.Etoposide;0.Rituximab;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Cytarabine;","17.Cisplatin;0.Etoposide;0.Rituximab;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Cytarabine;"
"995","134.184.1839.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, salvage therapy",184,"R-GDP",TRUE,"Cont.","14.Cisplatin;0.Gemcitabine;0.Rituximab;7.Gemcitabine;14.Cisplatin;0.Gemcitabine;0.Rituximab;7.Gemcitabine;","14.Cisplatin;0.Gemcitabine;0.Rituximab;7.Gemcitabine;"
"996","134.184.1839.2","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, salvage therapy",184,"R-GDP",TRUE,"Cont.","14.Cisplatin;0.Gemcitabine;0.Rituximab;1.Cisplatin;1.Cisplatin;5.Gemcitabine;14.Cisplatin;0.Gemcitabine;0.Rituximab;1.Cisplatin;1.Cisplatin;5.Gemcitabine;","14.Cisplatin;0.Gemcitabine;0.Rituximab;1.Cisplatin;1.Cisplatin;5.Gemcitabine;"
"997","134.184.1840.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, salvage therapy",184,"R-GemOx",TRUE,"Cont.","14.Oxaliplatin;0.Rituximab;1.Gemcitabine;14.Oxaliplatin;0.Rituximab;1.Gemcitabine;","14.Oxaliplatin;0.Rituximab;1.Gemcitabine;"
"998","134.184.1841.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, salvage therapy",184,"R-ICE",NA,NA,"0.Rituximab;2.Etoposide;0.Rituximab;1.Carboplatin;0.Etoposide;0.Ifosfamide;1.Etoposide;17.Etoposide;0.Rituximab;1.Carboplatin;0.Etoposide;0.Ifosfamide;1.Etoposide;","0.Rituximab;2.Etoposide;0.Rituximab;1.Carboplatin;0.Etoposide;0.Ifosfamide;1.Etoposide;17.Etoposide;0.Rituximab;1.Carboplatin;0.Etoposide;0.Ifosfamide;1.Etoposide;"
"999","134.184.1841.2","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, salvage therapy",184,"R-ICE",NA,NA,"0.Rituximab;2.Etoposide;0.Rituximab;1.Carboplatin;0.Etoposide;0.Ifosfamide;1.Etoposide;17.Etoposide;0.Rituximab;1.Carboplatin;0.Etoposide;0.Ifosfamide;1.Etoposide;19.Etoposide;0.Rituximab;1.Carboplatin;0.Etoposide;0.Ifosfamide;1.Etoposide;","0.Rituximab;2.Etoposide;0.Rituximab;1.Carboplatin;0.Etoposide;0.Ifosfamide;1.Etoposide;17.Etoposide;0.Rituximab;1.Carboplatin;0.Etoposide;0.Ifosfamide;1.Etoposide;19.Etoposide;0.Rituximab;1.Carboplatin;0.Etoposide;0.Ifosfamide;1.Etoposide;"
"1000","134.184.1841.3","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, salvage therapy",184,"R-ICE",NA,NA,"0.Rituximab;3.Rituximab;2.Etoposide;1.Carboplatin;0.Etoposide;0.Ifosfamide;8.Rituximab;2.Etoposide;1.Carboplatin;0.Etoposide;0.Ifosfamide;1.Etoposide;10.Rituximab;2.Etoposide;1.Carboplatin;0.Etoposide;0.Ifosfamide;1.Etoposide;","0.Rituximab;3.Rituximab;2.Etoposide;1.Carboplatin;0.Etoposide;0.Ifosfamide;8.Rituximab;2.Etoposide;1.Carboplatin;0.Etoposide;0.Ifosfamide;1.Etoposide;10.Rituximab;2.Etoposide;1.Carboplatin;0.Etoposide;0.Ifosfamide;1.Etoposide;"
"1001","134.184.1842.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, salvage therapy",184,"RICER",FALSE,"2","8.Lenalidomide;0.Rituximab;1.Carboplatin;0.Etoposide;0.Ifosfamide;0.Lenalidomide;1.Etoposide;0.Lenalidomide;1.Etoposide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","8.Lenalidomide;0.Rituximab;1.Carboplatin;0.Etoposide;0.Ifosfamide;0.Lenalidomide;1.Etoposide;0.Lenalidomide;1.Etoposide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1002","134.184.1843.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, salvage therapy",184,"R-IFE",TRUE,"Cont.","12.Etoposide;0.Ifosfamide;0.Rituximab;1.Etoposide;1.Etoposide;12.Etoposide;0.Ifosfamide;0.Rituximab;1.Etoposide;1.Etoposide;","12.Etoposide;0.Ifosfamide;0.Rituximab;1.Etoposide;1.Etoposide;"
"1003","134.184.1843.2","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, salvage therapy",184,"R-IFE",TRUE,"Cont.","11.Etoposide;0.Ifosfamide;0.Rituximab;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Ifosfamide;11.Etoposide;0.Ifosfamide;0.Rituximab;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Ifosfamide;","11.Etoposide;0.Ifosfamide;0.Rituximab;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Ifosfamide;"
"1004","134.184.1844.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, salvage therapy",184,"R-NIMP",FALSE,"3","14.Ifosfamide;0.Mitoxantrone;0.Rituximab;0.Vinorelbine;14.Vinorelbine;14.Ifosfamide;0.Mitoxantrone;0.Rituximab;0.Vinorelbine;14.Vinorelbine;","14.Ifosfamide;0.Mitoxantrone;0.Rituximab;0.Vinorelbine;14.Vinorelbine;"
"1005","134.184.1844.2","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Relapsed or refractory, salvage therapy",184,"R-NIMP",FALSE,"3","14.Ifosfamide;0.Mitoxantrone;0.Rituximab;0.Vinorelbine;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;9.Vinorelbine;14.Ifosfamide;0.Mitoxantrone;0.Rituximab;0.Vinorelbine;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;9.Vinorelbine;","14.Ifosfamide;0.Mitoxantrone;0.Rituximab;0.Vinorelbine;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;9.Vinorelbine;"
"1006","134.201.1812.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Untreated, non-randomized or retrospective data",201,"Bendamustine & Rituximab (BR)",TRUE,"Cont.","20.Bendamustine;0.Rituximab;1.Bendamustine;20.Bendamustine;0.Rituximab;1.Bendamustine;","20.Bendamustine;0.Rituximab;1.Bendamustine;"
"1007","134.201.1813.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Untreated, non-randomized or retrospective data",201,"O-miniCHOP",FALSE,"6","21.Cyclophosphamide;0.Doxorubicin;0.Ofatumumab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Ofatumumab;0.Vincristine;","21.Cyclophosphamide;0.Doxorubicin;0.Ofatumumab;0.Vincristine;"
"1008","134.201.1814.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Untreated, non-randomized or retrospective data",201,"R-BL",FALSE,"6","8.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;8.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","8.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1009","134.201.1815.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Untreated, non-randomized or retrospective data",201,"R-CDOP",FALSE,"6","21.Cyclophosphamide;0.Pegylatedliposomaldoxorubicin;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Pegylatedliposomaldoxorubicin;0.Rituximab;0.Vincristine;","21.Cyclophosphamide;0.Pegylatedliposomaldoxorubicin;0.Rituximab;0.Vincristine;"
"1010","134.201.1815.2","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Untreated, non-randomized or retrospective data",201,"R-CDOP",FALSE,"7","21.Cyclophosphamide;0.Pegylatedliposomaldoxorubicin;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Pegylatedliposomaldoxorubicin;0.Rituximab;0.Vincristine;","21.Cyclophosphamide;0.Pegylatedliposomaldoxorubicin;0.Rituximab;0.Vincristine;"
"1011","134.201.1815.3","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Untreated, non-randomized or retrospective data",201,"R-CDOP",FALSE,"8","21.Cyclophosphamide;0.Pegylatedliposomaldoxorubicin;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Pegylatedliposomaldoxorubicin;0.Rituximab;0.Vincristine;","21.Cyclophosphamide;0.Pegylatedliposomaldoxorubicin;0.Rituximab;0.Vincristine;"
"1012","134.201.1816.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Untreated, non-randomized or retrospective data",201,"R-CEOP90 (Epirubicin, Prednisolone)",FALSE,"4","20.Rituximab;1.Cyclophosphamide;0.Epirubicin;0.Vincristine;20.Rituximab;1.Cyclophosphamide;0.Epirubicin;0.Vincristine;","20.Rituximab;1.Cyclophosphamide;0.Epirubicin;0.Vincristine;"
"1013","134.201.1816.2","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Untreated, non-randomized or retrospective data",201,"R-CEOP90 (Epirubicin, Prednisolone)",FALSE,"6","20.Rituximab;1.Cyclophosphamide;0.Epirubicin;0.Vincristine;20.Rituximab;1.Cyclophosphamide;0.Epirubicin;0.Vincristine;","20.Rituximab;1.Cyclophosphamide;0.Epirubicin;0.Vincristine;"
"1014","134.201.1817.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Untreated, non-randomized or retrospective data",201,"R-CEOP (Etoposide)",FALSE,"3","19.Cyclophosphamide;0.Etoposide;0.Rituximab;0.Vincristine;1.Etoposide;1.Etoposide;19.Cyclophosphamide;0.Etoposide;0.Rituximab;0.Vincristine;1.Etoposide;1.Etoposide;","19.Cyclophosphamide;0.Etoposide;0.Rituximab;0.Vincristine;1.Etoposide;1.Etoposide;"
"1015","134.201.1817.2","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Untreated, non-randomized or retrospective data",201,"R-CEOP (Etoposide)",FALSE,"4","19.Cyclophosphamide;0.Etoposide;0.Rituximab;0.Vincristine;1.Etoposide;1.Etoposide;19.Cyclophosphamide;0.Etoposide;0.Rituximab;0.Vincristine;1.Etoposide;1.Etoposide;","19.Cyclophosphamide;0.Etoposide;0.Rituximab;0.Vincristine;1.Etoposide;1.Etoposide;"
"1016","134.201.1818.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Untreated, non-randomized or retrospective data",201,"R-GCVP",NA,NA,"0.Cyclophosphamide;0.Gemcitabine;0.Methotrexate;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Gemcitabine;0.Methotrexate;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Gemcitabine;0.Methotrexate;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Gemcitabine;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Gemcitabine;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Gemcitabine;0.Rituximab;0.Vincristine;","0.Cyclophosphamide;0.Gemcitabine;0.Methotrexate;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Gemcitabine;0.Methotrexate;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Gemcitabine;0.Methotrexate;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Gemcitabine;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Gemcitabine;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Gemcitabine;0.Rituximab;0.Vincristine;"
"1017","134.201.1819.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Untreated, non-randomized or retrospective data",201,"R-MegaCHOP-14",FALSE,"3","21.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;","21.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;"
"1018","134.201.1820.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Untreated, non-randomized or retrospective data",201,"R-miniCHOP",FALSE,"6","21.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;","21.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;"
"1019","134.202.1797.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Untreated, pre-phase",202,"Vincristine monotherapy",FALSE,"1","0.Vincristine;","0.Vincristine;0.Vincristine;"
"1020","134.203.1798.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Untreated, randomized data",203,"Pola-R-CHP",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;0.Polatuzumab;0.Rituximab;21.Cyclophosphamide;0.Doxorubicin;0.Polatuzumab;0.Rituximab;21.Cyclophosphamide;0.Doxorubicin;0.Polatuzumab;0.Rituximab;21.Cyclophosphamide;0.Doxorubicin;0.Polatuzumab;0.Rituximab;21.Cyclophosphamide;0.Doxorubicin;0.Polatuzumab;0.Rituximab;21.Cyclophosphamide;0.Doxorubicin;0.Polatuzumab;0.Rituximab;21.Cyclophosphamide;0.Doxorubicin;0.Rituximab;21.Cyclophosphamide;0.Doxorubicin;0.Rituximab;","0.Cyclophosphamide;0.Doxorubicin;0.Polatuzumab;0.Rituximab;21.Cyclophosphamide;0.Doxorubicin;0.Polatuzumab;0.Rituximab;21.Cyclophosphamide;0.Doxorubicin;0.Polatuzumab;0.Rituximab;21.Cyclophosphamide;0.Doxorubicin;0.Polatuzumab;0.Rituximab;21.Cyclophosphamide;0.Doxorubicin;0.Polatuzumab;0.Rituximab;21.Cyclophosphamide;0.Doxorubicin;0.Polatuzumab;0.Rituximab;21.Cyclophosphamide;0.Doxorubicin;0.Rituximab;21.Cyclophosphamide;0.Doxorubicin;0.Rituximab;"
"1021","134.203.1799.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Untreated, randomized data",203,"R-ACVBP",FALSE,"4","10.Bleomycin;0.Cyclophosphamide;0.Doxorubicin;0.Methotrexate;0.Rituximab;0.Vindesine;4.Bleomycin;0.Vindesine;10.Bleomycin;0.Cyclophosphamide;0.Doxorubicin;0.Methotrexate;0.Rituximab;0.Vindesine;4.Bleomycin;0.Vindesine;","10.Bleomycin;0.Cyclophosphamide;0.Doxorubicin;0.Methotrexate;0.Rituximab;0.Vindesine;4.Bleomycin;0.Vindesine;"
"1022","134.203.1800.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Untreated, randomized data",203,"R-CEOP70",NA,NA,"0.Rituximab;1.Cyclophosphamide;0.Etoposide;0.Vincristine;21.Rituximab;1.Cyclophosphamide;0.Etoposide;0.Vincristine;21.Rituximab;1.Cyclophosphamide;0.Etoposide;0.Vincristine;21.Rituximab;1.Cyclophosphamide;0.Etoposide;0.Vincristine;21.Rituximab;1.Cyclophosphamide;0.Etoposide;0.Vincristine;21.Rituximab;1.Cyclophosphamide;0.Etoposide;0.Vincristine;21.Rituximab;22.Rituximab;","0.Rituximab;1.Cyclophosphamide;0.Etoposide;0.Vincristine;21.Rituximab;1.Cyclophosphamide;0.Etoposide;0.Vincristine;21.Rituximab;1.Cyclophosphamide;0.Etoposide;0.Vincristine;21.Rituximab;1.Cyclophosphamide;0.Etoposide;0.Vincristine;21.Rituximab;1.Cyclophosphamide;0.Etoposide;0.Vincristine;21.Rituximab;1.Cyclophosphamide;0.Etoposide;0.Vincristine;21.Rituximab;22.Rituximab;"
"1023","134.203.1801.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Untreated, randomized data",203,"R-CHOEP-14",NA,NA,"0.Rituximab;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;1.Etoposide;1.Etoposide;12.Rituximab;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;1.Etoposide;1.Etoposide;12.Rituximab;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;1.Etoposide;1.Etoposide;12.Rituximab;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;1.Etoposide;1.Etoposide;13.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;1.Etoposide;1.Etoposide;12.Rituximab;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;1.Etoposide;1.Etoposide;13.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;1.Etoposide;1.Etoposide;12.Rituximab;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;1.Etoposide;1.Etoposide;","0.Rituximab;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;1.Etoposide;1.Etoposide;12.Rituximab;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;1.Etoposide;1.Etoposide;12.Rituximab;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;1.Etoposide;1.Etoposide;12.Rituximab;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;1.Etoposide;1.Etoposide;13.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;1.Etoposide;1.Etoposide;12.Rituximab;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;1.Etoposide;1.Etoposide;13.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;1.Etoposide;1.Etoposide;12.Rituximab;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;1.Etoposide;1.Etoposide;"
"1024","134.203.1801.2","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Untreated, randomized data",203,"R-CHOEP-14",FALSE,"8","12.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Rituximab;0.Vincristine;1.Etoposide;1.Etoposide;12.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Rituximab;0.Vincristine;1.Etoposide;1.Etoposide;","12.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Rituximab;0.Vincristine;1.Etoposide;1.Etoposide;"
"1025","134.203.1802.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Untreated, randomized data",203,"R-CHOP",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;0.Methotrexate;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Methotrexate;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Methotrexate;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Methotrexate;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;","0.Cyclophosphamide;0.Doxorubicin;0.Methotrexate;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Methotrexate;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Methotrexate;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Methotrexate;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;"
"1026","134.203.1802.2","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Untreated, randomized data",203,"R-CHOP",TRUE,"Cont.","21.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;","21.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;"
"1027","134.203.1802.3","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Untreated, randomized data",203,"R-CHOP",TRUE,"Cont.","19.Rituximab;4.Rituximab;4.Cyclophosphamide;0.Doxorubicin;0.Vincristine;19.Rituximab;4.Rituximab;4.Cyclophosphamide;0.Doxorubicin;0.Vincristine;","19.Rituximab;4.Rituximab;4.Cyclophosphamide;0.Doxorubicin;0.Vincristine;"
"1028","134.203.1802.4","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Untreated, randomized data",203,"R-CHOP",TRUE,"Cont.","21.Rituximab;3.Cyclophosphamide;0.Doxorubicin;0.Vincristine;21.Rituximab;3.Cyclophosphamide;0.Doxorubicin;0.Vincristine;","21.Rituximab;3.Cyclophosphamide;0.Doxorubicin;0.Vincristine;"
"1029","134.203.1802.5","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Untreated, randomized data",203,"R-CHOP",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;0.Methotrexate;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Methotrexate;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Methotrexate;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Methotrexate;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;","0.Cyclophosphamide;0.Doxorubicin;0.Methotrexate;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Methotrexate;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Methotrexate;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Methotrexate;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;"
"1030","134.203.1803.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Untreated, randomized data",203,"R-CHOP (Rituximab and hyaluronidase)",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;","0.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;"
"1031","134.203.1803.2","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Untreated, randomized data",203,"R-CHOP (Rituximab and hyaluronidase)",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;","0.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;"
"1032","134.203.1804.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Untreated, randomized data",203,"R-CHOP-14",TRUE,"Cont.","14.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;","14.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;"
"1033","134.203.1804.2","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Untreated, randomized data",203,"R-CHOP-14",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;0.Methotrexate;0.Rituximab;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Methotrexate;0.Rituximab;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Methotrexate;0.Rituximab;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Methotrexate;0.Rituximab;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;","0.Cyclophosphamide;0.Doxorubicin;0.Methotrexate;0.Rituximab;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Methotrexate;0.Rituximab;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Methotrexate;0.Rituximab;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Methotrexate;0.Rituximab;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;"
"1034","134.203.1804.3","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Untreated, randomized data",203,"R-CHOP-14",FALSE,"1","0.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;1.Rituximab;3.Rituximab;4.Rituximab;6.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Rituximab;7.Rituximab;6.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Rituximab;13.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Rituximab;13.Cyclophosphamide;0.Doxorubicin;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Vincristine;","0.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;1.Rituximab;3.Rituximab;4.Rituximab;6.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Rituximab;7.Rituximab;6.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Rituximab;13.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Rituximab;13.Cyclophosphamide;0.Doxorubicin;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Vincristine;"
"1035","134.203.1804.4","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Untreated, randomized data",203,"R-CHOP-14",TRUE,"Cont.","13.Rituximab;1.Cyclophosphamide;0.Doxorubicin;0.Vincristine;13.Rituximab;1.Cyclophosphamide;0.Doxorubicin;0.Vincristine;","13.Rituximab;1.Cyclophosphamide;0.Doxorubicin;0.Vincristine;"
"1036","134.203.1804.5","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Untreated, randomized data",203,"R-CHOP-14",TRUE,"Cont.","12.Rituximab;2.Cyclophosphamide;0.Doxorubicin;0.Vincristine;12.Rituximab;2.Cyclophosphamide;0.Doxorubicin;0.Vincristine;","12.Rituximab;2.Cyclophosphamide;0.Doxorubicin;0.Vincristine;"
"1037","134.203.1805.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Untreated, randomized data",203,"Rituximab monotherapy",TRUE,"Cont.","28.Rituximab;28.Rituximab;","28.Rituximab;28.Rituximab;"
"1038","134.203.1805.2","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Untreated, randomized data",203,"Rituximab monotherapy",TRUE,"Cont.","42.Rituximab;42.Rituximab;","42.Rituximab;42.Rituximab;"
"1039","134.203.1806.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Untreated, randomized data",203,"R-CHOP-14 (Rituximab and hyaluronidase)",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;","0.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;"
"1040","134.203.1806.2","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Untreated, randomized data",203,"R-CHOP-14 (Rituximab and hyaluronidase)",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;","0.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;"
"1041","134.203.1807.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Untreated, randomized data",203,"R2-CHOP",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;0.Lenalidomide;0.Methotrexate;0.Rituximab;0.Vincristine;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;15.Cyclophosphamide;0.Doxorubicin;0.Lenalidomide;0.Methotrexate;0.Rituximab;0.Vincristine;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;15.Cyclophosphamide;0.Doxorubicin;0.Lenalidomide;0.Methotrexate;0.Rituximab;0.Vincristine;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;15.Cyclophosphamide;0.Doxorubicin;0.Lenalidomide;0.Methotrexate;0.Rituximab;0.Vincristine;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;15.Cyclophosphamide;0.Doxorubicin;0.Lenalidomide;0.Rituximab;0.Vincristine;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;15.Cyclophosphamide;0.Doxorubicin;0.Lenalidomide;0.Rituximab;0.Vincristine;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","0.Cyclophosphamide;0.Doxorubicin;0.Lenalidomide;0.Methotrexate;0.Rituximab;0.Vincristine;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;15.Cyclophosphamide;0.Doxorubicin;0.Lenalidomide;0.Methotrexate;0.Rituximab;0.Vincristine;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;15.Cyclophosphamide;0.Doxorubicin;0.Lenalidomide;0.Methotrexate;0.Rituximab;0.Vincristine;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;15.Cyclophosphamide;0.Doxorubicin;0.Lenalidomide;0.Methotrexate;0.Rituximab;0.Vincristine;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;15.Cyclophosphamide;0.Doxorubicin;0.Lenalidomide;0.Rituximab;0.Vincristine;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;15.Cyclophosphamide;0.Doxorubicin;0.Lenalidomide;0.Rituximab;0.Vincristine;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1042","134.203.1807.2","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Untreated, randomized data",203,"R2-CHOP",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;0.Lenalidomide;0.Rituximab;0.Vincristine;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;15.Cyclophosphamide;0.Doxorubicin;0.Lenalidomide;0.Rituximab;0.Vincristine;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;15.Cyclophosphamide;0.Doxorubicin;0.Lenalidomide;0.Rituximab;0.Vincristine;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;15.Cyclophosphamide;0.Doxorubicin;0.Lenalidomide;0.Rituximab;0.Vincristine;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;15.Cyclophosphamide;0.Doxorubicin;0.Lenalidomide;0.Rituximab;0.Vincristine;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;15.Cyclophosphamide;0.Doxorubicin;0.Lenalidomide;0.Rituximab;0.Vincristine;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","0.Cyclophosphamide;0.Doxorubicin;0.Lenalidomide;0.Rituximab;0.Vincristine;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;15.Cyclophosphamide;0.Doxorubicin;0.Lenalidomide;0.Rituximab;0.Vincristine;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;15.Cyclophosphamide;0.Doxorubicin;0.Lenalidomide;0.Rituximab;0.Vincristine;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;15.Cyclophosphamide;0.Doxorubicin;0.Lenalidomide;0.Rituximab;0.Vincristine;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;15.Cyclophosphamide;0.Doxorubicin;0.Lenalidomide;0.Rituximab;0.Vincristine;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;15.Cyclophosphamide;0.Doxorubicin;0.Lenalidomide;0.Rituximab;0.Vincristine;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1043","134.203.1807.3","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Untreated, randomized data",203,"R2-CHOP",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;0.Lenalidomide;0.Rituximab;0.Vincristine;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;15.Cyclophosphamide;0.Doxorubicin;0.Lenalidomide;0.Rituximab;0.Vincristine;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;15.Cyclophosphamide;0.Doxorubicin;0.Lenalidomide;0.Rituximab;0.Vincristine;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;15.Cyclophosphamide;0.Doxorubicin;0.Lenalidomide;0.Rituximab;0.Vincristine;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;15.Cyclophosphamide;0.Doxorubicin;0.Lenalidomide;0.Rituximab;0.Vincristine;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;15.Cyclophosphamide;0.Doxorubicin;0.Lenalidomide;0.Rituximab;0.Vincristine;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","0.Cyclophosphamide;0.Doxorubicin;0.Lenalidomide;0.Rituximab;0.Vincristine;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;15.Cyclophosphamide;0.Doxorubicin;0.Lenalidomide;0.Rituximab;0.Vincristine;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;15.Cyclophosphamide;0.Doxorubicin;0.Lenalidomide;0.Rituximab;0.Vincristine;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;15.Cyclophosphamide;0.Doxorubicin;0.Lenalidomide;0.Rituximab;0.Vincristine;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;15.Cyclophosphamide;0.Doxorubicin;0.Lenalidomide;0.Rituximab;0.Vincristine;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;15.Cyclophosphamide;0.Doxorubicin;0.Lenalidomide;0.Rituximab;0.Vincristine;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1044","134.203.1808.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Untreated, randomized data",203,"R-Hyper-CVAD/R-MA",NA,NA,"0.Cyclophosphamide;0.Rituximab;1.Cyclophosphamide;1.Cyclophosphamide;2.Doxorubicin;0.Vincristine;17.Methotrexate;0.Rituximab;2.Cytarabine;1.Cytarabine;18.Cyclophosphamide;0.Rituximab;1.Cyclophosphamide;1.Cyclophosphamide;2.Doxorubicin;0.Vincristine;17.Methotrexate;0.Rituximab;2.Cytarabine;1.Cytarabine;18.Cyclophosphamide;0.Rituximab;1.Cyclophosphamide;1.Cyclophosphamide;2.Doxorubicin;0.Vincristine;17.Methotrexate;0.Rituximab;2.Cytarabine;1.Cytarabine;","0.Cyclophosphamide;0.Rituximab;1.Cyclophosphamide;1.Cyclophosphamide;2.Doxorubicin;0.Vincristine;17.Methotrexate;0.Rituximab;2.Cytarabine;1.Cytarabine;18.Cyclophosphamide;0.Rituximab;1.Cyclophosphamide;1.Cyclophosphamide;2.Doxorubicin;0.Vincristine;17.Methotrexate;0.Rituximab;2.Cytarabine;1.Cytarabine;18.Cyclophosphamide;0.Rituximab;1.Cyclophosphamide;1.Cyclophosphamide;2.Doxorubicin;0.Vincristine;17.Methotrexate;0.Rituximab;2.Cytarabine;1.Cytarabine;"
"1045","134.203.1809.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Untreated, randomized data",203,"R-MegaCHOP-14",FALSE,"6","14.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;","14.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;"
"1046","134.203.1810.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Untreated, randomized data",203,"R-miniCHOP (Rituximab and hyaluronidase)",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;","0.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximabandhyaluronidasehuman;0.Vincristine;"
"1047","134.203.1811.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Untreated, randomized data",203,"R-miniCEOP",FALSE,"6","21.Cyclophosphamide;0.Epirubicin;0.Rituximab;0.Vinblastine;21.Cyclophosphamide;0.Epirubicin;0.Rituximab;0.Vinblastine;","21.Cyclophosphamide;0.Epirubicin;0.Rituximab;0.Vinblastine;"
"1048","134.41.1845.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Consolidation after salvage therapy",41,"BEAC, then auto HSCT",FALSE,"1","0.Carmustine;1.Cyclophosphamide;0.Cytarabine;0.Etoposide;1.Cyclophosphamide;0.Cytarabine;0.Etoposide;1.Cyclophosphamide;0.Cytarabine;0.Etoposide;1.Cyclophosphamide;0.Cytarabine;0.Etoposide;","0.Carmustine;1.Cyclophosphamide;0.Cytarabine;0.Etoposide;1.Cyclophosphamide;0.Cytarabine;0.Etoposide;1.Cyclophosphamide;0.Cytarabine;0.Etoposide;1.Cyclophosphamide;0.Cytarabine;0.Etoposide;"
"1049","134.41.1846.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Consolidation after salvage therapy",41,"BEAM, then allo HSCT",FALSE,"1","0.Carmustine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Melphalan;","0.Carmustine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Melphalan;"
"1050","134.41.1847.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Consolidation after salvage therapy",41,"BeEAM, then auto HSCT",FALSE,"1","0.Bendamustine;1.Bendamustine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Melphalan;","0.Bendamustine;1.Bendamustine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Melphalan;"
"1051","134.41.1848.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Consolidation after salvage therapy",41,"Cyclophosphamide & TBI, then auto HSCT",FALSE,"1","0.Cyclophosphamide;1.Cyclophosphamide;","0.Cyclophosphamide;1.Cyclophosphamide;"
"1052","134.41.1849.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Consolidation after salvage therapy",41,"FEAM, then auto HSCT",FALSE,"1","0.Fotemustine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Melphalan;","0.Fotemustine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Melphalan;"
"1053","134.41.1850.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Consolidation after salvage therapy",41,"FluBuCy, then allo HSCT",FALSE,"1","0.Fludarabine;1.Fludarabine;1.Busulfan;0.Fludarabine;1.Busulfan;0.Fludarabine;1.Busulfan;0.Fludarabine;1.Antithymocyteglobulin;0.rabbitATG;0.Cyclophosphamide;1.Antithymocyteglobulin;0.rabbitATG;0.Cyclophosphamide;1.Antithymocyteglobulin;0.rabbitATG;","0.Fludarabine;1.Fludarabine;1.Busulfan;0.Fludarabine;1.Busulfan;0.Fludarabine;1.Busulfan;0.Fludarabine;1.Antithymocyteglobulin;0.rabbitATG;0.Cyclophosphamide;1.Antithymocyteglobulin;0.rabbitATG;0.Cyclophosphamide;1.Antithymocyteglobulin;0.rabbitATG;"
"1054","134.41.1851.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Consolidation after salvage therapy",41,"Fludarabine, Busulfan, ATG, Ibritumomab tiuxetan, then allo HSCT",FALSE,"1","0.Rituximab;7.Ibritumomabtiuxetan;0.Rituximab;8.Fludarabine;1.Busulfan;1.Busulfan;2.Fludarabine;1.Antithymocyteglobulin;0.rabbitATG;","0.Rituximab;7.Ibritumomabtiuxetan;0.Rituximab;8.Fludarabine;1.Busulfan;1.Busulfan;2.Fludarabine;1.Antithymocyteglobulin;0.rabbitATG;"
"1055","134.41.1852.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Consolidation after salvage therapy",41,"LEED, then auto HSCT",FALSE,"1","0.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;0.Etoposide;1.Etoposide;1.Melphalan;","0.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;0.Etoposide;1.Etoposide;1.Melphalan;"
"1056","134.41.1853.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Consolidation after salvage therapy",41,"R-BEAM, then auto HSCT",FALSE,"1","0.Rituximab;7.Rituximab;6.Carmustine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Melphalan;","0.Rituximab;7.Rituximab;6.Carmustine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Melphalan;"
"1057","134.41.1853.2","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Consolidation after salvage therapy",41,"R-BEAM, then auto HSCT",FALSE,"1","0.Rituximab;1.Carmustine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Melphalan;0.Rituximab;","0.Rituximab;1.Carmustine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Melphalan;0.Rituximab;"
"1058","134.41.1854.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Consolidation after salvage therapy",41,"R-TBI/Cy, then auto HSCT",FALSE,"1","0.Rituximab;5.Cyclophosphamide;1.Cyclophosphamide;0.Rituximab;","0.Rituximab;5.Cyclophosphamide;1.Cyclophosphamide;0.Rituximab;"
"1059","134.44.1821.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Consolidation after upfront therapy",44,"CBV, then auto HSCT",FALSE,"1","0.Carmustine;2.Etoposide;2.Cyclophosphamide;","0.Carmustine;2.Etoposide;2.Cyclophosphamide;"
"1060","134.44.1822.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Consolidation after upfront therapy",44,"CBVM, then auto HSCT",FALSE,"1","0.Carmustine;0.Methotrexate;2.Etoposide;2.Cyclophosphamide;","0.Carmustine;0.Methotrexate;2.Etoposide;2.Cyclophosphamide;"
"1061","134.44.1823.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Consolidation after upfront therapy",44,"Cytarabine monotherapy",FALSE,"2","11.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;","11.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"1062","134.44.1824.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Consolidation after upfront therapy",44,"Ibritumomab tiuxetan protocol",FALSE,"1","0.Rituximab;7.Ibritumomabtiuxetan&Yttrium-90;0.Rituximab;","0.Rituximab;7.Ibritumomabtiuxetan&Yttrium-90;0.Rituximab;"
"1063","134.44.1825.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Consolidation after upfront therapy",44,"R-IFE",FALSE,"4","14.Etoposide;0.Ifosfamide;0.Rituximab;14.Etoposide;0.Ifosfamide;0.Rituximab;","14.Etoposide;0.Ifosfamide;0.Rituximab;"
"1064","134.44.1826.1","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Consolidation after upfront therapy",44,"Z-BEAM, then auto HSCT",FALSE,"1","0.Ibritumomabtiuxetan&Yttrium-90;0.Rituximab;8.Carmustine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Melphalan;","0.Ibritumomabtiuxetan&Yttrium-90;0.Rituximab;8.Carmustine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Melphalan;"
"1065","134.44.1826.2","Malignant Hematology","Aggressive lymphomas","Diffuse large B-cell lymphoma",134,"Consolidation after upfront therapy",44,"Z-BEAM, then auto HSCT",FALSE,"1","0.Rituximab;7.Ibritumomabtiuxetan&Yttrium-90;0.Rituximab;7.Carmustine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Melphalan;","0.Rituximab;7.Ibritumomabtiuxetan&Yttrium-90;0.Rituximab;7.Carmustine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Melphalan;"
"1066","135.207.1885.1","Malignant Hematology","Aggressive lymphomas","HIV-associated lymphoma",135,"Upfront therapy",207,"CHOP",TRUE,"Cont.","21.Cyclophosphamide;0.Doxorubicin;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Vincristine;","21.Cyclophosphamide;0.Doxorubicin;0.Vincristine;"
"1067","135.207.1886.1","Malignant Hematology","Aggressive lymphomas","HIV-associated lymphoma",135,"Upfront therapy",207,"CODOX-M",FALSE,"3","12.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;3.Vincristine;2.Methotrexate;12.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;3.Vincristine;2.Methotrexate;","12.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;3.Vincristine;2.Methotrexate;"
"1068","135.207.1887.1","Malignant Hematology","Aggressive lymphomas","HIV-associated lymphoma",135,"Upfront therapy",207,"CODOX-M/IVAC",NA,NA,"0.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;0.Cytarabine;1.Cyclophosphamide;1.Cyclophosphamide;17.Cytarabine;0.Etoposide;0.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;0.Methotrexate;2.Cytarabine;15.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;0.Cytarabine;1.Cyclophosphamide;1.Cyclophosphamide;17.Cytarabine;0.Etoposide;0.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;0.Methotrexate;2.Cytarabine;","0.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;0.Cytarabine;1.Cyclophosphamide;1.Cyclophosphamide;17.Cytarabine;0.Etoposide;0.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;0.Methotrexate;2.Cytarabine;15.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;0.Cytarabine;1.Cyclophosphamide;1.Cyclophosphamide;17.Cytarabine;0.Etoposide;0.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;0.Methotrexate;2.Cytarabine;"
"1069","135.207.1887.2","Malignant Hematology","Aggressive lymphomas","HIV-associated lymphoma",135,"Upfront therapy",207,"CODOX-M/IVAC",NA,NA,"0.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;0.Cytarabine;1.Cyclophosphamide;1.Cyclophosphamide;0.Cytarabine;17.Cytarabine;0.Etoposide;0.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;0.Methotrexate;2.Cytarabine;15.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;0.Cytarabine;1.Cyclophosphamide;1.Cyclophosphamide;17.Cytarabine;0.Etoposide;0.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;0.Methotrexate;2.Cytarabine;","0.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;0.Cytarabine;1.Cyclophosphamide;1.Cyclophosphamide;0.Cytarabine;17.Cytarabine;0.Etoposide;0.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;0.Methotrexate;2.Cytarabine;15.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;0.Cytarabine;1.Cyclophosphamide;1.Cyclophosphamide;17.Cytarabine;0.Etoposide;0.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;0.Methotrexate;2.Cytarabine;"
"1070","135.207.1888.1","Malignant Hematology","Aggressive lymphomas","HIV-associated lymphoma",135,"Upfront therapy",207,"dmCODOX-M - Modified Magrath",TRUE,"Cont.","7.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;0.Cytarabine;1.Cyclophosphamide;1.Cyclophosphamide;3.Vincristine;2.Methotrexate;5.Methotrexate;7.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;0.Cytarabine;1.Cyclophosphamide;1.Cyclophosphamide;3.Vincristine;2.Methotrexate;5.Methotrexate;","7.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;0.Cytarabine;1.Cyclophosphamide;1.Cyclophosphamide;3.Vincristine;2.Methotrexate;5.Methotrexate;"
"1071","135.207.1888.2","Malignant Hematology","Aggressive lymphomas","HIV-associated lymphoma",135,"Upfront therapy",207,"dmCODOX-M - Modified Magrath",TRUE,"Cont.","5.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;0.Cytarabine;1.Cyclophosphamide;1.Cyclophosphamide;0.Cytarabine;3.Vincristine;2.Methotrexate;5.Methotrexate;2.Methotrexate;5.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;0.Cytarabine;1.Cyclophosphamide;1.Cyclophosphamide;0.Cytarabine;3.Vincristine;2.Methotrexate;5.Methotrexate;2.Methotrexate;","5.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;0.Cytarabine;1.Cyclophosphamide;1.Cyclophosphamide;0.Cytarabine;3.Vincristine;2.Methotrexate;5.Methotrexate;2.Methotrexate;"
"1072","135.207.1889.1","Malignant Hematology","Aggressive lymphomas","HIV-associated lymphoma",135,"Upfront therapy",207,"dmCODOX-M/IVAC - Modified Magrath",NA,NA,"0.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;0.Cytarabine;1.Cyclophosphamide;1.Cyclophosphamide;17.Cytarabine;0.Etoposide;0.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;0.Methotrexate;17.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;0.Cytarabine;1.Cyclophosphamide;1.Cyclophosphamide;17.Cytarabine;0.Etoposide;0.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;0.Methotrexate;","0.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;0.Cytarabine;1.Cyclophosphamide;1.Cyclophosphamide;17.Cytarabine;0.Etoposide;0.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;0.Methotrexate;17.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;0.Cytarabine;1.Cyclophosphamide;1.Cyclophosphamide;17.Cytarabine;0.Etoposide;0.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;0.Methotrexate;"
"1073","135.207.1890.1","Malignant Hematology","Aggressive lymphomas","HIV-associated lymphoma",135,"Upfront therapy",207,"EPOCH, dose-escalated",FALSE,"6","17.Doxorubicin;0.Etoposide;0.Vincristine;4.Cyclophosphamide;17.Doxorubicin;0.Etoposide;0.Vincristine;4.Cyclophosphamide;","17.Doxorubicin;0.Etoposide;0.Vincristine;4.Cyclophosphamide;"
"1074","135.207.1890.2","Malignant Hematology","Aggressive lymphomas","HIV-associated lymphoma",135,"Upfront therapy",207,"EPOCH, dose-escalated",FALSE,"6","17.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;17.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;","17.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;"
"1075","135.207.1891.1","Malignant Hematology","Aggressive lymphomas","HIV-associated lymphoma",135,"Upfront therapy",207,"m-BACOD",TRUE,"Cont.","1.Bleomycin;0.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Vincristine;7.Cytarabine;7.Cytarabine;0.Methotrexate;7.Cytarabine;1.Bleomycin;0.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Vincristine;7.Cytarabine;7.Cytarabine;0.Methotrexate;7.Cytarabine;","1.Bleomycin;0.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Vincristine;7.Cytarabine;7.Cytarabine;0.Methotrexate;7.Cytarabine;"
"1076","135.207.1891.2","Malignant Hematology","Aggressive lymphomas","HIV-associated lymphoma",135,"Upfront therapy",207,"m-BACOD",TRUE,"Cont.","1.Bleomycin;0.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Vincristine;7.Cytarabine;7.Methotrexate;6.Cytarabine;7.Cytarabine;1.Bleomycin;0.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Vincristine;7.Cytarabine;7.Methotrexate;6.Cytarabine;7.Cytarabine;","1.Bleomycin;0.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Vincristine;7.Cytarabine;7.Methotrexate;6.Cytarabine;7.Cytarabine;"
"1077","135.207.1892.1","Malignant Hematology","Aggressive lymphomas","HIV-associated lymphoma",135,"Upfront therapy",207,"R-CODOX-M",FALSE,"3","7.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Methotrexate;0.Rituximab;0.Vincristine;1.Cyclophosphamide;6.Vincristine;7.Methotrexate;7.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Methotrexate;0.Rituximab;0.Vincristine;1.Cyclophosphamide;6.Vincristine;7.Methotrexate;","7.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Methotrexate;0.Rituximab;0.Vincristine;1.Cyclophosphamide;6.Vincristine;7.Methotrexate;"
"1078","135.207.1892.2","Malignant Hematology","Aggressive lymphomas","HIV-associated lymphoma",135,"Upfront therapy",207,"R-CODOX-M",FALSE,"3","14.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Methotrexate;0.Rituximab;0.Vincristine;1.Cyclophosphamide;6.Vincristine;7.Methotrexate;14.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Methotrexate;0.Rituximab;0.Vincristine;1.Cyclophosphamide;6.Vincristine;7.Methotrexate;","14.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Methotrexate;0.Rituximab;0.Vincristine;1.Cyclophosphamide;6.Vincristine;7.Methotrexate;"
"1079","135.207.1893.1","Malignant Hematology","Aggressive lymphomas","HIV-associated lymphoma",135,"Upfront therapy",207,"R-CODOX-M/R-IVAC",NA,NA,"0.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Methotrexate;0.Rituximab;0.Vincristine;1.Cyclophosphamide;1.Cytarabine;19.Cytarabine;0.Etoposide;0.Ifosfamide;0.Rituximab;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;0.Methotrexate;17.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Methotrexate;0.Rituximab;0.Vincristine;1.Cyclophosphamide;1.Cytarabine;19.Cytarabine;0.Etoposide;0.Ifosfamide;0.Rituximab;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;0.Methotrexate;","0.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Methotrexate;0.Rituximab;0.Vincristine;1.Cyclophosphamide;1.Cytarabine;19.Cytarabine;0.Etoposide;0.Ifosfamide;0.Rituximab;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;0.Methotrexate;17.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Methotrexate;0.Rituximab;0.Vincristine;1.Cyclophosphamide;1.Cytarabine;19.Cytarabine;0.Etoposide;0.Ifosfamide;0.Rituximab;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;0.Methotrexate;"
"1080","135.207.1893.2","Malignant Hematology","Aggressive lymphomas","HIV-associated lymphoma",135,"Upfront therapy",207,"R-CODOX-M/R-IVAC",NA,NA,"0.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Methotrexate;0.Rituximab;0.Vincristine;1.Cyclophosphamide;1.Cytarabine;19.Cytarabine;0.Etoposide;0.Ifosfamide;0.Rituximab;1.Cytarabine;1.Cytarabine;2.Methotrexate;17.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Methotrexate;0.Rituximab;0.Vincristine;1.Cyclophosphamide;1.Cytarabine;19.Cytarabine;0.Etoposide;0.Ifosfamide;0.Rituximab;1.Cytarabine;1.Cytarabine;2.Methotrexate;","0.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Methotrexate;0.Rituximab;0.Vincristine;1.Cyclophosphamide;1.Cytarabine;19.Cytarabine;0.Etoposide;0.Ifosfamide;0.Rituximab;1.Cytarabine;1.Cytarabine;2.Methotrexate;17.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Methotrexate;0.Rituximab;0.Vincristine;1.Cyclophosphamide;1.Cytarabine;19.Cytarabine;0.Etoposide;0.Ifosfamide;0.Rituximab;1.Cytarabine;1.Cytarabine;2.Methotrexate;"
"1081","135.207.1894.1","Malignant Hematology","Aggressive lymphomas","HIV-associated lymphoma",135,"Upfront therapy",207,"R-EPOCH, dose-escalated",TRUE,"Cont.","17.Doxorubicin;0.Etoposide;0.Rituximab;0.Vincristine;4.Cyclophosphamide;17.Doxorubicin;0.Etoposide;0.Rituximab;0.Vincristine;4.Cyclophosphamide;","17.Doxorubicin;0.Etoposide;0.Rituximab;0.Vincristine;4.Cyclophosphamide;"
"1082","135.207.1894.2","Malignant Hematology","Aggressive lymphomas","HIV-associated lymphoma",135,"Upfront therapy",207,"R-EPOCH, dose-escalated",TRUE,"Cont.","17.Doxorubicin;0.Etoposide;0.Rituximab;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;17.Doxorubicin;0.Etoposide;0.Rituximab;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;","17.Doxorubicin;0.Etoposide;0.Rituximab;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;"
"1083","135.207.1895.1","Malignant Hematology","Aggressive lymphomas","HIV-associated lymphoma",135,"Upfront therapy",207,"SC-EPOCH-RR",TRUE,"Cont.","17.Doxorubicin;0.Etoposide;0.Methotrexate;0.Rituximab;0.Vincristine;4.Cyclophosphamide;0.Methotrexate;0.Rituximab;17.Doxorubicin;0.Etoposide;0.Methotrexate;0.Rituximab;0.Vincristine;4.Cyclophosphamide;0.Methotrexate;0.Rituximab;","17.Doxorubicin;0.Etoposide;0.Methotrexate;0.Rituximab;0.Vincristine;4.Cyclophosphamide;0.Methotrexate;0.Rituximab;"
"1084","135.207.1895.2","Malignant Hematology","Aggressive lymphomas","HIV-associated lymphoma",135,"Upfront therapy",207,"SC-EPOCH-RR",TRUE,"Cont.","17.Doxorubicin;0.Etoposide;0.Methotrexate;0.Rituximab;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Methotrexate;0.Rituximab;0.Vincristine;17.Doxorubicin;0.Etoposide;0.Methotrexate;0.Rituximab;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Methotrexate;0.Rituximab;0.Vincristine;","17.Doxorubicin;0.Etoposide;0.Methotrexate;0.Rituximab;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Methotrexate;0.Rituximab;0.Vincristine;"
"1085","135.207.1895.3","Malignant Hematology","Aggressive lymphomas","HIV-associated lymphoma",135,"Upfront therapy",207,"SC-EPOCH-RR",TRUE,"Cont.","17.Doxorubicin;0.Etoposide;0.Rituximab;0.Vincristine;4.Cyclophosphamide;0.Rituximab;17.Doxorubicin;0.Etoposide;0.Rituximab;0.Vincristine;4.Cyclophosphamide;0.Rituximab;","17.Doxorubicin;0.Etoposide;0.Rituximab;0.Vincristine;4.Cyclophosphamide;0.Rituximab;"
"1086","135.207.1895.4","Malignant Hematology","Aggressive lymphomas","HIV-associated lymphoma",135,"Upfront therapy",207,"SC-EPOCH-RR",TRUE,"Cont.","17.Doxorubicin;0.Etoposide;0.Rituximab;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Rituximab;0.Vincristine;17.Doxorubicin;0.Etoposide;0.Rituximab;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Rituximab;0.Vincristine;","17.Doxorubicin;0.Etoposide;0.Rituximab;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Rituximab;0.Vincristine;"
"1087","135.207.1896.1","Malignant Hematology","Aggressive lymphomas","HIV-associated lymphoma",135,"Upfront therapy",207,"Stanford V",FALSE,"1","0.Doxorubicin;0.Mechlorethamine;0.Vinblastine;1.Bleomycin;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vinblastine;1.Bleomycin;0.Vincristine;1.Doxorubicin;0.Mechlorethamine;0.Vinblastine;1.Bleomycin;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vinblastine;1.Bleomycin;0.Vincristine;1.Doxorubicin;0.Mechlorethamine;0.Vinblastine;1.Bleomycin;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vinblastine;1.Bleomycin;0.Vincristine;","0.Doxorubicin;0.Mechlorethamine;0.Vinblastine;1.Bleomycin;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vinblastine;1.Bleomycin;0.Vincristine;1.Doxorubicin;0.Mechlorethamine;0.Vinblastine;1.Bleomycin;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vinblastine;1.Bleomycin;0.Vincristine;1.Doxorubicin;0.Mechlorethamine;0.Vinblastine;1.Bleomycin;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vinblastine;1.Bleomycin;0.Vincristine;"
"1088","136.176.1918.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Relapsed or refractory, all lines of therapy",176,"BeGEV",FALSE,"4","18.Gemcitabine;0.Vinorelbine;1.Bendamustine;1.Bendamustine;1.Gemcitabine;18.Gemcitabine;0.Vinorelbine;1.Bendamustine;1.Bendamustine;1.Gemcitabine;","18.Gemcitabine;0.Vinorelbine;1.Bendamustine;1.Bendamustine;1.Gemcitabine;"
"1089","136.176.1919.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Relapsed or refractory, all lines of therapy",176,"Bendamustine monotherapy",TRUE,"Cont.","27.Bendamustine;1.Bendamustine;27.Bendamustine;1.Bendamustine;","27.Bendamustine;1.Bendamustine;"
"1090","136.176.1920.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Relapsed or refractory, all lines of therapy",176,"Bendamustine & Brentuximab vedotin",TRUE,"Cont.","20.Bendamustine;0.Brentuximabvedotin;1.Bendamustine;20.Bendamustine;0.Brentuximabvedotin;1.Bendamustine;","20.Bendamustine;0.Brentuximabvedotin;1.Bendamustine;"
"1091","136.176.1921.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Relapsed or refractory, all lines of therapy",176,"Brentuximab vedotin monotherapy",TRUE,"Cont.","28.Brentuximabvedotin;28.Brentuximabvedotin;","28.Brentuximabvedotin;28.Brentuximabvedotin;"
"1092","136.176.1922.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Relapsed or refractory, all lines of therapy",176,"Brentuximab vedotin & Nivolumab",TRUE,"Cont.","14.Brentuximabvedotin;7.Nivolumab;14.Brentuximabvedotin;7.Nivolumab;","14.Brentuximabvedotin;7.Nivolumab;"
"1093","136.176.1922.2","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Relapsed or refractory, all lines of therapy",176,"Brentuximab vedotin & Nivolumab",TRUE,"Cont.","21.Brentuximabvedotin;0.Nivolumab;21.Brentuximabvedotin;0.Nivolumab;","21.Brentuximabvedotin;0.Nivolumab;"
"1094","136.176.1923.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Relapsed or refractory, all lines of therapy",176,"Camrelizumab monotherapy",TRUE,"Cont.","14.Camrelizumab;14.Camrelizumab;","14.Camrelizumab;14.Camrelizumab;"
"1095","136.176.1924.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Relapsed or refractory, all lines of therapy",176,"DexaBEAM",FALSE,"2","23.Carmustine;2.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;","23.Carmustine;2.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;"
"1096","136.176.1927.2","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Relapsed or refractory, all lines of therapy",176,"ESHAP",FALSE,"3","28.Cisplatin;28.Cisplatin;","28.Cisplatin;28.Cisplatin;"
"1097","136.176.1927.3","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Relapsed or refractory, all lines of therapy",176,"ESHAP",FALSE,"3","17.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Cytarabine;17.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Cytarabine;","17.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Cytarabine;"
"1098","136.176.1927.4","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Relapsed or refractory, all lines of therapy",176,"ESHAP",FALSE,"3","24.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Cytarabine;24.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Cytarabine;","24.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Cytarabine;"
"1099","136.176.1928.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Relapsed or refractory, all lines of therapy",176,"GCD",TRUE,"Cont.","14.Carboplatin;0.Gemcitabine;7.Gemcitabine;14.Carboplatin;0.Gemcitabine;7.Gemcitabine;","14.Carboplatin;0.Gemcitabine;7.Gemcitabine;"
"1100","136.176.1929.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Relapsed or refractory, all lines of therapy",176,"GCD-R",TRUE,"Cont.","14.Carboplatin;0.Gemcitabine;7.Gemcitabine;0.Rituximab;14.Carboplatin;0.Gemcitabine;7.Gemcitabine;0.Rituximab;","14.Carboplatin;0.Gemcitabine;7.Gemcitabine;0.Rituximab;"
"1101","136.176.1930.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Relapsed or refractory, all lines of therapy",176,"Gemcitabine & Rituximab",TRUE,"Cont.","14.Gemcitabine;0.Rituximab;7.Gemcitabine;0.Rituximab;7.Rituximab;14.Gemcitabine;0.Rituximab;7.Gemcitabine;0.Rituximab;7.Rituximab;","14.Gemcitabine;0.Rituximab;7.Gemcitabine;0.Rituximab;7.Rituximab;"
"1102","136.176.1931.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Relapsed or refractory, all lines of therapy",176,"GVD",TRUE,"Cont.","14.Gemcitabine;0.Pegylatedliposomaldoxorubicin;0.Vinorelbine;7.Gemcitabine;0.Pegylatedliposomaldoxorubicin;0.Vinorelbine;14.Gemcitabine;0.Pegylatedliposomaldoxorubicin;0.Vinorelbine;7.Gemcitabine;0.Pegylatedliposomaldoxorubicin;0.Vinorelbine;","14.Gemcitabine;0.Pegylatedliposomaldoxorubicin;0.Vinorelbine;7.Gemcitabine;0.Pegylatedliposomaldoxorubicin;0.Vinorelbine;"
"1103","136.176.1932.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Relapsed or refractory, all lines of therapy",176,"GVP",FALSE,"4","21.Gemcitabine;0.Vinorelbine;7.Gemcitabine;0.Vinorelbine;21.Gemcitabine;0.Vinorelbine;7.Gemcitabine;0.Vinorelbine;","21.Gemcitabine;0.Vinorelbine;7.Gemcitabine;0.Vinorelbine;"
"1104","136.176.1933.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Relapsed or refractory, all lines of therapy",176,"ICE",FALSE,"2","12.Etoposide;1.Carboplatin;0.Etoposide;0.Ifosfamide;1.Etoposide;","12.Etoposide;1.Carboplatin;0.Etoposide;0.Ifosfamide;1.Etoposide;"
"1105","136.176.1933.2","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Relapsed or refractory, all lines of therapy",176,"ICE",FALSE,"2","12.Etoposide;1.Carboplatin;0.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;","12.Etoposide;1.Carboplatin;0.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;"
"1106","136.176.1933.3","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Relapsed or refractory, all lines of therapy",176,"ICE",FALSE,"2","12.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Carboplatin;0.Ifosfamide;","12.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Carboplatin;0.Ifosfamide;"
"1107","136.176.1934.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Relapsed or refractory, all lines of therapy",176,"Ifosfamide & Vinorelbine",TRUE,"Cont.","17.Ifosfamide;0.Vinorelbine;4.Vinorelbine;17.Ifosfamide;0.Vinorelbine;4.Vinorelbine;","17.Ifosfamide;0.Vinorelbine;4.Vinorelbine;"
"1108","136.176.1934.2","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Relapsed or refractory, all lines of therapy",176,"Ifosfamide & Vinorelbine",TRUE,"Cont.","17.Ifosfamide;0.Vinorelbine;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;0.Vinorelbine;17.Ifosfamide;0.Vinorelbine;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;0.Vinorelbine;","17.Ifosfamide;0.Vinorelbine;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;0.Vinorelbine;"
"1109","136.176.1935.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Relapsed or refractory, all lines of therapy",176,"IGEV",FALSE,"4","18.Gemcitabine;0.Ifosfamide;0.Vinorelbine;1.Ifosfamide;1.Ifosfamide;1.Gemcitabine;0.Ifosfamide;18.Gemcitabine;0.Ifosfamide;0.Vinorelbine;1.Ifosfamide;1.Ifosfamide;1.Gemcitabine;0.Ifosfamide;","18.Gemcitabine;0.Ifosfamide;0.Vinorelbine;1.Ifosfamide;1.Ifosfamide;1.Gemcitabine;0.Ifosfamide;"
"1110","136.176.1936.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Relapsed or refractory, all lines of therapy",176,"MINE",TRUE,"Cont.","19.Etoposide;0.Ifosfamide;0.Mitoxantrone;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;19.Etoposide;0.Ifosfamide;0.Mitoxantrone;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;","19.Etoposide;0.Ifosfamide;0.Mitoxantrone;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;"
"1111","136.176.1936.2","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Relapsed or refractory, all lines of therapy",176,"MINE",TRUE,"Cont.","26.Etoposide;0.Ifosfamide;0.Mitoxantrone;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;26.Etoposide;0.Ifosfamide;0.Mitoxantrone;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;","26.Etoposide;0.Ifosfamide;0.Mitoxantrone;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;"
"1112","136.176.1937.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Relapsed or refractory, all lines of therapy",176,"Mini-BEAM",TRUE,"Cont.","28.Carmustine;0.Cytarabine;0.Etoposide;0.Melphalan;28.Carmustine;0.Cytarabine;0.Etoposide;0.Melphalan;","28.Carmustine;0.Cytarabine;0.Etoposide;0.Melphalan;"
"1113","136.176.1937.2","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Relapsed or refractory, all lines of therapy",176,"Mini-BEAM",TRUE,"Cont.","23.Carmustine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Melphalan;23.Carmustine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Melphalan;","23.Carmustine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Melphalan;"
"1114","136.176.1937.3","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Relapsed or refractory, all lines of therapy",176,"Mini-BEAM",TRUE,"Cont.","30.Carmustine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Melphalan;30.Carmustine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Melphalan;","30.Carmustine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Melphalan;"
"1115","136.176.1937.4","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Relapsed or refractory, all lines of therapy",176,"Mini-BEAM",TRUE,"Cont.","37.Carmustine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Melphalan;37.Carmustine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Melphalan;","37.Carmustine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Melphalan;"
"1116","136.176.1938.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Relapsed or refractory, all lines of therapy",176,"Nivolumab monotherapy",TRUE,"Cont.","14.Nivolumab;14.Nivolumab;","14.Nivolumab;14.Nivolumab;"
"1117","136.176.1938.2","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Relapsed or refractory, all lines of therapy",176,"Nivolumab monotherapy",TRUE,"Cont.","21.Nivolumab;21.Nivolumab;","21.Nivolumab;21.Nivolumab;"
"1118","136.176.1939.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Relapsed or refractory, all lines of therapy",176,"O-ESHAP",NA,NA,"0.Cisplatin;0.Etoposide;0.Ofatumumab;1.Etoposide;1.Etoposide;1.Etoposide;1.Cytarabine;17.Cisplatin;0.Etoposide;0.Ofatumumab;1.Etoposide;1.Etoposide;1.Etoposide;1.Cytarabine;17.Cisplatin;0.Etoposide;0.Ofatumumab;1.Etoposide;1.Etoposide;1.Etoposide;1.Cytarabine;","0.Cisplatin;0.Etoposide;0.Ofatumumab;1.Etoposide;1.Etoposide;1.Etoposide;1.Cytarabine;17.Cisplatin;0.Etoposide;0.Ofatumumab;1.Etoposide;1.Etoposide;1.Etoposide;1.Cytarabine;17.Cisplatin;0.Etoposide;0.Ofatumumab;1.Etoposide;1.Etoposide;1.Etoposide;1.Cytarabine;"
"1119","136.176.1939.2","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Relapsed or refractory, all lines of therapy",176,"O-ESHAP",NA,NA,"0.Cisplatin;0.Etoposide;0.Ofatumumab;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Cytarabine;17.Cisplatin;0.Etoposide;0.Ofatumumab;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Cytarabine;17.Cisplatin;0.Etoposide;0.Ofatumumab;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Cytarabine;","0.Cisplatin;0.Etoposide;0.Ofatumumab;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Cytarabine;17.Cisplatin;0.Etoposide;0.Ofatumumab;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Cytarabine;17.Cisplatin;0.Etoposide;0.Ofatumumab;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Cytarabine;"
"1120","136.176.1940.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Relapsed or refractory, all lines of therapy",176,"Penpulimab monotherapy",TRUE,"Cont.","14.Penpulimab;14.Penpulimab;","14.Penpulimab;14.Penpulimab;"
"1121","136.176.1941.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Relapsed or refractory, all lines of therapy",176,"Rituximab monotherapy",FALSE,"1","0.Rituximab;7.Rituximab;7.Rituximab;7.Rituximab;7.Rituximab;7.Rituximab;","0.Rituximab;7.Rituximab;7.Rituximab;7.Rituximab;7.Rituximab;7.Rituximab;"
"1122","136.176.1942.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Relapsed or refractory, all lines of therapy",176,"Sintilimab monotherapy",TRUE,"Cont.","21.Sintilimab;21.Sintilimab;","21.Sintilimab;21.Sintilimab;"
"1123","136.176.1943.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Relapsed or refractory, all lines of therapy",176,"Tislelizumab monotherapy",TRUE,"Cont.","21.Tislelizumab;21.Tislelizumab;","21.Tislelizumab;21.Tislelizumab;"
"1124","136.176.1944.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Relapsed or refractory, all lines of therapy",176,"Vinblastine monotherapy",TRUE,"Cont.","7.Vinblastine;7.Vinblastine;","7.Vinblastine;7.Vinblastine;"
"1125","136.176.1944.2","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Relapsed or refractory, all lines of therapy",176,"Vinblastine monotherapy",TRUE,"Cont.","14.Vinblastine;14.Vinblastine;","14.Vinblastine;14.Vinblastine;"
"1126","136.176.1945.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Relapsed or refractory, all lines of therapy",176,"Zimberelimab monotherapy",TRUE,"Cont.","14.Zimberelimab;14.Zimberelimab;","14.Zimberelimab;14.Zimberelimab;"
"1127","136.176.1950.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Relapsed or refractory, all lines of therapy",176,"Fludarabine, Melphalan, Alemtuzumab, then allo HSCT",FALSE,"1","0.Fludarabine;1.Fludarabine;1.Fludarabine;1.Fludarabine;1.Fludarabine;1.Melphalan;","0.Fludarabine;1.Fludarabine;1.Fludarabine;1.Fludarabine;1.Fludarabine;1.Melphalan;"
"1128","136.176.1951.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Relapsed or refractory, all lines of therapy",176,"Pembrolizumab monotherapy",TRUE,"Cont.","21.Pembrolizumab;21.Pembrolizumab;","21.Pembrolizumab;21.Pembrolizumab;"
"1129","136.196.1907.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Untreated, advanced stage",196,"ABVD, DD-DI",FALSE,"6","11.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Vincristine;10.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Vincristine;11.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Vincristine;10.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Vincristine;","11.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Vincristine;10.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Vincristine;"
"1130","136.196.1908.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Untreated, advanced stage",196,"BEACOPP-14",FALSE,"8","7.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Procarbazine;1.Etoposide;0.Procarbazine;1.Etoposide;0.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Bleomycin;0.Vincristine;7.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Procarbazine;1.Etoposide;0.Procarbazine;1.Etoposide;0.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Bleomycin;0.Vincristine;","7.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Procarbazine;1.Etoposide;0.Procarbazine;1.Etoposide;0.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Bleomycin;0.Vincristine;"
"1131","136.196.1909.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Untreated, advanced stage",196,"C-MOPP/ABV",FALSE,"8","21.Cyclophosphamide;0.Procarbazine;0.Vincristine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Bleomycin;0.Doxorubicin;0.Vinblastine;21.Cyclophosphamide;0.Procarbazine;0.Vincristine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Bleomycin;0.Doxorubicin;0.Vinblastine;","21.Cyclophosphamide;0.Procarbazine;0.Vincristine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Bleomycin;0.Doxorubicin;0.Vinblastine;"
"1132","136.196.1910.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Untreated, advanced stage",196,"MOPP",TRUE,"Cont.","15.Mechlorethamine;0.Procarbazine;0.Vincristine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Mechlorethamine;0.Procarbazine;0.Vincristine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;15.Mechlorethamine;0.Procarbazine;0.Vincristine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Mechlorethamine;0.Procarbazine;0.Vincristine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;","15.Mechlorethamine;0.Procarbazine;0.Vincristine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Mechlorethamine;0.Procarbazine;0.Vincristine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;"
"1133","136.196.1910.2","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Untreated, advanced stage",196,"MOPP",TRUE,"Cont.","19.Mechlorethamine;0.Procarbazine;0.Vincristine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Mechlorethamine;0.Procarbazine;0.Vincristine;1.Procarbazine;1.Procarbazine;19.Mechlorethamine;0.Procarbazine;0.Vincristine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Mechlorethamine;0.Procarbazine;0.Vincristine;1.Procarbazine;1.Procarbazine;","19.Mechlorethamine;0.Procarbazine;0.Vincristine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Mechlorethamine;0.Procarbazine;0.Vincristine;1.Procarbazine;1.Procarbazine;"
"1134","136.196.1911.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Untreated, advanced stage",196,"RABVD",NA,NA,"0.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;","0.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;"
"1135","136.196.1911.2","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Untreated, advanced stage",196,"RABVD",NA,NA,"0.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;","0.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;"
"1136","136.196.1911.3","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Untreated, advanced stage",196,"RABVD",NA,NA,"0.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;","0.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;"
"1137","136.196.1911.4","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Untreated, advanced stage",196,"RABVD",NA,NA,"0.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;","0.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;"
"1138","136.196.1911.5","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Untreated, advanced stage",196,"RABVD",NA,NA,"0.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;","0.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;"
"1139","136.196.1911.6","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Untreated, advanced stage",196,"RABVD",NA,NA,"0.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;","0.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;28.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;"
"1140","136.196.1912.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Untreated, advanced stage",196,"VEBEP",FALSE,"8","20.Bleomycin;0.Cyclophosphamide;0.Epirubicin;0.Etoposide;1.Cyclophosphamide;0.Epirubicin;0.Etoposide;20.Bleomycin;0.Cyclophosphamide;0.Epirubicin;0.Etoposide;1.Cyclophosphamide;0.Epirubicin;0.Etoposide;","20.Bleomycin;0.Cyclophosphamide;0.Epirubicin;0.Etoposide;1.Cyclophosphamide;0.Epirubicin;0.Etoposide;"
"1141","136.197.1897.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Untreated, early-stage favorable (ESF)",197,"ABVD",TRUE,"Cont.","14.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Vinblastine;14.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Vinblastine;14.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Vinblastine;14.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Vinblastine;","14.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Vinblastine;"
"1142","136.197.1898.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Untreated, early-stage favorable (ESF)",197,"AVD",TRUE,"Cont.","14.Dacarbazine;0.Doxorubicin;0.Vinblastine;14.Dacarbazine;0.Doxorubicin;0.Vinblastine;14.Dacarbazine;0.Doxorubicin;0.Vinblastine;14.Dacarbazine;0.Doxorubicin;0.Vinblastine;","14.Dacarbazine;0.Doxorubicin;0.Vinblastine;"
"1143","136.197.1899.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Untreated, early-stage favorable (ESF)",197,"MOPP-ABV",TRUE,"Cont.","21.Mechlorethamine;0.Procarbazine;0.Vincristine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Bleomycin;0.Doxorubicin;0.Vinblastine;21.Mechlorethamine;0.Procarbazine;0.Vincristine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Bleomycin;0.Doxorubicin;0.Vinblastine;","21.Mechlorethamine;0.Procarbazine;0.Vincristine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Bleomycin;0.Doxorubicin;0.Vinblastine;"
"1144","136.197.1900.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Untreated, early-stage favorable (ESF)",197,"Stanford V",FALSE,"1","0.Doxorubicin;0.Mechlorethamine;0.Vinblastine;1.Bleomycin;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vinblastine;1.Bleomycin;0.Vincristine;1.Doxorubicin;0.Mechlorethamine;0.Vinblastine;1.Bleomycin;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vinblastine;1.Bleomycin;0.Vincristine;","0.Doxorubicin;0.Mechlorethamine;0.Vinblastine;1.Bleomycin;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vinblastine;1.Bleomycin;0.Vincristine;1.Doxorubicin;0.Mechlorethamine;0.Vinblastine;1.Bleomycin;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vinblastine;1.Bleomycin;0.Vincristine;"
"1145","136.198.1901.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Untreated, early-stage unfavorable (ESU)",198,"A-AVD",FALSE,"4","14.Brentuximabvedotin;0.Dacarbazine;0.Doxorubicin;0.Vinblastine;14.Brentuximabvedotin;0.Dacarbazine;0.Doxorubicin;0.Vinblastine;14.Brentuximabvedotin;0.Dacarbazine;0.Doxorubicin;0.Vinblastine;14.Brentuximabvedotin;0.Dacarbazine;0.Doxorubicin;0.Vinblastine;","14.Brentuximabvedotin;0.Dacarbazine;0.Doxorubicin;0.Vinblastine;"
"1146","136.198.1902.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Untreated, early-stage unfavorable (ESU)",198,"BEACOPP",FALSE,"4","14.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Procarbazine;1.Etoposide;0.Procarbazine;1.Etoposide;0.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Bleomycin;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Procarbazine;1.Etoposide;0.Procarbazine;1.Etoposide;0.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Bleomycin;0.Vincristine;","14.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Procarbazine;1.Etoposide;0.Procarbazine;1.Etoposide;0.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Bleomycin;0.Vincristine;"
"1147","136.198.1903.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Untreated, early-stage unfavorable (ESU)",198,"eBEACOPP",FALSE,"2","14.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Procarbazine;1.Etoposide;0.Procarbazine;1.Etoposide;0.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Bleomycin;0.Vincristine;","14.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Procarbazine;1.Etoposide;0.Procarbazine;1.Etoposide;0.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Bleomycin;0.Vincristine;"
"1148","136.198.1904.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Untreated, early-stage unfavorable (ESU)",198,"EBVP",FALSE,"6","21.Bleomycin;0.Epirubicin;0.Vinblastine;21.Bleomycin;0.Epirubicin;0.Vinblastine;","21.Bleomycin;0.Epirubicin;0.Vinblastine;"
"1149","136.198.1905.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Untreated, early-stage unfavorable (ESU)",198,"RABVD",TRUE,"Cont.","14.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;14.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Vinblastine;14.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;14.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Vinblastine;","14.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;14.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Vinblastine;"
"1150","136.198.1905.2","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Untreated, early-stage unfavorable (ESU)",198,"RABVD",TRUE,"Cont.","7.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;7.Rituximab;7.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;7.Rituximab;7.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;7.Rituximab;7.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;7.Rituximab;","7.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Rituximab;0.Vinblastine;7.Rituximab;"
"1151","136.198.1906.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Untreated, early-stage unfavorable (ESU)",198,"Stanford V",FALSE,"3","7.Doxorubicin;0.Mechlorethamine;0.Vinblastine;7.Bleomycin;0.Vincristine;7.Doxorubicin;0.Etoposide;0.Vinblastine;1.Etoposide;6.Bleomycin;0.Vincristine;7.Doxorubicin;0.Mechlorethamine;0.Vinblastine;7.Bleomycin;0.Vincristine;7.Doxorubicin;0.Etoposide;0.Vinblastine;1.Etoposide;6.Bleomycin;0.Vincristine;","7.Doxorubicin;0.Mechlorethamine;0.Vinblastine;7.Bleomycin;0.Vincristine;7.Doxorubicin;0.Etoposide;0.Vinblastine;1.Etoposide;6.Bleomycin;0.Vincristine;"
"1152","136.199.1913.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Untreated, elderly",199,"Brentuximab vedotin & Dacarbazine",TRUE,"Cont.","21.Brentuximabvedotin;0.Dacarbazine;21.Brentuximabvedotin;0.Dacarbazine;","21.Brentuximabvedotin;0.Dacarbazine;"
"1153","136.199.1914.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Untreated, elderly",199,"ChlVPP",TRUE,"Cont.","15.Chlorambucil;0.Procarbazine;0.Vinblastine;1.Chlorambucil;0.Procarbazine;1.Chlorambucil;0.Procarbazine;1.Chlorambucil;0.Procarbazine;1.Chlorambucil;0.Procarbazine;1.Chlorambucil;0.Procarbazine;1.Chlorambucil;0.Procarbazine;1.Chlorambucil;0.Procarbazine;0.Vinblastine;1.Chlorambucil;0.Procarbazine;1.Chlorambucil;0.Procarbazine;1.Chlorambucil;0.Procarbazine;1.Chlorambucil;0.Procarbazine;1.Chlorambucil;0.Procarbazine;1.Chlorambucil;0.Procarbazine;15.Chlorambucil;0.Procarbazine;0.Vinblastine;1.Chlorambucil;0.Procarbazine;1.Chlorambucil;0.Procarbazine;1.Chlorambucil;0.Procarbazine;1.Chlorambucil;0.Procarbazine;1.Chlorambucil;0.Procarbazine;1.Chlorambucil;0.Procarbazine;1.Chlorambucil;0.Procarbazine;0.Vinblastine;1.Chlorambucil;0.Procarbazine;1.Chlorambucil;0.Procarbazine;1.Chlorambucil;0.Procarbazine;1.Chlorambucil;0.Procarbazine;1.Chlorambucil;0.Procarbazine;1.Chlorambucil;0.Procarbazine;","15.Chlorambucil;0.Procarbazine;0.Vinblastine;1.Chlorambucil;0.Procarbazine;1.Chlorambucil;0.Procarbazine;1.Chlorambucil;0.Procarbazine;1.Chlorambucil;0.Procarbazine;1.Chlorambucil;0.Procarbazine;1.Chlorambucil;0.Procarbazine;1.Chlorambucil;0.Procarbazine;0.Vinblastine;1.Chlorambucil;0.Procarbazine;1.Chlorambucil;0.Procarbazine;1.Chlorambucil;0.Procarbazine;1.Chlorambucil;0.Procarbazine;1.Chlorambucil;0.Procarbazine;1.Chlorambucil;0.Procarbazine;"
"1154","136.199.1915.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Untreated, elderly",199,"ChlVPP/EVA",FALSE,"6","21.Chlorambucil;0.Etoposide;0.Procarbazine;0.Vincristine;1.Chlorambucil;0.Etoposide;0.Procarbazine;1.Chlorambucil;0.Etoposide;0.Procarbazine;1.Chlorambucil;0.Etoposide;0.Procarbazine;1.Chlorambucil;0.Etoposide;0.Procarbazine;1.Chlorambucil;0.Procarbazine;1.Chlorambucil;0.Procarbazine;1.Doxorubicin;0.Vinblastine;21.Chlorambucil;0.Etoposide;0.Procarbazine;0.Vincristine;1.Chlorambucil;0.Etoposide;0.Procarbazine;1.Chlorambucil;0.Etoposide;0.Procarbazine;1.Chlorambucil;0.Etoposide;0.Procarbazine;1.Chlorambucil;0.Etoposide;0.Procarbazine;1.Chlorambucil;0.Procarbazine;1.Chlorambucil;0.Procarbazine;1.Doxorubicin;0.Vinblastine;","21.Chlorambucil;0.Etoposide;0.Procarbazine;0.Vincristine;1.Chlorambucil;0.Etoposide;0.Procarbazine;1.Chlorambucil;0.Etoposide;0.Procarbazine;1.Chlorambucil;0.Etoposide;0.Procarbazine;1.Chlorambucil;0.Etoposide;0.Procarbazine;1.Chlorambucil;0.Procarbazine;1.Chlorambucil;0.Procarbazine;1.Doxorubicin;0.Vinblastine;"
"1155","136.199.1916.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Untreated, elderly",199,"PVAG",TRUE,"Cont.","21.Doxorubicin;0.Gemcitabine;0.Vinblastine;21.Doxorubicin;0.Gemcitabine;0.Vinblastine;","21.Doxorubicin;0.Gemcitabine;0.Vinblastine;"
"1156","136.199.1917.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Untreated, elderly",199,"VEPEMB",TRUE,"Cont.","10.Cyclophosphamide;0.Procarbazine;0.Vinblastine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;10.Bleomycin;0.Etoposide;0.Mitoxantrone;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;10.Cyclophosphamide;0.Procarbazine;0.Vinblastine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;10.Bleomycin;0.Etoposide;0.Mitoxantrone;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;","10.Cyclophosphamide;0.Procarbazine;0.Vinblastine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;10.Bleomycin;0.Etoposide;0.Mitoxantrone;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;"
"1157","136.199.1924.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Untreated, elderly",199,"DexaBEAM",FALSE,"2","24.Melphalan;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;","24.Melphalan;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"1158","136.199.1925.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Untreated, elderly",199,"DHAP",TRUE,"Cont.","20.Cisplatin;1.Cytarabine;20.Cisplatin;1.Cytarabine;","20.Cisplatin;1.Cytarabine;"
"1159","136.199.1925.2","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Untreated, elderly",199,"DHAP",TRUE,"Cont.","27.Cisplatin;1.Cytarabine;27.Cisplatin;1.Cytarabine;","27.Cisplatin;1.Cytarabine;"
"1160","136.199.1926.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Untreated, elderly",199,"DHAP - time intensified",TRUE,"Cont.","13.Cisplatin;1.Cytarabine;13.Cisplatin;1.Cytarabine;","13.Cisplatin;1.Cytarabine;"
"1161","136.199.1927.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Untreated, elderly",199,"ESHAP",FALSE,"3","17.Cisplatin;0.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Cytarabine;17.Cisplatin;0.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Cytarabine;","17.Cisplatin;0.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Cytarabine;"
"1162","136.199.1927.2","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Untreated, elderly",199,"ESHAP",FALSE,"3","24.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Cytarabine;24.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Cytarabine;","24.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Cytarabine;"
"1163","136.41.1946.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Consolidation after salvage therapy",41,"CBV, then auto HSCT",FALSE,"1","0.Carmustine;0.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;","0.Carmustine;0.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;"
"1164","136.41.1946.2","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Consolidation after salvage therapy",41,"CBV, then auto HSCT",FALSE,"1","0.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;1.Carmustine;","0.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;1.Carmustine;"
"1165","136.41.1947.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Consolidation after salvage therapy",41,"CBV-Mx, then auto HSCT",FALSE,"1","0.Mitoxantrone;1.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;0.Etoposide;1.Carmustine;0.Cyclophosphamide;0.Etoposide;","0.Mitoxantrone;1.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;0.Etoposide;1.Carmustine;0.Cyclophosphamide;0.Etoposide;"
"1166","136.41.1948.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Consolidation after salvage therapy",41,"Flu-Mel, then allo HSCT",FALSE,"1","0.Fludarabine;1.ATG;0.Fludarabine;1.ATG;0.Fludarabine;0.Melphalan;1.ATG;0.Fludarabine;0.Melphalan;","0.Fludarabine;1.ATG;0.Fludarabine;1.ATG;0.Fludarabine;0.Melphalan;1.ATG;0.Fludarabine;0.Melphalan;"
"1167","136.41.1949.1","Malignant Hematology","Aggressive lymphomas","Hodgkin lymphoma",136,"Consolidation after salvage therapy",41,"Flu-Mel, then allo HSCT",FALSE,"1","0.Fludarabine;1.Fludarabine;1.Fludarabine;1.Fludarabine;1.ATG;0.Fludarabine;1.ATG;0.Melphalan;1.ATG;0.Melphalan;","0.Fludarabine;1.Fludarabine;1.Fludarabine;1.Fludarabine;1.ATG;0.Fludarabine;1.ATG;0.Melphalan;1.ATG;0.Melphalan;"
"1168","137.114.1975.1","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"Maintenance after first-line therapy",114,"Bortezomib monotherapy",TRUE,"Cont.","74.Bortezomib;3.Bortezomib;4.Bortezomib;3.Bortezomib;74.Bortezomib;3.Bortezomib;4.Bortezomib;3.Bortezomib;","74.Bortezomib;3.Bortezomib;4.Bortezomib;3.Bortezomib;"
"1169","137.114.1985.1","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"Maintenance after first-line therapy",114,"Ibrutinib & Rituximab",NA,NA,"0.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;","0.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;"
"1170","137.180.1981.1","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"Relapsed or refractory, non-randomized or retrospective data",180,"Arsenic trioxide & Chlorambucil",TRUE,"Cont.","1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;1.Arsenictrioxide;0.Chlorambucil;","1.Arsenictrioxide;0.Chlorambucil;"
"1171","137.180.1982.1","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"Relapsed or refractory, non-randomized or retrospective data",180,"BeRT",TRUE,"Cont.","14.Bendamustine;0.Rituximab;0.Temsirolimus;1.Bendamustine;6.Temsirolimus;7.Temsirolimus;14.Bendamustine;0.Rituximab;0.Temsirolimus;1.Bendamustine;6.Temsirolimus;7.Temsirolimus;","14.Bendamustine;0.Rituximab;0.Temsirolimus;1.Bendamustine;6.Temsirolimus;7.Temsirolimus;"
"1172","137.180.1983.1","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"Relapsed or refractory, non-randomized or retrospective data",180,"BDR",FALSE,"6","11.Bortezomib;0.Rituximab;3.Bortezomib;4.Bortezomib;3.Bortezomib;11.Bortezomib;0.Rituximab;3.Bortezomib;4.Bortezomib;3.Bortezomib;","11.Bortezomib;0.Rituximab;3.Bortezomib;4.Bortezomib;3.Bortezomib;"
"1173","137.180.1984.1","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"Relapsed or refractory, non-randomized or retrospective data",180,"Brexucabtagene autoleucel monotherapy",FALSE,"1","0.Brexucabtageneautoleucel;","0.Brexucabtageneautoleucel;0.Brexucabtageneautoleucel;"
"1174","137.180.1989.1","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"Relapsed or refractory, non-randomized or retrospective data",180,"Pirtobrutinib monotherapy",TRUE,"Cont.","1.Pirtobrutinib;1.Pirtobrutinib;1.Pirtobrutinib;1.Pirtobrutinib;1.Pirtobrutinib;1.Pirtobrutinib;1.Pirtobrutinib;1.Pirtobrutinib;1.Pirtobrutinib;1.Pirtobrutinib;1.Pirtobrutinib;1.Pirtobrutinib;1.Pirtobrutinib;1.Pirtobrutinib;","1.Pirtobrutinib;1.Pirtobrutinib;"
"1175","137.180.1990.1","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"Relapsed or refractory, non-randomized or retrospective data",180,"R-BL",TRUE,"Cont.","15.Lenalidomide;0.Rituximab;1.Bendamustine;0.Lenalidomide;1.Bendamustine;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;15.Lenalidomide;0.Rituximab;1.Bendamustine;0.Lenalidomide;1.Bendamustine;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","15.Lenalidomide;0.Rituximab;1.Bendamustine;0.Lenalidomide;1.Bendamustine;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1176","137.180.1990.2","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"Relapsed or refractory, non-randomized or retrospective data",180,"R-BL",TRUE,"Cont.","15.Lenalidomide;1.Bendamustine;0.Lenalidomide;1.Bendamustine;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;15.Lenalidomide;1.Bendamustine;0.Lenalidomide;1.Bendamustine;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","15.Lenalidomide;1.Bendamustine;0.Lenalidomide;1.Bendamustine;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1177","137.180.1991.1","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"Relapsed or refractory, non-randomized or retrospective data",180,"RT-PEPC",NA,NA,"0.Cyclophosphamide;0.Etoposide;0.Procarbazine;0.Rituximab;0.Thalidomide;1.Cyclophosphamide;0.Etoposide;0.Procarbazine;0.Thalidomide;1.Cyclophosphamide;0.Etoposide;0.Procarbazine;0.Thalidomide;1.Cyclophosphamide;0.Etoposide;0.Procarbazine;0.Thalidomide;1.Cyclophosphamide;0.Etoposide;0.Procarbazine;0.Thalidomide;1.Cyclophosphamide;0.Etoposide;0.Procarbazine;0.Thalidomide;1.Cyclophosphamide;0.Etoposide;0.Procarbazine;0.Thalidomide;78.Rituximab;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;","0.Cyclophosphamide;0.Etoposide;0.Procarbazine;0.Rituximab;0.Thalidomide;1.Cyclophosphamide;0.Etoposide;0.Procarbazine;0.Thalidomide;1.Cyclophosphamide;0.Etoposide;0.Procarbazine;0.Thalidomide;1.Cyclophosphamide;0.Etoposide;0.Procarbazine;0.Thalidomide;1.Cyclophosphamide;0.Etoposide;0.Procarbazine;0.Thalidomide;1.Cyclophosphamide;0.Etoposide;0.Procarbazine;0.Thalidomide;1.Cyclophosphamide;0.Etoposide;0.Procarbazine;0.Thalidomide;78.Rituximab;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;"
"1178","137.180.1992.1","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"Relapsed or refractory, non-randomized or retrospective data",180,"Temsirolimus & Rituximab",NA,NA,"0.Rituximab;0.Temsirolimus;28.Rituximab;0.Temsirolimus;28.Rituximab;0.Temsirolimus;28.Rituximab;0.Temsirolimus;28.Rituximab;0.Temsirolimus;28.Rituximab;0.Temsirolimus;28.Rituximab;0.Temsirolimus;28.Rituximab;0.Temsirolimus;28.Rituximab;0.Temsirolimus;","0.Rituximab;0.Temsirolimus;28.Rituximab;0.Temsirolimus;28.Rituximab;0.Temsirolimus;28.Rituximab;0.Temsirolimus;28.Rituximab;0.Temsirolimus;28.Rituximab;0.Temsirolimus;28.Rituximab;0.Temsirolimus;28.Rituximab;0.Temsirolimus;28.Rituximab;0.Temsirolimus;"
"1179","137.180.1993.1","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"Relapsed or refractory, non-randomized or retrospective data",180,"Bortezomib & Rituximab (VR)",NA,NA,"0.Bortezomib;3.Bortezomib;18.Bortezomib;0.Rituximab;3.Bortezomib;18.Bortezomib;0.Rituximab;3.Bortezomib;18.Bortezomib;0.Rituximab;3.Bortezomib;18.Bortezomib;0.Rituximab;3.Bortezomib;","0.Bortezomib;3.Bortezomib;18.Bortezomib;0.Rituximab;3.Bortezomib;18.Bortezomib;0.Rituximab;3.Bortezomib;18.Bortezomib;0.Rituximab;3.Bortezomib;18.Bortezomib;0.Rituximab;3.Bortezomib;"
"1180","137.182.1976.1","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"Relapsed or refractory, randomized data",182,"Acalabrutinib monotherapy",TRUE,"Cont.","1.Acalabrutinib;1.Acalabrutinib;1.Acalabrutinib;1.Acalabrutinib;1.Acalabrutinib;1.Acalabrutinib;1.Acalabrutinib;1.Acalabrutinib;1.Acalabrutinib;1.Acalabrutinib;1.Acalabrutinib;1.Acalabrutinib;1.Acalabrutinib;1.Acalabrutinib;","1.Acalabrutinib;1.Acalabrutinib;"
"1181","137.182.1977.1","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"Relapsed or refractory, randomized data",182,"BCHOP",TRUE,"Cont.","14.Bortezomib;0.Cyclophosphamide;0.Doxorubicin;0.Vincristine;7.Bortezomib;14.Bortezomib;0.Cyclophosphamide;0.Doxorubicin;0.Vincristine;7.Bortezomib;","14.Bortezomib;0.Cyclophosphamide;0.Doxorubicin;0.Vincristine;7.Bortezomib;"
"1182","137.182.1978.1","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"Relapsed or refractory, randomized data",182,"R-FCM",FALSE,"4","26.Cyclophosphamide;0.Fludarabine;0.Mitoxantrone;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Mitoxantrone;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;","26.Cyclophosphamide;0.Fludarabine;0.Mitoxantrone;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;"
"1183","137.182.1979.1","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"Relapsed or refractory, randomized data",182,"Temsirolimus monotherapy",TRUE,"Cont.","7.Temsirolimus;7.Temsirolimus;7.Temsirolimus;7.Temsirolimus;7.Temsirolimus;7.Temsirolimus;","7.Temsirolimus;7.Temsirolimus;"
"1184","137.182.1980.1","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"Relapsed or refractory, randomized data",182,"Zanubrutinib monotherapy",TRUE,"Cont.","1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;","1.Zanubrutinib;1.Zanubrutinib;"
"1185","137.182.1985.1","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"Relapsed or refractory, randomized data",182,"Ibrutinib & Rituximab",NA,NA,"0.Rituximab;NA.Rituximab;NA.Rituximab;NA.Rituximab;NA.Rituximab;NA.Rituximab;","0.Rituximab;NA.Rituximab;NA.Rituximab;NA.Rituximab;NA.Rituximab;NA.Rituximab;"
"1186","137.182.1985.2","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"Relapsed or refractory, randomized data",182,"Ibrutinib & Rituximab",TRUE,"Cont.","1.Ibrutinib;0.Rituximab;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;0.Rituximab;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;","1.Ibrutinib;0.Rituximab;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;"
"1187","137.182.1986.1","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"Relapsed or refractory, randomized data",182,"Ibrutinib & Venetoclax",TRUE,"Cont.","1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;","1.Ibrutinib;0.Venetoclax;"
"1188","137.182.1987.1","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"Relapsed or refractory, randomized data",182,"Lenalidomide & Rituximab (R2)",TRUE,"Cont.","1.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","1.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1189","137.182.1988.1","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"Relapsed or refractory, randomized data",182,"PEP-C",TRUE,"Cont.","1.Cyclophosphamide;0.Etoposide;0.Procarbazine;1.Cyclophosphamide;0.Etoposide;0.Procarbazine;1.Cyclophosphamide;0.Etoposide;0.Procarbazine;1.Cyclophosphamide;0.Etoposide;0.Procarbazine;1.Cyclophosphamide;0.Etoposide;0.Procarbazine;1.Cyclophosphamide;0.Etoposide;0.Procarbazine;1.Cyclophosphamide;0.Etoposide;0.Procarbazine;1.Cyclophosphamide;0.Etoposide;0.Procarbazine;1.Cyclophosphamide;0.Etoposide;0.Procarbazine;1.Cyclophosphamide;0.Etoposide;0.Procarbazine;1.Cyclophosphamide;0.Etoposide;0.Procarbazine;1.Cyclophosphamide;0.Etoposide;0.Procarbazine;1.Cyclophosphamide;0.Etoposide;0.Procarbazine;1.Cyclophosphamide;0.Etoposide;0.Procarbazine;","1.Cyclophosphamide;0.Etoposide;0.Procarbazine;"
"1190","137.42.1994.1","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"Consolidation after second-line therapy",42,"BFR, then allo HSCT",NA,NA,"0.Rituximab;","0.Rituximab;"
"1191","137.42.1995.2","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"Consolidation after second-line therapy",42,"Rituximab monotherapy",TRUE,"Cont.","63.Rituximab;7.Rituximab;7.Rituximab;7.Rituximab;63.Rituximab;7.Rituximab;7.Rituximab;7.Rituximab;","63.Rituximab;7.Rituximab;7.Rituximab;7.Rituximab;"
"1192","137.42.1996.1","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"Consolidation after second-line therapy",42,"Bortezomib & Rituximab (VR)",FALSE,"1","0.Bortezomib;0.Rituximab;7.Bortezomib;0.Rituximab;","0.Bortezomib;0.Rituximab;7.Bortezomib;0.Rituximab;"
"1193","137.71.1956.1","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"First-line therapy, non-randomized or retrospective data",71,"BR/RC",NA,NA,"0.Bendamustine;1.Bendamustine;27.Bendamustine;1.Bendamustine;27.Bendamustine;1.Bendamustine;27.Cytarabine;1.Cytarabine;20.Cytarabine;1.Cytarabine;20.Cytarabine;1.Cytarabine;","0.Bendamustine;1.Bendamustine;27.Bendamustine;1.Bendamustine;27.Bendamustine;1.Bendamustine;27.Cytarabine;1.Cytarabine;20.Cytarabine;1.Cytarabine;20.Cytarabine;1.Cytarabine;"
"1194","137.71.1956.2","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"First-line therapy, non-randomized or retrospective data",71,"BR/RC",NA,NA,"0.Bendamustine;1.Bendamustine;27.Cytarabine;1.Cytarabine;20.Bendamustine;1.Bendamustine;27.Cytarabine;1.Cytarabine;20.Bendamustine;1.Bendamustine;27.Cytarabine;1.Cytarabine;","0.Bendamustine;1.Bendamustine;27.Cytarabine;1.Cytarabine;20.Bendamustine;1.Bendamustine;27.Cytarabine;1.Cytarabine;20.Bendamustine;1.Bendamustine;27.Cytarabine;1.Cytarabine;"
"1195","137.71.1957.1","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"First-line therapy, non-randomized or retrospective data",71,"Chlorambucil & Rituximab (RClb)",NA,NA,"0.Rituximab;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;22.Rituximab;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;22.Rituximab;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;22.Rituximab;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;22.Rituximab;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;22.Rituximab;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;22.Rituximab;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;22.Rituximab;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;22.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;","0.Rituximab;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;22.Rituximab;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;22.Rituximab;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;22.Rituximab;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;22.Rituximab;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;22.Rituximab;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;22.Rituximab;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;22.Rituximab;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;22.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;"
"1196","137.71.1958.1","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"First-line therapy, non-randomized or retrospective data",71,"Cladribine monotherapy",TRUE,"Cont.","24.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;24.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;","24.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;"
"1197","137.71.1959.1","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"First-line therapy, non-randomized or retrospective data",71,"Cladribine & Rituximab",TRUE,"Cont.","24.Cladribine;0.Rituximab;1.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;24.Cladribine;0.Rituximab;1.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;","24.Cladribine;0.Rituximab;1.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;"
"1198","137.71.1960.1","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"First-line therapy, non-randomized or retrospective data",71,"R-BAC",TRUE,"Cont.","25.Rituximab;1.Bendamustine;0.Cytarabine;1.Bendamustine;0.Cytarabine;1.Cytarabine;25.Rituximab;1.Bendamustine;0.Cytarabine;1.Bendamustine;0.Cytarabine;1.Cytarabine;","25.Rituximab;1.Bendamustine;0.Cytarabine;1.Bendamustine;0.Cytarabine;1.Cytarabine;"
"1199","137.71.1960.2","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"First-line therapy, non-randomized or retrospective data",71,"R-BAC",TRUE,"Cont.","26.Bendamustine;0.Cytarabine;0.Rituximab;1.Bendamustine;0.Cytarabine;1.Cytarabine;26.Bendamustine;0.Cytarabine;0.Rituximab;1.Bendamustine;0.Cytarabine;1.Cytarabine;","26.Bendamustine;0.Cytarabine;0.Rituximab;1.Bendamustine;0.Cytarabine;1.Cytarabine;"
"1200","137.71.1961.1","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"First-line therapy, non-randomized or retrospective data",71,"maxi-R-CHOP/R-HiDAC",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;21.Cytarabine;1.Cytarabine;20.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;21.Cytarabine;0.Rituximab;1.Cytarabine;20.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;21.Cytarabine;0.Rituximab;1.Cytarabine;","0.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;21.Cytarabine;1.Cytarabine;20.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;21.Cytarabine;0.Rituximab;1.Cytarabine;20.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;21.Cytarabine;0.Rituximab;1.Cytarabine;"
"1201","137.71.1962.1","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"First-line therapy, non-randomized or retrospective data",71,"R-DHAC",FALSE,"4","20.Carboplatin;0.Rituximab;1.Cytarabine;20.Carboplatin;0.Rituximab;1.Cytarabine;","20.Carboplatin;0.Rituximab;1.Cytarabine;"
"1202","137.71.1963.1","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"First-line therapy, non-randomized or retrospective data",71,"R-DHAOx",FALSE,"4","20.Oxaliplatin;0.Rituximab;1.Cytarabine;20.Oxaliplatin;0.Rituximab;1.Cytarabine;","20.Oxaliplatin;0.Rituximab;1.Cytarabine;"
"1203","137.71.1964.1","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"First-line therapy, non-randomized or retrospective data",71,"R-HiDAC",FALSE,"1","0.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;7.Rituximab;","0.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;7.Rituximab;"
"1204","137.71.1965.1","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"First-line therapy, non-randomized or retrospective data",71,"R-M-CHOP",FALSE,"1","0.Rituximab;1.Methotrexate;1.Cyclophosphamide;0.Doxorubicin;0.Vincristine;","0.Rituximab;1.Methotrexate;1.Cyclophosphamide;0.Doxorubicin;0.Vincristine;"
"1205","137.71.1966.1","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"First-line therapy, non-randomized or retrospective data",71,"R-MACLO/R-IVAM",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;17.Cytarabine;0.Etoposide;0.Ifosfamide;0.Rituximab;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;17.Cytarabine;0.Etoposide;0.Ifosfamide;0.Rituximab;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;","0.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;17.Cytarabine;0.Etoposide;0.Ifosfamide;0.Rituximab;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;17.Cytarabine;0.Etoposide;0.Ifosfamide;0.Rituximab;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;"
"1206","137.71.1967.1","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"First-line therapy, non-randomized or retrospective data",71,"RiPAD+C",NA,NA,"0.Bortezomib;0.Doxorubicin;0.Rituximab;3.Bortezomib;32.Bortezomib;0.Doxorubicin;0.Rituximab;3.Bortezomib;32.Bortezomib;0.Doxorubicin;0.Rituximab;3.Bortezomib;32.Bortezomib;0.Doxorubicin;0.Rituximab;3.Bortezomib;32.Bortezomib;0.Doxorubicin;0.Rituximab;3.Bortezomib;32.Bortezomib;0.Doxorubicin;0.Rituximab;3.Bortezomib;","0.Bortezomib;0.Doxorubicin;0.Rituximab;3.Bortezomib;32.Bortezomib;0.Doxorubicin;0.Rituximab;3.Bortezomib;32.Bortezomib;0.Doxorubicin;0.Rituximab;3.Bortezomib;32.Bortezomib;0.Doxorubicin;0.Rituximab;3.Bortezomib;32.Bortezomib;0.Doxorubicin;0.Rituximab;3.Bortezomib;32.Bortezomib;0.Doxorubicin;0.Rituximab;3.Bortezomib;"
"1207","137.71.1967.2","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"First-line therapy, non-randomized or retrospective data",71,"RiPAD+C",NA,NA,"0.Bortezomib;0.Doxorubicin;0.Rituximab;1.Doxorubicin;1.Doxorubicin;1.Bortezomib;0.Doxorubicin;32.Bortezomib;0.Doxorubicin;0.Rituximab;1.Doxorubicin;1.Doxorubicin;1.Bortezomib;0.Doxorubicin;32.Bortezomib;0.Doxorubicin;0.Rituximab;1.Doxorubicin;1.Doxorubicin;1.Bortezomib;0.Doxorubicin;32.Bortezomib;0.Doxorubicin;0.Rituximab;1.Doxorubicin;1.Doxorubicin;1.Bortezomib;0.Doxorubicin;32.Bortezomib;0.Doxorubicin;0.Rituximab;1.Doxorubicin;1.Doxorubicin;1.Bortezomib;0.Doxorubicin;32.Bortezomib;0.Doxorubicin;0.Rituximab;1.Doxorubicin;1.Doxorubicin;1.Bortezomib;0.Doxorubicin;","0.Bortezomib;0.Doxorubicin;0.Rituximab;1.Doxorubicin;1.Doxorubicin;1.Bortezomib;0.Doxorubicin;32.Bortezomib;0.Doxorubicin;0.Rituximab;1.Doxorubicin;1.Doxorubicin;1.Bortezomib;0.Doxorubicin;32.Bortezomib;0.Doxorubicin;0.Rituximab;1.Doxorubicin;1.Doxorubicin;1.Bortezomib;0.Doxorubicin;32.Bortezomib;0.Doxorubicin;0.Rituximab;1.Doxorubicin;1.Doxorubicin;1.Bortezomib;0.Doxorubicin;32.Bortezomib;0.Doxorubicin;0.Rituximab;1.Doxorubicin;1.Doxorubicin;1.Bortezomib;0.Doxorubicin;32.Bortezomib;0.Doxorubicin;0.Rituximab;1.Doxorubicin;1.Doxorubicin;1.Bortezomib;0.Doxorubicin;"
"1208","137.71.1968.1","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"First-line therapy, non-randomized or retrospective data",71,"R-VAD+C",TRUE,"Cont.","7.Doxorubicin;0.Rituximab;0.Vincristine;19.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;7.Doxorubicin;0.Rituximab;0.Vincristine;19.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;","7.Doxorubicin;0.Rituximab;0.Vincristine;19.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;"
"1209","137.71.1968.2","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"First-line therapy, non-randomized or retrospective data",71,"R-VAD+C",TRUE,"Cont.","7.Doxorubicin;0.Rituximab;0.Vincristine;1.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;16.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;7.Doxorubicin;0.Rituximab;0.Vincristine;1.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;16.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;","7.Doxorubicin;0.Rituximab;0.Vincristine;1.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;16.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;"
"1210","137.71.1969.1","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"First-line therapy, non-randomized or retrospective data",71,"VcR-CVAD",FALSE,"6","18.Bortezomib;0.Cyclophosphamide;0.Doxorubicin;0.Rituximab;1.Cyclophosphamide;1.Cyclophosphamide;0.Vincristine;1.Bortezomib;18.Bortezomib;0.Cyclophosphamide;0.Doxorubicin;0.Rituximab;1.Cyclophosphamide;1.Cyclophosphamide;0.Vincristine;1.Bortezomib;","18.Bortezomib;0.Cyclophosphamide;0.Doxorubicin;0.Rituximab;1.Cyclophosphamide;1.Cyclophosphamide;0.Vincristine;1.Bortezomib;"
"1211","137.71.1969.2","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"First-line therapy, non-randomized or retrospective data",71,"VcR-CVAD",FALSE,"6","18.Bortezomib;0.Cyclophosphamide;0.Doxorubicin;0.Rituximab;1.Cyclophosphamide;0.Doxorubicin;1.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Bortezomib;18.Bortezomib;0.Cyclophosphamide;0.Doxorubicin;0.Rituximab;1.Cyclophosphamide;0.Doxorubicin;1.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Bortezomib;","18.Bortezomib;0.Cyclophosphamide;0.Doxorubicin;0.Rituximab;1.Cyclophosphamide;0.Doxorubicin;1.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Bortezomib;"
"1212","137.71.1970.1","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"First-line therapy, non-randomized or retrospective data",71,"VR-CHOP",FALSE,"6","18.Bortezomib;0.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;3.Bortezomib;18.Bortezomib;0.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;3.Bortezomib;","18.Bortezomib;0.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;3.Bortezomib;"
"1213","137.71.1971.1","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"First-line therapy, non-randomized or retrospective data",71,"BEAM, then auto HSCT",FALSE,"1","0.Carmustine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Melphalan;","0.Carmustine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Melphalan;"
"1214","137.71.1972.1","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"First-line therapy, non-randomized or retrospective data",71,"Melphalan & TBI, then auto HSCT",FALSE,"1","0.Melphalan;","0.Melphalan;0.Melphalan;"
"1215","137.71.1973.1","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"First-line therapy, non-randomized or retrospective data",71,"R-BEAM, then auto HSCT",FALSE,"1","0.Rituximab;1.Carmustine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Melphalan;","0.Rituximab;1.Carmustine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Melphalan;"
"1216","137.71.1974.1","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"First-line therapy, non-randomized or retrospective data",71,"TAM6, then auto HSCT",FALSE,"1","0.Cytarabine;0.Melphalan;1.Cytarabine;","0.Cytarabine;0.Melphalan;1.Cytarabine;"
"1217","137.74.1952.1","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"First-line therapy, randomized data",74,"R-CHOP/R-DHAP",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;21.Cisplatin;0.Rituximab;1.Cisplatin;0.Cytarabine;20.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;21.Cisplatin;0.Rituximab;1.Cisplatin;0.Cytarabine;20.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;21.Cisplatin;0.Rituximab;1.Cisplatin;0.Cytarabine;","0.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;21.Cisplatin;0.Rituximab;1.Cisplatin;0.Cytarabine;20.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;21.Cisplatin;0.Rituximab;1.Cisplatin;0.Cytarabine;20.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;21.Cisplatin;0.Rituximab;1.Cisplatin;0.Cytarabine;"
"1218","137.74.1953.1","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"First-line therapy, randomized data",74,"R-CVP",TRUE,"Cont.","21.Cyclophosphamide;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Rituximab;0.Vincristine;","21.Cyclophosphamide;0.Rituximab;0.Vincristine;"
"1219","137.74.1954.1","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"First-line therapy, randomized data",74,"R-Hyper-CVAD/R-MA",NA,NA,"0.Rituximab;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;1.Doxorubicin;1.Doxorubicin;15.Rituximab;1.Methotrexate;1.Cytarabine;1.Cytarabine;18.Rituximab;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;1.Doxorubicin;1.Doxorubicin;15.Rituximab;1.Methotrexate;1.Cytarabine;1.Cytarabine;18.Rituximab;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;1.Doxorubicin;1.Doxorubicin;15.Rituximab;1.Methotrexate;1.Cytarabine;1.Cytarabine;18.Rituximab;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;1.Doxorubicin;1.Doxorubicin;15.Rituximab;1.Methotrexate;1.Cytarabine;1.Cytarabine;","0.Rituximab;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;1.Doxorubicin;1.Doxorubicin;15.Rituximab;1.Methotrexate;1.Cytarabine;1.Cytarabine;18.Rituximab;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;1.Doxorubicin;1.Doxorubicin;15.Rituximab;1.Methotrexate;1.Cytarabine;1.Cytarabine;18.Rituximab;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;1.Doxorubicin;1.Doxorubicin;15.Rituximab;1.Methotrexate;1.Cytarabine;1.Cytarabine;18.Rituximab;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;1.Doxorubicin;1.Doxorubicin;15.Rituximab;1.Methotrexate;1.Cytarabine;1.Cytarabine;"
"1220","137.74.1955.1","Malignant Hematology","Aggressive lymphomas","Mantle cell lymphoma",137,"First-line therapy, randomized data",74,"VR-CAP",TRUE,"Cont.","11.Bortezomib;0.Cyclophosphamide;0.Doxorubicin;0.Rituximab;3.Bortezomib;4.Bortezomib;3.Bortezomib;11.Bortezomib;0.Cyclophosphamide;0.Doxorubicin;0.Rituximab;3.Bortezomib;4.Bortezomib;3.Bortezomib;","11.Bortezomib;0.Cyclophosphamide;0.Doxorubicin;0.Rituximab;3.Bortezomib;4.Bortezomib;3.Bortezomib;"
"1221","139.178.1997.1","Malignant Hematology","Aggressive lymphomas","Primary mediastinal B-cell lymphoma",139,"Relapsed or refractory, further lines of therapy",178,"Axicabtagene ciloleucel monotherapy",FALSE,"1","0.Axicabtageneciloleucel;","0.Axicabtageneciloleucel;0.Axicabtageneciloleucel;"
"1222","14.134.380.1","Solid Tumor","Dermatologic Oncology","Merkel cell carcinoma",14,"Metastatic or advanced disease, first-line therapy",134,"Avelumab monotherapy",TRUE,"Cont.","14.Avelumab;14.Avelumab;","14.Avelumab;14.Avelumab;"
"1223","140.31.1998.1","Malignant Hematology","Aggressive lymphomas","Transformed lymphoma",140,"All lines of therapy",31,"131Iodine-Tositumomab monotherapy",FALSE,"1","0.131Iodine-Tositumomab;","0.131Iodine-Tositumomab;0.131Iodine-Tositumomab;"
"1224","140.31.1999.1","Malignant Hematology","Aggressive lymphomas","Transformed lymphoma",140,"All lines of therapy",31,"OFAR",NA,NA,"0.Oxaliplatin;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;0.Rituximab;1.Oxaliplatin;25.Oxaliplatin;0.Rituximab;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Oxaliplatin;25.Oxaliplatin;0.Rituximab;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Oxaliplatin;25.Oxaliplatin;0.Rituximab;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Oxaliplatin;25.Oxaliplatin;0.Rituximab;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Oxaliplatin;25.Oxaliplatin;0.Rituximab;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Oxaliplatin;","0.Oxaliplatin;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;0.Rituximab;1.Oxaliplatin;25.Oxaliplatin;0.Rituximab;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Oxaliplatin;25.Oxaliplatin;0.Rituximab;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Oxaliplatin;25.Oxaliplatin;0.Rituximab;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Oxaliplatin;25.Oxaliplatin;0.Rituximab;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Oxaliplatin;25.Oxaliplatin;0.Rituximab;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Oxaliplatin;"
"1225","140.31.2000.1","Malignant Hematology","Aggressive lymphomas","Transformed lymphoma",140,"All lines of therapy",31,"R-DHAP",TRUE,"Cont.","20.Cisplatin;0.Rituximab;1.Cytarabine;20.Cisplatin;0.Rituximab;1.Cytarabine;","20.Cisplatin;0.Rituximab;1.Cytarabine;"
"1226","141.182.2043.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"Relapsed or refractory, randomized data",182,"Bendamustine monotherapy",TRUE,"Cont.","20.Bendamustine;1.Bendamustine;20.Bendamustine;1.Bendamustine;","20.Bendamustine;1.Bendamustine;"
"1227","141.182.2044.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"Relapsed or refractory, randomized data",182,"Bendamustine & Rituximab (BR) & Idelalisib",TRUE,"Cont.","1.Bendamustine;0.Idelalisib;0.Rituximab;1.Bendamustine;0.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Bendamustine;0.Idelalisib;0.Rituximab;1.Bendamustine;0.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;","1.Bendamustine;0.Idelalisib;0.Rituximab;1.Bendamustine;0.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;"
"1228","141.182.2045.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"Relapsed or refractory, randomized data",182,"Duvelisib monotherapy",TRUE,"Cont.","1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;","1.Duvelisib;1.Duvelisib;"
"1229","141.182.2046.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"Relapsed or refractory, randomized data",182,"Fludarabine monotherapy",TRUE,"Cont.","24.Fludarabine;1.Fludarabine;1.Fludarabine;1.Fludarabine;1.Fludarabine;24.Fludarabine;1.Fludarabine;1.Fludarabine;1.Fludarabine;1.Fludarabine;","24.Fludarabine;1.Fludarabine;1.Fludarabine;1.Fludarabine;1.Fludarabine;"
"1230","141.182.2047.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"Relapsed or refractory, randomized data",182,"Idelalisib & Ofatumumab",NA,NA,"0.Idelalisib;0.Ofatumumab;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;22.Idelalisib;0.Ofatumumab;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;22.Idelalisib;0.Ofatumumab;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;22.Idelalisib;0.Ofatumumab;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;22.Idelalisib;0.Ofatumumab;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;22.Idelalisib;0.Ofatumumab;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;","0.Idelalisib;0.Ofatumumab;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;22.Idelalisib;0.Ofatumumab;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;22.Idelalisib;0.Ofatumumab;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;22.Idelalisib;0.Ofatumumab;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;22.Idelalisib;0.Ofatumumab;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;22.Idelalisib;0.Ofatumumab;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;"
"1231","141.182.2048.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"Relapsed or refractory, randomized data",182,"Idelalisib & Rituximab",FALSE,"1","0.Idelalisib;0.Rituximab;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;","0.Idelalisib;0.Rituximab;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;"
"1232","141.182.2048.2","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"Relapsed or refractory, randomized data",182,"Idelalisib & Rituximab",TRUE,"Cont.","1.Idelalisib;0.Rituximab;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;0.Rituximab;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;0.Rituximab;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;0.Rituximab;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;0.Rituximab;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;0.Rituximab;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;0.Rituximab;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;0.Rituximab;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;","1.Idelalisib;0.Rituximab;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;"
"1233","141.182.2048.3","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"Relapsed or refractory, randomized data",182,"Idelalisib & Rituximab",NA,NA,"0.Idelalisib;0.Rituximab;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;8.Idelalisib;0.Rituximab;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;22.Idelalisib;0.Rituximab;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;22.Idelalisib;0.Rituximab;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;22.Idelalisib;0.Rituximab;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;22.Idelalisib;0.Rituximab;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;","0.Idelalisib;0.Rituximab;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;8.Idelalisib;0.Rituximab;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;22.Idelalisib;0.Rituximab;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;22.Idelalisib;0.Rituximab;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;22.Idelalisib;0.Rituximab;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;22.Idelalisib;0.Rituximab;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;"
"1234","141.182.2053.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"Relapsed or refractory, randomized data",182,"Venetoclax monotherapy",TRUE,"Cont.","1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;","1.Venetoclax;1.Venetoclax;"
"1235","141.182.2054.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"Relapsed or refractory, randomized data",182,"Venetoclax & Bendamustine & Rituximab",TRUE,"Cont.","1.Bendamustine;0.Rituximab;0.Venetoclax;1.Bendamustine;0.Rituximab;0.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Bendamustine;0.Rituximab;0.Venetoclax;1.Bendamustine;0.Rituximab;0.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;","1.Bendamustine;0.Rituximab;0.Venetoclax;1.Bendamustine;0.Rituximab;0.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;"
"1236","141.182.2055.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"Relapsed or refractory, randomized data",182,"Alemtuzumab & Rituximab",TRUE,"Cont.","3.Alemtuzumab;0.Rituximab;1.Alemtuzumab;1.Alemtuzumab;5.Rituximab;2.Alemtuzumab;2.Alemtuzumab;3.Rituximab;2.Alemtuzumab;2.Alemtuzumab;3.Rituximab;2.Alemtuzumab;2.Alemtuzumab;3.Alemtuzumab;0.Rituximab;1.Alemtuzumab;1.Alemtuzumab;5.Rituximab;2.Alemtuzumab;2.Alemtuzumab;3.Rituximab;2.Alemtuzumab;2.Alemtuzumab;3.Rituximab;2.Alemtuzumab;2.Alemtuzumab;","3.Alemtuzumab;0.Rituximab;1.Alemtuzumab;1.Alemtuzumab;5.Rituximab;2.Alemtuzumab;2.Alemtuzumab;3.Rituximab;2.Alemtuzumab;2.Alemtuzumab;3.Rituximab;2.Alemtuzumab;2.Alemtuzumab;"
"1237","141.182.2056.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"Relapsed or refractory, randomized data",182,"Bendamustine & Ofatumumab",TRUE,"Cont.","21.Bendamustine;0.Ofatumumab;1.Bendamustine;6.Ofatumumab;21.Bendamustine;0.Ofatumumab;1.Bendamustine;6.Ofatumumab;","21.Bendamustine;0.Ofatumumab;1.Bendamustine;6.Ofatumumab;"
"1238","141.182.2056.2","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"Relapsed or refractory, randomized data",182,"Bendamustine & Ofatumumab",TRUE,"Cont.","27.Bendamustine;0.Ofatumumab;1.Bendamustine;27.Bendamustine;0.Ofatumumab;1.Bendamustine;","27.Bendamustine;0.Ofatumumab;1.Bendamustine;"
"1239","141.182.2057.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"Relapsed or refractory, randomized data",182,"DFCR",TRUE,"Cont.","1.Cyclophosphamide;0.Duvelisib;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Duvelisib;0.Fludarabine;1.Cyclophosphamide;0.Duvelisib;0.Fludarabine;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Cyclophosphamide;0.Duvelisib;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Duvelisib;0.Fludarabine;1.Cyclophosphamide;0.Duvelisib;0.Fludarabine;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;","1.Cyclophosphamide;0.Duvelisib;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Duvelisib;0.Fludarabine;1.Cyclophosphamide;0.Duvelisib;0.Fludarabine;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;1.Duvelisib;"
"1240","141.182.2058.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"Relapsed or refractory, randomized data",182,"Fludarabine & Ibrutinib",TRUE,"Cont.","1.Fludarabine;0.Ibrutinib;1.Fludarabine;0.Ibrutinib;1.Fludarabine;0.Ibrutinib;1.Fludarabine;0.Ibrutinib;1.Fludarabine;0.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Fludarabine;0.Ibrutinib;1.Fludarabine;0.Ibrutinib;1.Fludarabine;0.Ibrutinib;1.Fludarabine;0.Ibrutinib;1.Fludarabine;0.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;","1.Fludarabine;0.Ibrutinib;1.Fludarabine;0.Ibrutinib;1.Fludarabine;0.Ibrutinib;1.Fludarabine;0.Ibrutinib;1.Fludarabine;0.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;"
"1241","141.182.2059.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"Relapsed or refractory, randomized data",182,"Fludarabine & Prednisone",TRUE,"Cont.","24.Fludarabine;1.Fludarabine;1.Fludarabine;1.Fludarabine;1.Fludarabine;24.Fludarabine;1.Fludarabine;1.Fludarabine;1.Fludarabine;1.Fludarabine;","24.Fludarabine;1.Fludarabine;1.Fludarabine;1.Fludarabine;1.Fludarabine;"
"1242","141.182.2060.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"Relapsed or refractory, randomized data",182,"HDMP-R",FALSE,"3","7.Rituximab;2.Rituximab;2.Rituximab;3.Rituximab;9.Rituximab;5.Rituximab;7.Rituximab;2.Rituximab;2.Rituximab;3.Rituximab;9.Rituximab;5.Rituximab;","7.Rituximab;2.Rituximab;2.Rituximab;3.Rituximab;9.Rituximab;5.Rituximab;"
"1243","141.182.2060.2","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"Relapsed or refractory, randomized data",182,"HDMP-R",FALSE,"3","8.Rituximab;6.Rituximab;7.Rituximab;7.Rituximab;8.Rituximab;6.Rituximab;7.Rituximab;7.Rituximab;","8.Rituximab;6.Rituximab;7.Rituximab;7.Rituximab;"
"1244","141.182.2060.3","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"Relapsed or refractory, randomized data",182,"HDMP-R",FALSE,"3","24.Rituximab;1.Rituximab;1.Rituximab;2.Rituximab;24.Rituximab;1.Rituximab;1.Rituximab;2.Rituximab;","24.Rituximab;1.Rituximab;1.Rituximab;2.Rituximab;"
"1245","141.182.2061.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"Relapsed or refractory, randomized data",182,"Ibrutinib & Ofatumumab",NA,NA,"0.Ibrutinib;0.Ofatumumab;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Ibrutinib;0.Ofatumumab;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Ibrutinib;0.Ofatumumab;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Ibrutinib;0.Ofatumumab;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Ibrutinib;0.Ofatumumab;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Ibrutinib;0.Ofatumumab;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;","0.Ibrutinib;0.Ofatumumab;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Ibrutinib;0.Ofatumumab;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Ibrutinib;0.Ofatumumab;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Ibrutinib;0.Ofatumumab;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Ibrutinib;0.Ofatumumab;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Ibrutinib;0.Ofatumumab;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;"
"1246","141.182.2061.2","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"Relapsed or refractory, randomized data",182,"Ibrutinib & Ofatumumab",NA,NA,"0.Ibrutinib;0.Ofatumumab;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Ibrutinib;0.Ofatumumab;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Ibrutinib;0.Ofatumumab;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Ibrutinib;0.Ofatumumab;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Ibrutinib;0.Ofatumumab;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Ibrutinib;0.Ofatumumab;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;","0.Ibrutinib;0.Ofatumumab;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Ibrutinib;0.Ofatumumab;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Ibrutinib;0.Ofatumumab;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Ibrutinib;0.Ofatumumab;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Ibrutinib;0.Ofatumumab;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Ibrutinib;0.Ofatumumab;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;"
"1247","141.182.2062.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"Relapsed or refractory, randomized data",182,"Idelalisib monotherapy",TRUE,"Cont.","1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;1.Idelalisib;","1.Idelalisib;1.Idelalisib;"
"1248","141.182.2063.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"Relapsed or refractory, randomized data",182,"Lenalidomide monotherapy",TRUE,"Cont.","8.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;8.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","8.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1249","141.182.2064.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"Relapsed or refractory, randomized data",182,"Lenalidomide & Ofatumumab",NA,NA,"0.Ofatumumab;28.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Ofatumumab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Ofatumumab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Ofatumumab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Ofatumumab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Ofatumumab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","0.Ofatumumab;28.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Ofatumumab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Ofatumumab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Ofatumumab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Ofatumumab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Ofatumumab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1250","141.182.2065.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"Relapsed or refractory, randomized data",182,"Lenalidomide & Rituximab (R2)",NA,NA,"0.Rituximab;28.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","0.Rituximab;28.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1251","141.182.2066.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"Relapsed or refractory, randomized data",182,"OFAR",NA,NA,"0.Oxaliplatin;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;0.Rituximab;1.Oxaliplatin;25.Oxaliplatin;0.Rituximab;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Oxaliplatin;25.Oxaliplatin;0.Rituximab;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Oxaliplatin;25.Oxaliplatin;0.Rituximab;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Oxaliplatin;25.Oxaliplatin;0.Rituximab;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Oxaliplatin;25.Oxaliplatin;0.Rituximab;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Oxaliplatin;","0.Oxaliplatin;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;0.Rituximab;1.Oxaliplatin;25.Oxaliplatin;0.Rituximab;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Oxaliplatin;25.Oxaliplatin;0.Rituximab;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Oxaliplatin;25.Oxaliplatin;0.Rituximab;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Oxaliplatin;25.Oxaliplatin;0.Rituximab;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Oxaliplatin;25.Oxaliplatin;0.Rituximab;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Oxaliplatin;"
"1252","141.182.2066.2","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"Relapsed or refractory, randomized data",182,"OFAR",TRUE,"Cont.","25.Oxaliplatin;0.Rituximab;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Oxaliplatin;25.Oxaliplatin;0.Rituximab;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Oxaliplatin;","25.Oxaliplatin;0.Rituximab;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Cytarabine;0.Fludarabine;0.Oxaliplatin;1.Oxaliplatin;"
"1253","141.182.2067.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"Relapsed or refractory, randomized data",182,"PCR",NA,NA,"0.Cyclophosphamide;0.Pentostatin;28.Cyclophosphamide;0.Pentostatin;0.Rituximab;28.Cyclophosphamide;0.Pentostatin;0.Rituximab;28.Cyclophosphamide;0.Pentostatin;0.Rituximab;28.Cyclophosphamide;0.Pentostatin;0.Rituximab;28.Cyclophosphamide;0.Pentostatin;0.Rituximab;","0.Cyclophosphamide;0.Pentostatin;28.Cyclophosphamide;0.Pentostatin;0.Rituximab;28.Cyclophosphamide;0.Pentostatin;0.Rituximab;28.Cyclophosphamide;0.Pentostatin;0.Rituximab;28.Cyclophosphamide;0.Pentostatin;0.Rituximab;28.Cyclophosphamide;0.Pentostatin;0.Rituximab;"
"1254","141.182.2068.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"Relapsed or refractory, randomized data",182,"R-BAC",TRUE,"Cont.","26.Bendamustine;0.Cytarabine;0.Rituximab;1.Bendamustine;0.Cytarabine;1.Cytarabine;26.Bendamustine;0.Cytarabine;0.Rituximab;1.Bendamustine;0.Cytarabine;1.Cytarabine;","26.Bendamustine;0.Cytarabine;0.Rituximab;1.Bendamustine;0.Cytarabine;1.Cytarabine;"
"1255","141.46.2039.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"Consolidation and/or maintenance after first-line therapy",46,"Alemtuzumab monotherapy",TRUE,"Cont.","3.Alemtuzumab;2.Alemtuzumab;2.Alemtuzumab;3.Alemtuzumab;2.Alemtuzumab;2.Alemtuzumab;3.Alemtuzumab;2.Alemtuzumab;2.Alemtuzumab;3.Alemtuzumab;2.Alemtuzumab;2.Alemtuzumab;3.Alemtuzumab;2.Alemtuzumab;2.Alemtuzumab;3.Alemtuzumab;2.Alemtuzumab;2.Alemtuzumab;3.Alemtuzumab;2.Alemtuzumab;2.Alemtuzumab;3.Alemtuzumab;2.Alemtuzumab;2.Alemtuzumab;3.Alemtuzumab;2.Alemtuzumab;2.Alemtuzumab;3.Alemtuzumab;2.Alemtuzumab;2.Alemtuzumab;3.Alemtuzumab;2.Alemtuzumab;2.Alemtuzumab;3.Alemtuzumab;2.Alemtuzumab;2.Alemtuzumab;","3.Alemtuzumab;2.Alemtuzumab;2.Alemtuzumab;"
"1256","141.46.2040.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"Consolidation and/or maintenance after first-line therapy",46,"Lenalidomide monotherapy",TRUE,"Cont.","1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","1.Lenalidomide;1.Lenalidomide;"
"1257","141.46.2041.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"Consolidation and/or maintenance after first-line therapy",46,"Ofatumumab monotherapy",TRUE,"Cont.","28.Ofatumumab;28.Ofatumumab;","28.Ofatumumab;28.Ofatumumab;"
"1258","141.46.2042.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"Consolidation and/or maintenance after first-line therapy",46,"Rituximab monotherapy",TRUE,"Cont.","56.Rituximab;56.Rituximab;","56.Rituximab;56.Rituximab;"
"1259","141.46.2042.2","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"Consolidation and/or maintenance after first-line therapy",46,"Rituximab monotherapy",TRUE,"Cont.","84.Rituximab;84.Rituximab;","84.Rituximab;84.Rituximab;"
"1260","141.46.2042.3","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"Consolidation and/or maintenance after first-line therapy",46,"Rituximab monotherapy",TRUE,"Cont.","147.Rituximab;7.Rituximab;7.Rituximab;7.Rituximab;147.Rituximab;7.Rituximab;7.Rituximab;7.Rituximab;","147.Rituximab;7.Rituximab;7.Rituximab;7.Rituximab;"
"1261","141.46.2042.4","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"Consolidation and/or maintenance after first-line therapy",46,"Rituximab monotherapy",TRUE,"Cont.","91.Rituximab;91.Rituximab;","91.Rituximab;91.Rituximab;"
"1262","141.46.2050.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"Consolidation and/or maintenance after first-line therapy",46,"O-FC",NA,NA,"0.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Ofatumumab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Ofatumumab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Ofatumumab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Ofatumumab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Ofatumumab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;","0.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Ofatumumab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Ofatumumab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Ofatumumab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Ofatumumab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Ofatumumab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;"
"1263","141.46.2051.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"Consolidation and/or maintenance after first-line therapy",46,"Rituximab monotherapy",TRUE,"Cont.","14.Rituximab;14.Rituximab;","14.Rituximab;14.Rituximab;"
"1264","141.46.2051.2","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"Consolidation and/or maintenance after first-line therapy",46,"Rituximab monotherapy",TRUE,"Cont.","21.Rituximab;21.Rituximab;","21.Rituximab;21.Rituximab;"
"1265","141.46.2051.3","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"Consolidation and/or maintenance after first-line therapy",46,"Rituximab monotherapy",TRUE,"Cont.","14.Rituximab;14.Rituximab;14.Rituximab;14.Rituximab;","14.Rituximab;14.Rituximab;"
"1266","141.46.2052.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"Consolidation and/or maintenance after first-line therapy",46,"Venetoclax & Rituximab",TRUE,"Cont.","1.Rituximab;0.Venetoclax;1.Rituximab;0.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Rituximab;0.Venetoclax;1.Rituximab;0.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;","1.Rituximab;0.Venetoclax;1.Rituximab;0.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;"
"1267","141.47.2069.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"Consolidation and/or maintenance after subsequent lines of therapy",47,"FC, then allo HSCT",FALSE,"1","0.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;","0.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;"
"1268","141.47.2070.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"Consolidation and/or maintenance after subsequent lines of therapy",47,"Fludarabine & TBI, then allo HSCT",FALSE,"1","0.Fludarabine;1.Fludarabine;1.Fludarabine;","0.Fludarabine;1.Fludarabine;1.Fludarabine;"
"1269","141.47.2071.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"Consolidation and/or maintenance after subsequent lines of therapy",47,"Fludarabine, Busulfan, ATG, then allo HSCT",FALSE,"1","0.Fludarabine;1.Fludarabine;1.Fludarabine;1.Fludarabine;1.Busulfan;0.Fludarabine;1.Busulfan;0.Fludarabine;1.ATG-Fresenius;1.ATG-Fresenius;1.ATG-Fresenius;1.ATG-Fresenius;","0.Fludarabine;1.Fludarabine;1.Fludarabine;1.Fludarabine;1.Busulfan;0.Fludarabine;1.Busulfan;0.Fludarabine;1.ATG-Fresenius;1.ATG-Fresenius;1.ATG-Fresenius;1.ATG-Fresenius;"
"1270","141.47.2072.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"Consolidation and/or maintenance after subsequent lines of therapy",47,"Fludarabine, Cyclophosphamide, ATG, then allo HSCT",FALSE,"1","0.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;1.ATG-Fresenius;0.Cyclophosphamide;0.Fludarabine;1.ATG-Fresenius;0.Cyclophosphamide;0.Fludarabine;1.ATG-Fresenius;0.Cyclophosphamide;0.Fludarabine;1.ATG-Fresenius;","0.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;1.ATG-Fresenius;0.Cyclophosphamide;0.Fludarabine;1.ATG-Fresenius;0.Cyclophosphamide;0.Fludarabine;1.ATG-Fresenius;0.Cyclophosphamide;0.Fludarabine;1.ATG-Fresenius;"
"1271","141.47.2073.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"Consolidation and/or maintenance after subsequent lines of therapy",47,"Ofatumumab monotherapy",NA,NA,"0.Ofatumumab;6.Ofatumumab;50.Ofatumumab;56.Ofatumumab;56.Ofatumumab;56.Ofatumumab;56.Ofatumumab;56.Ofatumumab;56.Ofatumumab;56.Ofatumumab;","0.Ofatumumab;6.Ofatumumab;50.Ofatumumab;56.Ofatumumab;56.Ofatumumab;56.Ofatumumab;56.Ofatumumab;56.Ofatumumab;56.Ofatumumab;56.Ofatumumab;"
"1272","141.71.2023.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, non-randomized or retrospective data",71,"Alemtuzumab & Methylprednisolone",FALSE,"4","3.Alemtuzumab;2.Alemtuzumab;2.Alemtuzumab;3.Alemtuzumab;2.Alemtuzumab;2.Alemtuzumab;3.Alemtuzumab;2.Alemtuzumab;2.Alemtuzumab;3.Alemtuzumab;2.Alemtuzumab;2.Alemtuzumab;3.Alemtuzumab;2.Alemtuzumab;2.Alemtuzumab;3.Alemtuzumab;2.Alemtuzumab;2.Alemtuzumab;3.Alemtuzumab;2.Alemtuzumab;2.Alemtuzumab;3.Alemtuzumab;2.Alemtuzumab;2.Alemtuzumab;","3.Alemtuzumab;2.Alemtuzumab;2.Alemtuzumab;"
"1273","141.71.2024.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, non-randomized or retrospective data",71,"AVO",TRUE,"Cont.","1.Acalabrutinib;0.Obinutuzumab;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Obinutuzumab;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;","1.Acalabrutinib;0.Obinutuzumab;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;"
"1274","141.71.2024.2","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, non-randomized or retrospective data",71,"AVO",TRUE,"Cont.","1.Acalabrutinib;0.Obinutuzumab;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Obinutuzumab;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Obinutuzumab;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Obinutuzumab;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Obinutuzumab;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Obinutuzumab;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;","1.Acalabrutinib;0.Obinutuzumab;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Obinutuzumab;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Obinutuzumab;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;1.Acalabrutinib;0.Venetoclax;"
"1275","141.71.2025.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, non-randomized or retrospective data",71,"Bendamustine & Obinutuzumab",NA,NA,"0.Obinutuzumab;1.Bendamustine;0.Obinutuzumab;1.Bendamustine;26.Bendamustine;0.Obinutuzumab;1.Bendamustine;27.Bendamustine;0.Obinutuzumab;1.Bendamustine;27.Bendamustine;0.Obinutuzumab;1.Bendamustine;27.Bendamustine;0.Obinutuzumab;1.Bendamustine;27.Bendamustine;0.Obinutuzumab;1.Bendamustine;","0.Obinutuzumab;1.Bendamustine;0.Obinutuzumab;1.Bendamustine;26.Bendamustine;0.Obinutuzumab;1.Bendamustine;27.Bendamustine;0.Obinutuzumab;1.Bendamustine;27.Bendamustine;0.Obinutuzumab;1.Bendamustine;27.Bendamustine;0.Obinutuzumab;1.Bendamustine;27.Bendamustine;0.Obinutuzumab;1.Bendamustine;"
"1276","141.71.2026.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, non-randomized or retrospective data",71,"CFAR",FALSE,"6","24.Alemtuzumab;1.Rituximab;1.Alemtuzumab;0.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;1.Alemtuzumab;0.Cyclophosphamide;0.Fludarabine;24.Alemtuzumab;1.Rituximab;1.Alemtuzumab;0.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;1.Alemtuzumab;0.Cyclophosphamide;0.Fludarabine;","24.Alemtuzumab;1.Rituximab;1.Alemtuzumab;0.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;1.Alemtuzumab;0.Cyclophosphamide;0.Fludarabine;"
"1277","141.71.2027.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, non-randomized or retrospective data",71,"G-FC",NA,NA,"0.Obinutuzumab;1.Cyclophosphamide;0.Fludarabine;0.Obinutuzumab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;25.Cyclophosphamide;0.Fludarabine;0.Obinutuzumab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Obinutuzumab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Obinutuzumab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Obinutuzumab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Obinutuzumab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;","0.Obinutuzumab;1.Cyclophosphamide;0.Fludarabine;0.Obinutuzumab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;25.Cyclophosphamide;0.Fludarabine;0.Obinutuzumab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Obinutuzumab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Obinutuzumab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Obinutuzumab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Obinutuzumab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;"
"1278","141.71.2028.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, non-randomized or retrospective data",71,"HDMP-R",FALSE,"3","7.Rituximab;7.Rituximab;7.Rituximab;7.Rituximab;7.Rituximab;7.Rituximab;7.Rituximab;7.Rituximab;","7.Rituximab;7.Rituximab;"
"1279","141.71.2029.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, non-randomized or retrospective data",71,"Ibrutinib, Venetoclax, Obinutuzumab",NA,NA,"0.Obinutuzumab;1.Obinutuzumab;27.Ibrutinib;0.Obinutuzumab;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Ibrutinib;0.Obinutuzumab;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;22.Ibrutinib;0.Obinutuzumab;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;22.Ibrutinib;0.Obinutuzumab;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;22.Ibrutinib;0.Obinutuzumab;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;22.Ibrutinib;0.Obinutuzumab;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;22.Ibrutinib;0.Obinutuzumab;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;22.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;","0.Obinutuzumab;1.Obinutuzumab;27.Ibrutinib;0.Obinutuzumab;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Ibrutinib;0.Obinutuzumab;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;22.Ibrutinib;0.Obinutuzumab;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;22.Ibrutinib;0.Obinutuzumab;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;22.Ibrutinib;0.Obinutuzumab;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;22.Ibrutinib;0.Obinutuzumab;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;22.Ibrutinib;0.Obinutuzumab;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;22.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;"
"1280","141.71.2030.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, non-randomized or retrospective data",71,"iFCR",NA,NA,"0.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Cyclophosphamide;0.Fludarabine;0.Ibrutinib;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;0.Ibrutinib;1.Cyclophosphamide;0.Fludarabine;0.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Cyclophosphamide;0.Fludarabine;0.Ibrutinib;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;0.Ibrutinib;1.Cyclophosphamide;0.Fludarabine;0.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Cyclophosphamide;0.Fludarabine;0.Ibrutinib;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;0.Ibrutinib;1.Cyclophosphamide;0.Fludarabine;0.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Cyclophosphamide;0.Fludarabine;0.Ibrutinib;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;0.Ibrutinib;1.Cyclophosphamide;0.Fludarabine;0.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Cyclophosphamide;0.Fludarabine;0.Ibrutinib;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;0.Ibrutinib;1.Cyclophosphamide;0.Fludarabine;0.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Cyclophosphamide;0.Fludarabine;0.Ibrutinib;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;0.Ibrutinib;1.Cyclophosphamide;0.Fludarabine;0.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;","0.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Cyclophosphamide;0.Fludarabine;0.Ibrutinib;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;0.Ibrutinib;1.Cyclophosphamide;0.Fludarabine;0.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Cyclophosphamide;0.Fludarabine;0.Ibrutinib;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;0.Ibrutinib;1.Cyclophosphamide;0.Fludarabine;0.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Cyclophosphamide;0.Fludarabine;0.Ibrutinib;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;0.Ibrutinib;1.Cyclophosphamide;0.Fludarabine;0.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Cyclophosphamide;0.Fludarabine;0.Ibrutinib;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;0.Ibrutinib;1.Cyclophosphamide;0.Fludarabine;0.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Cyclophosphamide;0.Fludarabine;0.Ibrutinib;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;0.Ibrutinib;1.Cyclophosphamide;0.Fludarabine;0.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Cyclophosphamide;0.Fludarabine;0.Ibrutinib;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;0.Ibrutinib;1.Cyclophosphamide;0.Fludarabine;0.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;"
"1281","141.71.2031.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, non-randomized or retrospective data",71,"Lenalidomide & Rituximab (R2)",NA,NA,"0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;29.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;29.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1282","141.71.2031.2","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, non-randomized or retrospective data",71,"Lenalidomide & Rituximab (R2)",TRUE,"Cont.","8.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;8.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","8.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1283","141.71.2031.3","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, non-randomized or retrospective data",71,"Lenalidomide & Rituximab (R2)",TRUE,"Cont.","1.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","1.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1284","141.71.2032.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, non-randomized or retrospective data",71,"O-FC",NA,NA,"0.Ofatumumab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;25.Cyclophosphamide;0.Fludarabine;0.Ofatumumab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Ofatumumab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Ofatumumab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Ofatumumab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Ofatumumab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;","0.Ofatumumab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;25.Cyclophosphamide;0.Fludarabine;0.Ofatumumab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Ofatumumab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Ofatumumab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Ofatumumab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Ofatumumab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;"
"1285","141.71.2033.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, non-randomized or retrospective data",71,"PCO",TRUE,"Cont.","21.Cyclophosphamide;0.Ofatumumab;0.Pentostatin;7.Ofatumumab;21.Cyclophosphamide;0.Ofatumumab;0.Pentostatin;7.Ofatumumab;","21.Cyclophosphamide;0.Ofatumumab;0.Pentostatin;7.Ofatumumab;"
"1286","141.71.2033.2","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, non-randomized or retrospective data",71,"PCO",TRUE,"Cont.","28.Cyclophosphamide;0.Ofatumumab;0.Pentostatin;28.Cyclophosphamide;0.Ofatumumab;0.Pentostatin;","28.Cyclophosphamide;0.Ofatumumab;0.Pentostatin;"
"1287","141.71.2034.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, non-randomized or retrospective data",71,"PCR",NA,NA,"0.Cyclophosphamide;0.Pentostatin;0.Rituximab;2.Rituximab;2.Rituximab;24.Cyclophosphamide;0.Pentostatin;0.Rituximab;28.Cyclophosphamide;0.Pentostatin;0.Rituximab;28.Cyclophosphamide;0.Pentostatin;0.Rituximab;28.Cyclophosphamide;0.Pentostatin;0.Rituximab;28.Cyclophosphamide;0.Pentostatin;0.Rituximab;","0.Cyclophosphamide;0.Pentostatin;0.Rituximab;2.Rituximab;2.Rituximab;24.Cyclophosphamide;0.Pentostatin;0.Rituximab;28.Cyclophosphamide;0.Pentostatin;0.Rituximab;28.Cyclophosphamide;0.Pentostatin;0.Rituximab;28.Cyclophosphamide;0.Pentostatin;0.Rituximab;28.Cyclophosphamide;0.Pentostatin;0.Rituximab;"
"1288","141.71.2034.2","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, non-randomized or retrospective data",71,"PCR",FALSE,"6","21.Cyclophosphamide;0.Pentostatin;0.Rituximab;21.Cyclophosphamide;0.Pentostatin;0.Rituximab;","21.Cyclophosphamide;0.Pentostatin;0.Rituximab;"
"1289","141.71.2035.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, non-randomized or retrospective data",71,"RCC",FALSE,"6","25.Rituximab;1.Cladribine;0.Cyclophosphamide;1.Cladribine;0.Cyclophosphamide;1.Cladribine;0.Cyclophosphamide;25.Rituximab;1.Cladribine;0.Cyclophosphamide;1.Cladribine;0.Cyclophosphamide;1.Cladribine;0.Cyclophosphamide;","25.Rituximab;1.Cladribine;0.Cyclophosphamide;1.Cladribine;0.Cyclophosphamide;1.Cladribine;0.Cyclophosphamide;"
"1290","141.71.2036.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, non-randomized or retrospective data",71,"Rituximab monotherapy",FALSE,"1","0.Rituximab;7.Rituximab;7.Rituximab;7.Rituximab;","0.Rituximab;7.Rituximab;7.Rituximab;7.Rituximab;"
"1291","141.71.2037.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, non-randomized or retrospective data",71,"Ruxolitinib monotherapy",TRUE,"Cont.","1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;1.Ruxolitinib;","1.Ruxolitinib;1.Ruxolitinib;"
"1292","141.71.2038.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, non-randomized or retrospective data",71,"Zanubrutinib & Obinutuzumab",NA,NA,"0.Obinutuzumab;0.Zanubrutinib;1.Obinutuzumab;0.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;22.Obinutuzumab;0.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;22.Obinutuzumab;0.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;22.Obinutuzumab;0.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;22.Obinutuzumab;0.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;22.Obinutuzumab;0.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;","0.Obinutuzumab;0.Zanubrutinib;1.Obinutuzumab;0.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;22.Obinutuzumab;0.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;22.Obinutuzumab;0.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;22.Obinutuzumab;0.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;22.Obinutuzumab;0.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;22.Obinutuzumab;0.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;"
"1293","141.71.2049.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, non-randomized or retrospective data",71,"Ofatumumab monotherapy",TRUE,"Cont.","7.Ofatumumab;7.Ofatumumab;7.Ofatumumab;7.Ofatumumab;7.Ofatumumab;7.Ofatumumab;7.Ofatumumab;7.Ofatumumab;","7.Ofatumumab;7.Ofatumumab;"
"1294","141.71.2050.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, non-randomized or retrospective data",71,"O-FC",NA,NA,"0.Ofatumumab;","0.Ofatumumab;"
"1295","141.74.2001.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, randomized data",74,"Acalabrutinib monotherapy",TRUE,"Cont.","1.Acalabrutinib;1.Acalabrutinib;1.Acalabrutinib;1.Acalabrutinib;1.Acalabrutinib;1.Acalabrutinib;1.Acalabrutinib;1.Acalabrutinib;1.Acalabrutinib;1.Acalabrutinib;1.Acalabrutinib;1.Acalabrutinib;1.Acalabrutinib;1.Acalabrutinib;","1.Acalabrutinib;1.Acalabrutinib;"
"1296","141.74.2002.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, randomized data",74,"Acalabrutinib & Obinutuzumab",TRUE,"Cont.","1.Acalabrutinib;0.Obinutuzumab;1.Acalabrutinib;0.Obinutuzumab;1.Acalabrutinib;0.Obinutuzumab;1.Acalabrutinib;0.Obinutuzumab;1.Acalabrutinib;0.Obinutuzumab;1.Acalabrutinib;0.Obinutuzumab;1.Acalabrutinib;0.Obinutuzumab;1.Acalabrutinib;0.Obinutuzumab;1.Acalabrutinib;0.Obinutuzumab;1.Acalabrutinib;0.Obinutuzumab;1.Acalabrutinib;0.Obinutuzumab;1.Acalabrutinib;0.Obinutuzumab;1.Acalabrutinib;0.Obinutuzumab;1.Acalabrutinib;0.Obinutuzumab;","1.Acalabrutinib;0.Obinutuzumab;"
"1297","141.74.2003.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, randomized data",74,"Alemtuzumab monotherapy",TRUE,"Cont.","1.Alemtuzumab;1.Alemtuzumab;1.Alemtuzumab;1.Alemtuzumab;1.Alemtuzumab;1.Alemtuzumab;1.Alemtuzumab;1.Alemtuzumab;1.Alemtuzumab;1.Alemtuzumab;1.Alemtuzumab;1.Alemtuzumab;1.Alemtuzumab;1.Alemtuzumab;","1.Alemtuzumab;1.Alemtuzumab;"
"1298","141.74.2004.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, randomized data",74,"Bendamustine monotherapy",TRUE,"Cont.","27.Bendamustine;1.Bendamustine;27.Bendamustine;1.Bendamustine;","27.Bendamustine;1.Bendamustine;"
"1299","141.74.2005.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, randomized data",74,"Bendamustine & Rituximab (BR)",TRUE,"Cont.","27.Bendamustine;0.Rituximab;1.Bendamustine;27.Bendamustine;0.Rituximab;1.Bendamustine;","27.Bendamustine;0.Rituximab;1.Bendamustine;"
"1300","141.74.2006.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, randomized data",74,"Bendamustine & Rituximab (BR) & Ibrutinib",TRUE,"Cont.","1.Bendamustine;0.Ibrutinib;0.Rituximab;1.Bendamustine;0.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Bendamustine;0.Ibrutinib;0.Rituximab;1.Bendamustine;0.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;","1.Bendamustine;0.Ibrutinib;0.Rituximab;1.Bendamustine;0.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;"
"1301","141.74.2007.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, randomized data",74,"Cladribine & Cyclophosphamide (CC)",TRUE,"Cont.","26.Cladribine;0.Cyclophosphamide;1.Cladribine;1.Cladribine;26.Cladribine;0.Cyclophosphamide;1.Cladribine;1.Cladribine;","26.Cladribine;0.Cyclophosphamide;1.Cladribine;1.Cladribine;"
"1302","141.74.2007.2","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, randomized data",74,"Cladribine & Cyclophosphamide (CC)",TRUE,"Cont.","26.Cladribine;0.Cyclophosphamide;1.Cladribine;0.Cyclophosphamide;1.Cladribine;0.Cyclophosphamide;26.Cladribine;0.Cyclophosphamide;1.Cladribine;0.Cyclophosphamide;1.Cladribine;0.Cyclophosphamide;","26.Cladribine;0.Cyclophosphamide;1.Cladribine;0.Cyclophosphamide;1.Cladribine;0.Cyclophosphamide;"
"1303","141.74.2008.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, randomized data",74,"Chlorambucil & Obinutuzumab (GClb)",TRUE,"Cont.","14.Chlorambucil;0.Obinutuzumab;14.Chlorambucil;14.Chlorambucil;0.Obinutuzumab;14.Chlorambucil;","14.Chlorambucil;0.Obinutuzumab;14.Chlorambucil;"
"1304","141.74.2008.2","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, randomized data",74,"Chlorambucil & Obinutuzumab (GClb)",TRUE,"Cont.","14.Chlorambucil;0.Obinutuzumab;7.Obinutuzumab;7.Chlorambucil;0.Obinutuzumab;14.Chlorambucil;0.Obinutuzumab;7.Obinutuzumab;7.Chlorambucil;0.Obinutuzumab;","14.Chlorambucil;0.Obinutuzumab;7.Obinutuzumab;7.Chlorambucil;0.Obinutuzumab;"
"1305","141.74.2009.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, randomized data",74,"Chlorambucil & Ofatumumab",TRUE,"Cont.","21.Chlorambucil;0.Ofatumumab;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Ofatumumab;21.Chlorambucil;0.Ofatumumab;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Ofatumumab;","21.Chlorambucil;0.Ofatumumab;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Ofatumumab;"
"1306","141.74.2009.2","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, randomized data",74,"Chlorambucil & Ofatumumab",TRUE,"Cont.","22.Chlorambucil;0.Ofatumumab;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;22.Chlorambucil;0.Ofatumumab;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;","22.Chlorambucil;0.Ofatumumab;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;"
"1307","141.74.2010.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, randomized data",74,"Chlorambucil & Rituximab (RClb)",TRUE,"Cont.","14.Chlorambucil;0.Rituximab;14.Chlorambucil;14.Chlorambucil;0.Rituximab;14.Chlorambucil;","14.Chlorambucil;0.Rituximab;14.Chlorambucil;"
"1308","141.74.2010.2","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, randomized data",74,"Chlorambucil & Rituximab (RClb)",TRUE,"Cont.","22.Chlorambucil;0.Rituximab;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;22.Chlorambucil;0.Rituximab;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;","22.Chlorambucil;0.Rituximab;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;"
"1309","141.74.2011.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, randomized data",74,"Cladribine monotherapy",TRUE,"Cont.","24.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;24.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;","24.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;"
"1310","141.74.2011.2","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, randomized data",74,"Cladribine monotherapy",TRUE,"Cont.","22.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;22.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;","22.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;"
"1311","141.74.2011.3","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, randomized data",74,"Cladribine monotherapy",TRUE,"Cont.","28.Cladribine;28.Cladribine;","28.Cladribine;28.Cladribine;"
"1312","141.74.2012.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, randomized data",74,"FCA",NA,NA,"0.Alemtuzumab;NA.Alemtuzumab;NA.Alemtuzumab;NA.Cyclophosphamide;NA.Fludarabine;NA.Cyclophosphamide;NA.Fludarabine;NA.Cyclophosphamide;NA.Fludarabine;","0.Alemtuzumab;NA.Alemtuzumab;NA.Alemtuzumab;NA.Cyclophosphamide;NA.Fludarabine;NA.Cyclophosphamide;NA.Fludarabine;NA.Cyclophosphamide;NA.Fludarabine;"
"1313","141.74.2012.2","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, randomized data",74,"FCA",NA,NA,"0.Alemtuzumab;NA.Cyclophosphamide;NA.Fludarabine;NA.Cyclophosphamide;NA.Fludarabine;NA.Cyclophosphamide;NA.Fludarabine;NA.Alemtuzumab;NA.Cyclophosphamide;NA.Fludarabine;NA.Cyclophosphamide;NA.Fludarabine;NA.Cyclophosphamide;NA.Fludarabine;NA.Alemtuzumab;NA.Cyclophosphamide;NA.Fludarabine;NA.Cyclophosphamide;NA.Fludarabine;NA.Cyclophosphamide;NA.Fludarabine;NA.Alemtuzumab;NA.Cyclophosphamide;NA.Fludarabine;NA.Cyclophosphamide;NA.Fludarabine;NA.Cyclophosphamide;NA.Fludarabine;NA.Alemtuzumab;NA.Cyclophosphamide;NA.Fludarabine;NA.Cyclophosphamide;NA.Fludarabine;NA.Cyclophosphamide;NA.Fludarabine;","0.Alemtuzumab;NA.Cyclophosphamide;NA.Fludarabine;NA.Cyclophosphamide;NA.Fludarabine;NA.Cyclophosphamide;NA.Fludarabine;NA.Alemtuzumab;NA.Cyclophosphamide;NA.Fludarabine;NA.Cyclophosphamide;NA.Fludarabine;NA.Cyclophosphamide;NA.Fludarabine;NA.Alemtuzumab;NA.Cyclophosphamide;NA.Fludarabine;NA.Cyclophosphamide;NA.Fludarabine;NA.Cyclophosphamide;NA.Fludarabine;NA.Alemtuzumab;NA.Cyclophosphamide;NA.Fludarabine;NA.Cyclophosphamide;NA.Fludarabine;NA.Cyclophosphamide;NA.Fludarabine;NA.Alemtuzumab;NA.Cyclophosphamide;NA.Fludarabine;NA.Cyclophosphamide;NA.Fludarabine;NA.Cyclophosphamide;NA.Fludarabine;"
"1314","141.74.2013.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, randomized data",74,"FCR",NA,NA,"0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;","0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;"
"1315","141.74.2013.2","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, randomized data",74,"FCR",NA,NA,"0.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;","0.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;"
"1316","141.74.2013.3","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, randomized data",74,"FCR",NA,NA,"0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;","0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;"
"1317","141.74.2013.4","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, randomized data",74,"FCR",NA,NA,"0.Cyclophosphamide;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;27.Cyclophosphamide;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;27.Cyclophosphamide;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;27.Cyclophosphamide;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;","0.Cyclophosphamide;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;27.Cyclophosphamide;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;27.Cyclophosphamide;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;27.Cyclophosphamide;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;"
"1318","141.74.2013.5","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, randomized data",74,"FCR",TRUE,"Cont.","26.Cyclophosphamide;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;","26.Cyclophosphamide;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;"
"1319","141.74.2013.6","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, randomized data",74,"FCR",FALSE,"6","24.Cyclophosphamide;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;24.Cyclophosphamide;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;","24.Cyclophosphamide;0.Fludarabine;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;"
"1320","141.74.2014.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, randomized data",74,"FCR (Rituximab and hyaluronidase)",NA,NA,"0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Rituximabandhyaluronidase;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Rituximabandhyaluronidase;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Rituximabandhyaluronidase;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Rituximabandhyaluronidase;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Rituximabandhyaluronidase;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;","0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Rituximabandhyaluronidase;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Rituximabandhyaluronidase;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Rituximabandhyaluronidase;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Rituximabandhyaluronidase;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Rituximabandhyaluronidase;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;"
"1321","141.74.2015.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, randomized data",74,"Fludarabine & Alemtuzumab",TRUE,"Cont.","26.Alemtuzumab;0.Fludarabine;1.Alemtuzumab;0.Fludarabine;1.Alemtuzumab;0.Fludarabine;26.Alemtuzumab;0.Fludarabine;1.Alemtuzumab;0.Fludarabine;1.Alemtuzumab;0.Fludarabine;","26.Alemtuzumab;0.Fludarabine;1.Alemtuzumab;0.Fludarabine;1.Alemtuzumab;0.Fludarabine;"
"1322","141.74.2016.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, randomized data",74,"Ibrutinib monotherapy",TRUE,"Cont.","1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;","1.Ibrutinib;1.Ibrutinib;"
"1323","141.74.2017.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, randomized data",74,"Ibrutinib & Obinutuzumab",TRUE,"Cont.","14.Ibrutinib;0.Obinutuzumab;1.Ibrutinib;0.Obinutuzumab;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Obinutuzumab;7.Obinutuzumab;14.Ibrutinib;0.Obinutuzumab;1.Ibrutinib;0.Obinutuzumab;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Obinutuzumab;7.Obinutuzumab;","14.Ibrutinib;0.Obinutuzumab;1.Ibrutinib;0.Obinutuzumab;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Obinutuzumab;7.Obinutuzumab;"
"1324","141.74.2017.2","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, randomized data",74,"Ibrutinib & Obinutuzumab",TRUE,"Cont.","22.Ibrutinib;0.Obinutuzumab;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Ibrutinib;0.Obinutuzumab;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;","22.Ibrutinib;0.Obinutuzumab;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;"
"1325","141.74.2018.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, randomized data",74,"Ibrutinib & Rituximab",TRUE,"Cont.","1.Ibrutinib;0.Rituximab;1.Ibrutinib;0.Rituximab;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;0.Rituximab;1.Ibrutinib;0.Rituximab;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;","1.Ibrutinib;0.Rituximab;1.Ibrutinib;0.Rituximab;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;"
"1326","141.74.2018.2","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, randomized data",74,"Ibrutinib & Rituximab",TRUE,"Cont.","1.Ibrutinib;0.Rituximab;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;0.Rituximab;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;","1.Ibrutinib;0.Rituximab;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;"
"1327","141.74.2019.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, randomized data",74,"Ibrutinib & Venetoclax",TRUE,"Cont.","1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;","1.Ibrutinib;0.Venetoclax;"
"1328","141.74.2019.2","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, randomized data",74,"Ibrutinib & Venetoclax",TRUE,"Cont.","1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;","1.Ibrutinib;0.Venetoclax;"
"1329","141.74.2020.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, randomized data",74,"Obinutuzumab monotherapy",TRUE,"Cont.","7.Obinutuzumab;1.Obinutuzumab;6.Obinutuzumab;7.Obinutuzumab;7.Obinutuzumab;1.Obinutuzumab;6.Obinutuzumab;7.Obinutuzumab;","7.Obinutuzumab;1.Obinutuzumab;6.Obinutuzumab;7.Obinutuzumab;"
"1330","141.74.2020.2","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, randomized data",74,"Obinutuzumab monotherapy",TRUE,"Cont.","21.Obinutuzumab;21.Obinutuzumab;","21.Obinutuzumab;21.Obinutuzumab;"
"1331","141.74.2021.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, randomized data",74,"Venetoclax & Obinutuzumab",NA,NA,"0.Obinutuzumab;1.Obinutuzumab;27.Obinutuzumab;0.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;22.Obinutuzumab;0.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;22.Obinutuzumab;0.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;22.Obinutuzumab;0.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;22.Obinutuzumab;0.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;22.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;22.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;22.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;","0.Obinutuzumab;1.Obinutuzumab;27.Obinutuzumab;0.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;22.Obinutuzumab;0.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;22.Obinutuzumab;0.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;22.Obinutuzumab;0.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;22.Obinutuzumab;0.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;22.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;22.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;22.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;"
"1332","141.74.2022.1","Malignant Hematology","Indolent lymphomas","Chronic lymphocytic leukemia",141,"First-line therapy, randomized data",74,"Zanubrutinib monotherapy",TRUE,"Cont.","1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;1.Zanubrutinib;","1.Zanubrutinib;1.Zanubrutinib;"
"1333","142.11.2087.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Advanced disease, first-line therapy, non-randomized or retrospective data",11,"Bortezomib & Rituximab (VR)",NA,NA,"0.Bortezomib;0.Rituximab;35.Bortezomib;0.Rituximab;35.Bortezomib;0.Rituximab;","0.Bortezomib;0.Rituximab;35.Bortezomib;0.Rituximab;35.Bortezomib;0.Rituximab;"
"1334","142.11.2088.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Advanced disease, first-line therapy, non-randomized or retrospective data",11,"Fludarabine & Rituximab (FR)",NA,NA,"0.Rituximab;3.Rituximab;4.Fludarabine;1.Fludarabine;1.Fludarabine;1.Fludarabine;1.Fludarabine;NA.Fludarabine;NA.Rituximab;NA.Fludarabine;NA.Fludarabine;NA.Fludarabine;NA.Fludarabine;","0.Rituximab;3.Rituximab;4.Fludarabine;1.Fludarabine;1.Fludarabine;1.Fludarabine;1.Fludarabine;NA.Fludarabine;NA.Rituximab;NA.Fludarabine;NA.Fludarabine;NA.Fludarabine;NA.Fludarabine;"
"1335","142.11.2089.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Advanced disease, first-line therapy, non-randomized or retrospective data",11,"Ibritumomab tiuxetan protocol",FALSE,"1","0.Rituximab;8.Ibritumomabtiuxetan&yttrium-90;0.Rituximab;","0.Rituximab;8.Ibritumomabtiuxetan&yttrium-90;0.Rituximab;"
"1336","142.11.2090.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Advanced disease, first-line therapy, non-randomized or retrospective data",11,"O-CHOP",FALSE,"6","19.Ofatumumab;2.Cyclophosphamide;0.Doxorubicin;0.Vincristine;19.Ofatumumab;2.Cyclophosphamide;0.Doxorubicin;0.Vincristine;","19.Ofatumumab;2.Cyclophosphamide;0.Doxorubicin;0.Vincristine;"
"1337","142.11.2091.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Advanced disease, first-line therapy, non-randomized or retrospective data",11,"R-CMD",FALSE,"4","19.Cladribine;0.Mitoxantrone;0.Rituximab;1.Cladribine;1.Cladribine;19.Cladribine;0.Mitoxantrone;0.Rituximab;1.Cladribine;1.Cladribine;","19.Cladribine;0.Mitoxantrone;0.Rituximab;1.Cladribine;1.Cladribine;"
"1338","142.11.2092.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Advanced disease, first-line therapy, non-randomized or retrospective data",11,"R-FCM",NA,NA,"0.Cyclophosphamide;0.Fludarabine;0.Mitoxantrone;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Mitoxantrone;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Mitoxantrone;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Mitoxantrone;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Mitoxantrone;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Mitoxantrone;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;","0.Cyclophosphamide;0.Fludarabine;0.Mitoxantrone;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Mitoxantrone;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Mitoxantrone;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Mitoxantrone;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Mitoxantrone;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Cyclophosphamide;0.Fludarabine;0.Mitoxantrone;0.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;"
"1339","142.11.2093.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Advanced disease, first-line therapy, non-randomized or retrospective data",11,"VR-CHOP",TRUE,"Cont.","14.Bortezomib;0.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;7.Bortezomib;14.Bortezomib;0.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;7.Bortezomib;","14.Bortezomib;0.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;7.Bortezomib;"
"1340","142.114.2096.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Maintenance after first-line therapy",114,"Bortezomib & Rituximab (VR)",TRUE,"Cont.","147.Bortezomib;0.Rituximab;7.Bortezomib;0.Rituximab;7.Bortezomib;0.Rituximab;7.Bortezomib;0.Rituximab;147.Bortezomib;0.Rituximab;7.Bortezomib;0.Rituximab;7.Bortezomib;0.Rituximab;7.Bortezomib;0.Rituximab;","147.Bortezomib;0.Rituximab;7.Bortezomib;0.Rituximab;7.Bortezomib;0.Rituximab;7.Bortezomib;0.Rituximab;"
"1341","142.114.2097.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Maintenance after first-line therapy",114,"Lenalidomide & Rituximab (R2)",TRUE,"Cont.","1.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","1.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1342","142.114.2098.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Maintenance after first-line therapy",114,"Obinutuzumab monotherapy",TRUE,"Cont.","56.Obinutuzumab;56.Obinutuzumab;","56.Obinutuzumab;56.Obinutuzumab;"
"1343","142.114.2099.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Maintenance after first-line therapy",114,"Rituximab monotherapy, extended course",TRUE,"Cont.","147.Rituximab;0.Rituximab;0.Rituximab;7.Rituximab;0.Rituximab;7.Rituximab;0.Rituximab;7.Rituximab;0.Rituximab;147.Rituximab;0.Rituximab;0.Rituximab;7.Rituximab;0.Rituximab;7.Rituximab;0.Rituximab;7.Rituximab;0.Rituximab;","147.Rituximab;0.Rituximab;0.Rituximab;7.Rituximab;0.Rituximab;7.Rituximab;0.Rituximab;7.Rituximab;0.Rituximab;"
"1344","142.114.2100.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Maintenance after first-line therapy",114,"Rituximab and hyaluronidase monotherapy",TRUE,"Cont.","56.Rituximabandhyaluronidase;56.Rituximabandhyaluronidase;","56.Rituximabandhyaluronidase;56.Rituximabandhyaluronidase;"
"1345","142.117.2129.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Maintenance after subsequent lines of therapy",117,"Bortezomib & Rituximab (VR)",TRUE,"Cont.","161.Bortezomib;0.Rituximab;7.Bortezomib;0.Rituximab;161.Bortezomib;0.Rituximab;7.Bortezomib;0.Rituximab;","161.Bortezomib;0.Rituximab;7.Bortezomib;0.Rituximab;"
"1346","142.12.2075.3","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Advanced disease, pre-phase",12,"Rituximab monotherapy",FALSE,"1","0.Rituximab;7.Rituximab;7.Rituximab;7.Rituximab;","0.Rituximab;7.Rituximab;7.Rituximab;7.Rituximab;"
"1347","142.12.2076.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Advanced disease, pre-phase",12,"Bendamustine & Obinutuzumab",NA,NA,"0.Bendamustine;0.Obinutuzumab;1.Bendamustine;27.Bendamustine;0.Obinutuzumab;1.Bendamustine;27.Bendamustine;0.Obinutuzumab;1.Bendamustine;27.Bendamustine;0.Obinutuzumab;1.Bendamustine;27.Bendamustine;0.Obinutuzumab;1.Bendamustine;27.Bendamustine;0.Obinutuzumab;1.Bendamustine;","0.Bendamustine;0.Obinutuzumab;1.Bendamustine;27.Bendamustine;0.Obinutuzumab;1.Bendamustine;27.Bendamustine;0.Obinutuzumab;1.Bendamustine;27.Bendamustine;0.Obinutuzumab;1.Bendamustine;27.Bendamustine;0.Obinutuzumab;1.Bendamustine;27.Bendamustine;0.Obinutuzumab;1.Bendamustine;"
"1348","142.12.2077.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Advanced disease, pre-phase",12,"Chlorambucil monotherapy",TRUE,"Cont.","1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;","1.Chlorambucil;1.Chlorambucil;"
"1349","142.12.2078.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Advanced disease, pre-phase",12,"Cyclophosphamide monotherapy",TRUE,"Cont.","1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;","1.Cyclophosphamide;1.Cyclophosphamide;"
"1350","142.12.2079.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Advanced disease, pre-phase",12,"G-CVP",NA,NA,"0.Cyclophosphamide;0.Obinutuzumab;0.Vincristine;21.Cyclophosphamide;0.Obinutuzumab;0.Vincristine;21.Cyclophosphamide;0.Obinutuzumab;0.Vincristine;21.Cyclophosphamide;0.Obinutuzumab;0.Vincristine;21.Cyclophosphamide;0.Obinutuzumab;0.Vincristine;21.Cyclophosphamide;0.Obinutuzumab;0.Vincristine;21.Cyclophosphamide;0.Obinutuzumab;0.Vincristine;21.Cyclophosphamide;0.Obinutuzumab;0.Vincristine;","0.Cyclophosphamide;0.Obinutuzumab;0.Vincristine;21.Cyclophosphamide;0.Obinutuzumab;0.Vincristine;21.Cyclophosphamide;0.Obinutuzumab;0.Vincristine;21.Cyclophosphamide;0.Obinutuzumab;0.Vincristine;21.Cyclophosphamide;0.Obinutuzumab;0.Vincristine;21.Cyclophosphamide;0.Obinutuzumab;0.Vincristine;21.Cyclophosphamide;0.Obinutuzumab;0.Vincristine;21.Cyclophosphamide;0.Obinutuzumab;0.Vincristine;"
"1351","142.12.2080.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Advanced disease, pre-phase",12,"G-CHOP",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;0.Obinutuzumab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Obinutuzumab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Obinutuzumab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Obinutuzumab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Obinutuzumab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Obinutuzumab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Obinutuzumab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Obinutuzumab;0.Vincristine;","0.Cyclophosphamide;0.Doxorubicin;0.Obinutuzumab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Obinutuzumab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Obinutuzumab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Obinutuzumab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Obinutuzumab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Obinutuzumab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Obinutuzumab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Obinutuzumab;0.Vincristine;"
"1352","142.12.2081.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Advanced disease, pre-phase",12,"Lenalidomide & Rituximab (R2)",NA,NA,"0.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","0.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1353","142.12.2081.2","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Advanced disease, pre-phase",12,"Lenalidomide & Rituximab (R2)",NA,NA,"0.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","0.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1354","142.12.2081.3","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Advanced disease, pre-phase",12,"Lenalidomide & Rituximab (R2)",NA,NA,"0.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","0.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1355","142.12.2082.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Advanced disease, pre-phase",12,"R-CHOP",TRUE,"Cont.","21.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;","21.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;"
"1356","142.12.2082.2","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Advanced disease, pre-phase",12,"R-CHOP",NA,NA,"0.Rituximab;5.Rituximab;24.Cyclophosphamide;0.Doxorubicin;0.Vincristine;21.Rituximab;3.Cyclophosphamide;0.Doxorubicin;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Vincristine;","0.Rituximab;5.Rituximab;24.Cyclophosphamide;0.Doxorubicin;0.Vincristine;21.Rituximab;3.Cyclophosphamide;0.Doxorubicin;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Vincristine;"
"1357","142.12.2082.3","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Advanced disease, pre-phase",12,"R-CHOP",NA,NA,"0.Rituximab;3.Cyclophosphamide;0.Doxorubicin;0.Vincristine;21.Rituximab;3.Cyclophosphamide;0.Doxorubicin;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Vincristine;21.Rituximab;3.Cyclophosphamide;0.Doxorubicin;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Vincristine;21.Rituximab;3.Cyclophosphamide;0.Doxorubicin;0.Vincristine;","0.Rituximab;3.Cyclophosphamide;0.Doxorubicin;0.Vincristine;21.Rituximab;3.Cyclophosphamide;0.Doxorubicin;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Vincristine;21.Rituximab;3.Cyclophosphamide;0.Doxorubicin;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Vincristine;21.Rituximab;3.Cyclophosphamide;0.Doxorubicin;0.Vincristine;"
"1358","142.12.2083.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Advanced disease, pre-phase",12,"R-CHVP+I",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;21.Cyclophosphamide;0.Doxorubicin;0.Etoposide;21.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Rituximab;21.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Rituximab;21.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Rituximab;21.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Rituximab;","0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;21.Cyclophosphamide;0.Doxorubicin;0.Etoposide;21.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Rituximab;21.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Rituximab;21.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Rituximab;21.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Rituximab;"
"1359","142.12.2084.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Advanced disease, pre-phase",12,"R-CVP",TRUE,"Cont.","21.Cyclophosphamide;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Rituximab;0.Vincristine;","21.Cyclophosphamide;0.Rituximab;0.Vincristine;"
"1360","142.12.2085.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Advanced disease, pre-phase",12,"R-FM",FALSE,"4","25.Rituximab;1.Fludarabine;0.Mitoxantrone;1.Fludarabine;1.Fludarabine;25.Rituximab;1.Fludarabine;0.Mitoxantrone;1.Fludarabine;1.Fludarabine;","25.Rituximab;1.Fludarabine;0.Mitoxantrone;1.Fludarabine;1.Fludarabine;"
"1361","142.12.2085.2","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Advanced disease, pre-phase",12,"R-FM",NA,NA,"0.Fludarabine;0.Mitoxantrone;0.Rituximab;1.Fludarabine;1.Fludarabine;19.Fludarabine;0.Mitoxantrone;0.Rituximab;1.Fludarabine;1.Fludarabine;19.Fludarabine;0.Mitoxantrone;0.Rituximab;1.Fludarabine;1.Fludarabine;19.Fludarabine;0.Mitoxantrone;0.Rituximab;1.Fludarabine;1.Fludarabine;19.Fludarabine;0.Mitoxantrone;0.Rituximab;1.Fludarabine;1.Fludarabine;19.Fludarabine;0.Mitoxantrone;0.Rituximab;1.Fludarabine;1.Fludarabine;19.Rituximab;21.Rituximab;","0.Fludarabine;0.Mitoxantrone;0.Rituximab;1.Fludarabine;1.Fludarabine;19.Fludarabine;0.Mitoxantrone;0.Rituximab;1.Fludarabine;1.Fludarabine;19.Fludarabine;0.Mitoxantrone;0.Rituximab;1.Fludarabine;1.Fludarabine;19.Fludarabine;0.Mitoxantrone;0.Rituximab;1.Fludarabine;1.Fludarabine;19.Fludarabine;0.Mitoxantrone;0.Rituximab;1.Fludarabine;1.Fludarabine;19.Fludarabine;0.Mitoxantrone;0.Rituximab;1.Fludarabine;1.Fludarabine;19.Rituximab;21.Rituximab;"
"1362","142.12.2086.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Advanced disease, pre-phase",12,"R-MCP",TRUE,"Cont.","22.Rituximab;2.Chlorambucil;0.Mitoxantrone;1.Chlorambucil;0.Mitoxantrone;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;22.Rituximab;2.Chlorambucil;0.Mitoxantrone;1.Chlorambucil;0.Mitoxantrone;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;","22.Rituximab;2.Chlorambucil;0.Mitoxantrone;1.Chlorambucil;0.Mitoxantrone;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;"
"1363","142.180.2108.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Relapsed or refractory, non-randomized or retrospective data",180,"Axicabtagene ciloleucel monotherapy",FALSE,"1","0.Axicabtageneciloleucel;","0.Axicabtageneciloleucel;0.Axicabtageneciloleucel;"
"1364","142.180.2109.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Relapsed or refractory, non-randomized or retrospective data",180,"Bortezomib monotherapy",TRUE,"Cont.","11.Bortezomib;3.Bortezomib;4.Bortezomib;3.Bortezomib;11.Bortezomib;3.Bortezomib;4.Bortezomib;3.Bortezomib;","11.Bortezomib;3.Bortezomib;4.Bortezomib;3.Bortezomib;"
"1365","142.180.2110.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Relapsed or refractory, non-randomized or retrospective data",180,"BVR",FALSE,"6","18.Bendamustine;0.Bortezomib;0.Rituximab;3.Bendamustine;0.Bortezomib;4.Bortezomib;3.Bortezomib;18.Bendamustine;0.Bortezomib;0.Rituximab;3.Bendamustine;0.Bortezomib;4.Bortezomib;3.Bortezomib;","18.Bendamustine;0.Bortezomib;0.Rituximab;3.Bendamustine;0.Bortezomib;4.Bortezomib;3.Bortezomib;"
"1366","142.180.2110.2","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Relapsed or refractory, non-randomized or retrospective data",180,"BVR",NA,NA,"0.Bendamustine;0.Bortezomib;0.Rituximab;1.Bendamustine;34.Bendamustine;0.Bortezomib;0.Rituximab;1.Bendamustine;34.Bendamustine;0.Bortezomib;0.Rituximab;1.Bendamustine;34.Bendamustine;0.Bortezomib;0.Rituximab;1.Bendamustine;34.Bendamustine;0.Bortezomib;0.Rituximab;1.Bendamustine;","0.Bendamustine;0.Bortezomib;0.Rituximab;1.Bendamustine;34.Bendamustine;0.Bortezomib;0.Rituximab;1.Bendamustine;34.Bendamustine;0.Bortezomib;0.Rituximab;1.Bendamustine;34.Bendamustine;0.Bortezomib;0.Rituximab;1.Bendamustine;34.Bendamustine;0.Bortezomib;0.Rituximab;1.Bendamustine;"
"1367","142.180.2111.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Relapsed or refractory, non-randomized or retrospective data",180,"Copanlisib monotherapy",TRUE,"Cont.","14.Copanlisib;7.Copanlisib;7.Copanlisib;14.Copanlisib;7.Copanlisib;7.Copanlisib;","14.Copanlisib;7.Copanlisib;7.Copanlisib;"
"1368","142.180.2112.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Relapsed or refractory, non-randomized or retrospective data",180,"Inotuzumab ozogamicin monotherapy",TRUE,"Cont.","28.Inotuzumabozogamicin;28.Inotuzumabozogamicin;","28.Inotuzumabozogamicin;28.Inotuzumabozogamicin;"
"1369","142.180.2113.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Relapsed or refractory, non-randomized or retrospective data",180,"Lenalidomide, Dexamethasone, Rituximab",NA,NA,"0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1370","142.180.2114.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Relapsed or refractory, non-randomized or retrospective data",180,"Mosunetuzumab monotherapy",TRUE,"Cont.","7.Mosunetuzumab;7.Mosunetuzumab;7.Mosunetuzumab;7.Mosunetuzumab;7.Mosunetuzumab;7.Mosunetuzumab;","7.Mosunetuzumab;7.Mosunetuzumab;"
"1371","142.180.2114.2","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Relapsed or refractory, non-randomized or retrospective data",180,"Mosunetuzumab monotherapy",TRUE,"Cont.","21.Mosunetuzumab;21.Mosunetuzumab;","21.Mosunetuzumab;21.Mosunetuzumab;"
"1372","142.180.2115.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Relapsed or refractory, non-randomized or retrospective data",180,"PEP-C",TRUE,"Cont.","1.Cyclophosphamide;0.Etoposide;0.Procarbazine;1.Cyclophosphamide;0.Etoposide;0.Procarbazine;1.Cyclophosphamide;0.Etoposide;0.Procarbazine;1.Cyclophosphamide;0.Etoposide;0.Procarbazine;1.Cyclophosphamide;0.Etoposide;0.Procarbazine;1.Cyclophosphamide;0.Etoposide;0.Procarbazine;1.Cyclophosphamide;0.Etoposide;0.Procarbazine;1.Cyclophosphamide;0.Etoposide;0.Procarbazine;1.Cyclophosphamide;0.Etoposide;0.Procarbazine;1.Cyclophosphamide;0.Etoposide;0.Procarbazine;1.Cyclophosphamide;0.Etoposide;0.Procarbazine;1.Cyclophosphamide;0.Etoposide;0.Procarbazine;1.Cyclophosphamide;0.Etoposide;0.Procarbazine;1.Cyclophosphamide;0.Etoposide;0.Procarbazine;","1.Cyclophosphamide;0.Etoposide;0.Procarbazine;"
"1373","142.180.2116.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Relapsed or refractory, non-randomized or retrospective data",180,"R-DexaBEAM",FALSE,"2","21.Rituximab;1.Melphalan;1.Carmustine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Rituximab;","21.Rituximab;1.Melphalan;1.Carmustine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Rituximab;"
"1374","142.180.2116.2","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Relapsed or refractory, non-randomized or retrospective data",180,"R-DexaBEAM",FALSE,"2","28.Rituximab;1.Melphalan;1.Carmustine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Rituximab;","28.Rituximab;1.Melphalan;1.Carmustine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Rituximab;"
"1375","142.180.2116.3","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Relapsed or refractory, non-randomized or retrospective data",180,"R-DexaBEAM",FALSE,"2","35.Rituximab;1.Melphalan;1.Carmustine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Rituximab;","35.Rituximab;1.Melphalan;1.Carmustine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Rituximab;"
"1376","142.180.2117.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Relapsed or refractory, non-randomized or retrospective data",180,"R-FND",NA,NA,"0.Rituximab;1.Fludarabine;0.Mitoxantrone;1.Fludarabine;1.Fludarabine;25.Rituximab;1.Fludarabine;0.Mitoxantrone;1.Fludarabine;1.Fludarabine;25.Rituximab;1.Fludarabine;0.Mitoxantrone;1.Fludarabine;1.Fludarabine;25.Rituximab;1.Fludarabine;0.Mitoxantrone;1.Fludarabine;1.Fludarabine;25.Rituximab;1.Fludarabine;0.Mitoxantrone;1.Fludarabine;1.Fludarabine;","0.Rituximab;1.Fludarabine;0.Mitoxantrone;1.Fludarabine;1.Fludarabine;25.Rituximab;1.Fludarabine;0.Mitoxantrone;1.Fludarabine;1.Fludarabine;25.Rituximab;1.Fludarabine;0.Mitoxantrone;1.Fludarabine;1.Fludarabine;25.Rituximab;1.Fludarabine;0.Mitoxantrone;1.Fludarabine;1.Fludarabine;25.Rituximab;1.Fludarabine;0.Mitoxantrone;1.Fludarabine;1.Fludarabine;"
"1377","142.180.2118.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Relapsed or refractory, non-randomized or retrospective data",180,"R-INO",TRUE,"Cont.","27.Rituximab;1.Inotuzumabozogamicin;27.Rituximab;1.Inotuzumabozogamicin;","27.Rituximab;1.Inotuzumabozogamicin;"
"1378","142.180.2119.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Relapsed or refractory, non-randomized or retrospective data",180,"Tazemetostat monotherapy",TRUE,"Cont.","1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;","1.Tazemetostat;1.Tazemetostat;"
"1379","142.180.2120.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Relapsed or refractory, non-randomized or retrospective data",180,"Temsirolimus monotherapy",TRUE,"Cont.","1.Temsirolimus;1.Temsirolimus;1.Temsirolimus;1.Temsirolimus;1.Temsirolimus;1.Temsirolimus;1.Temsirolimus;1.Temsirolimus;1.Temsirolimus;1.Temsirolimus;1.Temsirolimus;1.Temsirolimus;1.Temsirolimus;1.Temsirolimus;","1.Temsirolimus;1.Temsirolimus;"
"1380","142.180.2121.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Relapsed or refractory, non-randomized or retrospective data",180,"Tisagenlecleucel monotherapy",FALSE,"1","0.Tisagenlecleucel;","0.Tisagenlecleucel;0.Tisagenlecleucel;"
"1381","142.180.2122.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Relapsed or refractory, non-randomized or retrospective data",180,"Vorinostat monotherapy",TRUE,"Cont.","8.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;8.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;","8.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;"
"1382","142.180.2123.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Relapsed or refractory, non-randomized or retrospective data",180,"Vorinostat & Rituximab",TRUE,"Cont.","8.Rituximab;0.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;8.Rituximab;0.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;","8.Rituximab;0.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;"
"1383","142.180.2124.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Relapsed or refractory, non-randomized or retrospective data",180,"VR-CP",FALSE,"6","14.Bortezomib;0.Cyclophosphamide;0.Rituximab;7.Bortezomib;14.Bortezomib;0.Cyclophosphamide;0.Rituximab;7.Bortezomib;","14.Bortezomib;0.Cyclophosphamide;0.Rituximab;7.Bortezomib;"
"1384","142.182.2101.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Relapsed or refractory, randomized data",182,"Bevacizumab & Rituximab",NA,NA,"0.Rituximab;2.Bevacizumab;82.Bevacizumab;0.Rituximab;56.Bevacizumab;0.Rituximab;56.Bevacizumab;0.Rituximab;56.Bevacizumab;0.Rituximab;","0.Rituximab;2.Bevacizumab;82.Bevacizumab;0.Rituximab;56.Bevacizumab;0.Rituximab;56.Bevacizumab;0.Rituximab;56.Bevacizumab;0.Rituximab;"
"1385","142.182.2102.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Relapsed or refractory, randomized data",182,"Bortezomib & Rituximab (VR)",NA,NA,"0.Bortezomib;3.Bortezomib;18.Bortezomib;0.Rituximab;3.Bortezomib;18.Bortezomib;0.Rituximab;3.Bortezomib;18.Bortezomib;0.Rituximab;3.Bortezomib;18.Bortezomib;0.Rituximab;3.Bortezomib;","0.Bortezomib;3.Bortezomib;18.Bortezomib;0.Rituximab;3.Bortezomib;18.Bortezomib;0.Rituximab;3.Bortezomib;18.Bortezomib;0.Rituximab;3.Bortezomib;18.Bortezomib;0.Rituximab;3.Bortezomib;"
"1386","142.182.2103.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Relapsed or refractory, randomized data",182,"Copanlisib & Rituximab",NA,NA,"0.Copanlisib;0.Rituximab;28.Copanlisib;28.Copanlisib;0.Rituximab;28.Copanlisib;28.Copanlisib;0.Rituximab;28.Copanlisib;28.Copanlisib;0.Rituximab;28.Copanlisib;28.Copanlisib;0.Rituximab;","0.Copanlisib;0.Rituximab;28.Copanlisib;28.Copanlisib;0.Rituximab;28.Copanlisib;28.Copanlisib;0.Rituximab;28.Copanlisib;28.Copanlisib;0.Rituximab;28.Copanlisib;28.Copanlisib;0.Rituximab;"
"1387","142.182.2104.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Relapsed or refractory, randomized data",182,"Ibritumomab tiuxetan protocol",FALSE,"1","0.Ibritumomabtiuxetan1.6mg&Indium-1115mCi;0.Rituximab;7.Ibritumomabtiuxetan&Yttrium-90;0.Rituximab;","0.Ibritumomabtiuxetan1.6mg&Indium-1115mCi;0.Rituximab;7.Ibritumomabtiuxetan&Yttrium-90;0.Rituximab;"
"1388","142.182.2105.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Relapsed or refractory, randomized data",182,"Lenalidomide & Rituximab (R2)",TRUE,"Cont.","1.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","1.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1389","142.182.2105.2","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Relapsed or refractory, randomized data",182,"Lenalidomide & Rituximab (R2)",NA,NA,"0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;23.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;23.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1390","142.182.2105.3","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Relapsed or refractory, randomized data",182,"Lenalidomide & Rituximab (R2)",NA,NA,"0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1391","142.182.2105.4","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Relapsed or refractory, randomized data",182,"Lenalidomide & Rituximab (R2)",NA,NA,"0.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","0.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1392","142.182.2105.5","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Relapsed or refractory, randomized data",182,"Lenalidomide & Rituximab (R2)",NA,NA,"0.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","0.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Lenalidomide;0.Rituximab;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1393","142.182.2106.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Relapsed or refractory, randomized data",182,"Obinutuzumab monotherapy",TRUE,"Cont.","7.Obinutuzumab;7.Obinutuzumab;7.Obinutuzumab;7.Obinutuzumab;7.Obinutuzumab;7.Obinutuzumab;7.Obinutuzumab;7.Obinutuzumab;","7.Obinutuzumab;7.Obinutuzumab;"
"1394","142.182.2106.2","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Relapsed or refractory, randomized data",182,"Obinutuzumab monotherapy",NA,NA,"0.Obinutuzumab;6.Obinutuzumab;15.Obinutuzumab;21.Obinutuzumab;21.Obinutuzumab;21.Obinutuzumab;21.Obinutuzumab;21.Obinutuzumab;21.Obinutuzumab;","0.Obinutuzumab;6.Obinutuzumab;15.Obinutuzumab;21.Obinutuzumab;21.Obinutuzumab;21.Obinutuzumab;21.Obinutuzumab;21.Obinutuzumab;21.Obinutuzumab;"
"1395","142.182.2107.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Relapsed or refractory, randomized data",182,"R-FCM",FALSE,"4","26.Rituximab;1.Cyclophosphamide;0.Fludarabine;0.Mitoxantrone;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;26.Rituximab;1.Cyclophosphamide;0.Fludarabine;0.Mitoxantrone;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;","26.Rituximab;1.Cyclophosphamide;0.Fludarabine;0.Mitoxantrone;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;"
"1396","142.40.2094.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Consolidation after first-line therapy",40,"Bortezomib & Rituximab (VR)",FALSE,"4","56.Bortezomib;0.Rituximab;56.Bortezomib;0.Rituximab;","56.Bortezomib;0.Rituximab;"
"1397","142.40.2095.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Consolidation after first-line therapy",40,"Rituximab monotherapy, abbreviated course",FALSE,"1","0.Rituximab;7.Rituximab;","0.Rituximab;7.Rituximab;"
"1398","142.43.2125.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Consolidation after subsequent lines of therapy",43,"FCR, then allo HSCT",FALSE,"1","0.Rituximab;7.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;4.Rituximab;7.Rituximab;","0.Rituximab;7.Rituximab;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;4.Rituximab;7.Rituximab;"
"1399","142.43.2126.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Consolidation after subsequent lines of therapy",43,"R-BEAM, then auto HSCT",FALSE,"1","0.Rituximab;1.Carmustine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Melphalan;0.Rituximab;","0.Rituximab;1.Carmustine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Melphalan;0.Rituximab;"
"1400","142.43.2127.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Consolidation after subsequent lines of therapy",43,"R-TBI/Cy, then auto HSCT",FALSE,"1","0.Rituximab;5.Cyclophosphamide;1.Cyclophosphamide;0.Rituximab;","0.Rituximab;5.Cyclophosphamide;1.Cyclophosphamide;0.Rituximab;"
"1401","142.43.2128.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Consolidation after subsequent lines of therapy",43,"(90)YFC, then allo HSCT",FALSE,"1","0.Ibritumomabtiuxetan1.6mg&Indium-1115mCi;0.Rituximab;7.Ibritumomabtiuxetan&Yttrium-90;0.Rituximab;2.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;1.Antithymocyteglobulin;0.rabbitATG;1.Antithymocyteglobulin;0.rabbitATG;","0.Ibritumomabtiuxetan1.6mg&Indium-1115mCi;0.Rituximab;7.Ibritumomabtiuxetan&Yttrium-90;0.Rituximab;2.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;1.Cyclophosphamide;0.Fludarabine;1.Antithymocyteglobulin;0.rabbitATG;1.Antithymocyteglobulin;0.rabbitATG;"
"1402","142.57.2074.1","Malignant Hematology","Indolent lymphomas","Follicular lymphoma",142,"Early disease, definitive therapy",57,"Ibritumomab tiuxetan protocol",FALSE,"1","0.Rituximab;7.Ibritumomabtiuxetan&yttrium-90;0.Rituximab;","0.Rituximab;7.Ibritumomabtiuxetan&yttrium-90;0.Rituximab;"
"1403","143.172.2133.1","Malignant Hematology","Indolent lymphomas","Hairy cell leukemia",143,"Relapsed or refractory",172,"Bendamustine & Rituximab (BR)",FALSE,"6","14.Bendamustine;0.Rituximab;1.Bendamustine;13.Rituximab;14.Bendamustine;0.Rituximab;1.Bendamustine;13.Rituximab;","14.Bendamustine;0.Rituximab;1.Bendamustine;13.Rituximab;"
"1404","143.172.2134.1","Malignant Hematology","Indolent lymphomas","Hairy cell leukemia",143,"Relapsed or refractory",172,"Interferon alfa-2a monotherapy",FALSE,"1","0.Interferonalfa-2a;","0.Interferonalfa-2a;0.Interferonalfa-2a;"
"1405","143.172.2135.1","Malignant Hematology","Indolent lymphomas","Hairy cell leukemia",143,"Relapsed or refractory",172,"Interferon alfa-2b monotherapy",FALSE,"1","0.Interferonalfa-2b;","0.Interferonalfa-2b;0.Interferonalfa-2b;"
"1406","143.172.2136.1","Malignant Hematology","Indolent lymphomas","Hairy cell leukemia",143,"Relapsed or refractory",172,"Moxetumomab pasudotox monotherapy",TRUE,"Cont.","24.Moxetumomabpasudotox;2.Moxetumomabpasudotox;2.Moxetumomabpasudotox;24.Moxetumomabpasudotox;2.Moxetumomabpasudotox;2.Moxetumomabpasudotox;","24.Moxetumomabpasudotox;2.Moxetumomabpasudotox;2.Moxetumomabpasudotox;"
"1407","143.172.2137.1","Malignant Hematology","Indolent lymphomas","Hairy cell leukemia",143,"Relapsed or refractory",172,"Vemurafenib monotherapy",TRUE,"Cont.","1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;","1.Vemurafenib;1.Vemurafenib;"
"1408","143.195.2130.1","Malignant Hematology","Indolent lymphomas","Hairy cell leukemia",143,"Untreated",195,"Cladribine monotherapy",FALSE,"1","0.Cladribine;","0.Cladribine;0.Cladribine;"
"1409","143.195.2130.2","Malignant Hematology","Indolent lymphomas","Hairy cell leukemia",143,"Untreated",195,"Cladribine monotherapy",FALSE,"1","0.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;","0.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;"
"1410","143.195.2130.3","Malignant Hematology","Indolent lymphomas","Hairy cell leukemia",143,"Untreated",195,"Cladribine monotherapy",FALSE,"1","0.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;","0.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;"
"1411","143.195.2131.1","Malignant Hematology","Indolent lymphomas","Hairy cell leukemia",143,"Untreated",195,"Cladribine & Rituximab",FALSE,"1","0.Cladribine;0.Rituximab;1.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;3.Rituximab;7.Rituximab;7.Rituximab;7.Rituximab;7.Rituximab;7.Rituximab;7.Rituximab;","0.Cladribine;0.Rituximab;1.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;3.Rituximab;7.Rituximab;7.Rituximab;7.Rituximab;7.Rituximab;7.Rituximab;7.Rituximab;"
"1412","143.195.2132.1","Malignant Hematology","Indolent lymphomas","Hairy cell leukemia",143,"Untreated",195,"Pentostatin monotherapy",TRUE,"Cont.","13.Pentostatin;1.Pentostatin;13.Pentostatin;1.Pentostatin;","13.Pentostatin;1.Pentostatin;"
"1413","143.195.2132.2","Malignant Hematology","Indolent lymphomas","Hairy cell leukemia",143,"Untreated",195,"Pentostatin monotherapy",TRUE,"Cont.","14.Pentostatin;14.Pentostatin;","14.Pentostatin;14.Pentostatin;"
"1414","144.195.2138.1","Malignant Hematology","Indolent lymphomas","Hodgkin lymphoma, nodular lymphocyte-predominant",144,"Untreated",195,"ABVD",TRUE,"Cont.","14.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Vinblastine;14.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Vinblastine;14.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Vinblastine;14.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Vinblastine;","14.Bleomycin;0.Dacarbazine;0.Doxorubicin;0.Vinblastine;"
"1415","144.195.2139.1","Malignant Hematology","Indolent lymphomas","Hodgkin lymphoma, nodular lymphocyte-predominant",144,"Untreated",195,"CHOP",TRUE,"Cont.","21.Cyclophosphamide;0.Doxorubicin;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Vincristine;","21.Cyclophosphamide;0.Doxorubicin;0.Vincristine;"
"1416","144.195.2140.1","Malignant Hematology","Indolent lymphomas","Hodgkin lymphoma, nodular lymphocyte-predominant",144,"Untreated",195,"CVP (Vinblastine/Prednisolone)",FALSE,"3","7.Cyclophosphamide;0.Vincristine;7.Vincristine;7.Cyclophosphamide;0.Vincristine;7.Vincristine;","7.Cyclophosphamide;0.Vincristine;7.Vincristine;"
"1417","144.195.2140.2","Malignant Hematology","Indolent lymphomas","Hodgkin lymphoma, nodular lymphocyte-predominant",144,"Untreated",195,"CVP (Vinblastine/Prednisolone)",FALSE,"3","14.Cyclophosphamide;0.Vincristine;7.Vincristine;14.Cyclophosphamide;0.Vincristine;7.Vincristine;","14.Cyclophosphamide;0.Vincristine;7.Vincristine;"
"1418","144.195.2141.1","Malignant Hematology","Indolent lymphomas","Hodgkin lymphoma, nodular lymphocyte-predominant",144,"Untreated",195,"EPOCH",FALSE,"6","17.Doxorubicin;0.Etoposide;0.Vincristine;4.Cyclophosphamide;17.Doxorubicin;0.Etoposide;0.Vincristine;4.Cyclophosphamide;","17.Doxorubicin;0.Etoposide;0.Vincristine;4.Cyclophosphamide;"
"1419","144.195.2141.2","Malignant Hematology","Indolent lymphomas","Hodgkin lymphoma, nodular lymphocyte-predominant",144,"Untreated",195,"EPOCH",FALSE,"6","17.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;17.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;","17.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;"
"1420","144.195.2142.1","Malignant Hematology","Indolent lymphomas","Hodgkin lymphoma, nodular lymphocyte-predominant",144,"Untreated",195,"R-EPOCH",FALSE,"6","17.Doxorubicin;0.Etoposide;0.Rituximab;0.Vincristine;4.Cyclophosphamide;17.Doxorubicin;0.Etoposide;0.Rituximab;0.Vincristine;4.Cyclophosphamide;","17.Doxorubicin;0.Etoposide;0.Rituximab;0.Vincristine;4.Cyclophosphamide;"
"1421","144.195.2142.2","Malignant Hematology","Indolent lymphomas","Hodgkin lymphoma, nodular lymphocyte-predominant",144,"Untreated",195,"R-EPOCH",TRUE,"Cont.","17.Doxorubicin;0.Etoposide;0.Rituximab;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;17.Doxorubicin;0.Etoposide;0.Rituximab;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;","17.Doxorubicin;0.Etoposide;0.Rituximab;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;"
"1422","145.180.2149.1","Malignant Hematology","Indolent lymphomas","B-cell lymphoma of mucosa-associated lymphoid tissue",145,"Relapsed or refractory, non-randomized or retrospective data",180,"Clarithromycin monotherapy",FALSE,"4","8.Clarithromycin;1.Clarithromycin;1.Clarithromycin;1.Clarithromycin;1.Clarithromycin;1.Clarithromycin;1.Clarithromycin;1.Clarithromycin;1.Clarithromycin;1.Clarithromycin;1.Clarithromycin;1.Clarithromycin;1.Clarithromycin;1.Clarithromycin;8.Clarithromycin;1.Clarithromycin;1.Clarithromycin;1.Clarithromycin;1.Clarithromycin;1.Clarithromycin;1.Clarithromycin;1.Clarithromycin;1.Clarithromycin;1.Clarithromycin;1.Clarithromycin;1.Clarithromycin;1.Clarithromycin;1.Clarithromycin;","8.Clarithromycin;1.Clarithromycin;1.Clarithromycin;1.Clarithromycin;1.Clarithromycin;1.Clarithromycin;1.Clarithromycin;1.Clarithromycin;1.Clarithromycin;1.Clarithromycin;1.Clarithromycin;1.Clarithromycin;1.Clarithromycin;1.Clarithromycin;"
"1423","145.40.2147.1","Malignant Hematology","Indolent lymphomas","B-cell lymphoma of mucosa-associated lymphoid tissue",145,"Consolidation after first-line therapy",40,"Chlorambucil monotherapy",TRUE,"Cont.","15.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;15.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;","15.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;"
"1424","145.40.2148.1","Malignant Hematology","Indolent lymphomas","B-cell lymphoma of mucosa-associated lymphoid tissue",145,"Consolidation after first-line therapy",40,"Chlorambucil & Rituximab (RClb)",TRUE,"Cont.","15.Chlorambucil;0.Rituximab;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;15.Chlorambucil;0.Rituximab;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;","15.Chlorambucil;0.Rituximab;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;"
"1425","145.63.2143.1","Malignant Hematology","Indolent lymphomas","B-cell lymphoma of mucosa-associated lymphoid tissue",145,"Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue, first-line therapy",63,"Chlorambucil & Rituximab (RClb)",FALSE,"1","0.Chlorambucil;0.Rituximab;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;0.Rituximab;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;0.Rituximab;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;0.Rituximab;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;","0.Chlorambucil;0.Rituximab;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;0.Rituximab;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;0.Rituximab;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;0.Rituximab;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;"
"1426","145.63.2144.1","Malignant Hematology","Indolent lymphomas","B-cell lymphoma of mucosa-associated lymphoid tissue",145,"Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue, first-line therapy",63,"Cladribine & Rituximab",TRUE,"Cont.","18.Cladribine;0.Rituximab;1.Cladribine;1.Cladribine;1.Cladribine;18.Cladribine;0.Rituximab;1.Cladribine;1.Cladribine;1.Cladribine;","18.Cladribine;0.Rituximab;1.Cladribine;1.Cladribine;1.Cladribine;"
"1427","145.63.2145.1","Malignant Hematology","Indolent lymphomas","B-cell lymphoma of mucosa-associated lymphoid tissue",145,"Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue, first-line therapy",63,"Fludarabine and Rituximab (FR)",TRUE,"Cont.","24.Fludarabine;0.Rituximab;1.Fludarabine;1.Fludarabine;1.Fludarabine;1.Fludarabine;24.Fludarabine;0.Rituximab;1.Fludarabine;1.Fludarabine;1.Fludarabine;1.Fludarabine;","24.Fludarabine;0.Rituximab;1.Fludarabine;1.Fludarabine;1.Fludarabine;1.Fludarabine;"
"1428","145.63.2145.2","Malignant Hematology","Indolent lymphomas","B-cell lymphoma of mucosa-associated lymphoid tissue",145,"Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue, first-line therapy",63,"Fludarabine and Rituximab (FR)",TRUE,"Cont.","26.Fludarabine;0.Rituximab;1.Fludarabine;1.Fludarabine;26.Fludarabine;0.Rituximab;1.Fludarabine;1.Fludarabine;","26.Fludarabine;0.Rituximab;1.Fludarabine;1.Fludarabine;"
"1429","145.63.2146.1","Malignant Hematology","Indolent lymphomas","B-cell lymphoma of mucosa-associated lymphoid tissue",145,"Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue, first-line therapy",63,"MCP",TRUE,"Cont.","24.Chlorambucil;0.Mitoxantrone;1.Chlorambucil;0.Mitoxantrone;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;24.Chlorambucil;0.Mitoxantrone;1.Chlorambucil;0.Mitoxantrone;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;","24.Chlorambucil;0.Mitoxantrone;1.Chlorambucil;0.Mitoxantrone;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;"
"1430","146.74.2150.1","Malignant Hematology","Indolent lymphomas","Marginal zone lymphoma",146,"First-line therapy, randomized data",74,"Chlorambucil monotherapy",TRUE,"Cont.","19.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;19.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;","19.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;1.Chlorambucil;"
"1431","146.74.2151.1","Malignant Hematology","Indolent lymphomas","Marginal zone lymphoma",146,"First-line therapy, randomized data",74,"Bendamustine & Rituximab (BR)",NA,NA,"0.Rituximab;35.Rituximab;1.Bendamustine;1.Bendamustine;26.Rituximab;1.Bendamustine;1.Bendamustine;26.Rituximab;1.Bendamustine;1.Bendamustine;","0.Rituximab;35.Rituximab;1.Bendamustine;1.Bendamustine;26.Rituximab;1.Bendamustine;1.Bendamustine;26.Rituximab;1.Bendamustine;1.Bendamustine;"
"1432","146.74.2152.1","Malignant Hematology","Indolent lymphomas","Marginal zone lymphoma",146,"First-line therapy, randomized data",74,"Ox-P",TRUE,"Cont.","21.Oxaliplatin;21.Oxaliplatin;","21.Oxaliplatin;21.Oxaliplatin;"
"1433","147.114.2165.1","Malignant Hematology","Indolent lymphomas","Waldenstrm macroglobulinemia",147,"Maintenance after first-line therapy",114,"CaRD",FALSE,"8","55.Carfilzomib;1.Carfilzomib;0.Rituximab;55.Carfilzomib;1.Carfilzomib;0.Rituximab;","55.Carfilzomib;1.Carfilzomib;0.Rituximab;"
"1434","147.114.2166.1","Malignant Hematology","Indolent lymphomas","Waldenstrm macroglobulinemia",147,"Maintenance after first-line therapy",114,"Fludarabine & Rituximab (FR)",TRUE,"Cont.","26.Fludarabine;0.Rituximab;1.Fludarabine;1.Fludarabine;26.Fludarabine;0.Rituximab;1.Fludarabine;1.Fludarabine;","26.Fludarabine;0.Rituximab;1.Fludarabine;1.Fludarabine;"
"1435","147.180.2167.1","Malignant Hematology","Indolent lymphomas","Waldenstrm macroglobulinemia",147,"Relapsed or refractory, non-randomized or retrospective data",180,"Alemtuzumab monotherapy",TRUE,"Cont.","3.Alemtuzumab;2.Alemtuzumab;2.Alemtuzumab;3.Alemtuzumab;2.Alemtuzumab;2.Alemtuzumab;","3.Alemtuzumab;2.Alemtuzumab;2.Alemtuzumab;"
"1436","147.71.2156.1","Malignant Hematology","Indolent lymphomas","Waldenstrm macroglobulinemia",147,"First-line therapy, non-randomized or retrospective data",71,"BDR",FALSE,"4","11.Bortezomib;3.Bortezomib;4.Bortezomib;3.Bortezomib;0.Rituximab;11.Bortezomib;3.Bortezomib;4.Bortezomib;3.Bortezomib;0.Rituximab;","11.Bortezomib;3.Bortezomib;4.Bortezomib;3.Bortezomib;0.Rituximab;"
"1437","147.71.2156.2","Malignant Hematology","Indolent lymphomas","Waldenstrm macroglobulinemia",147,"First-line therapy, non-randomized or retrospective data",71,"BDR",FALSE,"1","0.Bortezomib;3.Bortezomib;4.Bortezomib;3.Bortezomib;0.Rituximab;","0.Bortezomib;3.Bortezomib;4.Bortezomib;3.Bortezomib;0.Rituximab;"
"1438","147.71.2156.3","Malignant Hematology","Indolent lymphomas","Waldenstrm macroglobulinemia",147,"First-line therapy, non-randomized or retrospective data",71,"BDR",NA,NA,"0.Bortezomib;3.Bortezomib;18.Bortezomib;0.Rituximab;28.Bortezomib;28.Bortezomib;28.Bortezomib;0.Rituximab;","0.Bortezomib;3.Bortezomib;18.Bortezomib;0.Rituximab;28.Bortezomib;28.Bortezomib;28.Bortezomib;0.Rituximab;"
"1439","147.71.2157.1","Malignant Hematology","Indolent lymphomas","Waldenstrm macroglobulinemia",147,"First-line therapy, non-randomized or retrospective data",71,"Bortezomib & Rituximab (VR)",NA,NA,"0.Bortezomib;0.Rituximab;168.Bortezomib;0.Rituximab;168.Bortezomib;0.Rituximab;168.Bortezomib;0.Rituximab;168.Bortezomib;168.Bortezomib;","0.Bortezomib;0.Rituximab;168.Bortezomib;0.Rituximab;168.Bortezomib;0.Rituximab;168.Bortezomib;0.Rituximab;168.Bortezomib;168.Bortezomib;"
"1440","147.71.2158.1","Malignant Hematology","Indolent lymphomas","Waldenstrm macroglobulinemia",147,"First-line therapy, non-randomized or retrospective data",71,"CaRD",FALSE,"6","13.Carfilzomib;1.Carfilzomib;0.Rituximab;6.Carfilzomib;1.Carfilzomib;0.Rituximab;13.Carfilzomib;1.Carfilzomib;0.Rituximab;6.Carfilzomib;1.Carfilzomib;0.Rituximab;","13.Carfilzomib;1.Carfilzomib;0.Rituximab;6.Carfilzomib;1.Carfilzomib;0.Rituximab;"
"1441","147.71.2159.1","Malignant Hematology","Indolent lymphomas","Waldenstrm macroglobulinemia",147,"First-line therapy, non-randomized or retrospective data",71,"Cladribine & Rituximab",TRUE,"Cont.","24.Cladribine;0.Rituximab;1.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;24.Cladribine;0.Rituximab;1.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;","24.Cladribine;0.Rituximab;1.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;"
"1442","147.71.2160.1","Malignant Hematology","Indolent lymphomas","Waldenstrm macroglobulinemia",147,"First-line therapy, non-randomized or retrospective data",71,"Everolimus monotherapy",TRUE,"Cont.","1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;","1.Everolimus;1.Everolimus;"
"1443","147.71.2161.1","Malignant Hematology","Indolent lymphomas","Waldenstrm macroglobulinemia",147,"First-line therapy, non-randomized or retrospective data",71,"Fludarabine & Rituximab (FR)",NA,NA,"0.Rituximab;28.Fludarabine;1.Fludarabine;1.Fludarabine;1.Fludarabine;1.Fludarabine;24.Fludarabine;1.Fludarabine;1.Fludarabine;1.Fludarabine;1.Fludarabine;24.Fludarabine;1.Fludarabine;1.Fludarabine;1.Fludarabine;1.Fludarabine;24.Rituximab;","0.Rituximab;28.Fludarabine;1.Fludarabine;1.Fludarabine;1.Fludarabine;1.Fludarabine;24.Fludarabine;1.Fludarabine;1.Fludarabine;1.Fludarabine;1.Fludarabine;24.Fludarabine;1.Fludarabine;1.Fludarabine;1.Fludarabine;1.Fludarabine;24.Rituximab;"
"1444","147.71.2162.1","Malignant Hematology","Indolent lymphomas","Waldenstrm macroglobulinemia",147,"First-line therapy, non-randomized or retrospective data",71,"IDR",NA,NA,"0.Ixazomib;28.Ixazomib;28.Ixazomib;0.Rituximab;28.Ixazomib;0.Rituximab;28.Ixazomib;0.Rituximab;28.Ixazomib;0.Rituximab;28.Ixazomib;0.Rituximab;56.Ixazomib;0.Rituximab;56.Ixazomib;0.Rituximab;","0.Ixazomib;28.Ixazomib;28.Ixazomib;0.Rituximab;28.Ixazomib;0.Rituximab;28.Ixazomib;0.Rituximab;28.Ixazomib;0.Rituximab;28.Ixazomib;0.Rituximab;56.Ixazomib;0.Rituximab;56.Ixazomib;0.Rituximab;"
"1445","147.71.2163.1","Malignant Hematology","Indolent lymphomas","Waldenstrm macroglobulinemia",147,"First-line therapy, non-randomized or retrospective data",71,"Thalidomide & Rituximab",NA,NA,"0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;22.Rituximab;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;22.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;22.Rituximab;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;22.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;22.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;22.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;22.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;22.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;","0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;22.Rituximab;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;22.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;22.Rituximab;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;22.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;22.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;22.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;22.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;22.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;"
"1446","147.71.2164.1","Malignant Hematology","Indolent lymphomas","Waldenstrm macroglobulinemia",147,"First-line therapy, non-randomized or retrospective data",71,"Thioguanine monotherapy",TRUE,"Cont.","1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;","1.Thioguanine;1.Thioguanine;"
"1447","147.74.2153.1","Malignant Hematology","Indolent lymphomas","Waldenstrm macroglobulinemia",147,"First-line therapy, randomized data",74,"DRC",TRUE,"Cont.","21.Cyclophosphamide;0.Rituximab;21.Cyclophosphamide;0.Rituximab;","21.Cyclophosphamide;0.Rituximab;"
"1448","147.74.2154.1","Malignant Hematology","Indolent lymphomas","Waldenstrm macroglobulinemia",147,"First-line therapy, randomized data",74,"Ibrutinib & Rituximab",NA,NA,"0.Ibrutinib;0.Rituximab;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Ibrutinib;0.Rituximab;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;","0.Ibrutinib;0.Rituximab;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;22.Ibrutinib;0.Rituximab;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;1.Ibrutinib;"
"1449","147.74.2155.1","Malignant Hematology","Indolent lymphomas","Waldenstrm macroglobulinemia",147,"First-line therapy, randomized data",74,"R-CHOP",TRUE,"Cont.","21.Rituximab;1.Cyclophosphamide;0.Doxorubicin;0.Vincristine;21.Rituximab;1.Cyclophosphamide;0.Doxorubicin;0.Vincristine;","21.Rituximab;1.Cyclophosphamide;0.Doxorubicin;0.Vincristine;"
"1450","148.172.2181.1","Malignant Hematology","Plasma cell dyscrasias","Light-chain (AL) amyloidosis",148,"Relapsed or refractory",172,"Bendamustine monotherapy",TRUE,"Cont.","27.Bendamustine;1.Bendamustine;27.Bendamustine;1.Bendamustine;","27.Bendamustine;1.Bendamustine;"
"1451","148.172.2182.1","Malignant Hematology","Plasma cell dyscrasias","Light-chain (AL) amyloidosis",148,"Relapsed or refractory",172,"Cyclophosphamide monotherapy",TRUE,"Cont.","14.Cyclophosphamide;7.Cyclophosphamide;7.Cyclophosphamide;14.Cyclophosphamide;7.Cyclophosphamide;7.Cyclophosphamide;","14.Cyclophosphamide;7.Cyclophosphamide;7.Cyclophosphamide;"
"1452","148.172.2183.1","Malignant Hematology","Plasma cell dyscrasias","Light-chain (AL) amyloidosis",148,"Relapsed or refractory",172,"Daratumumab monotherapy",TRUE,"Cont.","7.Daratumumab;7.Daratumumab;7.Daratumumab;7.Daratumumab;7.Daratumumab;7.Daratumumab;7.Daratumumab;7.Daratumumab;","7.Daratumumab;7.Daratumumab;"
"1453","148.172.2183.2","Malignant Hematology","Plasma cell dyscrasias","Light-chain (AL) amyloidosis",148,"Relapsed or refractory",172,"Daratumumab monotherapy",TRUE,"Cont.","14.Daratumumab;14.Daratumumab;14.Daratumumab;14.Daratumumab;","14.Daratumumab;14.Daratumumab;"
"1454","148.172.2183.3","Malignant Hematology","Plasma cell dyscrasias","Light-chain (AL) amyloidosis",148,"Relapsed or refractory",172,"Daratumumab monotherapy",TRUE,"Cont.","28.Daratumumab;28.Daratumumab;","28.Daratumumab;28.Daratumumab;"
"1455","148.172.2184.1","Malignant Hematology","Plasma cell dyscrasias","Light-chain (AL) amyloidosis",148,"Relapsed or refractory",172,"Ixazomib monotherapy",TRUE,"Cont.","14.Ixazomib;7.Ixazomib;7.Ixazomib;14.Ixazomib;7.Ixazomib;7.Ixazomib;","14.Ixazomib;7.Ixazomib;7.Ixazomib;"
"1456","148.172.2185.1","Malignant Hematology","Plasma cell dyscrasias","Light-chain (AL) amyloidosis",148,"Relapsed or refractory",172,"Pomalidomide monotherapy",TRUE,"Cont.","1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;","1.Pomalidomide;1.Pomalidomide;"
"1457","148.172.2185.2","Malignant Hematology","Plasma cell dyscrasias","Light-chain (AL) amyloidosis",148,"Relapsed or refractory",172,"Pomalidomide monotherapy",TRUE,"Cont.","8.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;8.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;","8.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;"
"1458","148.172.2186.1","Malignant Hematology","Plasma cell dyscrasias","Light-chain (AL) amyloidosis",148,"Relapsed or refractory",172,"Thalidomide monotherapy",TRUE,"Cont.","1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;","1.Thalidomide;1.Thalidomide;"
"1459","148.40.2178.1","Malignant Hematology","Plasma cell dyscrasias","Light-chain (AL) amyloidosis",148,"Consolidation after first-line therapy",40,"Bortezomib & Melphalan, then auto HSCT",FALSE,"1","0.Bortezomib;3.Bortezomib;1.Melphalan;1.Melphalan;2.Bortezomib;3.Bortezomib;","0.Bortezomib;3.Bortezomib;1.Melphalan;1.Melphalan;2.Bortezomib;3.Bortezomib;"
"1460","148.40.2179.1","Malignant Hematology","Plasma cell dyscrasias","Light-chain (AL) amyloidosis",148,"Consolidation after first-line therapy",40,"Melphalan, then auto HSCT",FALSE,"1","0.Melphalan;","0.Melphalan;0.Melphalan;"
"1461","148.40.2180.1","Malignant Hematology","Plasma cell dyscrasias","Light-chain (AL) amyloidosis",148,"Consolidation after first-line therapy",40,"Bortezomib monotherapy",TRUE,"Cont.","14.Bortezomib;7.Bortezomib;7.Bortezomib;7.Bortezomib;14.Bortezomib;7.Bortezomib;7.Bortezomib;7.Bortezomib;","14.Bortezomib;7.Bortezomib;7.Bortezomib;7.Bortezomib;"
"1462","148.68.2168.1","Malignant Hematology","Plasma cell dyscrasias","Light-chain (AL) amyloidosis",148,"First-line therapy (including transplant ineligible)",68,"CRd",NA,NA,"0.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","0.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1463","148.68.2168.2","Malignant Hematology","Plasma cell dyscrasias","Light-chain (AL) amyloidosis",148,"First-line therapy (including transplant ineligible)",68,"CRd",TRUE,"Cont.","8.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;8.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","8.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1464","148.68.2168.3","Malignant Hematology","Plasma cell dyscrasias","Light-chain (AL) amyloidosis",148,"First-line therapy (including transplant ineligible)",68,"CRd",TRUE,"Cont.","8.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;8.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","8.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1465","148.68.2169.1","Malignant Hematology","Plasma cell dyscrasias","Light-chain (AL) amyloidosis",148,"First-line therapy (including transplant ineligible)",68,"CTD",TRUE,"Cont.","1.Cyclophosphamide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;","1.Cyclophosphamide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;"
"1466","148.68.2169.2","Malignant Hematology","Plasma cell dyscrasias","Light-chain (AL) amyloidosis",148,"First-line therapy (including transplant ineligible)",68,"CTD",TRUE,"Cont.","1.Cyclophosphamide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;","1.Cyclophosphamide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;"
"1467","148.68.2170.1","Malignant Hematology","Plasma cell dyscrasias","Light-chain (AL) amyloidosis",148,"First-line therapy (including transplant ineligible)",68,"Dara-CyBorD",NA,NA,"0.Bortezomib;0.Cyclophosphamide;0.Daratumumabandhyaluronidase;28.Bortezomib;0.Cyclophosphamide;0.Daratumumabandhyaluronidase;28.Bortezomib;0.Cyclophosphamide;0.Daratumumabandhyaluronidase;28.Bortezomib;0.Cyclophosphamide;0.Daratumumabandhyaluronidase;28.Bortezomib;0.Cyclophosphamide;0.Daratumumabandhyaluronidase;28.Bortezomib;0.Cyclophosphamide;0.Daratumumabandhyaluronidase;","0.Bortezomib;0.Cyclophosphamide;0.Daratumumabandhyaluronidase;28.Bortezomib;0.Cyclophosphamide;0.Daratumumabandhyaluronidase;28.Bortezomib;0.Cyclophosphamide;0.Daratumumabandhyaluronidase;28.Bortezomib;0.Cyclophosphamide;0.Daratumumabandhyaluronidase;28.Bortezomib;0.Cyclophosphamide;0.Daratumumabandhyaluronidase;28.Bortezomib;0.Cyclophosphamide;0.Daratumumabandhyaluronidase;"
"1468","148.68.2170.2","Malignant Hematology","Plasma cell dyscrasias","Light-chain (AL) amyloidosis",148,"First-line therapy (including transplant ineligible)",68,"Dara-CyBorD",TRUE,"Cont.","28.Daratumumabandhyaluronidase;28.Daratumumabandhyaluronidase;","28.Daratumumabandhyaluronidase;28.Daratumumabandhyaluronidase;"
"1469","148.68.2171.1","Malignant Hematology","Plasma cell dyscrasias","Light-chain (AL) amyloidosis",148,"First-line therapy (including transplant ineligible)",68,"Doxycycline-CyBorD",FALSE,"9","7.Bortezomib;0.Cyclophosphamide;7.Bortezomib;0.Cyclophosphamide;7.Bortezomib;0.Cyclophosphamide;7.Bortezomib;0.Cyclophosphamide;7.Bortezomib;0.Cyclophosphamide;7.Bortezomib;0.Cyclophosphamide;7.Bortezomib;0.Cyclophosphamide;7.Bortezomib;0.Cyclophosphamide;","7.Bortezomib;0.Cyclophosphamide;"
"1470","148.68.2172.1","Malignant Hematology","Plasma cell dyscrasias","Light-chain (AL) amyloidosis",148,"First-line therapy (including transplant ineligible)",68,"Lenalidomide monotherapy",TRUE,"Cont.","8.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;8.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","8.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1471","148.68.2173.1","Malignant Hematology","Plasma cell dyscrasias","Light-chain (AL) amyloidosis",148,"First-line therapy (including transplant ineligible)",68,"Melphalan monotherapy",TRUE,"Cont.","25.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;25.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;","25.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;"
"1472","148.68.2174.1","Malignant Hematology","Plasma cell dyscrasias","Light-chain (AL) amyloidosis",148,"First-line therapy (including transplant ineligible)",68,"MRD",TRUE,"Cont.","8.Lenalidomide;0.Melphalan;1.Lenalidomide;0.Melphalan;1.Lenalidomide;0.Melphalan;1.Lenalidomide;0.Melphalan;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;8.Lenalidomide;0.Melphalan;1.Lenalidomide;0.Melphalan;1.Lenalidomide;0.Melphalan;1.Lenalidomide;0.Melphalan;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","8.Lenalidomide;0.Melphalan;1.Lenalidomide;0.Melphalan;1.Lenalidomide;0.Melphalan;1.Lenalidomide;0.Melphalan;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1473","148.68.2175.1","Malignant Hematology","Plasma cell dyscrasias","Light-chain (AL) amyloidosis",148,"First-line therapy (including transplant ineligible)",68,"Bortezomib monotherapy",TRUE,"Cont.","11.Bortezomib;3.Bortezomib;4.Bortezomib;3.Bortezomib;11.Bortezomib;3.Bortezomib;4.Bortezomib;3.Bortezomib;","11.Bortezomib;3.Bortezomib;4.Bortezomib;3.Bortezomib;"
"1474","148.68.2176.1","Malignant Hematology","Plasma cell dyscrasias","Light-chain (AL) amyloidosis",148,"First-line therapy (including transplant ineligible)",68,"VDC",TRUE,"Cont.","7.Bortezomib;0.Cyclophosphamide;3.Bortezomib;4.Bortezomib;0.Cyclophosphamide;3.Bortezomib;4.Cyclophosphamide;7.Cyclophosphamide;7.Bortezomib;0.Cyclophosphamide;3.Bortezomib;4.Bortezomib;0.Cyclophosphamide;3.Bortezomib;4.Cyclophosphamide;7.Cyclophosphamide;","7.Bortezomib;0.Cyclophosphamide;3.Bortezomib;4.Bortezomib;0.Cyclophosphamide;3.Bortezomib;4.Cyclophosphamide;7.Cyclophosphamide;"
"1475","148.68.2176.2","Malignant Hematology","Plasma cell dyscrasias","Light-chain (AL) amyloidosis",148,"First-line therapy (including transplant ineligible)",68,"VDC",TRUE,"Cont.","7.Bortezomib;0.Cyclophosphamide;7.Bortezomib;0.Cyclophosphamide;7.Bortezomib;0.Cyclophosphamide;7.Bortezomib;0.Cyclophosphamide;7.Bortezomib;0.Cyclophosphamide;7.Bortezomib;0.Cyclophosphamide;7.Bortezomib;0.Cyclophosphamide;7.Bortezomib;0.Cyclophosphamide;","7.Bortezomib;0.Cyclophosphamide;"
"1476","148.68.2177.1","Malignant Hematology","Plasma cell dyscrasias","Light-chain (AL) amyloidosis",148,"First-line therapy (including transplant ineligible)",68,"VMD",NA,NA,"0.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Bortezomib;0.Melphalan;25.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Bortezomib;0.Melphalan;25.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;32.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;32.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;32.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;32.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;32.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;","0.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Bortezomib;0.Melphalan;25.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Bortezomib;0.Melphalan;25.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;32.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;32.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;32.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;32.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;32.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;"
"1477","148.68.2177.2","Malignant Hematology","Plasma cell dyscrasias","Light-chain (AL) amyloidosis",148,"First-line therapy (including transplant ineligible)",68,"VMD",TRUE,"Cont.","7.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;4.Bortezomib;7.Bortezomib;7.Bortezomib;7.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;4.Bortezomib;7.Bortezomib;7.Bortezomib;","7.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;4.Bortezomib;7.Bortezomib;7.Bortezomib;"
"1478","148.68.2177.3","Malignant Hematology","Plasma cell dyscrasias","Light-chain (AL) amyloidosis",148,"First-line therapy (including transplant ineligible)",68,"VMD",TRUE,"Cont.","14.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;4.Bortezomib;7.Bortezomib;7.Bortezomib;14.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;4.Bortezomib;7.Bortezomib;7.Bortezomib;","14.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;4.Bortezomib;7.Bortezomib;7.Bortezomib;"
"1479","148.68.2177.4","Malignant Hematology","Plasma cell dyscrasias","Light-chain (AL) amyloidosis",148,"First-line therapy (including transplant ineligible)",68,"VMD",TRUE,"Cont.","21.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;4.Bortezomib;7.Bortezomib;7.Bortezomib;21.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;4.Bortezomib;7.Bortezomib;7.Bortezomib;","21.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;4.Bortezomib;7.Bortezomib;7.Bortezomib;"
"1480","149.70.2187.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, doublets",70,"Bortezomib monotherapy",TRUE,"Cont.","7.Bortezomib;7.Bortezomib;7.Bortezomib;7.Bortezomib;7.Bortezomib;7.Bortezomib;7.Bortezomib;7.Bortezomib;","7.Bortezomib;7.Bortezomib;"
"1481","149.70.2188.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, doublets",70,"Lenalidomide monotherapy",TRUE,"Cont.","8.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;8.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","8.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1482","149.72.2220.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, other",72,"CVAD",TRUE,"Cont.","7.Cyclophosphamide;0.Doxorubicin;0.Vincristine;7.Cyclophosphamide;7.Cyclophosphamide;7.Cyclophosphamide;0.Doxorubicin;0.Vincristine;7.Cyclophosphamide;7.Cyclophosphamide;","7.Cyclophosphamide;0.Doxorubicin;0.Vincristine;7.Cyclophosphamide;7.Cyclophosphamide;"
"1483","149.72.2220.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, other",72,"CVAD",TRUE,"Cont.","7.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;3.Cyclophosphamide;7.Cyclophosphamide;7.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;3.Cyclophosphamide;7.Cyclophosphamide;","7.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;3.Cyclophosphamide;7.Cyclophosphamide;"
"1484","149.72.2221.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, other",72,"TVAD (Pegylated liposomal doxorubicin substituted)",TRUE,"Cont.","1.Pegylatedliposomaldoxorubicin;0.Thalidomide;0.Vincristine;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Pegylatedliposomaldoxorubicin;0.Thalidomide;0.Vincristine;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;","1.Pegylatedliposomaldoxorubicin;0.Thalidomide;0.Vincristine;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;"
"1485","149.72.2222.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, other",72,"VAD (Pegylated liposomal doxorubicin substituted)",TRUE,"Cont.","28.Pegylatedliposomaldoxorubicin;0.Vincristine;28.Pegylatedliposomaldoxorubicin;0.Vincristine;","28.Pegylatedliposomaldoxorubicin;0.Vincristine;"
"1486","149.72.2223.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, other",72,"VAD-P",TRUE,"Cont.","21.Doxorubicin;0.Vincristine;21.Doxorubicin;0.Vincristine;","21.Doxorubicin;0.Vincristine;"
"1487","149.72.2223.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, other",72,"VAD-P",TRUE,"Cont.","17.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;17.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;","17.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;"
"1488","149.72.2224.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, other",72,"VAD-P/Q",TRUE,"Cont.","16.Quinine;1.Doxorubicin;0.Quinine;0.Vincristine;1.Quinine;1.Quinine;1.Quinine;1.Quinine;16.Quinine;1.Doxorubicin;0.Quinine;0.Vincristine;1.Quinine;1.Quinine;1.Quinine;1.Quinine;","16.Quinine;1.Doxorubicin;0.Quinine;0.Vincristine;1.Quinine;1.Quinine;1.Quinine;1.Quinine;"
"1489","149.72.2224.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, other",72,"VAD-P/Q",TRUE,"Cont.","16.Quinine;1.Doxorubicin;0.Quinine;0.Vincristine;1.Doxorubicin;0.Quinine;0.Vincristine;1.Doxorubicin;0.Quinine;0.Vincristine;1.Doxorubicin;0.Quinine;0.Vincristine;1.Doxorubicin;0.Quinine;0.Vincristine;16.Quinine;1.Doxorubicin;0.Quinine;0.Vincristine;1.Doxorubicin;0.Quinine;0.Vincristine;1.Doxorubicin;0.Quinine;0.Vincristine;1.Doxorubicin;0.Quinine;0.Vincristine;1.Doxorubicin;0.Quinine;0.Vincristine;","16.Quinine;1.Doxorubicin;0.Quinine;0.Vincristine;1.Doxorubicin;0.Quinine;0.Vincristine;1.Doxorubicin;0.Quinine;0.Vincristine;1.Doxorubicin;0.Quinine;0.Vincristine;1.Doxorubicin;0.Quinine;0.Vincristine;"
"1490","149.72.2225.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, other",72,"VMP, then Rd",NA,NA,"0.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Bortezomib;0.Melphalan;39.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;25.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;25.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;25.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;25.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;25.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;25.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;25.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;","0.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Bortezomib;0.Melphalan;39.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;25.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;25.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;25.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;25.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;25.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;25.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;25.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;"
"1491","149.72.2226.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, other",72,"VMP/Rd",FALSE,"1","0.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Bortezomib;0.Melphalan;4.Bortezomib;3.Bortezomib;11.Bortezomib;3.Bortezomib;4.Bortezomib;3.Bortezomib;","0.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Bortezomib;0.Melphalan;4.Bortezomib;3.Bortezomib;11.Bortezomib;3.Bortezomib;4.Bortezomib;3.Bortezomib;"
"1492","149.72.2226.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, other",72,"VMP/Rd",NA,NA,"0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;25.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;25.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;25.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;25.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;25.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;25.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;25.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;25.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1493","149.72.2227.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, other",72,"Zoledronic acid therapy",TRUE,"Cont.","21.Zoledronicacid;21.Zoledronicacid;","21.Zoledronicacid;21.Zoledronicacid;"
"1494","149.72.2227.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, other",72,"Zoledronic acid therapy",TRUE,"Cont.","28.Zoledronicacid;28.Zoledronicacid;","28.Zoledronicacid;28.Zoledronicacid;"
"1495","149.72.2228.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, other",72,"Total Therapy (VTC-PACE)",FALSE,"1","0.Bortezomib;3.Bortezomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;3.Bortezomib;","0.Bortezomib;3.Bortezomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;3.Bortezomib;"
"1496","149.72.2228.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, other",72,"Total Therapy (VTC-PACE)",FALSE,"1","0.Bortezomib;3.Bortezomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Bortezomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;3.Bortezomib;","0.Bortezomib;3.Bortezomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Bortezomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;3.Bortezomib;"
"1497","149.72.2228.3","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, other",72,"Total Therapy (VTC-PACE)",FALSE,"1","0.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;4.Bortezomib;3.Bortezomib;","0.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;4.Bortezomib;3.Bortezomib;"
"1498","149.72.2228.4","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, other",72,"Total Therapy (VTC-PACE)",FALSE,"1","0.Bortezomib;3.Bortezomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Bortezomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;3.Bortezomib;","0.Bortezomib;3.Bortezomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Bortezomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;3.Bortezomib;"
"1499","149.72.2229.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, other",72,"Total Therapy (Interim)",FALSE,"1","0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;","0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;"
"1500","149.72.2230.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, other",72,"Total Therapy (Consolidation)",FALSE,"1","0.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;","0.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;"
"1501","149.73.2209.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, quadruplets",73,"CYKLONE",TRUE,"Cont.","1.Carfilzomib;0.Cyclophosphamide;0.Thalidomide;1.Carfilzomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Carfilzomib;0.Cyclophosphamide;0.Thalidomide;1.Carfilzomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Carfilzomib;0.Cyclophosphamide;0.Thalidomide;1.Carfilzomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Carfilzomib;0.Cyclophosphamide;0.Thalidomide;1.Carfilzomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Carfilzomib;0.Cyclophosphamide;0.Thalidomide;1.Carfilzomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Carfilzomib;0.Cyclophosphamide;0.Thalidomide;1.Carfilzomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;","1.Carfilzomib;0.Cyclophosphamide;0.Thalidomide;1.Carfilzomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Carfilzomib;0.Cyclophosphamide;0.Thalidomide;1.Carfilzomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Carfilzomib;0.Cyclophosphamide;0.Thalidomide;1.Carfilzomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;"
"1502","149.73.2210.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, quadruplets",73,"Dara-KRd",NA,NA,"0.Carfilzomib;0.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Carfilzomib;0.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Carfilzomib;0.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Carfilzomib;0.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Carfilzomib;0.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Carfilzomib;0.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Carfilzomib;0.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Carfilzomib;0.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","0.Carfilzomib;0.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Carfilzomib;0.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Carfilzomib;0.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Carfilzomib;0.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Carfilzomib;0.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Carfilzomib;0.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Carfilzomib;0.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Carfilzomib;0.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1503","149.73.2211.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, quadruplets",73,"Dara-RVd",TRUE,"Cont.","7.Bortezomib;0.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Daratumumab;7.Bortezomib;0.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Daratumumab;","7.Bortezomib;0.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Daratumumab;"
"1504","149.73.2212.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, quadruplets",73,"Dara-VMP",NA,NA,"0.Bortezomib;0.Daratumumuab;0.Melphalan;1.Melphalan;1.Melphalan;1.Bortezomib;0.Melphalan;39.Bortezomib;0.Daratumumuab;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;39.Bortezomib;0.Daratumumuab;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;39.Bortezomib;0.Daratumumuab;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;39.Bortezomib;0.Daratumumuab;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;39.Bortezomib;0.Daratumumuab;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;39.Bortezomib;0.Daratumumuab;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;39.Bortezomib;0.Daratumumuab;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;39.Bortezomib;0.Daratumumuab;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;","0.Bortezomib;0.Daratumumuab;0.Melphalan;1.Melphalan;1.Melphalan;1.Bortezomib;0.Melphalan;39.Bortezomib;0.Daratumumuab;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;39.Bortezomib;0.Daratumumuab;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;39.Bortezomib;0.Daratumumuab;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;39.Bortezomib;0.Daratumumuab;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;39.Bortezomib;0.Daratumumuab;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;39.Bortezomib;0.Daratumumuab;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;39.Bortezomib;0.Daratumumuab;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;39.Bortezomib;0.Daratumumuab;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;"
"1505","149.73.2213.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, quadruplets",73,"Dara-VMP (SC daratumumab)",NA,NA,"0.Bortezomib;0.Daratumumabandhyaluronidase;0.Melphalan;1.Melphalan;1.Melphalan;1.Bortezomib;0.Melphalan;39.Bortezomib;0.Daratumumabandhyaluronidase;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;39.Bortezomib;0.Daratumumabandhyaluronidase;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;39.Bortezomib;0.Daratumumabandhyaluronidase;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;39.Bortezomib;0.Daratumumabandhyaluronidase;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;39.Bortezomib;0.Daratumumabandhyaluronidase;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;39.Bortezomib;0.Daratumumabandhyaluronidase;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;39.Bortezomib;0.Daratumumabandhyaluronidase;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;39.Bortezomib;0.Daratumumabandhyaluronidase;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;","0.Bortezomib;0.Daratumumabandhyaluronidase;0.Melphalan;1.Melphalan;1.Melphalan;1.Bortezomib;0.Melphalan;39.Bortezomib;0.Daratumumabandhyaluronidase;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;39.Bortezomib;0.Daratumumabandhyaluronidase;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;39.Bortezomib;0.Daratumumabandhyaluronidase;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;39.Bortezomib;0.Daratumumabandhyaluronidase;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;39.Bortezomib;0.Daratumumabandhyaluronidase;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;39.Bortezomib;0.Daratumumabandhyaluronidase;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;39.Bortezomib;0.Daratumumabandhyaluronidase;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;39.Bortezomib;0.Daratumumabandhyaluronidase;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;"
"1506","149.73.2214.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, quadruplets",73,"SC daratumumab monotherapy",TRUE,"Cont.","28.Daratumumabandhyaluronidase;28.Daratumumabandhyaluronidase;","28.Daratumumabandhyaluronidase;28.Daratumumabandhyaluronidase;"
"1507","149.73.2215.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, quadruplets",73,"Dara-VTD",NA,NA,"0.Bortezomib;0.Daratumumab;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;22.Bortezomib;0.Daratumumab;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;22.Bortezomib;0.Daratumumab;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;22.Bortezomib;0.Daratumumab;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;","0.Bortezomib;0.Daratumumab;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;22.Bortezomib;0.Daratumumab;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;22.Bortezomib;0.Daratumumab;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;22.Bortezomib;0.Daratumumab;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;"
"1508","149.73.2216.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, quadruplets",73,"Isa-RVd",NA,NA,"0.Bortezomib;0.Isatuximab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;36.Bortezomib;0.Isatuximab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;36.Bortezomib;0.Isatuximab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","0.Bortezomib;0.Isatuximab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;36.Bortezomib;0.Isatuximab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;36.Bortezomib;0.Isatuximab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1509","149.73.2217.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, quadruplets",73,"KRdc",TRUE,"Cont.","8.Carfilzomib;0.Cyclophosphamide;0.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Carfilzomib;0.Cyclophosphamide;0.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;8.Carfilzomib;0.Cyclophosphamide;0.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Carfilzomib;0.Cyclophosphamide;0.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","8.Carfilzomib;0.Cyclophosphamide;0.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Carfilzomib;0.Cyclophosphamide;0.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1510","149.73.2218.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, quadruplets",73,"RVDC",TRUE,"Cont.","8.Bortezomib;0.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;8.Bortezomib;0.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","8.Bortezomib;0.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1511","149.73.2219.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, quadruplets",73,"VMPT",NA,NA,"0.Bortezomib;0.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Bortezomib;0.Melphalan;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;36.Bortezomib;0.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Bortezomib;0.Melphalan;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;36.Bortezomib;0.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Bortezomib;0.Melphalan;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;36.Bortezomib;0.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Bortezomib;0.Melphalan;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;36.Bortezomib;0.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;36.Bortezomib;0.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;36.Bortezomib;0.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;36.Bortezomib;0.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;36.Bortezomib;0.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;","0.Bortezomib;0.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Bortezomib;0.Melphalan;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;36.Bortezomib;0.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Bortezomib;0.Melphalan;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;36.Bortezomib;0.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Bortezomib;0.Melphalan;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;36.Bortezomib;0.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Bortezomib;0.Melphalan;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;36.Bortezomib;0.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;36.Bortezomib;0.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;36.Bortezomib;0.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;36.Bortezomib;0.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;36.Bortezomib;0.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;"
"1512","149.73.2219.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, quadruplets",73,"VMPT",TRUE,"Cont.","1.Bortezomib;0.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;","1.Bortezomib;0.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;"
"1513","149.75.2189.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, triplets",75,"BBD",TRUE,"Cont.","14.Bendamustine;0.Bortezomib;1.Bendamustine;6.Bortezomib;7.Bortezomib;14.Bendamustine;0.Bortezomib;1.Bendamustine;6.Bortezomib;7.Bortezomib;","14.Bendamustine;0.Bortezomib;1.Bendamustine;6.Bortezomib;7.Bortezomib;"
"1514","149.75.2190.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, triplets",75,"CPR",TRUE,"Cont.","8.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;8.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;","8.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;"
"1515","149.75.2191.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, triplets",75,"CRd",TRUE,"Cont.","8.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;8.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","8.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1516","149.75.2191.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, triplets",75,"CRd",TRUE,"Cont.","8.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;8.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","8.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1517","149.75.2192.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, triplets",75,"CTD",TRUE,"Cont.","1.Cyclophosphamide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;","1.Cyclophosphamide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;"
"1518","149.75.2192.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, triplets",75,"CTD",TRUE,"Cont.","1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;","1.Cyclophosphamide;0.Thalidomide;"
"1519","149.75.2193.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, triplets",75,"Dara-Rd",NA,NA,"0.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","0.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;22.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1520","149.75.2194.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, triplets",75,"IRd",TRUE,"Cont.","8.Ixazomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Ixazomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Ixazomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;8.Ixazomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Ixazomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Ixazomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","8.Ixazomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Ixazomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Ixazomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1521","149.75.2195.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, triplets",75,"KCD",FALSE,"9","13.Carfilzomib;0.Cyclophosphamide;1.Carfilzomib;6.Carfilzomib;0.Cyclophosphamide;1.Carfilzomib;6.Carfilzomib;0.Cyclophosphamide;1.Carfilzomib;13.Carfilzomib;0.Cyclophosphamide;1.Carfilzomib;6.Carfilzomib;0.Cyclophosphamide;1.Carfilzomib;6.Carfilzomib;0.Cyclophosphamide;1.Carfilzomib;","13.Carfilzomib;0.Cyclophosphamide;1.Carfilzomib;6.Carfilzomib;0.Cyclophosphamide;1.Carfilzomib;6.Carfilzomib;0.Cyclophosphamide;1.Carfilzomib;"
"1522","149.75.2195.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, triplets",75,"KCD",FALSE,"9","14.Carfilzomib;0.Cyclophosphamide;7.Carfilzomib;0.Cyclophosphamide;7.Carfilzomib;0.Cyclophosphamide;14.Carfilzomib;0.Cyclophosphamide;7.Carfilzomib;0.Cyclophosphamide;7.Carfilzomib;0.Cyclophosphamide;","14.Carfilzomib;0.Cyclophosphamide;7.Carfilzomib;0.Cyclophosphamide;7.Carfilzomib;0.Cyclophosphamide;"
"1523","149.75.2196.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, triplets",75,"KMP",FALSE,"9","13.Carfilzomib;0.Melphalan;1.Carfilzomib;0.Melphalan;1.Melphalan;1.Melphalan;4.Carfilzomib;1.Carfilzomib;13.Carfilzomib;1.Carfilzomib;6.Carfilzomib;1.Carfilzomib;13.Carfilzomib;0.Melphalan;1.Carfilzomib;0.Melphalan;1.Melphalan;1.Melphalan;4.Carfilzomib;1.Carfilzomib;13.Carfilzomib;1.Carfilzomib;6.Carfilzomib;1.Carfilzomib;","13.Carfilzomib;0.Melphalan;1.Carfilzomib;0.Melphalan;1.Melphalan;1.Melphalan;4.Carfilzomib;1.Carfilzomib;13.Carfilzomib;1.Carfilzomib;6.Carfilzomib;1.Carfilzomib;"
"1524","149.75.2197.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, triplets",75,"KRd",FALSE,"8","8.Carfilzomib;0.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;8.Carfilzomib;0.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","8.Carfilzomib;0.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1525","149.75.2198.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, triplets",75,"KTD",FALSE,"4","1.Carfilzomib;0.Thalidomide;1.Carfilzomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Carfilzomib;0.Thalidomide;1.Carfilzomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Carfilzomib;0.Thalidomide;1.Carfilzomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Carfilzomib;0.Thalidomide;1.Carfilzomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Carfilzomib;0.Thalidomide;1.Carfilzomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Carfilzomib;0.Thalidomide;1.Carfilzomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;","1.Carfilzomib;0.Thalidomide;1.Carfilzomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Carfilzomib;0.Thalidomide;1.Carfilzomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Carfilzomib;0.Thalidomide;1.Carfilzomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;"
"1526","149.75.2199.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, triplets",75,"MPR",FALSE,"9","8.Lenalidomide;0.Melphalan;1.Lenalidomide;0.Melphalan;1.Lenalidomide;0.Melphalan;1.Lenalidomide;0.Melphalan;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;8.Lenalidomide;0.Melphalan;1.Lenalidomide;0.Melphalan;1.Lenalidomide;0.Melphalan;1.Lenalidomide;0.Melphalan;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","8.Lenalidomide;0.Melphalan;1.Lenalidomide;0.Melphalan;1.Lenalidomide;0.Melphalan;1.Lenalidomide;0.Melphalan;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1527","149.75.2200.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, triplets",75,"MPT",TRUE,"Cont.","1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;","1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;"
"1528","149.75.2200.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, triplets",75,"MPT",TRUE,"Cont.","1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;","1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;"
"1529","149.75.2200.3","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, triplets",75,"MPT",TRUE,"Cont.","1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;","1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;"
"1530","149.75.2200.4","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, triplets",75,"MPT",TRUE,"Cont.","1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;","1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;"
"1531","149.75.2201.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, triplets",75,"PAD",TRUE,"Cont.","11.Bortezomib;0.Doxorubicin;3.Bortezomib;0.Doxorubicin;4.Bortezomib;3.Bortezomib;11.Bortezomib;0.Doxorubicin;3.Bortezomib;0.Doxorubicin;4.Bortezomib;3.Bortezomib;","11.Bortezomib;0.Doxorubicin;3.Bortezomib;0.Doxorubicin;4.Bortezomib;3.Bortezomib;"
"1532","149.75.2201.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, triplets",75,"PAD",TRUE,"Cont.","11.Bortezomib;0.Doxorubicin;1.Doxorubicin;1.Doxorubicin;1.Bortezomib;0.Doxorubicin;4.Bortezomib;3.Bortezomib;11.Bortezomib;0.Doxorubicin;1.Doxorubicin;1.Doxorubicin;1.Bortezomib;0.Doxorubicin;4.Bortezomib;3.Bortezomib;","11.Bortezomib;0.Doxorubicin;1.Doxorubicin;1.Doxorubicin;1.Bortezomib;0.Doxorubicin;4.Bortezomib;3.Bortezomib;"
"1533","149.75.2201.3","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, triplets",75,"PAD",TRUE,"Cont.","18.Bortezomib;0.Doxorubicin;1.Doxorubicin;1.Doxorubicin;1.Bortezomib;0.Doxorubicin;4.Bortezomib;3.Bortezomib;18.Bortezomib;0.Doxorubicin;1.Doxorubicin;1.Doxorubicin;1.Bortezomib;0.Doxorubicin;4.Bortezomib;3.Bortezomib;","18.Bortezomib;0.Doxorubicin;1.Doxorubicin;1.Doxorubicin;1.Bortezomib;0.Doxorubicin;4.Bortezomib;3.Bortezomib;"
"1534","149.75.2202.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, triplets",75,"PAD (Pegylated liposomal doxorubicin substituted)",TRUE,"Cont.","18.Bortezomib;0.Pegylatedliposomaldoxorubicin;3.Bortezomib;0.Pegylatedliposomaldoxorubicin;4.Bortezomib;0.Pegylatedliposomaldoxorubicin;3.Bortezomib;0.Pegylatedliposomaldoxorubicin;18.Bortezomib;0.Pegylatedliposomaldoxorubicin;3.Bortezomib;0.Pegylatedliposomaldoxorubicin;4.Bortezomib;0.Pegylatedliposomaldoxorubicin;3.Bortezomib;0.Pegylatedliposomaldoxorubicin;","18.Bortezomib;0.Pegylatedliposomaldoxorubicin;3.Bortezomib;0.Pegylatedliposomaldoxorubicin;4.Bortezomib;0.Pegylatedliposomaldoxorubicin;3.Bortezomib;0.Pegylatedliposomaldoxorubicin;"
"1535","149.75.2202.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, triplets",75,"PAD (Pegylated liposomal doxorubicin substituted)",TRUE,"Cont.","11.Bortezomib;3.Bortezomib;0.Pegylatedliposomaldoxorubicin;4.Bortezomib;3.Bortezomib;11.Bortezomib;3.Bortezomib;0.Pegylatedliposomaldoxorubicin;4.Bortezomib;3.Bortezomib;","11.Bortezomib;3.Bortezomib;0.Pegylatedliposomaldoxorubicin;4.Bortezomib;3.Bortezomib;"
"1536","149.75.2203.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, triplets",75,"RVD",TRUE,"Cont.","8.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;8.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","8.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1537","149.75.2203.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, triplets",75,"RVD",TRUE,"Cont.","8.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;8.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","8.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1538","149.75.2203.3","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, triplets",75,"RVD",TRUE,"Cont.","8.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;8.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","8.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1539","149.75.2204.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, triplets",75,"TAD (Thalidomide)",TRUE,"Cont.","1.Doxorubicin;0.Thalidomide;1.Doxorubicin;0.Thalidomide;1.Doxorubicin;0.Thalidomide;1.Doxorubicin;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Doxorubicin;0.Thalidomide;1.Doxorubicin;0.Thalidomide;1.Doxorubicin;0.Thalidomide;1.Doxorubicin;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;","1.Doxorubicin;0.Thalidomide;1.Doxorubicin;0.Thalidomide;1.Doxorubicin;0.Thalidomide;1.Doxorubicin;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;"
"1540","149.75.2205.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, triplets",75,"VDC",TRUE,"Cont.","7.Bortezomib;0.Cyclophosphamide;3.Bortezomib;4.Bortezomib;0.Cyclophosphamide;3.Bortezomib;4.Cyclophosphamide;7.Bortezomib;0.Cyclophosphamide;3.Bortezomib;4.Bortezomib;0.Cyclophosphamide;3.Bortezomib;4.Cyclophosphamide;","7.Bortezomib;0.Cyclophosphamide;3.Bortezomib;4.Bortezomib;0.Cyclophosphamide;3.Bortezomib;4.Cyclophosphamide;"
"1541","149.75.2205.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, triplets",75,"VDC",TRUE,"Cont.","11.Bortezomib;0.Cyclophosphamide;3.Bortezomib;4.Bortezomib;3.Bortezomib;11.Bortezomib;0.Cyclophosphamide;3.Bortezomib;4.Bortezomib;3.Bortezomib;","11.Bortezomib;0.Cyclophosphamide;3.Bortezomib;4.Bortezomib;3.Bortezomib;"
"1542","149.75.2205.3","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, triplets",75,"VDC",TRUE,"Cont.","7.Bortezomib;0.Cyclophosphamide;3.Bortezomib;4.Bortezomib;0.Cyclophosphamide;3.Bortezomib;4.Cyclophosphamide;7.Cyclophosphamide;7.Bortezomib;0.Cyclophosphamide;3.Bortezomib;4.Bortezomib;0.Cyclophosphamide;3.Bortezomib;4.Cyclophosphamide;7.Cyclophosphamide;","7.Bortezomib;0.Cyclophosphamide;3.Bortezomib;4.Bortezomib;0.Cyclophosphamide;3.Bortezomib;4.Cyclophosphamide;7.Cyclophosphamide;"
"1543","149.75.2206.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, triplets",75,"VMP",TRUE,"Cont.","11.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Bortezomib;0.Melphalan;4.Bortezomib;3.Bortezomib;11.Bortezomib;3.Bortezomib;4.Bortezomib;3.Bortezomib;11.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Bortezomib;0.Melphalan;4.Bortezomib;3.Bortezomib;11.Bortezomib;3.Bortezomib;4.Bortezomib;3.Bortezomib;","11.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Bortezomib;0.Melphalan;4.Bortezomib;3.Bortezomib;11.Bortezomib;3.Bortezomib;4.Bortezomib;3.Bortezomib;"
"1544","149.75.2206.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, triplets",75,"VMP",TRUE,"Cont.","18.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;1.Bortezomib;3.Bortezomib;18.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;1.Bortezomib;3.Bortezomib;","18.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;1.Bortezomib;3.Bortezomib;"
"1545","149.75.2206.3","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, triplets",75,"VMP",TRUE,"Cont.","14.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;4.Bortezomib;7.Bortezomib;7.Bortezomib;14.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;4.Bortezomib;7.Bortezomib;7.Bortezomib;","14.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;4.Bortezomib;7.Bortezomib;7.Bortezomib;"
"1546","149.75.2206.4","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, triplets",75,"VMP",NA,NA,"0.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Bortezomib;0.Melphalan;18.Bortezomib;3.Bortezomib;18.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Bortezomib;0.Melphalan;18.Bortezomib;3.Bortezomib;18.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Bortezomib;0.Melphalan;18.Bortezomib;3.Bortezomib;18.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Bortezomib;0.Melphalan;18.Bortezomib;3.Bortezomib;","0.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Bortezomib;0.Melphalan;18.Bortezomib;3.Bortezomib;18.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Bortezomib;0.Melphalan;18.Bortezomib;3.Bortezomib;18.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Bortezomib;0.Melphalan;18.Bortezomib;3.Bortezomib;18.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Bortezomib;0.Melphalan;18.Bortezomib;3.Bortezomib;"
"1547","149.75.2206.5","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, triplets",75,"VMP",TRUE,"Cont.","14.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;4.Bortezomib;14.Bortezomib;7.Bortezomib;14.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;4.Bortezomib;14.Bortezomib;7.Bortezomib;","14.Bortezomib;0.Melphalan;1.Melphalan;1.Melphalan;1.Melphalan;4.Bortezomib;14.Bortezomib;7.Bortezomib;"
"1548","149.75.2207.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, triplets",75,"VTD",TRUE,"Cont.","1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;","1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;"
"1549","149.75.2207.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, triplets",75,"VTD",TRUE,"Cont.","1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;","1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;"
"1550","149.75.2208.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, triplets",75,"VTP",NA,NA,"0.Bortezomib;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Bortezomib;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;","0.Bortezomib;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Bortezomib;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;"
"1551","149.75.2208.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, induction",149,"First-line therapy, triplets",75,"VTP",NA,NA,"0.Bortezomib;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Bortezomib;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Bortezomib;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Bortezomib;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Bortezomib;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;","0.Bortezomib;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Bortezomib;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Bortezomib;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Bortezomib;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Bortezomib;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;NA.Thalidomide;"
"1552","15.137.381.1","Solid Tumor","Dermatologic Oncology","Uveal melanoma",15,"Metastatic or unresectable disease",137,"Selumetinib monotherapy",TRUE,"Cont.","1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;","1.Selumetinib;1.Selumetinib;"
"1553","15.137.382.1","Solid Tumor","Dermatologic Oncology","Uveal melanoma",15,"Metastatic or unresectable disease",137,"Tebentafusp monotherapy",TRUE,"Cont.","7.Tebentafusp;7.Tebentafusp;","7.Tebentafusp;7.Tebentafusp;"
"1554","150.114.2236.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, consolidation and maintenance",150,"Maintenance after first-line therapy",114,"Bortezomib monotherapy",TRUE,"Cont.","14.Bortezomib;14.Bortezomib;","14.Bortezomib;14.Bortezomib;"
"1555","150.114.2237.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, consolidation and maintenance",150,"Maintenance after first-line therapy",114,"Carfilzomib monotherapy",TRUE,"Cont.","13.Carfilzomib;1.Carfilzomib;13.Carfilzomib;1.Carfilzomib;13.Carfilzomib;1.Carfilzomib;13.Carfilzomib;1.Carfilzomib;","13.Carfilzomib;1.Carfilzomib;"
"1556","150.114.2238.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, consolidation and maintenance",150,"Maintenance after first-line therapy",114,"Carfilzomib monotherapy",TRUE,"Cont.","14.Carfilzomib;7.Carfilzomib;7.Carfilzomib;14.Carfilzomib;7.Carfilzomib;7.Carfilzomib;","14.Carfilzomib;7.Carfilzomib;7.Carfilzomib;"
"1557","150.114.2239.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, consolidation and maintenance",150,"Maintenance after first-line therapy",114,"Carfilzomib & Lenalidomide (KR)",TRUE,"Cont.","8.Carfilzomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;8.Carfilzomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","8.Carfilzomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1558","150.114.2240.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, consolidation and maintenance",150,"Maintenance after first-line therapy",114,"Daratumumab monotherapy",TRUE,"Cont.","56.Daratumumab;56.Daratumumab;","56.Daratumumab;56.Daratumumab;"
"1559","150.114.2241.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, consolidation and maintenance",150,"Maintenance after first-line therapy",114,"KRd",TRUE,"Cont.","8.Carfilzomib;0.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;8.Carfilzomib;0.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","8.Carfilzomib;0.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1560","150.114.2242.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, consolidation and maintenance",150,"Maintenance after first-line therapy",114,"Lenalidomide monotherapy",TRUE,"Cont.","1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","1.Lenalidomide;1.Lenalidomide;"
"1561","150.114.2243.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, consolidation and maintenance",150,"Maintenance after first-line therapy",114,"RVD",TRUE,"Cont.","1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1562","150.114.2243.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, consolidation and maintenance",150,"Maintenance after first-line therapy",114,"RVD",TRUE,"Cont.","1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1563","150.114.2243.3","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, consolidation and maintenance",150,"Maintenance after first-line therapy",114,"RVD",TRUE,"Cont.","8.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;8.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","8.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1564","150.114.2244.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, consolidation and maintenance",150,"Maintenance after first-line therapy",114,"Bortezomib monotherapy",TRUE,"Cont.","74.Bortezomib;3.Bortezomib;4.Bortezomib;3.Bortezomib;74.Bortezomib;3.Bortezomib;4.Bortezomib;3.Bortezomib;","74.Bortezomib;3.Bortezomib;4.Bortezomib;3.Bortezomib;"
"1565","150.114.2245.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, consolidation and maintenance",150,"Maintenance after first-line therapy",114,"VT",TRUE,"Cont.","1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;","1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;"
"1566","150.114.2245.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, consolidation and maintenance",150,"Maintenance after first-line therapy",114,"VT",TRUE,"Cont.","1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;","1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;"
"1567","150.40.2231.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, consolidation and maintenance",150,"Consolidation after first-line therapy",40,"Bortezomib monotherapy",TRUE,"Cont.","14.Bortezomib;7.Bortezomib;7.Bortezomib;14.Bortezomib;7.Bortezomib;7.Bortezomib;","14.Bortezomib;7.Bortezomib;7.Bortezomib;"
"1568","150.40.2232.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, consolidation and maintenance",150,"Consolidation after first-line therapy",40,"DCEP",FALSE,"2","28.Cisplatin;0.Cyclophosphamide;0.Etoposide;","28.Cisplatin;0.Cyclophosphamide;0.Etoposide;"
"1569","150.40.2232.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, consolidation and maintenance",150,"Consolidation after first-line therapy",40,"DCEP",FALSE,"2","24.Cisplatin;0.Cyclophosphamide;0.Etoposide;1.Cisplatin;0.Cyclophosphamide;0.Etoposide;1.Cisplatin;0.Cyclophosphamide;0.Etoposide;1.Cisplatin;0.Cyclophosphamide;0.Etoposide;1.Cisplatin;0.Cyclophosphamide;0.Etoposide;","24.Cisplatin;0.Cyclophosphamide;0.Etoposide;1.Cisplatin;0.Cyclophosphamide;0.Etoposide;1.Cisplatin;0.Cyclophosphamide;0.Etoposide;1.Cisplatin;0.Cyclophosphamide;0.Etoposide;1.Cisplatin;0.Cyclophosphamide;0.Etoposide;"
"1570","150.40.2233.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, consolidation and maintenance",150,"Consolidation after first-line therapy",40,"Melphalan, then auto HSCT",FALSE,"1","0.Melphalan;1.Melphalan;","0.Melphalan;1.Melphalan;"
"1571","150.40.2234.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, consolidation and maintenance",150,"Consolidation after first-line therapy",40,"MPR",FALSE,"6","3.Lenalidomide;0.Melphalan;1.Lenalidomide;1.Lenalidomide;0.Melphalan;1.Lenalidomide;1.Lenalidomide;0.Melphalan;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Melphalan;1.Lenalidomide;1.Lenalidomide;0.Melphalan;1.Lenalidomide;1.Lenalidomide;0.Melphalan;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Melphalan;1.Lenalidomide;1.Lenalidomide;0.Melphalan;1.Lenalidomide;1.Lenalidomide;0.Melphalan;1.Lenalidomide;1.Lenalidomide;1.Melphalan;2.Melphalan;2.Melphalan;3.Lenalidomide;0.Melphalan;1.Lenalidomide;1.Lenalidomide;0.Melphalan;1.Lenalidomide;1.Lenalidomide;0.Melphalan;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Melphalan;1.Lenalidomide;1.Lenalidomide;0.Melphalan;1.Lenalidomide;1.Lenalidomide;0.Melphalan;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Melphalan;1.Lenalidomide;1.Lenalidomide;0.Melphalan;1.Lenalidomide;1.Lenalidomide;0.Melphalan;1.Lenalidomide;1.Lenalidomide;1.Melphalan;2.Melphalan;2.Melphalan;","3.Lenalidomide;0.Melphalan;1.Lenalidomide;1.Lenalidomide;0.Melphalan;1.Lenalidomide;1.Lenalidomide;0.Melphalan;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Melphalan;1.Lenalidomide;1.Lenalidomide;0.Melphalan;1.Lenalidomide;1.Lenalidomide;0.Melphalan;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Melphalan;1.Lenalidomide;1.Lenalidomide;0.Melphalan;1.Lenalidomide;1.Lenalidomide;0.Melphalan;1.Lenalidomide;1.Lenalidomide;1.Melphalan;2.Melphalan;2.Melphalan;"
"1572","150.40.2235.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, consolidation and maintenance",150,"Consolidation after first-line therapy",40,"RVD",TRUE,"Cont.","8.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;8.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","8.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1573","151.115.2303.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Maintenance after second-line therapy",115,"Bortezomib & Cyclophosphamide",TRUE,"Cont.","1.Bortezomib;0.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Bortezomib;0.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;","1.Bortezomib;0.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;"
"1574","151.115.2304.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Maintenance after second-line therapy",115,"KPD",TRUE,"Cont.","8.Carfilzomib;0.Carfilzomib;1.Carfilzomib;0.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;0.Carfilzomib;1.Carfilzomib;0.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;8.Carfilzomib;0.Carfilzomib;1.Carfilzomib;0.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;0.Carfilzomib;1.Carfilzomib;0.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;","8.Carfilzomib;0.Carfilzomib;1.Carfilzomib;0.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;0.Carfilzomib;1.Carfilzomib;0.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;"
"1575","151.115.2305.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Maintenance after second-line therapy",115,"RVD",TRUE,"Cont.","8.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;8.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","8.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Bortezomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1576","151.177.2254.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, doublets",177,"Bortezomib monotherapy",TRUE,"Cont.","14.Bortezomib;7.Bortezomib;14.Bortezomib;7.Bortezomib;","14.Bortezomib;7.Bortezomib;"
"1577","151.177.2255.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, doublets",177,"Bortezomib & Pegylated liposomal doxorubicin",TRUE,"Cont.","11.Bortezomib;3.Bortezomib;0.Pegylatedliposomaldoxorubicin;4.Bortezomib;3.Bortezomib;11.Bortezomib;3.Bortezomib;0.Pegylatedliposomaldoxorubicin;4.Bortezomib;3.Bortezomib;","11.Bortezomib;3.Bortezomib;0.Pegylatedliposomaldoxorubicin;4.Bortezomib;3.Bortezomib;"
"1578","151.177.2256.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, doublets",177,"Bortezomib & Vorinostat",TRUE,"Cont.","8.Bortezomib;0.Vorinostat;1.Vorinostat;1.Vorinostat;1.Bortezomib;0.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Bortezomib;0.Vorinostat;1.Vorinostat;1.Vorinostat;1.Bortezomib;0.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;8.Bortezomib;0.Vorinostat;1.Vorinostat;1.Vorinostat;1.Bortezomib;0.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Bortezomib;0.Vorinostat;1.Vorinostat;1.Vorinostat;1.Bortezomib;0.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;","8.Bortezomib;0.Vorinostat;1.Vorinostat;1.Vorinostat;1.Bortezomib;0.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Bortezomib;0.Vorinostat;1.Vorinostat;1.Vorinostat;1.Bortezomib;0.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;"
"1579","151.177.2257.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, doublets",177,"Carfilzomib & Panobinostat",TRUE,"Cont.","13.Carfilzomib;0.Panobinostat;1.Carfilzomib;0.Panobinostat;6.Carfilzomib;0.Panobinostat;1.Carfilzomib;0.Panobinostat;6.Carfilzomib;0.Panobinostat;1.Carfilzomib;0.Panobinostat;13.Carfilzomib;0.Panobinostat;1.Carfilzomib;0.Panobinostat;6.Carfilzomib;0.Panobinostat;1.Carfilzomib;0.Panobinostat;6.Carfilzomib;0.Panobinostat;1.Carfilzomib;0.Panobinostat;","13.Carfilzomib;0.Panobinostat;1.Carfilzomib;0.Panobinostat;6.Carfilzomib;0.Panobinostat;1.Carfilzomib;0.Panobinostat;6.Carfilzomib;0.Panobinostat;1.Carfilzomib;0.Panobinostat;"
"1580","151.177.2258.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, doublets",177,"Cyclophosphamide monotherapy",TRUE,"Cont.","1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;","1.Cyclophosphamide;1.Cyclophosphamide;"
"1581","151.177.2259.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, doublets",177,"Melphalan flufenamide monotherapy",TRUE,"Cont.","28.Melphalanflufenamide;28.Melphalanflufenamide;","28.Melphalanflufenamide;28.Melphalanflufenamide;"
"1582","151.177.2260.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, doublets",177,"Selinexor monotherapy",TRUE,"Cont.","5.Selinexor;2.Selinexor;5.Selinexor;2.Selinexor;5.Selinexor;2.Selinexor;5.Selinexor;2.Selinexor;5.Selinexor;2.Selinexor;5.Selinexor;2.Selinexor;5.Selinexor;2.Selinexor;5.Selinexor;2.Selinexor;","5.Selinexor;2.Selinexor;"
"1583","151.181.2296.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, other combinations",181,"Bortezomib, Thalidomide, Dexamethasone, Panobinostat",TRUE,"Cont.","1.Bortezomib;0.Panobinostat;0.Thalidomide;1.Thalidomide;1.Panobinostat;0.Thalidomide;1.Thalidomide;1.Panobinostat;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Panobinostat;0.Thalidomide;1.Thalidomide;1.Panobinostat;0.Thalidomide;1.Thalidomide;1.Panobinostat;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Panobinostat;0.Thalidomide;1.Thalidomide;1.Panobinostat;0.Thalidomide;1.Thalidomide;1.Panobinostat;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Panobinostat;0.Thalidomide;1.Thalidomide;1.Panobinostat;0.Thalidomide;1.Thalidomide;1.Panobinostat;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;","1.Bortezomib;0.Panobinostat;0.Thalidomide;1.Thalidomide;1.Panobinostat;0.Thalidomide;1.Thalidomide;1.Panobinostat;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Panobinostat;0.Thalidomide;1.Thalidomide;1.Panobinostat;0.Thalidomide;1.Thalidomide;1.Panobinostat;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;"
"1584","151.181.2297.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, other combinations",181,"DTPACE",TRUE,"Cont.","1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;","1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;"
"1585","151.181.2297.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, other combinations",181,"DTPACE",TRUE,"Cont.","1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;","1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;"
"1586","151.181.2297.3","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, other combinations",181,"DTPACE",TRUE,"Cont.","1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;","1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;"
"1587","151.181.2297.4","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, other combinations",181,"DTPACE",TRUE,"Cont.","1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;","1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;"
"1588","151.181.2297.5","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, other combinations",181,"DTPACE",TRUE,"Cont.","1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;","1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;"
"1589","151.181.2297.6","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, other combinations",181,"DTPACE",TRUE,"Cont.","1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;","1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;"
"1590","151.181.2298.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, other combinations",181,"Hyper-CVAD",TRUE,"Cont.","18.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;18.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;","18.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;"
"1591","151.181.2298.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, other combinations",181,"Hyper-CVAD",TRUE,"Cont.","16.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;16.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;","16.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;"
"1592","151.181.2298.3","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, other combinations",181,"Hyper-CVAD",TRUE,"Cont.","25.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;25.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;","25.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;"
"1593","151.181.2298.4","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, other combinations",181,"Hyper-CVAD",TRUE,"Cont.","23.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;23.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;","23.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;"
"1594","151.181.2299.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, other combinations",181,"KD-PACE",TRUE,"Cont.","20.Carfilzomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;1.Carfilzomib;6.Carfilzomib;1.Carfilzomib;20.Carfilzomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;1.Carfilzomib;6.Carfilzomib;1.Carfilzomib;","20.Carfilzomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;1.Carfilzomib;6.Carfilzomib;1.Carfilzomib;"
"1595","151.181.2299.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, other combinations",181,"KD-PACE",TRUE,"Cont.","27.Carfilzomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;1.Carfilzomib;6.Carfilzomib;1.Carfilzomib;27.Carfilzomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;1.Carfilzomib;6.Carfilzomib;1.Carfilzomib;","27.Carfilzomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;1.Carfilzomib;6.Carfilzomib;1.Carfilzomib;"
"1596","151.181.2299.3","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, other combinations",181,"KD-PACE",TRUE,"Cont.","34.Carfilzomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;1.Carfilzomib;6.Carfilzomib;1.Carfilzomib;34.Carfilzomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;1.Carfilzomib;6.Carfilzomib;1.Carfilzomib;","34.Carfilzomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;1.Carfilzomib;6.Carfilzomib;1.Carfilzomib;"
"1597","151.181.2299.4","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, other combinations",181,"KD-PACE",TRUE,"Cont.","20.Carfilzomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;1.Carfilzomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;4.Carfilzomib;1.Carfilzomib;20.Carfilzomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;1.Carfilzomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;4.Carfilzomib;1.Carfilzomib;","20.Carfilzomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;1.Carfilzomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;4.Carfilzomib;1.Carfilzomib;"
"1598","151.181.2299.5","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, other combinations",181,"KD-PACE",TRUE,"Cont.","27.Carfilzomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;1.Carfilzomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;4.Carfilzomib;1.Carfilzomib;27.Carfilzomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;1.Carfilzomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;4.Carfilzomib;1.Carfilzomib;","27.Carfilzomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;1.Carfilzomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;4.Carfilzomib;1.Carfilzomib;"
"1599","151.181.2299.6","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, other combinations",181,"KD-PACE",TRUE,"Cont.","34.Carfilzomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;1.Carfilzomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;4.Carfilzomib;1.Carfilzomib;34.Carfilzomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;1.Carfilzomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;4.Carfilzomib;1.Carfilzomib;","34.Carfilzomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;1.Carfilzomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;4.Carfilzomib;1.Carfilzomib;"
"1600","151.181.2300.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, other combinations",181,"KRD-PACE",TRUE,"Cont.","20.Carfilzomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;4.Carfilzomib;1.Carfilzomib;20.Carfilzomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;4.Carfilzomib;1.Carfilzomib;","20.Carfilzomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;4.Carfilzomib;1.Carfilzomib;"
"1601","151.181.2300.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, other combinations",181,"KRD-PACE",TRUE,"Cont.","20.Carfilzomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Lenalidomide;1.Carfilzomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Lenalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Lenalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Lenalidomide;4.Carfilzomib;1.Carfilzomib;20.Carfilzomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Lenalidomide;1.Carfilzomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Lenalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Lenalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Lenalidomide;4.Carfilzomib;1.Carfilzomib;","20.Carfilzomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Lenalidomide;1.Carfilzomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Lenalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Lenalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Lenalidomide;4.Carfilzomib;1.Carfilzomib;"
"1602","151.181.2300.3","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, other combinations",181,"KRD-PACE",TRUE,"Cont.","21.Carfilzomib;4.Carfilzomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;21.Carfilzomib;4.Carfilzomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","21.Carfilzomib;4.Carfilzomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1603","151.181.2300.4","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, other combinations",181,"KRD-PACE",TRUE,"Cont.","21.Carfilzomib;4.Carfilzomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Lenalidomide;1.Carfilzomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Lenalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Lenalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Lenalidomide;21.Carfilzomib;4.Carfilzomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Lenalidomide;1.Carfilzomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Lenalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Lenalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Lenalidomide;","21.Carfilzomib;4.Carfilzomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Lenalidomide;1.Carfilzomib;0.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Lenalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Lenalidomide;1.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Lenalidomide;"
"1604","151.181.2301.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, other combinations",181,"V-HyperCAD",TRUE,"Cont.","25.Bortezomib;0.Cyclophosphamide;0.Doxorubicin;1.Cyclophosphamide;1.Cyclophosphamide;1.Bortezomib;0.Cyclophosphamide;25.Bortezomib;0.Cyclophosphamide;0.Doxorubicin;1.Cyclophosphamide;1.Cyclophosphamide;1.Bortezomib;0.Cyclophosphamide;","25.Bortezomib;0.Cyclophosphamide;0.Doxorubicin;1.Cyclophosphamide;1.Cyclophosphamide;1.Bortezomib;0.Cyclophosphamide;"
"1605","151.181.2301.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, other combinations",181,"V-HyperCAD",TRUE,"Cont.","25.Bortezomib;0.Cyclophosphamide;0.Doxorubicin;1.Cyclophosphamide;0.Doxorubicin;1.Cyclophosphamide;0.Doxorubicin;1.Bortezomib;0.Cyclophosphamide;0.Doxorubicin;25.Bortezomib;0.Cyclophosphamide;0.Doxorubicin;1.Cyclophosphamide;0.Doxorubicin;1.Cyclophosphamide;0.Doxorubicin;1.Bortezomib;0.Cyclophosphamide;0.Doxorubicin;","25.Bortezomib;0.Cyclophosphamide;0.Doxorubicin;1.Cyclophosphamide;0.Doxorubicin;1.Cyclophosphamide;0.Doxorubicin;1.Bortezomib;0.Cyclophosphamide;0.Doxorubicin;"
"1606","151.181.2302.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, other combinations",181,"VMPT",TRUE,"Cont.","1.Bortezomib;0.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Bortezomib;0.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Bortezomib;0.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;","1.Bortezomib;0.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Bortezomib;0.Melphalan;0.Thalidomide;1.Melphalan;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;"
"1607","151.185.2246.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, single agents",185,"Ciltacabtagene autoleucel monotherapy",FALSE,"1","0.Ciltacabtageneautoleucel;","0.Ciltacabtageneautoleucel;0.Ciltacabtageneautoleucel;"
"1608","151.185.2247.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, single agents",185,"Carfilzomib monotherapy",TRUE,"Cont.","13.Carfilzomib;1.Carfilzomib;6.Carfilzomib;1.Carfilzomib;6.Carfilzomib;1.Carfilzomib;13.Carfilzomib;1.Carfilzomib;6.Carfilzomib;1.Carfilzomib;6.Carfilzomib;1.Carfilzomib;","13.Carfilzomib;1.Carfilzomib;6.Carfilzomib;1.Carfilzomib;6.Carfilzomib;1.Carfilzomib;"
"1609","151.185.2248.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, single agents",185,"Daratumumab and hyaluronidase monotherapy",TRUE,"Cont.","7.Daratumumabandhyaluronidase;7.Daratumumabandhyaluronidase;7.Daratumumabandhyaluronidase;7.Daratumumabandhyaluronidase;7.Daratumumabandhyaluronidase;7.Daratumumabandhyaluronidase;7.Daratumumabandhyaluronidase;7.Daratumumabandhyaluronidase;","7.Daratumumabandhyaluronidase;7.Daratumumabandhyaluronidase;"
"1610","151.185.2248.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, single agents",185,"Daratumumab and hyaluronidase monotherapy",TRUE,"Cont.","14.Daratumumabandhyaluronidase;14.Daratumumabandhyaluronidase;14.Daratumumabandhyaluronidase;14.Daratumumabandhyaluronidase;","14.Daratumumabandhyaluronidase;14.Daratumumabandhyaluronidase;"
"1611","151.185.2248.3","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, single agents",185,"Daratumumab and hyaluronidase monotherapy",TRUE,"Cont.","28.Daratumumabandhyaluronidase;28.Daratumumabandhyaluronidase;","28.Daratumumabandhyaluronidase;28.Daratumumabandhyaluronidase;"
"1612","151.185.2249.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, single agents",185,"Idecabtagene vicleucel monotherapy",FALSE,"1","0.Idecabtagenevicleucel;","0.Idecabtagenevicleucel;0.Idecabtagenevicleucel;"
"1613","151.185.2250.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, single agents",185,"Ixazomib monotherapy",TRUE,"Cont.","11.Ixazomib;3.Ixazomib;4.Ixazomib;3.Ixazomib;11.Ixazomib;3.Ixazomib;4.Ixazomib;3.Ixazomib;","11.Ixazomib;3.Ixazomib;4.Ixazomib;3.Ixazomib;"
"1614","151.185.2251.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, single agents",185,"Teclistamab monotherapy",TRUE,"Cont.","7.Teclistamab;3.Teclistamab;4.Teclistamab;7.Teclistamab;7.Teclistamab;7.Teclistamab;3.Teclistamab;4.Teclistamab;7.Teclistamab;7.Teclistamab;","7.Teclistamab;3.Teclistamab;4.Teclistamab;7.Teclistamab;7.Teclistamab;"
"1615","151.185.2252.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, single agents",185,"Vemurafenib monotherapy",TRUE,"Cont.","1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;","1.Vemurafenib;1.Vemurafenib;"
"1616","151.185.2253.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, single agents",185,"Venetoclax monotherapy",TRUE,"Cont.","1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;1.Venetoclax;","1.Venetoclax;1.Venetoclax;"
"1617","151.187.2261.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"BBD",TRUE,"Cont.","18.Bendamustine;0.Bortezomib;3.Bendamustine;0.Bortezomib;4.Bortezomib;3.Bortezomib;18.Bendamustine;0.Bortezomib;3.Bendamustine;0.Bortezomib;4.Bortezomib;3.Bortezomib;","18.Bendamustine;0.Bortezomib;3.Bendamustine;0.Bortezomib;4.Bortezomib;3.Bortezomib;"
"1618","151.187.2262.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"BID",TRUE,"Cont.","14.Bendamustine;0.Ixazomib;1.Bendamustine;6.Ixazomib;7.Ixazomib;14.Bendamustine;0.Ixazomib;1.Bendamustine;6.Ixazomib;7.Ixazomib;","14.Bendamustine;0.Ixazomib;1.Bendamustine;6.Ixazomib;7.Ixazomib;"
"1619","151.187.2263.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"BLD",TRUE,"Cont.","8.Bendamustine;0.Lenalidomide;1.Bendamustine;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;8.Bendamustine;0.Lenalidomide;1.Bendamustine;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","8.Bendamustine;0.Lenalidomide;1.Bendamustine;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1620","151.187.2264.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"Bortezomib & Dexamethasone (Vd) & Panobinostat",TRUE,"Cont.","10.Bortezomib;0.Panobinostat;2.Panobinostat;1.Bortezomib;1.Panobinostat;3.Bortezomib;0.Panobinostat;2.Panobinostat;1.Bortezomib;1.Panobinostat;10.Bortezomib;0.Panobinostat;2.Panobinostat;1.Bortezomib;1.Panobinostat;3.Bortezomib;0.Panobinostat;2.Panobinostat;1.Bortezomib;1.Panobinostat;","10.Bortezomib;0.Panobinostat;2.Panobinostat;1.Bortezomib;1.Panobinostat;3.Bortezomib;0.Panobinostat;2.Panobinostat;1.Bortezomib;1.Panobinostat;"
"1621","151.187.2264.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"Bortezomib & Dexamethasone (Vd) & Panobinostat",TRUE,"Cont.","10.Bortezomib;0.Panobinostat;2.Panobinostat;2.Panobinostat;3.Bortezomib;0.Panobinostat;2.Panobinostat;2.Panobinostat;10.Bortezomib;0.Panobinostat;2.Panobinostat;2.Panobinostat;3.Bortezomib;0.Panobinostat;2.Panobinostat;2.Panobinostat;","10.Bortezomib;0.Panobinostat;2.Panobinostat;2.Panobinostat;3.Bortezomib;0.Panobinostat;2.Panobinostat;2.Panobinostat;"
"1622","151.187.2265.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"B-Pd",TRUE,"Cont.","8.Bortezomib;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Bortezomib;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Bortezomib;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Bortezomib;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;8.Bortezomib;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Bortezomib;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Bortezomib;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Bortezomib;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;","8.Bortezomib;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Bortezomib;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Bortezomib;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Bortezomib;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;"
"1623","151.187.2266.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"BTD",TRUE,"Cont.","8.Bendamustine;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bendamustine;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;8.Bendamustine;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bendamustine;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;","8.Bendamustine;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bendamustine;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;"
"1624","151.187.2267.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"CPR",TRUE,"Cont.","1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;","1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;"
"1625","151.187.2267.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"CPR",TRUE,"Cont.","8.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;8.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","8.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1626","151.187.2268.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"CRD",TRUE,"Cont.","8.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;8.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","8.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Cyclophosphamide;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1627","151.187.2269.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"CTD",TRUE,"Cont.","11.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;9.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;11.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;9.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;","11.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;9.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;"
"1628","151.187.2269.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"CTD",TRUE,"Cont.","24.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;24.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;","24.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Cyclophosphamide;0.Thalidomide;"
"1629","151.187.2270.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"Dara-Kd",TRUE,"Cont.","7.Carfilzomib;0.Daratumumab;1.Carfilzomib;0.Daratumumab;6.Carfilzomib;0.Daratumumab;1.Carfilzomib;6.Carfilzomib;0.Daratumumab;1.Carfilzomib;6.Daratumumab;7.Carfilzomib;0.Daratumumab;1.Carfilzomib;0.Daratumumab;6.Carfilzomib;0.Daratumumab;1.Carfilzomib;6.Carfilzomib;0.Daratumumab;1.Carfilzomib;6.Daratumumab;","7.Carfilzomib;0.Daratumumab;1.Carfilzomib;0.Daratumumab;6.Carfilzomib;0.Daratumumab;1.Carfilzomib;6.Carfilzomib;0.Daratumumab;1.Carfilzomib;6.Daratumumab;"
"1630","151.187.2270.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"Dara-Kd",TRUE,"Cont.","7.Carfilzomib;0.Daratumumab;1.Carfilzomib;6.Carfilzomib;0.Daratumumab;1.Carfilzomib;6.Carfilzomib;0.Daratumumab;1.Carfilzomib;6.Daratumumab;7.Carfilzomib;0.Daratumumab;1.Carfilzomib;6.Carfilzomib;0.Daratumumab;1.Carfilzomib;6.Carfilzomib;0.Daratumumab;1.Carfilzomib;6.Daratumumab;","7.Carfilzomib;0.Daratumumab;1.Carfilzomib;6.Carfilzomib;0.Daratumumab;1.Carfilzomib;6.Carfilzomib;0.Daratumumab;1.Carfilzomib;6.Daratumumab;"
"1631","151.187.2270.3","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"Dara-Kd",TRUE,"Cont.","13.Carfilzomib;0.Daratumumab;1.Carfilzomib;6.Carfilzomib;1.Carfilzomib;6.Carfilzomib;0.Daratumumab;1.Carfilzomib;13.Carfilzomib;0.Daratumumab;1.Carfilzomib;6.Carfilzomib;1.Carfilzomib;6.Carfilzomib;0.Daratumumab;1.Carfilzomib;","13.Carfilzomib;0.Daratumumab;1.Carfilzomib;6.Carfilzomib;1.Carfilzomib;6.Carfilzomib;0.Daratumumab;1.Carfilzomib;"
"1632","151.187.2270.4","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"Dara-Kd",TRUE,"Cont.","13.Carfilzomib;0.Daratumumab;1.Carfilzomib;6.Carfilzomib;1.Carfilzomib;6.Carfilzomib;1.Carfilzomib;13.Carfilzomib;0.Daratumumab;1.Carfilzomib;6.Carfilzomib;1.Carfilzomib;6.Carfilzomib;1.Carfilzomib;","13.Carfilzomib;0.Daratumumab;1.Carfilzomib;6.Carfilzomib;1.Carfilzomib;6.Carfilzomib;1.Carfilzomib;"
"1633","151.187.2270.5","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"Dara-Kd",TRUE,"Cont.","7.Carfilzomib;0.Daratumumab;1.Daratumumab;6.Carfilzomib;0.Daratumumab;7.Carfilzomib;0.Daratumumab;7.Daratumumab;7.Carfilzomib;0.Daratumumab;1.Daratumumab;6.Carfilzomib;0.Daratumumab;7.Carfilzomib;0.Daratumumab;7.Daratumumab;","7.Carfilzomib;0.Daratumumab;1.Daratumumab;6.Carfilzomib;0.Daratumumab;7.Carfilzomib;0.Daratumumab;7.Daratumumab;"
"1634","151.187.2270.6","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"Dara-Kd",TRUE,"Cont.","7.Carfilzomib;0.Daratumumab;7.Carfilzomib;0.Daratumumab;7.Carfilzomib;0.Daratumumab;7.Daratumumab;7.Carfilzomib;0.Daratumumab;7.Carfilzomib;0.Daratumumab;7.Carfilzomib;0.Daratumumab;7.Daratumumab;","7.Carfilzomib;0.Daratumumab;7.Carfilzomib;0.Daratumumab;7.Carfilzomib;0.Daratumumab;7.Daratumumab;"
"1635","151.187.2270.7","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"Dara-Kd",TRUE,"Cont.","14.Carfilzomib;0.Daratumumab;7.Carfilzomib;7.Carfilzomib;0.Daratumumab;14.Carfilzomib;0.Daratumumab;7.Carfilzomib;7.Carfilzomib;0.Daratumumab;","14.Carfilzomib;0.Daratumumab;7.Carfilzomib;7.Carfilzomib;0.Daratumumab;"
"1636","151.187.2270.8","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"Dara-Kd",TRUE,"Cont.","14.Carfilzomib;0.Daratumumab;7.Carfilzomib;7.Carfilzomib;14.Carfilzomib;0.Daratumumab;7.Carfilzomib;7.Carfilzomib;","14.Carfilzomib;0.Daratumumab;7.Carfilzomib;7.Carfilzomib;"
"1637","151.187.2271.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"Dara-Kd (SC daratumumab)",TRUE,"Cont.","7.Carfilzomib;0.Daratumumabandhyaluronidase;1.Carfilzomib;0.Daratumumabandhyaluronidase;6.Carfilzomib;0.Daratumumabandhyaluronidase;1.Carfilzomib;6.Carfilzomib;0.Daratumumabandhyaluronidase;1.Carfilzomib;6.Daratumumabandhyaluronidase;7.Carfilzomib;0.Daratumumabandhyaluronidase;1.Carfilzomib;0.Daratumumabandhyaluronidase;6.Carfilzomib;0.Daratumumabandhyaluronidase;1.Carfilzomib;6.Carfilzomib;0.Daratumumabandhyaluronidase;1.Carfilzomib;6.Daratumumabandhyaluronidase;","7.Carfilzomib;0.Daratumumabandhyaluronidase;1.Carfilzomib;0.Daratumumabandhyaluronidase;6.Carfilzomib;0.Daratumumabandhyaluronidase;1.Carfilzomib;6.Carfilzomib;0.Daratumumabandhyaluronidase;1.Carfilzomib;6.Daratumumabandhyaluronidase;"
"1638","151.187.2271.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"Dara-Kd (SC daratumumab)",TRUE,"Cont.","7.Carfilzomib;0.Daratumumabandhyaluronidase;1.Carfilzomib;6.Carfilzomib;0.Daratumumabandhyaluronidase;1.Carfilzomib;6.Carfilzomib;0.Daratumumabandhyaluronidase;1.Carfilzomib;6.Daratumumabandhyaluronidase;7.Carfilzomib;0.Daratumumabandhyaluronidase;1.Carfilzomib;6.Carfilzomib;0.Daratumumabandhyaluronidase;1.Carfilzomib;6.Carfilzomib;0.Daratumumabandhyaluronidase;1.Carfilzomib;6.Daratumumabandhyaluronidase;","7.Carfilzomib;0.Daratumumabandhyaluronidase;1.Carfilzomib;6.Carfilzomib;0.Daratumumabandhyaluronidase;1.Carfilzomib;6.Carfilzomib;0.Daratumumabandhyaluronidase;1.Carfilzomib;6.Daratumumabandhyaluronidase;"
"1639","151.187.2271.3","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"Dara-Kd (SC daratumumab)",TRUE,"Cont.","13.Carfilzomib;0.Daratumumabandhyaluronidase;1.Carfilzomib;6.Carfilzomib;1.Carfilzomib;6.Carfilzomib;0.Daratumumabandhyaluronidase;1.Carfilzomib;13.Carfilzomib;0.Daratumumabandhyaluronidase;1.Carfilzomib;6.Carfilzomib;1.Carfilzomib;6.Carfilzomib;0.Daratumumabandhyaluronidase;1.Carfilzomib;","13.Carfilzomib;0.Daratumumabandhyaluronidase;1.Carfilzomib;6.Carfilzomib;1.Carfilzomib;6.Carfilzomib;0.Daratumumabandhyaluronidase;1.Carfilzomib;"
"1640","151.187.2271.4","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"Dara-Kd (SC daratumumab)",TRUE,"Cont.","13.Carfilzomib;0.Daratumumabandhyaluronidase;1.Carfilzomib;6.Carfilzomib;1.Carfilzomib;6.Carfilzomib;1.Carfilzomib;13.Carfilzomib;0.Daratumumabandhyaluronidase;1.Carfilzomib;6.Carfilzomib;1.Carfilzomib;6.Carfilzomib;1.Carfilzomib;","13.Carfilzomib;0.Daratumumabandhyaluronidase;1.Carfilzomib;6.Carfilzomib;1.Carfilzomib;6.Carfilzomib;1.Carfilzomib;"
"1641","151.187.2271.5","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"Dara-Kd (SC daratumumab)",TRUE,"Cont.","7.Carfilzomib;0.Daratumumabandhyaluronidase;1.Daratumumabandhyaluronidase;6.Carfilzomib;0.Daratumumabandhyaluronidase;7.Carfilzomib;0.Daratumumabandhyaluronidase;7.Daratumumabandhyaluronidase;7.Carfilzomib;0.Daratumumabandhyaluronidase;1.Daratumumabandhyaluronidase;6.Carfilzomib;0.Daratumumabandhyaluronidase;7.Carfilzomib;0.Daratumumabandhyaluronidase;7.Daratumumabandhyaluronidase;","7.Carfilzomib;0.Daratumumabandhyaluronidase;1.Daratumumabandhyaluronidase;6.Carfilzomib;0.Daratumumabandhyaluronidase;7.Carfilzomib;0.Daratumumabandhyaluronidase;7.Daratumumabandhyaluronidase;"
"1642","151.187.2271.6","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"Dara-Kd (SC daratumumab)",TRUE,"Cont.","7.Carfilzomib;0.Daratumumabandhyaluronidase;7.Carfilzomib;0.Daratumumabandhyaluronidase;7.Carfilzomib;0.Daratumumabandhyaluronidase;7.Daratumumabandhyaluronidase;7.Carfilzomib;0.Daratumumabandhyaluronidase;7.Carfilzomib;0.Daratumumabandhyaluronidase;7.Carfilzomib;0.Daratumumabandhyaluronidase;7.Daratumumabandhyaluronidase;","7.Carfilzomib;0.Daratumumabandhyaluronidase;7.Carfilzomib;0.Daratumumabandhyaluronidase;7.Carfilzomib;0.Daratumumabandhyaluronidase;7.Daratumumabandhyaluronidase;"
"1643","151.187.2271.7","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"Dara-Kd (SC daratumumab)",TRUE,"Cont.","14.Carfilzomib;0.Daratumumabandhyaluronidase;7.Carfilzomib;7.Carfilzomib;0.Daratumumabandhyaluronidase;14.Carfilzomib;0.Daratumumabandhyaluronidase;7.Carfilzomib;7.Carfilzomib;0.Daratumumabandhyaluronidase;","14.Carfilzomib;0.Daratumumabandhyaluronidase;7.Carfilzomib;7.Carfilzomib;0.Daratumumabandhyaluronidase;"
"1644","151.187.2271.8","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"Dara-Kd (SC daratumumab)",TRUE,"Cont.","14.Carfilzomib;0.Daratumumabandhyaluronidase;7.Carfilzomib;7.Carfilzomib;14.Carfilzomib;0.Daratumumabandhyaluronidase;7.Carfilzomib;7.Carfilzomib;","14.Carfilzomib;0.Daratumumabandhyaluronidase;7.Carfilzomib;7.Carfilzomib;"
"1645","151.187.2272.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"Dara-Pd",TRUE,"Cont.","7.Daratumumab;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Daratumumab;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Daratumumab;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Daratumumab;7.Daratumumab;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Daratumumab;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Daratumumab;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Daratumumab;","7.Daratumumab;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Daratumumab;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Daratumumab;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Daratumumab;"
"1646","151.187.2272.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"Dara-Pd",TRUE,"Cont.","8.Daratumumab;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Daratumumab;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;8.Daratumumab;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Daratumumab;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;","8.Daratumumab;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Daratumumab;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;"
"1647","151.187.2272.3","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"Dara-Pd",TRUE,"Cont.","8.Daratumumab;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;8.Daratumumab;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;","8.Daratumumab;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;"
"1648","151.187.2273.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"Dara-Pd (SC daratumumab)",TRUE,"Cont.","7.Daratumumabandhyaluronidase;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Daratumumabandhyaluronidase;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Daratumumabandhyaluronidase;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Daratumumabandhyaluronidase;7.Daratumumabandhyaluronidase;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Daratumumabandhyaluronidase;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Daratumumabandhyaluronidase;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Daratumumabandhyaluronidase;","7.Daratumumabandhyaluronidase;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Daratumumabandhyaluronidase;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Daratumumabandhyaluronidase;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Daratumumabandhyaluronidase;"
"1649","151.187.2273.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"Dara-Pd (SC daratumumab)",TRUE,"Cont.","8.Daratumumabandhyaluronidase;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Daratumumabandhyaluronidase;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;8.Daratumumabandhyaluronidase;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Daratumumabandhyaluronidase;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;","8.Daratumumabandhyaluronidase;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Daratumumabandhyaluronidase;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;"
"1650","151.187.2273.3","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"Dara-Pd (SC daratumumab)",TRUE,"Cont.","8.Daratumumabandhyaluronidase;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;8.Daratumumabandhyaluronidase;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;","8.Daratumumabandhyaluronidase;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;"
"1651","151.187.2274.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"Dara-Rd",TRUE,"Cont.","7.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Daratumumab;7.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Daratumumab;","7.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Daratumumab;"
"1652","151.187.2274.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"Dara-Rd",TRUE,"Cont.","8.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;8.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","8.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1653","151.187.2274.3","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"Dara-Rd",TRUE,"Cont.","8.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;8.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","8.Daratumumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1654","151.187.2275.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"Dara-Rd (SC daratumumab)",TRUE,"Cont.","7.Daratumumabandhyaluronidase;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Daratumumabandhyaluronidase;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Daratumumabandhyaluronidase;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Daratumumabandhyaluronidase;7.Daratumumabandhyaluronidase;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Daratumumabandhyaluronidase;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Daratumumabandhyaluronidase;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Daratumumabandhyaluronidase;","7.Daratumumabandhyaluronidase;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Daratumumabandhyaluronidase;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Daratumumabandhyaluronidase;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Daratumumabandhyaluronidase;"
"1655","151.187.2275.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"Dara-Rd (SC daratumumab)",TRUE,"Cont.","8.Daratumumabandhyaluronidase;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Daratumumabandhyaluronidase;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;8.Daratumumabandhyaluronidase;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Daratumumabandhyaluronidase;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","8.Daratumumabandhyaluronidase;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Daratumumabandhyaluronidase;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1656","151.187.2275.3","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"Dara-Rd (SC daratumumab)",TRUE,"Cont.","8.Daratumumabandhyaluronidase;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;8.Daratumumabandhyaluronidase;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","8.Daratumumabandhyaluronidase;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1657","151.187.2276.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"Dara-Vd",TRUE,"Cont.","7.Bortezomib;0.Daratumumab;3.Bortezomib;4.Bortezomib;0.Daratumumab;3.Bortezomib;4.Daratumumab;7.Bortezomib;0.Daratumumab;3.Bortezomib;4.Bortezomib;0.Daratumumab;3.Bortezomib;4.Daratumumab;","7.Bortezomib;0.Daratumumab;3.Bortezomib;4.Bortezomib;0.Daratumumab;3.Bortezomib;4.Daratumumab;"
"1658","151.187.2276.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"Dara-Vd",TRUE,"Cont.","11.Bortezomib;0.Daratumumab;3.Bortezomib;4.Bortezomib;3.Bortezomib;11.Bortezomib;0.Daratumumab;3.Bortezomib;4.Bortezomib;3.Bortezomib;","11.Bortezomib;0.Daratumumab;3.Bortezomib;4.Bortezomib;3.Bortezomib;"
"1659","151.187.2277.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"Dara-Vd (SC daratumumab)",TRUE,"Cont.","7.Bortezomib;0.Daratumumabandhyaluronidase;3.Bortezomib;4.Bortezomib;0.Daratumumabandhyaluronidase;3.Bortezomib;4.Daratumumabandhyaluronidase;7.Bortezomib;0.Daratumumabandhyaluronidase;3.Bortezomib;4.Bortezomib;0.Daratumumabandhyaluronidase;3.Bortezomib;4.Daratumumabandhyaluronidase;","7.Bortezomib;0.Daratumumabandhyaluronidase;3.Bortezomib;4.Bortezomib;0.Daratumumabandhyaluronidase;3.Bortezomib;4.Daratumumabandhyaluronidase;"
"1660","151.187.2277.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"Dara-Vd (SC daratumumab)",TRUE,"Cont.","11.Bortezomib;0.Daratumumabandhyaluronidase;3.Bortezomib;4.Bortezomib;3.Bortezomib;11.Bortezomib;0.Daratumumabandhyaluronidase;3.Bortezomib;4.Bortezomib;3.Bortezomib;","11.Bortezomib;0.Daratumumabandhyaluronidase;3.Bortezomib;4.Bortezomib;3.Bortezomib;"
"1661","151.187.2278.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"Elo-Pd",TRUE,"Cont.","7.Elotuzumab;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Elotuzumab;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Elotuzumab;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Elotuzumab;7.Elotuzumab;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Elotuzumab;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Elotuzumab;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Elotuzumab;","7.Elotuzumab;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Elotuzumab;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Elotuzumab;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Elotuzumab;"
"1662","151.187.2278.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"Elo-Pd",TRUE,"Cont.","8.Elotuzumab;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;8.Elotuzumab;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;","8.Elotuzumab;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;"
"1663","151.187.2279.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"Elo-Rd",TRUE,"Cont.","7.Elotuzumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Elotuzumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Elotuzumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Elotuzumab;7.Elotuzumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Elotuzumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Elotuzumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Elotuzumab;","7.Elotuzumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Elotuzumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Elotuzumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Elotuzumab;"
"1664","151.187.2279.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"Elo-Rd",TRUE,"Cont.","8.Elotuzumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Elotuzumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;8.Elotuzumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Elotuzumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","8.Elotuzumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Elotuzumab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1665","151.187.2280.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"Elo-Vd",TRUE,"Cont.","7.Bortezomib;0.Elotuzumab;3.Bortezomib;4.Bortezomib;0.Elotuzumab;3.Bortezomib;4.Elotuzumab;7.Bortezomib;0.Elotuzumab;3.Bortezomib;4.Bortezomib;0.Elotuzumab;3.Bortezomib;4.Elotuzumab;","7.Bortezomib;0.Elotuzumab;3.Bortezomib;4.Bortezomib;0.Elotuzumab;3.Bortezomib;4.Elotuzumab;"
"1666","151.187.2280.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"Elo-Vd",TRUE,"Cont.","11.Bortezomib;0.Elotuzumab;3.Bortezomib;4.Bortezomib;3.Bortezomib;0.Elotuzumab;11.Bortezomib;0.Elotuzumab;3.Bortezomib;4.Bortezomib;3.Bortezomib;0.Elotuzumab;","11.Bortezomib;0.Elotuzumab;3.Bortezomib;4.Bortezomib;3.Bortezomib;0.Elotuzumab;"
"1667","151.187.2280.3","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"Elo-Vd",TRUE,"Cont.","14.Bortezomib;0.Elotuzumab;7.Bortezomib;7.Bortezomib;0.Elotuzumab;14.Bortezomib;0.Elotuzumab;7.Bortezomib;7.Bortezomib;0.Elotuzumab;","14.Bortezomib;0.Elotuzumab;7.Bortezomib;7.Bortezomib;0.Elotuzumab;"
"1668","151.187.2281.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"FRD",TRUE,"Cont.","8.Lenalidomide;0.Panobinostat;1.Lenalidomide;1.Lenalidomide;0.Panobinostat;1.Lenalidomide;1.Lenalidomide;0.Panobinostat;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Panobinostat;1.Lenalidomide;1.Lenalidomide;0.Panobinostat;1.Lenalidomide;1.Lenalidomide;0.Panobinostat;1.Lenalidomide;1.Lenalidomide;8.Lenalidomide;0.Panobinostat;1.Lenalidomide;1.Lenalidomide;0.Panobinostat;1.Lenalidomide;1.Lenalidomide;0.Panobinostat;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Panobinostat;1.Lenalidomide;1.Lenalidomide;0.Panobinostat;1.Lenalidomide;1.Lenalidomide;0.Panobinostat;1.Lenalidomide;1.Lenalidomide;","8.Lenalidomide;0.Panobinostat;1.Lenalidomide;1.Lenalidomide;0.Panobinostat;1.Lenalidomide;1.Lenalidomide;0.Panobinostat;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Panobinostat;1.Lenalidomide;1.Lenalidomide;0.Panobinostat;1.Lenalidomide;1.Lenalidomide;0.Panobinostat;1.Lenalidomide;1.Lenalidomide;"
"1669","151.187.2282.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"Isa-Kd",TRUE,"Cont.","7.Carfilzomib;0.Isatuximab;1.Carfilzomib;6.Carfilzomib;0.Isatuximab;1.Carfilzomib;6.Carfilzomib;0.Isatuximab;1.Carfilzomib;6.Isatuximab;7.Carfilzomib;0.Isatuximab;1.Carfilzomib;6.Carfilzomib;0.Isatuximab;1.Carfilzomib;6.Carfilzomib;0.Isatuximab;1.Carfilzomib;6.Isatuximab;","7.Carfilzomib;0.Isatuximab;1.Carfilzomib;6.Carfilzomib;0.Isatuximab;1.Carfilzomib;6.Carfilzomib;0.Isatuximab;1.Carfilzomib;6.Isatuximab;"
"1670","151.187.2282.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"Isa-Kd",TRUE,"Cont.","13.Carfilzomib;0.Isatuximab;1.Carfilzomib;6.Carfilzomib;1.Carfilzomib;6.Carfilzomib;0.Isatuximab;1.Carfilzomib;13.Carfilzomib;0.Isatuximab;1.Carfilzomib;6.Carfilzomib;1.Carfilzomib;6.Carfilzomib;0.Isatuximab;1.Carfilzomib;","13.Carfilzomib;0.Isatuximab;1.Carfilzomib;6.Carfilzomib;1.Carfilzomib;6.Carfilzomib;0.Isatuximab;1.Carfilzomib;"
"1671","151.187.2283.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"Isa-Pd",TRUE,"Cont.","7.Isatuximab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Isatuximab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Isatuximab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Isatuximab;7.Isatuximab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Isatuximab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Isatuximab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Isatuximab;","7.Isatuximab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Isatuximab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Isatuximab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Isatuximab;"
"1672","151.187.2283.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"Isa-Pd",TRUE,"Cont.","8.Isatuximab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Isatuximab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;8.Isatuximab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Isatuximab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","8.Isatuximab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Isatuximab;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1673","151.187.2284.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"KPD",TRUE,"Cont.","8.Carfilzomib;0.Carfilzomib;1.Carfilzomib;0.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;0.Carfilzomib;1.Carfilzomib;0.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;0.Carfilzomib;1.Carfilzomib;0.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;8.Carfilzomib;0.Carfilzomib;1.Carfilzomib;0.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;0.Carfilzomib;1.Carfilzomib;0.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;0.Carfilzomib;1.Carfilzomib;0.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;","8.Carfilzomib;0.Carfilzomib;1.Carfilzomib;0.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;0.Carfilzomib;1.Carfilzomib;0.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;0.Carfilzomib;1.Carfilzomib;0.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;1.Carfilzomib;"
"1674","151.187.2285.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"KRd",TRUE,"Cont.","8.Carfilzomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;8.Carfilzomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","8.Carfilzomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Carfilzomib;0.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1675","151.187.2286.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"PAD",TRUE,"Cont.","18.Bortezomib;0.Doxorubicin;1.Doxorubicin;1.Doxorubicin;1.Bortezomib;0.Doxorubicin;4.Bortezomib;3.Bortezomib;18.Bortezomib;0.Doxorubicin;1.Doxorubicin;1.Doxorubicin;1.Bortezomib;0.Doxorubicin;4.Bortezomib;3.Bortezomib;","18.Bortezomib;0.Doxorubicin;1.Doxorubicin;1.Doxorubicin;1.Bortezomib;0.Doxorubicin;4.Bortezomib;3.Bortezomib;"
"1676","151.187.2287.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"PCD",TRUE,"Cont.","7.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Cyclophosphamide;7.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Cyclophosphamide;","7.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Cyclophosphamide;"
"1677","151.187.2287.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"PCD",TRUE,"Cont.","8.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;8.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;","8.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;"
"1678","151.187.2288.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"PCP",TRUE,"Cont.","1.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;1.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;1.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;1.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;1.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;1.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;1.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;1.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;1.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;1.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;1.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;1.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;1.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;1.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;1.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;1.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;1.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;1.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;1.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;1.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;1.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;1.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;1.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;1.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;1.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;1.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;1.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;1.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;","1.Cyclophosphamide;0.Pomalidomide;1.Pomalidomide;"
"1679","151.187.2289.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"PVD",TRUE,"Cont.","8.Bortezomib;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Bortezomib;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Bortezomib;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Bortezomib;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;8.Bortezomib;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Bortezomib;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Bortezomib;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Bortezomib;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;","8.Bortezomib;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Bortezomib;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Bortezomib;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Bortezomib;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;"
"1680","151.187.2289.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"PVD",TRUE,"Cont.","8.Bortezomib;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Bortezomib;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;8.Bortezomib;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Bortezomib;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;","8.Bortezomib;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Bortezomib;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;"
"1681","151.187.2289.3","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"PVD",TRUE,"Cont.","7.Bortezomib;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Bortezomib;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Bortezomib;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Bortezomib;7.Bortezomib;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Bortezomib;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Bortezomib;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Bortezomib;","7.Bortezomib;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Bortezomib;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Bortezomib;0.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Bortezomib;"
"1682","151.187.2290.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"SDd",TRUE,"Cont.","7.Daratumumab;0.Selinexor;7.Daratumumab;0.Selinexor;7.Daratumumab;0.Selinexor;7.Daratumumab;0.Selinexor;7.Daratumumab;0.Selinexor;7.Daratumumab;0.Selinexor;7.Daratumumab;0.Selinexor;7.Daratumumab;0.Selinexor;","7.Daratumumab;0.Selinexor;"
"1683","151.187.2290.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"SDd",TRUE,"Cont.","7.Daratumumab;0.Selinexor;7.Selinexor;7.Daratumumab;0.Selinexor;7.Selinexor;7.Daratumumab;0.Selinexor;7.Selinexor;7.Daratumumab;0.Selinexor;7.Selinexor;","7.Daratumumab;0.Selinexor;7.Selinexor;"
"1684","151.187.2290.3","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"SDd",TRUE,"Cont.","7.Daratumumab;0.Selinexor;7.Selinexor;7.Selinexor;7.Selinexor;7.Daratumumab;0.Selinexor;7.Selinexor;7.Selinexor;7.Selinexor;","7.Daratumumab;0.Selinexor;7.Selinexor;7.Selinexor;7.Selinexor;"
"1685","151.187.2291.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"SKd",TRUE,"Cont.","12.Carfilzomib;0.Selinexor;1.Carfilzomib;1.Selinexor;5.Carfilzomib;0.Selinexor;1.Carfilzomib;1.Selinexor;5.Carfilzomib;0.Selinexor;1.Carfilzomib;1.Selinexor;12.Carfilzomib;0.Selinexor;1.Carfilzomib;1.Selinexor;5.Carfilzomib;0.Selinexor;1.Carfilzomib;1.Selinexor;5.Carfilzomib;0.Selinexor;1.Carfilzomib;1.Selinexor;","12.Carfilzomib;0.Selinexor;1.Carfilzomib;1.Selinexor;5.Carfilzomib;0.Selinexor;1.Carfilzomib;1.Selinexor;5.Carfilzomib;0.Selinexor;1.Carfilzomib;1.Selinexor;"
"1686","151.187.2291.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"SKd",TRUE,"Cont.","12.Carfilzomib;0.Selinexor;1.Carfilzomib;1.Selinexor;5.Selinexor;2.Selinexor;5.Carfilzomib;0.Selinexor;1.Carfilzomib;1.Selinexor;12.Carfilzomib;0.Selinexor;1.Carfilzomib;1.Selinexor;5.Selinexor;2.Selinexor;5.Carfilzomib;0.Selinexor;1.Carfilzomib;1.Selinexor;","12.Carfilzomib;0.Selinexor;1.Carfilzomib;1.Selinexor;5.Selinexor;2.Selinexor;5.Carfilzomib;0.Selinexor;1.Carfilzomib;1.Selinexor;"
"1687","151.187.2292.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"SVd",TRUE,"Cont.","7.Bortezomib;0.Selinexor;7.Bortezomib;0.Selinexor;7.Bortezomib;0.Selinexor;7.Bortezomib;0.Selinexor;7.Selinexor;7.Bortezomib;0.Selinexor;7.Bortezomib;0.Selinexor;7.Bortezomib;0.Selinexor;7.Bortezomib;0.Selinexor;7.Selinexor;","7.Bortezomib;0.Selinexor;7.Bortezomib;0.Selinexor;7.Bortezomib;0.Selinexor;7.Bortezomib;0.Selinexor;7.Selinexor;"
"1688","151.187.2293.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"VDC",TRUE,"Cont.","1.Bortezomib;0.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Bortezomib;0.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Bortezomib;0.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Bortezomib;0.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Bortezomib;0.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Bortezomib;0.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Bortezomib;0.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Bortezomib;0.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;","1.Bortezomib;0.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Bortezomib;0.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Bortezomib;0.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Bortezomib;0.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;"
"1689","151.187.2293.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"VDC",TRUE,"Cont.","1.Bortezomib;0.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Bortezomib;0.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Bortezomib;0.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Bortezomib;0.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Bortezomib;0.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Bortezomib;0.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Bortezomib;0.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Bortezomib;0.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;","1.Bortezomib;0.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Bortezomib;0.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Bortezomib;0.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Bortezomib;0.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;"
"1690","151.187.2294.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"VTD",TRUE,"Cont.","1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;","1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;"
"1691","151.187.2294.2","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"VTD",TRUE,"Cont.","1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;","1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Bortezomib;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;"
"1692","151.187.2295.1","Malignant Hematology","Plasma cell dyscrasias","Multiple myeloma, relapsed-refractory",151,"Relapsed or refractory, triplets",187,"ZRd",TRUE,"Cont.","8.Lenalidomide;0.Vorinostat;1.Lenalidomide;0.Vorinostat;1.Lenalidomide;0.Vorinostat;1.Lenalidomide;0.Vorinostat;1.Lenalidomide;0.Vorinostat;1.Lenalidomide;0.Vorinostat;1.Lenalidomide;0.Vorinostat;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Vorinostat;1.Lenalidomide;0.Vorinostat;1.Lenalidomide;0.Vorinostat;1.Lenalidomide;0.Vorinostat;1.Lenalidomide;0.Vorinostat;1.Lenalidomide;0.Vorinostat;1.Lenalidomide;0.Vorinostat;8.Lenalidomide;0.Vorinostat;1.Lenalidomide;0.Vorinostat;1.Lenalidomide;0.Vorinostat;1.Lenalidomide;0.Vorinostat;1.Lenalidomide;0.Vorinostat;1.Lenalidomide;0.Vorinostat;1.Lenalidomide;0.Vorinostat;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Vorinostat;1.Lenalidomide;0.Vorinostat;1.Lenalidomide;0.Vorinostat;1.Lenalidomide;0.Vorinostat;1.Lenalidomide;0.Vorinostat;1.Lenalidomide;0.Vorinostat;1.Lenalidomide;0.Vorinostat;","8.Lenalidomide;0.Vorinostat;1.Lenalidomide;0.Vorinostat;1.Lenalidomide;0.Vorinostat;1.Lenalidomide;0.Vorinostat;1.Lenalidomide;0.Vorinostat;1.Lenalidomide;0.Vorinostat;1.Lenalidomide;0.Vorinostat;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;0.Vorinostat;1.Lenalidomide;0.Vorinostat;1.Lenalidomide;0.Vorinostat;1.Lenalidomide;0.Vorinostat;1.Lenalidomide;0.Vorinostat;1.Lenalidomide;0.Vorinostat;1.Lenalidomide;0.Vorinostat;"
"1693","152.67.2306.1","Malignant Hematology","Plasma cell dyscrasias","Plasma cell leukemia",152,"First-line therapy",67,"PAD/VCD",NA,NA,"0.Bortezomib;3.Bortezomib;0.Pegylatedliposomaldoxorubicin;18.Bortezomib;0.Cyclophosphamide;3.Bortezomib;18.Bortezomib;3.Bortezomib;0.Pegylatedliposomaldoxorubicin;18.Bortezomib;0.Cyclophosphamide;3.Bortezomib;","0.Bortezomib;3.Bortezomib;0.Pegylatedliposomaldoxorubicin;18.Bortezomib;0.Cyclophosphamide;3.Bortezomib;18.Bortezomib;3.Bortezomib;0.Pegylatedliposomaldoxorubicin;18.Bortezomib;0.Cyclophosphamide;3.Bortezomib;"
"1694","155.172.2309.1","Malignant Hematology","T-cell and NK-cell neoplasms","Adult T-cell leukemia-lymphoma",155,"Relapsed or refractory",172,"Alemtuzumab monotherapy",TRUE,"Cont.","3.Alemtuzumab;2.Alemtuzumab;2.Alemtuzumab;3.Alemtuzumab;2.Alemtuzumab;2.Alemtuzumab;","3.Alemtuzumab;2.Alemtuzumab;2.Alemtuzumab;"
"1695","155.172.2310.1","Malignant Hematology","T-cell and NK-cell neoplasms","Adult T-cell leukemia-lymphoma",155,"Relapsed or refractory",172,"Lenalidomide monotherapy",TRUE,"Cont.","1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","1.Lenalidomide;1.Lenalidomide;"
"1696","155.195.2307.1","Malignant Hematology","T-cell and NK-cell neoplasms","Adult T-cell leukemia-lymphoma",155,"Untreated",195,"CHOP-14",FALSE,"8","14.Cyclophosphamide;0.Doxorubicin;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Vincristine;","14.Cyclophosphamide;0.Doxorubicin;0.Vincristine;"
"1697","155.195.2307.2","Malignant Hematology","T-cell and NK-cell neoplasms","Adult T-cell leukemia-lymphoma",155,"Untreated",195,"CHOP-14",NA,NA,"0.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Methotrexate;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Vincristine;14.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Methotrexate;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Vincristine;14.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Methotrexate;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Vincristine;","0.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Methotrexate;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Vincristine;14.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Methotrexate;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Vincristine;14.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Methotrexate;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Vincristine;14.Cyclophosphamide;0.Doxorubicin;0.Vincristine;"
"1698","155.195.2308.1","Malignant Hematology","T-cell and NK-cell neoplasms","Adult T-cell leukemia-lymphoma",155,"Untreated",195,"mLSG15",FALSE,"6","12.Cyclophosphamide;0.Doxorubicin;0.Vincristine;7.Doxorubicin;0.Ranimustine;7.Carboplatin;0.Etoposide;0.Vindesine;1.Etoposide;1.Etoposide;12.Cyclophosphamide;0.Doxorubicin;0.Vincristine;7.Doxorubicin;0.Ranimustine;7.Carboplatin;0.Etoposide;0.Vindesine;1.Etoposide;1.Etoposide;","12.Cyclophosphamide;0.Doxorubicin;0.Vincristine;7.Doxorubicin;0.Ranimustine;7.Carboplatin;0.Etoposide;0.Vindesine;1.Etoposide;1.Etoposide;"
"1699","155.195.2308.2","Malignant Hematology","T-cell and NK-cell neoplasms","Adult T-cell leukemia-lymphoma",155,"Untreated",195,"mLSG15",NA,NA,"0.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Methotrexate;0.Vincristine;28.Cyclophosphamide;0.Doxorubicin;0.Vincristine;28.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Methotrexate;0.Vincristine;28.Cyclophosphamide;0.Doxorubicin;0.Vincristine;28.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Methotrexate;0.Vincristine;28.Cyclophosphamide;0.Doxorubicin;0.Vincristine;","0.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Methotrexate;0.Vincristine;28.Cyclophosphamide;0.Doxorubicin;0.Vincristine;28.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Methotrexate;0.Vincristine;28.Cyclophosphamide;0.Doxorubicin;0.Vincristine;28.Cyclophosphamide;0.Cytarabine;0.Doxorubicin;0.Methotrexate;0.Vincristine;28.Cyclophosphamide;0.Doxorubicin;0.Vincristine;"
"1700","156.184.2316.1","Malignant Hematology","T-cell and NK-cell neoplasms","Anaplastic large cell lymphoma",156,"Relapsed or refractory, salvage therapy",184,"Brentuximab vedotin monotherapy",TRUE,"Cont.","21.Brentuximabvedotin;21.Brentuximabvedotin;","21.Brentuximabvedotin;21.Brentuximabvedotin;"
"1701","156.184.2317.1","Malignant Hematology","T-cell and NK-cell neoplasms","Anaplastic large cell lymphoma",156,"Relapsed or refractory, salvage therapy",184,"DHAP",TRUE,"Cont.","20.Cisplatin;1.Cytarabine;20.Cisplatin;1.Cytarabine;","20.Cisplatin;1.Cytarabine;"
"1702","156.184.2317.2","Malignant Hematology","T-cell and NK-cell neoplasms","Anaplastic large cell lymphoma",156,"Relapsed or refractory, salvage therapy",184,"DHAP",TRUE,"Cont.","20.Cisplatin;1.Cisplatin;0.Cytarabine;20.Cisplatin;1.Cisplatin;0.Cytarabine;","20.Cisplatin;1.Cisplatin;0.Cytarabine;"
"1703","156.184.2318.1","Malignant Hematology","T-cell and NK-cell neoplasms","Anaplastic large cell lymphoma",156,"Relapsed or refractory, salvage therapy",184,"GDP",TRUE,"Cont.","14.Cisplatin;0.Gemcitabine;7.Gemcitabine;14.Cisplatin;0.Gemcitabine;7.Gemcitabine;","14.Cisplatin;0.Gemcitabine;7.Gemcitabine;"
"1704","156.195.2311.1","Malignant Hematology","T-cell and NK-cell neoplasms","Anaplastic large cell lymphoma",156,"Untreated",195,"BV-CHP",TRUE,"Cont.","21.Brentuximabvedotin;0.Cyclophosphamide;0.Doxorubicin;21.Brentuximabvedotin;0.Cyclophosphamide;0.Doxorubicin;","21.Brentuximabvedotin;0.Cyclophosphamide;0.Doxorubicin;"
"1705","156.195.2312.1","Malignant Hematology","T-cell and NK-cell neoplasms","Anaplastic large cell lymphoma",156,"Untreated",195,"CHOEP-14",TRUE,"Cont.","12.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;1.Etoposide;1.Etoposide;12.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;1.Etoposide;1.Etoposide;","12.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;1.Etoposide;1.Etoposide;"
"1706","156.195.2313.1","Malignant Hematology","T-cell and NK-cell neoplasms","Anaplastic large cell lymphoma",156,"Untreated",195,"CHOEP-21",TRUE,"Cont.","19.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;1.Etoposide;1.Etoposide;19.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;1.Etoposide;1.Etoposide;","19.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;1.Etoposide;1.Etoposide;"
"1707","156.195.2314.1","Malignant Hematology","T-cell and NK-cell neoplasms","Anaplastic large cell lymphoma",156,"Untreated",195,"CHOP",TRUE,"Cont.","21.Cyclophosphamide;0.Doxorubicin;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Vincristine;","21.Cyclophosphamide;0.Doxorubicin;0.Vincristine;"
"1708","156.195.2315.1","Malignant Hematology","T-cell and NK-cell neoplasms","Anaplastic large cell lymphoma",156,"Untreated",195,"DA-EPOCH",TRUE,"Cont.","17.Doxorubicin;0.Etoposide;0.Vincristine;4.Cyclophosphamide;17.Doxorubicin;0.Etoposide;0.Vincristine;4.Cyclophosphamide;","17.Doxorubicin;0.Etoposide;0.Vincristine;4.Cyclophosphamide;"
"1709","156.195.2315.2","Malignant Hematology","T-cell and NK-cell neoplasms","Anaplastic large cell lymphoma",156,"Untreated",195,"DA-EPOCH",TRUE,"Cont.","17.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;17.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;","17.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;"
"1710","156.41.2319.1","Malignant Hematology","T-cell and NK-cell neoplasms","Anaplastic large cell lymphoma",156,"Consolidation after salvage therapy",41,"FluBuCy, then allo HSCT",FALSE,"1","0.Fludarabine;1.Fludarabine;1.Busulfan;0.Fludarabine;1.Busulfan;0.Fludarabine;1.Busulfan;0.Fludarabine;1.Antithymocyteglobulin;0.rabbitATG;0.Cyclophosphamide;1.Antithymocyteglobulin;0.rabbitATG;0.Cyclophosphamide;1.Antithymocyteglobulin;0.rabbitATG;","0.Fludarabine;1.Fludarabine;1.Busulfan;0.Fludarabine;1.Busulfan;0.Fludarabine;1.Busulfan;0.Fludarabine;1.Antithymocyteglobulin;0.rabbitATG;0.Cyclophosphamide;1.Antithymocyteglobulin;0.rabbitATG;0.Cyclophosphamide;1.Antithymocyteglobulin;0.rabbitATG;"
"1711","157.172.2321.1","Malignant Hematology","T-cell and NK-cell neoplasms","Cutaneous T-cell lymphoma",157,"Relapsed or refractory",172,"Belinostat monotherapy",TRUE,"Cont.","17.Belinostat;1.Belinostat;1.Belinostat;1.Belinostat;1.Belinostat;17.Belinostat;1.Belinostat;1.Belinostat;1.Belinostat;1.Belinostat;","17.Belinostat;1.Belinostat;1.Belinostat;1.Belinostat;1.Belinostat;"
"1712","157.172.2322.1","Malignant Hematology","T-cell and NK-cell neoplasms","Cutaneous T-cell lymphoma",157,"Relapsed or refractory",172,"Bendamustine monotherapy",TRUE,"Cont.","20.Bendamustine;1.Bendamustine;20.Bendamustine;1.Bendamustine;","20.Bendamustine;1.Bendamustine;"
"1713","157.172.2323.1","Malignant Hematology","T-cell and NK-cell neoplasms","Cutaneous T-cell lymphoma",157,"Relapsed or refractory",172,"Bexarotene monotherapy",TRUE,"Cont.","1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;","1.Bexarotene;1.Bexarotene;"
"1714","157.172.2324.1","Malignant Hematology","T-cell and NK-cell neoplasms","Cutaneous T-cell lymphoma",157,"Relapsed or refractory",172,"Bexarotene & Pralatrexate",TRUE,"Cont.","1.Bexarotene;0.Pralatrexate;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;0.Pralatrexate;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;0.Pralatrexate;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;0.Pralatrexate;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;0.Pralatrexate;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;0.Pralatrexate;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;","1.Bexarotene;0.Pralatrexate;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;0.Pralatrexate;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;0.Pralatrexate;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;1.Bexarotene;"
"1715","157.172.2325.1","Malignant Hematology","T-cell and NK-cell neoplasms","Cutaneous T-cell lymphoma",157,"Relapsed or refractory",172,"Denileukin diftitox monotherapy",TRUE,"Cont.","17.Denileukindiftitox;1.Denileukindiftitox;1.Denileukindiftitox;1.Denileukindiftitox;1.Denileukindiftitox;17.Denileukindiftitox;1.Denileukindiftitox;1.Denileukindiftitox;1.Denileukindiftitox;1.Denileukindiftitox;","17.Denileukindiftitox;1.Denileukindiftitox;1.Denileukindiftitox;1.Denileukindiftitox;1.Denileukindiftitox;"
"1716","157.172.2326.1","Malignant Hematology","T-cell and NK-cell neoplasms","Cutaneous T-cell lymphoma",157,"Relapsed or refractory",172,"Lenalidomide monotherapy",TRUE,"Cont.","8.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;8.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;","8.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;1.Lenalidomide;"
"1717","157.172.2327.1","Malignant Hematology","T-cell and NK-cell neoplasms","Cutaneous T-cell lymphoma",157,"Relapsed or refractory",172,"Methotrexate monotherapy",TRUE,"Cont.","7.Methotrexate;7.Methotrexate;7.Methotrexate;7.Methotrexate;7.Methotrexate;7.Methotrexate;7.Methotrexate;7.Methotrexate;","7.Methotrexate;7.Methotrexate;"
"1718","157.172.2328.1","Malignant Hematology","T-cell and NK-cell neoplasms","Cutaneous T-cell lymphoma",157,"Relapsed or refractory",172,"Mogamulizumab monotherapy",TRUE,"Cont.","7.Mogamulizumab;7.Mogamulizumab;7.Mogamulizumab;7.Mogamulizumab;7.Mogamulizumab;7.Mogamulizumab;7.Mogamulizumab;7.Mogamulizumab;","7.Mogamulizumab;7.Mogamulizumab;"
"1719","157.172.2328.2","Malignant Hematology","T-cell and NK-cell neoplasms","Cutaneous T-cell lymphoma",157,"Relapsed or refractory",172,"Mogamulizumab monotherapy",TRUE,"Cont.","14.Mogamulizumab;14.Mogamulizumab;14.Mogamulizumab;14.Mogamulizumab;","14.Mogamulizumab;14.Mogamulizumab;"
"1720","157.172.2329.1","Malignant Hematology","T-cell and NK-cell neoplasms","Cutaneous T-cell lymphoma",157,"Relapsed or refractory",172,"Pralatrexate monotherapy",TRUE,"Cont.","14.Pralatrexate;7.Pralatrexate;7.Pralatrexate;14.Pralatrexate;7.Pralatrexate;7.Pralatrexate;","14.Pralatrexate;7.Pralatrexate;7.Pralatrexate;"
"1721","157.172.2330.1","Malignant Hematology","T-cell and NK-cell neoplasms","Cutaneous T-cell lymphoma",157,"Relapsed or refractory",172,"Romidepsin monotherapy",TRUE,"Cont.","14.Romidepsin;7.Romidepsin;7.Romidepsin;14.Romidepsin;7.Romidepsin;7.Romidepsin;","14.Romidepsin;7.Romidepsin;7.Romidepsin;"
"1722","157.172.2331.1","Malignant Hematology","T-cell and NK-cell neoplasms","Cutaneous T-cell lymphoma",157,"Relapsed or refractory",172,"Vorinostat monotherapy",TRUE,"Cont.","1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;1.Vorinostat;","1.Vorinostat;1.Vorinostat;"
"1723","157.207.2320.1","Malignant Hematology","T-cell and NK-cell neoplasms","Cutaneous T-cell lymphoma",157,"Upfront therapy",207,"PUVA",TRUE,"Cont.","3.Methoxsalen;2.Methoxsalen;2.Methoxsalen;3.Methoxsalen;2.Methoxsalen;2.Methoxsalen;","3.Methoxsalen;2.Methoxsalen;2.Methoxsalen;"
"1724","158.172.2340.1","Malignant Hematology","T-cell and NK-cell neoplasms","Extranodal NK- and T-cell lymphoma, nasal type",158,"Relapsed or refractory",172,"L-Asparaginase, Vincristine, Prednisolone",TRUE,"Cont.","17.Asparaginase;0.Vincristine;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;17.Asparaginase;0.Vincristine;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;","17.Asparaginase;0.Vincristine;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;"
"1725","158.195.2332.1","Malignant Hematology","T-cell and NK-cell neoplasms","Extranodal NK- and T-cell lymphoma, nasal type",158,"Untreated",195,"Cisplatin & RT",TRUE,"Cont.","7.Cisplatin;7.Cisplatin;7.Cisplatin;7.Cisplatin;7.Cisplatin;7.Cisplatin;7.Cisplatin;7.Cisplatin;","7.Cisplatin;7.Cisplatin;"
"1726","158.195.2333.1","Malignant Hematology","T-cell and NK-cell neoplasms","Extranodal NK- and T-cell lymphoma, nasal type",158,"Untreated",195,"DEP & RT",TRUE,"Cont.","25.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Etoposide;25.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Etoposide;","25.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Etoposide;"
"1727","158.195.2334.1","Malignant Hematology","T-cell and NK-cell neoplasms","Extranodal NK- and T-cell lymphoma, nasal type",158,"Untreated",195,"DeVIC & RT",TRUE,"Cont.","19.Carboplatin;0.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;19.Carboplatin;0.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;","19.Carboplatin;0.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;"
"1728","158.195.2335.1","Malignant Hematology","T-cell and NK-cell neoplasms","Extranodal NK- and T-cell lymphoma, nasal type",158,"Untreated",195,"GELOX/RT",TRUE,"Cont.","14.Asparaginase;0.Gemcitabine;0.Oxaliplatin;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Gemcitabine;14.Asparaginase;0.Gemcitabine;0.Oxaliplatin;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Gemcitabine;","14.Asparaginase;0.Gemcitabine;0.Oxaliplatin;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Gemcitabine;"
"1729","158.195.2336.1","Malignant Hematology","T-cell and NK-cell neoplasms","Extranodal NK- and T-cell lymphoma, nasal type",158,"Untreated",195,"LVP ""Sandwich""",NA,NA,"0.Asparaginase;0.Vincristine;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;17.Asparaginase;0.Vincristine;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;63.Asparaginase;0.Vincristine;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;17.Asparaginase;0.Vincristine;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;","0.Asparaginase;0.Vincristine;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;17.Asparaginase;0.Vincristine;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;63.Asparaginase;0.Vincristine;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;17.Asparaginase;0.Vincristine;1.Asparaginase;1.Asparaginase;1.Asparaginase;1.Asparaginase;"
"1730","158.195.2337.1","Malignant Hematology","T-cell and NK-cell neoplasms","Extranodal NK- and T-cell lymphoma, nasal type",158,"Untreated",195,"MESA/RT",TRUE,"Cont.","17.Methotrexate;1.Etoposide;1.Etoposide;1.Etoposide;1.Pegaspargase;17.Methotrexate;1.Etoposide;1.Etoposide;1.Etoposide;1.Pegaspargase;","17.Methotrexate;1.Etoposide;1.Etoposide;1.Etoposide;1.Pegaspargase;"
"1731","158.195.2338.1","Malignant Hematology","T-cell and NK-cell neoplasms","Extranodal NK- and T-cell lymphoma, nasal type",158,"Untreated",195,"SMILE",FALSE,"2","9.Methotrexate;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;4.Asparaginase;2.Asparaginase;2.Asparaginase;2.Asparaginase;2.Asparaginase;2.Asparaginase;2.Asparaginase;","9.Methotrexate;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;4.Asparaginase;2.Asparaginase;2.Asparaginase;2.Asparaginase;2.Asparaginase;2.Asparaginase;2.Asparaginase;"
"1732","158.44.2339.1","Malignant Hematology","T-cell and NK-cell neoplasms","Extranodal NK- and T-cell lymphoma, nasal type",158,"Consolidation after upfront therapy",44,"VIPD",FALSE,"3","19.Cisplatin;0.Etoposide;0.Ifosfamide;1.Cisplatin;0.Etoposide;0.Ifosfamide;1.Cisplatin;0.Etoposide;0.Ifosfamide;19.Cisplatin;0.Etoposide;0.Ifosfamide;1.Cisplatin;0.Etoposide;0.Ifosfamide;1.Cisplatin;0.Etoposide;0.Ifosfamide;","19.Cisplatin;0.Etoposide;0.Ifosfamide;1.Cisplatin;0.Etoposide;0.Ifosfamide;1.Cisplatin;0.Etoposide;0.Ifosfamide;"
"1733","159.93.2341.1","Malignant Hematology","T-cell and NK-cell neoplasms","Large granular lymphocytic leukemia",159,"Initial therapy",93,"Cyclophosphamide monotherapy",TRUE,"Cont.","1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;","1.Cyclophosphamide;1.Cyclophosphamide;"
"1734","16.169.388.1","Solid Tumor","Endocrine oncology","Adrenocortical carcinoma",16,"Recurrent, locally advanced, or metastatic disease",169,"Cisplatin & Mitotane",TRUE,"Cont.","1.Cisplatin;0.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Cisplatin;0.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;","1.Cisplatin;0.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;"
"1735","16.169.389.1","Solid Tumor","Endocrine oncology","Adrenocortical carcinoma",16,"Recurrent, locally advanced, or metastatic disease",169,"Doxorubicin monotherapy",TRUE,"Cont.","21.Doxorubicin;21.Doxorubicin;","21.Doxorubicin;21.Doxorubicin;"
"1736","16.169.390.1","Solid Tumor","Endocrine oncology","Adrenocortical carcinoma",16,"Recurrent, locally advanced, or metastatic disease",169,"Mitotane & EDP",TRUE,"Cont.","1.Doxorubicin;0.Mitotane;1.Etoposide;0.Mitotane;1.Cisplatin;0.Etoposide;0.Mitotane;1.Cisplatin;0.Etoposide;0.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Doxorubicin;0.Mitotane;1.Etoposide;0.Mitotane;1.Cisplatin;0.Etoposide;0.Mitotane;1.Cisplatin;0.Etoposide;0.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;","1.Doxorubicin;0.Mitotane;1.Etoposide;0.Mitotane;1.Cisplatin;0.Etoposide;0.Mitotane;1.Cisplatin;0.Etoposide;0.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;"
"1737","16.169.390.2","Solid Tumor","Endocrine oncology","Adrenocortical carcinoma",16,"Recurrent, locally advanced, or metastatic disease",169,"Mitotane & EDP",TRUE,"Cont.","1.Cisplatin;0.Doxorubicin;0.Mitotane;1.Cisplatin;0.Mitotane;1.Mitotane;1.Mitotane;1.Etoposide;0.Mitotane;1.Etoposide;0.Mitotane;1.Etoposide;0.Mitotane;1.Doxorubicin;0.Mitotane;1.Cisplatin;0.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Cisplatin;0.Doxorubicin;0.Mitotane;1.Cisplatin;0.Mitotane;1.Mitotane;1.Mitotane;1.Etoposide;0.Mitotane;1.Etoposide;0.Mitotane;1.Etoposide;0.Mitotane;1.Doxorubicin;0.Mitotane;1.Cisplatin;0.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;","1.Cisplatin;0.Doxorubicin;0.Mitotane;1.Cisplatin;0.Mitotane;1.Mitotane;1.Mitotane;1.Etoposide;0.Mitotane;1.Etoposide;0.Mitotane;1.Etoposide;0.Mitotane;1.Doxorubicin;0.Mitotane;1.Cisplatin;0.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;"
"1738","16.169.391.1","Solid Tumor","Endocrine oncology","Adrenocortical carcinoma",16,"Recurrent, locally advanced, or metastatic disease",169,"Mitotane & Streptozocin",TRUE,"Cont.","1.Mitotane;0.Streptozocin;1.Mitotane;0.Streptozocin;1.Mitotane;0.Streptozocin;1.Mitotane;0.Streptozocin;1.Mitotane;0.Streptozocin;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;0.Streptozocin;1.Mitotane;0.Streptozocin;1.Mitotane;0.Streptozocin;1.Mitotane;0.Streptozocin;1.Mitotane;0.Streptozocin;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;","1.Mitotane;0.Streptozocin;1.Mitotane;0.Streptozocin;1.Mitotane;0.Streptozocin;1.Mitotane;0.Streptozocin;1.Mitotane;0.Streptozocin;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;"
"1739","16.169.391.2","Solid Tumor","Endocrine oncology","Adrenocortical carcinoma",16,"Recurrent, locally advanced, or metastatic disease",169,"Mitotane & Streptozocin",TRUE,"Cont.","1.Mitotane;0.Streptozocin;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;0.Streptozocin;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;","1.Mitotane;0.Streptozocin;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;"
"1740","16.4.386.1","Solid Tumor","Endocrine oncology","Adrenocortical carcinoma",16,"Adjuvant therapy",4,"Mitotane monotherapy",TRUE,"Cont.","1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;","1.Mitotane;1.Mitotane;"
"1741","16.4.387.1","Solid Tumor","Endocrine oncology","Adrenocortical carcinoma",16,"Adjuvant therapy",4,"Mitotane & Streptozocin",FALSE,"1","0.Streptozocin;1.Streptozocin;1.Streptozocin;1.Streptozocin;1.Streptozocin;","0.Streptozocin;1.Streptozocin;1.Streptozocin;1.Streptozocin;1.Streptozocin;"
"1742","16.4.387.2","Solid Tumor","Endocrine oncology","Adrenocortical carcinoma",16,"Adjuvant therapy",4,"Mitotane & Streptozocin",TRUE,"Cont.","1.Mitotane;0.Streptozocin;1.Mitotane;0.Streptozocin;1.Mitotane;0.Streptozocin;1.Mitotane;0.Streptozocin;1.Mitotane;0.Streptozocin;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;0.Streptozocin;1.Mitotane;0.Streptozocin;1.Mitotane;0.Streptozocin;1.Mitotane;0.Streptozocin;1.Mitotane;0.Streptozocin;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;","1.Mitotane;0.Streptozocin;1.Mitotane;0.Streptozocin;1.Mitotane;0.Streptozocin;1.Mitotane;0.Streptozocin;1.Mitotane;0.Streptozocin;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;1.Mitotane;"
"1743","160.172.2343.1","Malignant Hematology","T-cell and NK-cell neoplasms","NK- and T-cell lymphoma",160,"Relapsed or refractory",172,"AspaMetDex",TRUE,"Cont.","14.Methotrexate;1.Asparaginase;2.Asparaginase;2.Asparaginase;2.Asparaginase;14.Methotrexate;1.Asparaginase;2.Asparaginase;2.Asparaginase;2.Asparaginase;","14.Methotrexate;1.Asparaginase;2.Asparaginase;2.Asparaginase;2.Asparaginase;"
"1744","160.172.2344.1","Malignant Hematology","T-cell and NK-cell neoplasms","NK- and T-cell lymphoma",160,"Relapsed or refractory",172,"AspaMetDex (Erwinaze)",TRUE,"Cont.","14.Methotrexate;1.AsparaginaseErwiniachrysanthemi;2.AsparaginaseErwiniachrysanthemi;2.AsparaginaseErwiniachrysanthemi;2.AsparaginaseErwiniachrysanthemi;14.Methotrexate;1.AsparaginaseErwiniachrysanthemi;2.AsparaginaseErwiniachrysanthemi;2.AsparaginaseErwiniachrysanthemi;2.AsparaginaseErwiniachrysanthemi;","14.Methotrexate;1.AsparaginaseErwiniachrysanthemi;2.AsparaginaseErwiniachrysanthemi;2.AsparaginaseErwiniachrysanthemi;2.AsparaginaseErwiniachrysanthemi;"
"1745","160.172.2345.1","Malignant Hematology","T-cell and NK-cell neoplasms","NK- and T-cell lymphoma",160,"Relapsed or refractory",172,"Pembrolizumab monotherapy",TRUE,"Cont.","21.Pembrolizumab;21.Pembrolizumab;","21.Pembrolizumab;21.Pembrolizumab;"
"1746","160.195.2342.1","Malignant Hematology","T-cell and NK-cell neoplasms","NK- and T-cell lymphoma",160,"Untreated",195,"DDGP",TRUE,"Cont.","14.Cisplatin;0.Gemcitabine;0.Pegaspargase;1.Cisplatin;1.Cisplatin;1.Cisplatin;4.Gemcitabine;14.Cisplatin;0.Gemcitabine;0.Pegaspargase;1.Cisplatin;1.Cisplatin;1.Cisplatin;4.Gemcitabine;","14.Cisplatin;0.Gemcitabine;0.Pegaspargase;1.Cisplatin;1.Cisplatin;1.Cisplatin;4.Gemcitabine;"
"1747","161.180.2355.1","Malignant Hematology","T-cell and NK-cell neoplasms","Peripheral T-cell lymphoma",161,"Relapsed or refractory, non-randomized or retrospective data",180,"Chidamide monotherapy",TRUE,"Cont.","4.Chidamide;3.Chidamide;4.Chidamide;3.Chidamide;","4.Chidamide;3.Chidamide;"
"1748","161.180.2356.1","Malignant Hematology","T-cell and NK-cell neoplasms","Peripheral T-cell lymphoma",161,"Relapsed or refractory, non-randomized or retrospective data",180,"Forodesine monotherapy",TRUE,"Cont.","1.Forodesine;1.Forodesine;1.Forodesine;1.Forodesine;1.Forodesine;1.Forodesine;1.Forodesine;1.Forodesine;1.Forodesine;1.Forodesine;1.Forodesine;1.Forodesine;1.Forodesine;1.Forodesine;","1.Forodesine;1.Forodesine;"
"1749","161.201.2348.1","Malignant Hematology","T-cell and NK-cell neoplasms","Peripheral T-cell lymphoma",161,"Untreated, non-randomized or retrospective data",201,"A-CHOP",NA,NA,"0.Alemtuzumab;1.Alemtuzumab;1.Alemtuzumab;1.Cyclophosphamide;0.Doxorubicin;0.Vincristine;23.Cyclophosphamide;0.Doxorubicin;0.Vincristine;","0.Alemtuzumab;1.Alemtuzumab;1.Alemtuzumab;1.Cyclophosphamide;0.Doxorubicin;0.Vincristine;23.Cyclophosphamide;0.Doxorubicin;0.Vincristine;"
"1750","161.201.2349.1","Malignant Hematology","T-cell and NK-cell neoplasms","Peripheral T-cell lymphoma",161,"Untreated, non-randomized or retrospective data",201,"CHOP & Everolimus",TRUE,"Cont.","8.Cyclophosphamide;0.Doxorubicin;0.Everolimus;0.Vincristine;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;8.Cyclophosphamide;0.Doxorubicin;0.Everolimus;0.Vincristine;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;","8.Cyclophosphamide;0.Doxorubicin;0.Everolimus;0.Vincristine;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;"
"1751","161.201.2350.1","Malignant Hematology","T-cell and NK-cell neoplasms","Peripheral T-cell lymphoma",161,"Untreated, non-randomized or retrospective data",201,"DD-CHOP",TRUE,"Cont.","19.Denileukindiftitox;1.Denileukindiftitox;1.Cyclophosphamide;0.Doxorubicin;0.Vincristine;19.Denileukindiftitox;1.Denileukindiftitox;1.Cyclophosphamide;0.Doxorubicin;0.Vincristine;","19.Denileukindiftitox;1.Denileukindiftitox;1.Cyclophosphamide;0.Doxorubicin;0.Vincristine;"
"1752","161.203.2346.1","Malignant Hematology","T-cell and NK-cell neoplasms","Peripheral T-cell lymphoma",161,"Untreated, randomized data",203,"CMED",TRUE,"Cont.","13.Cyclophosphamide;0.Etoposide;0.Methotrexate;1.Etoposide;13.Cyclophosphamide;0.Etoposide;0.Methotrexate;1.Etoposide;","13.Cyclophosphamide;0.Etoposide;0.Methotrexate;1.Etoposide;"
"1753","161.203.2347.1","Malignant Hematology","T-cell and NK-cell neoplasms","Peripheral T-cell lymphoma",161,"Untreated, randomized data",203,"GDPT",TRUE,"Cont.","1.Cisplatin;0.Gemcitabine;0.Thalidomide;1.Cisplatin;0.Thalidomide;1.Cisplatin;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Gemcitabine;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Cisplatin;0.Gemcitabine;0.Thalidomide;1.Cisplatin;0.Thalidomide;1.Cisplatin;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Gemcitabine;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;","1.Cisplatin;0.Gemcitabine;0.Thalidomide;1.Cisplatin;0.Thalidomide;1.Cisplatin;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Gemcitabine;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;"
"1754","161.203.2351.1","Malignant Hematology","T-cell and NK-cell neoplasms","Peripheral T-cell lymphoma",161,"Untreated, randomized data",203,"HyperCHidam",FALSE,"1","0.Cyclophosphamide;0.Cytarabine;0.Methotrexate;1.Cyclophosphamide;0.Cytarabine;1.Cyclophosphamide;0.Cytarabine;","0.Cyclophosphamide;0.Cytarabine;0.Methotrexate;1.Cyclophosphamide;0.Cytarabine;1.Cyclophosphamide;0.Cytarabine;"
"1755","161.48.2352.1","Malignant Hematology","T-cell and NK-cell neoplasms","Peripheral T-cell lymphoma",161,"Consolidation and/or maintenance after upfront therapy",48,"BEAM, then auto HSCT",FALSE,"1","0.Carmustine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Melphalan;","0.Carmustine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Melphalan;"
"1756","161.48.2353.1","Malignant Hematology","T-cell and NK-cell neoplasms","Peripheral T-cell lymphoma",161,"Consolidation and/or maintenance after upfront therapy",48,"Gemcitabine monotherapy",TRUE,"Cont.","14.Gemcitabine;7.Gemcitabine;7.Gemcitabine;14.Gemcitabine;7.Gemcitabine;7.Gemcitabine;","14.Gemcitabine;7.Gemcitabine;7.Gemcitabine;"
"1757","161.48.2354.1","Malignant Hematology","T-cell and NK-cell neoplasms","Peripheral T-cell lymphoma",161,"Consolidation and/or maintenance after upfront therapy",48,"Pralatrexate monotherapy",TRUE,"Cont.","14.Pralatrexate;7.Pralatrexate;7.Pralatrexate;7.Pralatrexate;7.Pralatrexate;7.Pralatrexate;14.Pralatrexate;7.Pralatrexate;7.Pralatrexate;7.Pralatrexate;7.Pralatrexate;7.Pralatrexate;","14.Pralatrexate;7.Pralatrexate;7.Pralatrexate;7.Pralatrexate;7.Pralatrexate;7.Pralatrexate;"
"1758","162.204.2357.1","Malignant Hematology","T-cell and NK-cell neoplasms","T-cell acute lymphoblastic leukemia",162,"Upfront induction therapy",204,"Cyclophosphamide, Daunorubicin, L-Asparaginase, Vincristine, Prednisone",FALSE,"1","0.Cyclophosphamide;0.Cytarabine;0.Daunorubicin;0.Methotrexate;0.Vincristine;1.Daunorubicin;1.Daunorubicin;5.Asparaginase;0.Cytarabine;0.Methotrexate;0.Vincristine;2.Asparaginase;2.Asparaginase;3.Cyclophosphamide;0.Daunorubicin;0.Vincristine;1.Cyclophosphamide;0.Daunorubicin;4.Asparaginase;2.Asparaginase;0.Vincristine;2.Asparaginase;2.Asparaginase;2.Asparaginase;","0.Cyclophosphamide;0.Cytarabine;0.Daunorubicin;0.Methotrexate;0.Vincristine;1.Daunorubicin;1.Daunorubicin;5.Asparaginase;0.Cytarabine;0.Methotrexate;0.Vincristine;2.Asparaginase;2.Asparaginase;3.Cyclophosphamide;0.Daunorubicin;0.Vincristine;1.Cyclophosphamide;0.Daunorubicin;4.Asparaginase;2.Asparaginase;0.Vincristine;2.Asparaginase;2.Asparaginase;2.Asparaginase;"
"1759","162.204.2358.1","Malignant Hematology","T-cell and NK-cell neoplasms","T-cell acute lymphoblastic leukemia",162,"Upfront induction therapy",204,"Daunorubicin, Pegaspargase, Vincristine, Dexamethasone",FALSE,"1","0.Cytarabine;0.Daunorubicin;0.Vincristine;3.Pegaspargase;4.Daunorubicin;0.Methotrexate;0.Vincristine;7.Daunorubicin;0.Vincristine;3.Pegaspargase;4.Daunorubicin;0.Vincristine;","0.Cytarabine;0.Daunorubicin;0.Vincristine;3.Pegaspargase;4.Daunorubicin;0.Methotrexate;0.Vincristine;7.Daunorubicin;0.Vincristine;3.Pegaspargase;4.Daunorubicin;0.Vincristine;"
"1760","162.204.2359.1","Malignant Hematology","T-cell and NK-cell neoplasms","T-cell acute lymphoblastic leukemia",162,"Upfront induction therapy",204,"Nelarabine monotherapy",TRUE,"Cont.","17.Nelarabine;1.Nelarabine;1.Nelarabine;1.Nelarabine;1.Nelarabine;17.Nelarabine;1.Nelarabine;1.Nelarabine;1.Nelarabine;1.Nelarabine;","17.Nelarabine;1.Nelarabine;1.Nelarabine;1.Nelarabine;1.Nelarabine;"
"1761","162.204.2359.2","Malignant Hematology","T-cell and NK-cell neoplasms","T-cell acute lymphoblastic leukemia",162,"Upfront induction therapy",204,"Nelarabine monotherapy",TRUE,"Cont.","17.Nelarabine;2.Nelarabine;2.Nelarabine;17.Nelarabine;2.Nelarabine;2.Nelarabine;","17.Nelarabine;2.Nelarabine;2.Nelarabine;"
"1762","163.184.2362.1","Malignant Hematology","T-cell and NK-cell neoplasms","T-cell prolymphocytic leukemia",163,"Relapsed or refractory, salvage therapy",184,"Ibrutinib & Venetoclax",TRUE,"Cont.","1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;1.Ibrutinib;0.Venetoclax;","1.Ibrutinib;0.Venetoclax;"
"1763","163.204.2360.1","Malignant Hematology","T-cell and NK-cell neoplasms","T-cell prolymphocytic leukemia",163,"Upfront induction therapy",204,"Alemtuzumab monotherapy",TRUE,"Cont.","5.Alemtuzumab;1.Alemtuzumab;1.Alemtuzumab;5.Alemtuzumab;1.Alemtuzumab;1.Alemtuzumab;","5.Alemtuzumab;1.Alemtuzumab;1.Alemtuzumab;"
"1764","163.204.2361.1","Malignant Hematology","T-cell and NK-cell neoplasms","T-cell prolymphocytic leukemia",163,"Upfront induction therapy",204,"Pentostatin & Alemtuzumab",TRUE,"Cont.","3.Alemtuzumab;0.Pentostatin;2.Alemtuzumab;2.Alemtuzumab;3.Alemtuzumab;0.Pentostatin;2.Alemtuzumab;2.Alemtuzumab;","3.Alemtuzumab;0.Pentostatin;2.Alemtuzumab;2.Alemtuzumab;"
"1765","164.44.2374.1","Malignant Hematology","Lymphoproliferative disorders","Post-transplant lymphoproliferative disorder",164,"Consolidation after upfront therapy",44,"Rituximab monotherapy",TRUE,"Cont.","21.Rituximab;21.Rituximab;","21.Rituximab;21.Rituximab;"
"1766","164.76.2364.1","Malignant Hematology","Lymphoproliferative disorders","Castleman disease",164,"HHV-8-negative/""Idiopathic"" multicentric Castleman disease, all lines of therapy",76,"Anakinra monotherapy",TRUE,"Cont.","1.Anakinra;1.Anakinra;1.Anakinra;1.Anakinra;1.Anakinra;1.Anakinra;1.Anakinra;1.Anakinra;1.Anakinra;1.Anakinra;1.Anakinra;1.Anakinra;1.Anakinra;1.Anakinra;","1.Anakinra;1.Anakinra;"
"1767","164.76.2365.1","Malignant Hematology","Lymphoproliferative disorders","Castleman disease",164,"HHV-8-negative/""Idiopathic"" multicentric Castleman disease, all lines of therapy",76,"Bortezomib monotherapy",TRUE,"Cont.","11.Bortezomib;3.Bortezomib;4.Bortezomib;3.Bortezomib;11.Bortezomib;3.Bortezomib;4.Bortezomib;3.Bortezomib;","11.Bortezomib;3.Bortezomib;4.Bortezomib;3.Bortezomib;"
"1768","164.76.2366.1","Malignant Hematology","Lymphoproliferative disorders","Castleman disease",164,"HHV-8-negative/""Idiopathic"" multicentric Castleman disease, all lines of therapy",76,"Cyclosporine monotherapy",FALSE,"1","0.CyclosporineA;","0.CyclosporineA;0.CyclosporineA;"
"1769","164.76.2367.1","Malignant Hematology","Lymphoproliferative disorders","Castleman disease",164,"HHV-8-negative/""Idiopathic"" multicentric Castleman disease, all lines of therapy",76,"Siltuximab monotherapy",TRUE,"Cont.","21.Siltuximab;21.Siltuximab;","21.Siltuximab;21.Siltuximab;"
"1770","164.76.2368.1","Malignant Hematology","Lymphoproliferative disorders","Castleman disease",164,"HHV-8-negative/""Idiopathic"" multicentric Castleman disease, all lines of therapy",76,"Sirolimus monotherapy",FALSE,"1","0.Sirolimus;","0.Sirolimus;0.Sirolimus;"
"1771","164.76.2369.1","Malignant Hematology","Lymphoproliferative disorders","Castleman disease",164,"HHV-8-negative/""Idiopathic"" multicentric Castleman disease, all lines of therapy",76,"TCP",TRUE,"Cont.","1.Cyclophosphamide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Cyclophosphamide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;","1.Cyclophosphamide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;"
"1772","164.76.2370.1","Malignant Hematology","Lymphoproliferative disorders","Castleman disease",164,"HHV-8-negative/""Idiopathic"" multicentric Castleman disease, all lines of therapy",76,"Thalidomide monotherapy",TRUE,"Cont.","1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;","1.Thalidomide;1.Thalidomide;"
"1773","164.76.2371.1","Malignant Hematology","Lymphoproliferative disorders","Castleman disease",164,"HHV-8-negative/""Idiopathic"" multicentric Castleman disease, all lines of therapy",76,"Tocilizumab monotherapy",TRUE,"Cont.","14.Tocilizumab;14.Tocilizumab;","14.Tocilizumab;14.Tocilizumab;"
"1774","164.81.2363.1","Malignant Hematology","Lymphoproliferative disorders","Castleman disease",164,"HIV-associated multicentric Castleman disease, all lines of therapy",81,"Rituximab monotherapy",TRUE,"Cont.","7.Rituximab;7.Rituximab;7.Rituximab;7.Rituximab;7.Rituximab;7.Rituximab;7.Rituximab;7.Rituximab;","7.Rituximab;7.Rituximab;"
"1775","164.88.2372.1","Malignant Hematology","Lymphoproliferative disorders","Post-transplant lymphoproliferative disorder",164,"Induction",88,"CHOP",TRUE,"Cont.","21.Cyclophosphamide;0.Doxorubicin;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Vincristine;","21.Cyclophosphamide;0.Doxorubicin;0.Vincristine;"
"1776","164.88.2373.1","Malignant Hematology","Lymphoproliferative disorders","Post-transplant lymphoproliferative disorder",164,"Induction",88,"R-CP",NA,NA,"0.Cyclophosphamide;0.Rituximab;21.Cyclophosphamide;0.Rituximab;21.Cyclophosphamide;21.Cyclophosphamide;21.Cyclophosphamide;21.Cyclophosphamide;","0.Cyclophosphamide;0.Rituximab;21.Cyclophosphamide;0.Rituximab;21.Cyclophosphamide;21.Cyclophosphamide;21.Cyclophosphamide;21.Cyclophosphamide;"
"1777","164.88.2375.1","Malignant Hematology","Lymphoproliferative disorders","Post-transplant lymphoproliferative disorder",164,"Induction",88,"R-CHOP",TRUE,"Cont.","21.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;","21.Cyclophosphamide;0.Doxorubicin;0.Rituximab;0.Vincristine;"
"1778","165.31.2376.1","Malignant Hematology","Histiocyte disorders","Erdheim-Chester disease",165,"All lines of therapy",31,"Cobimetinib monotherapy",TRUE,"Cont.","8.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;8.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;","8.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;1.Cobimetinib;"
"1779","165.31.2377.1","Malignant Hematology","Histiocyte disorders","Erdheim-Chester disease",165,"All lines of therapy",31,"Sirolimus monotherapy",TRUE,"Cont.","1.Sirolimus;1.Sirolimus;1.Sirolimus;1.Sirolimus;1.Sirolimus;1.Sirolimus;1.Sirolimus;1.Sirolimus;1.Sirolimus;1.Sirolimus;1.Sirolimus;1.Sirolimus;1.Sirolimus;1.Sirolimus;","1.Sirolimus;1.Sirolimus;"
"1780","165.31.2378.1","Malignant Hematology","Histiocyte disorders","Erdheim-Chester disease",165,"All lines of therapy",31,"Vemurafenib monotherapy",TRUE,"Cont.","1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;","1.Vemurafenib;1.Vemurafenib;"
"1781","166.172.2381.1","Malignant Hematology","Histiocyte disorders","Hemophagocytic lymphohistiocytosis",166,"Relapsed or refractory",172,"DEP",FALSE,"1","0.Etoposide;0.Pegylatedliposomaldoxorubicin;7.Etoposide;7.Etoposide;7.Etoposide;","0.Etoposide;0.Pegylatedliposomaldoxorubicin;7.Etoposide;7.Etoposide;7.Etoposide;"
"1782","166.172.2382.1","Malignant Hematology","Histiocyte disorders","Hemophagocytic lymphohistiocytosis",166,"Relapsed or refractory",172,"Emapalumab & Dexamethasone",TRUE,"Cont.","4.Emapalumab;3.Emapalumab;4.Emapalumab;3.Emapalumab;","4.Emapalumab;3.Emapalumab;"
"1783","166.195.2379.1","Malignant Hematology","Histiocyte disorders","Hemophagocytic lymphohistiocytosis",166,"Untreated",195,"HLH-94 regimen",TRUE,"Cont.","4.Etoposide;0.Methotrexate;3.Etoposide;4.Etoposide;0.Methotrexate;3.Etoposide;","4.Etoposide;0.Methotrexate;3.Etoposide;"
"1784","166.195.2380.1","Malignant Hematology","Histiocyte disorders","Hemophagocytic lymphohistiocytosis",166,"Untreated",195,"HLH-2004 regimen",TRUE,"Cont.","1.CyclosporineA;0.Etoposide;0.Methotrexate;1.CyclosporineA;1.CyclosporineA;1.CyclosporineA;0.Etoposide;1.CyclosporineA;1.CyclosporineA;1.CyclosporineA;1.CyclosporineA;0.Etoposide;0.Methotrexate;1.CyclosporineA;1.CyclosporineA;1.CyclosporineA;0.Etoposide;1.CyclosporineA;1.CyclosporineA;1.CyclosporineA;","1.CyclosporineA;0.Etoposide;0.Methotrexate;1.CyclosporineA;1.CyclosporineA;1.CyclosporineA;0.Etoposide;1.CyclosporineA;1.CyclosporineA;1.CyclosporineA;"
"1785","167.172.2388.1","Malignant Hematology","Histiocyte disorders","Langerhans cell histiocytosis",167,"Relapsed or refractory",172,"Cladribine monotherapy",TRUE,"Cont.","3.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;3.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;","3.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;"
"1786","167.172.2388.2","Malignant Hematology","Histiocyte disorders","Langerhans cell histiocytosis",167,"Relapsed or refractory",172,"Cladribine monotherapy",TRUE,"Cont.","31.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;31.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;","31.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;1.Cladribine;"
"1787","167.172.2388.3","Malignant Hematology","Histiocyte disorders","Langerhans cell histiocytosis",167,"Relapsed or refractory",172,"Cladribine monotherapy",TRUE,"Cont.","19.Cladribine;1.Cladribine;1.Cladribine;19.Cladribine;1.Cladribine;1.Cladribine;","19.Cladribine;1.Cladribine;1.Cladribine;"
"1788","167.172.2389.1","Malignant Hematology","Histiocyte disorders","Langerhans cell histiocytosis",167,"Relapsed or refractory",172,"Cladribine & Cytarabine",TRUE,"Cont.","30.Cytarabine;1.Cladribine;0.Cytarabine;1.Cladribine;0.Cytarabine;1.Cladribine;0.Cytarabine;1.Cladribine;0.Cytarabine;1.Cladribine;30.Cytarabine;1.Cladribine;0.Cytarabine;1.Cladribine;0.Cytarabine;1.Cladribine;0.Cytarabine;1.Cladribine;0.Cytarabine;1.Cladribine;","30.Cytarabine;1.Cladribine;0.Cytarabine;1.Cladribine;0.Cytarabine;1.Cladribine;0.Cytarabine;1.Cladribine;0.Cytarabine;1.Cladribine;"
"1789","167.179.2390.1","Malignant Hematology","Histiocyte disorders","Langerhans cell histiocytosis",167,"Relapsed or refractory, maintenance",179,"Mercaptopurine, Methotrexate, Vinblastine, Prednisolone",TRUE,"Cont.","1.Mercaptopurine;0.Methotrexate;0.Vinblastine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vinblastine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;","1.Mercaptopurine;0.Methotrexate;0.Vinblastine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;"
"1790","167.195.2383.1","Malignant Hematology","Histiocyte disorders","Langerhans cell histiocytosis",167,"Untreated",195,"Cytarabine & Methotrexate (CYM)",TRUE,"Cont.","35.Cytarabine;0.Methotrexate;35.Cytarabine;0.Methotrexate;","35.Cytarabine;0.Methotrexate;"
"1791","167.195.2383.2","Malignant Hematology","Histiocyte disorders","Langerhans cell histiocytosis",167,"Untreated",195,"Cytarabine & Methotrexate (CYM)",TRUE,"Cont.","30.Cytarabine;0.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;30.Cytarabine;0.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;","30.Cytarabine;0.Methotrexate;1.Cytarabine;0.Methotrexate;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"1792","167.195.2384.1","Malignant Hematology","Histiocyte disorders","Langerhans cell histiocytosis",167,"Untreated",195,"Etoposide monotherapy",TRUE,"Cont.","4.Etoposide;3.Etoposide;4.Etoposide;3.Etoposide;","4.Etoposide;3.Etoposide;"
"1793","167.195.2384.2","Malignant Hematology","Histiocyte disorders","Langerhans cell histiocytosis",167,"Untreated",195,"Etoposide monotherapy",TRUE,"Cont.","7.Etoposide;7.Etoposide;","7.Etoposide;7.Etoposide;"
"1794","167.195.2385.1","Malignant Hematology","Histiocyte disorders","Langerhans cell histiocytosis",167,"Untreated",195,"Etoposide, Vinblastine, Prednisone",NA,NA,"0.Etoposide;0.Vinblastine;42.Etoposide;0.Vinblastine;42.Etoposide;0.Vinblastine;42.Etoposide;0.Vinblastine;42.Etoposide;0.Vinblastine;42.Etoposide;0.Vinblastine;42.Etoposide;0.Vinblastine;","0.Etoposide;0.Vinblastine;42.Etoposide;0.Vinblastine;42.Etoposide;0.Vinblastine;42.Etoposide;0.Vinblastine;42.Etoposide;0.Vinblastine;42.Etoposide;0.Vinblastine;42.Etoposide;0.Vinblastine;"
"1795","167.195.2386.1","Malignant Hematology","Histiocyte disorders","Langerhans cell histiocytosis",167,"Untreated",195,"Methotrexate, Vinblastine, Prednisone",TRUE,"Cont.","7.Methotrexate;0.Vinblastine;7.Methotrexate;7.Methotrexate;7.Methotrexate;0.Vinblastine;7.Methotrexate;7.Methotrexate;","7.Methotrexate;0.Vinblastine;7.Methotrexate;7.Methotrexate;"
"1796","167.195.2387.1","Malignant Hematology","Histiocyte disorders","Langerhans cell histiocytosis",167,"Untreated",195,"Vinblastine monotherapy",TRUE,"Cont.","7.Vinblastine;7.Vinblastine;7.Vinblastine;7.Vinblastine;7.Vinblastine;7.Vinblastine;7.Vinblastine;7.Vinblastine;7.Vinblastine;7.Vinblastine;7.Vinblastine;7.Vinblastine;","7.Vinblastine;7.Vinblastine;"
"1797","167.195.2387.2","Malignant Hematology","Histiocyte disorders","Langerhans cell histiocytosis",167,"Untreated",195,"Vinblastine monotherapy",TRUE,"Cont.","21.Vinblastine;21.Vinblastine;","21.Vinblastine;21.Vinblastine;"
"1798","168.168.2392.1","Pediatric Neoplasms ","Pediatric CNS malignancies","Low-grade glioma, pediatric",168,"Recurrent or progressive, non-curative therapy",168,"Cisplatin & Etoposide (EP)",TRUE,"Cont.","26.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;26.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;","26.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;"
"1799","168.168.2392.2","Pediatric Neoplasms ","Pediatric CNS malignancies","Low-grade glioma, pediatric",168,"Recurrent or progressive, non-curative therapy",168,"Cisplatin & Etoposide (EP)",TRUE,"Cont.","33.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;33.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;","33.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;"
"1800","168.168.2392.3","Pediatric Neoplasms ","Pediatric CNS malignancies","Low-grade glioma, pediatric",168,"Recurrent or progressive, non-curative therapy",168,"Cisplatin & Etoposide (EP)",TRUE,"Cont.","40.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;40.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;","40.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;"
"1801","168.168.2393.1","Pediatric Neoplasms ","Pediatric CNS malignancies","Low-grade glioma, pediatric",168,"Recurrent or progressive, non-curative therapy",168,"Temozolomide monotherapy",TRUE,"Cont.","24.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;24.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;","24.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;"
"1802","168.4.2391.1","Pediatric Neoplasms ","Pediatric CNS malignancies","Low-grade glioma, pediatric",168,"Adjuvant therapy",4,"Carboplatin & Vincristine",FALSE,"1","0.Carboplatin;0.Vincristine;7.Carboplatin;0.Vincristine;7.Carboplatin;0.Vincristine;7.Carboplatin;0.Vincristine;21.Carboplatin;0.Vincristine;7.Carboplatin;0.Vincristine;7.Carboplatin;0.Vincristine;7.Carboplatin;0.Vincristine;","0.Carboplatin;0.Vincristine;7.Carboplatin;0.Vincristine;7.Carboplatin;0.Vincristine;7.Carboplatin;0.Vincristine;21.Carboplatin;0.Vincristine;7.Carboplatin;0.Vincristine;7.Carboplatin;0.Vincristine;7.Carboplatin;0.Vincristine;"
"1803","168.4.2391.2","Pediatric Neoplasms ","Pediatric CNS malignancies","Low-grade glioma, pediatric",168,"Adjuvant therapy",4,"Carboplatin & Vincristine",FALSE,"1","0.Carboplatin;0.Vincristine;7.Vincristine;7.Vincristine;","0.Carboplatin;0.Vincristine;7.Vincristine;7.Vincristine;"
"1804","168.4.2391.3","Pediatric Neoplasms ","Pediatric CNS malignancies","Low-grade glioma, pediatric",168,"Adjuvant therapy",4,"Carboplatin & Vincristine",FALSE,"1","0.Carboplatin;0.Vincristine;","0.Carboplatin;0.Vincristine;"
"1805","169.4.2394.1","Pediatric Neoplasms ","Pediatric CNS malignancies","High-grade glioma, pediatric",169,"Adjuvant therapy",4,"Lomustine, Vincristine, Prednisone",TRUE,"Cont.","21.Lomustine;0.Vincristine;21.Lomustine;0.Vincristine;","21.Lomustine;0.Vincristine;"
"1806","169.4.2395.1","Pediatric Neoplasms ","Pediatric CNS malignancies","High-grade glioma, pediatric",169,"Adjuvant therapy",4,"Temozolomide monotherapy",TRUE,"Cont.","1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;","1.Temozolomide;1.Temozolomide;"
"1807","169.4.2396.1","Pediatric Neoplasms ","Pediatric CNS malignancies","High-grade glioma, pediatric",169,"Adjuvant therapy",4,"Temozolomide monotherapy",TRUE,"Cont.","24.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;24.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;","24.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;"
"1808","17.31.392.1","Solid Tumor","Endocrine oncology","Neuroendocrine tumor",17,"All lines of therapy",31,"Everolimus monotherapy",TRUE,"Cont.","1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;","1.Everolimus;1.Everolimus;"
"1809","17.31.393.1","Solid Tumor","Endocrine oncology","Neuroendocrine tumor",17,"All lines of therapy",31,"Everolimus & Octreotide",TRUE,"Cont.","1.Everolimus;0.OctreotideLAR;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;0.OctreotideLAR;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;","1.Everolimus;0.OctreotideLAR;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;"
"1810","17.31.394.1","Solid Tumor","Endocrine oncology","Neuroendocrine tumor",17,"All lines of therapy",31,"Fluorouracil & Streptozocin",FALSE,"1","0.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;31.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","0.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;31.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"1811","17.31.395.1","Solid Tumor","Endocrine oncology","Neuroendocrine tumor",17,"All lines of therapy",31,"Interferon alfa-2b monotherapy",TRUE,"Cont.","3.Interferonalfa-2b;2.Interferonalfa-2b;2.Interferonalfa-2b;3.Interferonalfa-2b;2.Interferonalfa-2b;2.Interferonalfa-2b;","3.Interferonalfa-2b;2.Interferonalfa-2b;2.Interferonalfa-2b;"
"1812","17.31.396.1","Solid Tumor","Endocrine oncology","Neuroendocrine tumor",17,"All lines of therapy",31,"Lanreotide monotherapy",TRUE,"Cont.","1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;1.Lanreotide;","1.Lanreotide;1.Lanreotide;"
"1813","17.31.397.1","Solid Tumor","Endocrine oncology","Neuroendocrine tumor",17,"All lines of therapy",31,"Lanreotide LAR monotherapy",FALSE,"4","28.LanreotideLAR;28.LanreotideLAR;","28.LanreotideLAR;28.LanreotideLAR;"
"1814","17.31.398.1","Solid Tumor","Endocrine oncology","Neuroendocrine tumor",17,"All lines of therapy",31,"Lanreotide & Interferon alfa-2b",TRUE,"Cont.","1.Interferonalfa-2b;0.Lanreotide;1.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Lanreotide;1.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Lanreotide;1.Lanreotide;","1.Interferonalfa-2b;0.Lanreotide;1.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Lanreotide;1.Lanreotide;"
"1815","17.31.399.1","Solid Tumor","Endocrine oncology","Neuroendocrine tumor",17,"All lines of therapy",31,"Lutetium Lu 177 dotatate & Octreotide LAR",FALSE,"4","55.LutetiumLu177dotatate;1.OctreotideLAR;55.LutetiumLu177dotatate;1.OctreotideLAR;","55.LutetiumLu177dotatate;1.OctreotideLAR;"
"1816","17.31.399.2","Solid Tumor","Endocrine oncology","Neuroendocrine tumor",17,"All lines of therapy",31,"Lutetium Lu 177 dotatate & Octreotide LAR",TRUE,"Cont.","28.LutetiumLu177dotatate;0.OctreotideLAR;28.LutetiumLu177dotatate;0.OctreotideLAR;","28.LutetiumLu177dotatate;0.OctreotideLAR;"
"1817","17.31.400.1","Solid Tumor","Endocrine oncology","Neuroendocrine tumor",17,"All lines of therapy",31,"Octreotide monotherapy",TRUE,"Cont.","1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;","1.Octreotide;1.Octreotide;"
"1818","17.31.401.1","Solid Tumor","Endocrine oncology","Neuroendocrine tumor",17,"All lines of therapy",31,"Octreotide LAR monotherapy",TRUE,"Cont.","28.OctreotideLAR;28.OctreotideLAR;","28.OctreotideLAR;28.OctreotideLAR;"
"1819","17.31.402.1","Solid Tumor","Endocrine oncology","Neuroendocrine tumor",17,"All lines of therapy",31,"Octreotide & Interferon alfa",TRUE,"Cont.","1.Interferonalfa-2b;0.Octreotide;1.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Octreotide;1.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Octreotide;1.Octreotide;","1.Interferonalfa-2b;0.Octreotide;1.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Octreotide;1.Octreotide;"
"1820","17.31.403.1","Solid Tumor","Endocrine oncology","Neuroendocrine tumor",17,"All lines of therapy",31,"Temozolomide monotherapy",TRUE,"Cont.","24.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;24.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;","24.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;"
"1821","170.209.2397.1","Pediatric Neoplasms ","Pediatric CNS malignancies","Medulloblastoma",170,"Upfront Therapy Older Children",209,"COG ACNS0331 Standard Dose CSRT",NA,NA,"0.Cisplatin;0.Lomustine;0.Vincristine;42.Cisplatin;0.Lomustine;0.Vincristine;42.Cyclophosphamide;0.Vincristine;1.Cyclophosphamide;27.Cisplatin;0.Lomustine;0.Vincristine;NA.Cyclophosphamide;NA.Vincristine;NA.Cyclophosphamide;NA.Cisplatin;NA.Lomustine;NA.Vincristine;NA.Cisplatin;NA.Lomustine;NA.Vincristine;","0.Cisplatin;0.Lomustine;0.Vincristine;42.Cisplatin;0.Lomustine;0.Vincristine;42.Cyclophosphamide;0.Vincristine;1.Cyclophosphamide;27.Cisplatin;0.Lomustine;0.Vincristine;NA.Cyclophosphamide;NA.Vincristine;NA.Cyclophosphamide;NA.Cisplatin;NA.Lomustine;NA.Vincristine;NA.Cisplatin;NA.Lomustine;NA.Vincristine;"
"1822","170.209.2398.1","Pediatric Neoplasms ","Pediatric CNS malignancies","Medulloblastoma",170,"Upfront Therapy Older Children",209,"COG ACNS0332 Protocol A",NA,NA,"0.Vincristine;42.Cisplatin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;26.Cisplatin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;26.Cisplatin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;26.Cisplatin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;26.Cisplatin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;26.Cisplatin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;","0.Vincristine;42.Cisplatin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;26.Cisplatin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;26.Cisplatin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;26.Cisplatin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;26.Cisplatin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;26.Cisplatin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;"
"1823","170.209.2399.1","Pediatric Neoplasms ","Pediatric CNS malignancies","Medulloblastoma",170,"Upfront Therapy Older Children",209,"COG ACNS0332 Protocol A	01	2398",NA,NA,"0.Carboplatin;0.Vincristine;1.Carboplatin;1.Carboplatin;1.Carboplatin;39.Cisplatin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;26.Cisplatin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;26.Cisplatin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;26.Cisplatin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;26.Cisplatin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;26.Cisplatin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;","0.Carboplatin;0.Vincristine;1.Carboplatin;1.Carboplatin;1.Carboplatin;39.Cisplatin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;26.Cisplatin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;26.Cisplatin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;26.Cisplatin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;26.Cisplatin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;26.Cisplatin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;"
"1824","170.215.2400.1","Pediatric Neoplasms ","Pediatric CNS malignancies","Medulloblastoma",170,"Upfront Therapy, Younger Children",215,"COG ACNS0334 Protocol A Induction",FALSE,"3","7.Cyclophosphamide;0.Etoposide;0.Vincristine;1.Cyclophosphamide;0.Etoposide;1.Cisplatin;0.Etoposide;5.Vincristine;7.Vincristine;7.Cyclophosphamide;0.Etoposide;0.Vincristine;1.Cyclophosphamide;0.Etoposide;1.Cisplatin;0.Etoposide;5.Vincristine;7.Vincristine;","7.Cyclophosphamide;0.Etoposide;0.Vincristine;1.Cyclophosphamide;0.Etoposide;1.Cisplatin;0.Etoposide;5.Vincristine;7.Vincristine;"
"1825","170.215.2401.1","Pediatric Neoplasms ","Pediatric CNS malignancies","Medulloblastoma",170,"Upfront Therapy, Younger Children",215,"COG ACNS0334 Protocol A Consolidation",FALSE,"3","27.Carboplatin;0.Thiotepa;1.Carboplatin;0.Thiotepa;27.Carboplatin;0.Thiotepa;1.Carboplatin;0.Thiotepa;","27.Carboplatin;0.Thiotepa;1.Carboplatin;0.Thiotepa;"
"1826","170.215.2402.1","Pediatric Neoplasms ","Pediatric CNS malignancies","Medulloblastoma",170,"Upfront Therapy, Younger Children",215,"COG ACNS0334 Protocol A ",NA,NA,"0.Cyclophosphamide;0.Etoposide;0.Vincristine;1.Cyclophosphamide;0.Etoposide;1.Etoposide;19.Cyclophosphamide;0.Etoposide;0.Vincristine;1.Cyclophosphamide;0.Etoposide;1.Etoposide;19.Cyclophosphamide;0.Etoposide;0.Vincristine;1.Cyclophosphamide;0.Etoposide;1.Etoposide;19.Carboplatin;0.Thiotepa;1.Carboplatin;0.Thiotepa;1.Cisplatin;26.Carboplatin;0.Thiotepa;1.Carboplatin;0.Thiotepa;1.Cisplatin;26.Carboplatin;0.Thiotepa;1.Carboplatin;0.Thiotepa;1.Cisplatin;","0.Cyclophosphamide;0.Etoposide;0.Vincristine;1.Cyclophosphamide;0.Etoposide;1.Etoposide;19.Cyclophosphamide;0.Etoposide;0.Vincristine;1.Cyclophosphamide;0.Etoposide;1.Etoposide;19.Cyclophosphamide;0.Etoposide;0.Vincristine;1.Cyclophosphamide;0.Etoposide;1.Etoposide;19.Carboplatin;0.Thiotepa;1.Carboplatin;0.Thiotepa;1.Cisplatin;26.Carboplatin;0.Thiotepa;1.Carboplatin;0.Thiotepa;1.Cisplatin;26.Carboplatin;0.Thiotepa;1.Carboplatin;0.Thiotepa;1.Cisplatin;"
"1827","170.215.2403.1","Pediatric Neoplasms ","Pediatric CNS malignancies","Medulloblastoma",170,"Upfront Therapy, Younger Children",215,"COG ACNS0334 Protocol B Induction",FALSE,"3","7.Methotrexate;0.Vincristine;3.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;0.Etoposide;1.Cisplatin;0.Cyclophosphamide;0.Etoposide;2.Vincristine;7.Vincristine;7.Methotrexate;0.Vincristine;3.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;0.Etoposide;1.Cisplatin;0.Cyclophosphamide;0.Etoposide;2.Vincristine;7.Vincristine;","7.Methotrexate;0.Vincristine;3.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;0.Etoposide;1.Cisplatin;0.Cyclophosphamide;0.Etoposide;2.Vincristine;7.Vincristine;"
"1828","170.215.2404.1","Pediatric Neoplasms ","Pediatric CNS malignancies","Medulloblastoma",170,"Upfront Therapy, Younger Children",215,"COG ACNS0334 Protocol B Consolidation",FALSE,"3","27.Carboplatin;0.Thiotepa;1.Carboplatin;0.Thiotepa;27.Carboplatin;0.Thiotepa;1.Carboplatin;0.Thiotepa;","27.Carboplatin;0.Thiotepa;1.Carboplatin;0.Thiotepa;"
"1829","170.215.2405.1","Pediatric Neoplasms ","Pediatric CNS malignancies","Medulloblastoma",170,"Upfront Therapy, Younger Children",215,"COG ACNS0334 Protocol B",NA,NA,"0.Methotrexate;0.Vincristine;3.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;0.Etoposide;1.Cisplatin;0.Cyclophosphamide;0.Etoposide;16.Methotrexate;0.Vincristine;3.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;0.Etoposide;1.Cisplatin;0.Cyclophosphamide;0.Etoposide;16.Methotrexate;0.Vincristine;3.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;0.Etoposide;1.Cisplatin;0.Cyclophosphamide;0.Etoposide;16.Carboplatin;0.Thiotepa;1.Carboplatin;0.Thiotepa;27.Carboplatin;0.Thiotepa;1.Carboplatin;0.Thiotepa;27.Carboplatin;0.Thiotepa;1.Carboplatin;0.Thiotepa;","0.Methotrexate;0.Vincristine;3.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;0.Etoposide;1.Cisplatin;0.Cyclophosphamide;0.Etoposide;16.Methotrexate;0.Vincristine;3.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;0.Etoposide;1.Cisplatin;0.Cyclophosphamide;0.Etoposide;16.Methotrexate;0.Vincristine;3.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;0.Etoposide;1.Cisplatin;0.Cyclophosphamide;0.Etoposide;16.Carboplatin;0.Thiotepa;1.Carboplatin;0.Thiotepa;27.Carboplatin;0.Thiotepa;1.Carboplatin;0.Thiotepa;27.Carboplatin;0.Thiotepa;1.Carboplatin;0.Thiotepa;"
"1830","170.215.2406.1","Pediatric Neoplasms ","Pediatric CNS malignancies","Medulloblastoma",170,"Upfront Therapy, Younger Children",215,"Head Start III Protocol D2",NA,NA,"0.Cisplatin;0.Vincristine;1.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;0.Etoposide;0.Methotrexate;13.Etoposide;0.Temozolomide;0.Vincristine;1.Cyclophosphamide;0.Etoposide;0.Temozolomide;1.Cyclophosphamide;0.Etoposide;0.Temozolomide;1.Etoposide;0.Temozolomide;1.Etoposide;0.Temozolomide;1.Etoposide;1.Etoposide;9.Cisplatin;0.Vincristine;1.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;0.Etoposide;0.Methotrexate;13.Etoposide;0.Temozolomide;0.Vincristine;1.Cyclophosphamide;0.Etoposide;0.Temozolomide;1.Cyclophosphamide;0.Etoposide;0.Temozolomide;1.Etoposide;0.Temozolomide;1.Etoposide;0.Temozolomide;1.Etoposide;1.Etoposide;9.Cisplatin;1.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;0.Etoposide;0.Methotrexate;","0.Cisplatin;0.Vincristine;1.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;0.Etoposide;0.Methotrexate;13.Etoposide;0.Temozolomide;0.Vincristine;1.Cyclophosphamide;0.Etoposide;0.Temozolomide;1.Cyclophosphamide;0.Etoposide;0.Temozolomide;1.Etoposide;0.Temozolomide;1.Etoposide;0.Temozolomide;1.Etoposide;1.Etoposide;9.Cisplatin;0.Vincristine;1.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;0.Etoposide;0.Methotrexate;13.Etoposide;0.Temozolomide;0.Vincristine;1.Cyclophosphamide;0.Etoposide;0.Temozolomide;1.Cyclophosphamide;0.Etoposide;0.Temozolomide;1.Etoposide;0.Temozolomide;1.Etoposide;0.Temozolomide;1.Etoposide;1.Etoposide;9.Cisplatin;1.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;0.Etoposide;0.Methotrexate;"
"1831","170.215.2407.1","Pediatric Neoplasms ","Pediatric CNS malignancies","Medulloblastoma",170,"Upfront Therapy, Younger Children",215,"SJMB-96 Protocol High Risk",NA,NA,"0.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;10.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;52.Amifostine;0.Cisplatin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;26.Amifostine;0.Cisplatin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;26.Amifostine;0.Cisplatin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;26.Amifostine;0.Cisplatin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;","0.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;10.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;52.Amifostine;0.Cisplatin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;26.Amifostine;0.Cisplatin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;26.Amifostine;0.Cisplatin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;26.Amifostine;0.Cisplatin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;"
"1832","170.215.2408.1","Pediatric Neoplasms ","Pediatric CNS malignancies","Medulloblastoma",170,"Upfront Therapy, Younger Children",215,"SJMB-96 Protocol Average Risk",TRUE,"Cont.","18.Amifostine;0.Cisplatin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;8.Vincristine;18.Amifostine;0.Cisplatin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;8.Vincristine;","18.Amifostine;0.Cisplatin;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;8.Vincristine;"
"1833","171.118.2455.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Maintenance after upfront therapy",118,"Mercaptopurine & Methotrexate",TRUE,"Cont.","1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;","1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;"
"1834","171.160.2438.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Pre-phase",160,"Vincristine monotherapy",FALSE,"1","0.Vincristine;7.Vincristine;7.Vincristine;","0.Vincristine;7.Vincristine;7.Vincristine;"
"1835","171.172.2456.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Relapsed or refractory",172,"Blinatumomab monotherapy",TRUE,"Cont.","15.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;15.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;","15.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;1.Blinatumomab;"
"1836","171.172.2456.2","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Relapsed or refractory",172,"Blinatumomab monotherapy",TRUE,"Cont.","35.Blinatumomab;7.Blinatumomab;35.Blinatumomab;7.Blinatumomab;","35.Blinatumomab;7.Blinatumomab;"
"1837","171.172.2457.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Relapsed or refractory",172,"CCE",FALSE,"1","0.Clofarabine;0.Cyclophosphamide;0.Etoposide;1.Clofarabine;0.Cyclophosphamide;0.Etoposide;1.Clofarabine;0.Cyclophosphamide;0.Etoposide;1.Clofarabine;0.Cyclophosphamide;0.Etoposide;1.Clofarabine;0.Cyclophosphamide;0.Etoposide;","0.Clofarabine;0.Cyclophosphamide;0.Etoposide;1.Clofarabine;0.Cyclophosphamide;0.Etoposide;1.Clofarabine;0.Cyclophosphamide;0.Etoposide;1.Clofarabine;0.Cyclophosphamide;0.Etoposide;1.Clofarabine;0.Cyclophosphamide;0.Etoposide;"
"1838","171.172.2458.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Relapsed or refractory",172,"Clofarabine monotherapy",FALSE,"14","1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;","1.Clofarabine;1.Clofarabine;"
"1839","171.172.2458.2","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Relapsed or refractory",172,"Clofarabine monotherapy",FALSE,"21","1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;","1.Clofarabine;1.Clofarabine;"
"1840","171.172.2458.3","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Relapsed or refractory",172,"Clofarabine monotherapy",FALSE,"28","1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;","1.Clofarabine;1.Clofarabine;"
"1841","171.172.2458.4","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Relapsed or refractory",172,"Clofarabine monotherapy",FALSE,"35","1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;","1.Clofarabine;1.Clofarabine;"
"1842","171.172.2458.5","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Relapsed or refractory",172,"Clofarabine monotherapy",FALSE,"42","1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;1.Clofarabine;","1.Clofarabine;1.Clofarabine;"
"1843","171.172.2459.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Relapsed or refractory",172,"Doxorubicin, Pegaspargase, Vincristine",FALSE,"1","0.Doxorubicin;0.Vincristine;1.Pegaspargase;6.Methotrexate;0.Vincristine;1.Pegaspargase;6.Vincristine;1.Pegaspargase;6.Vincristine;1.Pegaspargase;6.Methotrexate;","0.Doxorubicin;0.Vincristine;1.Pegaspargase;6.Methotrexate;0.Vincristine;1.Pegaspargase;6.Vincristine;1.Pegaspargase;6.Vincristine;1.Pegaspargase;6.Methotrexate;"
"1844","171.172.2459.2","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Relapsed or refractory",172,"Doxorubicin, Pegaspargase, Vincristine",FALSE,"1","0.Cytarabine;0.Doxorubicin;0.Methotrexate;0.Vincristine;1.Pegaspargase;6.Methotrexate;0.Vincristine;1.Pegaspargase;6.Vincristine;1.Pegaspargase;6.Methotrexate;0.Vincristine;1.Pegaspargase;6.Methotrexate;","0.Cytarabine;0.Doxorubicin;0.Methotrexate;0.Vincristine;1.Pegaspargase;6.Methotrexate;0.Vincristine;1.Pegaspargase;6.Vincristine;1.Pegaspargase;6.Methotrexate;0.Vincristine;1.Pegaspargase;6.Methotrexate;"
"1845","171.172.2460.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Relapsed or refractory",172,"Inotuzumab ozogamicin monotherapy",TRUE,"Cont.","7.Inotuzumabozogamicin;7.Inotuzumabozogamicin;7.Inotuzumabozogamicin;7.Inotuzumabozogamicin;7.Inotuzumabozogamicin;7.Inotuzumabozogamicin;","7.Inotuzumabozogamicin;7.Inotuzumabozogamicin;"
"1846","171.172.2460.2","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Relapsed or refractory",172,"Inotuzumab ozogamicin monotherapy",TRUE,"Cont.","14.Inotuzumabozogamicin;7.Inotuzumabozogamicin;7.Inotuzumabozogamicin;14.Inotuzumabozogamicin;7.Inotuzumabozogamicin;7.Inotuzumabozogamicin;","14.Inotuzumabozogamicin;7.Inotuzumabozogamicin;7.Inotuzumabozogamicin;"
"1847","171.172.2461.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Relapsed or refractory",172,"Mitoxantrone, Asparaginase Erwinia chrysanthemi, Vincristine",FALSE,"1","0.Methotrexate;0.Mitoxantrone;2.AsparaginaseErwiniachrysanthemi;0.Vincristine;2.AsparaginaseErwiniachrysanthemi;2.AsparaginaseErwiniachrysanthemi;1.Methotrexate;0.Mitoxantrone;1.AsparaginaseErwiniachrysanthemi;1.Vincristine;1.AsparaginaseErwiniachrysanthemi;2.AsparaginaseErwiniachrysanthemi;4.Vincristine;1.AsparaginaseErwiniachrysanthemi;2.AsparaginaseErwiniachrysanthemi;2.AsparaginaseErwiniachrysanthemi;2.AsparaginaseErwiniachrysanthemi;0.Vincristine;2.AsparaginaseErwiniachrysanthemi;2.AsparaginaseErwiniachrysanthemi;","0.Methotrexate;0.Mitoxantrone;2.AsparaginaseErwiniachrysanthemi;0.Vincristine;2.AsparaginaseErwiniachrysanthemi;2.AsparaginaseErwiniachrysanthemi;1.Methotrexate;0.Mitoxantrone;1.AsparaginaseErwiniachrysanthemi;1.Vincristine;1.AsparaginaseErwiniachrysanthemi;2.AsparaginaseErwiniachrysanthemi;4.Vincristine;1.AsparaginaseErwiniachrysanthemi;2.AsparaginaseErwiniachrysanthemi;2.AsparaginaseErwiniachrysanthemi;2.AsparaginaseErwiniachrysanthemi;0.Vincristine;2.AsparaginaseErwiniachrysanthemi;2.AsparaginaseErwiniachrysanthemi;"
"1848","171.172.2462.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Relapsed or refractory",172,"Mitoxantrone, Pegaspargase, Vincristine",FALSE,"1","0.Methotrexate;0.Mitoxantrone;2.Pegaspargase;0.Vincristine;5.Methotrexate;0.Mitoxantrone;2.Vincristine;7.Vincristine;1.Pegaspargase;6.Vincristine;","0.Methotrexate;0.Mitoxantrone;2.Pegaspargase;0.Vincristine;5.Methotrexate;0.Mitoxantrone;2.Vincristine;7.Vincristine;1.Pegaspargase;6.Vincristine;"
"1849","171.172.2463.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Relapsed or refractory",172,"Tisagenlecleucel monotherapy",FALSE,"1","0.Tisagenlecleucel;","0.Tisagenlecleucel;0.Tisagenlecleucel;"
"1850","171.204.2439.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Upfront induction therapy",204,"Calaspargase, Daunorubicin, Vincristine, Prednisone",FALSE,"1","0.Daunorubicin;0.Vincristine;3.Calaspargase;4.Daunorubicin;0.Vincristine;7.Daunorubicin;0.Vincristine;7.Daunorubicin;0.Vincristine;","0.Daunorubicin;0.Vincristine;3.Calaspargase;4.Daunorubicin;0.Vincristine;7.Daunorubicin;0.Vincristine;7.Daunorubicin;0.Vincristine;"
"1851","171.204.2440.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Upfront induction therapy",204,"Daunorubicin, Pegaspargase, Vincristine, Dexamethasone",FALSE,"1","0.Cytarabine;0.Daunorubicin;0.Vincristine;3.Pegaspargase;4.Daunorubicin;0.Methotrexate;0.Vincristine;7.Daunorubicin;0.Vincristine;7.Daunorubicin;0.Vincristine;7.Methotrexate;","0.Cytarabine;0.Daunorubicin;0.Vincristine;3.Pegaspargase;4.Daunorubicin;0.Methotrexate;0.Vincristine;7.Daunorubicin;0.Vincristine;7.Daunorubicin;0.Vincristine;7.Methotrexate;"
"1852","171.204.2441.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Upfront induction therapy",204,"DOLP",FALSE,"1","0.Cytarabine;0.Daunorubicin;0.Vincristine;3.Asparaginase;2.Asparaginase;2.Asparaginase;0.Daunorubicin;0.Methotrexate;0.Vincristine;3.Asparaginase;2.Asparaginase;2.Asparaginase;0.Daunorubicin;0.Vincristine;3.Asparaginase;2.Asparaginase;2.Asparaginase;0.Daunorubicin;0.Vincristine;7.Methotrexate;","0.Cytarabine;0.Daunorubicin;0.Vincristine;3.Asparaginase;2.Asparaginase;2.Asparaginase;0.Daunorubicin;0.Methotrexate;0.Vincristine;3.Asparaginase;2.Asparaginase;2.Asparaginase;0.Daunorubicin;0.Vincristine;3.Asparaginase;2.Asparaginase;2.Asparaginase;0.Daunorubicin;0.Vincristine;7.Methotrexate;"
"1853","171.204.2441.2","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Upfront induction therapy",204,"DOLP",FALSE,"1","0.Methotrexate;7.Daunorubicin;0.Vincristine;4.Asparaginase;0.Methotrexate;3.Asparaginase;0.Daunorubicin;0.Vincristine;3.Asparaginase;3.Asparaginase;1.Daunorubicin;0.Vincristine;2.Asparaginase;3.Asparaginase;2.Daunorubicin;0.Vincristine;1.Asparaginase;3.Asparaginase;0.Methotrexate;","0.Methotrexate;7.Daunorubicin;0.Vincristine;4.Asparaginase;0.Methotrexate;3.Asparaginase;0.Daunorubicin;0.Vincristine;3.Asparaginase;3.Asparaginase;1.Daunorubicin;0.Vincristine;2.Asparaginase;3.Asparaginase;2.Daunorubicin;0.Vincristine;1.Asparaginase;3.Asparaginase;0.Methotrexate;"
"1854","171.204.2441.3","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Upfront induction therapy",204,"DOLP",FALSE,"1","0.Methotrexate;7.Daunorubicin;0.Vincristine;4.Asparaginase;3.Asparaginase;0.Daunorubicin;0.Methotrexate;0.Vincristine;3.Asparaginase;3.Asparaginase;1.Daunorubicin;0.Vincristine;2.Asparaginase;3.Asparaginase;2.Daunorubicin;0.Methotrexate;0.Vincristine;1.Asparaginase;3.Asparaginase;","0.Methotrexate;7.Daunorubicin;0.Vincristine;4.Asparaginase;3.Asparaginase;0.Daunorubicin;0.Methotrexate;0.Vincristine;3.Asparaginase;3.Asparaginase;1.Daunorubicin;0.Vincristine;2.Asparaginase;3.Asparaginase;2.Daunorubicin;0.Methotrexate;0.Vincristine;1.Asparaginase;3.Asparaginase;"
"1855","171.204.2441.4","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Upfront induction therapy",204,"DOLP",FALSE,"1","0.Daunorubicin;0.Vincristine;7.Daunorubicin;0.Vincristine;4.Asparaginase;3.Asparaginase;0.Daunorubicin;0.Vincristine;3.Asparaginase;3.Asparaginase;1.Daunorubicin;0.Vincristine;2.Asparaginase;3.Asparaginase;3.Asparaginase;3.Asparaginase;","0.Daunorubicin;0.Vincristine;7.Daunorubicin;0.Vincristine;4.Asparaginase;3.Asparaginase;0.Daunorubicin;0.Vincristine;3.Asparaginase;3.Asparaginase;1.Daunorubicin;0.Vincristine;2.Asparaginase;3.Asparaginase;3.Asparaginase;3.Asparaginase;"
"1856","171.204.2441.5","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Upfront induction therapy",204,"DOLP",FALSE,"1","0.Daunorubicin;0.Vincristine;1.Daunorubicin;1.Asparaginase;2.Asparaginase;2.Asparaginase;1.Daunorubicin;0.Vincristine;0.Vincristine;2.Asparaginase;2.Asparaginase;0.Asparaginase;2.Asparaginase;1.Asparaginase;0.Daunorubicin;0.Vincristine;0.Vincristine;2.Asparaginase;1.Asparaginase;1.Asparaginase;2.Asparaginase;1.Asparaginase;0.Daunorubicin;0.Vincristine;0.Vincristine;3.Asparaginase;4.Asparaginase;0.Daunorubicin;0.Vincristine;0.Vincristine;3.Asparaginase;3.Asparaginase;","0.Daunorubicin;0.Vincristine;1.Daunorubicin;1.Asparaginase;2.Asparaginase;2.Asparaginase;1.Daunorubicin;0.Vincristine;0.Vincristine;2.Asparaginase;2.Asparaginase;0.Asparaginase;2.Asparaginase;1.Asparaginase;0.Daunorubicin;0.Vincristine;0.Vincristine;2.Asparaginase;1.Asparaginase;1.Asparaginase;2.Asparaginase;1.Asparaginase;0.Daunorubicin;0.Vincristine;0.Vincristine;3.Asparaginase;4.Asparaginase;0.Daunorubicin;0.Vincristine;0.Vincristine;3.Asparaginase;3.Asparaginase;"
"1857","171.204.2442.6","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Upfront induction therapy",204,"Doxorubicin, Mercaptopurine, Pegaspargase, Vincristine, Prednisolone",FALSE,"1","0.Doxorubicin;0.Methotrexate;0.Vincristine;7.Methotrexate;0.Vincristine;7.Methotrexate;0.Vincristine;7.Doxorubicin;0.Vincristine;7.Methotrexate;0.Vincristine;1.Mercaptopurine;0.Pegaspargase;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;","0.Doxorubicin;0.Methotrexate;0.Vincristine;7.Methotrexate;0.Vincristine;7.Methotrexate;0.Vincristine;7.Doxorubicin;0.Vincristine;7.Methotrexate;0.Vincristine;1.Mercaptopurine;0.Pegaspargase;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;"
"1858","171.204.2443.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Upfront induction therapy",204,"Doxorubicin, Methotrexate, Pegaspargase, Vincristine, Methylprednisolone",FALSE,"1","0.Cytarabine;3.Doxorubicin;0.Vincristine;1.Doxorubicin;1.Methotrexate;1.Pegaspargase;4.Vincristine;7.Cytarabine;0.Methotrexate;0.Vincristine;7.Vincristine;7.Methotrexate;","0.Cytarabine;3.Doxorubicin;0.Vincristine;1.Doxorubicin;1.Methotrexate;1.Pegaspargase;4.Vincristine;7.Cytarabine;0.Methotrexate;0.Vincristine;7.Vincristine;7.Methotrexate;"
"1859","171.204.2444.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Upfront induction therapy",204,"Pegaspargase & Vincristine",FALSE,"1","0.Cytarabine;3.Cytarabine;0.Vincristine;3.Pegaspargase;4.Methotrexate;0.Vincristine;7.Vincristine;7.Vincristine;7.Methotrexate;","0.Cytarabine;3.Cytarabine;0.Vincristine;3.Pegaspargase;4.Methotrexate;0.Vincristine;7.Vincristine;7.Vincristine;7.Methotrexate;"
"1860","171.207.2409.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Upfront therapy",207,"COG AALL0932 Induction",FALSE,"1","0.Cytarabine;1.Vincristine;3.Pegaspargase;4.Methotrexate;0.Vincristine;7.Vincristine;7.Vincristine;7.Methotrexate;","0.Cytarabine;1.Vincristine;3.Pegaspargase;4.Methotrexate;0.Vincristine;7.Vincristine;7.Vincristine;7.Methotrexate;"
"1861","171.207.2410.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Upfront therapy",207,"COG AALL0932 Consolidation",FALSE,"1","0.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;","0.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;"
"1862","171.207.2411.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Upfront therapy",207,"COG AALL0932 Interim",FALSE,"1","0.Methotrexate;0.Vincristine;10.Methotrexate;0.Vincristine;10.Methotrexate;0.Vincristine;10.Methotrexate;0.Vincristine;10.Methotrexate;0.Vincristine;","0.Methotrexate;0.Vincristine;10.Methotrexate;0.Vincristine;10.Methotrexate;0.Vincristine;10.Methotrexate;0.Vincristine;10.Methotrexate;0.Vincristine;"
"1863","171.207.2412.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Upfront therapy",207,"COG AALL0932 Delayed Intensification",FALSE,"1","0.Doxorubicin;0.Methotrexate;0.Vincristine;3.Thioguanine;4.Doxorubicin;0.Vincristine;7.Doxorubicin;0.Vincristine;14.Cyclophosphamide;0.Cytarabine;0.Methotrexate;0.Pegaspargase;1.Cytarabine;0.Pegaspargase;1.Cytarabine;0.Pegaspargase;1.Cytarabine;0.Pegaspargase;1.Pegaspargase;1.Pegaspargase;1.Pegaspargase;1.Cytarabine;0.Pegaspargase;1.Cytarabine;0.Pegaspargase;1.Cytarabine;0.Pegaspargase;1.Cytarabine;0.Pegaspargase;1.Pegaspargase;1.Pegaspargase;1.Pegaspargase;","0.Doxorubicin;0.Methotrexate;0.Vincristine;3.Thioguanine;4.Doxorubicin;0.Vincristine;7.Doxorubicin;0.Vincristine;14.Cyclophosphamide;0.Cytarabine;0.Methotrexate;0.Pegaspargase;1.Cytarabine;0.Pegaspargase;1.Cytarabine;0.Pegaspargase;1.Cytarabine;0.Pegaspargase;1.Pegaspargase;1.Pegaspargase;1.Pegaspargase;1.Cytarabine;0.Pegaspargase;1.Cytarabine;0.Pegaspargase;1.Cytarabine;0.Pegaspargase;1.Cytarabine;0.Pegaspargase;1.Pegaspargase;1.Pegaspargase;1.Pegaspargase;"
"1864","171.207.2413.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Upfront therapy",207,"COG AALL0932 Maintenance A, B, C, D",TRUE,"Cont.","1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;","1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;"
"1865","171.207.2414.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Upfront therapy",207,"COG AALL0932 Maintenance DS",TRUE,"Cont.","1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;","1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;"
"1866","171.207.2415.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Upfront therapy",207,"COG AALL0932 Consolidation LR-M",TRUE,"Cont.","21.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;17.Methotrexate;21.Methotrexate;7.Vincristine;7.Vincristine;7.Methotrexate;21.Methotrexate;21.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;17.Methotrexate;21.Methotrexate;7.Vincristine;7.Vincristine;7.Methotrexate;21.Methotrexate;","21.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;17.Methotrexate;21.Methotrexate;7.Vincristine;7.Vincristine;7.Methotrexate;21.Methotrexate;"
"1867","171.207.2416.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Upfront therapy",207,"COG AALL0932 Maintenance LR-M",NA,NA,"0.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;106.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;106.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;106.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;106.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;106.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;106.Mercaptopurine;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;","0.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;106.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;106.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;106.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;106.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;106.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;106.Mercaptopurine;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;"
"1868","171.207.2417.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Upfront therapy",207,"COG AALL0932 Maintenance LLy",TRUE,"Cont.","1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;","1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;"
"1869","171.207.2418.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Upfront therapy",207,"COG AALL1131 Induction",FALSE,"1","0.Cytarabine;0.Daunorubicin;0.Vincristine;3.Pegaspargase;4.Daunorubicin;0.Methotrexate;0.Vincristine;7.Daunorubicin;0.Vincristine;7.Daunorubicin;0.Vincristine;","0.Cytarabine;0.Daunorubicin;0.Vincristine;3.Pegaspargase;4.Daunorubicin;0.Methotrexate;0.Vincristine;7.Daunorubicin;0.Vincristine;7.Daunorubicin;0.Vincristine;"
"1870","171.207.2419.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Upfront therapy",207,"COG AALL1131 protocol for HR B-ALL, Consolidation",FALSE,"1","0.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Methotrexate;0.Pegaspargase;0.Vincristine;7.Methotrexate;0.Vincristine;7.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Pegaspargase;0.Vincristine;7.Vincristine;","0.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Methotrexate;0.Pegaspargase;0.Vincristine;7.Methotrexate;0.Vincristine;7.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Pegaspargase;0.Vincristine;7.Vincristine;"
"1871","171.207.2420.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Upfront therapy",207,"COG AALL1131 protocol for HR B-ALL, Interim Maintenance, with HD MTX",FALSE,"1","0.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;","0.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;"
"1872","171.207.2421.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Upfront therapy",207,"COG AALL1131 protocol for HR B-ALL, Delayed Intensification",FALSE,"1","0.Doxorubicin;0.Methotrexate;0.Vincristine;3.Pegaspargase;4.Doxorubicin;0.Vincristine;7.Doxorubicin;0.Vincristine;14.Cyclophosphamide;0.Cytarabine;0.Methotrexate;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Cytarabine;0.Methotrexate;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Pegaspargase;0.Vincristine;7.Vincristine;","0.Doxorubicin;0.Methotrexate;0.Vincristine;3.Pegaspargase;4.Doxorubicin;0.Vincristine;7.Doxorubicin;0.Vincristine;14.Cyclophosphamide;0.Cytarabine;0.Methotrexate;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Cytarabine;0.Methotrexate;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Pegaspargase;0.Vincristine;7.Vincristine;"
"1873","171.207.2422.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Upfront therapy",207,"COG AALL1131 protocol for HR B-ALL, Maintenance",TRUE,"Cont.","1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;","1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;"
"1874","171.207.2423.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Upfront therapy",207,"COG AALL1131 protocol for VHR B-ALL",FALSE,"1","0.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Methotrexate;0.Pegaspargase;0.Vincristine;7.Methotrexate;0.Vincristine;7.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Pegaspargase;0.Vincristine;7.Vincristine;","0.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Methotrexate;0.Pegaspargase;0.Vincristine;7.Methotrexate;0.Vincristine;7.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Pegaspargase;0.Vincristine;7.Vincristine;"
"1875","171.207.2423.2","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Upfront therapy",207,"COG AALL1131 protocol for VHR B-ALL",FALSE,"1","0.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Pegaspargase;0.Vincristine;7.Vincristine;7.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Pegaspargase;0.Vincristine;7.Vincristine;","0.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Pegaspargase;0.Vincristine;7.Vincristine;7.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Pegaspargase;0.Vincristine;7.Vincristine;"
"1876","171.207.2424.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Upfront therapy",207,"COG AALL1131 protocol for VHR B-ALL, Interim Maintenance, I with HD MTX",FALSE,"1","0.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;","0.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;"
"1877","171.207.2425.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Upfront therapy",207,"COG AALL1131 protocol for VHR B-ALL, Delayed Intensification",FALSE,"1","0.Doxorubicin;0.Vincristine;3.Pegaspargase;4.Doxorubicin;0.Vincristine;7.Doxorubicin;0.Vincristine;14.Cyclophosphamide;0.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Pegaspargase;0.Vincristine;7.Vincristine;","0.Doxorubicin;0.Vincristine;3.Pegaspargase;4.Doxorubicin;0.Vincristine;7.Doxorubicin;0.Vincristine;14.Cyclophosphamide;0.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Pegaspargase;0.Vincristine;7.Vincristine;"
"1878","171.207.2426.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Upfront therapy",207,"COG AALL1131 protocol for VHR B-ALL, Interim Maintenance, II with Capizzi MTX",FALSE,"1","0.Methotrexate;0.Vincristine;1.Pegaspargase;9.Methotrexate;0.Vincristine;10.Methotrexate;0.Vincristine;1.Pegaspargase;9.Methotrexate;0.Vincristine;10.Methotrexate;0.Vincristine;","0.Methotrexate;0.Vincristine;1.Pegaspargase;9.Methotrexate;0.Vincristine;10.Methotrexate;0.Vincristine;1.Pegaspargase;9.Methotrexate;0.Vincristine;10.Methotrexate;0.Vincristine;"
"1879","171.207.2427.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Upfront therapy",207,"COG AALL1131 protocol for VHR B-ALL, Maintenance, VHR Arm",TRUE,"Cont.","1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;","1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;"
"1880","171.207.2427.2","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Upfront therapy",207,"COG AALL1131 protocol for VHR B-ALL, Maintenance, VHR Arm",TRUE,"Cont.","1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;","1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;"
"1881","171.207.2428.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Upfront therapy",207,"COG AALL1131 protocol for Ph-like B-ALL (Dasatinib Arm), Consolidation",FALSE,"1","0.Cyclophosphamide;0.Cytarabine;0.Dasatinib;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Dasatinib;0.Mercaptopurine;1.Cytarabine;0.Dasatinib;0.Mercaptopurine;1.Cytarabine;0.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Cytarabine;0.Dasatinib;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Dasatinib;0.Mercaptopurine;1.Cytarabine;0.Dasatinib;0.Mercaptopurine;1.Cytarabine;0.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Methotrexate;0.Pegaspargase;0.Vincristine;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;0.Methotrexate;0.Vincristine;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Cyclophosphamide;0.Cytarabine;0.Dasatinib;0.Mercaptopurine;1.Cytarabine;0.Dasatinib;0.Mercaptopurine;1.Cytarabine;0.Dasatinib;0.Mercaptopurine;1.Cytarabine;0.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Cytarabine;0.Dasatinib;0.Mercaptopurine;1.Cytarabine;0.Dasatinib;0.Mercaptopurine;1.Cytarabine;0.Dasatinib;0.Mercaptopurine;1.Cytarabine;0.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Pegaspargase;0.Vincristine;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;0.Vincristine;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;","0.Cyclophosphamide;0.Cytarabine;0.Dasatinib;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Dasatinib;0.Mercaptopurine;1.Cytarabine;0.Dasatinib;0.Mercaptopurine;1.Cytarabine;0.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Cytarabine;0.Dasatinib;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Dasatinib;0.Mercaptopurine;1.Cytarabine;0.Dasatinib;0.Mercaptopurine;1.Cytarabine;0.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Methotrexate;0.Pegaspargase;0.Vincristine;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;0.Methotrexate;0.Vincristine;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Cyclophosphamide;0.Cytarabine;0.Dasatinib;0.Mercaptopurine;1.Cytarabine;0.Dasatinib;0.Mercaptopurine;1.Cytarabine;0.Dasatinib;0.Mercaptopurine;1.Cytarabine;0.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Cytarabine;0.Dasatinib;0.Mercaptopurine;1.Cytarabine;0.Dasatinib;0.Mercaptopurine;1.Cytarabine;0.Dasatinib;0.Mercaptopurine;1.Cytarabine;0.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Pegaspargase;0.Vincristine;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;0.Vincristine;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;"
"1882","171.207.2429.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Upfront therapy",207,"COG AALL1131 protocol for Ph-like B-ALL (Dasatinib Arm), Interim Maintenance, with HD MTX",FALSE,"1","0.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;","0.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;"
"1883","171.207.2430.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Upfront therapy",207,"COG AALL1131 protocol for Ph-like B-ALL (Dasatinib Arm), Delayed Intensification",FALSE,"1","0.Dasatinib;0.Doxorubicin;0.Methotrexate;0.Vincristine;1.Dasatinib;1.Dasatinib;1.Dasatinib;0.Pegaspargase;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;0.Doxorubicin;0.Vincristine;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;0.Doxorubicin;0.Vincristine;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Cyclophosphamide;0.Cytarabine;0.Dasatinib;0.Methotrexate;0.Thioguanine;1.Cytarabine;0.Dasatinib;0.Thioguanine;1.Cytarabine;0.Dasatinib;0.Thioguanine;1.Cytarabine;0.Dasatinib;0.Thioguanine;1.Dasatinib;0.Thioguanine;1.Dasatinib;0.Thioguanine;1.Dasatinib;0.Thioguanine;1.Cytarabine;0.Dasatinib;0.Methotrexate;0.Thioguanine;1.Cytarabine;0.Dasatinib;0.Thioguanine;1.Cytarabine;0.Dasatinib;0.Thioguanine;1.Cytarabine;0.Dasatinib;0.Thioguanine;1.Dasatinib;0.Thioguanine;1.Dasatinib;0.Thioguanine;1.Dasatinib;0.Thioguanine;1.Dasatinib;0.Pegaspargase;0.Vincristine;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;0.Vincristine;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;","0.Dasatinib;0.Doxorubicin;0.Methotrexate;0.Vincristine;1.Dasatinib;1.Dasatinib;1.Dasatinib;0.Pegaspargase;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;0.Doxorubicin;0.Vincristine;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;0.Doxorubicin;0.Vincristine;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Cyclophosphamide;0.Cytarabine;0.Dasatinib;0.Methotrexate;0.Thioguanine;1.Cytarabine;0.Dasatinib;0.Thioguanine;1.Cytarabine;0.Dasatinib;0.Thioguanine;1.Cytarabine;0.Dasatinib;0.Thioguanine;1.Dasatinib;0.Thioguanine;1.Dasatinib;0.Thioguanine;1.Dasatinib;0.Thioguanine;1.Cytarabine;0.Dasatinib;0.Methotrexate;0.Thioguanine;1.Cytarabine;0.Dasatinib;0.Thioguanine;1.Cytarabine;0.Dasatinib;0.Thioguanine;1.Cytarabine;0.Dasatinib;0.Thioguanine;1.Dasatinib;0.Thioguanine;1.Dasatinib;0.Thioguanine;1.Dasatinib;0.Thioguanine;1.Dasatinib;0.Pegaspargase;0.Vincristine;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;0.Vincristine;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;"
"1884","171.207.2431.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Upfront therapy",207,"COG AALL1131 protocol for Ph-like B-ALL (Dasatinib Arm), Interim Maintenance, II with Capizzi MTX",FALSE,"1","0.Dasatinib;0.Methotrexate;0.Vincristine;1.Dasatinib;0.Pegaspargase;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;0.Methotrexate;0.Vincristine;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;0.Methotrexate;0.Vincristine;1.Dasatinib;0.Pegaspargase;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;0.Methotrexate;0.Vincristine;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;0.Methotrexate;0.Vincristine;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;","0.Dasatinib;0.Methotrexate;0.Vincristine;1.Dasatinib;0.Pegaspargase;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;0.Methotrexate;0.Vincristine;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;0.Methotrexate;0.Vincristine;1.Dasatinib;0.Pegaspargase;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;0.Methotrexate;0.Vincristine;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;0.Methotrexate;0.Vincristine;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;"
"1885","171.207.2432.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Upfront therapy",207,"COG AALL1131 protocol for Ph-like B-ALL (Dasatinib Arm), Maintenance",TRUE,"Cont.","1.Dasatinib;0.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;0.Methotrexate;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;0.Methotrexate;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;0.Methotrexate;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;0.Methotrexate;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;0.Methotrexate;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;0.Methotrexate;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;0.Methotrexate;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;0.Methotrexate;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;0.Methotrexate;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;0.Methotrexate;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;0.Methotrexate;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;0.Methotrexate;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;0.Methotrexate;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;0.Methotrexate;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;0.Methotrexate;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;0.Methotrexate;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;0.Methotrexate;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;0.Methotrexate;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;","1.Dasatinib;0.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;0.Methotrexate;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;0.Methotrexate;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;0.Methotrexate;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;1.Dasatinib;0.Mercaptopurine;"
"1886","171.207.2433.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Upfront therapy",207,"COG AALL1131 protocol for DS HR B-ALL, Induction",FALSE,"1","0.Cytarabine;0.Vincristine;3.Pegaspargase;4.Methotrexate;0.Vincristine;7.Daunorubicin;0.Vincristine;7.Vincristine;7.Methotrexate;","0.Cytarabine;0.Vincristine;3.Pegaspargase;4.Methotrexate;0.Vincristine;7.Daunorubicin;0.Vincristine;7.Vincristine;7.Methotrexate;"
"1887","171.207.2433.2","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Upfront therapy",207,"COG AALL1131 protocol for DS HR B-ALL, Induction",FALSE,"1","0.Cytarabine;0.Vincristine;3.Pegaspargase;4.Methotrexate;0.Vincristine;7.Daunorubicin;0.Methotrexate;0.Vincristine;7.Methotrexate;0.Vincristine;7.Methotrexate;","0.Cytarabine;0.Vincristine;3.Pegaspargase;4.Methotrexate;0.Vincristine;7.Daunorubicin;0.Methotrexate;0.Vincristine;7.Methotrexate;0.Vincristine;7.Methotrexate;"
"1888","171.207.2434.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Upfront therapy",207,"COG AALL1131 protocol for DS HR B-ALL, Consolidation",FALSE,"1","0.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Methotrexate;0.Pegaspargase;0.Vincristine;7.Methotrexate;0.Vincristine;7.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Pegaspargase;0.Vincristine;7.Vincristine;","0.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Methotrexate;0.Pegaspargase;0.Vincristine;7.Methotrexate;0.Vincristine;7.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Pegaspargase;0.Vincristine;7.Vincristine;"
"1889","171.207.2435.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Upfront therapy",207,"COG AALL1131 protocol for DS HR B-ALL, Interim Maintenance, with ID MTX",FALSE,"1","0.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;","0.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;"
"1890","171.207.2436.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Upfront therapy",207,"COG AALL1131 protocol for DS HR B-ALL, Delayed Intensification",FALSE,"1","0.Doxorubicin;0.Methotrexate;0.Vincristine;3.Pegaspargase;4.Doxorubicin;0.Vincristine;7.Doxorubicin;0.Vincristine;14.Cyclophosphamide;0.Cytarabine;0.Methotrexate;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Cytarabine;0.Methotrexate;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Pegaspargase;0.Vincristine;7.Vincristine;","0.Doxorubicin;0.Methotrexate;0.Vincristine;3.Pegaspargase;4.Doxorubicin;0.Vincristine;7.Doxorubicin;0.Vincristine;14.Cyclophosphamide;0.Cytarabine;0.Methotrexate;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Cytarabine;0.Methotrexate;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Pegaspargase;0.Vincristine;7.Vincristine;"
"1891","171.207.2437.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Upfront therapy",207,"COG AALL1131 protocol for DS HR B-ALL, Maintenance, DS HR Arm",TRUE,"Cont.","1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;","1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;"
"1892","171.45.2447.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Consolidation after upfront therapy (including post-remission therapy)",45,"AALL0232 consolidation",FALSE,"1","0.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Pegaspargase;0.Vincristine;7.Vincristine;7.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Pegaspargase;0.Vincristine;7.Vincristine;","0.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Pegaspargase;0.Vincristine;7.Vincristine;7.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Pegaspargase;0.Vincristine;7.Vincristine;"
"1893","171.45.2448.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Consolidation after upfront therapy (including post-remission therapy)",45,"Augmented BFM consolidation",FALSE,"1","0.Cyclophosphamide;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Asparaginase;0.Vincristine;1.Methotrexate;1.Asparaginase;2.Asparaginase;3.Asparaginase;0.Vincristine;1.Methotrexate;1.Asparaginase;2.Asparaginase;3.Cyclophosphamide;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Asparaginase;0.Mercaptopurine;3.Asparaginase;2.Asparaginase;3.Asparaginase;2.Asparaginase;2.Asparaginase;","0.Cyclophosphamide;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Asparaginase;0.Vincristine;1.Methotrexate;1.Asparaginase;2.Asparaginase;3.Asparaginase;0.Vincristine;1.Methotrexate;1.Asparaginase;2.Asparaginase;3.Cyclophosphamide;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Asparaginase;0.Mercaptopurine;3.Asparaginase;2.Asparaginase;3.Asparaginase;2.Asparaginase;2.Asparaginase;"
"1894","171.45.2449.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Consolidation after upfront therapy (including post-remission therapy)",45,"Cyclophosphamide & TBI, then allo HSCT",FALSE,"1","0.Cyclophosphamide;1.Cyclophosphamide;","0.Cyclophosphamide;1.Cyclophosphamide;"
"1895","171.45.2450.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Consolidation after upfront therapy (including post-remission therapy)",45,"Etoposide & TBI, then allo HSCT",FALSE,"1","0.Etoposide;","0.Etoposide;0.Etoposide;"
"1896","171.45.2451.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Consolidation after upfront therapy (including post-remission therapy)",45,"Mercaptopurine & Vincristine",FALSE,"1","0.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;","0.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;"
"1897","171.56.2454.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Delayed intensification",56,"AALL0932 delayed intensification",FALSE,"1","0.Doxorubicin;0.Methotrexate;0.Vincristine;3.Pegaspargase;4.Doxorubicin;0.Vincristine;7.Doxorubicin;0.Vincristine;14.Cyclophosphamide;0.Cytarabine;0.Methotrexate;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;","0.Doxorubicin;0.Methotrexate;0.Vincristine;3.Pegaspargase;4.Doxorubicin;0.Vincristine;7.Doxorubicin;0.Vincristine;14.Cyclophosphamide;0.Cytarabine;0.Methotrexate;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;"
"1898","171.58.2445.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Early intensification therapy",58,"Cyclophosphamide, Etoposide, Methotrexate",FALSE,"1","0.Methotrexate;7.Methotrexate;7.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;0.Etoposide;","0.Methotrexate;7.Methotrexate;7.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;0.Etoposide;"
"1899","171.58.2446.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Early intensification therapy",58,"Mercaptopurine monotherapy",TRUE,"Cont.","1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;","1.Mercaptopurine;1.Mercaptopurine;"
"1900","171.94.2452.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Interim maintenance",94,"Mercaptopurine, Methotrexate, Vincristine",FALSE,"1","0.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;","0.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;"
"1901","171.94.2453.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric",171,"Interim maintenance",94,"Methotrexate & Vincristine",FALSE,"1","0.Methotrexate;0.Vincristine;10.Methotrexate;0.Vincristine;10.Methotrexate;0.Vincristine;10.Methotrexate;0.Vincristine;10.Methotrexate;0.Vincristine;","0.Methotrexate;0.Vincristine;10.Methotrexate;0.Vincristine;10.Methotrexate;0.Vincristine;10.Methotrexate;0.Vincristine;10.Methotrexate;0.Vincristine;"
"1902","172.204.2464.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric, Ph-positive",172,"Upfront induction therapy",204,"Daunorubicin, Pegaspargase, Vincristine, Dasatinib",FALSE,"1","0.Cytarabine;0.Dasatinib;0.Daunorubicin;0.Vincristine;1.Dasatinib;1.Dasatinib;1.Dasatinib;0.Pegaspargase;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;0.Daunorubicin;0.Methotrexate;0.Vincristine;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;0.Daunorubicin;0.Vincristine;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;0.Daunorubicin;0.Vincristine;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;0.Methotrexate;","0.Cytarabine;0.Dasatinib;0.Daunorubicin;0.Vincristine;1.Dasatinib;1.Dasatinib;1.Dasatinib;0.Pegaspargase;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;0.Daunorubicin;0.Methotrexate;0.Vincristine;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;0.Daunorubicin;0.Vincristine;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;0.Daunorubicin;0.Vincristine;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;0.Methotrexate;"
"1903","172.204.2465.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric, Ph-positive",172,"Upfront induction therapy",204,"Daunorubicin, Pegaspargase, Vincristine, Imatinib",FALSE,"1","0.Cytarabine;0.Daunorubicin;0.Imatinib;0.Vincristine;1.Imatinib;1.Imatinib;1.Imatinib;0.Pegaspargase;1.Imatinib;1.Imatinib;1.Imatinib;1.Daunorubicin;0.Imatinib;0.Methotrexate;0.Vincristine;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Daunorubicin;0.Imatinib;0.Vincristine;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Daunorubicin;0.Imatinib;0.Vincristine;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;0.Methotrexate;","0.Cytarabine;0.Daunorubicin;0.Imatinib;0.Vincristine;1.Imatinib;1.Imatinib;1.Imatinib;0.Pegaspargase;1.Imatinib;1.Imatinib;1.Imatinib;1.Daunorubicin;0.Imatinib;0.Methotrexate;0.Vincristine;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Daunorubicin;0.Imatinib;0.Vincristine;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Daunorubicin;0.Imatinib;0.Vincristine;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;0.Methotrexate;"
"1904","172.45.2466.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric, Ph-positive",172,"Consolidation after upfront therapy (including post-remission therapy)",45,"Etoposide, Ifosfamide, Imatinib",FALSE,"1","0.Etoposide;0.Ifosfamide;0.Methotrexate;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;0.Methotrexate;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;","0.Etoposide;0.Ifosfamide;0.Methotrexate;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;0.Methotrexate;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;"
"1905","172.45.2466.2","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric, Ph-positive",172,"Consolidation after upfront therapy (including post-remission therapy)",45,"Etoposide, Ifosfamide, Imatinib",FALSE,"1","0.Etoposide;0.Ifosfamide;0.Imatinib;0.Methotrexate;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;0.Imatinib;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;0.Imatinib;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;0.Imatinib;0.Methotrexate;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;0.Imatinib;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;0.Imatinib;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;0.Imatinib;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;0.Imatinib;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;0.Imatinib;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;","0.Etoposide;0.Ifosfamide;0.Imatinib;0.Methotrexate;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;0.Imatinib;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;0.Imatinib;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;0.Imatinib;0.Methotrexate;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;0.Imatinib;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;0.Imatinib;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;0.Imatinib;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;0.Imatinib;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;0.Imatinib;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;"
"1906","172.45.2467.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric, Ph-positive",172,"Consolidation after upfront therapy (including post-remission therapy)",45,"HR Block 1",FALSE,"1","0.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;0.Etoposide;5.Asparaginase;0.Vincristine;3.Asparaginase;4.Asparaginase;0.Vincristine;3.Asparaginase;","0.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;0.Etoposide;5.Asparaginase;0.Vincristine;3.Asparaginase;4.Asparaginase;0.Vincristine;3.Asparaginase;"
"1907","172.45.2468.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric, Ph-positive",172,"Consolidation after upfront therapy (including post-remission therapy)",45,"HR Block 2/5",FALSE,"1","0.Methotrexate;14.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;3.Asparaginase;0.Vincristine;3.Asparaginase;4.Asparaginase;0.Vincristine;3.Asparaginase;","0.Methotrexate;14.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;3.Asparaginase;0.Vincristine;3.Asparaginase;4.Asparaginase;0.Vincristine;3.Asparaginase;"
"1908","172.45.2469.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric, Ph-positive",172,"Consolidation after upfront therapy (including post-remission therapy)",45,"HR Block 3",FALSE,"1","0.Methotrexate;14.Cytarabine;0.Fludarabine;0.Idarubin;1.Cytarabine;0.Fludarabine;0.Idarubin;1.Cytarabine;0.Fludarabine;0.Idarubin;","0.Methotrexate;14.Cytarabine;0.Fludarabine;0.Idarubin;1.Cytarabine;0.Fludarabine;0.Idarubin;1.Cytarabine;0.Fludarabine;0.Idarubin;"
"1909","172.45.2470.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric, Ph-positive",172,"Consolidation after upfront therapy (including post-remission therapy)",45,"HR Block 4",FALSE,"1","0.Methotrexate;14.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;0.Etoposide;5.Asparaginase;0.Vincristine;3.Asparaginase;4.Asparaginase;0.Vincristine;3.Asparaginase;","0.Methotrexate;14.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;0.Etoposide;1.Cyclophosphamide;0.Etoposide;5.Asparaginase;0.Vincristine;3.Asparaginase;4.Asparaginase;0.Vincristine;3.Asparaginase;"
"1910","172.45.2471.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric, Ph-positive",172,"Consolidation after upfront therapy (including post-remission therapy)",45,"HR Block 6",FALSE,"1","0.Methotrexate;14.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;","0.Methotrexate;14.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;"
"1911","172.45.2472.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","B-cell acute lymphoblastic leukemia, pediatric, Ph-positive",172,"Consolidation after upfront therapy (including post-remission therapy)",45,"HR Block 3 with Imatinib",FALSE,"1","0.Imatinib;0.Methotrexate;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Cytarabine;0.Fludarabine;0.Idarubin;0.Imatinib;1.Cytarabine;0.Fludarabine;0.Idarubin;0.Imatinib;1.Cytarabine;0.Fludarabine;0.Idarubin;0.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;","0.Imatinib;0.Methotrexate;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Cytarabine;0.Fludarabine;0.Idarubin;0.Imatinib;1.Cytarabine;0.Fludarabine;0.Idarubin;0.Imatinib;1.Cytarabine;0.Fludarabine;0.Idarubin;0.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;"
"1912","173.172.2498.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","T-cell acute lymphoblastic leukemia, pediatric",173,"Relapsed or refractory",172,"Mitoxantrone, Asparaginase Erwinia chrysanthemi, Vincristine, Dexamethasone",FALSE,"1","0.Methotrexate;0.Mitoxantrone;2.AsparaginaseErwiniachrysanthemi;0.Vincristine;2.AsparaginaseErwiniachrysanthemi;2.AsparaginaseErwiniachrysanthemi;1.Methotrexate;0.Mitoxantrone;1.AsparaginaseErwiniachrysanthemi;1.Vincristine;1.AsparaginaseErwiniachrysanthemi;2.AsparaginaseErwiniachrysanthemi;4.Vincristine;1.AsparaginaseErwiniachrysanthemi;2.AsparaginaseErwiniachrysanthemi;2.AsparaginaseErwiniachrysanthemi;2.AsparaginaseErwiniachrysanthemi;0.Vincristine;2.AsparaginaseErwiniachrysanthemi;2.AsparaginaseErwiniachrysanthemi;","0.Methotrexate;0.Mitoxantrone;2.AsparaginaseErwiniachrysanthemi;0.Vincristine;2.AsparaginaseErwiniachrysanthemi;2.AsparaginaseErwiniachrysanthemi;1.Methotrexate;0.Mitoxantrone;1.AsparaginaseErwiniachrysanthemi;1.Vincristine;1.AsparaginaseErwiniachrysanthemi;2.AsparaginaseErwiniachrysanthemi;4.Vincristine;1.AsparaginaseErwiniachrysanthemi;2.AsparaginaseErwiniachrysanthemi;2.AsparaginaseErwiniachrysanthemi;2.AsparaginaseErwiniachrysanthemi;0.Vincristine;2.AsparaginaseErwiniachrysanthemi;2.AsparaginaseErwiniachrysanthemi;"
"1913","173.172.2499.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","T-cell acute lymphoblastic leukemia, pediatric",173,"Relapsed or refractory",172,"Mitoxantrone, Pegaspargase, Vincristine, Dexamethasone",FALSE,"1","0.Methotrexate;0.Mitoxantrone;2.Pegaspargase;0.Vincristine;5.Methotrexate;0.Mitoxantrone;2.Vincristine;7.Vincristine;1.Pegaspargase;6.Vincristine;","0.Methotrexate;0.Mitoxantrone;2.Pegaspargase;0.Vincristine;5.Methotrexate;0.Mitoxantrone;2.Vincristine;7.Vincristine;1.Pegaspargase;6.Vincristine;"
"1914","173.172.2500.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","T-cell acute lymphoblastic leukemia, pediatric",173,"Relapsed or refractory",172,"Nelarabine monotherapy",TRUE,"Cont.","17.Nelarabine;1.Nelarabine;1.Nelarabine;1.Nelarabine;1.Nelarabine;17.Nelarabine;1.Nelarabine;1.Nelarabine;1.Nelarabine;1.Nelarabine;","17.Nelarabine;1.Nelarabine;1.Nelarabine;1.Nelarabine;1.Nelarabine;"
"1915","173.204.2488.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","T-cell acute lymphoblastic leukemia, pediatric",173,"Upfront induction therapy",204,"Daunorubicin, Pegaspargase, Vincristine, Dexamethasone",FALSE,"1","0.Cytarabine;0.Daunorubicin;0.Vincristine;3.Pegaspargase;4.Daunorubicin;0.Methotrexate;0.Vincristine;7.Daunorubicin;0.Vincristine;3.Pegaspargase;4.Daunorubicin;0.Vincristine;7.Methotrexate;","0.Cytarabine;0.Daunorubicin;0.Vincristine;3.Pegaspargase;4.Daunorubicin;0.Methotrexate;0.Vincristine;7.Daunorubicin;0.Vincristine;3.Pegaspargase;4.Daunorubicin;0.Vincristine;7.Methotrexate;"
"1916","173.204.2489.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","T-cell acute lymphoblastic leukemia, pediatric",173,"Upfront induction therapy",204,"Daunorubicin, Pegaspargase, Vincristine, Prednisone",FALSE,"1","0.Daunorubicin;0.Vincristine;4.Pegaspargase;3.Daunorubicin;0.Vincristine;7.Daunorubicin;0.Vincristine;7.Daunorubicin;0.Vincristine;","0.Daunorubicin;0.Vincristine;4.Pegaspargase;3.Daunorubicin;0.Vincristine;7.Daunorubicin;0.Vincristine;7.Daunorubicin;0.Vincristine;"
"1917","173.204.2490.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","T-cell acute lymphoblastic leukemia, pediatric",173,"Upfront induction therapy",204,"DOLP",FALSE,"1","0.Daunorubicin;0.Methotrexate;0.Vincristine;2.Asparaginase;2.Asparaginase;2.Asparaginase;1.Daunorubicin;0.Vincristine;2.Asparaginase;2.Asparaginase;2.Asparaginase;1.Daunorubicin;0.Methotrexate;0.Vincristine;2.Asparaginase;2.Asparaginase;2.Asparaginase;1.Daunorubicin;0.Vincristine;7.Methotrexate;","0.Daunorubicin;0.Methotrexate;0.Vincristine;2.Asparaginase;2.Asparaginase;2.Asparaginase;1.Daunorubicin;0.Vincristine;2.Asparaginase;2.Asparaginase;2.Asparaginase;1.Daunorubicin;0.Methotrexate;0.Vincristine;2.Asparaginase;2.Asparaginase;2.Asparaginase;1.Daunorubicin;0.Vincristine;7.Methotrexate;"
"1918","173.207.2473.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","T-cell acute lymphoblastic leukemia, pediatric",173,"Upfront therapy",207,"COG AALL0434 Induction, Arms B",FALSE,"1","0.Cytarabine;0.Daunorubicin;0.Vincristine;4.Pegaspargase;3.Daunorubicin;0.Methotrexate;0.Vincristine;7.Daunorubicin;0.Vincristine;7.Daunorubicin;0.Vincristine;7.Methotrexate;","0.Cytarabine;0.Daunorubicin;0.Vincristine;4.Pegaspargase;3.Daunorubicin;0.Methotrexate;0.Vincristine;7.Daunorubicin;0.Vincristine;7.Daunorubicin;0.Vincristine;7.Methotrexate;"
"1919","173.207.2473.2","Pediatric Neoplasms ","Pediatric hematologic neoplasms","T-cell acute lymphoblastic leukemia, pediatric",173,"Upfront therapy",207,"COG AALL0434 Induction, Arms B",FALSE,"1","0.Cytarabine;0.Daunorubicin;0.Vincristine;4.Pegaspargase;3.Daunorubicin;0.Methotrexate;0.Vincristine;7.Daunorubicin;0.Methotrexate;0.Vincristine;7.Daunorubicin;0.Methotrexate;0.Vincristine;7.Methotrexate;","0.Cytarabine;0.Daunorubicin;0.Vincristine;4.Pegaspargase;3.Daunorubicin;0.Methotrexate;0.Vincristine;7.Daunorubicin;0.Methotrexate;0.Vincristine;7.Daunorubicin;0.Methotrexate;0.Vincristine;7.Methotrexate;"
"1920","173.207.2474.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","T-cell acute lymphoblastic leukemia, pediatric",173,"Upfront therapy",207,"COG AALL0434 Consolidation",FALSE,"1","0.Nelarabine;1.Nelarabine;1.Nelarabine;1.Nelarabine;1.Nelarabine;3.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Methotrexate;0.Pegaspargase;0.Vincristine;7.Vincristine;14.Nelarabine;1.Nelarabine;1.Nelarabine;1.Nelarabine;1.Nelarabine;3.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Methotrexate;0.Pegaspargase;0.Vincristine;7.Vincristine;","0.Nelarabine;1.Nelarabine;1.Nelarabine;1.Nelarabine;1.Nelarabine;3.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Methotrexate;0.Pegaspargase;0.Vincristine;7.Vincristine;14.Nelarabine;1.Nelarabine;1.Nelarabine;1.Nelarabine;1.Nelarabine;3.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Methotrexate;0.Pegaspargase;0.Vincristine;7.Vincristine;"
"1921","173.207.2474.2","Pediatric Neoplasms ","Pediatric hematologic neoplasms","T-cell acute lymphoblastic leukemia, pediatric",173,"Upfront therapy",207,"COG AALL0434 Consolidation",FALSE,"1","0.Nelarabine;1.Nelarabine;1.Nelarabine;1.Nelarabine;1.Nelarabine;3.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Pegaspargase;0.Vincristine;7.Vincristine;14.Nelarabine;1.Nelarabine;1.Nelarabine;1.Nelarabine;1.Nelarabine;3.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Methotrexate;0.Pegaspargase;0.Vincristine;7.Vincristine;","0.Nelarabine;1.Nelarabine;1.Nelarabine;1.Nelarabine;1.Nelarabine;3.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Pegaspargase;0.Vincristine;7.Vincristine;14.Nelarabine;1.Nelarabine;1.Nelarabine;1.Nelarabine;1.Nelarabine;3.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Methotrexate;0.Pegaspargase;0.Vincristine;7.Vincristine;"
"1922","173.207.2475.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","T-cell acute lymphoblastic leukemia, pediatric",173,"Upfront therapy",207,"COG AALL0434 Interim Maintenance",FALSE,"1","0.Methotrexate;0.Vincristine;1.Pegaspargase;9.Methotrexate;0.Vincristine;10.Methotrexate;0.Vincristine;1.Pegaspargase;9.Methotrexate;0.Vincristine;10.Methotrexate;0.Vincristine;","0.Methotrexate;0.Vincristine;1.Pegaspargase;9.Methotrexate;0.Vincristine;10.Methotrexate;0.Vincristine;1.Pegaspargase;9.Methotrexate;0.Vincristine;10.Methotrexate;0.Vincristine;"
"1923","173.207.2476.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","T-cell acute lymphoblastic leukemia, pediatric",173,"Upfront therapy",207,"COG AALL0434 Delayed Intensification",FALSE,"1","0.Doxorubicin;0.Methotrexate;0.Vincristine;4.Pegaspargase;3.Doxorubicin;0.Vincristine;7.Doxorubicin;0.Vincristine;14.Cyclophosphamide;0.Cytarabine;0.Methotrexate;0.Nelarabine;0.Thioguanine;1.Cytarabine;0.Nelarabine;0.Thioguanine;1.Cytarabine;0.Nelarabine;0.Thioguanine;1.Cytarabine;0.Nelarabine;0.Thioguanine;1.Nelarabine;0.Thioguanine;1.Thioguanine;1.Thioguanine;1.Cytarabine;0.Methotrexate;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Pegaspargase;0.Vincristine;7.Vincristine;","0.Doxorubicin;0.Methotrexate;0.Vincristine;4.Pegaspargase;3.Doxorubicin;0.Vincristine;7.Doxorubicin;0.Vincristine;14.Cyclophosphamide;0.Cytarabine;0.Methotrexate;0.Nelarabine;0.Thioguanine;1.Cytarabine;0.Nelarabine;0.Thioguanine;1.Cytarabine;0.Nelarabine;0.Thioguanine;1.Cytarabine;0.Nelarabine;0.Thioguanine;1.Nelarabine;0.Thioguanine;1.Thioguanine;1.Thioguanine;1.Cytarabine;0.Methotrexate;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Pegaspargase;0.Vincristine;7.Vincristine;"
"1924","173.207.2477.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","T-cell acute lymphoblastic leukemia, pediatric",173,"Upfront therapy",207,"COG AALL0434 Maintenance B and D",FALSE,"1","0.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Nelarabine;1.Nelarabine;1.Nelarabine;1.Nelarabine;1.Nelarabine;3.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;","0.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Nelarabine;1.Nelarabine;1.Nelarabine;1.Nelarabine;1.Nelarabine;3.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;"
"1925","173.207.2478.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","T-cell acute lymphoblastic leukemia, pediatric",173,"Upfront therapy",207,"COG AALL0434 Maintenance, continuation after cycle 3",FALSE,"1","0.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;","0.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;"
"1926","173.207.2479.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","T-cell acute lymphoblastic leukemia, pediatric",173,"Upfront therapy",207,"COG AALL1231 Protocol Arm A",FALSE,"1","0.Cytarabine;0.Daunorubicin;0.Vincristine;3.Pegaspargase;4.Daunorubicin;0.Methotrexate;0.Vincristine;7.Daunorubicin;0.Vincristine;3.Pegaspargase;4.Daunorubicin;0.Vincristine;7.Methotrexate;","0.Cytarabine;0.Daunorubicin;0.Vincristine;3.Pegaspargase;4.Daunorubicin;0.Methotrexate;0.Vincristine;7.Daunorubicin;0.Vincristine;3.Pegaspargase;4.Daunorubicin;0.Vincristine;7.Methotrexate;"
"1927","173.207.2479.2","Pediatric Neoplasms ","Pediatric hematologic neoplasms","T-cell acute lymphoblastic leukemia, pediatric",173,"Upfront therapy",207,"COG AALL1231 Protocol Arm A",FALSE,"1","0.Cytarabine;0.Daunorubicin;0.Vincristine;3.Pegaspargase;4.Daunorubicin;0.Methotrexate;0.Vincristine;7.Daunorubicin;0.Methotrexate;0.Vincristine;3.Pegaspargase;4.Daunorubicin;0.Methotrexate;0.Vincristine;7.Methotrexate;","0.Cytarabine;0.Daunorubicin;0.Vincristine;3.Pegaspargase;4.Daunorubicin;0.Methotrexate;0.Vincristine;7.Daunorubicin;0.Methotrexate;0.Vincristine;3.Pegaspargase;4.Daunorubicin;0.Methotrexate;0.Vincristine;7.Methotrexate;"
"1928","173.207.2480.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","T-cell acute lymphoblastic leukemia, pediatric",173,"Upfront therapy",207,"COG AALL1231 Consolidation",FALSE,"1","0.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Methotrexate;0.Pegaspargase;0.Vincristine;7.Methotrexate;0.Vincristine;7.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Pegaspargase;0.Vincristine;7.Vincristine;","0.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Methotrexate;0.Pegaspargase;0.Vincristine;7.Methotrexate;0.Vincristine;7.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Pegaspargase;0.Vincristine;7.Vincristine;"
"1929","173.207.2480.2","Pediatric Neoplasms ","Pediatric hematologic neoplasms","T-cell acute lymphoblastic leukemia, pediatric",173,"Upfront therapy",207,"COG AALL1231 Consolidation",FALSE,"1","0.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Pegaspargase;0.Vincristine;7.Vincristine;7.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Pegaspargase;0.Vincristine;7.Vincristine;","0.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Pegaspargase;0.Vincristine;7.Vincristine;7.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Pegaspargase;0.Vincristine;7.Vincristine;"
"1930","173.207.2481.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","T-cell acute lymphoblastic leukemia, pediatric",173,"Upfront therapy",207,"COG AALL1231 Interim Maintenance, SR patients",FALSE,"1","0.Methotrexate;0.Vincristine;1.Pegaspargase;9.Methotrexate;0.Vincristine;10.Methotrexate;0.Vincristine;1.Pegaspargase;9.Methotrexate;0.Vincristine;10.Methotrexate;0.Vincristine;","0.Methotrexate;0.Vincristine;1.Pegaspargase;9.Methotrexate;0.Vincristine;10.Methotrexate;0.Vincristine;1.Pegaspargase;9.Methotrexate;0.Vincristine;10.Methotrexate;0.Vincristine;"
"1931","173.207.2482.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","T-cell acute lymphoblastic leukemia, pediatric",173,"Upfront therapy",207,"COG AALL1231 Delayed Intensification",FALSE,"1","0.Doxorubicin;0.Methotrexate;0.Vincristine;3.Pegaspargase;4.Doxorubicin;0.Vincristine;7.Doxorubicin;0.Vincristine;3.Pegaspargase;11.Cyclophosphamide;0.Cytarabine;0.Methotrexate;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Cytarabine;0.Methotrexate;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Pegaspargase;0.Vincristine;7.Vincristine;","0.Doxorubicin;0.Methotrexate;0.Vincristine;3.Pegaspargase;4.Doxorubicin;0.Vincristine;7.Doxorubicin;0.Vincristine;3.Pegaspargase;11.Cyclophosphamide;0.Cytarabine;0.Methotrexate;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Cytarabine;0.Methotrexate;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Pegaspargase;0.Vincristine;7.Vincristine;"
"1932","173.207.2483.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","T-cell acute lymphoblastic leukemia, pediatric",173,"Upfront therapy",207,"COG AALL1231 Interim Maintenance, IR patients",FALSE,"1","0.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;","0.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;"
"1933","173.207.2484.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","T-cell acute lymphoblastic leukemia, pediatric",173,"Upfront therapy",207,"COG AALL1231 Intensification, Block 1",FALSE,"1","0.Cytarabine;0.Methotrexate;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cytarabine;1.Pegaspargase;0.Vincristine;","0.Cytarabine;0.Methotrexate;0.Vincristine;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cytarabine;1.Pegaspargase;0.Vincristine;"
"1934","173.207.2485.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","T-cell acute lymphoblastic leukemia, pediatric",173,"Upfront therapy",207,"COG AALL1231 Intensification, Block 2",FALSE,"1","0.Cytarabine;0.Methotrexate;0.Vincristine;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Daunorubicin;1.Pegaspargase;0.Vincristine;","0.Cytarabine;0.Methotrexate;0.Vincristine;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Daunorubicin;1.Pegaspargase;0.Vincristine;"
"1935","173.207.2486.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","T-cell acute lymphoblastic leukemia, pediatric",173,"Upfront therapy",207,"COG AALL1231 Intensification, Block 3",FALSE,"1","0.Cytarabine;0.Methotrexate;1.Cytarabine;1.Etoposide;1.Etoposide;1.Etoposide;1.Pegaspargase;","0.Cytarabine;0.Methotrexate;1.Cytarabine;1.Etoposide;1.Etoposide;1.Etoposide;1.Pegaspargase;"
"1936","173.207.2487.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","T-cell acute lymphoblastic leukemia, pediatric",173,"Upfront therapy",207,"COG AALL1231 Maintenance",FALSE,"1","0.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;","0.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;"
"1937","173.44.2491.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","T-cell acute lymphoblastic leukemia, pediatric",173,"Consolidation after upfront therapy",44,"Cyclophosphamide, Cytarabine, Mercaptopurine, Nelarabine, Pegaspargase, Vincristine",FALSE,"1","0.Nelarabine;1.Nelarabine;1.Nelarabine;1.Nelarabine;1.Nelarabine;3.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Methotrexate;0.Pegaspargase;0.Vincristine;21.Nelarabine;1.Nelarabine;1.Nelarabine;1.Nelarabine;1.Nelarabine;3.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Methotrexate;0.Pegaspargase;0.Vincristine;7.Vincristine;","0.Nelarabine;1.Nelarabine;1.Nelarabine;1.Nelarabine;1.Nelarabine;3.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Methotrexate;0.Pegaspargase;0.Vincristine;21.Nelarabine;1.Nelarabine;1.Nelarabine;1.Nelarabine;1.Nelarabine;3.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Methotrexate;0.Pegaspargase;0.Vincristine;7.Vincristine;"
"1938","173.44.2492.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","T-cell acute lymphoblastic leukemia, pediatric",173,"Consolidation after upfront therapy",44,"Cyclophosphamide, Cytarabine, Mercaptopurine, Pegaspargase, Vincristine",FALSE,"1","0.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Methotrexate;0.Pegaspargase;0.Vincristine;28.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Methotrexate;0.Pegaspargase;0.Vincristine;7.Vincristine;","0.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Methotrexate;0.Pegaspargase;0.Vincristine;28.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Methotrexate;0.Pegaspargase;0.Vincristine;7.Vincristine;"
"1939","173.44.2492.2","Pediatric Neoplasms ","Pediatric hematologic neoplasms","T-cell acute lymphoblastic leukemia, pediatric",173,"Consolidation after upfront therapy",44,"Cyclophosphamide, Cytarabine, Mercaptopurine, Pegaspargase, Vincristine",FALSE,"1","0.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Pegaspargase;0.Vincristine;7.Vincristine;7.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Pegaspargase;0.Vincristine;7.Vincristine;","0.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;0.Methotrexate;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Pegaspargase;0.Vincristine;7.Vincristine;7.Cyclophosphamide;0.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Cytarabine;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Pegaspargase;0.Vincristine;7.Vincristine;"
"1940","173.44.2493.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","T-cell acute lymphoblastic leukemia, pediatric",173,"Consolidation after upfront therapy",44,"Doxorubicin, L-asparaginase, Mercaptopurine, Vincristine, Prednisone",TRUE,"Cont.","7.Asparaginase;0.Doxorubicin;0.Mercaptopurine;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Asparaginase;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Asparaginase;7.Asparaginase;0.Doxorubicin;0.Mercaptopurine;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Asparaginase;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Asparaginase;","7.Asparaginase;0.Doxorubicin;0.Mercaptopurine;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Asparaginase;0.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Asparaginase;"
"1941","173.44.2494.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","T-cell acute lymphoblastic leukemia, pediatric",173,"Consolidation after upfront therapy",44,"Doxorubicin, L-asparaginase, Mercaptopurine, Methotrexate, Vincristine, Prednisone",TRUE,"Cont.","7.Asparaginase;0.Doxorubicin;0.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Asparaginase;0.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Asparaginase;0.Methotrexate;7.Asparaginase;0.Doxorubicin;0.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Asparaginase;0.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Asparaginase;0.Methotrexate;","7.Asparaginase;0.Doxorubicin;0.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Asparaginase;0.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Asparaginase;0.Methotrexate;"
"1942","173.44.2495.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","T-cell acute lymphoblastic leukemia, pediatric",173,"Consolidation after upfront therapy",44,"L-asparaginase monotherapy",TRUE,"Cont.","7.Asparaginase;7.Asparaginase;7.Asparaginase;7.Asparaginase;7.Asparaginase;7.Asparaginase;7.Asparaginase;7.Asparaginase;","7.Asparaginase;7.Asparaginase;"
"1943","173.94.2496.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","T-cell acute lymphoblastic leukemia, pediatric",173,"Interim maintenance",94,"Mercaptopurine, Methotrexate, Vincristine",FALSE,"1","0.Mercaptopurine;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;","0.Mercaptopurine;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;0.Vincristine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;"
"1944","173.94.2497.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","T-cell acute lymphoblastic leukemia, pediatric",173,"Interim maintenance",94,"Methotrexate, Pegaspargase, Vincristine",FALSE,"1","0.Methotrexate;0.Vincristine;1.Pegaspargase;13.Vincristine;7.Pegaspargase;7.Methotrexate;0.Vincristine;14.Vincristine;","0.Methotrexate;0.Vincristine;1.Pegaspargase;13.Vincristine;7.Pegaspargase;7.Methotrexate;0.Vincristine;14.Vincristine;"
"1945","174.184.2513.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","Acute myeloid leukemia, pediatric",174,"Relapsed or refractory, salvage therapy",184,"COGAAML1421 protocol",NA,NA,"0.Cytarabine;0.Cytarabineanddaunorubicinliposomal;2.Cytarabineanddaunorubicinliposomal;2.Cytarabineanddaunorubicinliposomal;10.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;","0.Cytarabine;0.Cytarabineanddaunorubicinliposomal;2.Cytarabineanddaunorubicinliposomal;2.Cytarabineanddaunorubicinliposomal;10.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;"
"1946","174.184.2513.2","Pediatric Neoplasms ","Pediatric hematologic neoplasms","Acute myeloid leukemia, pediatric",174,"Relapsed or refractory, salvage therapy",184,"COGAAML1421 protocol",NA,NA,"0.Cytarabine;0.Cytarabineanddaunorubicinliposomal;2.Cytarabineanddaunorubicinliposomal;2.Cytarabineanddaunorubicinliposomal;10.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;","0.Cytarabine;0.Cytarabineanddaunorubicinliposomal;2.Cytarabineanddaunorubicinliposomal;2.Cytarabineanddaunorubicinliposomal;10.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;"
"1947","174.184.2514.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","Acute myeloid leukemia, pediatric",174,"Relapsed or refractory, salvage therapy",184,"FLAG",FALSE,"1","0.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;","0.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;1.Cytarabine;0.Fludarabine;"
"1948","174.204.2501.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","Acute myeloid leukemia, pediatric",174,"Upfront induction therapy",204,"COG AAML1031 arm A (low-risk)",NA,NA,"0.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;1.Cytarabine;4.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;1.Cytarabine;50.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;1.Cytarabine;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Mitoxantrone;1.Mitoxantrone;","0.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;1.Cytarabine;4.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;1.Cytarabine;50.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;1.Cytarabine;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Mitoxantrone;1.Mitoxantrone;"
"1949","174.204.2502.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","Acute myeloid leukemia, pediatric",174,"Upfront induction therapy",204,"COG AAML1031 arm A (high-risk)",NA,NA,"0.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;1.Cytarabine;4.Cytarabine;1.Cytarabine;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Mitoxantrone;1.Mitoxantrone;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;1.Asparaginase;0.Cytarabine;","0.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;1.Cytarabine;4.Cytarabine;1.Cytarabine;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Mitoxantrone;1.Mitoxantrone;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;1.Asparaginase;0.Cytarabine;"
"1950","174.204.2502.2","Pediatric Neoplasms ","Pediatric hematologic neoplasms","Acute myeloid leukemia, pediatric",174,"Upfront induction therapy",204,"COG AAML1031 arm A (high-risk)",NA,NA,"0.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;1.Cytarabine;4.Cytarabine;1.Cytarabine;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Mitoxantrone;1.Mitoxantrone;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;1.AsparaginaseErwiniachrysanthemi;0.Cytarabine;","0.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;1.Cytarabine;4.Cytarabine;1.Cytarabine;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Mitoxantrone;1.Mitoxantrone;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;1.AsparaginaseErwiniachrysanthemi;0.Cytarabine;"
"1951","174.204.2503.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","Acute myeloid leukemia, pediatric",174,"Upfront induction therapy",204,"COG AAML1031 arm C (FLT3/ITD+)",NA,NA,"0.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;1.Cytarabine;22.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;1.Cytarabine;30.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Sorafenib;1.Sorafenib;27.Cytarabine;1.Cytarabine;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Mitoxantrone;1.Mitoxantrone;1.Sorafenib;","0.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;1.Cytarabine;22.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;1.Cytarabine;30.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Sorafenib;1.Sorafenib;27.Cytarabine;1.Cytarabine;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Mitoxantrone;1.Mitoxantrone;1.Sorafenib;"
"1952","174.204.2504.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","Acute myeloid leukemia, pediatric",174,"Upfront induction therapy",204,"COG AAML0531 arm B (Gemtuzumab)",NA,NA,"0.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Gemtuzumab;1.Cytarabine;4.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;1.Cytarabine;22.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;1.Cytarabine;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Mitoxantrone;1.Mitoxantrone;1.Gemtuzumab;1.Cytarabine;1.Asparaginase;0.Cytarabine;","0.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Gemtuzumab;1.Cytarabine;4.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;1.Cytarabine;22.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;1.Cytarabine;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Mitoxantrone;1.Mitoxantrone;1.Gemtuzumab;1.Cytarabine;1.Asparaginase;0.Cytarabine;"
"1953","174.204.2504.2","Pediatric Neoplasms ","Pediatric hematologic neoplasms","Acute myeloid leukemia, pediatric",174,"Upfront induction therapy",204,"COG AAML0531 arm B (Gemtuzumab)",NA,NA,"0.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Gemtuzumab;1.Cytarabine;4.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;1.Cytarabine;22.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;1.Cytarabine;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Mitoxantrone;1.Mitoxantrone;1.Gemtuzumab;1.Cytarabine;1.AsparaginaseErwiniachrysanthemi;0.Cytarabine;","0.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Gemtuzumab;1.Cytarabine;4.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;1.Cytarabine;22.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;1.Cytarabine;1.Cytarabine;0.Mitoxantrone;1.Cytarabine;0.Mitoxantrone;1.Mitoxantrone;1.Mitoxantrone;1.Gemtuzumab;1.Cytarabine;1.AsparaginaseErwiniachrysanthemi;0.Cytarabine;"
"1954","174.204.2505.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","Acute myeloid leukemia, pediatric",174,"Upfront induction therapy",204,"ADE (standard-dose Ara-C)",FALSE,"1","0.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;1.Cytarabine;1.Cytarabine;","0.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"1955","174.204.2505.2","Pediatric Neoplasms ","Pediatric hematologic neoplasms","Acute myeloid leukemia, pediatric",174,"Upfront induction therapy",204,"ADE (standard-dose Ara-C)",FALSE,"1","0.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;","0.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"1956","174.204.2505.3","Pediatric Neoplasms ","Pediatric hematologic neoplasms","Acute myeloid leukemia, pediatric",174,"Upfront induction therapy",204,"ADE (standard-dose Ara-C)",FALSE,"1","0.Cytarabine;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;","0.Cytarabine;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"1957","174.204.2506.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","Acute myeloid leukemia, pediatric",174,"Upfront induction therapy",204,"ADE (high-dose Ara-C)",FALSE,"1","0.Cytarabine;1.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Daunorubicin;0.Etoposide;","0.Cytarabine;1.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Daunorubicin;0.Etoposide;"
"1958","174.204.2507.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","Acute myeloid leukemia, pediatric",174,"Upfront induction therapy",204,"ADE & GO",FALSE,"1","0.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Gemtuzumab;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;","0.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Daunorubicin;0.Etoposide;1.Cytarabine;0.Gemtuzumab;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"1959","174.204.2508.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","Acute myeloid leukemia, pediatric",174,"Upfront induction therapy",204,"AIE",FALSE,"1","0.Cytarabine;0.Etoposide;0.Idarubicin;1.Cytarabine;0.Etoposide;0.Idarubicin;1.Cytarabine;0.Etoposide;0.Idarubicin;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;1.Cytarabine;","0.Cytarabine;0.Etoposide;0.Idarubicin;1.Cytarabine;0.Etoposide;0.Idarubicin;1.Cytarabine;0.Etoposide;0.Idarubicin;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;1.Cytarabine;"
"1960","174.204.2509.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","Acute myeloid leukemia, pediatric",174,"Upfront induction therapy",204,"DA 3 + 10",FALSE,"1","0.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;","0.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"1961","174.204.2510.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","Acute myeloid leukemia, pediatric",174,"Upfront induction therapy",204,"DA 3 + 10, GO",FALSE,"1","0.Cytarabine;0.Daunorubicin;0.Gemtuzumab;1.Cytarabine;1.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;","0.Cytarabine;0.Daunorubicin;0.Gemtuzumab;1.Cytarabine;1.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;0.Daunorubicin;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"1962","174.204.2511.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","Acute myeloid leukemia, pediatric",174,"Upfront induction therapy",204,"FLAG-Ida",FALSE,"1","0.Lenograstim;1.Cytarabine;0.Fludarabine;0.Lenograstim;1.Cytarabine;0.Fludarabine;0.Lenograstim;1.Cytarabine;0.Fludarabine;0.Idarubicin;0.Lenograstim;1.Cytarabine;0.Fludarabine;0.Idarubicin;0.Lenograstim;1.Cytarabine;0.Fludarabine;0.Idarubicin;0.Lenograstim;1.Lenograstim;","0.Lenograstim;1.Cytarabine;0.Fludarabine;0.Lenograstim;1.Cytarabine;0.Fludarabine;0.Lenograstim;1.Cytarabine;0.Fludarabine;0.Idarubicin;0.Lenograstim;1.Cytarabine;0.Fludarabine;0.Idarubicin;0.Lenograstim;1.Cytarabine;0.Fludarabine;0.Idarubicin;0.Lenograstim;1.Lenograstim;"
"1963","174.41.2515.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","Acute myeloid leukemia, pediatric",174,"Consolidation after salvage therapy",41,"Cytarabine & Thioguanine",TRUE,"Cont.","1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;","1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Cytarabine;0.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;1.Thioguanine;"
"1964","174.41.2516.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","Acute myeloid leukemia, pediatric",174,"Consolidation after salvage therapy",41,"CYVE",FALSE,"1","0.Cytarabine;0.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;","0.Cytarabine;0.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;"
"1965","174.41.2516.2","Pediatric Neoplasms ","Pediatric hematologic neoplasms","Acute myeloid leukemia, pediatric",174,"Consolidation after salvage therapy",41,"CYVE",FALSE,"1","0.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;","0.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;"
"1966","174.44.2512.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","Acute myeloid leukemia, pediatric",174,"Consolidation after upfront therapy",44,"BuCy, then auto HSCT",FALSE,"1","0.Busulfan;1.Busulfan;1.Busulfan;1.Busulfan;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;","0.Busulfan;1.Busulfan;1.Busulfan;1.Busulfan;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;"
"1967","175.186.2522.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","Anaplastic large cell lymphoma, pediatric",175,"Relapsed or refractory, subsequent lines of therapy",186,"Crizotinib monotherapy",TRUE,"Cont.","1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;","1.Crizotinib;1.Crizotinib;"
"1968","175.195.2517.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","Anaplastic large cell lymphoma, pediatric",175,"Untreated",195,"COG ANHL12P1 protocol, pre-phase",NA,NA,"0.Cyclophosphamide;NA.Methotrexate;NA.Cyclophosphamide;","0.Cyclophosphamide;NA.Methotrexate;NA.Cyclophosphamide;"
"1969","175.195.2518.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","Anaplastic large cell lymphoma, pediatric",175,"Untreated",195,"COG ANHL12P1 protocol, Induction",NA,NA,"0.Brentuximabvedotin;0.Ifosfamide;0.Methotrexate;1.Ifosfamide;1.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;17.Brentuximabvedotin;0.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Doxorubicin;1.Cyclophosphamide;0.Doxorubicin;17.Brentuximabvedotin;0.Ifosfamide;0.Methotrexate;1.Ifosfamide;1.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;17.Brentuximabvedotin;0.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Doxorubicin;1.Cyclophosphamide;0.Doxorubicin;17.Brentuximabvedotin;0.Ifosfamide;0.Methotrexate;1.Ifosfamide;1.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;17.Brentuximabvedotin;0.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Doxorubicin;1.Cyclophosphamide;0.Doxorubicin;","0.Brentuximabvedotin;0.Ifosfamide;0.Methotrexate;1.Ifosfamide;1.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;17.Brentuximabvedotin;0.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Doxorubicin;1.Cyclophosphamide;0.Doxorubicin;17.Brentuximabvedotin;0.Ifosfamide;0.Methotrexate;1.Ifosfamide;1.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;17.Brentuximabvedotin;0.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Doxorubicin;1.Cyclophosphamide;0.Doxorubicin;17.Brentuximabvedotin;0.Ifosfamide;0.Methotrexate;1.Ifosfamide;1.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;17.Brentuximabvedotin;0.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Doxorubicin;1.Cyclophosphamide;0.Doxorubicin;"
"1970","175.195.2519.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","Anaplastic large cell lymphoma, pediatric",175,"Untreated",195,"EICNHL ALCL99 protocol, pre-phase",FALSE,"1","0.Cyclophosphamide;0.Cytarabine;0.Methotrexate;1.Cyclophosphamide;","0.Cyclophosphamide;0.Cytarabine;0.Methotrexate;1.Cyclophosphamide;"
"1971","175.195.2520.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","Anaplastic large cell lymphoma, pediatric",175,"Untreated",195,"EICNHL ALCL99 protocol, Induction",NA,NA,"0.Ifosfamide;0.Methotrexate;1.Ifosfamide;1.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Doxorubicin;1.Cyclophosphamide;0.Doxorubicin;17.Ifosfamide;0.Methotrexate;1.Ifosfamide;1.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Doxorubicin;1.Cyclophosphamide;0.Doxorubicin;17.Ifosfamide;0.Methotrexate;1.Ifosfamide;1.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Doxorubicin;1.Cyclophosphamide;0.Doxorubicin;","0.Ifosfamide;0.Methotrexate;1.Ifosfamide;1.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Doxorubicin;1.Cyclophosphamide;0.Doxorubicin;17.Ifosfamide;0.Methotrexate;1.Ifosfamide;1.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Doxorubicin;1.Cyclophosphamide;0.Doxorubicin;17.Ifosfamide;0.Methotrexate;1.Ifosfamide;1.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;1.Cytarabine;0.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Doxorubicin;1.Cyclophosphamide;0.Doxorubicin;"
"1972","175.195.2521.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","Anaplastic large cell lymphoma, pediatric",175,"Untreated",195,"APO",FALSE,"1","0.Doxorubicin;0.Methotrexate;0.Vincristine;7.Methotrexate;0.Vincristine;7.Vincristine;7.Doxorubicin;0.Methotrexate;0.Vincristine;7.Vincristine;","0.Doxorubicin;0.Methotrexate;0.Vincristine;7.Methotrexate;0.Vincristine;7.Vincristine;7.Doxorubicin;0.Methotrexate;0.Vincristine;7.Vincristine;"
"1973","176.34.2523.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","Chronic myeloid leukemia, pediatric",176,"Chronic phase, first-line therapy",34,"Imatinib monotherapy",TRUE,"Cont.","1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;","1.Imatinib;1.Imatinib;"
"1974","176.34.2524.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","Chronic myeloid leukemia, pediatric",176,"Chronic phase, first-line therapy",34,"Nilotinib monotherapy",TRUE,"Cont.","1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;1.Nilotinib;","1.Nilotinib;1.Nilotinib;"
"1975","176.35.2525.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","Chronic myeloid leukemia, pediatric",176,"Chronic phase, relapsed or refractory",35,"Dasatinib monotherapy",TRUE,"Cont.","1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;1.Dasatinib;","1.Dasatinib;1.Dasatinib;"
"1976","177.67.2526.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","Juvenile myelomonocytic leukemia",177,"First-line therapy",67,"Azacitidine monotherapy",TRUE,"Cont.","22.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;22.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;","22.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;1.Azacitidine;"
"1977","178.210.2527.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","Hodgkin lymphoma, pediatric",178,"Upfront therapy, High Risk",210,"ABVE-PC",TRUE,"Cont.","14.Bleomycin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;1.Etoposide;5.Bleomycin;0.Vincristine;14.Bleomycin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;1.Etoposide;5.Bleomycin;0.Vincristine;","14.Bleomycin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;1.Etoposide;5.Bleomycin;0.Vincristine;"
"1978","178.210.2528.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","Hodgkin lymphoma, pediatric",178,"Upfront therapy, High Risk",210,"Bv-AVEPC",TRUE,"Cont.","14.Brentuximabvedotin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;1.Etoposide;5.Vincristine;14.Brentuximabvedotin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;1.Etoposide;5.Vincristine;","14.Brentuximabvedotin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;1.Cyclophosphamide;0.Doxorubicin;0.Etoposide;1.Etoposide;5.Vincristine;"
"1979","178.211.2527.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","Hodgkin lymphoma, pediatric",178,"Upfront Therapy, Intermediate Risk",211,"ABVE-PC",TRUE,"Cont.","14.Bleomycin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;1.Etoposide;5.Bleomycin;0.Vincristine;14.Bleomycin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;1.Etoposide;5.Bleomycin;0.Vincristine;","14.Bleomycin;0.Cyclophosphamide;0.Doxorubicin;0.Etoposide;0.Vincristine;1.Doxorubicin;0.Etoposide;1.Etoposide;5.Bleomycin;0.Vincristine;"
"1980","178.211.2528.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","Hodgkin lymphoma, pediatric",178,"Upfront Therapy, Intermediate Risk",211,"DECA",TRUE,"Cont.","20.Cisplatin;0.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;20.Cisplatin;0.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;","20.Cisplatin;0.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;"
"1981","178.212.2529.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","Hodgkin lymphoma, pediatric",178,"Upfront Therapy, Low Risk",212,"OEPA",TRUE,"Cont.","14.Doxorubicin;0.Vincristine;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;2.Vincristine;7.Doxorubicin;0.Vincristine;14.Doxorubicin;0.Vincristine;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;2.Vincristine;7.Doxorubicin;0.Vincristine;","14.Doxorubicin;0.Vincristine;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;2.Vincristine;7.Doxorubicin;0.Vincristine;"
"1982","179.200.2531.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","Non-Hodgkin lymphoma, pediatric",179,"Untreated, induction",200,"COPADM",FALSE,"1","0.Methotrexate;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;2.Methotrexate;","0.Methotrexate;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;2.Methotrexate;"
"1983","179.200.2532.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","Non-Hodgkin lymphoma, pediatric",179,"Untreated, induction",200,"R-COPADM",FALSE,"1","0.Rituximab;3.Methotrexate;0.Rituximab;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;3.Methotrexate;","0.Rituximab;3.Methotrexate;0.Rituximab;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;3.Methotrexate;"
"1984","179.202.2530.1","Pediatric Neoplasms ","Pediatric hematologic neoplasms","Non-Hodgkin lymphoma, pediatric",179,"Untreated, pre-phase",202,"CVP",FALSE,"1","0.Cyclophosphamide;0.Methotrexate;0.Vincristine;","0.Cyclophosphamide;0.Methotrexate;0.Vincristine;"
"1985","18.31.404.1","Solid Tumor","Endocrine oncology","Pancreatic NET",18,"All lines of therapy",31,"Capecitabine & Temozolomide",TRUE,"Cont.","15.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Temozolomide;1.Capecitabine;0.Temozolomide;1.Capecitabine;0.Temozolomide;1.Capecitabine;0.Temozolomide;1.Capecitabine;0.Temozolomide;15.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Temozolomide;1.Capecitabine;0.Temozolomide;1.Capecitabine;0.Temozolomide;1.Capecitabine;0.Temozolomide;1.Capecitabine;0.Temozolomide;","15.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Temozolomide;1.Capecitabine;0.Temozolomide;1.Capecitabine;0.Temozolomide;1.Capecitabine;0.Temozolomide;1.Capecitabine;0.Temozolomide;"
"1986","18.31.405.1","Solid Tumor","Endocrine oncology","Pancreatic NET",18,"All lines of therapy",31,"Doxorubicin & Streptozocin",TRUE,"Cont.","21.Doxorubicin;0.Streptozocin;1.Streptozocin;1.Streptozocin;1.Streptozocin;1.Streptozocin;17.Doxorubicin;21.Doxorubicin;0.Streptozocin;1.Streptozocin;1.Streptozocin;1.Streptozocin;1.Streptozocin;17.Doxorubicin;","21.Doxorubicin;0.Streptozocin;1.Streptozocin;1.Streptozocin;1.Streptozocin;1.Streptozocin;17.Doxorubicin;"
"1987","18.31.406.1","Solid Tumor","Endocrine oncology","Pancreatic NET",18,"All lines of therapy",31,"FAS",TRUE,"Cont.","24.Doxorubicin;0.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;24.Doxorubicin;0.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;","24.Doxorubicin;0.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;"
"1988","18.31.407.1","Solid Tumor","Endocrine oncology","Pancreatic NET",18,"All lines of therapy",31,"Fluorouracil & Streptozocin",TRUE,"Cont.","38.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;38.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;","38.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;"
"1989","18.31.408.1","Solid Tumor","Endocrine oncology","Pancreatic NET",18,"All lines of therapy",31,"Lanreotide Depot/Autogel monotherapy",TRUE,"Cont.","28.LanreotideDepot/Autogel;28.LanreotideDepot/Autogel;","28.LanreotideDepot/Autogel;28.LanreotideDepot/Autogel;"
"1990","18.31.409.1","Solid Tumor","Endocrine oncology","Pancreatic NET",18,"All lines of therapy",31,"Lanreotide & Interferon alfa-2b",TRUE,"Cont.","1.Interferonalfa-2b;0.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;","1.Interferonalfa-2b;0.Lanreotide;"
"1991","18.31.409.2","Solid Tumor","Endocrine oncology","Pancreatic NET",18,"All lines of therapy",31,"Lanreotide & Interferon alfa-2b",TRUE,"Cont.","1.Interferonalfa-2b;0.Lanreotide;1.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;","1.Interferonalfa-2b;0.Lanreotide;1.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;"
"1992","18.31.410.1","Solid Tumor","Endocrine oncology","Pancreatic NET",18,"All lines of therapy",31,"Octreotide & Interferon alfa",TRUE,"Cont.","1.Interferonalfa-2b;0.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Interferonalfa-2b;0.Octreotide;","1.Interferonalfa-2b;0.Octreotide;"
"1993","18.31.410.2","Solid Tumor","Endocrine oncology","Pancreatic NET",18,"All lines of therapy",31,"Octreotide & Interferon alfa",TRUE,"Cont.","1.Interferonalfa-2b;0.Octreotide;1.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Octreotide;1.Interferonalfa-2b;0.Octreotide;","1.Interferonalfa-2b;0.Octreotide;1.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Octreotide;1.Interferonalfa-2b;0.Octreotide;"
"1994","18.31.411.1","Solid Tumor","Endocrine oncology","Pancreatic NET",18,"All lines of therapy",31,"Lutetium Lu 177 dotatate & Octreotide LAR",NA,NA,"0.LutetiumLu177dotatate;0.OctreotideLAR;28.LutetiumLu177dotatate;0.OctreotideLAR;28.LutetiumLu177dotatate;0.OctreotideLAR;28.LutetiumLu177dotatate;0.OctreotideLAR;28.LutetiumLu177dotatate;28.LutetiumLu177dotatate;28.LutetiumLu177dotatate;28.LutetiumLu177dotatate;","0.LutetiumLu177dotatate;0.OctreotideLAR;28.LutetiumLu177dotatate;0.OctreotideLAR;28.LutetiumLu177dotatate;0.OctreotideLAR;28.LutetiumLu177dotatate;0.OctreotideLAR;28.LutetiumLu177dotatate;28.LutetiumLu177dotatate;28.LutetiumLu177dotatate;28.LutetiumLu177dotatate;"
"1995","18.31.412.1","Solid Tumor","Endocrine oncology","Pancreatic NET",18,"All lines of therapy",31,"Sunitinib monotherapy",TRUE,"Cont.","1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;","1.Sunitinib;1.Sunitinib;"
"1996","18.31.413.1","Solid Tumor","Endocrine oncology","Pancreatic NET",18,"All lines of therapy",31,"Temozolomide & Bevacizumab",TRUE,"Cont.","8.Bevacizumab;0.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;8.Bevacizumab;0.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;8.Bevacizumab;0.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;8.Bevacizumab;0.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;","8.Bevacizumab;0.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;"
"1997","18.31.414.1","Solid Tumor","Endocrine oncology","Pancreatic NET",18,"All lines of therapy",31,"Temozolomide & Thalidomide",TRUE,"Cont.","1.Temozolomide;0.Thalidomide;1.Temozolomide;0.Thalidomide;1.Temozolomide;0.Thalidomide;1.Temozolomide;0.Thalidomide;1.Temozolomide;0.Thalidomide;1.Temozolomide;0.Thalidomide;1.Temozolomide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Temozolomide;0.Thalidomide;1.Temozolomide;0.Thalidomide;1.Temozolomide;0.Thalidomide;1.Temozolomide;0.Thalidomide;1.Temozolomide;0.Thalidomide;1.Temozolomide;0.Thalidomide;1.Temozolomide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Temozolomide;0.Thalidomide;1.Temozolomide;0.Thalidomide;1.Temozolomide;0.Thalidomide;1.Temozolomide;0.Thalidomide;1.Temozolomide;0.Thalidomide;1.Temozolomide;0.Thalidomide;1.Temozolomide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Temozolomide;0.Thalidomide;1.Temozolomide;0.Thalidomide;1.Temozolomide;0.Thalidomide;1.Temozolomide;0.Thalidomide;1.Temozolomide;0.Thalidomide;1.Temozolomide;0.Thalidomide;1.Temozolomide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;","1.Temozolomide;0.Thalidomide;1.Temozolomide;0.Thalidomide;1.Temozolomide;0.Thalidomide;1.Temozolomide;0.Thalidomide;1.Temozolomide;0.Thalidomide;1.Temozolomide;0.Thalidomide;1.Temozolomide;0.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;"
"1998","180.31.2533.1","Pediatric Neoplasms ","Pediatric solid tumors","Epithelioid sarcoma",180,"All lines of therapy",31,"Tazemetostat monotherapy",TRUE,"Cont.","1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;","1.Tazemetostat;1.Tazemetostat;"
"1999","181.207.2534.1","Pediatric Neoplasms ","Pediatric solid tumors","Ewing sarcoma, pediatric",181,"Upfront therapy",207,"COG AEWS1031 Regimen A",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;3.Cyclophosphamide;0.Vincristine;1.Vincristine;9.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;11.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;3.Cyclophosphamide;0.Vincristine;1.Vincristine;9.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;11.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;3.Cyclophosphamide;0.Vincristine;1.Vincristine;9.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;","0.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;3.Cyclophosphamide;0.Vincristine;1.Vincristine;9.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;11.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;3.Cyclophosphamide;0.Vincristine;1.Vincristine;9.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;11.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;3.Cyclophosphamide;0.Vincristine;1.Vincristine;9.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;"
"2000","182.31.2541.1","Pediatric Neoplasms ","Pediatric solid tumors","Hepatoblastoma",182,"All lines of therapy",31,"Cisplatin monotherapy",TRUE,"Cont.","14.Cisplatin;14.Cisplatin;","14.Cisplatin;14.Cisplatin;"
"2001","182.31.2542.1","Pediatric Neoplasms ","Pediatric solid tumors","Hepatoblastoma",182,"All lines of therapy",31,"Cisplatin & Doxorubicin",TRUE,"Cont.","19.Cisplatin;1.Doxorubicin;1.Doxorubicin;19.Cisplatin;1.Doxorubicin;1.Doxorubicin;","19.Cisplatin;1.Doxorubicin;1.Doxorubicin;"
"2002","182.4.2540.1","Pediatric Neoplasms ","Pediatric solid tumors","Hepatoblastoma",182,"Adjuvant therapy",4,"Cisplatin & Fluorouracil (CF) & Vincristine",FALSE,"1","0.Cisplatin;1.Fluorouracil;0.Vincristine;7.Vincristine;7.Vincristine;","0.Cisplatin;1.Fluorouracil;0.Vincristine;7.Vincristine;7.Vincristine;"
"2003","182.79.2535.1","Pediatric Neoplasms ","Pediatric solid tumors","Hepatoblastoma",182,"High-risk, upfront therapy",79,"COG AHEP0731 protocol W, pre-phase",TRUE,"Cont.","14.Irinotecan;0.Vincristine;1.Irinotecan;1.Irinotecan;1.Irinotecan;1.Irinotecan;3.Vincristine;14.Irinotecan;0.Vincristine;1.Irinotecan;1.Irinotecan;1.Irinotecan;1.Irinotecan;3.Vincristine;","14.Irinotecan;0.Vincristine;1.Irinotecan;1.Irinotecan;1.Irinotecan;1.Irinotecan;3.Vincristine;"
"2004","182.79.2536.1","Pediatric Neoplasms ","Pediatric solid tumors","Hepatoblastoma",182,"High-risk, upfront therapy",79,"COG AHEP0731 protocol W, C5VD",TRUE,"Cont.","6.Cisplatin;0.Doxorubicin;1.Doxorubicin;0.Fluorouracil;0.Vincristine;7.Vincristine;7.Vincristine;6.Cisplatin;0.Doxorubicin;1.Doxorubicin;0.Fluorouracil;0.Vincristine;7.Vincristine;7.Vincristine;","6.Cisplatin;0.Doxorubicin;1.Doxorubicin;0.Fluorouracil;0.Vincristine;7.Vincristine;7.Vincristine;"
"2005","182.79.2537.1","Pediatric Neoplasms ","Pediatric solid tumors","Hepatoblastoma",182,"High-risk, upfront therapy",79,"SIOPEL-4 protocol",TRUE,"Cont.","1.Cisplatin;7.Cisplatin;0.Doxorubicin;1.Doxorubicin;6.Cisplatin;14.Cisplatin;7.Cisplatin;0.Doxorubicin;1.Doxorubicin;6.Cisplatin;14.Cisplatin;0.Doxorubicin;1.Doxorubicin;6.Cisplatin;1.Cisplatin;7.Cisplatin;0.Doxorubicin;1.Doxorubicin;6.Cisplatin;14.Cisplatin;7.Cisplatin;0.Doxorubicin;1.Doxorubicin;6.Cisplatin;14.Cisplatin;0.Doxorubicin;1.Doxorubicin;6.Cisplatin;","1.Cisplatin;7.Cisplatin;0.Doxorubicin;1.Doxorubicin;6.Cisplatin;14.Cisplatin;7.Cisplatin;0.Doxorubicin;1.Doxorubicin;6.Cisplatin;14.Cisplatin;0.Doxorubicin;1.Doxorubicin;6.Cisplatin;"
"2006","182.79.2538.1","Pediatric Neoplasms ","Pediatric solid tumors","Hepatoblastoma",182,"High-risk, upfront therapy",79,"SIOPEL-4 protocol, unresectable",TRUE,"Cont.","5.Carboplatin;0.Doxorubicin;1.Doxorubicin;1.Doxorubicin;19.Carboplatin;0.Doxorubicin;1.Doxorubicin;1.Doxorubicin;5.Carboplatin;0.Doxorubicin;1.Doxorubicin;1.Doxorubicin;19.Carboplatin;0.Doxorubicin;1.Doxorubicin;1.Doxorubicin;","5.Carboplatin;0.Doxorubicin;1.Doxorubicin;1.Doxorubicin;19.Carboplatin;0.Doxorubicin;1.Doxorubicin;1.Doxorubicin;"
"2007","182.79.2539.1","Pediatric Neoplasms ","Pediatric solid tumors","Hepatoblastoma",182,"High-risk, upfront therapy",79,"SIOPEL-4 protocol, post-surgery",TRUE,"Cont.","6.Carboplatin;0.Doxorubicin;1.Doxorubicin;20.Carboplatin;0.Doxorubicin;1.Doxorubicin;20.Carboplatin;0.Doxorubicin;1.Doxorubicin;6.Carboplatin;0.Doxorubicin;1.Doxorubicin;20.Carboplatin;0.Doxorubicin;1.Doxorubicin;20.Carboplatin;0.Doxorubicin;1.Doxorubicin;","6.Carboplatin;0.Doxorubicin;1.Doxorubicin;20.Carboplatin;0.Doxorubicin;1.Doxorubicin;20.Carboplatin;0.Doxorubicin;1.Doxorubicin;"
"2008","183.110.2550.1","Pediatric Neoplasms ","Pediatric solid tumors","Neuroblastoma",183,"Low-risk",110,"COG A3961 regimen",NA,NA,"0.Carboplatin;0.Etoposide;1.Etoposide;1.Etoposide;5.Carboplatin;0.Cyclophosphamide;0.Doxorubicin;7.Cyclophosphamide;0.Etoposide;1.Etoposide;1.Etoposide;5.Carboplatin;0.Doxorubicin;0.Etoposide;1.Etoposide;1.Etoposide;5.Cyclophosphamide;0.Etoposide;1.Etoposide;1.Etoposide;5.Carboplatin;0.Cyclophosphamide;0.Doxorubicin;","0.Carboplatin;0.Etoposide;1.Etoposide;1.Etoposide;5.Carboplatin;0.Cyclophosphamide;0.Doxorubicin;7.Cyclophosphamide;0.Etoposide;1.Etoposide;1.Etoposide;5.Carboplatin;0.Doxorubicin;0.Etoposide;1.Etoposide;1.Etoposide;5.Cyclophosphamide;0.Etoposide;1.Etoposide;1.Etoposide;5.Carboplatin;0.Cyclophosphamide;0.Doxorubicin;"
"2009","183.172.2557.1","Pediatric Neoplasms ","Pediatric solid tumors","Neuroblastoma",183,"Relapsed or refractory",172,"Irinotecan, Temozolomide, Dinutuximab",TRUE,"Cont.","10.Irinotecan;0.Temozolomide;1.Dinutuximab;0.Irinotecan;0.Temozolomide;1.Dinutuximab;0.Irinotecan;0.Temozolomide;1.Dinutuximab;0.Irinotecan;0.Temozolomide;1.Dinutuximab;0.Irinotecan;0.Temozolomide;1.Sargramostim;1.Sargramostim;1.Sargramostim;1.Sargramostim;1.Sargramostim;1.Sargramostim;1.Sargramostim;10.Irinotecan;0.Temozolomide;1.Dinutuximab;0.Irinotecan;0.Temozolomide;1.Dinutuximab;0.Irinotecan;0.Temozolomide;1.Dinutuximab;0.Irinotecan;0.Temozolomide;1.Dinutuximab;0.Irinotecan;0.Temozolomide;1.Sargramostim;1.Sargramostim;1.Sargramostim;1.Sargramostim;1.Sargramostim;1.Sargramostim;1.Sargramostim;","10.Irinotecan;0.Temozolomide;1.Dinutuximab;0.Irinotecan;0.Temozolomide;1.Dinutuximab;0.Irinotecan;0.Temozolomide;1.Dinutuximab;0.Irinotecan;0.Temozolomide;1.Dinutuximab;0.Irinotecan;0.Temozolomide;1.Sargramostim;1.Sargramostim;1.Sargramostim;1.Sargramostim;1.Sargramostim;1.Sargramostim;1.Sargramostim;"
"2010","183.172.2558.1","Pediatric Neoplasms ","Pediatric solid tumors","Neuroblastoma",183,"Relapsed or refractory",172,"Naxitamab monotherapy",TRUE,"Cont.","24.Naxitamab;2.Naxitamab;2.Naxitamab;24.Naxitamab;2.Naxitamab;2.Naxitamab;","24.Naxitamab;2.Naxitamab;2.Naxitamab;"
"2011","183.77.2553.1","Pediatric Neoplasms ","Pediatric solid tumors","Neuroblastoma",183,"High-risk, consolidation",77,"Busulfan & Melphalan, then auto HSCT",FALSE,"1","0.Busulfan;1.Busulfan;1.Busulfan;1.Busulfan;1.Melphalan;","0.Busulfan;1.Busulfan;1.Busulfan;1.Busulfan;1.Melphalan;"
"2012","183.77.2554.1","Pediatric Neoplasms ","Pediatric solid tumors","Neuroblastoma",183,"High-risk, consolidation",77,"GM-CSF, IL-2, Isotretinoin, Dinutuximab [COG ANBL0032]",NA,NA,"0.Sargramostim;1.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Sargramostim;22.Aldesleukin;6.Dinutuximab;22.Sargramostim;1.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Sargramostim;22.Aldesleukin;6.Dinutuximab;22.Sargramostim;1.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Sargramostim;28.Dinutuximab;","0.Sargramostim;1.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Sargramostim;22.Aldesleukin;6.Dinutuximab;22.Sargramostim;1.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Sargramostim;22.Aldesleukin;6.Dinutuximab;22.Sargramostim;1.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Sargramostim;28.Dinutuximab;"
"2013","183.77.2554.2","Pediatric Neoplasms ","Pediatric solid tumors","Neuroblastoma",183,"High-risk, consolidation",77,"GM-CSF, IL-2, Isotretinoin, Dinutuximab [COG ANBL0032]",NA,NA,"0.Sargramostim;1.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Sargramostim;22.Aldesleukin;1.Aldesleukin;1.Aldesleukin;1.Aldesleukin;1.Aldesleukin;2.Dinutuximab;22.Sargramostim;1.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Sargramostim;22.Aldesleukin;1.Aldesleukin;1.Aldesleukin;1.Aldesleukin;1.Aldesleukin;2.Dinutuximab;22.Sargramostim;1.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Sargramostim;28.Dinutuximab;","0.Sargramostim;1.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Sargramostim;22.Aldesleukin;1.Aldesleukin;1.Aldesleukin;1.Aldesleukin;1.Aldesleukin;2.Dinutuximab;22.Sargramostim;1.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Sargramostim;22.Aldesleukin;1.Aldesleukin;1.Aldesleukin;1.Aldesleukin;1.Aldesleukin;2.Dinutuximab;22.Sargramostim;1.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Sargramostim;28.Dinutuximab;"
"2014","183.77.2555.1","Pediatric Neoplasms ","Pediatric solid tumors","Neuroblastoma",183,"High-risk, consolidation",77,"Isotretinoin monotherapy",TRUE,"Cont.","15.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;15.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;","15.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;"
"2015","183.77.2556.1","Pediatric Neoplasms ","Pediatric solid tumors","Neuroblastoma",183,"High-risk, consolidation",77,"Isotretinoin & Dinutuximab",TRUE,"Cont.","15.Dinutuximab;0.Isotretinoin;1.Dinutuximab;0.Isotretinoin;1.Dinutuximab;0.Isotretinoin;1.Dinutuximab;0.Isotretinoin;1.Dinutuximab;0.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;15.Dinutuximab;0.Isotretinoin;1.Dinutuximab;0.Isotretinoin;1.Dinutuximab;0.Isotretinoin;1.Dinutuximab;0.Isotretinoin;1.Dinutuximab;0.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;","15.Dinutuximab;0.Isotretinoin;1.Dinutuximab;0.Isotretinoin;1.Dinutuximab;0.Isotretinoin;1.Dinutuximab;0.Isotretinoin;1.Dinutuximab;0.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;"
"2016","183.78.2551.1","Pediatric Neoplasms ","Pediatric solid tumors","Neuroblastoma",183,"High-risk, induction",78,"COJEC",FALSE,"1","0.Cisplatin;0.Cyclophosphamide;0.Etoposide;0.Vincristine;20.Carboplatin;0.Cyclophosphamide;0.Etoposide;0.Vincristine;21.Cisplatin;0.Cyclophosphamide;0.Etoposide;0.Vincristine;21.Carboplatin;0.Cyclophosphamide;0.Etoposide;0.Vincristine;21.Cisplatin;0.Cyclophosphamide;0.Etoposide;0.Vincristine;21.Carboplatin;0.Cyclophosphamide;0.Etoposide;0.Vincristine;21.Cisplatin;0.Cyclophosphamide;0.Etoposide;0.Vincristine;","0.Cisplatin;0.Cyclophosphamide;0.Etoposide;0.Vincristine;20.Carboplatin;0.Cyclophosphamide;0.Etoposide;0.Vincristine;21.Cisplatin;0.Cyclophosphamide;0.Etoposide;0.Vincristine;21.Carboplatin;0.Cyclophosphamide;0.Etoposide;0.Vincristine;21.Cisplatin;0.Cyclophosphamide;0.Etoposide;0.Vincristine;21.Carboplatin;0.Cyclophosphamide;0.Etoposide;0.Vincristine;21.Cisplatin;0.Cyclophosphamide;0.Etoposide;0.Vincristine;"
"2017","183.78.2551.2","Pediatric Neoplasms ","Pediatric solid tumors","Neuroblastoma",183,"High-risk, induction",78,"COJEC",FALSE,"1","0.Carboplatin;0.Etoposide;0.Vincristine;10.Cisplatin;0.Vincristine;10.Cyclophosphamide;0.Etoposide;0.Vincristine;10.Cisplatin;0.Vincristine;10.Carboplatin;0.Etoposide;0.Vincristine;10.Cisplatin;0.Vincristine;10.Cyclophosphamide;0.Etoposide;0.Vincristine;10.Cisplatin;","0.Carboplatin;0.Etoposide;0.Vincristine;10.Cisplatin;0.Vincristine;10.Cyclophosphamide;0.Etoposide;0.Vincristine;10.Cisplatin;0.Vincristine;10.Carboplatin;0.Etoposide;0.Vincristine;10.Cisplatin;0.Vincristine;10.Cyclophosphamide;0.Etoposide;0.Vincristine;10.Cisplatin;"
"2018","183.78.2552.1","Pediatric Neoplasms ","Pediatric solid tumors","Neuroblastoma",183,"High-risk, induction",78,"N5/N6",NA,NA,"0.Cisplatin;0.Etoposide;0.Vincristine;21.Dacarbazine;0.Ifosfamide;0.Vincristine;1.Dacarbazine;1.Dacarbazine;1.Dacarbazine;1.Dacarbazine;1.Doxorubicin;1.Doxorubicin;15.Cisplatin;0.Etoposide;0.Vincristine;21.Dacarbazine;0.Ifosfamide;0.Vincristine;1.Dacarbazine;1.Dacarbazine;1.Dacarbazine;1.Dacarbazine;1.Doxorubicin;1.Doxorubicin;15.Cisplatin;0.Etoposide;0.Vincristine;21.Dacarbazine;0.Ifosfamide;0.Vincristine;1.Dacarbazine;1.Dacarbazine;1.Dacarbazine;1.Dacarbazine;1.Doxorubicin;1.Doxorubicin;","0.Cisplatin;0.Etoposide;0.Vincristine;21.Dacarbazine;0.Ifosfamide;0.Vincristine;1.Dacarbazine;1.Dacarbazine;1.Dacarbazine;1.Dacarbazine;1.Doxorubicin;1.Doxorubicin;15.Cisplatin;0.Etoposide;0.Vincristine;21.Dacarbazine;0.Ifosfamide;0.Vincristine;1.Dacarbazine;1.Dacarbazine;1.Dacarbazine;1.Dacarbazine;1.Doxorubicin;1.Doxorubicin;15.Cisplatin;0.Etoposide;0.Vincristine;21.Dacarbazine;0.Ifosfamide;0.Vincristine;1.Dacarbazine;1.Dacarbazine;1.Dacarbazine;1.Dacarbazine;1.Doxorubicin;1.Doxorubicin;"
"2019","183.78.2552.2","Pediatric Neoplasms ","Pediatric solid tumors","Neuroblastoma",183,"High-risk, induction",78,"N5/N6",NA,NA,"0.Cisplatin;0.Etoposide;0.Vincristine;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;17.Dacarbazine;0.Ifosfamide;0.Vincristine;1.Dacarbazine;0.Ifosfamide;1.Dacarbazine;0.Ifosfamide;1.Dacarbazine;0.Ifosfamide;1.Dacarbazine;0.Ifosfamide;1.Doxorubicin;0.Ifosfamide;1.Doxorubicin;15.Cisplatin;0.Etoposide;0.Vincristine;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;17.Dacarbazine;0.Ifosfamide;0.Vincristine;1.Dacarbazine;0.Ifosfamide;1.Dacarbazine;0.Ifosfamide;1.Dacarbazine;0.Ifosfamide;1.Dacarbazine;0.Ifosfamide;1.Doxorubicin;0.Ifosfamide;1.Doxorubicin;15.Cisplatin;0.Etoposide;0.Vincristine;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;17.Dacarbazine;0.Ifosfamide;0.Vincristine;1.Dacarbazine;0.Ifosfamide;1.Dacarbazine;0.Ifosfamide;1.Dacarbazine;0.Ifosfamide;1.Dacarbazine;0.Ifosfamide;1.Doxorubicin;0.Ifosfamide;1.Doxorubicin;","0.Cisplatin;0.Etoposide;0.Vincristine;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;17.Dacarbazine;0.Ifosfamide;0.Vincristine;1.Dacarbazine;0.Ifosfamide;1.Dacarbazine;0.Ifosfamide;1.Dacarbazine;0.Ifosfamide;1.Dacarbazine;0.Ifosfamide;1.Doxorubicin;0.Ifosfamide;1.Doxorubicin;15.Cisplatin;0.Etoposide;0.Vincristine;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;17.Dacarbazine;0.Ifosfamide;0.Vincristine;1.Dacarbazine;0.Ifosfamide;1.Dacarbazine;0.Ifosfamide;1.Dacarbazine;0.Ifosfamide;1.Dacarbazine;0.Ifosfamide;1.Doxorubicin;0.Ifosfamide;1.Doxorubicin;15.Cisplatin;0.Etoposide;0.Vincristine;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;17.Dacarbazine;0.Ifosfamide;0.Vincristine;1.Dacarbazine;0.Ifosfamide;1.Dacarbazine;0.Ifosfamide;1.Dacarbazine;0.Ifosfamide;1.Dacarbazine;0.Ifosfamide;1.Doxorubicin;0.Ifosfamide;1.Doxorubicin;"
"2020","183.80.2543.1","Pediatric Neoplasms ","Pediatric solid tumors","Neuroblastoma",183,"High Risk",80,"COG ANBL0931 post-consolidation",NA,NA,"0.Sargramostim;1.Sargramostim;1.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;19.Aldesleukin;34.Dinutuximab;1.Dinutuximab;1.Dinutuximab;1.Dinutuximab;19.Aldesleukin;34.Dinutuximab;1.Dinutuximab;1.Dinutuximab;1.Dinutuximab;","0.Sargramostim;1.Sargramostim;1.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;19.Aldesleukin;34.Dinutuximab;1.Dinutuximab;1.Dinutuximab;1.Dinutuximab;19.Aldesleukin;34.Dinutuximab;1.Dinutuximab;1.Dinutuximab;1.Dinutuximab;"
"2021","183.80.2544.1","Pediatric Neoplasms ","Pediatric solid tumors","Neuroblastoma",183,"High Risk",80,"COG ANBL0532 Regimen B, Induction",NA,NA,"0.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;17.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;17.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;18.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;19.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;18.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;","0.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;17.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;17.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;18.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;19.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;18.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Doxorubicin;0.Vincristine;"
"2022","183.80.2545.1","Pediatric Neoplasms ","Pediatric solid tumors","Neuroblastoma",183,"High Risk",80,"COG ANBL0532 Regimen B, Consolidation",NA,NA,"0.Thiotepa;1.Thiotepa;1.Cyclophosphamide;0.Thiotepa;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;45.Carboplatin;0.Etoposide;0.Melphalan;1.Carboplatin;0.Etoposide;0.Melphalan;1.Carboplatin;0.Etoposide;0.Melphalan;1.Carboplatin;0.Etoposide;","0.Thiotepa;1.Thiotepa;1.Cyclophosphamide;0.Thiotepa;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;45.Carboplatin;0.Etoposide;0.Melphalan;1.Carboplatin;0.Etoposide;0.Melphalan;1.Carboplatin;0.Etoposide;0.Melphalan;1.Carboplatin;0.Etoposide;"
"2023","183.80.2546.1","Pediatric Neoplasms ","Pediatric solid tumors","Neuroblastoma",183,"High Risk",80,"COG ANBL0532 Regimen B, Maintenance",TRUE,"Cont.","15.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;15.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;","15.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Isotretinoin;"
"2024","183.80.2547.1","Pediatric Neoplasms ","Pediatric solid tumors","Neuroblastoma",183,"High Risk",80,"COG ANBL17P1 protocol, Induction",NA,NA,"0.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;17.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;17.Cisplatin;0.Etoposide;1.Cisplatin;0.Dinutuximab;0.Etoposide;1.Cisplatin;0.Dinutuximab;0.Etoposide;1.Dinutuximab;1.Dinutuximab;17.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Cyclophosphamide;0.Dinutuximab;0.Doxorubicin;1.Dinutuximab;1.Dinutuximab;1.Dinutuximab;17.Cisplatin;0.Etoposide;1.Cisplatin;0.Dinutuximab;0.Etoposide;1.Cisplatin;0.Dinutuximab;0.Etoposide;1.Dinutuximab;1.Dinutuximab;","0.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;17.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;17.Cisplatin;0.Etoposide;1.Cisplatin;0.Dinutuximab;0.Etoposide;1.Cisplatin;0.Dinutuximab;0.Etoposide;1.Dinutuximab;1.Dinutuximab;17.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Cyclophosphamide;0.Dinutuximab;0.Doxorubicin;1.Dinutuximab;1.Dinutuximab;1.Dinutuximab;17.Cisplatin;0.Etoposide;1.Cisplatin;0.Dinutuximab;0.Etoposide;1.Cisplatin;0.Dinutuximab;0.Etoposide;1.Dinutuximab;1.Dinutuximab;"
"2025","183.80.2548.1","Pediatric Neoplasms ","Pediatric solid tumors","Neuroblastoma",183,"High Risk",80,"COG ANBL17P1 protocol, Consolidation",NA,NA,"0.Thiotepa;1.Thiotepa;1.Cyclophosphamide;0.Thiotepa;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;45.Carboplatin;0.Etoposide;0.Melphalan;1.Etoposide;0.Melphalan;1.Etoposide;0.Melphalan;1.Etoposide;","0.Thiotepa;1.Thiotepa;1.Cyclophosphamide;0.Thiotepa;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;45.Carboplatin;0.Etoposide;0.Melphalan;1.Etoposide;0.Melphalan;1.Etoposide;0.Melphalan;1.Etoposide;"
"2026","183.80.2549.1","Pediatric Neoplasms ","Pediatric solid tumors","Neuroblastoma",183,"High Risk",80,"COG ANBL17P1 protocol, Post-consolidation",NA,NA,"0.Sargramostim;1.Sargramostim;1.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;22.Sargramostim;1.Sargramostim;1.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;22.Sargramostim;1.Sargramostim;1.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;22.Sargramostim;1.Sargramostim;1.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;22.Sargramostim;1.Sargramostim;1.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;","0.Sargramostim;1.Sargramostim;1.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;22.Sargramostim;1.Sargramostim;1.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;22.Sargramostim;1.Sargramostim;1.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;22.Sargramostim;1.Sargramostim;1.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;22.Sargramostim;1.Sargramostim;1.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;1.Dinutuximab;0.Sargramostim;"
"2027","184.31.2559.1","Pediatric Neoplasms ","Pediatric solid tumors","Osteosarcoma, pediatric",184,"All lines of therapy",31,"MAP [COG AOST0331], Neoadjuvant",FALSE,"1","0.Cisplatin;0.Doxorubicin;1.Doxorubicin;26.Methotrexate;7.Methotrexate;8.Cisplatin;0.Doxorubicin;1.Doxorubicin;19.Methotrexate;7.Methotrexate;","0.Cisplatin;0.Doxorubicin;1.Doxorubicin;26.Methotrexate;7.Methotrexate;8.Cisplatin;0.Doxorubicin;1.Doxorubicin;19.Methotrexate;7.Methotrexate;"
"2028","184.31.2560.1","Pediatric Neoplasms ","Pediatric solid tumors","Osteosarcoma, pediatric",184,"All lines of therapy",31,"MAP [COG AOST0331], Adjuvant",FALSE,"1","0.Cisplatin;0.Doxorubicin;1.Doxorubicin;20.Methotrexate;7.Methotrexate;7.Cisplatin;0.Doxorubicin;1.Doxorubicin;20.Methotrexate;7.Methotrexate;","0.Cisplatin;0.Doxorubicin;1.Doxorubicin;20.Methotrexate;7.Methotrexate;7.Cisplatin;0.Doxorubicin;1.Doxorubicin;20.Methotrexate;7.Methotrexate;"
"2029","184.31.2561.1","Pediatric Neoplasms ","Pediatric solid tumors","Osteosarcoma, pediatric",184,"All lines of therapy",31,"MAP [COG AOST0331], Consolidation",FALSE,"1","0.Doxorubicin;14.Methotrexate;7.Methotrexate;7.Doxorubicin;14.Methotrexate;7.Methotrexate;","0.Doxorubicin;14.Methotrexate;7.Methotrexate;7.Doxorubicin;14.Methotrexate;7.Methotrexate;"
"2030","185.112.2571.1","Pediatric Neoplasms ","Pediatric solid tumors","Rhabdomyosarcoma, pediatric",185,"Low Risk",112,"COG ARST1431 Protocol C (VAC/VA)",NA,NA,"0.Cyclophosphamide;0.Dactinomycin;0.Vincristine;7.Vincristine;7.Vincristine;7.Cyclophosphamide;0.Dactinomycin;0.Vincristine;7.Vincristine;7.Vincristine;7.Cyclophosphamide;0.Dactinomycin;0.Vincristine;7.Vincristine;7.Vincristine;","0.Cyclophosphamide;0.Dactinomycin;0.Vincristine;7.Vincristine;7.Vincristine;7.Cyclophosphamide;0.Dactinomycin;0.Vincristine;7.Vincristine;7.Vincristine;7.Cyclophosphamide;0.Dactinomycin;0.Vincristine;7.Vincristine;7.Vincristine;"
"2031","185.80.2572.1","Pediatric Neoplasms ","Pediatric solid tumors","Rhabdomyosarcoma, pediatric",185,"High Risk",80,"COG ARST0431 protocol",NA,NA,"0.Irinotecan;0.Vincristine;7.Vincristine;7.Vincristine;7.Irinotecan;0.Vincristine;7.Vincristine;NA.Cyclophosphamide;NA.Doxorubicin;NA.Vincristine;NA.Vincristine;NA.Etoposide;NA.Ifosfamide;NA.Vincristine;NA.Etoposide;NA.Ifosfamide;NA.Etoposide;NA.Ifosfamide;NA.Etoposide;NA.Ifosfamide;NA.Etoposide;NA.Ifosfamide;","0.Irinotecan;0.Vincristine;7.Vincristine;7.Vincristine;7.Irinotecan;0.Vincristine;7.Vincristine;NA.Cyclophosphamide;NA.Doxorubicin;NA.Vincristine;NA.Vincristine;NA.Etoposide;NA.Ifosfamide;NA.Vincristine;NA.Etoposide;NA.Ifosfamide;NA.Etoposide;NA.Ifosfamide;NA.Etoposide;NA.Ifosfamide;NA.Etoposide;NA.Ifosfamide;"
"2032","185.95.2562.1","Pediatric Neoplasms ","Pediatric solid tumors","Rhabdomyosarcoma, pediatric",185,"Intermediate risk",95,"COG ARST1431 Protocol A (VAC/VI Only), Part 1",FALSE,"1","0.Cyclophosphamide;0.Dactinomycin;0.Vincristine;7.Cyclophosphamide;0.Dactinomycin;0.Vincristine;7.Cyclophosphamide;0.Dactinomycin;0.Vincristine;7.Cyclophosphamide;0.Dactinomycin;0.Irinotecan;0.Vincristine;7.Cyclophosphamide;0.Dactinomycin;0.Irinotecan;0.Vincristine;7.Cyclophosphamide;0.Dactinomycin;0.Irinotecan;0.Vincristine;7.Cyclophosphamide;0.Dactinomycin;0.Irinotecan;0.Vincristine;7.Irinotecan;0.Vincristine;7.Irinotecan;0.Vincristine;7.Irinotecan;0.Vincristine;7.Vincristine;7.Vincristine;","0.Cyclophosphamide;0.Dactinomycin;0.Vincristine;7.Cyclophosphamide;0.Dactinomycin;0.Vincristine;7.Cyclophosphamide;0.Dactinomycin;0.Vincristine;7.Cyclophosphamide;0.Dactinomycin;0.Irinotecan;0.Vincristine;7.Cyclophosphamide;0.Dactinomycin;0.Irinotecan;0.Vincristine;7.Cyclophosphamide;0.Dactinomycin;0.Irinotecan;0.Vincristine;7.Cyclophosphamide;0.Dactinomycin;0.Irinotecan;0.Vincristine;7.Irinotecan;0.Vincristine;7.Irinotecan;0.Vincristine;7.Irinotecan;0.Vincristine;7.Vincristine;7.Vincristine;"
"2033","185.95.2563.1","Pediatric Neoplasms ","Pediatric solid tumors","Rhabdomyosarcoma, pediatric",185,"Intermediate risk",95,"COG ARST1431 Protocol A (VAC/VI Only), Part 2",FALSE,"1","0.Cyclophosphamide;0.Dactinomycin;0.Vincristine;21.Irinotecan;0.Vincristine;7.Vincristine;14.Irinotecan;0.Vincristine;7.Vincristine;14.Cyclophosphamide;0.Dactinomycin;0.Vincristine;7.Vincristine;7.Vincristine;4.Vincristine;3.Irinotecan;0.Vincristine;11.Cyclophosphamide;0.Dactinomycin;0.Vincristine;","0.Cyclophosphamide;0.Dactinomycin;0.Vincristine;21.Irinotecan;0.Vincristine;7.Vincristine;14.Irinotecan;0.Vincristine;7.Vincristine;14.Cyclophosphamide;0.Dactinomycin;0.Vincristine;7.Vincristine;7.Vincristine;4.Vincristine;3.Irinotecan;0.Vincristine;11.Cyclophosphamide;0.Dactinomycin;0.Vincristine;"
"2034","185.95.2564.1","Pediatric Neoplasms ","Pediatric solid tumors","Rhabdomyosarcoma, pediatric",185,"Intermediate risk",95,"COG ARST1431 Protocol A (VAC/VI Only), Part 3",FALSE,"1","0.Irinotecan;0.Vincristine;7.Vincristine;7.Vincristine;7.Cyclophosphamide;0.Dactinomycin;0.Vincristine;21.Irinotecan;0.Vincristine;7.Vincristine;14.Cyclophosphamide;0.Dactinomycin;0.Vincristine;","0.Irinotecan;0.Vincristine;7.Vincristine;7.Vincristine;7.Cyclophosphamide;0.Dactinomycin;0.Vincristine;21.Irinotecan;0.Vincristine;7.Vincristine;14.Cyclophosphamide;0.Dactinomycin;0.Vincristine;"
"2035","185.95.2565.1","Pediatric Neoplasms ","Pediatric solid tumors","Rhabdomyosarcoma, pediatric",185,"Intermediate risk",95,"COG ARST1431 Protocol A (VAC/VI Only), Maintenance",TRUE,"Cont.","1.Cyclophosphamide;0.Vinorelbine;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Vinorelbine;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Vinorelbine;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Vinorelbine;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Vinorelbine;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Vinorelbine;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;","1.Cyclophosphamide;0.Vinorelbine;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Vinorelbine;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Vinorelbine;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;"
"2036","185.95.2566.1","Pediatric Neoplasms ","Pediatric solid tumors","Rhabdomyosarcoma, pediatric",185,"Intermediate risk",95,"COG ARST1431 Protocol B (VAC/VI & Temsirolimus), Part 1",FALSE,"1","0.Cyclophosphamide;0.Dactinomycin;0.Temsirolimus;0.Vincristine;7.Cyclophosphamide;0.Dactinomycin;0.Temsirolimus;0.Vincristine;7.Cyclophosphamide;0.Dactinomycin;0.Temsirolimus;0.Vincristine;7.Cyclophosphamide;0.Dactinomycin;0.Temsirolimus;0.Vincristine;7.Cyclophosphamide;0.Dactinomycin;0.Irinotecan;0.Temsirolimus;0.Vincristine;7.Cyclophosphamide;0.Dactinomycin;0.Temsirolimus;0.Vincristine;7.Cyclophosphamide;0.Dactinomycin;0.Temsirolimus;0.Vincristine;7.Temsirolimus;0.Vincristine;7.Temsirolimus;0.Vincristine;7.Temsirolimus;0.Vincristine;7.Irinotecan;0.Temsirolimus;0.Vincristine;7.Temsirolimus;0.Vincristine;","0.Cyclophosphamide;0.Dactinomycin;0.Temsirolimus;0.Vincristine;7.Cyclophosphamide;0.Dactinomycin;0.Temsirolimus;0.Vincristine;7.Cyclophosphamide;0.Dactinomycin;0.Temsirolimus;0.Vincristine;7.Cyclophosphamide;0.Dactinomycin;0.Temsirolimus;0.Vincristine;7.Cyclophosphamide;0.Dactinomycin;0.Irinotecan;0.Temsirolimus;0.Vincristine;7.Cyclophosphamide;0.Dactinomycin;0.Temsirolimus;0.Vincristine;7.Cyclophosphamide;0.Dactinomycin;0.Temsirolimus;0.Vincristine;7.Temsirolimus;0.Vincristine;7.Temsirolimus;0.Vincristine;7.Temsirolimus;0.Vincristine;7.Irinotecan;0.Temsirolimus;0.Vincristine;7.Temsirolimus;0.Vincristine;"
"2037","185.95.2567.1","Pediatric Neoplasms ","Pediatric solid tumors","Rhabdomyosarcoma, pediatric",185,"Intermediate risk",95,"COG ARST1431 Protocol B (VAC/VI & Temsirolimus), Part 2",FALSE,"1","0.Cyclophosphamide;0.Dactinomycin;0.Vincristine;21.Vincristine;7.Irinotecan;0.Vincristine;14.Vincristine;7.Irinotecan;0.Vincristine;7.Vincristine;14.Cyclophosphamide;0.Dactinomycin;0.Temsirolimus;0.Vincristine;7.Temsirolimus;0.Vincristine;7.Temsirolimus;0.Vincristine;7.Irinotecan;0.Temsirolimus;0.Vincristine;7.Temsirolimus;0.Vincristine;7.Temsirolimus;0.Vincristine;7.Temsirolimus;7.Cyclophosphamide;0.Dactinomycin;0.Temsirolimus;0.Vincristine;7.Temsirolimus;7.Temsirolimus;","0.Cyclophosphamide;0.Dactinomycin;0.Vincristine;21.Vincristine;7.Irinotecan;0.Vincristine;14.Vincristine;7.Irinotecan;0.Vincristine;7.Vincristine;14.Cyclophosphamide;0.Dactinomycin;0.Temsirolimus;0.Vincristine;7.Temsirolimus;0.Vincristine;7.Temsirolimus;0.Vincristine;7.Irinotecan;0.Temsirolimus;0.Vincristine;7.Temsirolimus;0.Vincristine;7.Temsirolimus;0.Vincristine;7.Temsirolimus;7.Cyclophosphamide;0.Dactinomycin;0.Temsirolimus;0.Vincristine;7.Temsirolimus;7.Temsirolimus;"
"2038","185.95.2568.1","Pediatric Neoplasms ","Pediatric solid tumors","Rhabdomyosarcoma, pediatric",185,"Intermediate risk",95,"COG ARST1431 Protocol B (VAC/VI & Temsirolimus), Part 3",FALSE,"1","0.Irinotecan;0.Temsirolimus;0.Vincristine;7.Temsirolimus;0.Vincristine;7.Temsirolimus;0.Vincristine;7.Temsirolimus;0.Vincristine;7.Cyclophosphamide;0.Dactinomycin;0.Temsirolimus;7.Temsirolimus;6.Vincristine;1.Temsirolimus;6.Vincristine;1.Irinotecan;0.Temsirolimus;7.Temsirolimus;7.Temsirolimus;7.Cyclophosphamide;0.Dactinomycin;0.Temsirolimus;0.Vincristine;7.Temsirolimus;","0.Irinotecan;0.Temsirolimus;0.Vincristine;7.Temsirolimus;0.Vincristine;7.Temsirolimus;0.Vincristine;7.Temsirolimus;0.Vincristine;7.Cyclophosphamide;0.Dactinomycin;0.Temsirolimus;7.Temsirolimus;6.Vincristine;1.Temsirolimus;6.Vincristine;1.Irinotecan;0.Temsirolimus;7.Temsirolimus;7.Temsirolimus;7.Cyclophosphamide;0.Dactinomycin;0.Temsirolimus;0.Vincristine;7.Temsirolimus;"
"2039","185.95.2569.1","Pediatric Neoplasms ","Pediatric solid tumors","Rhabdomyosarcoma, pediatric",185,"Intermediate risk",95,"COG ARST1431 Protocol B (VAC/VI & Temsirolimus), Maintenance",TRUE,"Cont.","1.Cyclophosphamide;0.Vinorelbine;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Vinorelbine;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Vinorelbine;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Vinorelbine;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Vinorelbine;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Vinorelbine;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;","1.Cyclophosphamide;0.Vinorelbine;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Vinorelbine;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Vinorelbine;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;"
"2040","185.95.2570.1","Pediatric Neoplasms ","Pediatric solid tumors","Rhabdomyosarcoma, pediatric",185,"Intermediate risk",95,"COG ARST0531 VAC Arm",NA,NA,"0.Cyclophosphamide;0.Dactinomycin;0.Vincristine;7.Vincristine;7.Vincristine;7.Cyclophosphamide;0.Dactinomycin;0.Vincristine;7.Vincristine;7.Vincristine;7.Cyclophosphamide;0.Vincristine;7.Vincristine;7.Vincristine;","0.Cyclophosphamide;0.Dactinomycin;0.Vincristine;7.Vincristine;7.Vincristine;7.Cyclophosphamide;0.Dactinomycin;0.Vincristine;7.Vincristine;7.Vincristine;7.Cyclophosphamide;0.Vincristine;7.Vincristine;7.Vincristine;"
"2041","186.31.2573.1","Pediatric Neoplasms ","Pediatric solid tumors","Wilms tumor",186,"All lines of therapy",31,"Dactinomycin monotherapy",TRUE,"Cont.","38.Dactinomycin;1.Dactinomycin;1.Dactinomycin;1.Dactinomycin;1.Dactinomycin;38.Dactinomycin;1.Dactinomycin;1.Dactinomycin;1.Dactinomycin;1.Dactinomycin;","38.Dactinomycin;1.Dactinomycin;1.Dactinomycin;1.Dactinomycin;1.Dactinomycin;"
"2042","186.31.2573.2","Pediatric Neoplasms ","Pediatric solid tumors","Wilms tumor",186,"All lines of therapy",31,"Dactinomycin monotherapy",TRUE,"Cont.","80.Dactinomycin;1.Dactinomycin;1.Dactinomycin;1.Dactinomycin;1.Dactinomycin;80.Dactinomycin;1.Dactinomycin;1.Dactinomycin;1.Dactinomycin;1.Dactinomycin;","80.Dactinomycin;1.Dactinomycin;1.Dactinomycin;1.Dactinomycin;1.Dactinomycin;"
"2043","186.31.2574.1","Pediatric Neoplasms ","Pediatric solid tumors","Wilms tumor",186,"All lines of therapy",31,"Dactinomycin & Vincristine",NA,NA,"0.Vincristine;7.Vincristine;7.Vincristine;7.Vincristine;7.Dactinomycin;0.Vincristine;7.Vincristine;7.Vincristine;7.Dactinomycin;0.Vincristine;","0.Vincristine;7.Vincristine;7.Vincristine;7.Vincristine;7.Dactinomycin;0.Vincristine;7.Vincristine;7.Vincristine;7.Dactinomycin;0.Vincristine;"
"2044","186.31.2575.1","Pediatric Neoplasms ","Pediatric solid tumors","Wilms tumor",186,"All lines of therapy",31,"Vincristine monotherapy",TRUE,"Cont.","21.Vincristine;21.Vincristine;","21.Vincristine;21.Vincristine;"
"2045","19.31.415.1","Solid Tumor","Endocrine oncology","Pheochromocytoma",19,"All lines of therapy",31,"Cyclophosphamide, Dacarbazine, Vincristine",TRUE,"Cont.","20.Cyclophosphamide;0.Dacarbazine;0.Vincristine;1.Dacarbazine;20.Cyclophosphamide;0.Dacarbazine;0.Vincristine;1.Dacarbazine;","20.Cyclophosphamide;0.Dacarbazine;0.Vincristine;1.Dacarbazine;"
"2046","19.31.416.1","Solid Tumor","Endocrine oncology","Pheochromocytoma",19,"All lines of therapy",31,"131I-Metaiodobenzylguanidine (131I-MIBG)",TRUE,"Cont.","84.131I-Metaiodobenzylguanidine;84.131I-Metaiodobenzylguanidine;","84.131I-Metaiodobenzylguanidine;84.131I-Metaiodobenzylguanidine;"
"2047","2.127.167.1","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Metastatic disease, first-line therapy",127,"Abemaciclib & Anastrozole",TRUE,"Cont.","1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;1.Abemaciclib;0.Anastrozole;","1.Abemaciclib;0.Anastrozole;"
"2048","2.127.168.1","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Metastatic disease, first-line therapy",127,"Abemaciclib & Letrozole",TRUE,"Cont.","1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;1.Abemaciclib;0.Letrozole;","1.Abemaciclib;0.Letrozole;"
"2049","2.127.169.1","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Metastatic disease, first-line therapy",127,"Anastrozole monotherapy",TRUE,"Cont.","1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;","1.Anastrozole;1.Anastrozole;"
"2050","2.127.170.1","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Metastatic disease, first-line therapy",127,"Anastrozole & Fulvestrant",TRUE,"Cont.","1.Anastrozole;0.Fulvestrant;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;0.Fulvestrant;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;0.Fulvestrant;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;0.Fulvestrant;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;","1.Anastrozole;0.Fulvestrant;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;"
"2051","2.127.170.2","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Metastatic disease, first-line therapy",127,"Anastrozole & Fulvestrant",TRUE,"Cont.","1.Anastrozole;0.Fulvestrant;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;0.Fulvestrant;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;","1.Anastrozole;0.Fulvestrant;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;"
"2052","2.127.171.1","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Metastatic disease, first-line therapy",127,"Exemestane monotherapy",TRUE,"Cont.","1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;","1.Exemestane;1.Exemestane;"
"2053","2.127.172.1","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Metastatic disease, first-line therapy",127,"Fulvestrant monotherapy",TRUE,"Cont.","28.Fulvestrant;28.Fulvestrant;","28.Fulvestrant;28.Fulvestrant;"
"2054","2.127.172.2","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Metastatic disease, first-line therapy",127,"Fulvestrant monotherapy",TRUE,"Cont.","14.Fulvestrant;14.Fulvestrant;14.Fulvestrant;14.Fulvestrant;","14.Fulvestrant;14.Fulvestrant;"
"2055","2.127.173.1","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Metastatic disease, first-line therapy",127,"Fulvestrant & Ribociclib",TRUE,"Cont.","8.Fulvestrant;0.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Fulvestrant;0.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;8.Fulvestrant;0.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Fulvestrant;0.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;","8.Fulvestrant;0.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Fulvestrant;0.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;"
"2056","2.127.173.2","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Metastatic disease, first-line therapy",127,"Fulvestrant & Ribociclib",TRUE,"Cont.","8.Fulvestrant;0.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;8.Fulvestrant;0.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;","8.Fulvestrant;0.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;"
"2057","2.127.174.1","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Metastatic disease, first-line therapy",127,"Letrozole & Bevacizumab",TRUE,"Cont.","1.Bevacizumab;0.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Bevacizumab;0.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;","1.Bevacizumab;0.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;"
"2058","2.127.175.1","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Metastatic disease, first-line therapy",127,"Letrozole & Palbociclib",TRUE,"Cont.","1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;","1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;0.Palbociclib;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;"
"2059","2.127.176.1","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Metastatic disease, first-line therapy",127,"Letrozole & Ribociclib",TRUE,"Cont.","1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;","1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;"
"2060","2.129.177.1","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Metastatic disease, maintenance after first-line therapy",129,"Abemaciclib monotherapy",TRUE,"Cont.","1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;","1.Abemaciclib;1.Abemaciclib;"
"2061","2.129.178.1","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Metastatic disease, maintenance after first-line therapy",129,"Abemaciclib & Fulvestrant",TRUE,"Cont.","1.Abemaciclib;0.Fulvestrant;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;0.Fulvestrant;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;0.Fulvestrant;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;0.Fulvestrant;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;","1.Abemaciclib;0.Fulvestrant;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;"
"2062","2.129.178.2","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Metastatic disease, maintenance after first-line therapy",129,"Abemaciclib & Fulvestrant",TRUE,"Cont.","1.Abemaciclib;0.Fulvestrant;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;0.Fulvestrant;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;","1.Abemaciclib;0.Fulvestrant;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;1.Abemaciclib;"
"2063","2.129.179.1","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Metastatic disease, maintenance after first-line therapy",129,"Capecitabine & Fulvestrant",TRUE,"Cont.","1.Capecitabine;0.Fulvestrant;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Fulvestrant;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Fulvestrant;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Fulvestrant;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","1.Capecitabine;0.Fulvestrant;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2064","2.129.179.2","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Metastatic disease, maintenance after first-line therapy",129,"Capecitabine & Fulvestrant",TRUE,"Cont.","1.Capecitabine;0.Fulvestrant;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Fulvestrant;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","1.Capecitabine;0.Fulvestrant;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2065","2.129.180.1","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Metastatic disease, maintenance after first-line therapy",129,"Elacestrant monotherapy",TRUE,"Cont.","1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;1.Elacestrant;","1.Elacestrant;1.Elacestrant;"
"2066","2.129.181.1","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Metastatic disease, maintenance after first-line therapy",129,"Everolimus & Exemestane",TRUE,"Cont.","1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;1.Everolimus;0.Exemestane;","1.Everolimus;0.Exemestane;"
"2067","2.129.182.1","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Metastatic disease, maintenance after first-line therapy",129,"Everolimus & Tamoxifen",TRUE,"Cont.","1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;1.Everolimus;0.Tamoxifen;","1.Everolimus;0.Tamoxifen;"
"2068","2.129.183.1","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Metastatic disease, maintenance after first-line therapy",129,"Exemestane & Tucidinostat",TRUE,"Cont.","1.Chidamide;0.Exemestane;1.Exemestane;1.Exemestane;1.Chidamide;0.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Chidamide;0.Exemestane;1.Exemestane;1.Exemestane;1.Chidamide;0.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Chidamide;0.Exemestane;1.Exemestane;1.Exemestane;1.Chidamide;0.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Chidamide;0.Exemestane;1.Exemestane;1.Exemestane;1.Chidamide;0.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Chidamide;0.Exemestane;1.Exemestane;1.Exemestane;1.Chidamide;0.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Chidamide;0.Exemestane;1.Exemestane;1.Exemestane;1.Chidamide;0.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Chidamide;0.Exemestane;1.Exemestane;1.Exemestane;1.Chidamide;0.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Chidamide;0.Exemestane;1.Exemestane;1.Exemestane;1.Chidamide;0.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;","1.Chidamide;0.Exemestane;1.Exemestane;1.Exemestane;1.Chidamide;0.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;"
"2069","2.129.184.1","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Metastatic disease, maintenance after first-line therapy",129,"Fulvestrant & Palbociclib",TRUE,"Cont.","8.Fulvestrant;0.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Fulvestrant;0.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;8.Fulvestrant;0.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Fulvestrant;0.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;","8.Fulvestrant;0.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Fulvestrant;0.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;"
"2070","2.129.184.2","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Metastatic disease, maintenance after first-line therapy",129,"Fulvestrant & Palbociclib",TRUE,"Cont.","8.Fulvestrant;0.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;8.Fulvestrant;0.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;","8.Fulvestrant;0.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;1.Palbociclib;"
"2071","2.129.185.1","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Metastatic disease, maintenance after first-line therapy",129,"Fulvestrant & Ribociclib",TRUE,"Cont.","8.Fulvestrant;0.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Fulvestrant;0.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;8.Fulvestrant;0.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Fulvestrant;0.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;","8.Fulvestrant;0.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Fulvestrant;0.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;"
"2072","2.129.185.2","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Metastatic disease, maintenance after first-line therapy",129,"Fulvestrant & Ribociclib",TRUE,"Cont.","8.Fulvestrant;0.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;8.Fulvestrant;0.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;","8.Fulvestrant;0.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;1.Ribociclib;"
"2073","2.149.147.1","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Neoadjuvant endocrine therapy, postmenopausal",149,"Anastrozole monotherapy",FALSE,"16","1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;","1.Anastrozole;1.Anastrozole;"
"2074","2.150.144.1","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Neoadjuvant endocrine therapy, premenopausal",150,"Anastrozole & Goserelin",FALSE,"6","1.Anastrozole;0.Goserelin;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;0.Goserelin;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;","1.Anastrozole;0.Goserelin;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;"
"2075","2.150.145.1","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Neoadjuvant endocrine therapy, premenopausal",150,"Anastrozole, Goserelin, Palbociclib",NA,NA,"0.Anastrozole;0.Goserelin;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;22.Anastrozole;0.Goserelin;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;22.Anastrozole;0.Goserelin;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;22.Anastrozole;0.Goserelin;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;22.Anastrozole;0.Goserelin;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;","0.Anastrozole;0.Goserelin;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;22.Anastrozole;0.Goserelin;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;22.Anastrozole;0.Goserelin;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;22.Anastrozole;0.Goserelin;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;22.Anastrozole;0.Goserelin;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;"
"2076","2.150.146.1","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Neoadjuvant endocrine therapy, premenopausal",150,"Goserelin & Tamoxifen",FALSE,"6","1.Goserelin;0.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Goserelin;0.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;","1.Goserelin;0.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;"
"2077","2.150.147.2","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Neoadjuvant endocrine therapy, premenopausal",150,"Anastrozole monotherapy",FALSE,"17","1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;","1.Anastrozole;1.Anastrozole;"
"2078","2.150.147.3","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Neoadjuvant endocrine therapy, premenopausal",150,"Anastrozole monotherapy",FALSE,"18","1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;","1.Anastrozole;1.Anastrozole;"
"2079","2.150.148.1","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Neoadjuvant endocrine therapy, premenopausal",150,"Anastrozole & Palbociclib",NA,NA,"0.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;22.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;22.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;22.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;22.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;","0.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;22.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;22.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;22.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;22.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;1.Anastrozole;0.Palbociclib;"
"2080","2.150.149.1","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Neoadjuvant endocrine therapy, premenopausal",150,"Exemestane monotherapy",FALSE,"3","1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;","1.Exemestane;1.Exemestane;"
"2081","2.150.150.1","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Neoadjuvant endocrine therapy, premenopausal",150,"Letrozole monotherapy",FALSE,"4","1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;","1.Letrozole;1.Letrozole;"
"2082","2.4.157.1","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Adjuvant therapy",4,"Anastrozole monotherapy",TRUE,"Cont.","1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;","1.Anastrozole;1.Anastrozole;"
"2083","2.4.158.1","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Adjuvant therapy",4,"Exemestane monotherapy",TRUE,"Cont.","1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;","1.Exemestane;1.Exemestane;"
"2084","2.4.159.1","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Adjuvant therapy",4,"Letrozole monotherapy",TRUE,"Cont.","1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;","1.Letrozole;1.Letrozole;"
"2085","2.4.160.1","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Adjuvant therapy",4,"Toremifene monotherapy",TRUE,"Cont.","1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;1.Toremifene;","1.Toremifene;1.Toremifene;"
"2086","2.4.161.1","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Adjuvant therapy",4,"Anastrozole & Goserelin",TRUE,"Cont.","1.Anastrozole;0.Goserelin;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;0.Goserelin;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;","1.Anastrozole;0.Goserelin;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;"
"2087","2.4.162.1","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Adjuvant therapy",4,"Anastrozole, Goserelin, Ribociclib",TRUE,"Cont.","1.Anastrozole;0.Goserelin;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;0.Goserelin;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;","1.Anastrozole;0.Goserelin;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;0.Ribociclib;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;"
"2088","2.4.163.1","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Adjuvant therapy",4,"Goserelin & Letrozole",TRUE,"Cont.","1.Goserelin;0.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Goserelin;0.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;","1.Goserelin;0.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;"
"2089","2.4.164.1","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Adjuvant therapy",4,"Goserelin, Letrozole, Ribociclib",TRUE,"Cont.","1.Goserelin;0.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Goserelin;0.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;","1.Goserelin;0.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;0.Ribociclib;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;"
"2090","2.4.165.1","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Adjuvant therapy",4,"Goserelin, Ribociclib, Tamoxifen",TRUE,"Cont.","1.Goserelin;0.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Goserelin;0.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;","1.Goserelin;0.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Ribociclib;0.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;"
"2091","2.4.166.1","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Adjuvant therapy",4,"Goserelin & Tamoxifen",TRUE,"Cont.","1.Goserelin;0.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Goserelin;0.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;","1.Goserelin;0.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;"
"2092","2.8.151.1","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Adjuvant therapy, premenopausal",8,"Exemestane & OFS",TRUE,"Cont.","1.Exemestane;0.Triptorelin;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;0.Triptorelin;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;","1.Exemestane;0.Triptorelin;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;"
"2093","2.8.152.1","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Adjuvant therapy, premenopausal",8,"Goserelin monotherapy",TRUE,"Cont.","28.Goserelin;28.Goserelin;","28.Goserelin;28.Goserelin;"
"2094","2.8.153.1","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Adjuvant therapy, premenopausal",8,"Goserelin & Tamoxifen",TRUE,"Cont.","1.Goserelin;0.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Goserelin;0.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;","1.Goserelin;0.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;"
"2095","2.8.154.1","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Adjuvant therapy, premenopausal",8,"Leuprolide monotherapy",TRUE,"Cont.","84.Leuprolide;84.Leuprolide;","84.Leuprolide;84.Leuprolide;"
"2096","2.8.155.1","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Adjuvant therapy, premenopausal",8,"Tamoxifen monotherapy",TRUE,"Cont.","1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;","1.Tamoxifen;1.Tamoxifen;"
"2097","2.8.156.1","Solid Tumor","Breast Oncology","Breast cancer, ER-positive",2,"Adjuvant therapy, premenopausal",8,"Tamoxifen & OFS",TRUE,"Cont.","1.Goserelin;0.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Goserelin;0.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;","1.Goserelin;0.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;"
"2098","20.13.417.1","Solid Tumor","Endocrine oncology","Thyroid cancer",20,"Advanced or metastatic disease",13,"Axitinib monotherapy",TRUE,"Cont.","1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;","1.Axitinib;1.Axitinib;"
"2099","20.13.418.1","Solid Tumor","Endocrine oncology","Thyroid cancer",20,"Advanced or metastatic disease",13,"Sorafenib monotherapy",TRUE,"Cont.","1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;","1.Sorafenib;1.Sorafenib;"
"2100","21.13.423.1","Solid Tumor","Endocrine oncology","Thyroid cancer, differentiated",21,"Advanced or metastatic disease",13,"Apatinib monotherapy",TRUE,"Cont.","1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;","1.Apatinib;1.Apatinib;"
"2101","21.31.419.1","Solid Tumor","Endocrine oncology","Thyroid cancer, differentiated",21,"All lines of therapy",31,"Cabozantinib monotherapy",TRUE,"Cont.","1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;","1.Cabozantinib;1.Cabozantinib;"
"2102","21.31.420.1","Solid Tumor","Endocrine oncology","Thyroid cancer, differentiated",21,"All lines of therapy",31,"Lenvatinib monotherapy",TRUE,"Cont.","1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;","1.Lenvatinib;1.Lenvatinib;"
"2103","21.31.421.1","Solid Tumor","Endocrine oncology","Thyroid cancer, differentiated",21,"All lines of therapy",31,"Pazopanib monotherapy",TRUE,"Cont.","1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;","1.Pazopanib;1.Pazopanib;"
"2104","21.31.422.1","Solid Tumor","Endocrine oncology","Thyroid cancer, differentiated",21,"All lines of therapy",31,"Vandetanib monotherapy",TRUE,"Cont.","1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;","1.Vandetanib;1.Vandetanib;"
"2105","23.13.424.1","Solid Tumor","Endocrine oncology","Thyroid cancer, BRAF-mutated",23,"Advanced or metastatic disease",13,"Vemurafenib monotherapy",TRUE,"Cont.","1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;","1.Vemurafenib;1.Vemurafenib;"
"2106","23.13.425.1","Solid Tumor","Endocrine oncology","Thyroid cancer, BRAF-mutated",23,"Advanced or metastatic disease",13,"Dabrafenib & Trametinib",TRUE,"Cont.","1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;","1.Dabrafenib;0.Trametinib;"
"2107","24.13.426.1","Solid Tumor","Endocrine oncology","Thyroid cancer, RET-positive",24,"Advanced or metastatic disease",13,"Pralsetinib monotherapy",TRUE,"Cont.","1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;","1.Pralsetinib;1.Pralsetinib;"
"2108","24.13.427.1","Solid Tumor","Endocrine oncology","Thyroid cancer, RET-positive",24,"Advanced or metastatic disease",13,"Selpercatinib monotherapy",TRUE,"Cont.","1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;","1.Selpercatinib;1.Selpercatinib;"
"2109","25.127.431.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Anal cancer",25,"Metastatic disease, first-line therapy",127,"Cisplatin & Fluorouracil (CF) & RT",TRUE,"Cont.","27.Fluorouracil;1.Cisplatin;27.Fluorouracil;1.Cisplatin;","27.Fluorouracil;1.Cisplatin;"
"2110","25.127.431.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Anal cancer",25,"Metastatic disease, first-line therapy",127,"Cisplatin & Fluorouracil (CF) & RT",TRUE,"Cont.","21.Cisplatin;0.Fluorouracil;21.Cisplatin;0.Fluorouracil;","21.Cisplatin;0.Fluorouracil;"
"2111","25.127.431.3","Solid Tumor","Gastrointestinal Oncology, Intestinal","Anal cancer",25,"Metastatic disease, first-line therapy",127,"Cisplatin & Fluorouracil (CF) & RT",TRUE,"Cont.","23.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;23.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","23.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2112","25.127.431.4","Solid Tumor","Gastrointestinal Oncology, Intestinal","Anal cancer",25,"Metastatic disease, first-line therapy",127,"Cisplatin & Fluorouracil (CF) & RT",TRUE,"Cont.","16.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;16.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","16.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2113","25.127.432.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Anal cancer",25,"Metastatic disease, first-line therapy",127,"Carboplatin & Paclitaxel (CP)",TRUE,"Cont.","14.Carboplatin;0.Paclitaxel;7.Paclitaxel;7.Paclitaxel;14.Carboplatin;0.Paclitaxel;7.Paclitaxel;7.Paclitaxel;","14.Carboplatin;0.Paclitaxel;7.Paclitaxel;7.Paclitaxel;"
"2114","25.127.433.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Anal cancer",25,"Metastatic disease, first-line therapy",127,"mDCF",FALSE,"8","14.Cisplatin;0.Docetaxel;0.Fluorouracil;14.Cisplatin;0.Docetaxel;0.Fluorouracil;","14.Cisplatin;0.Docetaxel;0.Fluorouracil;"
"2115","25.127.433.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Anal cancer",25,"Metastatic disease, first-line therapy",127,"mDCF",FALSE,"8","13.Cisplatin;0.Docetaxel;0.Fluorouracil;1.Fluorouracil;13.Cisplatin;0.Docetaxel;0.Fluorouracil;1.Fluorouracil;","13.Cisplatin;0.Docetaxel;0.Fluorouracil;1.Fluorouracil;"
"2116","25.133.434.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Anal cancer",25,"Metastatic disease, subsequent lines of therapy",133,"Nivolumab monotherapy",TRUE,"Cont.","14.Nivolumab;0.Pembrolizumab;14.Nivolumab;0.Pembrolizumab;","14.Nivolumab;0.Pembrolizumab;"
"2117","25.52.428.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Anal cancer",25,"Definitive chemoradiotherapy for locally advanced disease",52,"Capecitabine, Mitomycin, RT",FALSE,"1","0.Capecitabine;0.Mitomycin;1.Capecitabine;2.Capecitabine;1.Capecitabine;2.Capecitabine;1.Capecitabine;2.Capecitabine;1.Capecitabine;2.Capecitabine;1.Capecitabine;2.Capecitabine;1.Capecitabine;2.Capecitabine;1.Capecitabine;2.Capecitabine;1.Capecitabine;2.Capecitabine;1.Capecitabine;2.Capecitabine;1.Capecitabine;2.Capecitabine;1.Capecitabine;2.Capecitabine;1.Capecitabine;2.Capecitabine;1.Capecitabine;2.Capecitabine;1.Capecitabine;","0.Capecitabine;0.Mitomycin;1.Capecitabine;2.Capecitabine;1.Capecitabine;2.Capecitabine;1.Capecitabine;2.Capecitabine;1.Capecitabine;2.Capecitabine;1.Capecitabine;2.Capecitabine;1.Capecitabine;2.Capecitabine;1.Capecitabine;2.Capecitabine;1.Capecitabine;2.Capecitabine;1.Capecitabine;2.Capecitabine;1.Capecitabine;2.Capecitabine;1.Capecitabine;2.Capecitabine;1.Capecitabine;2.Capecitabine;1.Capecitabine;2.Capecitabine;1.Capecitabine;"
"2118","25.52.429.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Anal cancer",25,"Definitive chemoradiotherapy for locally advanced disease",52,"Cisplatin & Fluorouracil (CF) & RT",FALSE,"1","0.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;25.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","0.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;25.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2119","25.52.430.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Anal cancer",25,"Definitive chemoradiotherapy for locally advanced disease",52,"Fluorouracil, Mitomycin, RT",FALSE,"2","28.Fluorouracil;0.Mitomycin;","28.Fluorouracil;0.Mitomycin;"
"2120","25.52.430.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Anal cancer",25,"Definitive chemoradiotherapy for locally advanced disease",52,"Fluorouracil, Mitomycin, RT",FALSE,"2","23.Fluorouracil;0.Mitomycin;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","23.Fluorouracil;0.Mitomycin;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2121","27.4.435.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colon cancer",27,"Adjuvant therapy",4,"Capecitabine monotherapy",FALSE,"8","8.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2122","27.4.436.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colon cancer",27,"Adjuvant therapy",4,"CapeOx",FALSE,"4","8.Capecitabine;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Capecitabine;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Capecitabine;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2123","27.4.436.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colon cancer",27,"Adjuvant therapy",4,"CapeOx",FALSE,"8","8.Capecitabine;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Capecitabine;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Capecitabine;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2124","27.4.437.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colon cancer",27,"Adjuvant therapy",4,"FLOX",FALSE,"3","21.Fluorouracil;0.Oxaliplatin;7.Fluorouracil;7.Fluorouracil;0.Oxaliplatin;7.Fluorouracil;7.Fluorouracil;0.Oxaliplatin;7.Fluorouracil;21.Fluorouracil;0.Oxaliplatin;7.Fluorouracil;7.Fluorouracil;0.Oxaliplatin;7.Fluorouracil;7.Fluorouracil;0.Oxaliplatin;7.Fluorouracil;","21.Fluorouracil;0.Oxaliplatin;7.Fluorouracil;7.Fluorouracil;0.Oxaliplatin;7.Fluorouracil;7.Fluorouracil;0.Oxaliplatin;7.Fluorouracil;"
"2125","27.4.438.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colon cancer",27,"Adjuvant therapy",4,"FOLFOX4",FALSE,"12","13.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;13.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;","13.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;"
"2126","27.4.439.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colon cancer",27,"Adjuvant therapy",4,"mFOLFOX6",FALSE,"12","14.Fluorouracil;0.Oxaliplatin;14.Fluorouracil;0.Oxaliplatin;","14.Fluorouracil;0.Oxaliplatin;"
"2127","27.4.439.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colon cancer",27,"Adjuvant therapy",4,"mFOLFOX6",FALSE,"12","12.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;","12.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;"
"2128","27.4.440.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colon cancer",27,"Adjuvant therapy",4,"mFOLFOX6 (L-Leucovorin)",FALSE,"6","14.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;14.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;","14.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;"
"2129","27.4.440.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colon cancer",27,"Adjuvant therapy",4,"mFOLFOX6 (L-Leucovorin)",FALSE,"6","12.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;","12.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;"
"2130","27.4.441.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colon cancer",27,"Adjuvant therapy",4,"FULV",FALSE,"3","21.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;21.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;","21.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;"
"2131","27.4.441.10","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colon cancer",27,"Adjuvant therapy",4,"FULV",TRUE,"Cont.","12.Fluorouracil;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","12.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2132","27.4.441.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colon cancer",27,"Adjuvant therapy",4,"FULV",FALSE,"4","21.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;21.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;","21.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;"
"2133","27.4.441.3","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colon cancer",27,"Adjuvant therapy",4,"FULV",FALSE,"5","21.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;21.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;","21.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;"
"2134","27.4.441.4","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colon cancer",27,"Adjuvant therapy",4,"FULV",FALSE,"6","21.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;21.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;","21.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;"
"2135","27.4.441.5","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colon cancer",27,"Adjuvant therapy",4,"FULV",FALSE,"6","24.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;24.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","24.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2136","27.4.441.6","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colon cancer",27,"Adjuvant therapy",4,"FULV",FALSE,"12","13.Fluorouracil;1.Fluorouracil;13.Fluorouracil;1.Fluorouracil;","13.Fluorouracil;1.Fluorouracil;"
"2137","27.4.441.7","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colon cancer",27,"Adjuvant therapy",4,"FULV",NA,NA,"0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;24.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;24.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;24.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;31.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;31.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;24.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;24.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;24.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;31.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;31.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2138","27.4.441.8","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colon cancer",27,"Adjuvant therapy",4,"FULV",FALSE,"12","14.Fluorouracil;14.Fluorouracil;","14.Fluorouracil;14.Fluorouracil;"
"2139","27.4.441.9","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colon cancer",27,"Adjuvant therapy",4,"FULV",TRUE,"Cont.","14.Fluorouracil;14.Fluorouracil;","14.Fluorouracil;14.Fluorouracil;"
"2140","27.4.442.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colon cancer",27,"Adjuvant therapy",4,"SOX",FALSE,"8","8.Oxaliplatin;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;8.Oxaliplatin;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;","8.Oxaliplatin;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;"
"2141","28.4.443.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colon cancer, RAS wild-type",28,"Adjuvant therapy",4,"Tegafur, Uracil, Folinic acid",FALSE,"5","8.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;8.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;","8.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;"
"2142","28.4.444.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colon cancer, RAS wild-type",28,"Adjuvant therapy",4,"mFOLFOX6 & Cetuximab",FALSE,"12","7.Cetuximab;0.Fluorouracil;0.Oxaliplatin;7.Cetuximab;7.Cetuximab;0.Fluorouracil;0.Oxaliplatin;7.Cetuximab;","7.Cetuximab;0.Fluorouracil;0.Oxaliplatin;7.Cetuximab;"
"2143","29.114.490.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Maintenance after first-line therapy",114,"Bevacizumab monotherapy",TRUE,"Cont.","21.Bevacizumab;21.Bevacizumab;","21.Bevacizumab;21.Bevacizumab;"
"2144","29.114.491.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Maintenance after first-line therapy",114,"Capecitabine & Bevacizumab",TRUE,"Cont.","1.Bevacizumab;0.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Bevacizumab;0.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","1.Bevacizumab;0.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2145","29.114.492.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Maintenance after first-line therapy",114,"Fluorouracil & Bevacizumab",TRUE,"Cont.","14.Bevacizumab;0.Fluorouracil;14.Bevacizumab;0.Fluorouracil;","14.Bevacizumab;0.Fluorouracil;"
"2146","29.114.492.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Maintenance after first-line therapy",114,"Fluorouracil & Bevacizumab",TRUE,"Cont.","12.Bevacizumab;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;12.Bevacizumab;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","12.Bevacizumab;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2147","29.19.454.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"Capecitabine & Bevacizumab",TRUE,"Cont.","8.Bevacizumab;0.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Bevacizumab;0.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Bevacizumab;0.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2148","29.19.455.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"CapeOx",TRUE,"Cont.","8.Capecitabine;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Capecitabine;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Capecitabine;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2149","29.19.455.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"CapeOx",TRUE,"Cont.","8.Capecitabine;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Capecitabine;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Capecitabine;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2150","29.19.456.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"CapeOx & Bevacizumab",TRUE,"Cont.","8.Bevacizumab;0.Capecitabine;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Bevacizumab;0.Capecitabine;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Bevacizumab;0.Capecitabine;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2151","29.19.456.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"CapeOx & Bevacizumab",FALSE,"6","8.Bevacizumab;0.Capecitabine;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Bevacizumab;0.Capecitabine;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Bevacizumab;0.Capecitabine;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2152","29.19.457.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"CAPIRI",TRUE,"Cont.","8.Capecitabine;0.Irinotecan;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Capecitabine;0.Irinotecan;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Capecitabine;0.Irinotecan;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2153","29.19.458.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"CAPIRI-Bev",FALSE,"6","8.Bevacizumab;0.Bevacizumab;0.Capecitabine;0.Capecitabine;0.Irinotecan;0.Irinotecan;1.Capecitabine;0.Capecitabine;1.Capecitabine;0.Capecitabine;1.Capecitabine;0.Capecitabine;1.Capecitabine;0.Capecitabine;1.Capecitabine;0.Capecitabine;1.Capecitabine;0.Capecitabine;1.Capecitabine;0.Capecitabine;1.Capecitabine;0.Capecitabine;1.Capecitabine;0.Capecitabine;1.Capecitabine;0.Capecitabine;1.Capecitabine;0.Capecitabine;1.Capecitabine;0.Capecitabine;1.Capecitabine;0.Capecitabine;8.Bevacizumab;0.Bevacizumab;0.Capecitabine;0.Capecitabine;0.Irinotecan;0.Irinotecan;1.Capecitabine;0.Capecitabine;1.Capecitabine;0.Capecitabine;1.Capecitabine;0.Capecitabine;1.Capecitabine;0.Capecitabine;1.Capecitabine;0.Capecitabine;1.Capecitabine;0.Capecitabine;1.Capecitabine;0.Capecitabine;1.Capecitabine;0.Capecitabine;1.Capecitabine;0.Capecitabine;1.Capecitabine;0.Capecitabine;1.Capecitabine;0.Capecitabine;1.Capecitabine;0.Capecitabine;1.Capecitabine;0.Capecitabine;","8.Bevacizumab;0.Bevacizumab;0.Capecitabine;0.Capecitabine;0.Irinotecan;0.Irinotecan;1.Capecitabine;0.Capecitabine;1.Capecitabine;0.Capecitabine;1.Capecitabine;0.Capecitabine;1.Capecitabine;0.Capecitabine;1.Capecitabine;0.Capecitabine;1.Capecitabine;0.Capecitabine;1.Capecitabine;0.Capecitabine;1.Capecitabine;0.Capecitabine;1.Capecitabine;0.Capecitabine;1.Capecitabine;0.Capecitabine;1.Capecitabine;0.Capecitabine;1.Capecitabine;0.Capecitabine;1.Capecitabine;0.Capecitabine;"
"2154","29.19.460.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"FOLFIRI",TRUE,"Cont.","13.Fluorouracil;0.Irinotecan;1.Fluorouracil;13.Fluorouracil;0.Irinotecan;1.Fluorouracil;","13.Fluorouracil;0.Irinotecan;1.Fluorouracil;"
"2155","29.19.460.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"FOLFIRI",TRUE,"Cont.","14.Fluorouracil;0.Irinotecan;7.Fluorouracil;0.Irinotecan;7.Fluorouracil;0.Irinotecan;7.Fluorouracil;0.Irinotecan;7.Fluorouracil;0.Irinotecan;7.Fluorouracil;0.Irinotecan;14.Fluorouracil;0.Irinotecan;7.Fluorouracil;0.Irinotecan;7.Fluorouracil;0.Irinotecan;7.Fluorouracil;0.Irinotecan;7.Fluorouracil;0.Irinotecan;7.Fluorouracil;0.Irinotecan;","14.Fluorouracil;0.Irinotecan;7.Fluorouracil;0.Irinotecan;7.Fluorouracil;0.Irinotecan;7.Fluorouracil;0.Irinotecan;7.Fluorouracil;0.Irinotecan;7.Fluorouracil;0.Irinotecan;"
"2156","29.19.460.3","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"FOLFIRI",TRUE,"Cont.","7.Fluorouracil;0.Irinotecan;7.Fluorouracil;0.Irinotecan;","7.Fluorouracil;0.Irinotecan;"
"2157","29.19.461.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"FOLFIRI (L-Leucovorin)",TRUE,"Cont.","13.Fluorouracil;0.Irinotecan;0.Levoleucovorin;1.Fluorouracil;0.Levoleucovorin;13.Fluorouracil;0.Irinotecan;0.Levoleucovorin;1.Fluorouracil;0.Levoleucovorin;","13.Fluorouracil;0.Irinotecan;0.Levoleucovorin;1.Fluorouracil;0.Levoleucovorin;"
"2158","29.19.461.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"FOLFIRI (L-Leucovorin)",TRUE,"Cont.","12.Fluorouracil;0.Irinotecan;0.Levoleucovorin;1.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;12.Fluorouracil;0.Irinotecan;0.Levoleucovorin;1.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;","12.Fluorouracil;0.Irinotecan;0.Levoleucovorin;1.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;"
"2159","29.19.462.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"FOLFIRI & Bevacizumab",TRUE,"Cont.","14.Bevacizumab;0.Fluorouracil;0.Irinotecan;14.Bevacizumab;0.Fluorouracil;0.Irinotecan;","14.Bevacizumab;0.Fluorouracil;0.Irinotecan;"
"2160","29.19.462.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"FOLFIRI & Bevacizumab",TRUE,"Cont.","12.Bevacizumab;0.Fluorouracil;0.Irinotecan;1.Fluorouracil;1.Fluorouracil;12.Bevacizumab;0.Fluorouracil;0.Irinotecan;1.Fluorouracil;1.Fluorouracil;","12.Bevacizumab;0.Fluorouracil;0.Irinotecan;1.Fluorouracil;1.Fluorouracil;"
"2161","29.19.463.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"FOLFIRI & Bevacizumab (L-Leucovorin)",TRUE,"Cont.","14.Bevacizumab;0.Fluorouracil;0.Irinotecan;0.Levoleucovorin;14.Bevacizumab;0.Fluorouracil;0.Irinotecan;0.Levoleucovorin;","14.Bevacizumab;0.Fluorouracil;0.Irinotecan;0.Levoleucovorin;"
"2162","29.19.463.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"FOLFIRI & Bevacizumab (L-Leucovorin)",TRUE,"Cont.","12.Bevacizumab;0.Fluorouracil;0.Irinotecan;0.Levoleucovorin;1.Fluorouracil;1.Fluorouracil;12.Bevacizumab;0.Fluorouracil;0.Irinotecan;0.Levoleucovorin;1.Fluorouracil;1.Fluorouracil;","12.Bevacizumab;0.Fluorouracil;0.Irinotecan;0.Levoleucovorin;1.Fluorouracil;1.Fluorouracil;"
"2163","29.19.464.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"FOLFIRINOX",TRUE,"Cont.","14.Fluorouracil;0.Irinotecan;0.Oxaliplatin;14.Fluorouracil;0.Irinotecan;0.Oxaliplatin;","14.Fluorouracil;0.Irinotecan;0.Oxaliplatin;"
"2164","29.19.464.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"FOLFIRINOX",TRUE,"Cont.","12.Fluorouracil;0.Irinotecan;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Irinotecan;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;","12.Fluorouracil;0.Irinotecan;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;"
"2165","29.19.465.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"FOLFIRINOX & Bevacizumab",TRUE,"Cont.","14.Bevacizumab;0.Fluorouracil;0.Irinotecan;0.Oxaliplatin;14.Bevacizumab;0.Fluorouracil;0.Irinotecan;0.Oxaliplatin;","14.Bevacizumab;0.Fluorouracil;0.Irinotecan;0.Oxaliplatin;"
"2166","29.19.465.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"FOLFIRINOX & Bevacizumab",TRUE,"Cont.","12.Bevacizumab;0.Fluorouracil;0.Irinotecan;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Bevacizumab;0.Fluorouracil;0.Irinotecan;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;","12.Bevacizumab;0.Fluorouracil;0.Irinotecan;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;"
"2167","29.19.466.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"FOLFIRINOX & Bevacizumab (L-Leucovorin)",TRUE,"Cont.","14.Bevacizumab;0.Fluorouracil;0.Irinotecan;0.Levoleucovorin;0.Oxaliplatin;14.Bevacizumab;0.Fluorouracil;0.Irinotecan;0.Levoleucovorin;0.Oxaliplatin;","14.Bevacizumab;0.Fluorouracil;0.Irinotecan;0.Levoleucovorin;0.Oxaliplatin;"
"2168","29.19.466.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"FOLFIRINOX & Bevacizumab (L-Leucovorin)",TRUE,"Cont.","12.Bevacizumab;0.Fluorouracil;0.Irinotecan;0.Levoleucovorin;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Bevacizumab;0.Fluorouracil;0.Irinotecan;0.Levoleucovorin;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;","12.Bevacizumab;0.Fluorouracil;0.Irinotecan;0.Levoleucovorin;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;"
"2169","29.19.467.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"FOLFOX2",TRUE,"Cont.","13.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;13.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;","13.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;"
"2170","29.19.467.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"FOLFOX2",TRUE,"Cont.","12.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;","12.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;"
"2171","29.19.468.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"FOLFOX4 (L-Leucovorin)",TRUE,"Cont.","13.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;1.Fluorouracil;0.Levoleucovorin;13.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;1.Fluorouracil;0.Levoleucovorin;","13.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;1.Fluorouracil;0.Levoleucovorin;"
"2172","29.19.468.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"FOLFOX4 (L-Leucovorin)",TRUE,"Cont.","12.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;1.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;12.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;1.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;","12.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;1.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;"
"2173","29.19.469.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"FOLFOX 7/sLV5FU2",FALSE,"6","14.Fluorouracil;0.Fluorouracil;0.Oxaliplatin;14.Fluorouracil;0.Fluorouracil;0.Oxaliplatin;","14.Fluorouracil;0.Fluorouracil;0.Oxaliplatin;"
"2174","29.19.469.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"FOLFOX 7/sLV5FU2",FALSE,"6","12.Fluorouracil;0.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;","12.Fluorouracil;0.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;"
"2175","29.19.470.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"FOLFOX 7/sLV5FU2 (L-Leucovorin)",NA,NA,"0.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;14.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;14.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;14.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;14.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;14.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;14.Fluorouracil;0.Levoleucovorin;14.Fluorouracil;0.Levoleucovorin;14.Fluorouracil;0.Levoleucovorin;","0.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;14.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;14.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;14.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;14.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;14.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;14.Fluorouracil;0.Levoleucovorin;14.Fluorouracil;0.Levoleucovorin;14.Fluorouracil;0.Levoleucovorin;"
"2176","29.19.470.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"FOLFOX 7/sLV5FU2 (L-Leucovorin)",NA,NA,"0.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;1.Fluorouracil;","0.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;1.Fluorouracil;"
"2177","29.19.471.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"mFOLFOX7",FALSE,"6","14.Fluorouracil;0.Oxaliplatin;14.Fluorouracil;0.Oxaliplatin;","14.Fluorouracil;0.Oxaliplatin;"
"2178","29.19.471.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"mFOLFOX7",FALSE,"6","12.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;","12.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;"
"2179","29.19.472.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"mFOLFOX7 (L-Leucovorin)",FALSE,"6","14.Fluorouracil;0.Levoleucovorin;14.Fluorouracil;0.Levoleucovorin;","14.Fluorouracil;0.Levoleucovorin;"
"2180","29.19.472.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"mFOLFOX7 (L-Leucovorin)",FALSE,"6","12.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;1.Fluorouracil;","12.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;1.Fluorouracil;"
"2181","29.19.474.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"mFOLFOX6-B",FALSE,"9","14.Bevacizumab;0.Fluorouracil;0.Oxaliplatin;14.Bevacizumab;0.Fluorouracil;0.Oxaliplatin;","14.Bevacizumab;0.Fluorouracil;0.Oxaliplatin;"
"2182","29.19.474.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"mFOLFOX6-B",FALSE,"9","12.Bevacizumab;0.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Bevacizumab;0.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;","12.Bevacizumab;0.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;"
"2183","29.19.475.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"mFOLFOX6-B (L-Leucovorin)",TRUE,"Cont.","14.Bevacizumab;0.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;14.Bevacizumab;0.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;","14.Bevacizumab;0.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;"
"2184","29.19.475.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"mFOLFOX6-B (L-Leucovorin)",TRUE,"Cont.","12.Bevacizumab;0.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Bevacizumab;0.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;","12.Bevacizumab;0.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;"
"2185","29.19.476.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"FUIRI",TRUE,"Cont.","7.Fluorouracil;0.Irinotecan;7.Fluorouracil;0.Irinotecan;","7.Fluorouracil;0.Irinotecan;"
"2186","29.19.476.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"FUIRI",TRUE,"Cont.","5.Fluorouracil;0.Irinotecan;1.Fluorouracil;1.Fluorouracil;5.Fluorouracil;0.Irinotecan;1.Fluorouracil;1.Fluorouracil;","5.Fluorouracil;0.Irinotecan;1.Fluorouracil;1.Fluorouracil;"
"2187","29.19.477.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"FULV",TRUE,"Cont.","7.Fluorouracil;7.Fluorouracil;","7.Fluorouracil;7.Fluorouracil;"
"2188","29.19.478.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"FULV (L-Leucovorin)",TRUE,"Cont.","24.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;0.Levoleucovorin;24.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;0.Levoleucovorin;","24.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;0.Levoleucovorin;"
"2189","29.19.478.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"FULV (L-Leucovorin)",TRUE,"Cont.","17.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;0.Levoleucovorin;17.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;0.Levoleucovorin;","17.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;0.Levoleucovorin;"
"2190","29.19.478.3","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"FULV (L-Leucovorin)",TRUE,"Cont.","14.Fluorouracil;0.Levoleucovorin;14.Fluorouracil;0.Levoleucovorin;","14.Fluorouracil;0.Levoleucovorin;"
"2191","29.19.478.4","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"FULV (L-Leucovorin)",TRUE,"Cont.","12.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;1.Fluorouracil;","12.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;1.Fluorouracil;"
"2192","29.19.479.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"FUOX",TRUE,"Cont.","7.Fluorouracil;0.Oxaliplatin;7.Fluorouracil;7.Fluorouracil;0.Oxaliplatin;7.Fluorouracil;","7.Fluorouracil;0.Oxaliplatin;7.Fluorouracil;"
"2193","29.19.479.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"FUOX",TRUE,"Cont.","5.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;5.Fluorouracil;1.Fluorouracil;1.Fluorouracil;5.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;5.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","5.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;5.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2194","29.19.480.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"IFL",TRUE,"Cont.","21.Fluorouracil;0.Irinotecan;21.Fluorouracil;0.Irinotecan;","21.Fluorouracil;0.Irinotecan;"
"2195","29.19.480.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"IFL",TRUE,"Cont.","21.Fluorouracil;0.Irinotecan;7.Fluorouracil;0.Irinotecan;7.Fluorouracil;0.Irinotecan;7.Fluorouracil;0.Irinotecan;21.Fluorouracil;0.Irinotecan;7.Fluorouracil;0.Irinotecan;7.Fluorouracil;0.Irinotecan;7.Fluorouracil;0.Irinotecan;","21.Fluorouracil;0.Irinotecan;7.Fluorouracil;0.Irinotecan;7.Fluorouracil;0.Irinotecan;7.Fluorouracil;0.Irinotecan;"
"2196","29.19.481.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"IFL & Bevacizumab",TRUE,"Cont.","7.Bevacizumab;0.Bevacizumab;0.Fluorouracil;0.Fluorouracil;0.Irinotecan;0.Irinotecan;4.Bevacizumab;3.Fluorouracil;0.Fluorouracil;0.Irinotecan;0.Irinotecan;7.Fluorouracil;0.Irinotecan;7.Bevacizumab;0.Bevacizumab;0.Fluorouracil;0.Fluorouracil;0.Irinotecan;0.Irinotecan;4.Bevacizumab;3.Fluorouracil;0.Fluorouracil;0.Irinotecan;0.Irinotecan;7.Fluorouracil;0.Irinotecan;","7.Bevacizumab;0.Bevacizumab;0.Fluorouracil;0.Fluorouracil;0.Irinotecan;0.Irinotecan;4.Bevacizumab;3.Fluorouracil;0.Fluorouracil;0.Irinotecan;0.Irinotecan;7.Fluorouracil;0.Irinotecan;"
"2197","29.19.482.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"Irinotecan monotherapy",TRUE,"Cont.","21.Irinotecan;7.Irinotecan;7.Irinotecan;7.Irinotecan;21.Irinotecan;7.Irinotecan;7.Irinotecan;7.Irinotecan;","21.Irinotecan;7.Irinotecan;7.Irinotecan;7.Irinotecan;"
"2198","29.19.483.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"IRIS & Bevacizumab",TRUE,"Cont.","7.Bevacizumab;0.Irinotecan;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;7.Bevacizumab;0.Irinotecan;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;","7.Bevacizumab;0.Irinotecan;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;"
"2199","29.19.483.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"IRIS & Bevacizumab",TRUE,"Cont.","14.Bevacizumab;0.Irinotecan;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Bevacizumab;0.Irinotecan;0.Tegafur;0.gimeracil;0.oteracil;14.Bevacizumab;0.Irinotecan;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Bevacizumab;0.Irinotecan;0.Tegafur;0.gimeracil;0.oteracil;","14.Bevacizumab;0.Irinotecan;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Bevacizumab;0.Irinotecan;0.Tegafur;0.gimeracil;0.oteracil;"
"2200","29.19.484.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"IROX",TRUE,"Cont.","21.Irinotecan;0.Oxaliplatin;21.Irinotecan;0.Oxaliplatin;","21.Irinotecan;0.Oxaliplatin;"
"2201","29.19.485.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"Nordic FLOX",FALSE,"8","13.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;13.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;","13.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;"
"2202","29.19.485.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"Nordic FLOX",TRUE,"Cont.","13.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;13.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;","13.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;"
"2203","29.19.486.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"OXAFAFU",TRUE,"Cont.","13.Oxaliplatin;1.Fluorouracil;13.Oxaliplatin;1.Fluorouracil;","13.Oxaliplatin;1.Fluorouracil;"
"2204","29.19.487.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"S-1 monotherapy",TRUE,"Cont.","8.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;8.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;","8.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;"
"2205","29.19.488.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"SOX",TRUE,"Cont.","8.Oxaliplatin;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;8.Oxaliplatin;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;","8.Oxaliplatin;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;"
"2206","29.19.489.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, first-line",19,"SOX & Bevacizumab",TRUE,"Cont.","8.Bevacizumab;0.Oxaliplatin;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;8.Bevacizumab;0.Oxaliplatin;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;","8.Bevacizumab;0.Oxaliplatin;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;"
"2207","29.194.446.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Therapy for oligometastatic disease, including perioperative therapy and hyperthermic intra-peritoneal chemotherapy",194,"FOLFIRI",FALSE,"8","13.Fluorouracil;0.Irinotecan;1.Fluorouracil;13.Fluorouracil;0.Irinotecan;1.Fluorouracil;","13.Fluorouracil;0.Irinotecan;1.Fluorouracil;"
"2208","29.194.446.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Therapy for oligometastatic disease, including perioperative therapy and hyperthermic intra-peritoneal chemotherapy",194,"FOLFIRI",FALSE,"8","12.Fluorouracil;0.Irinotecan;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Irinotecan;1.Fluorouracil;1.Fluorouracil;","12.Fluorouracil;0.Irinotecan;1.Fluorouracil;1.Fluorouracil;"
"2209","29.194.447.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Therapy for oligometastatic disease, including perioperative therapy and hyperthermic intra-peritoneal chemotherapy",194,"mFOLFOX6",TRUE,"Cont.","14.Fluorouracil;0.Oxaliplatin;14.Fluorouracil;0.Oxaliplatin;","14.Fluorouracil;0.Oxaliplatin;"
"2210","29.194.447.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Therapy for oligometastatic disease, including perioperative therapy and hyperthermic intra-peritoneal chemotherapy",194,"mFOLFOX6",TRUE,"Cont.","12.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;","12.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;"
"2211","29.194.448.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Therapy for oligometastatic disease, including perioperative therapy and hyperthermic intra-peritoneal chemotherapy",194,"mFOLFOX6 (L-Leucovorin)",FALSE,"12","14.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;14.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;","14.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;"
"2212","29.194.448.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Therapy for oligometastatic disease, including perioperative therapy and hyperthermic intra-peritoneal chemotherapy",194,"mFOLFOX6 (L-Leucovorin)",FALSE,"12","12.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;","12.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;"
"2213","29.194.449.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Therapy for oligometastatic disease, including perioperative therapy and hyperthermic intra-peritoneal chemotherapy",194,"mFOLFOX6-B",TRUE,"Cont.","14.Bevacizumab;0.Fluorouracil;0.Oxaliplatin;14.Bevacizumab;0.Fluorouracil;0.Oxaliplatin;","14.Bevacizumab;0.Fluorouracil;0.Oxaliplatin;"
"2214","29.194.449.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Therapy for oligometastatic disease, including perioperative therapy and hyperthermic intra-peritoneal chemotherapy",194,"mFOLFOX6-B",TRUE,"Cont.","12.Bevacizumab;0.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Bevacizumab;0.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;","12.Bevacizumab;0.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;"
"2215","29.194.450.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Therapy for oligometastatic disease, including perioperative therapy and hyperthermic intra-peritoneal chemotherapy",194,"Hepatic arterial chemotherapy",FALSE,"6","7.Floxuridine;7.Floxuridine;","7.Floxuridine;7.Floxuridine;"
"2216","29.194.451.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Therapy for oligometastatic disease, including perioperative therapy and hyperthermic intra-peritoneal chemotherapy",194,"Intraperitoneal 5-FU",FALSE,"6","28.Fluorouracil;28.Fluorouracil;","28.Fluorouracil;28.Fluorouracil;"
"2217","29.194.451.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Therapy for oligometastatic disease, including perioperative therapy and hyperthermic intra-peritoneal chemotherapy",194,"Intraperitoneal 5-FU",FALSE,"6","23.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;23.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","23.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2218","29.194.452.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Therapy for oligometastatic disease, including perioperative therapy and hyperthermic intra-peritoneal chemotherapy",194,"Intraperitoneal hyperthermic mitomycin",FALSE,"1","0.HyperthermicMitomycin;","0.HyperthermicMitomycin;0.HyperthermicMitomycin;"
"2219","29.194.453.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Therapy for oligometastatic disease, including perioperative therapy and hyperthermic intra-peritoneal chemotherapy",194,"Intraperitoneal hyperthermic oxaliplatin",FALSE,"1","0.Fluorouracil;0.HyperthermicOxaliplatin;","0.Fluorouracil;0.HyperthermicOxaliplatin;"
"2220","29.194.459.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Therapy for oligometastatic disease, including perioperative therapy and hyperthermic intra-peritoneal chemotherapy",194,"Fluorouracil monotherapy",TRUE,"Cont.","24.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;24.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","24.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2221","29.194.459.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Therapy for oligometastatic disease, including perioperative therapy and hyperthermic intra-peritoneal chemotherapy",194,"Fluorouracil monotherapy",TRUE,"Cont.","3.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;3.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","3.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2222","29.194.459.3","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Therapy for oligometastatic disease, including perioperative therapy and hyperthermic intra-peritoneal chemotherapy",194,"Fluorouracil monotherapy",TRUE,"Cont.","31.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;31.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","31.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2223","29.194.459.4","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Therapy for oligometastatic disease, including perioperative therapy and hyperthermic intra-peritoneal chemotherapy",194,"Fluorouracil monotherapy",TRUE,"Cont.","21.Fluorouracil;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;5.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;21.Fluorouracil;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;5.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;","21.Fluorouracil;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;5.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;"
"2224","29.194.472.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Therapy for oligometastatic disease, including perioperative therapy and hyperthermic intra-peritoneal chemotherapy",194,"mFOLFOX7 (L-Leucovorin)",FALSE,"6","14.Oxaliplatin;14.Oxaliplatin;","14.Oxaliplatin;14.Oxaliplatin;"
"2225","29.194.472.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Therapy for oligometastatic disease, including perioperative therapy and hyperthermic intra-peritoneal chemotherapy",194,"mFOLFOX7 (L-Leucovorin)",FALSE,"6","14.Oxaliplatin;14.Oxaliplatin;","14.Oxaliplatin;14.Oxaliplatin;"
"2226","29.194.473.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Therapy for oligometastatic disease, including perioperative therapy and hyperthermic intra-peritoneal chemotherapy",194,"FOLFOX4 & Bevacizumab",TRUE,"Cont.","13.Bevacizumab;0.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;13.Bevacizumab;0.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;","13.Bevacizumab;0.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;"
"2227","29.194.473.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Therapy for oligometastatic disease, including perioperative therapy and hyperthermic intra-peritoneal chemotherapy",194,"FOLFOX4 & Bevacizumab",TRUE,"Cont.","12.Bevacizumab;0.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Bevacizumab;0.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;","12.Bevacizumab;0.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;"
"2228","29.24.493.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, second-line therapy",24,"CapeOx & Erlotinib",TRUE,"Cont.","1.Capecitabine;0.Erlotinib;0.Oxaliplatin;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Capecitabine;0.Erlotinib;0.Oxaliplatin;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;","1.Capecitabine;0.Erlotinib;0.Oxaliplatin;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;"
"2229","29.24.494.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, second-line therapy",24,"Fluorouracil monotherapy",TRUE,"Cont.","1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","1.Fluorouracil;1.Fluorouracil;"
"2230","29.24.495.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, second-line therapy",24,"FOLFIRI (L-Leucovorin)",TRUE,"Cont.","14.Fluorouracil;0.Irinotecan;0.Levoleucovorin;14.Fluorouracil;0.Irinotecan;0.Levoleucovorin;","14.Fluorouracil;0.Irinotecan;0.Levoleucovorin;"
"2231","29.24.495.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, second-line therapy",24,"FOLFIRI (L-Leucovorin)",TRUE,"Cont.","12.Fluorouracil;0.Irinotecan;0.Levoleucovorin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Irinotecan;0.Levoleucovorin;1.Fluorouracil;1.Fluorouracil;","12.Fluorouracil;0.Irinotecan;0.Levoleucovorin;1.Fluorouracil;1.Fluorouracil;"
"2232","29.24.496.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, second-line therapy",24,"FOLFIRI & Ramucirumab",TRUE,"Cont.","14.Fluorouracil;0.Irinotecan;0.Ramucirumab;14.Fluorouracil;0.Irinotecan;0.Ramucirumab;","14.Fluorouracil;0.Irinotecan;0.Ramucirumab;"
"2233","29.24.496.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, second-line therapy",24,"FOLFIRI & Ramucirumab",TRUE,"Cont.","12.Fluorouracil;0.Irinotecan;0.Ramucirumab;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Irinotecan;0.Ramucirumab;1.Fluorouracil;1.Fluorouracil;","12.Fluorouracil;0.Irinotecan;0.Ramucirumab;1.Fluorouracil;1.Fluorouracil;"
"2234","29.24.497.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, second-line therapy",24,"FOLFIRI & Ziv-aflibercept",TRUE,"Cont.","14.Fluorouracil;0.Irinotecan;0.Ziv-aflibercept;14.Fluorouracil;0.Irinotecan;0.Ziv-aflibercept;","14.Fluorouracil;0.Irinotecan;0.Ziv-aflibercept;"
"2235","29.24.497.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, second-line therapy",24,"FOLFIRI & Ziv-aflibercept",TRUE,"Cont.","12.Fluorouracil;0.Irinotecan;0.Ziv-aflibercept;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Irinotecan;0.Ziv-aflibercept;1.Fluorouracil;1.Fluorouracil;","12.Fluorouracil;0.Irinotecan;0.Ziv-aflibercept;1.Fluorouracil;1.Fluorouracil;"
"2236","29.24.498.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, second-line therapy",24,"Irinotecan monotherapy",TRUE,"Cont.","21.Irinotecan;21.Irinotecan;","21.Irinotecan;21.Irinotecan;"
"2237","29.24.499.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, second-line therapy",24,"IRIS",TRUE,"Cont.","14.Irinotecan;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Irinotecan;14.Irinotecan;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Irinotecan;","14.Irinotecan;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Irinotecan;"
"2238","29.26.501.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, subsequent lines of therapy",26,"Durvalumab & Tremelimumab",TRUE,"Cont.","28.Durvalumab;0.Tremelimumab;28.Durvalumab;0.Tremelimumab;","28.Durvalumab;0.Tremelimumab;"
"2239","29.26.502.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, subsequent lines of therapy",26,"FULV & Bevacizumab",TRUE,"Cont.","14.Bevacizumab;0.Fluorouracil;7.Fluorouracil;7.Bevacizumab;0.Fluorouracil;7.Fluorouracil;7.Bevacizumab;0.Fluorouracil;7.Fluorouracil;7.Bevacizumab;14.Bevacizumab;0.Fluorouracil;7.Fluorouracil;7.Bevacizumab;0.Fluorouracil;7.Fluorouracil;7.Bevacizumab;0.Fluorouracil;7.Fluorouracil;7.Bevacizumab;","14.Bevacizumab;0.Fluorouracil;7.Fluorouracil;7.Bevacizumab;0.Fluorouracil;7.Fluorouracil;7.Bevacizumab;0.Fluorouracil;7.Fluorouracil;7.Bevacizumab;"
"2240","29.26.502.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, subsequent lines of therapy",26,"FULV & Bevacizumab",TRUE,"Cont.","13.Bevacizumab;0.Fluorouracil;1.Fluorouracil;13.Bevacizumab;0.Fluorouracil;1.Fluorouracil;","13.Bevacizumab;0.Fluorouracil;1.Fluorouracil;"
"2241","29.26.503.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, subsequent lines of therapy",26,"Trifluridine and tipiracil monotherapy",TRUE,"Cont.","17.Trifluridineandtipiracil;1.Trifluridineandtipiracil;1.Trifluridineandtipiracil;1.Trifluridineandtipiracil;1.Trifluridineandtipiracil;3.Trifluridineandtipiracil;1.Trifluridineandtipiracil;1.Trifluridineandtipiracil;1.Trifluridineandtipiracil;1.Trifluridineandtipiracil;17.Trifluridineandtipiracil;1.Trifluridineandtipiracil;1.Trifluridineandtipiracil;1.Trifluridineandtipiracil;1.Trifluridineandtipiracil;3.Trifluridineandtipiracil;1.Trifluridineandtipiracil;1.Trifluridineandtipiracil;1.Trifluridineandtipiracil;1.Trifluridineandtipiracil;","17.Trifluridineandtipiracil;1.Trifluridineandtipiracil;1.Trifluridineandtipiracil;1.Trifluridineandtipiracil;1.Trifluridineandtipiracil;3.Trifluridineandtipiracil;1.Trifluridineandtipiracil;1.Trifluridineandtipiracil;1.Trifluridineandtipiracil;1.Trifluridineandtipiracil;"
"2242","29.26.504.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, subsequent lines of therapy",26,"Trifluridine and tipiracil & Bevacizumab",TRUE,"Cont.","14.Bevacizumab;0.Trifluridineandtipiracil;1.Trifluridineandtipiracil;1.Trifluridineandtipiracil;1.Trifluridineandtipiracil;1.Trifluridineandtipiracil;3.Trifluridineandtipiracil;1.Trifluridineandtipiracil;1.Trifluridineandtipiracil;1.Trifluridineandtipiracil;1.Trifluridineandtipiracil;3.Bevacizumab;14.Bevacizumab;0.Trifluridineandtipiracil;1.Trifluridineandtipiracil;1.Trifluridineandtipiracil;1.Trifluridineandtipiracil;1.Trifluridineandtipiracil;3.Trifluridineandtipiracil;1.Trifluridineandtipiracil;1.Trifluridineandtipiracil;1.Trifluridineandtipiracil;1.Trifluridineandtipiracil;3.Bevacizumab;","14.Bevacizumab;0.Trifluridineandtipiracil;1.Trifluridineandtipiracil;1.Trifluridineandtipiracil;1.Trifluridineandtipiracil;1.Trifluridineandtipiracil;3.Trifluridineandtipiracil;1.Trifluridineandtipiracil;1.Trifluridineandtipiracil;1.Trifluridineandtipiracil;1.Trifluridineandtipiracil;3.Bevacizumab;"
"2243","29.28.500.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Advanced or metastatic disease, third-line therapy",28,"Regorafenib monotherapy",TRUE,"Cont.","8.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;8.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;","8.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;"
"2244","29.4.445.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Adjuvant therapy",4,"FULV (L-Leucovorin)",FALSE,"30","7.Fluorouracil;0.Levoleucovorin;7.Fluorouracil;0.Levoleucovorin;","7.Fluorouracil;0.Levoleucovorin;"
"2245","29.4.445.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer",29,"Adjuvant therapy",4,"FULV (L-Leucovorin)",FALSE,"6","24.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;0.Levoleucovorin;24.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;0.Levoleucovorin;","24.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;0.Levoleucovorin;1.Fluorouracil;0.Levoleucovorin;"
"2246","3.120.295.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Maintenance for metastatic or unresectable disease",120,"Pertuzumab & Trastuzumab",TRUE,"Cont.","21.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;","21.Pertuzumab;0.Trastuzumab;"
"2247","3.139.253.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, first-line",139,"ACH",TRUE,"Cont.","21.Cyclophosphamide;0.Doxorubicin;0.Trastuzumab;21.Cyclophosphamide;0.Doxorubicin;0.Trastuzumab;","21.Cyclophosphamide;0.Doxorubicin;0.Trastuzumab;"
"2248","3.139.254.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, first-line",139,"Capecitabine, Bevacizumab, Trastuzumab",TRUE,"Cont.","8.Bevacizumab;0.Capecitabine;0.Trastuzumab;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Bevacizumab;0.Capecitabine;0.Trastuzumab;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Bevacizumab;0.Capecitabine;0.Trastuzumab;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2249","3.139.255.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, first-line",139,"Capecitabine & Lapatinib",TRUE,"Cont.","1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;","1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;"
"2250","3.139.256.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, first-line",139,"Capecitabine & Trastuzumab (XH)",TRUE,"Cont.","8.Capecitabine;0.Trastuzumab;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Capecitabine;0.Trastuzumab;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Capecitabine;0.Trastuzumab;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2251","3.139.257.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, first-line",139,"Carboplatin & Paclitaxel (CP) & Trastuzumab",FALSE,"6","7.Carboplatin;0.Paclitaxel;0.Trastuzumab;7.Carboplatin;0.Paclitaxel;0.Trastuzumab;7.Carboplatin;0.Paclitaxel;0.Trastuzumab;7.Trastuzumab;7.Carboplatin;0.Paclitaxel;0.Trastuzumab;7.Carboplatin;0.Paclitaxel;0.Trastuzumab;7.Carboplatin;0.Paclitaxel;0.Trastuzumab;7.Trastuzumab;","7.Carboplatin;0.Paclitaxel;0.Trastuzumab;7.Carboplatin;0.Paclitaxel;0.Trastuzumab;7.Carboplatin;0.Paclitaxel;0.Trastuzumab;7.Trastuzumab;"
"2252","3.139.257.2","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, first-line",139,"Carboplatin & Paclitaxel (CP) & Trastuzumab",TRUE,"Cont.","7.Trastuzumab;1.Carboplatin;0.Paclitaxel;6.Trastuzumab;7.Trastuzumab;7.Trastuzumab;1.Carboplatin;0.Paclitaxel;6.Trastuzumab;7.Trastuzumab;","7.Trastuzumab;1.Carboplatin;0.Paclitaxel;6.Trastuzumab;7.Trastuzumab;"
"2253","3.139.257.3","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, first-line",139,"Carboplatin & Paclitaxel (CP) & Trastuzumab",TRUE,"Cont.","21.Carboplatin;0.Paclitaxel;0.Trastuzumab;21.Carboplatin;0.Paclitaxel;0.Trastuzumab;","21.Carboplatin;0.Paclitaxel;0.Trastuzumab;"
"2254","3.139.258.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, first-line",139,"ECH",TRUE,"Cont.","21.Cyclophosphamide;0.Epirubicin;0.Trastuzumab;21.Cyclophosphamide;0.Epirubicin;0.Trastuzumab;","21.Cyclophosphamide;0.Epirubicin;0.Trastuzumab;"
"2255","3.139.259.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, first-line",139,"nab-Paclitaxel & Trastuzumab",TRUE,"Cont.","7.Paclitaxel;0.nanoparticlealbumin-bound;0.Trastuzumab;7.Paclitaxel;0.nanoparticlealbumin-bound;0.Trastuzumab;7.Paclitaxel;0.nanoparticlealbumin-bound;0.Trastuzumab;7.Trastuzumab;7.Paclitaxel;0.nanoparticlealbumin-bound;0.Trastuzumab;7.Paclitaxel;0.nanoparticlealbumin-bound;0.Trastuzumab;7.Paclitaxel;0.nanoparticlealbumin-bound;0.Trastuzumab;7.Trastuzumab;","7.Paclitaxel;0.nanoparticlealbumin-bound;0.Trastuzumab;7.Paclitaxel;0.nanoparticlealbumin-bound;0.Trastuzumab;7.Paclitaxel;0.nanoparticlealbumin-bound;0.Trastuzumab;7.Trastuzumab;"
"2256","3.139.260.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, first-line",139,"Pertuzumab & T-DM1",TRUE,"Cont.","21.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;","21.Pertuzumab;0.Trastuzumab;"
"2257","3.139.261.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, first-line",139,"TCH (Docetaxel, Carboplatin)",FALSE,"8","7.Carboplatin;0.Docetaxel;0.Trastuzumab;7.Trastuzumab;7.Trastuzumab;7.Carboplatin;0.Docetaxel;0.Trastuzumab;7.Trastuzumab;7.Trastuzumab;","7.Carboplatin;0.Docetaxel;0.Trastuzumab;7.Trastuzumab;7.Trastuzumab;"
"2258","3.139.262.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, first-line",139,"Docetaxel & Trastuzumab (TH)",TRUE,"Cont.","14.Docetaxel;0.Trastuzumab;7.Docetaxel;0.Trastuzumab;7.Docetaxel;0.Trastuzumab;14.Docetaxel;0.Trastuzumab;7.Docetaxel;0.Trastuzumab;7.Docetaxel;0.Trastuzumab;","14.Docetaxel;0.Trastuzumab;7.Docetaxel;0.Trastuzumab;7.Docetaxel;0.Trastuzumab;"
"2259","3.139.262.2","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, first-line",139,"Docetaxel & Trastuzumab (TH)",TRUE,"Cont.","7.Docetaxel;0.Trastuzumab;7.Trastuzumab;7.Trastuzumab;7.Docetaxel;0.Trastuzumab;7.Trastuzumab;7.Trastuzumab;","7.Docetaxel;0.Trastuzumab;7.Trastuzumab;7.Trastuzumab;"
"2260","3.139.263.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, first-line",139,"Paclitaxel & Trastuzumab (TH)",TRUE,"Cont.","7.Paclitaxel;0.Trastuzumab;7.Paclitaxel;0.Trastuzumab;7.Paclitaxel;0.Trastuzumab;7.Paclitaxel;0.Trastuzumab;7.Paclitaxel;0.Trastuzumab;7.Paclitaxel;0.Trastuzumab;7.Paclitaxel;0.Trastuzumab;7.Paclitaxel;0.Trastuzumab;","7.Paclitaxel;0.Trastuzumab;"
"2261","3.139.263.2","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, first-line",139,"Paclitaxel & Trastuzumab (TH)",FALSE,"6","7.Paclitaxel;0.Trastuzumab;7.Paclitaxel;0.Trastuzumab;7.Paclitaxel;0.Trastuzumab;7.Trastuzumab;7.Paclitaxel;0.Trastuzumab;7.Paclitaxel;0.Trastuzumab;7.Paclitaxel;0.Trastuzumab;7.Trastuzumab;","7.Paclitaxel;0.Trastuzumab;7.Paclitaxel;0.Trastuzumab;7.Paclitaxel;0.Trastuzumab;7.Trastuzumab;"
"2262","3.139.263.3","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, first-line",139,"Paclitaxel & Trastuzumab (TH)",TRUE,"Cont.","7.Paclitaxel;0.Trastuzumab;7.Paclitaxel;0.Trastuzumab;7.Paclitaxel;0.Trastuzumab;7.Trastuzumab;7.Paclitaxel;0.Trastuzumab;7.Paclitaxel;0.Trastuzumab;7.Paclitaxel;0.Trastuzumab;7.Trastuzumab;","7.Paclitaxel;0.Trastuzumab;7.Paclitaxel;0.Trastuzumab;7.Paclitaxel;0.Trastuzumab;7.Trastuzumab;"
"2263","3.139.263.4","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, first-line",139,"Paclitaxel & Trastuzumab (TH)",TRUE,"Cont.","7.Paclitaxel;0.Trastuzumab;7.Trastuzumab;7.Trastuzumab;7.Paclitaxel;0.Trastuzumab;7.Trastuzumab;7.Trastuzumab;","7.Paclitaxel;0.Trastuzumab;7.Trastuzumab;7.Trastuzumab;"
"2264","3.139.264.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, first-line",139,"THP (Docetaxel)",TRUE,"Cont.","21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;","21.Docetaxel;0.Pertuzumab;0.Trastuzumab;"
"2265","3.139.265.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, first-line",139,"Lapatinib & Paclitaxel (TL)",TRUE,"Cont.","1.Lapatinib;0.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Lapatinib;0.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Lapatinib;0.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Lapatinib;0.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Lapatinib;0.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Lapatinib;0.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;","1.Lapatinib;0.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Lapatinib;0.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Lapatinib;0.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;1.Paclitaxel;"
"2266","3.139.266.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, first-line",139,"Trastuzumab monotherapy",TRUE,"Cont.","7.Trastuzumab;7.Trastuzumab;","7.Trastuzumab;7.Trastuzumab;"
"2267","3.139.267.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, first-line",139,"Trastuzumab emtansine monotherapy",TRUE,"Cont.","21.Trastuzumabemtansine;21.Trastuzumabemtansine;","21.Trastuzumabemtansine;21.Trastuzumabemtansine;"
"2268","3.139.268.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, first-line",139,"Vinorelbine & Trastuzumab (VH)",TRUE,"Cont.","7.Trastuzumab;0.Vinorelbine;7.Trastuzumab;0.Vinorelbine;7.Trastuzumab;0.Vinorelbine;7.Trastuzumab;0.Vinorelbine;7.Trastuzumab;0.Vinorelbine;7.Trastuzumab;0.Vinorelbine;7.Trastuzumab;0.Vinorelbine;7.Trastuzumab;0.Vinorelbine;","7.Trastuzumab;0.Vinorelbine;"
"2269","3.139.268.2","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, first-line",139,"Vinorelbine & Trastuzumab (VH)",TRUE,"Cont.","14.Trastuzumab;0.Vinorelbine;7.Vinorelbine;14.Trastuzumab;0.Vinorelbine;7.Vinorelbine;","14.Trastuzumab;0.Vinorelbine;7.Vinorelbine;"
"2270","3.142.269.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, subsequent lines",142,"Capecitabine & Lapatinib",TRUE,"Cont.","1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;","1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Capecitabine;0.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;"
"2271","3.142.270.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, subsequent lines",142,"Capecitabine & Margetuximab",TRUE,"Cont.","8.Capecitabine;0.Margetuximab;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Capecitabine;0.Margetuximab;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Capecitabine;0.Margetuximab;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2272","3.142.271.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, subsequent lines",142,"Capecitabine & Neratinib",TRUE,"Cont.","1.Capecitabine;0.Neratinib;1.Capecitabine;0.Neratinib;1.Capecitabine;0.Neratinib;1.Capecitabine;0.Neratinib;1.Capecitabine;0.Neratinib;1.Capecitabine;0.Neratinib;1.Capecitabine;0.Neratinib;1.Capecitabine;0.Neratinib;1.Capecitabine;0.Neratinib;1.Capecitabine;0.Neratinib;1.Capecitabine;0.Neratinib;1.Capecitabine;0.Neratinib;1.Capecitabine;0.Neratinib;1.Capecitabine;0.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Capecitabine;0.Neratinib;1.Capecitabine;0.Neratinib;1.Capecitabine;0.Neratinib;1.Capecitabine;0.Neratinib;1.Capecitabine;0.Neratinib;1.Capecitabine;0.Neratinib;1.Capecitabine;0.Neratinib;1.Capecitabine;0.Neratinib;1.Capecitabine;0.Neratinib;1.Capecitabine;0.Neratinib;1.Capecitabine;0.Neratinib;1.Capecitabine;0.Neratinib;1.Capecitabine;0.Neratinib;1.Capecitabine;0.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;","1.Capecitabine;0.Neratinib;1.Capecitabine;0.Neratinib;1.Capecitabine;0.Neratinib;1.Capecitabine;0.Neratinib;1.Capecitabine;0.Neratinib;1.Capecitabine;0.Neratinib;1.Capecitabine;0.Neratinib;1.Capecitabine;0.Neratinib;1.Capecitabine;0.Neratinib;1.Capecitabine;0.Neratinib;1.Capecitabine;0.Neratinib;1.Capecitabine;0.Neratinib;1.Capecitabine;0.Neratinib;1.Capecitabine;0.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;"
"2273","3.142.272.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, subsequent lines",142,"Capecitabine & Pyrotinib",TRUE,"Cont.","1.Capecitabine;0.Pyrotinib;1.Capecitabine;0.Pyrotinib;1.Capecitabine;0.Pyrotinib;1.Capecitabine;0.Pyrotinib;1.Capecitabine;0.Pyrotinib;1.Capecitabine;0.Pyrotinib;1.Capecitabine;0.Pyrotinib;1.Capecitabine;0.Pyrotinib;1.Capecitabine;0.Pyrotinib;1.Capecitabine;0.Pyrotinib;1.Capecitabine;0.Pyrotinib;1.Capecitabine;0.Pyrotinib;1.Capecitabine;0.Pyrotinib;1.Capecitabine;0.Pyrotinib;1.Pyrotinib;1.Pyrotinib;1.Pyrotinib;1.Pyrotinib;1.Pyrotinib;1.Pyrotinib;1.Pyrotinib;1.Capecitabine;0.Pyrotinib;1.Capecitabine;0.Pyrotinib;1.Capecitabine;0.Pyrotinib;1.Capecitabine;0.Pyrotinib;1.Capecitabine;0.Pyrotinib;1.Capecitabine;0.Pyrotinib;1.Capecitabine;0.Pyrotinib;1.Capecitabine;0.Pyrotinib;1.Capecitabine;0.Pyrotinib;1.Capecitabine;0.Pyrotinib;1.Capecitabine;0.Pyrotinib;1.Capecitabine;0.Pyrotinib;1.Capecitabine;0.Pyrotinib;1.Capecitabine;0.Pyrotinib;1.Pyrotinib;1.Pyrotinib;1.Pyrotinib;1.Pyrotinib;1.Pyrotinib;1.Pyrotinib;1.Pyrotinib;","1.Capecitabine;0.Pyrotinib;1.Capecitabine;0.Pyrotinib;1.Capecitabine;0.Pyrotinib;1.Capecitabine;0.Pyrotinib;1.Capecitabine;0.Pyrotinib;1.Capecitabine;0.Pyrotinib;1.Capecitabine;0.Pyrotinib;1.Capecitabine;0.Pyrotinib;1.Capecitabine;0.Pyrotinib;1.Capecitabine;0.Pyrotinib;1.Capecitabine;0.Pyrotinib;1.Capecitabine;0.Pyrotinib;1.Capecitabine;0.Pyrotinib;1.Capecitabine;0.Pyrotinib;1.Pyrotinib;1.Pyrotinib;1.Pyrotinib;1.Pyrotinib;1.Pyrotinib;1.Pyrotinib;1.Pyrotinib;"
"2274","3.142.273.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, subsequent lines",142,"Capecitabine & Trastuzumab (XH)",TRUE,"Cont.","8.Capecitabine;0.Trastuzumab;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Capecitabine;0.Trastuzumab;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Capecitabine;0.Trastuzumab;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2275","3.142.274.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, subsequent lines",142,"Capecitabine & Trastuzumab (XH) & Tucatinib",TRUE,"Cont.","1.Capecitabine;0.Trastuzumab;0.Tucatinib;1.Capecitabine;0.Tucatinib;1.Capecitabine;0.Tucatinib;1.Capecitabine;0.Tucatinib;1.Capecitabine;0.Tucatinib;1.Capecitabine;0.Tucatinib;1.Capecitabine;0.Tucatinib;1.Capecitabine;0.Tucatinib;1.Capecitabine;0.Tucatinib;1.Capecitabine;0.Tucatinib;1.Capecitabine;0.Tucatinib;1.Capecitabine;0.Tucatinib;1.Capecitabine;0.Tucatinib;1.Capecitabine;0.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Capecitabine;0.Trastuzumab;0.Tucatinib;1.Capecitabine;0.Tucatinib;1.Capecitabine;0.Tucatinib;1.Capecitabine;0.Tucatinib;1.Capecitabine;0.Tucatinib;1.Capecitabine;0.Tucatinib;1.Capecitabine;0.Tucatinib;1.Capecitabine;0.Tucatinib;1.Capecitabine;0.Tucatinib;1.Capecitabine;0.Tucatinib;1.Capecitabine;0.Tucatinib;1.Capecitabine;0.Tucatinib;1.Capecitabine;0.Tucatinib;1.Capecitabine;0.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;","1.Capecitabine;0.Trastuzumab;0.Tucatinib;1.Capecitabine;0.Tucatinib;1.Capecitabine;0.Tucatinib;1.Capecitabine;0.Tucatinib;1.Capecitabine;0.Tucatinib;1.Capecitabine;0.Tucatinib;1.Capecitabine;0.Tucatinib;1.Capecitabine;0.Tucatinib;1.Capecitabine;0.Tucatinib;1.Capecitabine;0.Tucatinib;1.Capecitabine;0.Tucatinib;1.Capecitabine;0.Tucatinib;1.Capecitabine;0.Tucatinib;1.Capecitabine;0.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;"
"2276","3.142.275.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, subsequent lines",142,"Docetaxel & Trastuzumab (TH)",TRUE,"Cont.","21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;","21.Docetaxel;0.Trastuzumab;"
"2277","3.142.276.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, subsequent lines",142,"EHP",TRUE,"Cont.","14.Eribulin;0.Pertuzumab;0.Trastuzumab;7.Eribulin;14.Eribulin;0.Pertuzumab;0.Trastuzumab;7.Eribulin;","14.Eribulin;0.Pertuzumab;0.Trastuzumab;7.Eribulin;"
"2278","3.142.277.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, subsequent lines",142,"Eribulin & Margetuximab",TRUE,"Cont.","14.Eribulin;0.Margetuximab;7.Eribulin;14.Eribulin;0.Margetuximab;7.Eribulin;","14.Eribulin;0.Margetuximab;7.Eribulin;"
"2279","3.142.278.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, subsequent lines",142,"Eribulin & Trastuzumab",TRUE,"Cont.","14.Eribulin;0.Trastuzumab;7.Eribulin;14.Eribulin;0.Trastuzumab;7.Eribulin;","14.Eribulin;0.Trastuzumab;7.Eribulin;"
"2280","3.142.279.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, subsequent lines",142,"Gemcitabine & Margetuximab",TRUE,"Cont.","14.Gemcitabine;0.Margetuximab;7.Gemcitabine;14.Gemcitabine;0.Margetuximab;7.Gemcitabine;","14.Gemcitabine;0.Margetuximab;7.Gemcitabine;"
"2281","3.142.280.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, subsequent lines",142,"Gemcitabine & Trastuzumab",TRUE,"Cont.","14.Gemcitabine;0.Trastuzumab;7.Gemcitabine;14.Gemcitabine;0.Trastuzumab;7.Gemcitabine;","14.Gemcitabine;0.Trastuzumab;7.Gemcitabine;"
"2282","3.142.280.2","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, subsequent lines",142,"Gemcitabine & Trastuzumab",TRUE,"Cont.","7.Gemcitabine;0.Trastuzumab;7.Gemcitabine;0.Trastuzumab;7.Trastuzumab;7.Gemcitabine;0.Trastuzumab;7.Gemcitabine;0.Trastuzumab;7.Trastuzumab;","7.Gemcitabine;0.Trastuzumab;7.Gemcitabine;0.Trastuzumab;7.Trastuzumab;"
"2283","3.142.281.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, subsequent lines",142,"GHP",TRUE,"Cont.","14.Gemcitabine;0.Pertuzumab;0.Trastuzumab;7.Gemcitabine;14.Gemcitabine;0.Pertuzumab;0.Trastuzumab;7.Gemcitabine;","14.Gemcitabine;0.Pertuzumab;0.Trastuzumab;7.Gemcitabine;"
"2284","3.142.282.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, subsequent lines",142,"Lapatinib & Trastuzumab",TRUE,"Cont.","1.Lapatinib;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;","1.Lapatinib;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;"
"2285","3.142.283.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, subsequent lines",142,"Paclitaxel & Trastuzumab (TH)",TRUE,"Cont.","7.Paclitaxel;0.Trastuzumab;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;0.Trastuzumab;7.Paclitaxel;7.Paclitaxel;","7.Paclitaxel;0.Trastuzumab;7.Paclitaxel;7.Paclitaxel;"
"2286","3.142.284.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, subsequent lines",142,"Paclitaxel, Pertuzumab, Trastuzumab emtansine",TRUE,"Cont.","7.Paclitaxel;0.Pertuzumab;0.Trastuzumabemtansine;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;0.Pertuzumab;0.Trastuzumabemtansine;7.Paclitaxel;7.Paclitaxel;","7.Paclitaxel;0.Pertuzumab;0.Trastuzumabemtansine;7.Paclitaxel;7.Paclitaxel;"
"2287","3.142.284.2","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, subsequent lines",142,"Paclitaxel, Pertuzumab, Trastuzumab emtansine",TRUE,"Cont.","7.Paclitaxel;0.Pertuzumab;0.Trastuzumabemtansine;7.Paclitaxel;0.Trastuzumabemtansine;7.Paclitaxel;0.Trastuzumabemtansine;7.Paclitaxel;0.Pertuzumab;0.Trastuzumabemtansine;7.Paclitaxel;0.Trastuzumabemtansine;7.Paclitaxel;0.Trastuzumabemtansine;","7.Paclitaxel;0.Pertuzumab;0.Trastuzumabemtansine;7.Paclitaxel;0.Trastuzumabemtansine;7.Paclitaxel;0.Trastuzumabemtansine;"
"2288","3.142.285.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, subsequent lines",142,"nab-Paclitaxel & Trastuzumab",TRUE,"Cont.","21.Paclitaxel;0.nanoparticlealbumin-bound;0.Trastuzumab;21.Paclitaxel;0.nanoparticlealbumin-bound;0.Trastuzumab;","21.Paclitaxel;0.nanoparticlealbumin-bound;0.Trastuzumab;"
"2289","3.142.286.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, subsequent lines",142,"nab-Paclitaxel, Pertuzumab, Trastuzumab",TRUE,"Cont.","21.Paclitaxel;0.nanoparticlealbumin-bound;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.nanoparticlealbumin-bound;0.Pertuzumab;0.Trastuzumab;","21.Paclitaxel;0.nanoparticlealbumin-bound;0.Pertuzumab;0.Trastuzumab;"
"2290","3.142.287.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, subsequent lines",142,"Pertuzumab & Trastuzumab",NA,NA,"0.Trastuzumab;21.Trastuzumab;1.Pertuzumab;20.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;","0.Trastuzumab;21.Trastuzumab;1.Pertuzumab;20.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;"
"2291","3.142.288.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, subsequent lines",142,"THP (Paclitaxel)",TRUE,"Cont.","7.Paclitaxel;0.Pertuzumab;0.Trastuzumab;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;0.Pertuzumab;0.Trastuzumab;7.Paclitaxel;7.Paclitaxel;","7.Paclitaxel;0.Pertuzumab;0.Trastuzumab;7.Paclitaxel;7.Paclitaxel;"
"2292","3.142.289.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, subsequent lines",142,"Trastuzumab deruxtecan monotherapy",TRUE,"Cont.","21.Trastuzumabderuxtecan;21.Trastuzumabderuxtecan;","21.Trastuzumabderuxtecan;21.Trastuzumabderuxtecan;"
"2293","3.142.290.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, subsequent lines",142,"Trastuzumab emtansine monotherapy",TRUE,"Cont.","21.Trastuzumabemtansine;21.Trastuzumabemtansine;","21.Trastuzumabemtansine;21.Trastuzumabemtansine;"
"2294","3.142.291.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, subsequent lines",142,"Vinorelbine & Margetuximab",TRUE,"Cont.","14.Margetuximab;0.Vinorelbine;7.Vinorelbine;14.Margetuximab;0.Vinorelbine;7.Vinorelbine;","14.Margetuximab;0.Vinorelbine;7.Vinorelbine;"
"2295","3.142.292.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, subsequent lines",142,"VHP",TRUE,"Cont.","14.Pertuzumab;0.Trastuzumab;0.Vinorelbine;7.Vinorelbine;14.Pertuzumab;0.Trastuzumab;0.Vinorelbine;7.Vinorelbine;","14.Pertuzumab;0.Trastuzumab;0.Vinorelbine;7.Vinorelbine;"
"2296","3.142.293.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, subsequent lines",142,"Vinorelbine & Trastuzumab (VH) & Everolimus",TRUE,"Cont.","1.Everolimus;0.Trastuzumab;0.Vinorelbine;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;0.Trastuzumab;0.Vinorelbine;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;0.Trastuzumab;0.Vinorelbine;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;0.Trastuzumab;0.Vinorelbine;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;0.Trastuzumab;0.Vinorelbine;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;0.Trastuzumab;0.Vinorelbine;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;0.Trastuzumab;0.Vinorelbine;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;0.Trastuzumab;0.Vinorelbine;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;","1.Everolimus;0.Trastuzumab;0.Vinorelbine;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;"
"2297","3.142.294.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Metastatic or unresectable disease, subsequent lines",142,"XHP",TRUE,"Cont.","8.Capecitabine;0.Pertuzumab;0.Trastuzumab;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Capecitabine;0.Pertuzumab;0.Trastuzumab;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Capecitabine;0.Pertuzumab;0.Trastuzumab;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2298","3.148.186.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Neoadjuvant chemotherapy, sequential protocols",148,"AC-TH (Paclitaxel)",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Paclitaxel;0.Trastuzumab;28.Paclitaxel;0.Trastuzumab;28.Paclitaxel;0.Trastuzumab;28.Paclitaxel;0.Trastuzumab;","0.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Paclitaxel;0.Trastuzumab;28.Paclitaxel;0.Trastuzumab;28.Paclitaxel;0.Trastuzumab;28.Paclitaxel;0.Trastuzumab;"
"2299","3.148.187.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Neoadjuvant chemotherapy, sequential protocols",148,"AC-THL (Paclitaxel)",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Lapatinib;0.Paclitaxel;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;22.Lapatinib;0.Paclitaxel;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;22.Lapatinib;0.Paclitaxel;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;22.Lapatinib;0.Paclitaxel;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;","0.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Lapatinib;0.Paclitaxel;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;22.Lapatinib;0.Paclitaxel;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;22.Lapatinib;0.Paclitaxel;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;22.Lapatinib;0.Paclitaxel;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;"
"2300","3.148.188.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Neoadjuvant chemotherapy, sequential protocols",148,"ddAC-THP (Paclitaxel)",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;","0.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;"
"2301","3.148.189.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Neoadjuvant chemotherapy, sequential protocols",148,"AC-TL (Paclitaxel)",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Lapatinib;0.Paclitaxel;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;22.Lapatinib;0.Paclitaxel;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;22.Lapatinib;0.Paclitaxel;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;22.Lapatinib;0.Paclitaxel;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;","0.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Lapatinib;0.Paclitaxel;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;22.Lapatinib;0.Paclitaxel;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;22.Lapatinib;0.Paclitaxel;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;22.Lapatinib;0.Paclitaxel;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;"
"2302","3.148.190.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Neoadjuvant chemotherapy, sequential protocols",148,"EC-TH (Docetaxel)",NA,NA,"0.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;","0.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;"
"2303","3.148.191.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Neoadjuvant chemotherapy, sequential protocols",148,"ECH-TH (Docetaxel)",NA,NA,"0.Cyclophosphamide;0.Epirubicin;0.Trastuzumab;21.Cyclophosphamide;0.Epirubicin;0.Trastuzumab;21.Cyclophosphamide;0.Epirubicin;0.Trastuzumab;21.Cyclophosphamide;0.Epirubicin;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;","0.Cyclophosphamide;0.Epirubicin;0.Trastuzumab;21.Cyclophosphamide;0.Epirubicin;0.Trastuzumab;21.Cyclophosphamide;0.Epirubicin;0.Trastuzumab;21.Cyclophosphamide;0.Epirubicin;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;"
"2304","3.148.192.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Neoadjuvant chemotherapy, sequential protocols",148,"FEC-TH (Paclitaxel)",NA,NA,"0.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;","0.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;"
"2305","3.148.193.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Neoadjuvant chemotherapy, sequential protocols",148,"FEC-THP (Docetaxel)",NA,NA,"0.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;","0.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;"
"2306","3.148.193.2","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Neoadjuvant chemotherapy, sequential protocols",148,"FEC-THP (Docetaxel)",NA,NA,"0.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;28.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;28.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;28.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;28.Docetaxel;0.Pertuzumab;0.Trastuzumab;28.Docetaxel;0.Pertuzumab;0.Trastuzumab;28.Docetaxel;0.Pertuzumab;0.Trastuzumab;28.Docetaxel;0.Pertuzumab;0.Trastuzumab;","0.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;28.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;28.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;28.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;28.Docetaxel;0.Pertuzumab;0.Trastuzumab;28.Docetaxel;0.Pertuzumab;0.Trastuzumab;28.Docetaxel;0.Pertuzumab;0.Trastuzumab;28.Docetaxel;0.Pertuzumab;0.Trastuzumab;"
"2307","3.148.194.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Neoadjuvant chemotherapy, sequential protocols",148,"Neratinib & Paclitaxel, then AC",NA,NA,"0.Neratinib;0.Paclitaxel;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;15.Neratinib;0.Paclitaxel;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;15.Neratinib;0.Paclitaxel;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;15.Neratinib;0.Paclitaxel;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;15.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;","0.Neratinib;0.Paclitaxel;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;15.Neratinib;0.Paclitaxel;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;15.Neratinib;0.Paclitaxel;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;15.Neratinib;0.Paclitaxel;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;15.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;"
"2308","3.148.195.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Neoadjuvant chemotherapy, sequential protocols",148,"Neratinib & Paclitaxel, then ddAC",NA,NA,"0.Neratinib;0.Paclitaxel;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;15.Neratinib;0.Paclitaxel;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;15.Neratinib;0.Paclitaxel;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;15.Neratinib;0.Paclitaxel;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;15.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;","0.Neratinib;0.Paclitaxel;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;15.Neratinib;0.Paclitaxel;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;15.Neratinib;0.Paclitaxel;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;15.Neratinib;0.Paclitaxel;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;15.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;"
"2309","3.148.196.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Neoadjuvant chemotherapy, sequential protocols",148,"TH-AC (Paclitaxel)",NA,NA,"0.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;","0.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;"
"2310","3.148.197.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Neoadjuvant chemotherapy, sequential protocols",148,"TH-ddAC (Paclitaxel)",NA,NA,"0.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;","0.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;"
"2311","3.148.198.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Neoadjuvant chemotherapy, sequential protocols",148,"TH-FEC & H (Docetaxel)",NA,NA,"0.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;0.Trastuzumab;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;0.Trastuzumab;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;0.Trastuzumab;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;0.Trastuzumab;","0.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;0.Trastuzumab;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;0.Trastuzumab;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;0.Trastuzumab;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;0.Trastuzumab;"
"2312","3.148.199.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Neoadjuvant chemotherapy, sequential protocols",148,"TH-FEC & H (Docetaxel, SC Trastuzumab)",NA,NA,"0.Docetaxel;0.Trastuzumabandhyaluronidase;21.Docetaxel;0.Trastuzumabandhyaluronidase;21.Docetaxel;0.Trastuzumabandhyaluronidase;21.Docetaxel;0.Trastuzumabandhyaluronidase;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;0.Trastuzumabandhyaluronidase;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;0.Trastuzumabandhyaluronidase;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;0.Trastuzumabandhyaluronidase;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;0.Trastuzumabandhyaluronidase;","0.Docetaxel;0.Trastuzumabandhyaluronidase;21.Docetaxel;0.Trastuzumabandhyaluronidase;21.Docetaxel;0.Trastuzumabandhyaluronidase;21.Docetaxel;0.Trastuzumabandhyaluronidase;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;0.Trastuzumabandhyaluronidase;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;0.Trastuzumabandhyaluronidase;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;0.Trastuzumabandhyaluronidase;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;0.Trastuzumabandhyaluronidase;"
"2313","3.148.200.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Neoadjuvant chemotherapy, sequential protocols",148,"TH-FEC & H (Paclitaxel)",NA,NA,"0.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;0.Trastuzumab;3.Fluorouracil;18.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;0.Trastuzumab;3.Fluorouracil;18.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;0.Trastuzumab;3.Fluorouracil;18.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;0.Trastuzumab;3.Fluorouracil;","0.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;0.Trastuzumab;3.Fluorouracil;18.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;0.Trastuzumab;3.Fluorouracil;18.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;0.Trastuzumab;3.Fluorouracil;18.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;0.Trastuzumab;3.Fluorouracil;"
"2314","3.148.200.2","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Neoadjuvant chemotherapy, sequential protocols",148,"TH-FEC & H (Paclitaxel)",NA,NA,"0.Paclitaxel;0.Trastuzumab;1.Paclitaxel;20.Paclitaxel;0.Trastuzumab;1.Paclitaxel;20.Paclitaxel;0.Trastuzumab;1.Paclitaxel;20.Paclitaxel;0.Trastuzumab;1.Paclitaxel;20.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;0.Trastuzumab;3.Fluorouracil;18.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;0.Trastuzumab;3.Fluorouracil;18.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;0.Trastuzumab;3.Fluorouracil;18.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;0.Trastuzumab;3.Fluorouracil;","0.Paclitaxel;0.Trastuzumab;1.Paclitaxel;20.Paclitaxel;0.Trastuzumab;1.Paclitaxel;20.Paclitaxel;0.Trastuzumab;1.Paclitaxel;20.Paclitaxel;0.Trastuzumab;1.Paclitaxel;20.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;0.Trastuzumab;3.Fluorouracil;18.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;0.Trastuzumab;3.Fluorouracil;18.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;0.Trastuzumab;3.Fluorouracil;18.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;0.Trastuzumab;3.Fluorouracil;"
"2315","3.153.201.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Neoadjuvant therapy",153,"Lapatinib & Trastuzumab",FALSE,"1","0.Lapatinib;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;","0.Lapatinib;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;"
"2316","3.153.202.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Neoadjuvant therapy",153,"TCHP (Paclitaxel)",FALSE,"9","14.Carboplatin;0.Paclitaxel;0.Pertuzumab;0.Trastuzumab;7.Paclitaxel;14.Carboplatin;0.Paclitaxel;0.Pertuzumab;0.Trastuzumab;7.Paclitaxel;","14.Carboplatin;0.Paclitaxel;0.Pertuzumab;0.Trastuzumab;7.Paclitaxel;"
"2317","3.153.202.2","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Neoadjuvant therapy",153,"TCHP (Paclitaxel)",FALSE,"9","14.Carboplatin;0.Paclitaxel;0.Pertuzumab;0.Trastuzumab;7.Carboplatin;0.Paclitaxel;14.Carboplatin;0.Paclitaxel;0.Pertuzumab;0.Trastuzumab;7.Carboplatin;0.Paclitaxel;","14.Carboplatin;0.Paclitaxel;0.Pertuzumab;0.Trastuzumab;7.Carboplatin;0.Paclitaxel;"
"2318","3.153.203.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Neoadjuvant therapy",153,"TCHP (Docetaxel)",FALSE,"6","14.Carboplatin;0.Docetaxel;0.Pertuzumab;0.Trastuzumab;7.Docetaxel;14.Carboplatin;0.Docetaxel;0.Pertuzumab;0.Trastuzumab;7.Docetaxel;","14.Carboplatin;0.Docetaxel;0.Pertuzumab;0.Trastuzumab;7.Docetaxel;"
"2319","3.153.204.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Neoadjuvant therapy",153,"Paclitaxel & Trastuzumab (TH)",FALSE,"4","7.Paclitaxel;0.Trastuzumab;7.Paclitaxel;0.Trastuzumab;7.Paclitaxel;0.Trastuzumab;7.Paclitaxel;0.Trastuzumab;7.Paclitaxel;0.Trastuzumab;7.Paclitaxel;0.Trastuzumab;","7.Paclitaxel;0.Trastuzumab;"
"2320","3.153.204.2","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Neoadjuvant therapy",153,"Paclitaxel & Trastuzumab (TH)",FALSE,"4","7.Paclitaxel;0.Trastuzumab;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;0.Trastuzumab;7.Paclitaxel;7.Paclitaxel;","7.Paclitaxel;0.Trastuzumab;7.Paclitaxel;7.Paclitaxel;"
"2321","3.153.204.3","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Neoadjuvant therapy",153,"Paclitaxel & Trastuzumab (TH)",FALSE,"4","7.Paclitaxel;0.Trastuzumab;7.Paclitaxel;0.Trastuzumab;7.Paclitaxel;0.Trastuzumab;7.Paclitaxel;0.Trastuzumab;7.Paclitaxel;0.Trastuzumab;7.Paclitaxel;0.Trastuzumab;7.Paclitaxel;0.Trastuzumab;7.Paclitaxel;0.Trastuzumab;","7.Paclitaxel;0.Trastuzumab;"
"2322","3.153.204.4","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Neoadjuvant therapy",153,"Paclitaxel & Trastuzumab (TH)",FALSE,"4","21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;","21.Paclitaxel;0.Trastuzumab;"
"2323","3.153.205.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Neoadjuvant therapy",153,"Docetaxel & Trastuzumab (TH)",FALSE,"4","21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;","21.Docetaxel;0.Trastuzumab;"
"2324","3.153.205.2","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Neoadjuvant therapy",153,"Docetaxel & Trastuzumab (TH)",FALSE,"5","7.Docetaxel;0.Trastuzumab;7.Trastuzumab;7.Trastuzumab;7.Docetaxel;0.Trastuzumab;7.Trastuzumab;7.Trastuzumab;","7.Docetaxel;0.Trastuzumab;7.Trastuzumab;7.Trastuzumab;"
"2325","3.153.206.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Neoadjuvant therapy",153,"Docetaxel & Trastuzumab (TH) & Pyrotinib",FALSE,"4","21.Docetaxel;0.Pyrotinib;0.Trastuzumab;21.Docetaxel;0.Pyrotinib;0.Trastuzumab;","21.Docetaxel;0.Pyrotinib;0.Trastuzumab;"
"2326","3.153.207.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Neoadjuvant therapy",153,"THL (Paclitaxel)",FALSE,"3","1.Lapatinib;0.Paclitaxel;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Paclitaxel;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Paclitaxel;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Paclitaxel;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Paclitaxel;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Paclitaxel;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Paclitaxel;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Paclitaxel;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;","1.Lapatinib;0.Paclitaxel;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;"
"2327","3.153.207.2","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Neoadjuvant therapy",153,"THL (Paclitaxel)",FALSE,"4","1.Lapatinib;0.Paclitaxel;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Paclitaxel;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Paclitaxel;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Paclitaxel;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Paclitaxel;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Paclitaxel;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Paclitaxel;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Paclitaxel;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;","1.Lapatinib;0.Paclitaxel;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;"
"2328","3.153.208.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Neoadjuvant therapy",153,"THP (Docetaxel)",FALSE,"4","21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;","21.Docetaxel;0.Pertuzumab;0.Trastuzumab;"
"2329","3.153.209.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Neoadjuvant therapy",153,"Lapatinib & Paclitaxel (TL)",FALSE,"3","1.Lapatinib;0.Paclitaxel;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Paclitaxel;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Paclitaxel;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Paclitaxel;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Paclitaxel;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Paclitaxel;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Paclitaxel;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Paclitaxel;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;","1.Lapatinib;0.Paclitaxel;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;"
"2330","3.153.209.2","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Neoadjuvant therapy",153,"Lapatinib & Paclitaxel (TL)",FALSE,"4","1.Lapatinib;0.Paclitaxel;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Paclitaxel;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Paclitaxel;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Paclitaxel;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Paclitaxel;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Paclitaxel;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Paclitaxel;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Paclitaxel;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;","1.Lapatinib;0.Paclitaxel;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;"
"2331","3.153.210.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Neoadjuvant therapy",153,"Trastuzumab monotherapy",FALSE,"1","0.Trastuzumab;7.Trastuzumab;7.Trastuzumab;7.Trastuzumab;7.Trastuzumab;7.Trastuzumab;","0.Trastuzumab;7.Trastuzumab;7.Trastuzumab;7.Trastuzumab;7.Trastuzumab;7.Trastuzumab;"
"2332","3.4.242.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy",4,"FEC & H",NA,NA,"0.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;0.Trastuzumab;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;0.Trastuzumab;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;0.Trastuzumab;21.Trastuzumab;21.Trastuzumab;21.Trastuzumab;21.Trastuzumab;21.Trastuzumab;21.Trastuzumab;","0.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;0.Trastuzumab;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;0.Trastuzumab;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;0.Trastuzumab;21.Trastuzumab;21.Trastuzumab;21.Trastuzumab;21.Trastuzumab;21.Trastuzumab;21.Trastuzumab;"
"2333","3.4.243.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy",4,"Lapatinib & Trastuzumab",FALSE,"12","1.Lapatinib;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;","1.Lapatinib;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;"
"2334","3.4.244.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy",4,"Neratinib monotherapy",FALSE,"12","1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;1.Neratinib;","1.Neratinib;1.Neratinib;"
"2335","3.4.245.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy",4,"TCH (Docetaxel, Carboplatin)",NA,NA,"0.Carboplatin;0.Docetaxel;0.Trastuzumab;21.Carboplatin;0.Docetaxel;0.Trastuzumab;21.Carboplatin;0.Docetaxel;0.Trastuzumab;21.Carboplatin;0.Docetaxel;0.Trastuzumab;21.Carboplatin;0.Docetaxel;0.Trastuzumab;21.Carboplatin;0.Docetaxel;0.Trastuzumab;21.Trastuzumab;21.Trastuzumab;21.Trastuzumab;","0.Carboplatin;0.Docetaxel;0.Trastuzumab;21.Carboplatin;0.Docetaxel;0.Trastuzumab;21.Carboplatin;0.Docetaxel;0.Trastuzumab;21.Carboplatin;0.Docetaxel;0.Trastuzumab;21.Carboplatin;0.Docetaxel;0.Trastuzumab;21.Carboplatin;0.Docetaxel;0.Trastuzumab;21.Trastuzumab;21.Trastuzumab;21.Trastuzumab;"
"2336","3.4.245.2","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy",4,"TCH (Docetaxel, Carboplatin)",NA,NA,"0.Carboplatin;0.Docetaxel;0.Trastuzumab;21.Carboplatin;0.Docetaxel;0.Trastuzumab;21.Carboplatin;0.Docetaxel;0.Trastuzumab;21.Carboplatin;0.Docetaxel;0.Trastuzumab;21.Carboplatin;0.Docetaxel;0.Trastuzumab;21.Carboplatin;0.Docetaxel;0.Trastuzumab;21.Trastuzumab;21.Trastuzumab;21.Trastuzumab;","0.Carboplatin;0.Docetaxel;0.Trastuzumab;21.Carboplatin;0.Docetaxel;0.Trastuzumab;21.Carboplatin;0.Docetaxel;0.Trastuzumab;21.Carboplatin;0.Docetaxel;0.Trastuzumab;21.Carboplatin;0.Docetaxel;0.Trastuzumab;21.Carboplatin;0.Docetaxel;0.Trastuzumab;21.Trastuzumab;21.Trastuzumab;21.Trastuzumab;"
"2337","3.4.246.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy",4,"TCH (Docetaxel, Cyclophosphamide)",NA,NA,"0.Cyclophosphamide;0.Docetaxel;0.Trastuzumab;21.Cyclophosphamide;0.Docetaxel;0.Trastuzumab;21.Cyclophosphamide;0.Docetaxel;0.Trastuzumab;21.Cyclophosphamide;0.Docetaxel;0.Trastuzumab;NA.Trastuzumab;NA.Trastuzumab;NA.Trastuzumab;NA.Trastuzumab;","0.Cyclophosphamide;0.Docetaxel;0.Trastuzumab;21.Cyclophosphamide;0.Docetaxel;0.Trastuzumab;21.Cyclophosphamide;0.Docetaxel;0.Trastuzumab;21.Cyclophosphamide;0.Docetaxel;0.Trastuzumab;NA.Trastuzumab;NA.Trastuzumab;NA.Trastuzumab;NA.Trastuzumab;"
"2338","3.4.247.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy",4,"TCHP (Docetaxel)",NA,NA,"0.Carboplatin;0.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Carboplatin;0.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Carboplatin;0.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Carboplatin;0.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Carboplatin;0.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Carboplatin;0.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;","0.Carboplatin;0.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Carboplatin;0.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Carboplatin;0.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Carboplatin;0.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Carboplatin;0.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Carboplatin;0.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;"
"2339","3.4.248.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy",4,"Paclitaxel & Trastuzumab (TH)",NA,NA,"0.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Trastuzumab;21.Trastuzumab;21.Trastuzumab;21.Trastuzumab;21.Trastuzumab;","0.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Trastuzumab;21.Trastuzumab;21.Trastuzumab;21.Trastuzumab;21.Trastuzumab;"
"2340","3.4.248.2","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy",4,"Paclitaxel & Trastuzumab (TH)",NA,NA,"0.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Trastuzumab;21.Trastuzumab;21.Trastuzumab;21.Trastuzumab;21.Trastuzumab;","0.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Trastuzumab;21.Trastuzumab;21.Trastuzumab;21.Trastuzumab;21.Trastuzumab;"
"2341","3.4.249.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy",4,"Docetaxel & Trastuzumab (TH)",FALSE,"4","21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;","21.Docetaxel;0.Trastuzumab;"
"2342","3.4.249.2","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy",4,"Docetaxel & Trastuzumab (TH)",FALSE,"4","7.Docetaxel;0.Trastuzumab;7.Trastuzumab;7.Trastuzumab;7.Docetaxel;0.Trastuzumab;7.Trastuzumab;7.Trastuzumab;","7.Docetaxel;0.Trastuzumab;7.Trastuzumab;7.Trastuzumab;"
"2343","3.4.250.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy",4,"Trastuzumab monotherapy",FALSE,"9","21.Trastuzumab;21.Trastuzumab;","21.Trastuzumab;21.Trastuzumab;"
"2344","3.4.250.2","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy",4,"Trastuzumab monotherapy",FALSE,"10","21.Trastuzumab;21.Trastuzumab;","21.Trastuzumab;21.Trastuzumab;"
"2345","3.4.250.3","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy",4,"Trastuzumab monotherapy",FALSE,"12","21.Trastuzumab;21.Trastuzumab;","21.Trastuzumab;21.Trastuzumab;"
"2346","3.4.250.4","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy",4,"Trastuzumab monotherapy",FALSE,"14","21.Trastuzumab;21.Trastuzumab;","21.Trastuzumab;21.Trastuzumab;"
"2347","3.4.250.5","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy",4,"Trastuzumab monotherapy",FALSE,"18","21.Trastuzumab;21.Trastuzumab;","21.Trastuzumab;21.Trastuzumab;"
"2348","3.4.250.6","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy",4,"Trastuzumab monotherapy",FALSE,"35","21.Trastuzumab;21.Trastuzumab;","21.Trastuzumab;21.Trastuzumab;"
"2349","3.4.251.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy",4,"Trastuzumab and hyaluronidase monotherapy",FALSE,"9","21.Trastuzumabandhyaluronidase;21.Trastuzumabandhyaluronidase;","21.Trastuzumabandhyaluronidase;21.Trastuzumabandhyaluronidase;"
"2350","3.4.251.2","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy",4,"Trastuzumab and hyaluronidase monotherapy",FALSE,"18","21.Trastuzumabandhyaluronidase;21.Trastuzumabandhyaluronidase;","21.Trastuzumabandhyaluronidase;21.Trastuzumabandhyaluronidase;"
"2351","3.4.252.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy",4,"Trastuzumab emtansine monotherapy",FALSE,"14","21.Trastuzumabemtansine;21.Trastuzumabemtansine;","21.Trastuzumabemtansine;21.Trastuzumabemtansine;"
"2352","3.9.211.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"AC-H",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Trastuzumab;28.Trastuzumab;28.Trastuzumab;28.Trastuzumab;28.Trastuzumab;","0.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Trastuzumab;28.Trastuzumab;28.Trastuzumab;28.Trastuzumab;28.Trastuzumab;"
"2353","3.9.212.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"AC-TH (Paclitaxel)",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Trastuzumab;","0.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Trastuzumab;"
"2354","3.9.212.2","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"AC-TH (Paclitaxel)",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Trastuzumab;","0.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Trastuzumab;"
"2355","3.9.212.3","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"AC-TH (Paclitaxel)",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Trastuzumab;","0.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Trastuzumab;"
"2356","3.9.213.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"ddAC-ddTH (Paclitaxel)",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Paclitaxel;0.Trastuzumab;14.Paclitaxel;0.Trastuzumab;14.Paclitaxel;0.Trastuzumab;14.Paclitaxel;0.Trastuzumab;14.Trastuzumab;","0.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Paclitaxel;0.Trastuzumab;14.Paclitaxel;0.Trastuzumab;14.Paclitaxel;0.Trastuzumab;14.Paclitaxel;0.Trastuzumab;14.Trastuzumab;"
"2357","3.9.214.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"AC-TH (Docetaxel)",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Trastuzumab;","0.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Trastuzumab;"
"2358","3.9.214.2","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"AC-TH (Docetaxel)",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Trastuzumab;21.Trastuzumab;","0.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Trastuzumab;21.Trastuzumab;"
"2359","3.9.214.3","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"AC-TH (Docetaxel)",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Trastuzumab;","0.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Trastuzumab;"
"2360","3.9.215.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"AC-THP (Paclitaxel)",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;","0.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;"
"2361","3.9.216.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"AC-THP (Docetaxel)",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;","0.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;"
"2362","3.9.216.2","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"AC-THP (Docetaxel)",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;","0.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Cyclophosphamide;0.Doxorubicin;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;"
"2363","3.9.217.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"ddAC-TH (Paclitaxel)",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Trastuzumab;","0.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Trastuzumab;"
"2364","3.9.218.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"ddAC-TH (Docetaxel)",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Trastuzumab;","0.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Trastuzumab;"
"2365","3.9.218.2","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"ddAC-TH (Docetaxel)",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Trastuzumab;21.Trastuzumab;","0.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Trastuzumab;21.Trastuzumab;"
"2366","3.9.219.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"ddAC-THP (Paclitaxel)",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;","0.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;"
"2367","3.9.220.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"ddAC-THP (Docetaxel)",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;","0.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;"
"2368","3.9.220.2","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"ddAC-THP (Docetaxel)",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;","0.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Cyclophosphamide;0.Doxorubicin;14.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;"
"2369","3.9.221.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"EC-TH (Paclitaxel)",NA,NA,"0.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Trastuzumab;","0.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Trastuzumab;"
"2370","3.9.223.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"EC-TH (Docetaxel)",NA,NA,"0.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Trastuzumab;","0.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Trastuzumab;"
"2371","3.9.223.2","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"EC-TH (Docetaxel)",NA,NA,"0.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Trastuzumab;21.Trastuzumab;","0.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Trastuzumab;21.Trastuzumab;"
"2372","3.9.224.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"EC-THP (Paclitaxel)",NA,NA,"0.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;","0.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;"
"2373","3.9.225.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"EC-THP (Docetaxel)",NA,NA,"0.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;","0.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;"
"2374","3.9.225.2","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"EC-THP (Docetaxel)",NA,NA,"0.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;","0.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;"
"2375","3.9.226.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"ddEC-TH (Paclitaxel)",NA,NA,"0.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;14.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Trastuzumab;","0.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;14.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Trastuzumab;"
"2376","3.9.227.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"ddEC-TH (Docetaxel)",NA,NA,"0.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;14.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Trastuzumab;","0.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;14.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Trastuzumab;"
"2377","3.9.227.2","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"ddEC-TH (Docetaxel)",NA,NA,"0.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;14.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Trastuzumab;21.Trastuzumab;","0.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;14.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Trastuzumab;21.Trastuzumab;"
"2378","3.9.228.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"ddEC-THP (Paclitaxel)",NA,NA,"0.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;14.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;","0.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;14.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;"
"2379","3.9.229.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"ddEC-THP (Docetaxel)",NA,NA,"0.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;14.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;","0.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;14.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;"
"2380","3.9.229.2","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"ddEC-THP (Docetaxel)",NA,NA,"0.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;14.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;","0.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;14.Cyclophosphamide;0.Epirubicin;14.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;"
"2381","3.9.230.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"FAC-TH (Paclitaxel)",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Trastuzumab;21.Trastuzumab;","0.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Trastuzumab;21.Trastuzumab;"
"2382","3.9.231.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"FAC-TH (Docetaxel)",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Trastuzumab;21.Trastuzumab;","0.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Trastuzumab;21.Trastuzumab;"
"2383","3.9.231.2","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"FAC-TH (Docetaxel)",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Trastuzumab;21.Trastuzumab;21.Trastuzumab;","0.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Trastuzumab;21.Trastuzumab;21.Trastuzumab;"
"2384","3.9.232.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"FAC-THP (Paclitaxel)",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;","0.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;"
"2385","3.9.233.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"FAC-THP (Docetaxel)",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;","0.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;"
"2386","3.9.233.2","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"FAC-THP (Docetaxel)",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;","0.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;"
"2387","3.9.234.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"FEC-TH (Paclitaxel)",NA,NA,"0.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Trastuzumab;21.Trastuzumab;","0.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Paclitaxel;0.Trastuzumab;21.Trastuzumab;21.Trastuzumab;"
"2388","3.9.235.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"FEC-TH (Docetaxel)",NA,NA,"0.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Trastuzumab;21.Trastuzumab;","0.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Trastuzumab;21.Trastuzumab;"
"2389","3.9.235.2","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"FEC-TH (Docetaxel)",NA,NA,"0.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Trastuzumab;21.Trastuzumab;21.Trastuzumab;","0.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Trastuzumab;21.Trastuzumab;21.Trastuzumab;"
"2390","3.9.236.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"ddFEC-ddTH (Docetaxel)",NA,NA,"0.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;14.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;14.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;14.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;14.Docetaxel;0.Trastuzumab;14.Docetaxel;0.Trastuzumab;14.Docetaxel;0.Trastuzumab;14.Docetaxel;0.Trastuzumab;14.Trastuzumab;","0.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;14.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;14.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;14.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;14.Docetaxel;0.Trastuzumab;14.Docetaxel;0.Trastuzumab;14.Docetaxel;0.Trastuzumab;14.Docetaxel;0.Trastuzumab;14.Trastuzumab;"
"2391","3.9.237.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"FEC-THP (Paclitaxel)",NA,NA,"0.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;","0.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;"
"2392","3.9.237.2","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"FEC-THP (Paclitaxel)",NA,NA,"0.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;","0.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Paclitaxel;0.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;"
"2393","3.9.238.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"FEC-THP (Docetaxel)",NA,NA,"0.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;","0.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;"
"2394","3.9.238.2","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"FEC-THP (Docetaxel)",NA,NA,"0.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;","0.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;"
"2395","3.9.238.3","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"FEC-THP (Docetaxel)",NA,NA,"0.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;","0.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Cyclophosphamide;0.Epirubicin;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;"
"2396","3.9.238.4","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"FEC-THP (Docetaxel)",NA,NA,"0.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;","0.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Docetaxel;0.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;"
"2397","3.9.239.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"TH-FEC (Docetaxel)",NA,NA,"0.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;","0.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;"
"2398","3.9.239.2","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"TH-FEC (Docetaxel)",NA,NA,"0.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;","0.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Docetaxel;0.Trastuzumab;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;"
"2399","3.9.240.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"TH-FEC (Docetaxel, SC Trastuzumab)",NA,NA,"0.Docetaxel;0.Trastuzumabandhyaluronidase;21.Docetaxel;0.Trastuzumabandhyaluronidase;21.Docetaxel;0.Trastuzumabandhyaluronidase;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;","0.Docetaxel;0.Trastuzumabandhyaluronidase;21.Docetaxel;0.Trastuzumabandhyaluronidase;21.Docetaxel;0.Trastuzumabandhyaluronidase;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;"
"2400","3.9.241.1","Solid Tumor","Breast Oncology","Breast cancer, HER2-positive",3,"Adjuvant therapy, sequential protocols",9,"VH-FEC",NA,NA,"0.Trastuzumab;0.Vinorelbine;21.Trastuzumab;0.Vinorelbine;21.Trastuzumab;0.Vinorelbine;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;","0.Trastuzumab;0.Vinorelbine;21.Trastuzumab;0.Vinorelbine;21.Trastuzumab;0.Vinorelbine;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Epirubicin;0.Fluorouracil;"
"2401","30.25.505.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer, BRAF-mutated",30,"Advanced or metastatic disease, second or third-line therapy",25,"Binimetinib, Encorafenib, Cetuximab",TRUE,"Cont.","1.Binimetinib;0.Cetuximab;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Cetuximab;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Cetuximab;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Cetuximab;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Cetuximab;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Cetuximab;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Cetuximab;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Cetuximab;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;","1.Binimetinib;0.Cetuximab;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;1.Binimetinib;0.Encorafenib;"
"2402","30.25.506.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer, BRAF-mutated",30,"Advanced or metastatic disease, second or third-line therapy",25,"Encorafenib & Cetuximab",TRUE,"Cont.","1.Cetuximab;0.Encorafenib;1.Encorafenib;1.Encorafenib;1.Encorafenib;1.Encorafenib;1.Encorafenib;1.Encorafenib;1.Cetuximab;0.Encorafenib;1.Encorafenib;1.Encorafenib;1.Encorafenib;1.Encorafenib;1.Encorafenib;1.Encorafenib;1.Cetuximab;0.Encorafenib;1.Encorafenib;1.Encorafenib;1.Encorafenib;1.Encorafenib;1.Encorafenib;1.Encorafenib;1.Cetuximab;0.Encorafenib;1.Encorafenib;1.Encorafenib;1.Encorafenib;1.Encorafenib;1.Encorafenib;1.Encorafenib;1.Cetuximab;0.Encorafenib;1.Encorafenib;1.Encorafenib;1.Encorafenib;1.Encorafenib;1.Encorafenib;1.Encorafenib;1.Cetuximab;0.Encorafenib;1.Encorafenib;1.Encorafenib;1.Encorafenib;1.Encorafenib;1.Encorafenib;1.Encorafenib;1.Cetuximab;0.Encorafenib;1.Encorafenib;1.Encorafenib;1.Encorafenib;1.Encorafenib;1.Encorafenib;1.Encorafenib;1.Cetuximab;0.Encorafenib;1.Encorafenib;1.Encorafenib;1.Encorafenib;1.Encorafenib;1.Encorafenib;1.Encorafenib;","1.Cetuximab;0.Encorafenib;1.Encorafenib;1.Encorafenib;1.Encorafenib;1.Encorafenib;1.Encorafenib;1.Encorafenib;"
"2403","30.25.507.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer, BRAF-mutated",30,"Advanced or metastatic disease, second or third-line therapy",25,"Irinotecan, Vemurafenib, Cetuximab",TRUE,"Cont.","14.Cetuximab;0.Irinotecan;0.Vemurafenib;14.Cetuximab;0.Irinotecan;0.Vemurafenib;","14.Cetuximab;0.Irinotecan;0.Vemurafenib;"
"2404","30.25.508.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer, BRAF-mutated",30,"Advanced or metastatic disease, second or third-line therapy",25,"Dabrafenib, Trametinib, Panitumumab",TRUE,"Cont.","1.Dabrafenib;0.Panitumumab;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Panitumumab;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;","1.Dabrafenib;0.Panitumumab;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;"
"2405","31.25.509.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer, HER2-positive",31,"Advanced or metastatic disease, second or third-line therapy",25,"Pertuzumab & Trastuzumab",TRUE,"Cont.","21.Pertuzumab;0.Trastuzumab;21.Pertuzumab;0.Trastuzumab;","21.Pertuzumab;0.Trastuzumab;"
"2406","31.25.510.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer, HER2-positive",31,"Advanced or metastatic disease, second or third-line therapy",25,"Lapatinib & Trastuzumab",TRUE,"Cont.","1.Lapatinib;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;","1.Lapatinib;0.Trastuzumab;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;1.Lapatinib;"
"2407","31.25.511.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer, HER2-positive",31,"Advanced or metastatic disease, second or third-line therapy",25,"Trastuzumab deruxtecan monotherapy",TRUE,"Cont.","21.Trastuzumabderuxtecan;21.Trastuzumabderuxtecan;","21.Trastuzumabderuxtecan;21.Trastuzumabderuxtecan;"
"2408","31.25.512.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer, HER2-positive",31,"Advanced or metastatic disease, second or third-line therapy",25,"Tucatinib & Trastuzumab",TRUE,"Cont.","1.Trastuzumab;0.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Trastuzumab;0.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;","1.Trastuzumab;0.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;1.Tucatinib;"
"2409","32.19.513.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer, MSI-H or dMMR",32,"Advanced or metastatic disease, first-line",19,"Atezolizumab monotherapy",TRUE,"Cont.","14.Atezolizumab;14.Atezolizumab;","14.Atezolizumab;14.Atezolizumab;"
"2410","32.26.514.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer, MSI-H or dMMR",32,"Advanced or metastatic disease, subsequent lines of therapy",26,"Ipilimumab & Nivolumab",TRUE,"Cont.","21.Ipilimumab;0.Nivolumab;21.Ipilimumab;0.Nivolumab;","21.Ipilimumab;0.Nivolumab;"
"2411","32.26.514.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer, MSI-H or dMMR",32,"Advanced or metastatic disease, subsequent lines of therapy",26,"Ipilimumab & Nivolumab",TRUE,"Cont.","14.Ipilimumab;0.Nivolumab;14.Ipilimumab;0.Nivolumab;","14.Ipilimumab;0.Nivolumab;"
"2412","33.114.525.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer, RAS wild-type",33,"Maintenance after first-line therapy",114,"Cetuximab monotherapy",TRUE,"Cont.","7.Cetuximab;7.Cetuximab;","7.Cetuximab;7.Cetuximab;"
"2413","33.114.525.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer, RAS wild-type",33,"Maintenance after first-line therapy",114,"Cetuximab monotherapy",TRUE,"Cont.","14.Cetuximab;14.Cetuximab;","14.Cetuximab;14.Cetuximab;"
"2414","33.114.527.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer, RAS wild-type",33,"Maintenance after first-line therapy",114,"Irinotecan monotherapy",TRUE,"Cont.","14.Irinotecan;14.Irinotecan;","14.Irinotecan;14.Irinotecan;"
"2415","33.114.528.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer, RAS wild-type",33,"Maintenance after first-line therapy",114,"Irinotecan & Cetuximab",TRUE,"Cont.","7.Cetuximab;0.Irinotecan;7.Cetuximab;7.Cetuximab;7.Cetuximab;0.Irinotecan;7.Cetuximab;7.Cetuximab;","7.Cetuximab;0.Irinotecan;7.Cetuximab;7.Cetuximab;"
"2416","33.158.515.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer, RAS wild-type",33,"Perioperative therapy for oligometastatic disease",158,"FOLFIRI & Cetuximab",TRUE,"Cont.","7.Cetuximab;0.Fluorouracil;0.Irinotecan;7.Cetuximab;7.Cetuximab;0.Fluorouracil;0.Irinotecan;7.Cetuximab;","7.Cetuximab;0.Fluorouracil;0.Irinotecan;7.Cetuximab;"
"2417","33.158.515.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer, RAS wild-type",33,"Perioperative therapy for oligometastatic disease",158,"FOLFIRI & Cetuximab",TRUE,"Cont.","14.Cetuximab;0.Fluorouracil;0.Irinotecan;14.Cetuximab;0.Fluorouracil;0.Irinotecan;","14.Cetuximab;0.Fluorouracil;0.Irinotecan;"
"2418","33.158.515.3","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer, RAS wild-type",33,"Perioperative therapy for oligometastatic disease",158,"FOLFIRI & Cetuximab",TRUE,"Cont.","7.Cetuximab;0.Fluorouracil;0.Irinotecan;1.Fluorouracil;1.Fluorouracil;5.Cetuximab;7.Cetuximab;0.Fluorouracil;0.Irinotecan;1.Fluorouracil;1.Fluorouracil;5.Cetuximab;","7.Cetuximab;0.Fluorouracil;0.Irinotecan;1.Fluorouracil;1.Fluorouracil;5.Cetuximab;"
"2419","33.158.515.4","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer, RAS wild-type",33,"Perioperative therapy for oligometastatic disease",158,"FOLFIRI & Cetuximab",TRUE,"Cont.","12.Cetuximab;0.Fluorouracil;0.Irinotecan;1.Fluorouracil;1.Fluorouracil;12.Cetuximab;0.Fluorouracil;0.Irinotecan;1.Fluorouracil;1.Fluorouracil;","12.Cetuximab;0.Fluorouracil;0.Irinotecan;1.Fluorouracil;1.Fluorouracil;"
"2420","33.158.516.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer, RAS wild-type",33,"Perioperative therapy for oligometastatic disease",158,"mFOLFOX6 & Cetuximab",TRUE,"Cont.","14.Cetuximab;0.Fluorouracil;0.Oxaliplatin;14.Cetuximab;0.Fluorouracil;0.Oxaliplatin;","14.Cetuximab;0.Fluorouracil;0.Oxaliplatin;"
"2421","33.158.516.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer, RAS wild-type",33,"Perioperative therapy for oligometastatic disease",158,"mFOLFOX6 & Cetuximab",TRUE,"Cont.","12.Cetuximab;0.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Cetuximab;0.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;","12.Cetuximab;0.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;"
"2422","33.19.517.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer, RAS wild-type",33,"Advanced or metastatic disease, first-line",19,"CapeOx & Panitumumab",TRUE,"Cont.","8.Capecitabine;0.Oxaliplatin;0.Panitumumab;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Capecitabine;0.Oxaliplatin;0.Panitumumab;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Capecitabine;0.Oxaliplatin;0.Panitumumab;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2423","33.19.518.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer, RAS wild-type",33,"Advanced or metastatic disease, first-line",19,"FOLFIRI & Cetuximab (L-Leucovorin)",TRUE,"Cont.","14.Cetuximab;0.Fluorouracil;0.Irinotecan;0.Levoleucovorin;14.Cetuximab;0.Fluorouracil;0.Irinotecan;0.Levoleucovorin;","14.Cetuximab;0.Fluorouracil;0.Irinotecan;0.Levoleucovorin;"
"2424","33.19.519.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer, RAS wild-type",33,"Advanced or metastatic disease, first-line",19,"FOLFOX4",TRUE,"Cont.","13.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;13.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;","13.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;"
"2425","33.19.519.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer, RAS wild-type",33,"Advanced or metastatic disease, first-line",19,"FOLFOX4",TRUE,"Cont.","12.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;","12.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;"
"2426","33.19.520.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer, RAS wild-type",33,"Advanced or metastatic disease, first-line",19,"FOLFOX4 & Cetuximab",TRUE,"Cont.","7.Cetuximab;0.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;6.Cetuximab;7.Cetuximab;0.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;6.Cetuximab;","7.Cetuximab;0.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;6.Cetuximab;"
"2427","33.19.520.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer, RAS wild-type",33,"Advanced or metastatic disease, first-line",19,"FOLFOX4 & Cetuximab",TRUE,"Cont.","7.Cetuximab;0.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;5.Cetuximab;7.Cetuximab;0.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;5.Cetuximab;","7.Cetuximab;0.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;5.Cetuximab;"
"2428","33.19.521.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer, RAS wild-type",33,"Advanced or metastatic disease, first-line",19,"FOLFOX4 & Panitumumab",TRUE,"Cont.","13.Fluorouracil;0.Oxaliplatin;0.Panitumumab;1.Fluorouracil;13.Fluorouracil;0.Oxaliplatin;0.Panitumumab;1.Fluorouracil;","13.Fluorouracil;0.Oxaliplatin;0.Panitumumab;1.Fluorouracil;"
"2429","33.19.521.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer, RAS wild-type",33,"Advanced or metastatic disease, first-line",19,"FOLFOX4 & Panitumumab",TRUE,"Cont.","12.Fluorouracil;0.Oxaliplatin;0.Panitumumab;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Oxaliplatin;0.Panitumumab;1.Fluorouracil;1.Fluorouracil;","12.Fluorouracil;0.Oxaliplatin;0.Panitumumab;1.Fluorouracil;1.Fluorouracil;"
"2430","33.19.522.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer, RAS wild-type",33,"Advanced or metastatic disease, first-line",19,"mFOLFOX6 & Panitumumab",TRUE,"Cont.","14.Fluorouracil;0.Oxaliplatin;0.Panitumumab;14.Fluorouracil;0.Oxaliplatin;0.Panitumumab;","14.Fluorouracil;0.Oxaliplatin;0.Panitumumab;"
"2431","33.19.522.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer, RAS wild-type",33,"Advanced or metastatic disease, first-line",19,"mFOLFOX6 & Panitumumab",TRUE,"Cont.","12.Fluorouracil;0.Oxaliplatin;0.Panitumumab;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Oxaliplatin;0.Panitumumab;1.Fluorouracil;1.Fluorouracil;","12.Fluorouracil;0.Oxaliplatin;0.Panitumumab;1.Fluorouracil;1.Fluorouracil;"
"2432","33.19.523.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer, RAS wild-type",33,"Advanced or metastatic disease, first-line",19,"mFOLFOXIRI & Cetuximab (L-Leucovorin)",FALSE,"8","14.Cetuximab;0.Fluorouracil;0.Irinotecan;0.Levoleucovorin;0.Oxaliplatin;14.Cetuximab;0.Fluorouracil;0.Irinotecan;0.Levoleucovorin;0.Oxaliplatin;","14.Cetuximab;0.Fluorouracil;0.Irinotecan;0.Levoleucovorin;0.Oxaliplatin;"
"2433","33.19.523.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer, RAS wild-type",33,"Advanced or metastatic disease, first-line",19,"mFOLFOXIRI & Cetuximab (L-Leucovorin)",FALSE,"8","12.Cetuximab;0.Fluorouracil;0.Irinotecan;0.Levoleucovorin;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Cetuximab;0.Fluorouracil;0.Irinotecan;0.Levoleucovorin;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;","12.Cetuximab;0.Fluorouracil;0.Irinotecan;0.Levoleucovorin;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;"
"2434","33.19.524.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer, RAS wild-type",33,"Advanced or metastatic disease, first-line",19,"FOLFOXIRI & Panitumumab",TRUE,"Cont.","14.Fluorouracil;0.Irinotecan;0.Oxaliplatin;0.Panitumumab;14.Fluorouracil;0.Irinotecan;0.Oxaliplatin;0.Panitumumab;","14.Fluorouracil;0.Irinotecan;0.Oxaliplatin;0.Panitumumab;"
"2435","33.19.524.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer, RAS wild-type",33,"Advanced or metastatic disease, first-line",19,"FOLFOXIRI & Panitumumab",TRUE,"Cont.","12.Fluorouracil;0.Irinotecan;0.Oxaliplatin;0.Panitumumab;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Irinotecan;0.Oxaliplatin;0.Panitumumab;1.Fluorouracil;1.Fluorouracil;","12.Fluorouracil;0.Irinotecan;0.Oxaliplatin;0.Panitumumab;1.Fluorouracil;1.Fluorouracil;"
"2436","33.23.526.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer, RAS wild-type",33,"Advanced or metastatic disease, second-line",23,"FOLFIRI & Panitumumab",TRUE,"Cont.","14.Fluorouracil;0.Irinotecan;0.Panitumumab;14.Fluorouracil;0.Irinotecan;0.Panitumumab;","14.Fluorouracil;0.Irinotecan;0.Panitumumab;"
"2437","33.23.526.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer, RAS wild-type",33,"Advanced or metastatic disease, second-line",23,"FOLFIRI & Panitumumab",TRUE,"Cont.","12.Fluorouracil;0.Irinotecan;0.Panitumumab;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Irinotecan;0.Panitumumab;1.Fluorouracil;1.Fluorouracil;","12.Fluorouracil;0.Irinotecan;0.Panitumumab;1.Fluorouracil;1.Fluorouracil;"
"2438","33.26.528.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer, RAS wild-type",33,"Advanced or metastatic disease, subsequent lines of therapy",26,"Irinotecan & Cetuximab",TRUE,"Cont.","7.Cetuximab;0.Irinotecan;7.Cetuximab;0.Irinotecan;7.Cetuximab;7.Cetuximab;0.Irinotecan;7.Cetuximab;0.Irinotecan;7.Cetuximab;","7.Cetuximab;0.Irinotecan;7.Cetuximab;0.Irinotecan;7.Cetuximab;"
"2439","33.26.528.3","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer, RAS wild-type",33,"Advanced or metastatic disease, subsequent lines of therapy",26,"Irinotecan & Cetuximab",TRUE,"Cont.","7.Cetuximab;0.Irinotecan;7.Cetuximab;0.Irinotecan;7.Cetuximab;0.Irinotecan;7.Cetuximab;0.Irinotecan;7.Cetuximab;7.Cetuximab;7.Cetuximab;0.Irinotecan;7.Cetuximab;0.Irinotecan;7.Cetuximab;0.Irinotecan;7.Cetuximab;0.Irinotecan;7.Cetuximab;7.Cetuximab;","7.Cetuximab;0.Irinotecan;7.Cetuximab;0.Irinotecan;7.Cetuximab;0.Irinotecan;7.Cetuximab;0.Irinotecan;7.Cetuximab;7.Cetuximab;"
"2440","33.26.528.4","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer, RAS wild-type",33,"Advanced or metastatic disease, subsequent lines of therapy",26,"Irinotecan & Cetuximab",TRUE,"Cont.","14.Cetuximab;0.Irinotecan;14.Cetuximab;0.Irinotecan;","14.Cetuximab;0.Irinotecan;"
"2441","33.26.528.5","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer, RAS wild-type",33,"Advanced or metastatic disease, subsequent lines of therapy",26,"Irinotecan & Cetuximab",TRUE,"Cont.","7.Cetuximab;0.Irinotecan;7.Cetuximab;7.Cetuximab;0.Irinotecan;7.Cetuximab;0.Irinotecan;7.Cetuximab;7.Cetuximab;0.Irinotecan;","7.Cetuximab;0.Irinotecan;7.Cetuximab;7.Cetuximab;0.Irinotecan;"
"2442","33.26.529.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer, RAS wild-type",33,"Advanced or metastatic disease, subsequent lines of therapy",26,"Cetuximab monotherapy",TRUE,"Cont.","7.Cetuximab;7.Cetuximab;7.Cetuximab;7.Cetuximab;7.Cetuximab;7.Cetuximab;7.Cetuximab;7.Cetuximab;","7.Cetuximab;7.Cetuximab;"
"2443","33.26.530.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Colorectal cancer, RAS wild-type",33,"Advanced or metastatic disease, subsequent lines of therapy",26,"Panitumumab monotherapy",TRUE,"Cont.","14.Panitumumab;14.Panitumumab;","14.Panitumumab;14.Panitumumab;"
"2444","34.135.561.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Metastatic or locally advanced disease, first-line",135,"Carboplatin & Paclitaxel (CP) & RT",TRUE,"Cont.","21.Carboplatin;0.Paclitaxel;21.Carboplatin;0.Paclitaxel;","21.Carboplatin;0.Paclitaxel;"
"2445","34.135.562.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Metastatic or locally advanced disease, first-line",135,"Cisplatin & Fluorouracil (CF) & Pembrolizumab",TRUE,"Cont.","21.Cisplatin;0.Fluorouracil;0.Pembrolizumab;21.Cisplatin;0.Fluorouracil;0.Pembrolizumab;","21.Cisplatin;0.Fluorouracil;0.Pembrolizumab;"
"2446","34.135.562.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Metastatic or locally advanced disease, first-line",135,"Cisplatin & Fluorouracil (CF) & Pembrolizumab",TRUE,"Cont.","16.Cisplatin;0.Fluorouracil;0.Pembrolizumab;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;16.Cisplatin;0.Fluorouracil;0.Pembrolizumab;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","16.Cisplatin;0.Fluorouracil;0.Pembrolizumab;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2447","34.135.563.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Metastatic or locally advanced disease, first-line",135,"Cisplatin & Irinotecan (IC)",TRUE,"Cont.","7.Cisplatin;0.Cisplatin;0.Irinotecan;0.Irinotecan;7.Cisplatin;0.Cisplatin;0.Irinotecan;0.Irinotecan;7.Cisplatin;0.Irinotecan;7.Cisplatin;0.Cisplatin;0.Irinotecan;0.Irinotecan;7.Cisplatin;0.Cisplatin;0.Irinotecan;0.Irinotecan;7.Cisplatin;0.Irinotecan;","7.Cisplatin;0.Cisplatin;0.Irinotecan;0.Irinotecan;7.Cisplatin;0.Cisplatin;0.Irinotecan;0.Irinotecan;7.Cisplatin;0.Irinotecan;"
"2448","34.135.564.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Metastatic or locally advanced disease, first-line",135,"Cisplatin & Paclitaxel",TRUE,"Cont.","20.Paclitaxel;1.Cisplatin;20.Paclitaxel;1.Cisplatin;","20.Paclitaxel;1.Cisplatin;"
"2449","34.135.564.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Metastatic or locally advanced disease, first-line",135,"Cisplatin & Paclitaxel",TRUE,"Cont.","14.Cisplatin;0.Paclitaxel;14.Cisplatin;0.Paclitaxel;","14.Cisplatin;0.Paclitaxel;"
"2450","34.135.564.3","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Metastatic or locally advanced disease, first-line",135,"Cisplatin & Paclitaxel",TRUE,"Cont.","13.Paclitaxel;1.Cisplatin;0.Paclitaxel;13.Paclitaxel;1.Cisplatin;0.Paclitaxel;","13.Paclitaxel;1.Cisplatin;0.Paclitaxel;"
"2451","34.135.565.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Metastatic or locally advanced disease, first-line",135,"Docetaxel & Irinotecan",TRUE,"Cont.","14.Docetaxel;0.Irinotecan;7.Docetaxel;0.Irinotecan;14.Docetaxel;0.Irinotecan;7.Docetaxel;0.Irinotecan;","14.Docetaxel;0.Irinotecan;7.Docetaxel;0.Irinotecan;"
"2452","34.135.566.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Metastatic or locally advanced disease, first-line",135,"ECF",TRUE,"Cont.","21.Cisplatin;0.Epirubicin;0.Fluorouracil;21.Cisplatin;0.Epirubicin;0.Fluorouracil;","21.Cisplatin;0.Epirubicin;0.Fluorouracil;"
"2453","34.135.566.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Metastatic or locally advanced disease, first-line",135,"ECF",TRUE,"Cont.","1.Cisplatin;0.Epirubicin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Cisplatin;0.Epirubicin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","1.Cisplatin;0.Epirubicin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2454","34.135.567.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Metastatic or locally advanced disease, first-line",135,"ECX",TRUE,"Cont.","1.Capecitabine;0.Cisplatin;0.Epirubicin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Cisplatin;0.Epirubicin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","1.Capecitabine;0.Cisplatin;0.Epirubicin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2455","34.135.568.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Metastatic or locally advanced disease, first-line",135,"EOF",TRUE,"Cont.","21.Epirubicin;0.Fluorouracil;0.Oxaliplatin;21.Epirubicin;0.Fluorouracil;0.Oxaliplatin;","21.Epirubicin;0.Fluorouracil;0.Oxaliplatin;"
"2456","34.135.568.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Metastatic or locally advanced disease, first-line",135,"EOF",TRUE,"Cont.","1.Epirubicin;0.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Epirubicin;0.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","1.Epirubicin;0.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2457","34.135.569.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Metastatic or locally advanced disease, first-line",135,"EOX",TRUE,"Cont.","1.Capecitabine;0.Epirubicin;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Epirubicin;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","1.Capecitabine;0.Epirubicin;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2458","34.135.570.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Metastatic or locally advanced disease, first-line",135,"mFOLFOX6 & Cetuximab",TRUE,"Cont.","7.Cetuximab;0.Fluorouracil;0.Oxaliplatin;7.Cetuximab;7.Cetuximab;0.Fluorouracil;0.Oxaliplatin;7.Cetuximab;","7.Cetuximab;0.Fluorouracil;0.Oxaliplatin;7.Cetuximab;"
"2459","34.135.571.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Metastatic or locally advanced disease, first-line",135,"FULV & Gemcitabine",TRUE,"Cont.","14.Fluorouracil;0.Gemcitabine;7.Fluorouracil;0.Gemcitabine;7.Fluorouracil;0.Gemcitabine;14.Fluorouracil;0.Gemcitabine;7.Fluorouracil;0.Gemcitabine;7.Fluorouracil;0.Gemcitabine;","14.Fluorouracil;0.Gemcitabine;7.Fluorouracil;0.Gemcitabine;7.Fluorouracil;0.Gemcitabine;"
"2460","34.135.572.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Metastatic or locally advanced disease, first-line",135,"LdCF",TRUE,"Cont.","14.Cisplatin;0.Fluorouracil;0.Pegylatedliposomaldoxorubicin;14.Cisplatin;0.Fluorouracil;0.Pegylatedliposomaldoxorubicin;","14.Cisplatin;0.Fluorouracil;0.Pegylatedliposomaldoxorubicin;"
"2461","34.135.572.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Metastatic or locally advanced disease, first-line",135,"LdCF",TRUE,"Cont.","13.Cisplatin;0.Fluorouracil;0.Pegylatedliposomaldoxorubicin;1.Fluorouracil;13.Cisplatin;0.Fluorouracil;0.Pegylatedliposomaldoxorubicin;1.Fluorouracil;","13.Cisplatin;0.Fluorouracil;0.Pegylatedliposomaldoxorubicin;1.Fluorouracil;"
"2462","34.135.573.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Metastatic or locally advanced disease, first-line",135,"MCF",TRUE,"Cont.","21.Cisplatin;0.Fluorouracil;0.Mitomycin;21.Cisplatin;21.Cisplatin;0.Fluorouracil;0.Mitomycin;21.Cisplatin;","21.Cisplatin;0.Fluorouracil;0.Mitomycin;21.Cisplatin;"
"2463","34.135.573.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Metastatic or locally advanced disease, first-line",135,"MCF",TRUE,"Cont.","1.Cisplatin;0.Fluorouracil;0.Mitomycin;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Cisplatin;0.Fluorouracil;0.Mitomycin;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","1.Cisplatin;0.Fluorouracil;0.Mitomycin;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2464","34.135.574.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Metastatic or locally advanced disease, first-line",135,"Paclitaxel monotherapy",TRUE,"Cont.","7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;","7.Paclitaxel;7.Paclitaxel;"
"2465","34.135.574.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Metastatic or locally advanced disease, first-line",135,"Paclitaxel monotherapy",TRUE,"Cont.","21.Paclitaxel;21.Paclitaxel;","21.Paclitaxel;21.Paclitaxel;"
"2466","34.135.574.3","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Metastatic or locally advanced disease, first-line",135,"Paclitaxel monotherapy",TRUE,"Cont.","20.Paclitaxel;1.Paclitaxel;20.Paclitaxel;1.Paclitaxel;","20.Paclitaxel;1.Paclitaxel;"
"2467","34.136.574.4","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Metastatic or locally advanced disease, subsequent lines of therapy",136,"Paclitaxel monotherapy",TRUE,"Cont.","14.Paclitaxel;7.Paclitaxel;7.Paclitaxel;14.Paclitaxel;7.Paclitaxel;7.Paclitaxel;","14.Paclitaxel;7.Paclitaxel;7.Paclitaxel;"
"2468","34.136.575.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Metastatic or locally advanced disease, subsequent lines of therapy",136,"Docetaxel monotherapy",TRUE,"Cont.","21.Docetaxel;21.Docetaxel;","21.Docetaxel;21.Docetaxel;"
"2469","34.136.576.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Metastatic or locally advanced disease, subsequent lines of therapy",136,"Erlotinib monotherapy",TRUE,"Cont.","1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;","1.Erlotinib;1.Erlotinib;"
"2470","34.136.577.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Metastatic or locally advanced disease, subsequent lines of therapy",136,"IRIS",TRUE,"Cont.","5.Irinotecan;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;5.Irinotecan;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;","5.Irinotecan;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;"
"2471","34.146.539.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Neoadjuvant chemoradiotherapy",146,"Capecitabine, Carboplatin, Paclitaxel, RT",FALSE,"1","0.Capecitabine;1.Capecitabine;0.Carboplatin;0.Paclitaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Carboplatin;0.Paclitaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Carboplatin;0.Paclitaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Carboplatin;0.Paclitaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Carboplatin;0.Paclitaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","0.Capecitabine;1.Capecitabine;0.Carboplatin;0.Paclitaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Carboplatin;0.Paclitaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Carboplatin;0.Paclitaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Carboplatin;0.Paclitaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Carboplatin;0.Paclitaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2472","34.146.540.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Neoadjuvant chemoradiotherapy",146,"Capecitabine, Cisplatin, RT",TRUE,"Cont.","3.Capecitabine;0.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;3.Capecitabine;0.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;","3.Capecitabine;0.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;"
"2473","34.146.541.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Neoadjuvant chemoradiotherapy",146,"Capecitabine, Docetaxel, RT",FALSE,"5","3.Capecitabine;0.Docetaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;3.Capecitabine;0.Docetaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","3.Capecitabine;0.Docetaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2474","34.146.542.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Neoadjuvant chemoradiotherapy",146,"Capecitabine, Docetaxel, Oxaliplatin, RT",FALSE,"1","0.Capecitabine;0.Docetaxel;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Docetaxel;0.Oxaliplatin;7.Capecitabine;0.Docetaxel;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Docetaxel;0.Oxaliplatin;7.Capecitabine;0.Docetaxel;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","0.Capecitabine;0.Docetaxel;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Docetaxel;0.Oxaliplatin;7.Capecitabine;0.Docetaxel;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Docetaxel;0.Oxaliplatin;7.Capecitabine;0.Docetaxel;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2475","34.146.543.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Neoadjuvant chemoradiotherapy",146,"Capecitabine, Oxaliplatin, RT",FALSE,"1","0.Capecitabine;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;3.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;3.Capecitabine;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;3.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;3.Capecitabine;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","0.Capecitabine;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;3.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;3.Capecitabine;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;3.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;3.Capecitabine;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2476","34.146.544.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Neoadjuvant chemoradiotherapy",146,"Capecitabine, Paclitaxel, RT",FALSE,"1","0.Capecitabine;0.Paclitaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;3.Capecitabine;0.Paclitaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;3.Capecitabine;0.Paclitaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;3.Capecitabine;0.Paclitaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;3.Capecitabine;0.Paclitaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","0.Capecitabine;0.Paclitaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;3.Capecitabine;0.Paclitaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;3.Capecitabine;0.Paclitaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;3.Capecitabine;0.Paclitaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;3.Capecitabine;0.Paclitaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2477","34.146.545.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Neoadjuvant chemoradiotherapy",146,"Carboplatin, Fluorouracil, RT",FALSE,"2","21.Carboplatin;0.Fluorouracil;","21.Carboplatin;0.Fluorouracil;"
"2478","34.146.545.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Neoadjuvant chemoradiotherapy",146,"Carboplatin, Fluorouracil, RT",FALSE,"2","1.Carboplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","1.Carboplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2479","34.146.546.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Neoadjuvant chemoradiotherapy",146,"Carboplatin & Paclitaxel (CP) & RT",FALSE,"1","0.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;","0.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;"
"2480","34.146.546.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Neoadjuvant chemoradiotherapy",146,"Carboplatin & Paclitaxel (CP) & RT",FALSE,"6","7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;","7.Carboplatin;0.Paclitaxel;"
"2481","34.146.547.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Neoadjuvant chemoradiotherapy",146,"Cisplatin, Docetaxel, RT",FALSE,"1","0.Cisplatin;0.Docetaxel;7.Cisplatin;0.Docetaxel;7.Cisplatin;0.Docetaxel;7.Cisplatin;0.Docetaxel;7.Cisplatin;0.Docetaxel;","0.Cisplatin;0.Docetaxel;7.Cisplatin;0.Docetaxel;7.Cisplatin;0.Docetaxel;7.Cisplatin;0.Docetaxel;7.Cisplatin;0.Docetaxel;"
"2482","34.146.548.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Neoadjuvant chemoradiotherapy",146,"Cisplatin & Fluorouracil (CF) & RT",FALSE,"2","28.Cisplatin;0.Fluorouracil;","28.Cisplatin;0.Fluorouracil;"
"2483","34.146.548.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Neoadjuvant chemoradiotherapy",146,"Cisplatin & Fluorouracil (CF) & RT",FALSE,"2","27.Fluorouracil;1.Cisplatin;","27.Fluorouracil;1.Cisplatin;"
"2484","34.146.548.3","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Neoadjuvant chemoradiotherapy",146,"Cisplatin & Fluorouracil (CF) & RT",FALSE,"2","17.Cisplatin;0.Fluorouracil;1.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;","17.Cisplatin;0.Fluorouracil;1.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;"
"2485","34.146.548.4","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Neoadjuvant chemoradiotherapy",146,"Cisplatin & Fluorouracil (CF) & RT",FALSE,"2","24.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","24.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2486","34.146.548.5","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Neoadjuvant chemoradiotherapy",146,"Cisplatin & Fluorouracil (CF) & RT",FALSE,"2","24.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","24.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2487","34.146.548.6","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Neoadjuvant chemoradiotherapy",146,"Cisplatin & Fluorouracil (CF) & RT",FALSE,"2","17.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;","17.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;"
"2488","34.146.549.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Neoadjuvant chemoradiotherapy",146,"Cisplatin, Irinotecan, RT",FALSE,"2","14.Cisplatin;0.Irinotecan;7.Cisplatin;0.Irinotecan;","14.Cisplatin;0.Irinotecan;7.Cisplatin;0.Irinotecan;"
"2489","34.146.550.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Neoadjuvant chemoradiotherapy",146,"Cisplatin, Paclitaxel, RT",FALSE,"1","0.Cisplatin;0.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;","0.Cisplatin;0.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;"
"2490","34.146.551.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Neoadjuvant chemoradiotherapy",146,"Cisplatin, Vinorelbine, RT",FALSE,"2","14.Cisplatin;0.Vinorelbine;7.Vinorelbine;","14.Cisplatin;0.Vinorelbine;7.Vinorelbine;"
"2491","34.146.551.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Neoadjuvant chemoradiotherapy",146,"Cisplatin, Vinorelbine, RT",FALSE,"2","14.Cisplatin;0.Vinorelbine;1.Cisplatin;1.Cisplatin;1.Cisplatin;4.Vinorelbine;","14.Cisplatin;0.Vinorelbine;1.Cisplatin;1.Cisplatin;1.Cisplatin;4.Vinorelbine;"
"2492","34.146.552.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Neoadjuvant chemoradiotherapy",146,"Docetaxel, Fluorouracil, RT",FALSE,"2","14.Docetaxel;0.Fluorouracil;7.Docetaxel;0.Fluorouracil;7.Fluorouracil;","14.Docetaxel;0.Fluorouracil;7.Docetaxel;0.Fluorouracil;7.Fluorouracil;"
"2493","34.146.552.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Neoadjuvant chemoradiotherapy",146,"Docetaxel, Fluorouracil, RT",FALSE,"5","7.Docetaxel;0.Fluorouracil;7.Docetaxel;0.Fluorouracil;","7.Docetaxel;0.Fluorouracil;"
"2494","34.146.552.3","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Neoadjuvant chemoradiotherapy",146,"Docetaxel, Fluorouracil, RT",FALSE,"2","9.Docetaxel;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;2.Docetaxel;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;2.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","9.Docetaxel;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;2.Docetaxel;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;2.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2495","34.146.552.4","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Neoadjuvant chemoradiotherapy",146,"Docetaxel, Fluorouracil, RT",FALSE,"5","2.Docetaxel;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;2.Docetaxel;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","2.Docetaxel;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2496","34.146.553.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Neoadjuvant chemoradiotherapy",146,"Fluorouracil, Oxaliplatin, RT",FALSE,"1","0.Oxaliplatin;4.Oxaliplatin;3.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","0.Oxaliplatin;4.Oxaliplatin;3.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2497","34.146.553.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Neoadjuvant chemoradiotherapy",146,"Fluorouracil, Oxaliplatin, RT",FALSE,"1","0.Oxaliplatin;4.Oxaliplatin;3.Fluorouracil;21.Oxaliplatin;","0.Oxaliplatin;4.Oxaliplatin;3.Fluorouracil;21.Oxaliplatin;"
"2498","34.146.553.3","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Neoadjuvant chemoradiotherapy",146,"Fluorouracil, Oxaliplatin, RT",FALSE,"5","7.Fluorouracil;0.Oxaliplatin;7.Fluorouracil;0.Oxaliplatin;","7.Fluorouracil;0.Oxaliplatin;"
"2499","34.146.553.4","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Neoadjuvant chemoradiotherapy",146,"Fluorouracil, Oxaliplatin, RT",FALSE,"5","3.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;3.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","3.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2500","34.152.531.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Neoadjuvant induction therapy",152,"Capecitabine & Cisplatin (CX)",TRUE,"Cont.","8.Capecitabine;0.Cisplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Capecitabine;0.Cisplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Capecitabine;0.Cisplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2501","34.152.532.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Neoadjuvant induction therapy",152,"Cisplatin & Docetaxel (DC)",FALSE,"2","21.Cisplatin;0.Docetaxel;","21.Cisplatin;0.Docetaxel;"
"2502","34.152.533.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Neoadjuvant induction therapy",152,"Cisplatin & Fluorouracil (CF)",FALSE,"2","21.Cisplatin;0.Fluorouracil;","21.Cisplatin;0.Fluorouracil;"
"2503","34.152.533.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Neoadjuvant induction therapy",152,"Cisplatin & Fluorouracil (CF)",FALSE,"3","28.Cisplatin;0.Fluorouracil;28.Cisplatin;0.Fluorouracil;","28.Cisplatin;0.Fluorouracil;"
"2504","34.152.534.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Neoadjuvant induction therapy",152,"Cisplatin & Irinotecan (IC)",FALSE,"2","14.Cisplatin;0.Irinotecan;7.Cisplatin;0.Irinotecan;","14.Cisplatin;0.Irinotecan;7.Cisplatin;0.Irinotecan;"
"2505","34.152.535.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Neoadjuvant induction therapy",152,"EOF",TRUE,"Cont.","21.Epirubicin;0.Fluorouracil;0.Oxaliplatin;21.Epirubicin;0.Fluorouracil;0.Oxaliplatin;","21.Epirubicin;0.Fluorouracil;0.Oxaliplatin;"
"2506","34.152.536.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Neoadjuvant induction therapy",152,"EOX",TRUE,"Cont.","1.Capecitabine;0.Epirubicin;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Epirubicin;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","1.Capecitabine;0.Epirubicin;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2507","34.152.537.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Neoadjuvant induction therapy",152,"FLEP",TRUE,"Cont.","19.Cisplatin;0.Etoposide;0.Fluorouracil;1.Cisplatin;0.Etoposide;0.Fluorouracil;1.Cisplatin;0.Etoposide;0.Fluorouracil;19.Cisplatin;0.Etoposide;0.Fluorouracil;1.Cisplatin;0.Etoposide;0.Fluorouracil;1.Cisplatin;0.Etoposide;0.Fluorouracil;","19.Cisplatin;0.Etoposide;0.Fluorouracil;1.Cisplatin;0.Etoposide;0.Fluorouracil;1.Cisplatin;0.Etoposide;0.Fluorouracil;"
"2508","34.152.538.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Neoadjuvant induction therapy",152,"PCF",FALSE,"2","20.Fluorouracil;0.Paclitaxel;1.Cisplatin;","20.Fluorouracil;0.Paclitaxel;1.Cisplatin;"
"2509","34.152.538.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Neoadjuvant induction therapy",152,"PCF",FALSE,"2","16.Fluorouracil;0.Paclitaxel;1.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","16.Fluorouracil;0.Paclitaxel;1.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2510","34.39.559.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Consolidation after definitive therapy",39,"Cisplatin & Fluorouracil (CF)",FALSE,"2","28.Cisplatin;0.Fluorouracil;","28.Cisplatin;0.Fluorouracil;"
"2511","34.4.559.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Adjuvant therapy",4,"Cisplatin & Fluorouracil (CF)",FALSE,"3","28.Cisplatin;0.Fluorouracil;28.Cisplatin;0.Fluorouracil;","28.Cisplatin;0.Fluorouracil;"
"2512","34.4.559.3","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Adjuvant therapy",4,"Cisplatin & Fluorouracil (CF)",FALSE,"2","21.Cisplatin;0.Fluorouracil;","21.Cisplatin;0.Fluorouracil;"
"2513","34.4.560.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Adjuvant therapy",4,"Nivolumab monotherapy",FALSE,"9","28.Nivolumab;28.Nivolumab;","28.Nivolumab;28.Nivolumab;"
"2514","34.53.554.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Definitive therapy",53,"Capecitabine, Cisplatin, RT",FALSE,"4","1.Capecitabine;0.Cisplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Cisplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","1.Capecitabine;0.Cisplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2515","34.53.554.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Definitive therapy",53,"Capecitabine, Cisplatin, RT",TRUE,"Cont.","3.Capecitabine;0.Cisplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;3.Capecitabine;0.Cisplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","3.Capecitabine;0.Cisplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2516","34.53.555.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Definitive therapy",53,"Cisplatin & Fluorouracil (CF) & RT",FALSE,"4","1.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","1.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2517","34.53.555.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Definitive therapy",53,"Cisplatin & Fluorouracil (CF) & RT",FALSE,"4","21.Cisplatin;0.Fluorouracil;21.Cisplatin;0.Fluorouracil;","21.Cisplatin;0.Fluorouracil;"
"2518","34.53.555.3","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Definitive therapy",53,"Cisplatin & Fluorouracil (CF) & RT",FALSE,"2","8.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","8.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2519","34.53.555.4","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Definitive therapy",53,"Cisplatin & Fluorouracil (CF) & RT",FALSE,"2","28.Cisplatin;0.Fluorouracil;","28.Cisplatin;0.Fluorouracil;"
"2520","34.53.555.5","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Definitive therapy",53,"Cisplatin & Fluorouracil (CF) & RT",FALSE,"1","0.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","0.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2521","34.53.555.6","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Definitive therapy",53,"Cisplatin & Fluorouracil (CF) & RT",FALSE,"2","24.Cisplatin;0.Fluorouracil;1.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;","24.Cisplatin;0.Fluorouracil;1.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;"
"2522","34.53.556.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Definitive therapy",53,"Cisplatin, Paclitaxel, RT",FALSE,"1","0.Cisplatin;0.Paclitaxel;7.Cisplatin;0.Paclitaxel;7.Cisplatin;0.Paclitaxel;7.Cisplatin;0.Paclitaxel;7.Cisplatin;0.Paclitaxel;","0.Cisplatin;0.Paclitaxel;7.Cisplatin;0.Paclitaxel;7.Cisplatin;0.Paclitaxel;7.Cisplatin;0.Paclitaxel;7.Cisplatin;0.Paclitaxel;"
"2523","34.53.557.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Definitive therapy",53,"FOLFOX4 & RT",FALSE,"3","14.Fluorouracil;0.Oxaliplatin;14.Fluorouracil;0.Oxaliplatin;","14.Fluorouracil;0.Oxaliplatin;"
"2524","34.53.557.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Definitive therapy",53,"FOLFOX4 & RT",FALSE,"3","12.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;","12.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;"
"2525","34.53.558.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal cancer",34,"Definitive therapy",53,"S-1 & RT",TRUE,"Cont.","1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;","1.Tegafur;0.gimeracil;0.oteracil;"
"2526","35.135.587.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal adenocarcinoma",35,"Metastatic or locally advanced disease, first-line",135,"Capecitabine & Cisplatin (CX) & Cetuximab",FALSE,"1","0.Capecitabine;0.Cetuximab;0.Cisplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","0.Capecitabine;0.Cetuximab;0.Cisplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2527","35.135.587.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal adenocarcinoma",35,"Metastatic or locally advanced disease, first-line",135,"Capecitabine & Cisplatin (CX) & Cetuximab",TRUE,"Cont.","7.Capecitabine;0.Cetuximab;0.Cisplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Cetuximab;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Cetuximab;7.Capecitabine;0.Cetuximab;0.Cisplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Cetuximab;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Cetuximab;","7.Capecitabine;0.Cetuximab;0.Cisplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Cetuximab;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Cetuximab;"
"2528","35.135.588.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal adenocarcinoma",35,"Metastatic or locally advanced disease, first-line",135,"CapeOx & Nivolumab",TRUE,"Cont.","8.Capecitabine;0.Nivolumab;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Capecitabine;0.Nivolumab;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Capecitabine;0.Nivolumab;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2529","35.135.589.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal adenocarcinoma",35,"Metastatic or locally advanced disease, first-line",135,"Cisplatin & Fluorouracil (CF)",TRUE,"Cont.","28.Cisplatin;0.Fluorouracil;28.Cisplatin;0.Fluorouracil;","28.Cisplatin;0.Fluorouracil;"
"2530","35.135.590.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal adenocarcinoma",35,"Metastatic or locally advanced disease, first-line",135,"ECX",TRUE,"Cont.","7.Cisplatin;0.Epirubicin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;7.Cisplatin;0.Epirubicin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","7.Cisplatin;0.Epirubicin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2531","35.135.591.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal adenocarcinoma",35,"Metastatic or locally advanced disease, first-line",135,"FLOT",TRUE,"Cont.","14.Docetaxel;0.Fluorouracil;0.Oxaliplatin;14.Docetaxel;0.Fluorouracil;0.Oxaliplatin;","14.Docetaxel;0.Fluorouracil;0.Oxaliplatin;"
"2532","35.135.592.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal adenocarcinoma",35,"Metastatic or locally advanced disease, first-line",135,"FOLFIRI",TRUE,"Cont.","14.Fluorouracil;0.Irinotecan;7.Fluorouracil;0.Irinotecan;7.Fluorouracil;0.Irinotecan;7.Fluorouracil;0.Irinotecan;7.Fluorouracil;0.Irinotecan;7.Fluorouracil;0.Irinotecan;14.Fluorouracil;0.Irinotecan;7.Fluorouracil;0.Irinotecan;7.Fluorouracil;0.Irinotecan;7.Fluorouracil;0.Irinotecan;7.Fluorouracil;0.Irinotecan;7.Fluorouracil;0.Irinotecan;","14.Fluorouracil;0.Irinotecan;7.Fluorouracil;0.Irinotecan;7.Fluorouracil;0.Irinotecan;7.Fluorouracil;0.Irinotecan;7.Fluorouracil;0.Irinotecan;7.Fluorouracil;0.Irinotecan;"
"2533","35.135.593.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal adenocarcinoma",35,"Metastatic or locally advanced disease, first-line",135,"Irinotecan monotherapy",TRUE,"Cont.","21.Irinotecan;7.Irinotecan;7.Irinotecan;7.Irinotecan;21.Irinotecan;7.Irinotecan;7.Irinotecan;7.Irinotecan;","21.Irinotecan;7.Irinotecan;7.Irinotecan;7.Irinotecan;"
"2534","35.135.594.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal adenocarcinoma",35,"Metastatic or locally advanced disease, first-line",135,"Irinotecan & Mitomycin",TRUE,"Cont.","20.Mitomycin;1.Irinotecan;7.Irinotecan;20.Mitomycin;1.Irinotecan;7.Irinotecan;","20.Mitomycin;1.Irinotecan;7.Irinotecan;"
"2535","35.135.595.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal adenocarcinoma",35,"Metastatic or locally advanced disease, first-line",135,"mFOLFOX6 & Nivolumab",TRUE,"Cont.","14.Fluorouracil;0.Nivolumab;0.Oxaliplatin;14.Fluorouracil;0.Nivolumab;0.Oxaliplatin;","14.Fluorouracil;0.Nivolumab;0.Oxaliplatin;"
"2536","35.135.595.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal adenocarcinoma",35,"Metastatic or locally advanced disease, first-line",135,"mFOLFOX6 & Nivolumab",TRUE,"Cont.","12.Fluorouracil;0.Nivolumab;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Nivolumab;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;","12.Fluorouracil;0.Nivolumab;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;"
"2537","35.136.596.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal adenocarcinoma",35,"Metastatic or locally advanced disease, subsequent lines of therapy",136,"Apatinib monotherapy",TRUE,"Cont.","1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;","1.Apatinib;1.Apatinib;"
"2538","35.136.597.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal adenocarcinoma",35,"Metastatic or locally advanced disease, subsequent lines of therapy",136,"Irinotecan monotherapy",TRUE,"Cont.","21.Irinotecan;21.Irinotecan;","21.Irinotecan;21.Irinotecan;"
"2539","35.136.598.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal adenocarcinoma",35,"Metastatic or locally advanced disease, subsequent lines of therapy",136,"Irinotecan liposomal monotherapy",TRUE,"Cont.","21.Irinotecanliposome;21.Irinotecanliposome;","21.Irinotecanliposome;21.Irinotecanliposome;"
"2540","35.136.599.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal adenocarcinoma",35,"Metastatic or locally advanced disease, subsequent lines of therapy",136,"Irinotecan & Mitomycin",TRUE,"Cont.","14.Irinotecan;0.Mitomycin;14.Irinotecan;14.Irinotecan;0.Mitomycin;14.Irinotecan;","14.Irinotecan;0.Mitomycin;14.Irinotecan;"
"2541","35.136.600.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal adenocarcinoma",35,"Metastatic or locally advanced disease, subsequent lines of therapy",136,"Paclitaxel & Ramucirumab",TRUE,"Cont.","14.Paclitaxel;0.Ramucirumab;7.Paclitaxel;7.Paclitaxel;0.Ramucirumab;14.Paclitaxel;0.Ramucirumab;7.Paclitaxel;7.Paclitaxel;0.Ramucirumab;","14.Paclitaxel;0.Ramucirumab;7.Paclitaxel;7.Paclitaxel;0.Ramucirumab;"
"2542","35.136.601.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal adenocarcinoma",35,"Metastatic or locally advanced disease, subsequent lines of therapy",136,"Ramucirumab monotherapy",TRUE,"Cont.","14.Ramucirumab;14.Ramucirumab;","14.Ramucirumab;14.Ramucirumab;"
"2543","35.146.581.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal adenocarcinoma",35,"Neoadjuvant chemoradiotherapy",146,"Cisplatin, Etoposide, RT",FALSE,"1","0.Cisplatin;2.Etoposide;1.Etoposide;1.Etoposide;3.Cisplatin;","0.Cisplatin;2.Etoposide;1.Etoposide;1.Etoposide;3.Cisplatin;"
"2544","35.146.582.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal adenocarcinoma",35,"Neoadjuvant chemoradiotherapy",146,"Cisplatin, Irinotecan, RT",FALSE,"1","0.Cisplatin;0.Irinotecan;7.Cisplatin;0.Irinotecan;7.Cisplatin;0.Irinotecan;7.Cisplatin;0.Irinotecan;","0.Cisplatin;0.Irinotecan;7.Cisplatin;0.Irinotecan;7.Cisplatin;0.Irinotecan;7.Cisplatin;0.Irinotecan;"
"2545","35.146.583.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal adenocarcinoma",35,"Neoadjuvant chemoradiotherapy",146,"Fluorouracil, Paclitaxel, RT",FALSE,"5","7.Fluorouracil;0.Paclitaxel;7.Fluorouracil;0.Paclitaxel;","7.Fluorouracil;0.Paclitaxel;"
"2546","35.146.583.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal adenocarcinoma",35,"Neoadjuvant chemoradiotherapy",146,"Fluorouracil, Paclitaxel, RT",FALSE,"5","2.Fluorouracil;0.Paclitaxel;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;2.Fluorouracil;0.Paclitaxel;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","2.Fluorouracil;0.Paclitaxel;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2547","35.152.579.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal adenocarcinoma",35,"Neoadjuvant induction therapy",152,"Cisplatin & Fluorouracil (CF) & RT",FALSE,"2","24.Cisplatin;0.Fluorouracil;4.Cisplatin;","24.Cisplatin;0.Fluorouracil;4.Cisplatin;"
"2548","35.152.580.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal adenocarcinoma",35,"Neoadjuvant induction therapy",152,"CLF",FALSE,"2","7.Cisplatin;0.Fluorouracil;7.Fluorouracil;7.Cisplatin;0.Fluorouracil;7.Fluorouracil;7.Cisplatin;0.Fluorouracil;7.Fluorouracil;","7.Cisplatin;0.Fluorouracil;7.Fluorouracil;"
"2549","35.157.578.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal adenocarcinoma",35,"Perioperative therapy",157,"FLOT",FALSE,"4","14.Docetaxel;0.Fluorouracil;0.Oxaliplatin;14.Docetaxel;0.Fluorouracil;0.Oxaliplatin;","14.Docetaxel;0.Fluorouracil;0.Oxaliplatin;"
"2550","35.4.584.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal adenocarcinoma",35,"Adjuvant therapy",4,"Cisplatin & Paclitaxel",FALSE,"3","21.Cisplatin;0.Paclitaxel;21.Cisplatin;0.Paclitaxel;","21.Cisplatin;0.Paclitaxel;"
"2551","35.4.585.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal adenocarcinoma",35,"Adjuvant therapy",4,"ECF/5-FU & RT",NA,NA,"0.Cisplatin;0.Epirubicin;0.Fluorouracil;84.Cisplatin;0.Epirubicin;0.Fluorouracil;21.Cisplatin;0.Epirubicin;0.Fluorouracil;","0.Cisplatin;0.Epirubicin;0.Fluorouracil;84.Cisplatin;0.Epirubicin;0.Fluorouracil;21.Cisplatin;0.Epirubicin;0.Fluorouracil;"
"2552","35.4.585.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal adenocarcinoma",35,"Adjuvant therapy",4,"ECF/5-FU & RT",NA,NA,"0.Cisplatin;0.Epirubicin;0.Fluorouracil;84.Cisplatin;0.Epirubicin;0.Fluorouracil;21.Cisplatin;0.Epirubicin;0.Fluorouracil;","0.Cisplatin;0.Epirubicin;0.Fluorouracil;84.Cisplatin;0.Epirubicin;0.Fluorouracil;21.Cisplatin;0.Epirubicin;0.Fluorouracil;"
"2553","35.4.585.3","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal adenocarcinoma",35,"Adjuvant therapy",4,"ECF/5-FU & RT",NA,NA,"0.Cisplatin;0.Epirubicin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;78.Cisplatin;0.Epirubicin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;15.Cisplatin;0.Epirubicin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","0.Cisplatin;0.Epirubicin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;78.Cisplatin;0.Epirubicin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;15.Cisplatin;0.Epirubicin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2554","35.4.586.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal adenocarcinoma",35,"Adjuvant therapy",4,"FULV/FULV & RT",NA,NA,"0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;59.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;24.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;59.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;24.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2555","36.135.608.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal squamous cell carcinoma",36,"Metastatic or locally advanced disease, first-line",135,"Cisplatin & Fluorouracil (CF) & Cetuximab",TRUE,"Cont.","8.Cetuximab;0.Cisplatin;0.Fluorouracil;7.Cetuximab;7.Cetuximab;7.Cetuximab;8.Cetuximab;0.Cisplatin;0.Fluorouracil;7.Cetuximab;7.Cetuximab;7.Cetuximab;","8.Cetuximab;0.Cisplatin;0.Fluorouracil;7.Cetuximab;7.Cetuximab;7.Cetuximab;"
"2556","36.135.608.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal squamous cell carcinoma",36,"Metastatic or locally advanced disease, first-line",135,"Cisplatin & Fluorouracil (CF) & Cetuximab",TRUE,"Cont.","8.Cetuximab;0.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;2.Cetuximab;7.Cetuximab;7.Cetuximab;8.Cetuximab;0.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;2.Cetuximab;7.Cetuximab;7.Cetuximab;","8.Cetuximab;0.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;2.Cetuximab;7.Cetuximab;7.Cetuximab;"
"2557","36.135.609.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal squamous cell carcinoma",36,"Metastatic or locally advanced disease, first-line",135,"Cisplatin & Fluorouracil (CF) & Nivolumab",TRUE,"Cont.","14.Cisplatin;0.Fluorouracil;0.Nivolumab;14.Nivolumab;14.Cisplatin;0.Fluorouracil;0.Nivolumab;14.Nivolumab;","14.Cisplatin;0.Fluorouracil;0.Nivolumab;14.Nivolumab;"
"2558","36.135.609.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal squamous cell carcinoma",36,"Metastatic or locally advanced disease, first-line",135,"Cisplatin & Fluorouracil (CF) & Nivolumab",TRUE,"Cont.","14.Cisplatin;0.Fluorouracil;0.Nivolumab;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;9.Nivolumab;14.Cisplatin;0.Fluorouracil;0.Nivolumab;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;9.Nivolumab;","14.Cisplatin;0.Fluorouracil;0.Nivolumab;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;9.Nivolumab;"
"2559","36.135.610.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal squamous cell carcinoma",36,"Metastatic or locally advanced disease, first-line",135,"Cisplatin & Fluorouracil (CF) & Pembrolizumab",TRUE,"Cont.","21.Cisplatin;0.Fluorouracil;0.Pembrolizumab;21.Cisplatin;0.Fluorouracil;21.Cisplatin;0.Fluorouracil;0.Pembrolizumab;21.Cisplatin;0.Fluorouracil;","21.Cisplatin;0.Fluorouracil;0.Pembrolizumab;21.Cisplatin;0.Fluorouracil;"
"2560","36.135.611.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal squamous cell carcinoma",36,"Metastatic or locally advanced disease, first-line",135,"Cisplatin & Fluorouracil (CF) & Sintilimab",TRUE,"Cont.","28.Cisplatin;0.Fluorouracil;0.Sintilimab;28.Cisplatin;0.Fluorouracil;0.Sintilimab;","28.Cisplatin;0.Fluorouracil;0.Sintilimab;"
"2561","36.135.611.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal squamous cell carcinoma",36,"Metastatic or locally advanced disease, first-line",135,"Cisplatin & Fluorouracil (CF) & Sintilimab",TRUE,"Cont.","23.Cisplatin;0.Fluorouracil;0.Sintilimab;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;23.Cisplatin;0.Fluorouracil;0.Sintilimab;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","23.Cisplatin;0.Fluorouracil;0.Sintilimab;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2562","36.135.612.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal squamous cell carcinoma",36,"Metastatic or locally advanced disease, first-line",135,"Cisplatin & Paclitaxel",TRUE,"Cont.","21.Cisplatin;0.Paclitaxel;21.Cisplatin;0.Paclitaxel;","21.Cisplatin;0.Paclitaxel;"
"2563","36.135.613.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal squamous cell carcinoma",36,"Metastatic or locally advanced disease, first-line",135,"Cisplatin, Paclitaxel, Camrelizumab",TRUE,"Cont.","21.Camrelizumab;0.Cisplatin;0.Paclitaxel;21.Camrelizumab;0.Cisplatin;0.Paclitaxel;","21.Camrelizumab;0.Cisplatin;0.Paclitaxel;"
"2564","36.135.614.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal squamous cell carcinoma",36,"Metastatic or locally advanced disease, first-line",135,"Cisplatin, Paclitaxel, Pembrolizumab",TRUE,"Cont.","21.Camrelizumab;0.Cisplatin;0.Paclitaxel;21.Cisplatin;0.Paclitaxel;21.Camrelizumab;0.Cisplatin;0.Paclitaxel;21.Cisplatin;0.Paclitaxel;","21.Camrelizumab;0.Cisplatin;0.Paclitaxel;21.Cisplatin;0.Paclitaxel;"
"2565","36.135.615.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal squamous cell carcinoma",36,"Metastatic or locally advanced disease, first-line",135,"Cisplatin, Paclitaxel, Sintilimab",TRUE,"Cont.","28.Cisplatin;0.Paclitaxel;0.Sintilimab;28.Cisplatin;0.Paclitaxel;0.Sintilimab;","28.Cisplatin;0.Paclitaxel;0.Sintilimab;"
"2566","36.135.616.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal squamous cell carcinoma",36,"Metastatic or locally advanced disease, first-line",135,"Cisplatin, Paclitaxel, Toripalimab",TRUE,"Cont.","21.Cisplatin;0.Paclitaxel;0.Toripalimab;21.Cisplatin;0.Paclitaxel;0.Toripalimab;","21.Cisplatin;0.Paclitaxel;0.Toripalimab;"
"2567","36.135.617.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal squamous cell carcinoma",36,"Metastatic or locally advanced disease, first-line",135,"Etoposide monotherapy",TRUE,"Cont.","19.Etoposide;1.Etoposide;1.Etoposide;19.Etoposide;1.Etoposide;1.Etoposide;","19.Etoposide;1.Etoposide;1.Etoposide;"
"2568","36.135.618.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal squamous cell carcinoma",36,"Metastatic or locally advanced disease, first-line",135,"Ipilimumab & Nivolumab",TRUE,"Cont.","14.Ipilimumab;0.Nivolumab;14.Nivolumab;14.Nivolumab;14.Ipilimumab;0.Nivolumab;14.Nivolumab;14.Nivolumab;","14.Ipilimumab;0.Nivolumab;14.Nivolumab;14.Nivolumab;"
"2569","36.135.619.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal squamous cell carcinoma",36,"Metastatic or locally advanced disease, first-line",135,"mFOLFOX6 & Pembrolizumab",TRUE,"Cont.","14.Fluorouracil;0.Oxoliplatin;0.Pembrolizumab;14.Fluorouracil;0.Oxoliplatin;14.Fluorouracil;0.Oxoliplatin;14.Fluorouracil;0.Oxoliplatin;0.Pembrolizumab;14.Fluorouracil;0.Oxoliplatin;14.Fluorouracil;0.Oxoliplatin;","14.Fluorouracil;0.Oxoliplatin;0.Pembrolizumab;14.Fluorouracil;0.Oxoliplatin;14.Fluorouracil;0.Oxoliplatin;"
"2570","36.135.619.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal squamous cell carcinoma",36,"Metastatic or locally advanced disease, first-line",135,"mFOLFOX6 & Pembrolizumab",TRUE,"Cont.","12.Fluorouracil;0.Oxoliplatin;0.Pembrolizumab;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Oxoliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Oxoliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Oxoliplatin;0.Pembrolizumab;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Oxoliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Oxoliplatin;1.Fluorouracil;1.Fluorouracil;","12.Fluorouracil;0.Oxoliplatin;0.Pembrolizumab;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Oxoliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Oxoliplatin;1.Fluorouracil;1.Fluorouracil;"
"2571","36.136.602.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal squamous cell carcinoma",36,"Metastatic or locally advanced disease, subsequent lines of therapy",136,"Cisplatin & Etoposide (EP)",FALSE,"3","20.Cisplatin;0.Etoposide;1.Etoposide;20.Cisplatin;0.Etoposide;1.Etoposide;","20.Cisplatin;0.Etoposide;1.Etoposide;"
"2572","36.136.602.3","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal squamous cell carcinoma",36,"Metastatic or locally advanced disease, subsequent lines of therapy",136,"Cisplatin & Etoposide (EP)",FALSE,"4","20.Cisplatin;0.Etoposide;1.Etoposide;20.Cisplatin;0.Etoposide;1.Etoposide;","20.Cisplatin;0.Etoposide;1.Etoposide;"
"2573","36.136.620.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal squamous cell carcinoma",36,"Metastatic or locally advanced disease, subsequent lines of therapy",136,"Camrelizumab monotherapy",TRUE,"Cont.","14.Camrelizumab;14.Camrelizumab;","14.Camrelizumab;14.Camrelizumab;"
"2574","36.136.621.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal squamous cell carcinoma",36,"Metastatic or locally advanced disease, subsequent lines of therapy",136,"Paclitaxel monotherapy",TRUE,"Cont.","14.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;14.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;","14.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;"
"2575","36.136.622.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal squamous cell carcinoma",36,"Metastatic or locally advanced disease, subsequent lines of therapy",136,"Pembrolizumab monotherapy",TRUE,"Cont.","21.Pembrolizumab;21.Pembrolizumab;","21.Pembrolizumab;21.Pembrolizumab;"
"2576","36.136.623.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal squamous cell carcinoma",36,"Metastatic or locally advanced disease, subsequent lines of therapy",136,"Tislelizumab monotherapy",TRUE,"Cont.","21.Tizlelizumab;21.Tizlelizumab;","21.Tizlelizumab;21.Tizlelizumab;"
"2577","36.146.603.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal squamous cell carcinoma",36,"Neoadjuvant chemoradiotherapy",146,"Fluorouracil, Oxaliplatin, RT",FALSE,"1","0.Fluorouracil;0.Oxoliplatin;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;0.Oxoliplatin;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;0.Oxoliplatin;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;0.Oxoliplatin;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;0.Oxoliplatin;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","0.Fluorouracil;0.Oxoliplatin;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;0.Oxoliplatin;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;0.Oxoliplatin;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;0.Oxoliplatin;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;0.Oxoliplatin;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2578","36.146.603.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal squamous cell carcinoma",36,"Neoadjuvant chemoradiotherapy",146,"Fluorouracil, Oxaliplatin, RT",FALSE,"1","0.Fluorouracil;0.Oxoliplatin;7.Oxoliplatin;7.Oxoliplatin;7.Oxoliplatin;7.Oxoliplatin;","0.Fluorouracil;0.Oxoliplatin;7.Oxoliplatin;7.Oxoliplatin;7.Oxoliplatin;7.Oxoliplatin;"
"2579","36.152.602.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal squamous cell carcinoma",36,"Neoadjuvant induction therapy",152,"Cisplatin & Etoposide (EP)",FALSE,"2","20.Cisplatin;0.Etoposide;1.Etoposide;","20.Cisplatin;0.Etoposide;1.Etoposide;"
"2580","36.39.607.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal squamous cell carcinoma",36,"Consolidation after definitive therapy",39,"Fluorouracil & Paclitaxel",FALSE,"2","28.Fluorouracil;0.Paclitaxel;","28.Fluorouracil;0.Paclitaxel;"
"2581","36.39.607.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal squamous cell carcinoma",36,"Consolidation after definitive therapy",39,"Fluorouracil & Paclitaxel",FALSE,"2","25.Fluorouracil;0.Paclitaxel;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","25.Fluorouracil;0.Paclitaxel;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2582","36.53.604.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal squamous cell carcinoma",36,"Definitive therapy",53,"Capecitabine & Cisplatin (CX) & RT",FALSE,"1","0.Carboplatin;0.Cisplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;","0.Carboplatin;0.Cisplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;"
"2583","36.53.605.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal squamous cell carcinoma",36,"Definitive therapy",53,"Cisplatin, Docetaxel, RT",FALSE,"2","21.Cisplatin;0.Docetaxel;","21.Cisplatin;0.Docetaxel;"
"2584","36.53.606.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal squamous cell carcinoma",36,"Definitive therapy",53,"Cisplatin, Paclitaxel, RT",FALSE,"2","26.Cisplatin;0.Paclitaxel;1.Cisplatin;1.Cisplatin;","26.Cisplatin;0.Paclitaxel;1.Cisplatin;1.Cisplatin;"
"2585","36.53.606.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Esophageal squamous cell carcinoma",36,"Definitive therapy",53,"Cisplatin, Paclitaxel, RT",FALSE,"2","19.Cisplatin;0.Paclitaxel;1.Cisplatin;1.Cisplatin;","19.Cisplatin;0.Paclitaxel;1.Cisplatin;1.Cisplatin;"
"2586","37.114.653.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Maintenance after first-line therapy",114,"Irinotecan & Mitomycin",TRUE,"Cont.","14.Irinotecan;0.Mitomycin;14.Irinotecan;0.Mitomycin;","14.Irinotecan;0.Mitomycin;"
"2587","37.114.654.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Maintenance after first-line therapy",114,"Paclitaxel monotherapy",TRUE,"Cont.","7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;","7.Paclitaxel;7.Paclitaxel;"
"2588","37.114.655.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Maintenance after first-line therapy",114,"nab-Paclitaxel monotherapy",TRUE,"Cont.","14.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;14.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;","14.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;"
"2589","37.135.638.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Metastatic or locally advanced disease, first-line",135,"Capecitabine & Cisplatin (CX) & Pembrolizumab",TRUE,"Cont.","8.Capecitabine;0.Cisplatin;0.Pembrolizumab;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Capecitabine;0.Cisplatin;0.Pembrolizumab;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Capecitabine;0.Cisplatin;0.Pembrolizumab;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2590","37.135.639.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Metastatic or locally advanced disease, first-line",135,"Cisplatin & Docetaxel (DC)",TRUE,"Cont.","21.Cisplatin;0.Docetaxel;21.Cisplatin;0.Docetaxel;","21.Cisplatin;0.Docetaxel;"
"2591","37.135.640.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Metastatic or locally advanced disease, first-line",135,"Cisplatin & Fluorouracil (CF) & RT",TRUE,"Cont.","24.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;24.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","24.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2592","37.135.640.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Metastatic or locally advanced disease, first-line",135,"Cisplatin & Fluorouracil (CF) & RT",FALSE,"8","21.Cisplatin;0.Fluorouracil;21.Cisplatin;0.Fluorouracil;","21.Cisplatin;0.Fluorouracil;"
"2593","37.135.640.3","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Metastatic or locally advanced disease, first-line",135,"Cisplatin & Fluorouracil (CF) & RT",TRUE,"Cont.","21.Cisplatin;0.Fluorouracil;21.Cisplatin;0.Fluorouracil;","21.Cisplatin;0.Fluorouracil;"
"2594","37.135.640.4","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Metastatic or locally advanced disease, first-line",135,"Cisplatin & Fluorouracil (CF) & RT",TRUE,"Cont.","28.Cisplatin;0.Fluorouracil;28.Cisplatin;0.Fluorouracil;","28.Cisplatin;0.Fluorouracil;"
"2595","37.135.641.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Metastatic or locally advanced disease, first-line",135,"Cisplatin & S-1",TRUE,"Cont.","8.Cisplatin;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;8.Cisplatin;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;","8.Cisplatin;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;"
"2596","37.135.641.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Metastatic or locally advanced disease, first-line",135,"Cisplatin & S-1",TRUE,"Cont.","8.Cisplatin;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;8.Cisplatin;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;","8.Cisplatin;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;"
"2597","37.135.641.3","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Metastatic or locally advanced disease, first-line",135,"Cisplatin & S-1",TRUE,"Cont.","15.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Cisplatin;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;15.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Cisplatin;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;","15.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Cisplatin;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;"
"2598","37.135.642.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Metastatic or locally advanced disease, first-line",135,"CLF",TRUE,"Cont.","7.Cisplatin;0.Fluorouracil;7.Fluorouracil;7.Cisplatin;0.Fluorouracil;7.Fluorouracil;7.Cisplatin;0.Fluorouracil;7.Fluorouracil;7.Cisplatin;7.Cisplatin;0.Fluorouracil;7.Fluorouracil;7.Cisplatin;0.Fluorouracil;7.Fluorouracil;7.Cisplatin;0.Fluorouracil;7.Fluorouracil;7.Cisplatin;","7.Cisplatin;0.Fluorouracil;7.Fluorouracil;7.Cisplatin;0.Fluorouracil;7.Fluorouracil;7.Cisplatin;0.Fluorouracil;7.Fluorouracil;7.Cisplatin;"
"2599","37.135.642.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Metastatic or locally advanced disease, first-line",135,"CLF",TRUE,"Cont.","14.Cisplatin;0.Fluorouracil;14.Cisplatin;0.Fluorouracil;","14.Cisplatin;0.Fluorouracil;"
"2600","37.135.642.3","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Metastatic or locally advanced disease, first-line",135,"CLF",TRUE,"Cont.","13.Fluorouracil;1.Cisplatin;13.Fluorouracil;1.Cisplatin;","13.Fluorouracil;1.Cisplatin;"
"2601","37.135.642.4","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Metastatic or locally advanced disease, first-line",135,"CLF",TRUE,"Cont.","7.Cisplatin;0.Fluorouracil;1.Fluorouracil;6.Fluorouracil;1.Fluorouracil;6.Cisplatin;0.Fluorouracil;1.Fluorouracil;6.Fluorouracil;1.Fluorouracil;6.Cisplatin;0.Fluorouracil;1.Fluorouracil;6.Fluorouracil;1.Fluorouracil;6.Cisplatin;7.Cisplatin;0.Fluorouracil;1.Fluorouracil;6.Fluorouracil;1.Fluorouracil;6.Cisplatin;0.Fluorouracil;1.Fluorouracil;6.Fluorouracil;1.Fluorouracil;6.Cisplatin;0.Fluorouracil;1.Fluorouracil;6.Fluorouracil;1.Fluorouracil;6.Cisplatin;","7.Cisplatin;0.Fluorouracil;1.Fluorouracil;6.Fluorouracil;1.Fluorouracil;6.Cisplatin;0.Fluorouracil;1.Fluorouracil;6.Fluorouracil;1.Fluorouracil;6.Cisplatin;0.Fluorouracil;1.Fluorouracil;6.Fluorouracil;1.Fluorouracil;6.Cisplatin;"
"2602","37.135.642.5","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Metastatic or locally advanced disease, first-line",135,"CLF",TRUE,"Cont.","13.Cisplatin;0.Fluorouracil;1.Fluorouracil;13.Cisplatin;0.Fluorouracil;1.Fluorouracil;","13.Cisplatin;0.Fluorouracil;1.Fluorouracil;"
"2603","37.135.642.6","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Metastatic or locally advanced disease, first-line",135,"CLF",TRUE,"Cont.","13.Fluorouracil;1.Cisplatin;0.Fluorouracil;13.Fluorouracil;1.Cisplatin;0.Fluorouracil;","13.Fluorouracil;1.Cisplatin;0.Fluorouracil;"
"2604","37.135.643.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Metastatic or locally advanced disease, first-line",135,"DCF",TRUE,"Cont.","21.Cisplatin;0.Docetaxel;0.Fluorouracil;21.Cisplatin;0.Docetaxel;0.Fluorouracil;","21.Cisplatin;0.Docetaxel;0.Fluorouracil;"
"2605","37.135.643.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Metastatic or locally advanced disease, first-line",135,"DCF",TRUE,"Cont.","16.Cisplatin;0.Docetaxel;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;16.Cisplatin;0.Docetaxel;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","16.Cisplatin;0.Docetaxel;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2606","37.135.644.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Metastatic or locally advanced disease, first-line",135,"mDCF",TRUE,"Cont.","12.Docetaxel;0.Fluorouracil;2.Cisplatin;12.Docetaxel;0.Fluorouracil;2.Cisplatin;","12.Docetaxel;0.Fluorouracil;2.Cisplatin;"
"2607","37.135.644.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Metastatic or locally advanced disease, first-line",135,"mDCF",TRUE,"Cont.","21.Cisplatin;0.Docetaxel;0.Fluorouracil;21.Cisplatin;0.Docetaxel;0.Fluorouracil;","21.Cisplatin;0.Docetaxel;0.Fluorouracil;"
"2608","37.135.644.3","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Metastatic or locally advanced disease, first-line",135,"mDCF",TRUE,"Cont.","12.Docetaxel;0.Fluorouracil;1.Fluorouracil;1.Cisplatin;0.Fluorouracil;12.Docetaxel;0.Fluorouracil;1.Fluorouracil;1.Cisplatin;0.Fluorouracil;","12.Docetaxel;0.Fluorouracil;1.Fluorouracil;1.Cisplatin;0.Fluorouracil;"
"2609","37.135.644.4","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Metastatic or locally advanced disease, first-line",135,"mDCF",TRUE,"Cont.","17.Cisplatin;0.Docetaxel;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;17.Cisplatin;0.Docetaxel;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","17.Cisplatin;0.Docetaxel;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2610","37.135.644.5","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Metastatic or locally advanced disease, first-line",135,"mDCF",TRUE,"Cont.","16.Cisplatin;0.Docetaxel;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;16.Cisplatin;0.Docetaxel;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","16.Cisplatin;0.Docetaxel;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2611","37.135.645.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Metastatic or locally advanced disease, first-line",135,"mDCF & Bevacizumab",TRUE,"Cont.","12.Bevacizumab;0.Docetaxel;0.Fluorouracil;2.Cisplatin;12.Bevacizumab;0.Docetaxel;0.Fluorouracil;2.Cisplatin;","12.Bevacizumab;0.Docetaxel;0.Fluorouracil;2.Cisplatin;"
"2612","37.135.645.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Metastatic or locally advanced disease, first-line",135,"mDCF & Bevacizumab",TRUE,"Cont.","12.Bevacizumab;0.Docetaxel;0.Fluorouracil;1.Fluorouracil;1.Cisplatin;0.Fluorouracil;12.Bevacizumab;0.Docetaxel;0.Fluorouracil;1.Fluorouracil;1.Cisplatin;0.Fluorouracil;","12.Bevacizumab;0.Docetaxel;0.Fluorouracil;1.Fluorouracil;1.Cisplatin;0.Fluorouracil;"
"2613","37.135.646.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Metastatic or locally advanced disease, first-line",135,"Docetaxel & S-1",TRUE,"Cont.","8.Docetaxel;0.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;8.Docetaxel;0.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;","8.Docetaxel;0.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;"
"2614","37.135.647.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Metastatic or locally advanced disease, first-line",135,"Fluorouracil monotherapy",TRUE,"Cont.","17.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;17.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","17.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2615","37.135.648.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Metastatic or locally advanced disease, first-line",135,"Fluorouracil, Folinic acid, Mitomycin",FALSE,"2","21.Fluorouracil;0.Mitomycin;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;0.Mitomycin;7.Fluorouracil;7.Fluorouracil;","21.Fluorouracil;0.Mitomycin;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;0.Mitomycin;7.Fluorouracil;7.Fluorouracil;"
"2616","37.135.648.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Metastatic or locally advanced disease, first-line",135,"Fluorouracil, Folinic acid, Mitomycin",FALSE,"2","20.Fluorouracil;0.Mitomycin;1.Fluorouracil;6.Fluorouracil;1.Fluorouracil;6.Fluorouracil;1.Fluorouracil;6.Fluorouracil;0.Mitomycin;1.Fluorouracil;6.Fluorouracil;1.Fluorouracil;6.Fluorouracil;1.Fluorouracil;","20.Fluorouracil;0.Mitomycin;1.Fluorouracil;6.Fluorouracil;1.Fluorouracil;6.Fluorouracil;1.Fluorouracil;6.Fluorouracil;0.Mitomycin;1.Fluorouracil;6.Fluorouracil;1.Fluorouracil;6.Fluorouracil;1.Fluorouracil;"
"2617","37.135.649.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Metastatic or locally advanced disease, first-line",135,"FOLFIRI",TRUE,"Cont.","14.Fluorouracil;0.Irinotecan;14.Fluorouracil;0.Irinotecan;","14.Fluorouracil;0.Irinotecan;"
"2618","37.135.650.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Metastatic or locally advanced disease, first-line",135,"OLF",TRUE,"Cont.","14.Fluorouracil;0.Oxaliplatin;14.Fluorouracil;0.Oxaliplatin;14.Fluorouracil;0.Oxaliplatin;14.Fluorouracil;0.Oxaliplatin;14.Fluorouracil;0.Oxaliplatin;14.Fluorouracil;0.Oxaliplatin;14.Fluorouracil;0.Oxaliplatin;14.Fluorouracil;0.Oxaliplatin;","14.Fluorouracil;0.Oxaliplatin;"
"2619","37.135.650.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Metastatic or locally advanced disease, first-line",135,"OLF",TRUE,"Cont.","13.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;13.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;13.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;13.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;13.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;13.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;13.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;13.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;","13.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;"
"2620","37.135.651.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Metastatic or locally advanced disease, first-line",135,"Paclitaxel & S-1",TRUE,"Cont.","22.Paclitaxel;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Paclitaxel;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;22.Paclitaxel;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Paclitaxel;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;","22.Paclitaxel;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Paclitaxel;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;"
"2621","37.135.652.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Metastatic or locally advanced disease, first-line",135,"UFTM",TRUE,"Cont.","1.Mitomycin;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Mitomycin;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Mitomycin;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Mitomycin;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Mitomycin;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Mitomycin;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Mitomycin;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Mitomycin;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;","1.Mitomycin;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;"
"2622","37.147.631.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Neoadjuvant chemotherapy",147,"DOS",FALSE,"3","8.Docetaxel;0.Oxaliplatin;0.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;8.Docetaxel;0.Oxaliplatin;0.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;","8.Docetaxel;0.Oxaliplatin;0.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;"
"2623","37.157.624.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Perioperative therapy",157,"Capecitabine & Cisplatin (CX) & RT",FALSE,"6","8.Carboplatin;0.Cisplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;8.Carboplatin;0.Cisplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;","8.Carboplatin;0.Cisplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;"
"2624","37.157.625.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Perioperative therapy",157,"Cisplatin & Fluorouracil (CF)",FALSE,"6","21.Cisplatin;0.Fluorouracil;21.Cisplatin;0.Fluorouracil;","21.Cisplatin;0.Fluorouracil;"
"2625","37.157.625.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Perioperative therapy",157,"Cisplatin & Fluorouracil (CF)",FALSE,"6","28.Cisplatin;0.Fluorouracil;28.Cisplatin;0.Fluorouracil;","28.Cisplatin;0.Fluorouracil;"
"2626","37.157.626.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Perioperative therapy",157,"ECF",FALSE,"6","21.Cisplatin;0.Epirubicin;0.Fluorouracil;21.Cisplatin;0.Epirubicin;0.Fluorouracil;","21.Cisplatin;0.Epirubicin;0.Fluorouracil;"
"2627","37.157.627.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Perioperative therapy",157,"ECX",FALSE,"6","8.Capecitabine;0.Cisplatin;0.Epirubicin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Capecitabine;0.Cisplatin;0.Epirubicin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Capecitabine;0.Cisplatin;0.Epirubicin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2628","37.157.628.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Perioperative therapy",157,"EOF",FALSE,"6","21.Epirubicin;0.Fluorouracil;0.Oxoliplatin;21.Epirubicin;0.Fluorouracil;0.Oxoliplatin;","21.Epirubicin;0.Fluorouracil;0.Oxoliplatin;"
"2629","37.157.629.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Perioperative therapy",157,"EOX",FALSE,"6","1.Capecitabine;0.Epirubicin;0.Oxoliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Epirubicin;0.Oxoliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","1.Capecitabine;0.Epirubicin;0.Oxoliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2630","37.157.630.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Perioperative therapy",157,"FLOT",TRUE,"Cont.","21.Docetaxel;0.Fluorouracil;0.Oxaliplatin;21.Docetaxel;0.Fluorouracil;0.Oxaliplatin;","21.Docetaxel;0.Fluorouracil;0.Oxaliplatin;"
"2631","37.157.630.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Perioperative therapy",157,"FLOT",TRUE,"Cont.","14.Docetaxel;0.Fluorouracil;0.Oxaliplatin;14.Docetaxel;0.Fluorouracil;0.Oxaliplatin;","14.Docetaxel;0.Fluorouracil;0.Oxaliplatin;"
"2632","37.157.630.3","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Perioperative therapy",157,"FLOT",TRUE,"Cont.","20.Docetaxel;0.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;20.Docetaxel;0.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;","20.Docetaxel;0.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;"
"2633","37.157.630.4","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Perioperative therapy",157,"FLOT",TRUE,"Cont.","13.Docetaxel;0.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;13.Docetaxel;0.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;","13.Docetaxel;0.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;"
"2634","37.4.632.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Adjuvant therapy",4,"Carboplatin & Docetaxel",FALSE,"6","21.Carboplatin;0.Docetaxel;21.Carboplatin;0.Docetaxel;","21.Carboplatin;0.Docetaxel;"
"2635","37.4.633.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Adjuvant therapy",4,"Capecitabine & Cisplatin (CX) & RT",FALSE,"6","8.Carboplatin;0.Cisplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;8.Carboplatin;0.Cisplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;","8.Carboplatin;0.Cisplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;"
"2636","37.4.634.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Adjuvant therapy",4,"Docetaxel & S-1",FALSE,"8","8.Docetaxel;0.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.Docetaxel;0.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;8.Docetaxel;0.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.Docetaxel;0.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;","8.Docetaxel;0.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.Docetaxel;0.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;"
"2637","37.4.634.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Adjuvant therapy",4,"Docetaxel & S-1",NA,NA,"0.Docetaxel;0.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;15.Docetaxel;0.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;36.Docetaxel;0.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;36.Docetaxel;0.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;36.Docetaxel;0.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;36.Docetaxel;0.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;36.Docetaxel;0.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;36.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;36.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;","0.Docetaxel;0.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;15.Docetaxel;0.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;36.Docetaxel;0.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;36.Docetaxel;0.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;36.Docetaxel;0.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;36.Docetaxel;0.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;36.Docetaxel;0.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;36.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;36.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;1.S-1;"
"2638","37.4.635.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Adjuvant therapy",4,"FP/Capecitabine & RT",NA,NA,"0.Cisplatin;0.Fluorouracil;21.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;57.Cisplatin;0.Fluorouracil;21.Cisplatin;0.Fluorouracil;21.Cisplatin;0.Fluorouracil;","0.Cisplatin;0.Fluorouracil;21.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;57.Cisplatin;0.Fluorouracil;21.Cisplatin;0.Fluorouracil;21.Cisplatin;0.Fluorouracil;"
"2639","37.4.635.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Adjuvant therapy",4,"FP/Capecitabine & RT",NA,NA,"0.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;16.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;57.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;16.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;16.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","0.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;16.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;57.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;16.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;16.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2640","37.4.636.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Adjuvant therapy",4,"FULV",FALSE,"9","13.Fluorouracil;1.Fluorouracil;13.Fluorouracil;1.Fluorouracil;","13.Fluorouracil;1.Fluorouracil;"
"2641","37.4.637.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer",37,"Adjuvant therapy",4,"S-1 monotherapy",FALSE,"8","15.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;15.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;","15.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;"
"2642","38.135.656.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer, HER2-positive",38,"Metastatic or locally advanced disease, first-line",135,"Capecitabine & Cisplatin (CX) & Trastuzumab",TRUE,"Cont.","8.Capecitabine;0.Cisplatin;0.Trastuzumab;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Capecitabine;0.Cisplatin;0.Trastuzumab;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Capecitabine;0.Cisplatin;0.Trastuzumab;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2643","38.135.657.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer, HER2-positive",38,"Metastatic or locally advanced disease, first-line",135,"CapeOx, Pembrolizumab, Trastuzumab",TRUE,"Cont.","8.Capecitabine;0.Oxaliplatin;0.Pembrolizumab;0.Trastuzumab;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Capecitabine;0.Oxaliplatin;0.Pembrolizumab;0.Trastuzumab;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Capecitabine;0.Oxaliplatin;0.Pembrolizumab;0.Trastuzumab;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2644","38.135.658.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer, HER2-positive",38,"Metastatic or locally advanced disease, first-line",135,"CapeOx & Trastuzumab",TRUE,"Cont.","8.Capecitabine;0.Oxaliplatin;0.Trastuzumab;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Capecitabine;0.Oxaliplatin;0.Trastuzumab;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Capecitabine;0.Oxaliplatin;0.Trastuzumab;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2645","38.135.659.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer, HER2-positive",38,"Metastatic or locally advanced disease, first-line",135,"Cisplatin & Fluorouracil (CF) & Trastuzumab",TRUE,"Cont.","21.Cisplatin;0.Fluorouracil;0.Trastuzumab;21.Cisplatin;0.Fluorouracil;0.Trastuzumab;","21.Cisplatin;0.Fluorouracil;0.Trastuzumab;"
"2646","38.135.659.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer, HER2-positive",38,"Metastatic or locally advanced disease, first-line",135,"Cisplatin & Fluorouracil (CF) & Trastuzumab",TRUE,"Cont.","16.Cisplatin;0.Fluorouracil;0.Trastuzumab;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;16.Cisplatin;0.Fluorouracil;0.Trastuzumab;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","16.Cisplatin;0.Fluorouracil;0.Trastuzumab;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2647","38.136.660.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Gastric cancer, HER2-positive",38,"Metastatic or locally advanced disease, subsequent lines of therapy",136,"Trastuzumab deruxtecan monotherapy",TRUE,"Cont.","21.Trastuzumabderuxtecan;21.Trastuzumabderuxtecan;","21.Trastuzumabderuxtecan;21.Trastuzumabderuxtecan;"
"2648","39.1.670.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Rectal cancer",39,"Adjuvant chemoradiotherapy",1,"Fluorouracil/Fluorouracil & RT",NA,NA,"0.Fluorouracil;0.Fluorouracil;1.Fluorouracil;0.Fluorouracil;1.Fluorouracil;0.Fluorouracil;1.Fluorouracil;0.Fluorouracil;1.Fluorouracil;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;22.Fluorouracil;0.Fluorouracil;1.Fluorouracil;0.Fluorouracil;1.Fluorouracil;0.Fluorouracil;1.Fluorouracil;0.Fluorouracil;1.Fluorouracil;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;22.Fluorouracil;0.Fluorouracil;1.Fluorouracil;0.Fluorouracil;1.Fluorouracil;0.Fluorouracil;1.Fluorouracil;0.Fluorouracil;1.Fluorouracil;0.Fluorouracil;1.Fluorouracil;0.Fluorouracil;1.Fluorouracil;0.Fluorouracil;64.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;24.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","0.Fluorouracil;0.Fluorouracil;1.Fluorouracil;0.Fluorouracil;1.Fluorouracil;0.Fluorouracil;1.Fluorouracil;0.Fluorouracil;1.Fluorouracil;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;22.Fluorouracil;0.Fluorouracil;1.Fluorouracil;0.Fluorouracil;1.Fluorouracil;0.Fluorouracil;1.Fluorouracil;0.Fluorouracil;1.Fluorouracil;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;22.Fluorouracil;0.Fluorouracil;1.Fluorouracil;0.Fluorouracil;1.Fluorouracil;0.Fluorouracil;1.Fluorouracil;0.Fluorouracil;1.Fluorouracil;0.Fluorouracil;1.Fluorouracil;0.Fluorouracil;1.Fluorouracil;0.Fluorouracil;64.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;24.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2649","39.145.661.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Rectal cancer",39,"Neoadjucvant therapy",145,"Capecitabine & RT",FALSE,"5","3.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;3.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","3.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2650","39.145.661.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Rectal cancer",39,"Neoadjucvant therapy",145,"Capecitabine & RT",FALSE,"1","0.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","0.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2651","39.145.662.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Rectal cancer",39,"Neoadjucvant therapy",145,"Capecitabine, Sorafenib, RT",FALSE,"1","0.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Sorafenib;1.Sorafenib;","0.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Capecitabine;0.Sorafenib;1.Sorafenib;1.Sorafenib;"
"2652","39.145.663.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Rectal cancer",39,"Neoadjucvant therapy",145,"CapeOx, Cetuximab, RT",NA,NA,"0.Capecitabine;0.Cetuximab;0.Oxoliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;31.Capecitabine;0.Cetuximab;0.Oxoliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","0.Capecitabine;0.Cetuximab;0.Oxoliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;31.Capecitabine;0.Cetuximab;0.Oxoliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2653","39.145.664.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Rectal cancer",39,"Neoadjucvant therapy",145,"CapIriRT",FALSE,"5","3.Capecitabine;0.Irinotecan;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;3.Capecitabine;0.Irinotecan;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","3.Capecitabine;0.Irinotecan;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2654","39.145.665.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Rectal cancer",39,"Neoadjucvant therapy",145,"Fluorouracil & RT",FALSE,"1","0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2655","39.145.665.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Rectal cancer",39,"Neoadjucvant therapy",145,"Fluorouracil & RT",FALSE,"2","1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","1.Fluorouracil;1.Fluorouracil;"
"2656","39.145.665.3","Solid Tumor","Gastrointestinal Oncology, Intestinal","Rectal cancer",39,"Neoadjucvant therapy",145,"Fluorouracil & RT",FALSE,"1","0.Fluorouracil;","0.Fluorouracil;0.Fluorouracil;"
"2657","39.145.665.4","Solid Tumor","Gastrointestinal Oncology, Intestinal","Rectal cancer",39,"Neoadjucvant therapy",145,"Fluorouracil & RT",FALSE,"2","28.Fluorouracil;","28.Fluorouracil;28.Fluorouracil;"
"2658","39.145.666.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Rectal cancer",39,"Neoadjucvant therapy",145,"FULV & RT",FALSE,"3","13.Fluorouracil;1.Fluorouracil;13.Fluorouracil;1.Fluorouracil;","13.Fluorouracil;1.Fluorouracil;"
"2659","39.145.666.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Rectal cancer",39,"Neoadjucvant therapy",145,"FULV & RT",FALSE,"2","24.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","24.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2660","39.145.666.3","Solid Tumor","Gastrointestinal Oncology, Intestinal","Rectal cancer",39,"Neoadjucvant therapy",145,"FULV & RT",FALSE,"5","12.Fluorouracil;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","12.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2661","39.145.666.4","Solid Tumor","Gastrointestinal Oncology, Intestinal","Rectal cancer",39,"Neoadjucvant therapy",145,"FULV & RT",FALSE,"5","14.Fluorouracil;14.Fluorouracil;","14.Fluorouracil;14.Fluorouracil;"
"2662","39.145.667.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Rectal cancer",39,"Neoadjucvant therapy",145,"FUOX & RT",FALSE,"5","7.Fluorouracil;0.Oxaliplatin;7.Fluorouracil;0.Oxaliplatin;","7.Fluorouracil;0.Oxaliplatin;"
"2663","39.145.667.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Rectal cancer",39,"Neoadjucvant therapy",145,"FUOX & RT",FALSE,"1","0.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","0.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2664","39.145.667.3","Solid Tumor","Gastrointestinal Oncology, Intestinal","Rectal cancer",39,"Neoadjucvant therapy",145,"FUOX & RT",FALSE,"1","0.Fluorouracil;0.Oxaliplatin;7.Oxaliplatin;7.Oxaliplatin;7.Oxaliplatin;7.Oxaliplatin;7.Oxaliplatin;","0.Fluorouracil;0.Oxaliplatin;7.Oxaliplatin;7.Oxaliplatin;7.Oxaliplatin;7.Oxaliplatin;7.Oxaliplatin;"
"2665","39.145.667.4","Solid Tumor","Gastrointestinal Oncology, Intestinal","Rectal cancer",39,"Neoadjucvant therapy",145,"FUOX & RT",FALSE,"2","8.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","8.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2666","39.145.667.5","Solid Tumor","Gastrointestinal Oncology, Intestinal","Rectal cancer",39,"Neoadjucvant therapy",145,"FUOX & RT",FALSE,"2","14.Fluorouracil;0.Oxaliplatin;7.Oxaliplatin;","14.Fluorouracil;0.Oxaliplatin;7.Oxaliplatin;"
"2667","39.145.667.6","Solid Tumor","Gastrointestinal Oncology, Intestinal","Rectal cancer",39,"Neoadjucvant therapy",145,"FUOX & RT",FALSE,"5","2.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;2.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","2.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2668","39.145.668.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Rectal cancer",39,"Neoadjucvant therapy",145,"mFOLFOX6 & RT",TRUE,"Cont.","14.Fluorouracil;0.Oxoliplatin;14.Fluorouracil;0.Oxoliplatin;","14.Fluorouracil;0.Oxoliplatin;"
"2669","39.145.668.2","Solid Tumor","Gastrointestinal Oncology, Intestinal","Rectal cancer",39,"Neoadjucvant therapy",145,"mFOLFOX6 & RT",TRUE,"Cont.","12.Fluorouracil;0.Oxoliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Oxoliplatin;1.Fluorouracil;1.Fluorouracil;","12.Fluorouracil;0.Oxoliplatin;1.Fluorouracil;1.Fluorouracil;"
"2670","39.2.669.1","Solid Tumor","Gastrointestinal Oncology, Intestinal","Rectal cancer",39,"Adjuvant chemotherapy",2,"UFT monotherapy",TRUE,"Cont.","3.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;3.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;","3.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;"
"2671","4.127.298.1","Solid Tumor","Breast Oncology","Breast caner, ER and HER2 co-expressing",4,"Metastatic disease, first-line therapy",127,"Anastrozole & Trastuzumab",TRUE,"Cont.","1.Anastrozole;0.Trastuzumab;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;0.Trastuzumab;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;0.Trastuzumab;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;0.Trastuzumab;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;0.Trastuzumab;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;0.Trastuzumab;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;0.Trastuzumab;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;0.Trastuzumab;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;","1.Anastrozole;0.Trastuzumab;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;"
"2672","4.127.298.2","Solid Tumor","Breast Oncology","Breast caner, ER and HER2 co-expressing",4,"Metastatic disease, first-line therapy",127,"Anastrozole & Trastuzumab",TRUE,"Cont.","1.Anastrozole;0.Trastuzumab;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;0.Trastuzumab;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;","1.Anastrozole;0.Trastuzumab;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;"
"2673","4.127.299.1","Solid Tumor","Breast Oncology","Breast caner, ER and HER2 co-expressing",4,"Metastatic disease, first-line therapy",127,"Anastrozole, Lapatinib, Trastuzumab",TRUE,"Cont.","1.Anastrozole;0.Lapatinib;0.Trastuzumab;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;0.Trastuzumab;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;","1.Anastrozole;0.Lapatinib;0.Trastuzumab;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;1.Anastrozole;0.Lapatinib;"
"2674","4.127.300.1","Solid Tumor","Breast Oncology","Breast caner, ER and HER2 co-expressing",4,"Metastatic disease, first-line therapy",127,"Exemestane & Trastuzumab",TRUE,"Cont.","1.Exemestane;0.Trastuzumab;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;0.Trastuzumab;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;","1.Exemestane;0.Trastuzumab;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;1.Exemestane;"
"2675","4.127.301.1","Solid Tumor","Breast Oncology","Breast caner, ER and HER2 co-expressing",4,"Metastatic disease, first-line therapy",127,"Exemestane, Lapatinib, Trastuzumab",TRUE,"Cont.","1.Exemestane;0.Lapatinib;0.Trastuzumab;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;0.Trastuzumab;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;","1.Exemestane;0.Lapatinib;0.Trastuzumab;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;1.Exemestane;0.Lapatinib;"
"2676","4.127.302.1","Solid Tumor","Breast Oncology","Breast caner, ER and HER2 co-expressing",4,"Metastatic disease, first-line therapy",127,"Lapatinib & Letrozole",TRUE,"Cont.","1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;","1.Lapatinib;0.Letrozole;"
"2677","4.127.303.1","Solid Tumor","Breast Oncology","Breast caner, ER and HER2 co-expressing",4,"Metastatic disease, first-line therapy",127,"Lapatinib, Letrozole, Trastuzumab",TRUE,"Cont.","1.Lapatinib;0.Letrozole;0.Trastuzumab;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;0.Trastuzumab;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;","1.Lapatinib;0.Letrozole;0.Trastuzumab;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;1.Lapatinib;0.Letrozole;"
"2678","4.127.304.1","Solid Tumor","Breast Oncology","Breast caner, ER and HER2 co-expressing",4,"Metastatic disease, first-line therapy",127,"Letrozole & Trastuzumab",TRUE,"Cont.","21.Letrozole;0.Trastuzumab;21.Letrozole;0.Trastuzumab;","21.Letrozole;0.Trastuzumab;"
"2679","4.147.296.1","Solid Tumor","Breast Oncology","Breast caner, ER and HER2 co-expressing",4,"Neoadjuvant chemotherapy",147,"T-DM1 & ET",FALSE,"4","21.Tamoxifen;0.Trastuzumabemtansine;21.Tamoxifen;0.Trastuzumabemtansine;","21.Tamoxifen;0.Trastuzumabemtansine;"
"2680","4.147.296.2","Solid Tumor","Breast Oncology","Breast caner, ER and HER2 co-expressing",4,"Neoadjuvant chemotherapy",147,"T-DM1 & ET",FALSE,"4","21.GnRHanalog;0.Trastuzumabemtansine;21.GnRHanalog;0.Trastuzumabemtansine;","21.GnRHanalog;0.Trastuzumabemtansine;"
"2681","4.147.296.3","Solid Tumor","Breast Oncology","Breast caner, ER and HER2 co-expressing",4,"Neoadjuvant chemotherapy",147,"T-DM1 & ET",FALSE,"4","21.Aromataseinhibitor;0.Trastuzumabemtansine;21.Aromataseinhibitor;0.Trastuzumabemtansine;","21.Aromataseinhibitor;0.Trastuzumabemtansine;"
"2682","4.147.297.1","Solid Tumor","Breast Oncology","Breast caner, ER and HER2 co-expressing",4,"Neoadjuvant chemotherapy",147,"Trastuzumab & ET",FALSE,"4","21.Tamoxifen;0.Trastuzumab;21.Tamoxifen;0.Trastuzumab;","21.Tamoxifen;0.Trastuzumab;"
"2683","4.147.297.2","Solid Tumor","Breast Oncology","Breast caner, ER and HER2 co-expressing",4,"Neoadjuvant chemotherapy",147,"Trastuzumab & ET",FALSE,"4","21.GnRHanalog;0.Trastuzumab;21.GnRHanalog;0.Trastuzumab;","21.GnRHanalog;0.Trastuzumab;"
"2684","4.147.297.3","Solid Tumor","Breast Oncology","Breast caner, ER and HER2 co-expressing",4,"Neoadjuvant chemotherapy",147,"Trastuzumab & ET",FALSE,"4","21.Aromataseinhibitor;0.Trastuzumab;21.Aromataseinhibitor;0.Trastuzumab;","21.Aromataseinhibitor;0.Trastuzumab;"
"2685","40.124.670.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Cholangiocarcinoma",40,"Metastatic disease, all lines of therapy",124,"Gemcitabine, Cisplatin, S-1",TRUE,"Cont.","8.Cisplatin;0.Gemcitabine;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;8.Cisplatin;0.Gemcitabine;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;","8.Cisplatin;0.Gemcitabine;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;"
"2686","40.124.671.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Cholangiocarcinoma",40,"Metastatic disease, all lines of therapy",124,"Gemcitabine & Mitomycin",TRUE,"Cont.","14.Gemcitabine;0.Mitomycin;14.Gemcitabine;14.Gemcitabine;0.Mitomycin;14.Gemcitabine;","14.Gemcitabine;0.Mitomycin;14.Gemcitabine;"
"2687","40.124.672.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Cholangiocarcinoma",40,"Metastatic disease, all lines of therapy",124,"Gemcitabine & S-1",TRUE,"Cont.","8.Gemcitabine;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;8.Gemcitabine;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;","8.Gemcitabine;0.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;"
"2688","40.124.682.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Cholangiocarcinoma",40,"Metastatic disease, all lines of therapy",124,"GemOx",TRUE,"Cont.","21.Gemcitabine;0.Oxaliplatin;21.Gemcitabine;0.Oxaliplatin;","21.Gemcitabine;0.Oxaliplatin;"
"2689","40.124.682.2","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Cholangiocarcinoma",40,"Metastatic disease, all lines of therapy",124,"GemOx",TRUE,"Cont.","20.Gemcitabine;1.Oxaliplatin;20.Gemcitabine;1.Oxaliplatin;","20.Gemcitabine;1.Oxaliplatin;"
"2690","40.124.682.3","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Cholangiocarcinoma",40,"Metastatic disease, all lines of therapy",124,"GemOx",TRUE,"Cont.","14.Gemcitabine;0.Oxaliplatin;7.Gemcitabine;7.Gemcitabine;0.Oxaliplatin;14.Gemcitabine;0.Oxaliplatin;7.Gemcitabine;7.Gemcitabine;0.Oxaliplatin;","14.Gemcitabine;0.Oxaliplatin;7.Gemcitabine;7.Gemcitabine;0.Oxaliplatin;"
"2691","40.124.683.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Cholangiocarcinoma",40,"Metastatic disease, all lines of therapy",124,"GEMOX-B",TRUE,"Cont.","14.Bevacizumab;0.Gemcitabine;0.Gemcitabine;0.Mitomycin;0.Oxaliplatin;1.Gemcitabine;1.Gemcitabine;1.Gemcitabine;1.Gemcitabine;1.Gemcitabine;1.Gemcitabine;1.Gemcitabine;1.Gemcitabine;1.Gemcitabine;1.Gemcitabine;1.Gemcitabine;1.Gemcitabine;1.Gemcitabine;1.Bevacizumab;0.Gemcitabine;0.Oxaliplatin;14.Bevacizumab;0.Gemcitabine;0.Gemcitabine;0.Mitomycin;0.Oxaliplatin;1.Gemcitabine;1.Gemcitabine;1.Gemcitabine;1.Gemcitabine;1.Gemcitabine;1.Gemcitabine;1.Gemcitabine;1.Gemcitabine;1.Gemcitabine;1.Gemcitabine;1.Gemcitabine;1.Gemcitabine;1.Gemcitabine;1.Bevacizumab;0.Gemcitabine;0.Oxaliplatin;","14.Bevacizumab;0.Gemcitabine;0.Gemcitabine;0.Mitomycin;0.Oxaliplatin;1.Gemcitabine;1.Gemcitabine;1.Gemcitabine;1.Gemcitabine;1.Gemcitabine;1.Gemcitabine;1.Gemcitabine;1.Gemcitabine;1.Gemcitabine;1.Gemcitabine;1.Gemcitabine;1.Gemcitabine;1.Gemcitabine;1.Bevacizumab;0.Gemcitabine;0.Oxaliplatin;"
"2692","40.124.684.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Cholangiocarcinoma",40,"Metastatic disease, all lines of therapy",124,"Cisplatin & Gemcitabine (GC)",TRUE,"Cont.","14.Cisplatin;0.Gemcitabine;0.Nivolumab;7.Cisplatin;0.Gemcitabine;14.Cisplatin;0.Gemcitabine;0.Nivolumab;7.Cisplatin;0.Gemcitabine;","14.Cisplatin;0.Gemcitabine;0.Nivolumab;7.Cisplatin;0.Gemcitabine;"
"2693","40.124.684.2","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Cholangiocarcinoma",40,"Metastatic disease, all lines of therapy",124,"Nivolumab monotherapy",TRUE,"Cont.","28.Nivolumab;28.Nivolumab;","28.Nivolumab;28.Nivolumab;"
"2694","40.124.685.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Cholangiocarcinoma",40,"Metastatic disease, all lines of therapy",124,"Cisplatin & Gemcitabine (GC) & nab-Paclitaxel",TRUE,"Cont.","14.Cisplatin;0.Gemcitabine;0.Paclitaxel;0.nanoparticlealbumin-bound;0.Pembrolizumab;7.Cisplatin;0.Gemcitabine;0.Paclitaxel;0.nanoparticlealbumin-bound;14.Cisplatin;0.Gemcitabine;0.Paclitaxel;0.nanoparticlealbumin-bound;0.Pembrolizumab;7.Cisplatin;0.Gemcitabine;0.Paclitaxel;0.nanoparticlealbumin-bound;","14.Cisplatin;0.Gemcitabine;0.Paclitaxel;0.nanoparticlealbumin-bound;0.Pembrolizumab;7.Cisplatin;0.Gemcitabine;0.Paclitaxel;0.nanoparticlealbumin-bound;"
"2695","40.124.686.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Cholangiocarcinoma",40,"Metastatic disease, all lines of therapy",124,"Erlotinib & Bevacizumab",TRUE,"Cont.","1.Bevacizumab;0.Erlotinib;0.Pemigatinib;1.Erlotinib;0.Pemigatinib;1.Erlotinib;0.Pemigatinib;1.Erlotinib;0.Pemigatinib;1.Erlotinib;0.Pemigatinib;1.Erlotinib;0.Pemigatinib;1.Erlotinib;0.Pemigatinib;1.Erlotinib;0.Pemigatinib;1.Erlotinib;0.Pemigatinib;1.Erlotinib;0.Pemigatinib;1.Erlotinib;0.Pemigatinib;1.Erlotinib;0.Pemigatinib;1.Erlotinib;0.Pemigatinib;1.Erlotinib;0.Pemigatinib;1.Bevacizumab;0.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Bevacizumab;0.Erlotinib;0.Pemigatinib;1.Erlotinib;0.Pemigatinib;1.Erlotinib;0.Pemigatinib;1.Erlotinib;0.Pemigatinib;1.Erlotinib;0.Pemigatinib;1.Erlotinib;0.Pemigatinib;1.Erlotinib;0.Pemigatinib;1.Erlotinib;0.Pemigatinib;1.Erlotinib;0.Pemigatinib;1.Erlotinib;0.Pemigatinib;1.Erlotinib;0.Pemigatinib;1.Erlotinib;0.Pemigatinib;1.Erlotinib;0.Pemigatinib;1.Erlotinib;0.Pemigatinib;1.Bevacizumab;0.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;","1.Bevacizumab;0.Erlotinib;0.Pemigatinib;1.Erlotinib;0.Pemigatinib;1.Erlotinib;0.Pemigatinib;1.Erlotinib;0.Pemigatinib;1.Erlotinib;0.Pemigatinib;1.Erlotinib;0.Pemigatinib;1.Erlotinib;0.Pemigatinib;1.Erlotinib;0.Pemigatinib;1.Erlotinib;0.Pemigatinib;1.Erlotinib;0.Pemigatinib;1.Erlotinib;0.Pemigatinib;1.Erlotinib;0.Pemigatinib;1.Erlotinib;0.Pemigatinib;1.Erlotinib;0.Pemigatinib;1.Bevacizumab;0.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;"
"2696","40.124.687.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Cholangiocarcinoma",40,"Metastatic disease, all lines of therapy",124,"FULV",TRUE,"Cont.","13.Fluorouracil;1.Fluorouracil;13.Fluorouracil;1.Fluorouracil;","13.Fluorouracil;1.Fluorouracil;"
"2697","40.124.688.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Cholangiocarcinoma",40,"Metastatic disease, all lines of therapy",124,"FULV & Gemcitabine",TRUE,"Cont.","14.Fluorouracil;0.Gemcitabine;1.Fluorouracil;6.Gemcitabine;14.Fluorouracil;0.Gemcitabine;1.Fluorouracil;6.Gemcitabine;","14.Fluorouracil;0.Gemcitabine;1.Fluorouracil;6.Gemcitabine;"
"2698","40.124.688.2","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Cholangiocarcinoma",40,"Metastatic disease, all lines of therapy",124,"FULV & Gemcitabine",TRUE,"Cont.","14.Fluorouracil;0.Gemcitabine;7.Gemcitabine;14.Fluorouracil;0.Gemcitabine;7.Gemcitabine;","14.Fluorouracil;0.Gemcitabine;7.Gemcitabine;"
"2699","40.124.689.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Cholangiocarcinoma",40,"Metastatic disease, all lines of therapy",124,"Gemcitabine monotherapy",TRUE,"Cont.","16.Gemcitabine;7.Gemcitabine;7.Gemcitabine;16.Gemcitabine;7.Gemcitabine;7.Gemcitabine;","16.Gemcitabine;7.Gemcitabine;7.Gemcitabine;"
"2700","40.133.687.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Cholangiocarcinoma",40,"Metastatic disease, subsequent lines of therapy",133,"mFOLFOX6",TRUE,"Cont.","14.Fluorouracil;0.Oxaliplatin;14.Fluorouracil;0.Oxaliplatin;","14.Fluorouracil;0.Oxaliplatin;"
"2701","40.133.687.2","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Cholangiocarcinoma",40,"Metastatic disease, subsequent lines of therapy",133,"mFOLFOX6",TRUE,"Cont.","12.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;","12.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;"
"2702","40.133.688.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Cholangiocarcinoma",40,"Metastatic disease, subsequent lines of therapy",133,"mFOLFOX6 (L-Leucovorin)",TRUE,"Cont.","14.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;14.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;","14.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;"
"2703","40.133.688.2","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Cholangiocarcinoma",40,"Metastatic disease, subsequent lines of therapy",133,"mFOLFOX6 (L-Leucovorin)",TRUE,"Cont.","12.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;","12.Fluorouracil;0.Levoleucovorin;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;"
"2704","40.133.689.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Cholangiocarcinoma",40,"Metastatic disease, subsequent lines of therapy",133,"Futibatinib monotherapy",TRUE,"Cont.","1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;1.Futibatinib;","1.Futibatinib;1.Futibatinib;"
"2705","40.133.690.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Cholangiocarcinoma",40,"Metastatic disease, subsequent lines of therapy",133,"Infigratinib monotherapy",TRUE,"Cont.","1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;1.Infigratinib;","1.Infigratinib;1.Infigratinib;"
"2706","40.133.691.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Cholangiocarcinoma",40,"Metastatic disease, subsequent lines of therapy",133,"Ivosidenib monotherapy",TRUE,"Cont.","1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;1.Ivosidenib;","1.Ivosidenib;1.Ivosidenib;"
"2707","40.133.692.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Cholangiocarcinoma",40,"Metastatic disease, subsequent lines of therapy",133,"Lenvatinib & Pembrolizumab",TRUE,"Cont.","1.Lenvatinib;0.Pembrolizumab;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;0.Pembrolizumab;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;","1.Lenvatinib;0.Pembrolizumab;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;"
"2708","40.133.693.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Cholangiocarcinoma",40,"Metastatic disease, subsequent lines of therapy",133,"Regorafenib monotherapy",TRUE,"Cont.","8.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;8.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;","8.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;"
"2709","40.144.676.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Cholangiocarcinoma",40,"Metastatic, first-line therapy",144,"CapeOx",FALSE,"8","8.Capecitabine;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Capecitabine;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Capecitabine;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2710","40.144.677.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Cholangiocarcinoma",40,"Metastatic, first-line therapy",144,"Cisplatin & Gemcitabine (GC)",TRUE,"Cont.","14.Cisplatin;0.Gemcitabine;7.Cisplatin;0.Gemcitabine;14.Cisplatin;0.Gemcitabine;7.Cisplatin;0.Gemcitabine;","14.Cisplatin;0.Gemcitabine;7.Cisplatin;0.Gemcitabine;"
"2711","40.144.678.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Cholangiocarcinoma",40,"Metastatic, first-line therapy",144,"Cisplatin & Gemcitabine (GC) & Durvalumab",TRUE,"Cont.","14.Cisplatin;0.Durvalumab;0.Gemcitabine;7.Cisplatin;0.Gemcitabine;14.Cisplatin;0.Durvalumab;0.Gemcitabine;7.Cisplatin;0.Gemcitabine;","14.Cisplatin;0.Durvalumab;0.Gemcitabine;7.Cisplatin;0.Gemcitabine;"
"2712","40.144.679.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Cholangiocarcinoma",40,"Metastatic, first-line therapy",144,"ECF",TRUE,"Cont.","21.Cisplatin;0.Epirubicin;0.Fluorouracil;21.Cisplatin;0.Epirubicin;0.Fluorouracil;","21.Cisplatin;0.Epirubicin;0.Fluorouracil;"
"2713","40.144.679.2","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Cholangiocarcinoma",40,"Metastatic, first-line therapy",144,"ECF",TRUE,"Cont.","1.Cisplatin;0.Epirubicin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Cisplatin;0.Epirubicin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","1.Cisplatin;0.Epirubicin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2714","40.144.680.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Cholangiocarcinoma",40,"Metastatic, first-line therapy",144,"FELV",TRUE,"Cont.","19.Etoposide;0.Fluorouracil;1.Etoposide;0.Fluorouracil;1.Etoposide;0.Fluorouracil;19.Etoposide;0.Fluorouracil;1.Etoposide;0.Fluorouracil;1.Etoposide;0.Fluorouracil;","19.Etoposide;0.Fluorouracil;1.Etoposide;0.Fluorouracil;1.Etoposide;0.Fluorouracil;"
"2715","40.144.681.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Cholangiocarcinoma",40,"Metastatic, first-line therapy",144,"Gemcitabine & nab-Paclitaxel",TRUE,"Cont.","14.Gemcitabine;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Gemcitabine;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Gemcitabine;0.Paclitaxel;0.nanoparticlealbumin-bound;14.Gemcitabine;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Gemcitabine;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Gemcitabine;0.Paclitaxel;0.nanoparticlealbumin-bound;","14.Gemcitabine;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Gemcitabine;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Gemcitabine;0.Paclitaxel;0.nanoparticlealbumin-bound;"
"2716","40.144.682.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Cholangiocarcinoma",40,"Metastatic, first-line therapy",144,"GemOx",FALSE,"8","14.Gemcitabine;0.Oxaliplatin;7.Gemcitabine;14.Gemcitabine;0.Oxaliplatin;7.Gemcitabine;","14.Gemcitabine;0.Oxaliplatin;7.Gemcitabine;"
"2717","40.4.671.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Cholangiocarcinoma",40,"Adjuvant therapy",4,"Capecitabine monotherapy",FALSE,"8","8.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2718","40.4.672.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Cholangiocarcinoma",40,"Adjuvant therapy",4,"Capecitabine & Gemcitabine",FALSE,"4","8.Capecitabine;0.Gemcitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Gemcitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Capecitabine;0.Gemcitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Gemcitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Capecitabine;0.Gemcitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Gemcitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2719","40.4.673.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Cholangiocarcinoma",40,"Adjuvant therapy",4,"Gemcitabine monotherapy",FALSE,"6","14.Gemcitabine;7.Gemcitabine;7.Gemcitabine;14.Gemcitabine;7.Gemcitabine;7.Gemcitabine;","14.Gemcitabine;7.Gemcitabine;7.Gemcitabine;"
"2720","40.4.674.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Cholangiocarcinoma",40,"Adjuvant therapy",4,"Gemcitabine/Fluorouracil & RT",NA,NA,"0.Gemcitabine;28.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;64.Gemcitabine;28.Gemcitabine;28.Gemcitabine;","0.Gemcitabine;28.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;64.Gemcitabine;28.Gemcitabine;28.Gemcitabine;"
"2721","40.4.674.2","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Cholangiocarcinoma",40,"Adjuvant therapy",4,"Gemcitabine/Fluorouracil & RT",NA,NA,"0.Gemcitabine;28.Fluorouracil;70.Gemcitabine;28.Gemcitabine;28.Gemcitabine;","0.Gemcitabine;28.Fluorouracil;70.Gemcitabine;28.Gemcitabine;28.Gemcitabine;"
"2722","40.4.675.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Cholangiocarcinoma",40,"Adjuvant therapy",4,"GemOx",FALSE,"12","13.Gemcitabine;1.Oxaliplatin;13.Gemcitabine;1.Oxaliplatin;","13.Gemcitabine;1.Oxaliplatin;"
"2723","41.138.694.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Gallbladder cancer",41,"Metastatic or unresectable disease, all lines of therapy",138,"CAPIRI",TRUE,"Cont.","8.Capecitabine;0.Irinotecan;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Capecitabine;0.Irinotecan;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Capecitabine;0.Irinotecan;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2724","41.4.695.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Gallbladder cancer",41,"Adjuvant therapy",4,"GemOx",TRUE,"Cont.","14.Gemcitabine;0.Oxaliplatin;14.Gemcitabine;0.Oxaliplatin;","14.Gemcitabine;0.Oxaliplatin;"
"2725","41.4.696.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Gallbladder cancer",41,"Adjuvant therapy",4,"Irinotecan monotherapy",TRUE,"Cont.","21.Irinotecan;21.Irinotecan;","21.Irinotecan;21.Irinotecan;"
"2726","42.193.715.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Hepatocellular carcinoma",42,"Subsequent lines of therapy",193,"Apatinib monotherapy",TRUE,"Cont.","1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;1.Apatinib;","1.Apatinib;1.Apatinib;"
"2727","42.193.716.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Hepatocellular carcinoma",42,"Subsequent lines of therapy",193,"Cabozantinib monotherapy",TRUE,"Cont.","1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;","1.Cabozantinib;1.Cabozantinib;"
"2728","42.193.717.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Hepatocellular carcinoma",42,"Subsequent lines of therapy",193,"Camrelizumab monotherapy",TRUE,"Cont.","14.Camrelizumab;14.Camrelizumab;","14.Camrelizumab;14.Camrelizumab;"
"2729","42.193.717.2","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Hepatocellular carcinoma",42,"Subsequent lines of therapy",193,"Camrelizumab monotherapy",TRUE,"Cont.","21.Camrelizumab;21.Camrelizumab;","21.Camrelizumab;21.Camrelizumab;"
"2730","42.193.718.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Hepatocellular carcinoma",42,"Subsequent lines of therapy",193,"Ipilimumab & Nivolumab",FALSE,"4","21.Ipilimumab;0.Nivolumab;21.Ipilimumab;0.Nivolumab;","21.Ipilimumab;0.Nivolumab;"
"2731","42.193.718.2","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Hepatocellular carcinoma",42,"Subsequent lines of therapy",193,"Ipilimumab & Nivolumab",TRUE,"Cont.","14.Ipilimumab;0.Nivolumab;14.Ipilimumab;0.Nivolumab;","14.Ipilimumab;0.Nivolumab;"
"2732","42.193.719.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Hepatocellular carcinoma",42,"Subsequent lines of therapy",193,"Lenvatinib monotherapy",TRUE,"Cont.","1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;","1.Lenvatinib;1.Lenvatinib;"
"2733","42.193.720.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Hepatocellular carcinoma",42,"Subsequent lines of therapy",193,"Pembrolizumab monotherapy",TRUE,"Cont.","21.Pembrolizumab;21.Pembrolizumab;","21.Pembrolizumab;21.Pembrolizumab;"
"2734","42.193.720.2","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Hepatocellular carcinoma",42,"Subsequent lines of therapy",193,"Pembrolizumab monotherapy",TRUE,"Cont.","42.Pembrolizumab;42.Pembrolizumab;","42.Pembrolizumab;42.Pembrolizumab;"
"2735","42.193.721.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Hepatocellular carcinoma",42,"Subsequent lines of therapy",193,"Ramucirumab monotherapy",TRUE,"Cont.","14.Ramucirumab;14.Ramucirumab;","14.Ramucirumab;14.Ramucirumab;"
"2736","42.193.722.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Hepatocellular carcinoma",42,"Subsequent lines of therapy",193,"Tislelizumab monotherapy",TRUE,"Cont.","21.Tislelizumab;21.Tislelizumab;","21.Tislelizumab;21.Tislelizumab;"
"2737","42.4.697.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Hepatocellular carcinoma",42,"Adjuvant therapy",4,"TACE monotherapy",FALSE,"1","0.Doxorubicin;","0.Doxorubicin;0.Doxorubicin;"
"2738","42.4.697.2","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Hepatocellular carcinoma",42,"Adjuvant therapy",4,"TACE monotherapy",FALSE,"1","0.Carboplatin;0.Epirubicin;0.Mitomycin;","0.Carboplatin;0.Epirubicin;0.Mitomycin;"
"2739","42.69.703.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Hepatocellular carcinoma",42,"First-line therapy for advanced or metastatic disease",69,"Atezolizumab & Bevacizumab",TRUE,"Cont.","21.Atezolizumab;0.Bevacizumab;21.Atezolizumab;0.Bevacizumab;","21.Atezolizumab;0.Bevacizumab;"
"2740","42.69.704.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Hepatocellular carcinoma",42,"First-line therapy for advanced or metastatic disease",69,"Bevacizumab monotherapy",TRUE,"Cont.","14.Bevacizumab;14.Bevacizumab;","14.Bevacizumab;14.Bevacizumab;"
"2741","42.69.705.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Hepatocellular carcinoma",42,"First-line therapy for advanced or metastatic disease",69,"Capecitabine & Bevacizumab",TRUE,"Cont.","8.Bevacizumab;0.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Bevacizumab;0.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Bevacizumab;0.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2742","42.69.706.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Hepatocellular carcinoma",42,"First-line therapy for advanced or metastatic disease",69,"CapeOx & Bevacizumab",TRUE,"Cont.","8.Bevacizumab;0.Capecitabine;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Bevacizumab;0.Capecitabine;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Bevacizumab;0.Capecitabine;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2743","42.69.707.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Hepatocellular carcinoma",42,"First-line therapy for advanced or metastatic disease",69,"Doxorubicin monotherapy",TRUE,"Cont.","21.Doxorubicin;21.Doxorubicin;","21.Doxorubicin;21.Doxorubicin;"
"2744","42.69.708.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Hepatocellular carcinoma",42,"First-line therapy for advanced or metastatic disease",69,"Durvalumab & Tremelimumab",TRUE,"Cont.","28.Durvalumab;0.Tremelimumab;28.Durvalumab;0.Tremelimumab;","28.Durvalumab;0.Tremelimumab;"
"2745","42.69.709.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Hepatocellular carcinoma",42,"First-line therapy for advanced or metastatic disease",69,"Durvalumab monotherapy",TRUE,"Cont.","28.Durvalumab;28.Durvalumab;","28.Durvalumab;28.Durvalumab;"
"2746","42.69.710.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Hepatocellular carcinoma",42,"First-line therapy for advanced or metastatic disease",69,"FULV",TRUE,"Cont.","24.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;24.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","24.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2747","42.69.711.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Hepatocellular carcinoma",42,"First-line therapy for advanced or metastatic disease",69,"FOLFOX4",TRUE,"Cont.","13.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;13.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;","13.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;"
"2748","42.69.711.2","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Hepatocellular carcinoma",42,"First-line therapy for advanced or metastatic disease",69,"FOLFOX4",TRUE,"Cont.","12.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;","12.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;"
"2749","42.69.712.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Hepatocellular carcinoma",42,"First-line therapy for advanced or metastatic disease",69,"mFOLFOX & Sorafenib",TRUE,"Cont.","1.Fluorouracil;0.Oxaliplatin;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Fluorouracil;0.Oxaliplatin;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;","1.Fluorouracil;0.Oxaliplatin;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;"
"2750","42.69.712.2","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Hepatocellular carcinoma",42,"First-line therapy for advanced or metastatic disease",69,"mFOLFOX & Sorafenib",TRUE,"Cont.","1.Fluorouracil;0.Oxaliplatin;0.Sorafenib;1.Fluorouracil;0.Sorafenib;1.Fluorouracil;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Fluorouracil;0.Oxaliplatin;0.Sorafenib;1.Fluorouracil;0.Sorafenib;1.Fluorouracil;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;","1.Fluorouracil;0.Oxaliplatin;0.Sorafenib;1.Fluorouracil;0.Sorafenib;1.Fluorouracil;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;"
"2751","42.69.713.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Hepatocellular carcinoma",42,"First-line therapy for advanced or metastatic disease",69,"GemOx & Sorafenib",TRUE,"Cont.","1.Gemcitabine;0.Oxaliplatin;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Gemcitabine;0.Oxaliplatin;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;","1.Gemcitabine;0.Oxaliplatin;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;"
"2752","42.69.714.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Hepatocellular carcinoma",42,"First-line therapy for advanced or metastatic disease",69,"Sorafenib monotherapy",TRUE,"Cont.","1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;","1.Sorafenib;1.Sorafenib;"
"2753","42.99.698.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Hepatocellular carcinoma",42,"Local therapy for advanced disease",99,"Axitinib monotherapy",TRUE,"Cont.","1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;","1.Axitinib;1.Axitinib;"
"2754","42.99.699.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Hepatocellular carcinoma",42,"Local therapy for advanced disease",99,"Lenvatinib monotherapy",TRUE,"Cont.","1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;","1.Lenvatinib;1.Lenvatinib;"
"2755","42.99.700.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Hepatocellular carcinoma",42,"Local therapy for advanced disease",99,"FOLFOX-HAIC",TRUE,"Cont.","21.Fluorouracil;0.Oxaliplatin;21.Fluorouracil;0.Oxaliplatin;","21.Fluorouracil;0.Oxaliplatin;"
"2756","42.99.700.2","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Hepatocellular carcinoma",42,"Local therapy for advanced disease",99,"FOLFOX-HAIC",TRUE,"Cont.","20.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;20.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;","20.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;"
"2757","42.99.701.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Hepatocellular carcinoma",42,"Local therapy for advanced disease",99,"FOFLFOX-HAIC & Sorafenib",TRUE,"Cont.","1.Fluorouracil;0.Oxaliplatin;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Fluorouracil;0.Oxaliplatin;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;","1.Fluorouracil;0.Oxaliplatin;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;"
"2758","42.99.701.2","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Hepatocellular carcinoma",42,"Local therapy for advanced disease",99,"FOFLFOX-HAIC & Sorafenib",TRUE,"Cont.","1.Fluorouracil;0.Oxaliplatin;0.Sorafenib;1.Fluorouracil;0.Sorafenib;1.Fluorouracil;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Fluorouracil;0.Oxaliplatin;0.Sorafenib;1.Fluorouracil;0.Sorafenib;1.Fluorouracil;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;","1.Fluorouracil;0.Oxaliplatin;0.Sorafenib;1.Fluorouracil;0.Sorafenib;1.Fluorouracil;0.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;"
"2759","42.99.702.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Hepatocellular carcinoma",42,"Local therapy for advanced disease",99,"TACE, then 5-FU",FALSE,"1","0.Doxorubicin;14.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","0.Doxorubicin;14.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2760","44.125.736.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Metastatic disease, first-line",125,"Capecitabine & Gemcitabine",TRUE,"Cont.","8.Capecitabine;0.Gemcitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Gemcitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Gemcitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Capecitabine;0.Gemcitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Gemcitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Gemcitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Capecitabine;0.Gemcitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Gemcitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Gemcitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2761","44.125.736.2","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Metastatic disease, first-line",125,"Capecitabine & Gemcitabine",TRUE,"Cont.","8.Capecitabine;0.Gemcitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Gemcitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Capecitabine;0.Gemcitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Gemcitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Capecitabine;0.Gemcitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Gemcitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2762","44.125.737.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Metastatic disease, first-line",125,"Fluorouracil monotherapy",TRUE,"Cont.","1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","1.Fluorouracil;1.Fluorouracil;"
"2763","44.125.737.2","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Metastatic disease, first-line",125,"Fluorouracil monotherapy",TRUE,"Cont.","24.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;24.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","24.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2764","44.125.737.3","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Metastatic disease, first-line",125,"Fluorouracil monotherapy",TRUE,"Cont.","31.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;31.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","31.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2765","44.125.737.4","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Metastatic disease, first-line",125,"Fluorouracil monotherapy",TRUE,"Cont.","7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;","7.Fluorouracil;7.Fluorouracil;"
"2766","44.125.738.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Metastatic disease, first-line",125,"FOLFIRINOX",TRUE,"Cont.","14.Fluorouracil;0.Irinotecan;0.Oxaliplatin;14.Fluorouracil;0.Irinotecan;0.Oxaliplatin;","14.Fluorouracil;0.Irinotecan;0.Oxaliplatin;"
"2767","44.125.738.2","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Metastatic disease, first-line",125,"FOLFIRINOX",TRUE,"Cont.","12.Fluorouracil;0.Irinotecan;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Irinotecan;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;","12.Fluorouracil;0.Irinotecan;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;"
"2768","44.125.739.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Metastatic disease, first-line",125,"Gemcitabine & nab-Paclitaxel",FALSE,"1","0.Gemcitabine;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Gemcitabine;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Gemcitabine;0.Paclitaxel;0.nanoparticlealbumin-bound;14.Gemcitabine;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Gemcitabine;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Gemcitabine;0.Paclitaxel;0.nanoparticlealbumin-bound;","0.Gemcitabine;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Gemcitabine;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Gemcitabine;0.Paclitaxel;0.nanoparticlealbumin-bound;14.Gemcitabine;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Gemcitabine;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Gemcitabine;0.Paclitaxel;0.nanoparticlealbumin-bound;"
"2769","44.125.739.2","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Metastatic disease, first-line",125,"Gemcitabine & nab-Paclitaxel",TRUE,"Cont.","14.Gemcitabine;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Gemcitabine;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Gemcitabine;0.Paclitaxel;0.nanoparticlealbumin-bound;14.Gemcitabine;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Gemcitabine;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Gemcitabine;0.Paclitaxel;0.nanoparticlealbumin-bound;","14.Gemcitabine;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Gemcitabine;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Gemcitabine;0.Paclitaxel;0.nanoparticlealbumin-bound;"
"2770","44.125.740.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Metastatic disease, first-line",125,"GTX",TRUE,"Cont.","8.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Docetaxel;0.Gemcitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Docetaxel;0.Gemcitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Docetaxel;0.Gemcitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Docetaxel;0.Gemcitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Docetaxel;0.Gemcitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Docetaxel;0.Gemcitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2771","44.128.741.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Metastatic disease, gemcitabine-refractory",128,"Capecitabine & Erlotinib",TRUE,"Cont.","1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;","1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Capecitabine;0.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;"
"2772","44.128.742.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Metastatic disease, gemcitabine-refractory",128,"CapeOx",TRUE,"Cont.","8.Capecitabine;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Capecitabine;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Capecitabine;0.Oxaliplatin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2773","44.128.743.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Metastatic disease, gemcitabine-refractory",128,"FULV",TRUE,"Cont.","21.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;21.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;","21.Fluorouracil;7.Fluorouracil;7.Fluorouracil;7.Fluorouracil;"
"2774","44.128.743.2","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Metastatic disease, gemcitabine-refractory",128,"FULV",TRUE,"Cont.","20.Fluorouracil;1.Fluorouracil;6.Fluorouracil;1.Fluorouracil;6.Fluorouracil;1.Fluorouracil;6.Fluorouracil;1.Fluorouracil;20.Fluorouracil;1.Fluorouracil;6.Fluorouracil;1.Fluorouracil;6.Fluorouracil;1.Fluorouracil;6.Fluorouracil;1.Fluorouracil;","20.Fluorouracil;1.Fluorouracil;6.Fluorouracil;1.Fluorouracil;6.Fluorouracil;1.Fluorouracil;6.Fluorouracil;1.Fluorouracil;"
"2775","44.128.743.3","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Metastatic disease, gemcitabine-refractory",128,"FULV",TRUE,"Cont.","14.Fluorouracil;14.Fluorouracil;","14.Fluorouracil;14.Fluorouracil;"
"2776","44.128.743.4","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Metastatic disease, gemcitabine-refractory",128,"FULV",TRUE,"Cont.","12.Fluorouracil;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","12.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2777","44.128.744.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Metastatic disease, gemcitabine-refractory",128,"FULV & nanoliposomal Irinotecan",TRUE,"Cont.","14.Fluorouracil;0.Irinotecanliposomal;14.Fluorouracil;0.Irinotecanliposomal;","14.Fluorouracil;0.Irinotecanliposomal;"
"2778","44.128.744.2","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Metastatic disease, gemcitabine-refractory",128,"FULV & nanoliposomal Irinotecan",TRUE,"Cont.","12.Fluorouracil;0.Irinotecanliposomal;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Irinotecanliposomal;1.Fluorouracil;1.Fluorouracil;","12.Fluorouracil;0.Irinotecanliposomal;1.Fluorouracil;1.Fluorouracil;"
"2779","44.128.745.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Metastatic disease, gemcitabine-refractory",128,"FOLFIRI",TRUE,"Cont.","13.Fluorouracil;0.Irinotecan;1.Fluorouracil;13.Fluorouracil;0.Irinotecan;1.Fluorouracil;","13.Fluorouracil;0.Irinotecan;1.Fluorouracil;"
"2780","44.128.745.2","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Metastatic disease, gemcitabine-refractory",128,"FOLFIRI",TRUE,"Cont.","12.Fluorouracil;0.Irinotecan;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Irinotecan;1.Fluorouracil;1.Fluorouracil;","12.Fluorouracil;0.Irinotecan;1.Fluorouracil;1.Fluorouracil;"
"2781","44.128.745.3","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Metastatic disease, gemcitabine-refractory",128,"FOLFIRI",TRUE,"Cont.","12.Fluorouracil;0.Irinotecan;1.Fluorouracil;1.Irinotecan;12.Fluorouracil;0.Irinotecan;1.Fluorouracil;1.Irinotecan;","12.Fluorouracil;0.Irinotecan;1.Fluorouracil;1.Irinotecan;"
"2782","44.128.745.4","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Metastatic disease, gemcitabine-refractory",128,"FOLFIRI",TRUE,"Cont.","12.Fluorouracil;0.Irinotecan;1.Fluorouracil;1.Fluorouracil;0.Irinotecan;12.Fluorouracil;0.Irinotecan;1.Fluorouracil;1.Fluorouracil;0.Irinotecan;","12.Fluorouracil;0.Irinotecan;1.Fluorouracil;1.Fluorouracil;0.Irinotecan;"
"2783","44.128.746.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Metastatic disease, gemcitabine-refractory",128,"FOLFOX",TRUE,"Cont.","13.Fluorouracil;0.Irinotecan;1.Fluorouracil;13.Fluorouracil;0.Irinotecan;1.Fluorouracil;","13.Fluorouracil;0.Irinotecan;1.Fluorouracil;"
"2784","44.128.747.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Metastatic disease, gemcitabine-refractory",128,"Irinotecan liposomal monotherapy",TRUE,"Cont.","21.Irinotecanliposomal;21.Irinotecanliposomal;","21.Irinotecanliposomal;21.Irinotecanliposomal;"
"2785","44.128.748.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Metastatic disease, gemcitabine-refractory",128,"OLF",TRUE,"Cont.","21.Fluorouracil;7.Fluorouracil;0.Oxaliplatin;7.Fluorouracil;7.Fluorouracil;0.Oxaliplatin;21.Fluorouracil;7.Fluorouracil;0.Oxaliplatin;7.Fluorouracil;7.Fluorouracil;0.Oxaliplatin;","21.Fluorouracil;7.Fluorouracil;0.Oxaliplatin;7.Fluorouracil;7.Fluorouracil;0.Oxaliplatin;"
"2786","44.128.748.2","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Metastatic disease, gemcitabine-refractory",128,"OLF",TRUE,"Cont.","20.Fluorouracil;1.Fluorouracil;6.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;6.Fluorouracil;1.Fluorouracil;6.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;20.Fluorouracil;1.Fluorouracil;6.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;6.Fluorouracil;1.Fluorouracil;6.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;","20.Fluorouracil;1.Fluorouracil;6.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;6.Fluorouracil;1.Fluorouracil;6.Fluorouracil;0.Oxaliplatin;1.Fluorouracil;"
"2787","44.128.749.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Metastatic disease, gemcitabine-refractory",128,"nab-Paclitaxel monotherapy",TRUE,"Cont.","14.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;14.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;","14.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;"
"2788","44.130.750.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Metastatic disease, second-line",130,"Sotorasib monotherapy",TRUE,"Cont.","1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;","1.Sotorasib;1.Sotorasib;"
"2789","44.4.723.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Adjuvant therapy",4,"Capecitabine & Gemcitabine",FALSE,"6","8.Capecitabine;0.Gemcitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Gemcitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Gemcitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Capecitabine;0.Gemcitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Gemcitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Gemcitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Capecitabine;0.Gemcitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Gemcitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Gemcitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"2790","44.4.724.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Adjuvant therapy",4,"Fluorouracil/Fluorouracil & RT",NA,NA,"0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;29.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;57.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;36.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;29.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;57.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;36.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2791","44.4.725.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Adjuvant therapy",4,"mFOLFIRINOX",FALSE,"12","14.Fluorouracil;0.Irinotecan;0.Oxaliplatin;14.Fluorouracil;0.Irinotecan;0.Oxaliplatin;","14.Fluorouracil;0.Irinotecan;0.Oxaliplatin;"
"2792","44.4.725.2","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Adjuvant therapy",4,"mFOLFIRINOX",TRUE,"Cont.","12.Fluorouracil;0.Irinotecan;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Irinotecan;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;","12.Fluorouracil;0.Irinotecan;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;"
"2793","44.4.725.3","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Adjuvant therapy",4,"mFOLFIRINOX",TRUE,"Cont.","14.Fluorouracil;0.Irinotecan;0.Oxaliplatin;14.Fluorouracil;0.Irinotecan;0.Oxaliplatin;","14.Fluorouracil;0.Irinotecan;0.Oxaliplatin;"
"2794","44.4.726.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Adjuvant therapy",4,"Gemcitabine monotherapy",FALSE,"5","14.Gemcitabine;7.Gemcitabine;14.Gemcitabine;7.Gemcitabine;","14.Gemcitabine;7.Gemcitabine;"
"2795","44.4.726.2","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Adjuvant therapy",4,"Gemcitabine monotherapy",TRUE,"Cont.","14.Gemcitabine;7.Gemcitabine;7.Gemcitabine;14.Gemcitabine;7.Gemcitabine;7.Gemcitabine;","14.Gemcitabine;7.Gemcitabine;7.Gemcitabine;"
"2796","44.4.727.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Adjuvant therapy",4,"S-1 monotherapy",TRUE,"Cont.","15.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;15.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;","15.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;"
"2797","44.91.728.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Induction therapy for locally advanced disease, potentially resectable",91,"Docetaxel, Gemcitabine, RT",NA,NA,"0.Docetaxel;0.Gemcitabine;14.Docetaxel;0.Gemcitabine;14.Docetaxel;0.Gemcitabine;14.Gemcitabine;3.Gemcitabine;11.Gemcitabine;3.Gemcitabine;11.Gemcitabine;3.Gemcitabine;","0.Docetaxel;0.Gemcitabine;14.Docetaxel;0.Gemcitabine;14.Docetaxel;0.Gemcitabine;14.Gemcitabine;3.Gemcitabine;11.Gemcitabine;3.Gemcitabine;11.Gemcitabine;3.Gemcitabine;"
"2798","44.91.728.2","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Induction therapy for locally advanced disease, potentially resectable",91,"Docetaxel, Gemcitabine, RT",NA,NA,"0.Docetaxel;0.Gemcitabine;14.Docetaxel;0.Gemcitabine;14.Docetaxel;0.Gemcitabine;15.Gemcitabine;3.Gemcitabine;11.Gemcitabine;3.Gemcitabine;11.Gemcitabine;3.Gemcitabine;","0.Docetaxel;0.Gemcitabine;14.Docetaxel;0.Gemcitabine;14.Docetaxel;0.Gemcitabine;15.Gemcitabine;3.Gemcitabine;11.Gemcitabine;3.Gemcitabine;11.Gemcitabine;3.Gemcitabine;"
"2799","44.91.729.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Induction therapy for locally advanced disease, potentially resectable",91,"Gemcitabine & RT",FALSE,"1","0.Gemcitabine;7.Gemcitabine;7.Gemcitabine;7.Gemcitabine;7.Gemcitabine;7.Gemcitabine;","0.Gemcitabine;7.Gemcitabine;7.Gemcitabine;7.Gemcitabine;7.Gemcitabine;7.Gemcitabine;"
"2800","44.91.729.2","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Induction therapy for locally advanced disease, potentially resectable",91,"Gemcitabine & RT",FALSE,"3","14.Gemcitabine;7.Gemcitabine;7.Gemcitabine;14.Gemcitabine;7.Gemcitabine;7.Gemcitabine;","14.Gemcitabine;7.Gemcitabine;7.Gemcitabine;"
"2801","44.91.729.3","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Induction therapy for locally advanced disease, potentially resectable",91,"Gemcitabine & RT",NA,NA,"0.Gemcitabine;21.Gemcitabine;56.Gemcitabine;28.Gemcitabine;28.Gemcitabine;28.Gemcitabine;","0.Gemcitabine;21.Gemcitabine;56.Gemcitabine;28.Gemcitabine;28.Gemcitabine;28.Gemcitabine;"
"2802","44.91.730.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Induction therapy for locally advanced disease, potentially resectable",91,"Gemcitabine, Cetuximab, RT",FALSE,"6","4.Cetuximab;0.Gemcitabine;3.Gemcitabine;4.Cetuximab;0.Gemcitabine;3.Gemcitabine;","4.Cetuximab;0.Gemcitabine;3.Gemcitabine;"
"2803","44.91.731.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Induction therapy for locally advanced disease, potentially resectable",91,"FOLFIRINOX/modified FOLFIRINOX +/- Chemoradiation",TRUE,"Cont.","14.Fluorouracil;0.Irinotecan;0.Oxaliplatin;14.Fluorouracil;0.Irinotecan;0.Oxaliplatin;","14.Fluorouracil;0.Irinotecan;0.Oxaliplatin;"
"2804","44.91.731.2","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Induction therapy for locally advanced disease, potentially resectable",91,"FOLFIRINOX/modified FOLFIRINOX +/- Chemoradiation",TRUE,"Cont.","12.Fluorouracil;0.Irinotecan;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Irinotecan;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;","12.Fluorouracil;0.Irinotecan;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;"
"2805","44.91.732.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Induction therapy for locally advanced disease, potentially resectable",91,"mFOLFIRINOX, Gemcitabine, RT",NA,NA,"0.Fluorouracil;0.Irinotecan;0.Oxaliplatin;14.Fluorouracil;0.Irinotecan;0.Oxaliplatin;14.Fluorouracil;0.Irinotecan;0.Oxaliplatin;14.Fluorouracil;0.Irinotecan;0.Oxaliplatin;14.Fluorouracil;0.Irinotecan;0.Oxaliplatin;14.Fluorouracil;0.Irinotecan;0.Oxaliplatin;14.Gemcitabine;","0.Fluorouracil;0.Irinotecan;0.Oxaliplatin;14.Fluorouracil;0.Irinotecan;0.Oxaliplatin;14.Fluorouracil;0.Irinotecan;0.Oxaliplatin;14.Fluorouracil;0.Irinotecan;0.Oxaliplatin;14.Fluorouracil;0.Irinotecan;0.Oxaliplatin;14.Fluorouracil;0.Irinotecan;0.Oxaliplatin;14.Gemcitabine;"
"2806","44.91.732.2","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Induction therapy for locally advanced disease, potentially resectable",91,"mFOLFIRINOX, Gemcitabine, RT",NA,NA,"0.Fluorouracil;0.Irinotecan;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Irinotecan;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Irinotecan;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Irinotecan;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Irinotecan;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Irinotecan;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Gemcitabine;","0.Fluorouracil;0.Irinotecan;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Irinotecan;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Irinotecan;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Irinotecan;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Irinotecan;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Irinotecan;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Gemcitabine;"
"2807","44.91.732.3","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Induction therapy for locally advanced disease, potentially resectable",91,"mFOLFIRINOX, Gemcitabine, RT",NA,NA,"0.Fluorouracil;0.Irinotecan;0.Oxaliplatin;14.Fluorouracil;0.Irinotecan;0.Oxaliplatin;14.Fluorouracil;0.Irinotecan;0.Oxaliplatin;14.Fluorouracil;0.Irinotecan;0.Oxaliplatin;14.Fluorouracil;0.Irinotecan;0.Oxaliplatin;14.Fluorouracil;0.Irinotecan;0.Oxaliplatin;14.Gemcitabine;","0.Fluorouracil;0.Irinotecan;0.Oxaliplatin;14.Fluorouracil;0.Irinotecan;0.Oxaliplatin;14.Fluorouracil;0.Irinotecan;0.Oxaliplatin;14.Fluorouracil;0.Irinotecan;0.Oxaliplatin;14.Fluorouracil;0.Irinotecan;0.Oxaliplatin;14.Fluorouracil;0.Irinotecan;0.Oxaliplatin;14.Gemcitabine;"
"2808","44.91.732.4","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Induction therapy for locally advanced disease, potentially resectable",91,"mFOLFIRINOX, Gemcitabine, RT",NA,NA,"0.Fluorouracil;0.Irinotecan;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Irinotecan;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Irinotecan;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Irinotecan;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Irinotecan;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Irinotecan;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Gemcitabine;","0.Fluorouracil;0.Irinotecan;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Irinotecan;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Irinotecan;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Irinotecan;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Irinotecan;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Fluorouracil;0.Irinotecan;0.Oxaliplatin;1.Fluorouracil;1.Fluorouracil;12.Gemcitabine;"
"2809","44.92.733.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Induction therapy for locally advanced disease, unresectable",92,"Erlotinib & Gemcitabine",TRUE,"Cont.","1.Erlotinib;0.Gemcitabine;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;0.Gemcitabine;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;0.Gemcitabine;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;0.Gemcitabine;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;0.Gemcitabine;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;0.Gemcitabine;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;","1.Erlotinib;0.Gemcitabine;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;0.Gemcitabine;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;0.Gemcitabine;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;"
"2810","44.92.733.2","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Induction therapy for locally advanced disease, unresectable",92,"Erlotinib & Gemcitabine",FALSE,"6","1.Erlotinib;0.Gemcitabine;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;0.Gemcitabine;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;0.Gemcitabine;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;0.Gemcitabine;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;0.Gemcitabine;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;0.Gemcitabine;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;","1.Erlotinib;0.Gemcitabine;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;0.Gemcitabine;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;0.Gemcitabine;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;"
"2811","44.92.733.3","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Induction therapy for locally advanced disease, unresectable",92,"Erlotinib & Gemcitabine",FALSE,"1","0.Erlotinib;0.Gemcitabine;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;0.Gemcitabine;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;0.Gemcitabine;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;0.Gemcitabine;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;0.Gemcitabine;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;0.Gemcitabine;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;0.Gemcitabine;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;","0.Erlotinib;0.Gemcitabine;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;0.Gemcitabine;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;0.Gemcitabine;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;0.Gemcitabine;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;0.Gemcitabine;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;0.Gemcitabine;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;0.Gemcitabine;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;"
"2812","44.92.734.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Induction therapy for locally advanced disease, unresectable",92,"Fluorouracil & RT",FALSE,"5","3.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;3.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","3.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2813","44.92.735.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Induction therapy for locally advanced disease, unresectable",92,"Gemcitabine & RT",NA,NA,"0.Gemcitabine;66.Gemcitabine;28.Gemcitabine;28.Gemcitabine;28.Gemcitabine;28.Gemcitabine;","0.Gemcitabine;66.Gemcitabine;28.Gemcitabine;28.Gemcitabine;28.Gemcitabine;28.Gemcitabine;"
"2814","44.92.735.2","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer",44,"Induction therapy for locally advanced disease, unresectable",92,"Gemcitabine & RT",NA,NA,"0.Gemcitabine;66.Gemcitabine;28.Gemcitabine;","0.Gemcitabine;66.Gemcitabine;28.Gemcitabine;"
"2815","45.114.752.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer, BRCA-mutated",45,"Maintenance after first-line therapy",114,"Olaparib monotherapy",TRUE,"Cont.","1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;","1.Olaparib;1.Olaparib;"
"2816","45.19.751.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic cancer, BRCA-mutated",45,"Advanced or metastatic disease, first-line",19,"Cisplatin & Gemcitabine (GC)",TRUE,"Cont.","14.Cisplatin;0.Gemcitabine;7.Cisplatin;0.Gemcitabine;14.Cisplatin;0.Gemcitabine;7.Cisplatin;0.Gemcitabine;","14.Cisplatin;0.Gemcitabine;7.Cisplatin;0.Gemcitabine;"
"2817","45.31.753.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic NET",45,"All lines of therapy",31,"Capecitabine & Temozolomide",TRUE,"Cont.","15.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Temozolomide;1.Capecitabine;0.Temozolomide;1.Capecitabine;0.Temozolomide;1.Capecitabine;0.Temozolomide;1.Capecitabine;0.Temozolomide;15.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Temozolomide;1.Capecitabine;0.Temozolomide;1.Capecitabine;0.Temozolomide;1.Capecitabine;0.Temozolomide;1.Capecitabine;0.Temozolomide;","15.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Temozolomide;1.Capecitabine;0.Temozolomide;1.Capecitabine;0.Temozolomide;1.Capecitabine;0.Temozolomide;1.Capecitabine;0.Temozolomide;"
"2818","45.31.754.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic NET",45,"All lines of therapy",31,"Doxorubicin & Streptozocin",TRUE,"Cont.","21.Doxorubicin;0.Streptozocin;1.Streptozocin;1.Streptozocin;1.Streptozocin;1.Streptozocin;17.Doxorubicin;21.Doxorubicin;0.Streptozocin;1.Streptozocin;1.Streptozocin;1.Streptozocin;1.Streptozocin;17.Doxorubicin;","21.Doxorubicin;0.Streptozocin;1.Streptozocin;1.Streptozocin;1.Streptozocin;1.Streptozocin;17.Doxorubicin;"
"2819","45.31.755.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic NET",45,"All lines of therapy",31,"Everolimus monotherapy",TRUE,"Cont.","1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;","1.Everolimus;1.Everolimus;"
"2820","45.31.756.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic NET",45,"All lines of therapy",31,"Everolimus & Octreotide",TRUE,"Cont.","1.Everolimus;0.OctreotideLAR;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;0.OctreotideLAR;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;","1.Everolimus;0.OctreotideLAR;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;"
"2821","45.31.757.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic NET",45,"All lines of therapy",31,"FAS",TRUE,"Cont.","24.Doxorubicin;0.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;24.Doxorubicin;0.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;","24.Doxorubicin;0.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;"
"2822","45.31.758.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic NET",45,"All lines of therapy",31,"Fluorouracil & Streptozocin",TRUE,"Cont.","38.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;38.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;","38.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;1.Fluorouracil;0.Streptozocin;"
"2823","45.31.759.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic NET",45,"All lines of therapy",31,"Lanreotide Depot/Autogel monotherapy",TRUE,"Cont.","28.LanreotideDepot/Autogel;28.LanreotideDepot/Autogel;","28.LanreotideDepot/Autogel;28.LanreotideDepot/Autogel;"
"2824","45.31.760.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic NET",45,"All lines of therapy",31,"Lanreotide & Interferon alfa-2b",TRUE,"Cont.","1.Interferonalfa-2b;0.Lanreotide;1.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Lanreotide;1.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Lanreotide;1.Lanreotide;","1.Interferonalfa-2b;0.Lanreotide;1.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Lanreotide;1.Lanreotide;"
"2825","45.31.760.2","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic NET",45,"All lines of therapy",31,"Lanreotide & Interferon alfa-2b",TRUE,"Cont.","1.Interferonalfa-2b;0.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Lanreotide;1.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Lanreotide;1.Lanreotide;","1.Interferonalfa-2b;0.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Lanreotide;1.Lanreotide;"
"2826","45.31.760.3","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic NET",45,"All lines of therapy",31,"Lanreotide & Interferon alfa-2b",TRUE,"Cont.","1.Interferonalfa-2b;0.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;1.Interferonalfa-2b;0.Lanreotide;","1.Interferonalfa-2b;0.Lanreotide;"
"2827","45.31.761.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic NET",45,"All lines of therapy",31,"Octreotide monotherapy",TRUE,"Cont.","1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;1.Octreotide;","1.Octreotide;1.Octreotide;"
"2828","45.31.762.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic NET",45,"All lines of therapy",31,"Octreotide LAR monotherapy",TRUE,"Cont.","28.OctreotideLAR;28.OctreotideLAR;","28.OctreotideLAR;28.OctreotideLAR;"
"2829","45.31.763.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic NET",45,"All lines of therapy",31,"Octreotide & Interferon alfa",TRUE,"Cont.","1.Interferonalfa-2b;0.Octreotide;1.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Octreotide;1.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Octreotide;1.Octreotide;","1.Interferonalfa-2b;0.Octreotide;1.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Octreotide;1.Octreotide;"
"2830","45.31.763.2","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic NET",45,"All lines of therapy",31,"Octreotide & Interferon alfa",TRUE,"Cont.","1.Interferonalfa-2b;0.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Octreotide;1.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Octreotide;1.Octreotide;","1.Interferonalfa-2b;0.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Octreotide;1.Octreotide;"
"2831","45.31.763.3","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic NET",45,"All lines of therapy",31,"Octreotide & Interferon alfa",TRUE,"Cont.","1.Interferonalfa-2b;0.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Interferonalfa-2b;0.Octreotide;1.Interferonalfa-2b;0.Octreotide;","1.Interferonalfa-2b;0.Octreotide;"
"2832","45.31.764.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic NET",45,"All lines of therapy",31,"Lutetium Lu 177 dotatate & Octreotide LAR",TRUE,"Cont.","28.LutetiumLu177dotatate;0.OctreotideLAR;28.LutetiumLu177dotatate;0.OctreotideLAR;","28.LutetiumLu177dotatate;0.OctreotideLAR;"
"2833","45.31.765.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic NET",45,"All lines of therapy",31,"Sunitinib monotherapy",TRUE,"Cont.","1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;","1.Sunitinib;1.Sunitinib;"
"2834","45.31.766.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic NET",45,"All lines of therapy",31,"Temozolomide monotherapy",TRUE,"Cont.","1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;","1.Temozolomide;1.Temozolomide;"
"2835","45.31.767.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic NET",45,"All lines of therapy",31,"Temozolomide & Bevacizumab",TRUE,"Cont.","1.Bevacizumab;0.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Bevacizumab;0.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Bevacizumab;0.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Bevacizumab;0.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;","1.Bevacizumab;0.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;"
"2836","45.31.768.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic NET",45,"All lines of therapy",31,"Temozolomide & Thalidomide",TRUE,"Cont.","8.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;8.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;8.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;8.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;","8.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;"
"2837","46.104.796.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Locally advanced or metastatic disease, first-line, platinum-eligible",104,"Carboplatin & Gemcitabine (GCb)",TRUE,"Cont.","14.Carboplatin;0.Gemcitabine;7.Gemcitabine;14.Carboplatin;0.Gemcitabine;7.Gemcitabine;","14.Carboplatin;0.Gemcitabine;7.Gemcitabine;"
"2838","46.104.796.2","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Locally advanced or metastatic disease, first-line, platinum-eligible",104,"Carboplatin & Gemcitabine (GCb)",TRUE,"Cont.","14.Gemcitabine;1.Carboplatin;6.Gemcitabine;14.Gemcitabine;1.Carboplatin;6.Gemcitabine;","14.Gemcitabine;1.Carboplatin;6.Gemcitabine;"
"2839","46.104.797.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Locally advanced or metastatic disease, first-line, platinum-eligible",104,"Carboplatin & Gemcitabine (GCb) & Atezolizumab",TRUE,"Cont.","14.Atezolizumab;0.Carboplatin;0.Gemcitabine;7.Gemcitabine;14.Atezolizumab;0.Carboplatin;0.Gemcitabine;7.Gemcitabine;","14.Atezolizumab;0.Carboplatin;0.Gemcitabine;7.Gemcitabine;"
"2840","46.104.798.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Locally advanced or metastatic disease, first-line, platinum-eligible",104,"Carboplatin & Gemcitabine (GCb) & Pembrolizumab",TRUE,"Cont.","14.Carboplatin;0.Gemcitabine;0.Pembrolizumab;7.Gemcitabine;14.Carboplatin;0.Gemcitabine;0.Pembrolizumab;7.Gemcitabine;","14.Carboplatin;0.Gemcitabine;0.Pembrolizumab;7.Gemcitabine;"
"2841","46.104.799.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Locally advanced or metastatic disease, first-line, platinum-eligible",104,"Carboplatin & Paclitaxel (CP)",TRUE,"Cont.","21.Carboplatin;0.Paclitaxel;21.Carboplatin;0.Paclitaxel;","21.Carboplatin;0.Paclitaxel;"
"2842","46.104.800.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Locally advanced or metastatic disease, first-line, platinum-eligible",104,"CISCA",TRUE,"Cont.","20.Cyclophosphamide;1.Cisplatin;0.Doxorubicin;20.Cyclophosphamide;1.Cisplatin;0.Doxorubicin;","20.Cyclophosphamide;1.Cisplatin;0.Doxorubicin;"
"2843","46.104.801.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Locally advanced or metastatic disease, first-line, platinum-eligible",104,"Cisplatin & Gemcitabine (GC)",TRUE,"Cont.","14.Gemcitabine;1.Cisplatin;6.Gemcitabine;7.Gemcitabine;14.Gemcitabine;1.Cisplatin;6.Gemcitabine;7.Gemcitabine;","14.Gemcitabine;1.Cisplatin;6.Gemcitabine;7.Gemcitabine;"
"2844","46.104.802.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Locally advanced or metastatic disease, first-line, platinum-eligible",104,"Cisplatin & Gemcitabine (GC) & Atezolizumab",TRUE,"Cont.","14.Atezolizumab;0.Cisplatin;0.Gemcitabine;7.Gemcitabine;14.Atezolizumab;0.Cisplatin;0.Gemcitabine;7.Gemcitabine;","14.Atezolizumab;0.Cisplatin;0.Gemcitabine;7.Gemcitabine;"
"2845","46.104.803.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Locally advanced or metastatic disease, first-line, platinum-eligible",104,"Cisplatin & Gemcitabine (GC) & Bevacizumab",TRUE,"Cont.","14.Bevacizumab;0.Cisplatin;0.Gemcitabine;7.Gemcitabine;14.Bevacizumab;0.Cisplatin;0.Gemcitabine;7.Gemcitabine;","14.Bevacizumab;0.Cisplatin;0.Gemcitabine;7.Gemcitabine;"
"2846","46.104.804.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Locally advanced or metastatic disease, first-line, platinum-eligible",104,"Cisplatin & Gemcitabine (GC) & Pembrolizumab",TRUE,"Cont.","14.Cisplatin;0.Gemcitabine;0.Pembrolizumab;7.Gemcitabine;14.Cisplatin;0.Gemcitabine;0.Pembrolizumab;7.Gemcitabine;","14.Cisplatin;0.Gemcitabine;0.Pembrolizumab;7.Gemcitabine;"
"2847","46.104.805.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Locally advanced or metastatic disease, first-line, platinum-eligible",104,"Gemcitabine & Paclitaxel",TRUE,"Cont.","14.Gemcitabine;0.Paclitaxel;14.Gemcitabine;0.Paclitaxel;","14.Gemcitabine;0.Paclitaxel;"
"2848","46.104.805.2","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Locally advanced or metastatic disease, first-line, platinum-eligible",104,"Gemcitabine & Paclitaxel",TRUE,"Cont.","7.Gemcitabine;0.Paclitaxel;7.Gemcitabine;7.Gemcitabine;7.Gemcitabine;0.Paclitaxel;7.Gemcitabine;7.Gemcitabine;","7.Gemcitabine;0.Paclitaxel;7.Gemcitabine;7.Gemcitabine;"
"2849","46.104.806.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Locally advanced or metastatic disease, first-line, platinum-eligible",104,"MVAC",TRUE,"Cont.","7.Methotrexate;1.Cisplatin;0.Doxorubicin;0.Vinblastine;13.Methotrexate;0.Vinblastine;7.Methotrexate;0.Vinblastine;7.Methotrexate;1.Cisplatin;0.Doxorubicin;0.Vinblastine;13.Methotrexate;0.Vinblastine;7.Methotrexate;0.Vinblastine;","7.Methotrexate;1.Cisplatin;0.Doxorubicin;0.Vinblastine;13.Methotrexate;0.Vinblastine;7.Methotrexate;0.Vinblastine;"
"2850","46.104.806.2","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Locally advanced or metastatic disease, first-line, platinum-eligible",104,"MVAC",TRUE,"Cont.","7.Cisplatin;0.Doxorubicin;0.Methotrexate;0.Vinblastine;14.Methotrexate;0.Vinblastine;7.Methotrexate;0.Vinblastine;7.Cisplatin;0.Doxorubicin;0.Methotrexate;0.Vinblastine;14.Methotrexate;0.Vinblastine;7.Methotrexate;0.Vinblastine;","7.Cisplatin;0.Doxorubicin;0.Methotrexate;0.Vinblastine;14.Methotrexate;0.Vinblastine;7.Methotrexate;0.Vinblastine;"
"2851","46.104.807.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Locally advanced or metastatic disease, first-line, platinum-eligible",104,"MVAC, dose-dense",TRUE,"Cont.","13.Methotrexate;1.Cisplatin;0.Doxorubicin;0.Vinblastine;13.Methotrexate;1.Cisplatin;0.Doxorubicin;0.Vinblastine;","13.Methotrexate;1.Cisplatin;0.Doxorubicin;0.Vinblastine;"
"2852","46.104.808.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Locally advanced or metastatic disease, first-line, platinum-eligible",104,"PGC",TRUE,"Cont.","14.Cisplatin;0.Gemcitabine;0.Paclitaxel;7.Cisplatin;0.Gemcitabine;0.Paclitaxel;14.Cisplatin;0.Gemcitabine;0.Paclitaxel;7.Cisplatin;0.Gemcitabine;0.Paclitaxel;","14.Cisplatin;0.Gemcitabine;0.Paclitaxel;7.Cisplatin;0.Gemcitabine;0.Paclitaxel;"
"2853","46.105.795.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Locally advanced or metastatic disease, first-line, platinum-ineligible",105,"Atezolizumab monotherapy",TRUE,"Cont.","21.Atezolizumab;21.Atezolizumab;","21.Atezolizumab;21.Atezolizumab;"
"2854","46.106.809.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Locally advanced or metastatic disease, maintenance after platinum chemotherapy",106,"Avelumab monotherapy",TRUE,"Cont.","14.Avelumab;14.Avelumab;14.Avelumab;14.Avelumab;","14.Avelumab;14.Avelumab;"
"2855","46.107.809.2","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Locally advanced or metastatic disease, refractory/intolerant to platinum chemotherapy",107,"Avelumab monotherapy",TRUE,"Cont.","14.Avelumab;14.Avelumab;","14.Avelumab;14.Avelumab;"
"2856","46.107.810.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Locally advanced or metastatic disease, refractory/intolerant to platinum chemotherapy",107,"Docetaxel monotherapy",TRUE,"Cont.","21.Docetaxel;21.Docetaxel;","21.Docetaxel;21.Docetaxel;"
"2857","46.107.811.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Locally advanced or metastatic disease, refractory/intolerant to platinum chemotherapy",107,"Docetaxel & Ramucirumab",TRUE,"Cont.","21.Docetaxel;0.Ramucirumab;21.Docetaxel;0.Ramucirumab;","21.Docetaxel;0.Ramucirumab;"
"2858","46.107.812.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Locally advanced or metastatic disease, refractory/intolerant to platinum chemotherapy",107,"Erdafitinib monotherapy",TRUE,"Cont.","1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;1.Erdafitinib;","1.Erdafitinib;1.Erdafitinib;"
"2859","46.107.813.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Locally advanced or metastatic disease, refractory/intolerant to platinum chemotherapy",107,"Intravesicular Gemcitabine monotherapy",TRUE,"Cont.","14.Gemcitabine;7.Gemcitabine;7.Gemcitabine;14.Gemcitabine;7.Gemcitabine;7.Gemcitabine;","14.Gemcitabine;7.Gemcitabine;7.Gemcitabine;"
"2860","46.107.814.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Locally advanced or metastatic disease, refractory/intolerant to platinum chemotherapy",107,"Gemcitabine & Paclitaxel",TRUE,"Cont.","14.Gemcitabine;0.Paclitaxel;7.Gemcitabine;14.Gemcitabine;0.Paclitaxel;7.Gemcitabine;","14.Gemcitabine;0.Paclitaxel;7.Gemcitabine;"
"2861","46.107.814.2","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Locally advanced or metastatic disease, refractory/intolerant to platinum chemotherapy",107,"Gemcitabine & Paclitaxel",TRUE,"Cont.","7.Gemcitabine;0.Paclitaxel;7.Gemcitabine;7.Gemcitabine;7.Gemcitabine;0.Paclitaxel;7.Gemcitabine;7.Gemcitabine;","7.Gemcitabine;0.Paclitaxel;7.Gemcitabine;7.Gemcitabine;"
"2862","46.107.815.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Locally advanced or metastatic disease, refractory/intolerant to platinum chemotherapy",107,"nab-Paclitaxel monotherapy",TRUE,"Cont.","21.Paclitaxel;0.nanoparticlealbumin-bound;21.Paclitaxel;0.nanoparticlealbumin-bound;","21.Paclitaxel;0.nanoparticlealbumin-bound;"
"2863","46.107.816.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Locally advanced or metastatic disease, refractory/intolerant to platinum chemotherapy",107,"Paclitaxel monotherapy",TRUE,"Cont.","21.Paclitaxel;21.Paclitaxel;","21.Paclitaxel;21.Paclitaxel;"
"2864","46.107.816.2","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Locally advanced or metastatic disease, refractory/intolerant to platinum chemotherapy",107,"Paclitaxel monotherapy",TRUE,"Cont.","14.Paclitaxel;7.Paclitaxel;7.Paclitaxel;14.Paclitaxel;7.Paclitaxel;7.Paclitaxel;","14.Paclitaxel;7.Paclitaxel;7.Paclitaxel;"
"2865","46.107.816.3","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Locally advanced or metastatic disease, refractory/intolerant to platinum chemotherapy",107,"Paclitaxel monotherapy",TRUE,"Cont.","7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;","7.Paclitaxel;7.Paclitaxel;"
"2866","46.107.817.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Locally advanced or metastatic disease, refractory/intolerant to platinum chemotherapy",107,"Pemetrexed monotherapy",TRUE,"Cont.","21.Pemetrexed;21.Pemetrexed;","21.Pemetrexed;21.Pemetrexed;"
"2867","46.107.818.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Locally advanced or metastatic disease, refractory/intolerant to platinum chemotherapy",107,"Tislelizumab monotherapy",TRUE,"Cont.","21.Tislelizumab;21.Tislelizumab;","21.Tislelizumab;21.Tislelizumab;"
"2868","46.107.819.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Locally advanced or metastatic disease, refractory/intolerant to platinum chemotherapy",107,"Toripalimab monotherapy",TRUE,"Cont.","14.Toripalimab;14.Toripalimab;","14.Toripalimab;14.Toripalimab;"
"2869","46.107.820.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Locally advanced or metastatic disease, refractory/intolerant to platinum chemotherapy",107,"Vinflunine monotherapy",TRUE,"Cont.","21.Vinflunine;21.Vinflunine;","21.Vinflunine;21.Vinflunine;"
"2870","46.108.821.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Locally advanced or metastatic disease, refractory/intolerant to platinum chemotherapy and/or immune checkpoint inhibitor",108,"Enfortumab vedotin monotherapy",TRUE,"Cont.","14.Enfortumabvedotin;7.Enfortumabvedotin;7.Enfortumabvedotin;14.Enfortumabvedotin;7.Enfortumabvedotin;7.Enfortumabvedotin;","14.Enfortumabvedotin;7.Enfortumabvedotin;7.Enfortumabvedotin;"
"2871","46.108.822.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Locally advanced or metastatic disease, refractory/intolerant to platinum chemotherapy and/or immune checkpoint inhibitor",108,"Sacituzumab govitecan monotherapy",TRUE,"Cont.","14.Sacituzumabgovitecan;7.Sacituzumabgovitecan;14.Sacituzumabgovitecan;7.Sacituzumabgovitecan;","14.Sacituzumabgovitecan;7.Sacituzumabgovitecan;"
"2872","46.147.775.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Neoadjuvant chemotherapy",147,"Atezolizumab monotherapy",FALSE,"2","21.Atezolizumab;","21.Atezolizumab;21.Atezolizumab;"
"2873","46.147.776.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Neoadjuvant chemotherapy",147,"Cisplatin & Gemcitabine (GC)",FALSE,"4","14.Cisplatin;0.Gemcitabine;7.Gemcitabine;14.Cisplatin;0.Gemcitabine;7.Gemcitabine;","14.Cisplatin;0.Gemcitabine;7.Gemcitabine;"
"2874","46.147.776.2","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Neoadjuvant chemotherapy",147,"Cisplatin & Gemcitabine (GC)",FALSE,"4","14.Cisplatin;0.Gemcitabine;7.Cisplatin;0.Gemcitabine;14.Cisplatin;0.Gemcitabine;7.Cisplatin;0.Gemcitabine;","14.Cisplatin;0.Gemcitabine;7.Cisplatin;0.Gemcitabine;"
"2875","46.147.777.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Neoadjuvant chemotherapy",147,"Cisplatin & Gemcitabine (GC) & Pembrolizumab",FALSE,"4","14.Cisplatin;0.Gemcitabine;0.Pembrolizumab;7.Cisplatin;0.Gemcitabine;14.Cisplatin;0.Gemcitabine;0.Pembrolizumab;7.Cisplatin;0.Gemcitabine;","14.Cisplatin;0.Gemcitabine;0.Pembrolizumab;7.Cisplatin;0.Gemcitabine;"
"2876","46.147.778.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Neoadjuvant chemotherapy",147,"MCV",FALSE,"2","7.Methotrexate;1.Cisplatin;0.Vinblastine;13.Methotrexate;0.Vinblastine;7.Methotrexate;0.Vinblastine;","7.Methotrexate;1.Cisplatin;0.Vinblastine;13.Methotrexate;0.Vinblastine;7.Methotrexate;0.Vinblastine;"
"2877","46.147.778.2","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Neoadjuvant chemotherapy",147,"MCV",FALSE,"3","14.Methotrexate;0.Vinblastine;1.Cisplatin;6.Methotrexate;0.Vinblastine;14.Methotrexate;0.Vinblastine;1.Cisplatin;6.Methotrexate;0.Vinblastine;","14.Methotrexate;0.Vinblastine;1.Cisplatin;6.Methotrexate;0.Vinblastine;"
"2878","46.147.779.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Neoadjuvant chemotherapy",147,"MVAC",FALSE,"2","7.Methotrexate;1.Cisplatin;0.Doxorubicin;0.Vinblastine;13.Methotrexate;0.Vinblastine;7.Methotrexate;0.Vinblastine;","7.Methotrexate;1.Cisplatin;0.Doxorubicin;0.Vinblastine;13.Methotrexate;0.Vinblastine;7.Methotrexate;0.Vinblastine;"
"2879","46.147.779.2","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Neoadjuvant chemotherapy",147,"MVAC",FALSE,"3","7.Methotrexate;1.Cisplatin;0.Doxorubicin;0.Vinblastine;13.Methotrexate;0.Vinblastine;7.Methotrexate;0.Vinblastine;7.Methotrexate;1.Cisplatin;0.Doxorubicin;0.Vinblastine;13.Methotrexate;0.Vinblastine;7.Methotrexate;0.Vinblastine;","7.Methotrexate;1.Cisplatin;0.Doxorubicin;0.Vinblastine;13.Methotrexate;0.Vinblastine;7.Methotrexate;0.Vinblastine;"
"2880","46.147.780.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Neoadjuvant chemotherapy",147,"MVAC, dose-dense",TRUE,"Cont.","14.Cisplatin;0.Doxorubicin;0.Methotrexate;0.Vinblastine;14.Cisplatin;0.Doxorubicin;0.Methotrexate;0.Vinblastine;","14.Cisplatin;0.Doxorubicin;0.Methotrexate;0.Vinblastine;"
"2881","46.147.781.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Neoadjuvant chemotherapy",147,"Cisplatin & RT",FALSE,"3","6.Cisplatin;1.Cisplatin;6.Cisplatin;1.Cisplatin;","6.Cisplatin;1.Cisplatin;"
"2882","46.147.781.2","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Neoadjuvant chemotherapy",147,"Cisplatin & RT",FALSE,"2","21.Cisplatin;","21.Cisplatin;21.Cisplatin;"
"2883","46.147.782.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Neoadjuvant chemotherapy",147,"Cisplatin & Fluorouracil (CF) & RT",FALSE,"2","12.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;","12.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;"
"2884","46.147.782.2","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Neoadjuvant chemotherapy",147,"Cisplatin & Fluorouracil (CF) & RT",FALSE,"1","0.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;5.Cisplatin;1.Cisplatin;1.Cisplatin;5.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;","0.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;5.Cisplatin;1.Cisplatin;1.Cisplatin;5.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;"
"2885","46.147.782.3","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Neoadjuvant chemotherapy",147,"Cisplatin & Fluorouracil (CF) & RT",FALSE,"3","5.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;5.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;","5.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;"
"2886","46.147.783.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Neoadjuvant chemotherapy",147,"Cisplatin, Paclitaxel, RT",FALSE,"3","6.Cisplatin;0.Paclitaxel;1.Cisplatin;6.Cisplatin;0.Paclitaxel;1.Cisplatin;","6.Cisplatin;0.Paclitaxel;1.Cisplatin;"
"2887","46.147.783.2","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Neoadjuvant chemotherapy",147,"Cisplatin, Paclitaxel, RT",FALSE,"3","5.Cisplatin;0.Paclitaxel;1.Cisplatin;1.Cisplatin;5.Cisplatin;0.Paclitaxel;1.Cisplatin;1.Cisplatin;","5.Cisplatin;0.Paclitaxel;1.Cisplatin;1.Cisplatin;"
"2888","46.147.784.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Neoadjuvant chemotherapy",147,"Fluorouracil, Mitomycin, RT",FALSE,"1","0.Fluorouracil;0.Mitomycin;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;11.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","0.Fluorouracil;0.Mitomycin;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;11.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2889","46.147.784.2","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Neoadjuvant chemotherapy",147,"Fluorouracil, Mitomycin, RT",FALSE,"1","0.Fluorouracil;0.Mitomycin;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;11.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","0.Fluorouracil;0.Mitomycin;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;11.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2890","46.147.785.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Neoadjuvant chemotherapy",147,"Gemcitabine & RT",FALSE,"2","4.Gemcitabine;3.Gemcitabine;4.Gemcitabine;3.Gemcitabine;","4.Gemcitabine;3.Gemcitabine;"
"2891","46.147.786.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Neoadjuvant chemotherapy",147,"Paclitaxel & RT",TRUE,"Cont.","7.Paclitaxel;7.Paclitaxel;","7.Paclitaxel;7.Paclitaxel;"
"2892","46.156.769.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Nonmuscle invasive bladder cancer",156,"Bacillus Calmette-Gurin (BCG) monotherapy",FALSE,"1","0.BacillusCalmette-Gurin;7.BacillusCalmette-Gurin;7.BacillusCalmette-Gurin;7.BacillusCalmette-Gurin;7.BacillusCalmette-Gurin;7.BacillusCalmette-Gurin;","0.BacillusCalmette-Gurin;7.BacillusCalmette-Gurin;7.BacillusCalmette-Gurin;7.BacillusCalmette-Gurin;7.BacillusCalmette-Gurin;7.BacillusCalmette-Gurin;"
"2893","46.156.769.2","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Nonmuscle invasive bladder cancer",156,"Bacillus Calmette-Gurin (BCG) monotherapy",FALSE,"6","14.BacillusCalmette-Gurin;14.BacillusCalmette-Gurin;","14.BacillusCalmette-Gurin;14.BacillusCalmette-Gurin;"
"2894","46.156.769.3","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Nonmuscle invasive bladder cancer",156,"Bacillus Calmette-Gurin (BCG) monotherapy",TRUE,"Cont.","7.BacillusCalmette-Gurin;7.BacillusCalmette-Gurin;7.BacillusCalmette-Gurin;7.BacillusCalmette-Gurin;7.BacillusCalmette-Gurin;7.BacillusCalmette-Gurin;","7.BacillusCalmette-Gurin;7.BacillusCalmette-Gurin;"
"2895","46.156.769.4","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Nonmuscle invasive bladder cancer",156,"Bacillus Calmette-Gurin (BCG) monotherapy",TRUE,"Cont.","84.BacillusCalmette-Gurin;84.BacillusCalmette-Gurin;","84.BacillusCalmette-Gurin;84.BacillusCalmette-Gurin;"
"2896","46.156.770.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Nonmuscle invasive bladder cancer",156,"Intravesicular Gemcitabine monotherapy",FALSE,"1","0.Gemcitabine;","0.Gemcitabine;0.Gemcitabine;"
"2897","46.156.770.2","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Nonmuscle invasive bladder cancer",156,"Intravesicular Gemcitabine monotherapy",FALSE,"1","0.Gemcitabine;7.Gemcitabine;7.Gemcitabine;7.Gemcitabine;7.Gemcitabine;7.Gemcitabine;","0.Gemcitabine;7.Gemcitabine;7.Gemcitabine;7.Gemcitabine;7.Gemcitabine;7.Gemcitabine;"
"2898","46.156.771.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Nonmuscle invasive bladder cancer",156,"Intravesicular Mitomycin monotherapy",NA,NA,"0.Mitomycin;14.Mitomycin;14.Mitomycin;14.Mitomycin;14.Mitomycin;14.Mitomycin;14.Mitomycin;14.Mitomycin;14.Mitomycin;","0.Mitomycin;14.Mitomycin;14.Mitomycin;14.Mitomycin;14.Mitomycin;14.Mitomycin;14.Mitomycin;14.Mitomycin;14.Mitomycin;"
"2899","46.156.771.2","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Nonmuscle invasive bladder cancer",156,"Intravesicular Mitomycin monotherapy",NA,NA,"0.Mitomycin;14.Mitomycin;14.Mitomycin;14.Mitomycin;14.Mitomycin;28.Mitomycin;28.Mitomycin;28.Mitomycin;28.Mitomycin;","0.Mitomycin;14.Mitomycin;14.Mitomycin;14.Mitomycin;14.Mitomycin;28.Mitomycin;28.Mitomycin;28.Mitomycin;28.Mitomycin;"
"2900","46.156.772.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Nonmuscle invasive bladder cancer",156,"Nadofaragene firadenovec monotherapy",FALSE,"3","84.Nadofaragenefiradenovec;84.Nadofaragenefiradenovec;","84.Nadofaragenefiradenovec;84.Nadofaragenefiradenovec;"
"2901","46.156.773.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Nonmuscle invasive bladder cancer",156,"Pembrolizumab monotherapy",TRUE,"Cont.","21.Pembrolizumab;21.Pembrolizumab;","21.Pembrolizumab;21.Pembrolizumab;"
"2902","46.156.774.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Nonmuscle invasive bladder cancer",156,"Intravesicular Valrubicin monotherapy",FALSE,"1","0.Valrubicin;7.Valrubicin;7.Valrubicin;7.Valrubicin;7.Valrubicin;7.Valrubicin;","0.Valrubicin;7.Valrubicin;7.Valrubicin;7.Valrubicin;7.Valrubicin;7.Valrubicin;"
"2903","46.31.768.1","Solid Tumor","Gastrointestinal Oncology, Extraintestinal","Pancreatic NET",46,"All lines of therapy",31,"Temozolomide & Thalidomide",TRUE,"Cont.","1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;1.Thalidomide;","1.Thalidomide;1.Thalidomide;"
"2904","46.4.790.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Adjuvant therapy",4,"Cisplatin & Gemcitabine (GC)",FALSE,"4","14.Cisplatin;0.Gemcitabine;7.Gemcitabine;7.Gemcitabine;14.Cisplatin;0.Gemcitabine;7.Gemcitabine;7.Gemcitabine;","14.Cisplatin;0.Gemcitabine;7.Gemcitabine;7.Gemcitabine;"
"2905","46.4.791.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Adjuvant therapy",4,"Cisplatin & Methotrexate",FALSE,"3","7.Cisplatin;7.Methotrexate;7.Methotrexate;7.Cisplatin;7.Methotrexate;7.Methotrexate;","7.Cisplatin;7.Methotrexate;7.Methotrexate;"
"2906","46.4.792.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Adjuvant therapy",4,"MCV",FALSE,"3","7.Methotrexate;1.Cisplatin;0.Vinblastine;1.Cisplatin;1.Cisplatin;11.Methotrexate;0.Vinblastine;7.Methotrexate;0.Vinblastine;7.Methotrexate;1.Cisplatin;0.Vinblastine;1.Cisplatin;1.Cisplatin;11.Methotrexate;0.Vinblastine;7.Methotrexate;0.Vinblastine;","7.Methotrexate;1.Cisplatin;0.Vinblastine;1.Cisplatin;1.Cisplatin;11.Methotrexate;0.Vinblastine;7.Methotrexate;0.Vinblastine;"
"2907","46.4.793.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Adjuvant therapy",4,"Nivolumab monotherapy",TRUE,"Cont.","14.Nivolumab;14.Nivolumab;","14.Nivolumab;14.Nivolumab;"
"2908","46.4.794.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Adjuvant therapy",4,"PGC",FALSE,"4","14.Cisplatin;0.Gemcitabine;0.Paclitaxel;7.Cisplatin;0.Gemcitabine;0.Paclitaxel;14.Cisplatin;0.Gemcitabine;0.Paclitaxel;7.Cisplatin;0.Gemcitabine;0.Paclitaxel;","14.Cisplatin;0.Gemcitabine;0.Paclitaxel;7.Cisplatin;0.Gemcitabine;0.Paclitaxel;"
"2909","46.4.794.2","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Adjuvant therapy",4,"PGC",FALSE,"4","14.Cisplatin;0.Gemcitabine;0.Paclitaxel;7.Gemcitabine;0.Paclitaxel;14.Cisplatin;0.Gemcitabine;0.Paclitaxel;7.Gemcitabine;0.Paclitaxel;","14.Cisplatin;0.Gemcitabine;0.Paclitaxel;7.Gemcitabine;0.Paclitaxel;"
"2910","46.49.787.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Consolidation chemoradiotherapy",49,"Cisplatin & RT",FALSE,"2","6.Cisplatin;1.Cisplatin;","6.Cisplatin;1.Cisplatin;"
"2911","46.49.787.2","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Consolidation chemoradiotherapy",49,"Cisplatin & RT",FALSE,"1","0.Cisplatin;","0.Cisplatin;0.Cisplatin;"
"2912","46.49.788.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Consolidation chemoradiotherapy",49,"Cisplatin & Fluorouracil (CF) & RT",FALSE,"2","5.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Fluorouracil;","5.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Fluorouracil;"
"2913","46.49.789.1","Solid Tumor","Genitourinary Oncology","Bladder cancer",46,"Consolidation chemoradiotherapy",49,"Cisplatin, Paclitaxel, RT",FALSE,"2","6.Cisplatin;0.Paclitaxel;1.Cisplatin;","6.Cisplatin;0.Paclitaxel;1.Cisplatin;"
"2914","47.137.826.1","Solid Tumor","Genitourinary Oncology","Penile cancer",47,"Metastatic or unresectable disease",137,"BMP",TRUE,"Cont.","14.Bleomycine;0.Cisplatin;0.Methotrexate;7.Bleomycine;0.Methotrexate;14.Bleomycine;0.Cisplatin;0.Methotrexate;7.Bleomycine;0.Methotrexate;","14.Bleomycine;0.Cisplatin;0.Methotrexate;7.Bleomycine;0.Methotrexate;"
"2915","47.137.826.2","Solid Tumor","Genitourinary Oncology","Penile cancer",47,"Metastatic or unresectable disease",137,"BMP",TRUE,"Cont.","7.Methotrexate;1.Bleomycine;0.Cisplatin;1.Bleomycine;0.Cisplatin;1.Bleomycine;0.Cisplatin;1.Bleomycine;0.Cisplatin;1.Bleomycine;0.Cisplatin;9.Methotrexate;7.Methotrexate;7.Methotrexate;1.Bleomycine;0.Cisplatin;1.Bleomycine;0.Cisplatin;1.Bleomycine;0.Cisplatin;1.Bleomycine;0.Cisplatin;1.Bleomycine;0.Cisplatin;9.Methotrexate;7.Methotrexate;","7.Methotrexate;1.Bleomycine;0.Cisplatin;1.Bleomycine;0.Cisplatin;1.Bleomycine;0.Cisplatin;1.Bleomycine;0.Cisplatin;1.Bleomycine;0.Cisplatin;9.Methotrexate;7.Methotrexate;"
"2916","47.137.827.1","Solid Tumor","Genitourinary Oncology","Penile cancer",47,"Metastatic or unresectable disease",137,"Cisplatin & Fluorouracil (CF)",FALSE,"1","0.Cisplatin;0.Fluorouracil;","0.Cisplatin;0.Fluorouracil;"
"2917","47.137.827.2","Solid Tumor","Genitourinary Oncology","Penile cancer",47,"Metastatic or unresectable disease",137,"Cisplatin & Fluorouracil (CF)",FALSE,"1","0.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","0.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2918","47.137.828.1","Solid Tumor","Genitourinary Oncology","Penile cancer",47,"Metastatic or unresectable disease",137,"Cisplatin & Irinotecan (IC)",TRUE,"Cont.","21.Cisplatin;0.Irinotecan;7.Irinotecan;21.Cisplatin;0.Irinotecan;7.Irinotecan;","21.Cisplatin;0.Irinotecan;7.Irinotecan;"
"2919","47.137.829.1","Solid Tumor","Genitourinary Oncology","Penile cancer",47,"Metastatic or unresectable disease",137,"Panitumumab monotherapy",TRUE,"Cont.","14.Panitumumab;14.Panitumumab;","14.Panitumumab;14.Panitumumab;"
"2920","47.137.830.1","Solid Tumor","Genitourinary Oncology","Penile cancer",47,"Metastatic or unresectable disease",137,"PCF",TRUE,"Cont.","20.Cisplatin;0.Fluorouracil;0.Paclitaxel;1.Cisplatin;20.Cisplatin;0.Fluorouracil;0.Paclitaxel;1.Cisplatin;","20.Cisplatin;0.Fluorouracil;0.Paclitaxel;1.Cisplatin;"
"2921","47.137.830.2","Solid Tumor","Genitourinary Oncology","Penile cancer",47,"Metastatic or unresectable disease",137,"PCF",TRUE,"Cont.","17.Cisplatin;0.Fluorouracil;0.Paclitaxel;1.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;17.Cisplatin;0.Fluorouracil;0.Paclitaxel;1.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","17.Cisplatin;0.Fluorouracil;0.Paclitaxel;1.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2922","47.147.823.1","Solid Tumor","Genitourinary Oncology","Penile cancer",47,"Neoadjuvant chemotherapy",147,"TIP",FALSE,"4","19.Cisplatin;0.Ifosfamide;0.Paclitaxel;1.Cisplatin;0.Ifosfamide;1.Cisplatin;0.Ifosfamide;19.Cisplatin;0.Ifosfamide;0.Paclitaxel;1.Cisplatin;0.Ifosfamide;1.Cisplatin;0.Ifosfamide;","19.Cisplatin;0.Ifosfamide;0.Paclitaxel;1.Cisplatin;0.Ifosfamide;1.Cisplatin;0.Ifosfamide;"
"2923","47.147.823.2","Solid Tumor","Genitourinary Oncology","Penile cancer",47,"Neoadjuvant chemotherapy",147,"TIP",FALSE,"4","26.Cisplatin;0.Ifosfamide;0.Paclitaxel;1.Cisplatin;0.Ifosfamide;1.Cisplatin;0.Ifosfamide;26.Cisplatin;0.Ifosfamide;0.Paclitaxel;1.Cisplatin;0.Ifosfamide;1.Cisplatin;0.Ifosfamide;","26.Cisplatin;0.Ifosfamide;0.Paclitaxel;1.Cisplatin;0.Ifosfamide;1.Cisplatin;0.Ifosfamide;"
"2924","47.147.824.1","Solid Tumor","Genitourinary Oncology","Penile cancer",47,"Neoadjuvant chemotherapy",147,"VBM (Vincristine)",FALSE,"4","5.Bleomycine;0.Vincristine;1.Bleomycine;1.Methotrexate;5.Bleomycine;0.Vincristine;1.Bleomycine;1.Methotrexate;5.Bleomycine;0.Vincristine;1.Bleomycine;1.Methotrexate;5.Bleomycine;0.Vincristine;1.Bleomycine;1.Methotrexate;5.Bleomycine;0.Vincristine;1.Bleomycine;1.Methotrexate;5.Bleomycine;0.Vincristine;1.Bleomycine;1.Methotrexate;","5.Bleomycine;0.Vincristine;1.Bleomycine;1.Methotrexate;"
"2925","47.2.825.1","Solid Tumor","Genitourinary Oncology","Penile cancer",47,"Adjuvant chemotherapy",2,"DCF",FALSE,"3","21.Cisplatin;0.Docetaxel;0.Fluorouracil;21.Cisplatin;0.Docetaxel;0.Fluorouracil;","21.Cisplatin;0.Docetaxel;0.Fluorouracil;"
"2926","47.2.825.2","Solid Tumor","Genitourinary Oncology","Penile cancer",47,"Adjuvant chemotherapy",2,"DCF",FALSE,"3","17.Cisplatin;0.Docetaxel;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;17.Cisplatin;0.Docetaxel;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","17.Cisplatin;0.Docetaxel;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"2927","48.131.866.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Metastatic disease, second-line hormonal therapy",131,"Abiraterone monotherapy",TRUE,"Cont.","1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;","1.Abiraterone;1.Abiraterone;"
"2928","48.131.867.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Metastatic disease, second-line hormonal therapy",131,"Abiraterone & Apalutamide",TRUE,"Cont.","1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;1.Abiraterone;0.Apalutamide;","1.Abiraterone;0.Apalutamide;"
"2929","48.131.868.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Metastatic disease, second-line hormonal therapy",131,"Abiraterone & Olaparib",TRUE,"Cont.","1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;1.Abiraterone;0.Olaparib;","1.Abiraterone;0.Olaparib;"
"2930","48.131.869.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Metastatic disease, second-line hormonal therapy",131,"Apalutamide monotherapy",TRUE,"Cont.","1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;","1.Apalutamide;1.Apalutamide;"
"2931","48.131.870.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Metastatic disease, second-line hormonal therapy",131,"BAT",TRUE,"Cont.","1.Enzalutamide;0.Goserelin;0.Testosteronecypionate;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;0.Testosteronecypionate;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;","1.Enzalutamide;0.Goserelin;0.Testosteronecypionate;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;1.Enzalutamide;0.Goserelin;"
"2932","48.131.870.2","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Metastatic disease, second-line hormonal therapy",131,"BAT",TRUE,"Cont.","1.Enzalutamide;0.Leuprolide;0.Testosteronecypionate;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;0.Testosteronecypionate;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;","1.Enzalutamide;0.Leuprolide;0.Testosteronecypionate;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;1.Enzalutamide;0.Leuprolide;"
"2933","48.131.870.3","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Metastatic disease, second-line hormonal therapy",131,"BAT",TRUE,"Cont.","1.Enzalutamide;0.Testosteronecypionate;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Testosteronecypionate;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;","1.Enzalutamide;0.Testosteronecypionate;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;0.Triptorelin;"
"2934","48.131.871.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Metastatic disease, second-line hormonal therapy",131,"Enzalutamide monotherapy",TRUE,"Cont.","1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;","1.Enzalutamide;1.Enzalutamide;"
"2935","48.131.872.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Metastatic disease, second-line hormonal therapy",131,"Hydrocortisone monotherapy",TRUE,"Cont.","1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;","1.Hydrocortisone;1.Hydrocortisone;"
"2936","48.131.873.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Metastatic disease, second-line hormonal therapy",131,"Ketoconazole & Hydrocortisone",TRUE,"Cont.","1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;1.Hydrocortisone;0.Ketoconazole;","1.Hydrocortisone;0.Ketoconazole;"
"2937","48.131.874.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Metastatic disease, second-line hormonal therapy",131,"Ketoconazole, Hydrocortisone, Dutasteride",TRUE,"Cont.","1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;","1.Dutasteride;0.Hydrocortisone;0.Ketoconazole;"
"2938","48.131.875.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Metastatic disease, second-line hormonal therapy",131,"Cabazitaxel & Prednisone",TRUE,"Cont.","21.Cabazitaxel;21.Cabazitaxel;","21.Cabazitaxel;21.Cabazitaxel;"
"2939","48.161.886.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Radioactive agents for bony metastatic disease",161,"Lutetium Lu 177 vipivotide tetraxetan monotherapy",FALSE,"6","42.LutetiumLu177vipivotidetetraxetan;42.LutetiumLu177vipivotidetetraxetan;","42.LutetiumLu177vipivotidetetraxetan;42.LutetiumLu177vipivotidetetraxetan;"
"2940","48.161.887.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Radioactive agents for bony metastatic disease",161,"Radium-223 monotherapy",FALSE,"6","28.Radium-223;28.Radium-223;","28.Radium-223;28.Radium-223;"
"2941","48.161.887.2","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Radioactive agents for bony metastatic disease",161,"Radium-223 monotherapy",FALSE,"4","28.Radium-223;28.Radium-223;","28.Radium-223;28.Radium-223;"
"2942","48.161.888.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Radioactive agents for bony metastatic disease",161,"Samarium-153 monotherapy",FALSE,"1","0.Samarium-153;","0.Samarium-153;0.Samarium-153;"
"2943","48.33.876.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Chemotherapy for metastatic castrate-resistant disease",33,"Cabozantinib monotherapy",TRUE,"Cont.","1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;1.Cabazitaxel;","1.Cabazitaxel;1.Cabazitaxel;"
"2944","48.33.877.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Chemotherapy for metastatic castrate-resistant disease",33,"Carboplatin & Docetaxel",TRUE,"Cont.","21.Carboplatin;0.Docetaxel;21.Carboplatin;0.Docetaxel;","21.Carboplatin;0.Docetaxel;"
"2945","48.33.877.2","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Chemotherapy for metastatic castrate-resistant disease",33,"Carboplatin & Docetaxel",TRUE,"Cont.","14.Carboplatin;0.Docetaxel;7.Docetaxel;7.Docetaxel;14.Carboplatin;0.Docetaxel;7.Docetaxel;7.Docetaxel;","14.Carboplatin;0.Docetaxel;7.Docetaxel;7.Docetaxel;"
"2946","48.33.878.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Chemotherapy for metastatic castrate-resistant disease",33,"Carboplatin & Paclitaxel (CP)",TRUE,"Cont.","14.Carboplatin;0.Paclitaxel;14.Carboplatin;0.Paclitaxel;14.Carboplatin;0.Paclitaxel;14.Carboplatin;0.Paclitaxel;","14.Carboplatin;0.Paclitaxel;"
"2947","48.33.878.2","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Chemotherapy for metastatic castrate-resistant disease",33,"Carboplatin & Paclitaxel (CP)",TRUE,"Cont.","14.Carboplatin;0.Paclitaxel;7.Paclitaxel;7.Paclitaxel;14.Carboplatin;0.Paclitaxel;7.Paclitaxel;7.Paclitaxel;","14.Carboplatin;0.Paclitaxel;7.Paclitaxel;7.Paclitaxel;"
"2948","48.33.879.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Chemotherapy for metastatic castrate-resistant disease",33,"Docetaxel, Enzalutamide, Prednisolone",TRUE,"Cont.","1.Docetaxel;0.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Docetaxel;0.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;","1.Docetaxel;0.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;"
"2949","48.33.880.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Chemotherapy for metastatic castrate-resistant disease",33,"Docetaxel & Estramustine",TRUE,"Cont.","17.Estramustine;1.Docetaxel;0.Estramustine;1.Estramustine;1.Estramustine;1.Estramustine;17.Estramustine;1.Docetaxel;0.Estramustine;1.Estramustine;1.Estramustine;1.Estramustine;","17.Estramustine;1.Docetaxel;0.Estramustine;1.Estramustine;1.Estramustine;1.Estramustine;"
"2950","48.33.881.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Chemotherapy for metastatic castrate-resistant disease",33,"Docetaxel & Prednisone",TRUE,"Cont.","14.Docetaxel;7.Docetaxel;7.Docetaxel;7.Docetaxel;7.Docetaxel;14.Docetaxel;7.Docetaxel;7.Docetaxel;7.Docetaxel;7.Docetaxel;","14.Docetaxel;7.Docetaxel;7.Docetaxel;7.Docetaxel;7.Docetaxel;"
"2951","48.33.881.2","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Chemotherapy for metastatic castrate-resistant disease",33,"Docetaxel & Prednisone",TRUE,"Cont.","21.Docetaxel;21.Docetaxel;","21.Docetaxel;21.Docetaxel;"
"2952","48.33.881.3","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Chemotherapy for metastatic castrate-resistant disease",33,"Docetaxel & Prednisone",TRUE,"Cont.","14.Docetaxel;14.Docetaxel;14.Docetaxel;14.Docetaxel;","14.Docetaxel;14.Docetaxel;"
"2953","48.33.882.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Chemotherapy for metastatic castrate-resistant disease",33,"Mitoxantrone & Hydrocortisone",TRUE,"Cont.","1.Hydrocortisone;0.Mitoxantrone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;0.Mitoxantrone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;","1.Hydrocortisone;0.Mitoxantrone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;1.Hydrocortisone;"
"2954","48.33.883.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Chemotherapy for metastatic castrate-resistant disease",33,"Mitoxantrone & Prednisone",TRUE,"Cont.","21.Mitoxantrone;21.Mitoxantrone;","21.Mitoxantrone;21.Mitoxantrone;"
"2955","48.4.839.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Adjuvant therapy",4,"Bicalutamide & Goserelin",TRUE,"Cont.","1.Bicalutamide;0.Goserelin;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;0.Goserelin;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;","1.Bicalutamide;0.Goserelin;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;"
"2956","48.4.840.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Adjuvant therapy",4,"Triptorelin & RT",TRUE,"Cont.","84.Triptorelin;84.Triptorelin;","84.Triptorelin;84.Triptorelin;"
"2957","48.4.841.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Adjuvant therapy",4,"Salvage ADT & radiotherapy",TRUE,"Cont.","1.Bicalutamide;0.Leuprolide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;0.Leuprolide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;","1.Bicalutamide;0.Leuprolide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;"
"2958","48.4.841.2","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Adjuvant therapy",4,"Salvage ADT & radiotherapy",TRUE,"Cont.","1.Bicalutamide;0.Goserelin;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;0.Goserelin;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;","1.Bicalutamide;0.Goserelin;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;"
"2959","48.4.841.3","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Adjuvant therapy",4,"Salvage ADT & radiotherapy",TRUE,"Cont.","1.Bicalutamide;0.Buserelin;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;0.Buserelin;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;","1.Bicalutamide;0.Buserelin;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;"
"2960","48.4.841.4","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Adjuvant therapy",4,"Salvage ADT & radiotherapy",TRUE,"Cont.","1.Bicalutamide;0.Triptorelin;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;0.Triptorelin;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;","1.Bicalutamide;0.Triptorelin;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;"
"2961","48.4.841.5","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Adjuvant therapy",4,"Salvage ADT & radiotherapy",TRUE,"Cont.","1.Flutamide;0.Leuprolide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;0.Leuprolide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;","1.Flutamide;0.Leuprolide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;"
"2962","48.4.841.6","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Adjuvant therapy",4,"Salvage ADT & radiotherapy",TRUE,"Cont.","1.Flutamide;0.Goserelin;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;0.Goserelin;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;","1.Flutamide;0.Goserelin;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;"
"2963","48.4.841.7","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Adjuvant therapy",4,"Salvage ADT & radiotherapy",TRUE,"Cont.","1.Buserelin;0.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Buserelin;0.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;","1.Buserelin;0.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;"
"2964","48.4.841.8","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Adjuvant therapy",4,"Salvage ADT & radiotherapy",TRUE,"Cont.","1.Flutamide;0.Triptorelin;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;0.Triptorelin;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;","1.Flutamide;0.Triptorelin;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;"
"2965","48.4.842.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Adjuvant therapy",4,"Bicalutamide & RT",TRUE,"Cont.","1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;","1.Bicalutamide;1.Bicalutamide;"
"2966","48.4.843.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Adjuvant therapy",4,"Goserelin & RT",FALSE,"1","0.Goserelin;","0.Goserelin;0.Goserelin;"
"2967","48.55.836.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Definitive therapy, including active surveillance",55,"Flutamide, Goserelin, RT",TRUE,"Cont.","1.Flutamide;0.Goserelin;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;0.Goserelin;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;","1.Flutamide;0.Goserelin;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;"
"2968","48.55.837.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Definitive therapy, including active surveillance",55,"Flutamide, Leuprolide, RT",FALSE,"4","1.Flutamide;0.Leuprolide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;0.Leuprolide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;","1.Flutamide;0.Leuprolide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;"
"2969","48.55.837.2","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Definitive therapy, including active surveillance",55,"Flutamide, Leuprolide, RT",FALSE,"1","0.Flutamide;0.Leuprolide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;","0.Flutamide;0.Leuprolide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;"
"2970","48.55.837.3","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Definitive therapy, including active surveillance",55,"Flutamide, Leuprolide, RT",TRUE,"Cont.","1.Flutamide;0.Leuprolide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;0.Leuprolide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;","1.Flutamide;0.Leuprolide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;"
"2971","48.55.838.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Definitive therapy, including active surveillance",55,"Goserelin & RT",TRUE,"Cont.","28.Goserelin;28.Goserelin;","28.Goserelin;28.Goserelin;"
"2972","48.82.847.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Hormonal therapy for metastatic or locally advanced disease",82,"Abarelix monotherapy",TRUE,"Cont.","28.Abarelix;28.Abarelix;","28.Abarelix;28.Abarelix;"
"2973","48.82.848.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Hormonal therapy for metastatic or locally advanced disease",82,"ADT & Abiraterone",TRUE,"Cont.","1.Abiraterone;0.Goserelin;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;0.Goserelin;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;","1.Abiraterone;0.Goserelin;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;"
"2974","48.82.848.2","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Hormonal therapy for metastatic or locally advanced disease",82,"ADT & Abiraterone",TRUE,"Cont.","1.Abiraterone;0.Leuproline;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;0.Leuproline;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;","1.Abiraterone;0.Leuproline;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;"
"2975","48.82.848.3","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Hormonal therapy for metastatic or locally advanced disease",82,"ADT & Abiraterone",TRUE,"Cont.","1.Abiraterone;0.Triptorelin;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;0.Triptorelin;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;","1.Abiraterone;0.Triptorelin;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;1.Abiraterone;"
"2976","48.82.849.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Hormonal therapy for metastatic or locally advanced disease",82,"ADT & Bicalutamide",TRUE,"Cont.","1.Bicalutamide;0.Goserelin;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;0.Goserelin;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;","1.Bicalutamide;0.Goserelin;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;"
"2977","48.82.849.2","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Hormonal therapy for metastatic or locally advanced disease",82,"ADT & Bicalutamide",TRUE,"Cont.","1.Bicalutamide;0.Leuproline;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;0.Leuproline;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;","1.Bicalutamide;0.Leuproline;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;"
"2978","48.82.849.3","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Hormonal therapy for metastatic or locally advanced disease",82,"ADT & Bicalutamide",TRUE,"Cont.","1.Bicalutamide;0.Triptorelin;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;0.Triptorelin;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;","1.Bicalutamide;0.Triptorelin;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;"
"2979","48.82.850.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Hormonal therapy for metastatic or locally advanced disease",82,"ADT, Darolutamide, Docetaxel",TRUE,"Cont.","1.Darolutamide;0.Docetaxel;0.Goserelin;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;0.Docetaxel;0.Goserelin;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;","1.Darolutamide;0.Docetaxel;0.Goserelin;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;"
"2980","48.82.850.2","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Hormonal therapy for metastatic or locally advanced disease",82,"ADT, Darolutamide, Docetaxel",TRUE,"Cont.","1.Darolutamide;0.Docetaxel;0.Leuproline;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;0.Docetaxel;0.Leuproline;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;","1.Darolutamide;0.Docetaxel;0.Leuproline;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;"
"2981","48.82.850.3","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Hormonal therapy for metastatic or locally advanced disease",82,"ADT, Darolutamide, Docetaxel",TRUE,"Cont.","1.Darolutamide;0.Docetaxel;0.Triptorelin;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;0.Docetaxel;0.Triptorelin;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;","1.Darolutamide;0.Docetaxel;0.Triptorelin;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;"
"2982","48.82.851.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Hormonal therapy for metastatic or locally advanced disease",82,"ADT & Docetaxel",TRUE,"Cont.","28.Docetaxel;0.Goserelin;28.Docetaxel;0.Goserelin;","28.Docetaxel;0.Goserelin;"
"2983","48.82.851.2","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Hormonal therapy for metastatic or locally advanced disease",82,"ADT & Docetaxel",TRUE,"Cont.","28.Docetaxel;0.Leuproline;28.Docetaxel;0.Leuproline;","28.Docetaxel;0.Leuproline;"
"2984","48.82.851.3","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Hormonal therapy for metastatic or locally advanced disease",82,"ADT & Docetaxel",TRUE,"Cont.","28.Docetaxel;0.Triptorelin;28.Docetaxel;0.Triptorelin;","28.Docetaxel;0.Triptorelin;"
"2985","48.82.852.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Hormonal therapy for metastatic or locally advanced disease",82,"Docetaxel, Estramustine, Goserelin",NA,NA,"0.Estramustine;1.Docetaxel;0.Estramustine;1.Estramustine;1.Estramustine;1.Estramustine;17.Estramustine;1.Docetaxel;0.Estramustine;1.Estramustine;1.Estramustine;1.Estramustine;17.Estramustine;1.Docetaxel;0.Estramustine;1.Estramustine;1.Estramustine;1.Estramustine;17.Estramustine;1.Docetaxel;0.Estramustine;1.Estramustine;1.Estramustine;1.Estramustine;17.Goserelin;84.Goserelin;84.Goserelin;84.Goserelin;84.Goserelin;","0.Estramustine;1.Docetaxel;0.Estramustine;1.Estramustine;1.Estramustine;1.Estramustine;17.Estramustine;1.Docetaxel;0.Estramustine;1.Estramustine;1.Estramustine;1.Estramustine;17.Estramustine;1.Docetaxel;0.Estramustine;1.Estramustine;1.Estramustine;1.Estramustine;17.Estramustine;1.Docetaxel;0.Estramustine;1.Estramustine;1.Estramustine;1.Estramustine;17.Goserelin;84.Goserelin;84.Goserelin;84.Goserelin;84.Goserelin;"
"2986","48.82.853.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Hormonal therapy for metastatic or locally advanced disease",82,"Bicalutamide monotherapy",TRUE,"Cont.","1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;","1.Bicalutamide;1.Bicalutamide;"
"2987","48.82.854.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Hormonal therapy for metastatic or locally advanced disease",82,"Bicalutamide & Goserelin",TRUE,"Cont.","1.Bicalutamide;0.Goserelin;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;0.Goserelin;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;","1.Bicalutamide;0.Goserelin;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;"
"2988","48.82.855.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Hormonal therapy for metastatic or locally advanced disease",82,"Bicalutamide & Leuprolide",TRUE,"Cont.","1.Bicalutamide;0.Leuprolide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;0.Leuprolide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;","1.Bicalutamide;0.Leuprolide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;"
"2989","48.82.855.2","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Hormonal therapy for metastatic or locally advanced disease",82,"Bicalutamide & Leuprolide",TRUE,"Cont.","1.Bicalutamide;0.Leuprolide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;0.Leuprolide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;","1.Bicalutamide;0.Leuprolide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;"
"2990","48.82.856.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Hormonal therapy for metastatic or locally advanced disease",82,"Degarelix monotherapy",TRUE,"Cont.","28.Degarelix;28.Degarelix;","28.Degarelix;28.Degarelix;"
"2991","48.82.857.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Hormonal therapy for metastatic or locally advanced disease",82,"Flutamide monotherapy",TRUE,"Cont.","1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;","1.Flutamide;1.Flutamide;"
"2992","48.82.858.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Hormonal therapy for metastatic or locally advanced disease",82,"Flutamide & Goserelin",TRUE,"Cont.","1.Flutamide;0.Goserelin;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;0.Goserelin;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;","1.Flutamide;0.Goserelin;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;"
"2993","48.82.859.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Hormonal therapy for metastatic or locally advanced disease",82,"Flutamide & Leuprolide",TRUE,"Cont.","1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;1.Flutamide;0.Leuprolide;","1.Flutamide;0.Leuprolide;"
"2994","48.82.859.2","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Hormonal therapy for metastatic or locally advanced disease",82,"Flutamide & Leuprolide",TRUE,"Cont.","1.Flutamide;0.Leuprolide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;0.Leuprolide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;","1.Flutamide;0.Leuprolide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;"
"2995","48.82.860.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Hormonal therapy for metastatic or locally advanced disease",82,"Goserelin monotherapy",TRUE,"Cont.","28.Goserelin;28.Goserelin;","28.Goserelin;28.Goserelin;"
"2996","48.82.860.2","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Hormonal therapy for metastatic or locally advanced disease",82,"Goserelin monotherapy",TRUE,"Cont.","84.Goserelin;84.Goserelin;","84.Goserelin;84.Goserelin;"
"2997","48.82.861.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Hormonal therapy for metastatic or locally advanced disease",82,"Histrelin monotherapy",TRUE,"Cont.","1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;1.Histrelin;","1.Histrelin;1.Histrelin;"
"2998","48.82.862.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Hormonal therapy for metastatic or locally advanced disease",82,"Leuprolide monotherapy",TRUE,"Cont.","1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;1.Leuprolide;","1.Leuprolide;1.Leuprolide;"
"2999","48.82.862.2","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Hormonal therapy for metastatic or locally advanced disease",82,"Leuprolide monotherapy",TRUE,"Cont.","28.Leuprolide;28.Leuprolide;","28.Leuprolide;28.Leuprolide;"
"3000","48.82.863.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Hormonal therapy for metastatic or locally advanced disease",82,"Nilutamide & Orchiectomy",TRUE,"Cont.","1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;1.Nilutamide;","1.Nilutamide;1.Nilutamide;"
"3001","48.82.864.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Hormonal therapy for metastatic or locally advanced disease",82,"Relugolix monotherapy",TRUE,"Cont.","1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;1.Relugolix;","1.Relugolix;1.Relugolix;"
"3002","48.82.865.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Hormonal therapy for metastatic or locally advanced disease",82,"Triptorelin monotherapy",TRUE,"Cont.","1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;1.Triptorelin;","1.Triptorelin;1.Triptorelin;"
"3003","48.83.844.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Hormonal therapy for non-metastatic castrate resistant disease",83,"ADT & Apalutamide",TRUE,"Cont.","1.Apalutamide;0.Goserelin;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;0.Goserelin;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;","1.Apalutamide;0.Goserelin;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;"
"3004","48.83.844.2","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Hormonal therapy for non-metastatic castrate resistant disease",83,"ADT & Apalutamide",TRUE,"Cont.","1.Apalutamide;0.Leuproline;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;0.Leuproline;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;","1.Apalutamide;0.Leuproline;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;"
"3005","48.83.844.3","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Hormonal therapy for non-metastatic castrate resistant disease",83,"ADT & Apalutamide",TRUE,"Cont.","1.Apalutamide;0.Triptorelin;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;0.Triptorelin;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;","1.Apalutamide;0.Triptorelin;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;1.Apalutamide;"
"3006","48.83.845.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Hormonal therapy for non-metastatic castrate resistant disease",83,"ADT & Darolutamide",TRUE,"Cont.","1.Darolutamide;0.Goserelin;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;0.Goserelin;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;","1.Darolutamide;0.Goserelin;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;"
"3007","48.83.845.2","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Hormonal therapy for non-metastatic castrate resistant disease",83,"ADT & Darolutamide",TRUE,"Cont.","1.Darolutamide;0.Leuproline;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;0.Leuproline;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;","1.Darolutamide;0.Leuproline;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;"
"3008","48.83.845.3","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Hormonal therapy for non-metastatic castrate resistant disease",83,"ADT & Darolutamide",TRUE,"Cont.","1.Darolutamide;0.Triptorelin;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;0.Triptorelin;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;","1.Darolutamide;0.Triptorelin;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;1.Darolutamide;"
"3009","48.83.846.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Hormonal therapy for non-metastatic castrate resistant disease",83,"ADT & Enzalutamide",TRUE,"Cont.","1.Enzalutamide;0.Goserelin;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;0.Goserelin;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;","1.Enzalutamide;0.Goserelin;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;"
"3010","48.83.846.2","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Hormonal therapy for non-metastatic castrate resistant disease",83,"ADT & Enzalutamide",TRUE,"Cont.","1.Enzalutamide;0.Leuproline;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;0.Leuproline;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;","1.Enzalutamide;0.Leuproline;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;"
"3011","48.83.846.3","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Hormonal therapy for non-metastatic castrate resistant disease",83,"ADT & Enzalutamide",TRUE,"Cont.","1.Enzalutamide;0.Triptorelin;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;0.Triptorelin;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;","1.Enzalutamide;0.Triptorelin;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;"
"3012","48.87.884.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Immunotherapy for metastatic castrate-resistant disease",87,"Ipilimumab & RT",FALSE,"4","21.Ipilimumab;21.Ipilimumab;","21.Ipilimumab;21.Ipilimumab;"
"3013","48.87.885.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Immunotherapy for metastatic castrate-resistant disease",87,"Sipuleucel-T monotherapy",FALSE,"1","0.Sipuleucel-T;14.Sipuleucel-T;14.Sipuleucel-T;","0.Sipuleucel-T;14.Sipuleucel-T;14.Sipuleucel-T;"
"3014","48.89.831.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Induction ADT",89,"ADT",TRUE,"Cont.","1.Bicalutamide;0.LNRHagonist;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;0.LNRHagonist;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;","1.Bicalutamide;0.LNRHagonist;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;"
"3015","48.89.831.2","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Induction ADT",89,"ADT",TRUE,"Cont.","1.Flutamide;0.LNRHagonist;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;0.LNRHagonist;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;","1.Flutamide;0.LNRHagonist;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;"
"3016","48.89.832.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Induction ADT",89,"Bicalutamide & Goserelin",FALSE,"1","0.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;0.Goserelin;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;15.Goserelin;28.Goserelin;","0.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;0.Goserelin;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;1.Bicalutamide;15.Goserelin;28.Goserelin;"
"3017","48.89.833.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Induction ADT",89,"Degarelix monotherapy",FALSE,"1","0.Degarelix;28.Degarelix;28.Degarelix;","0.Degarelix;28.Degarelix;28.Degarelix;"
"3018","48.89.834.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Induction ADT",89,"Flutamide & Goserelin",FALSE,"1","0.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;0.Goserelin;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;15.Goserelin;28.Goserelin;","0.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;0.Goserelin;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;1.Flutamide;15.Goserelin;28.Goserelin;"
"3019","48.89.835.1","Solid Tumor","Genitourinary Oncology","Prostate cancer",48,"Induction ADT",89,"Leuprolide monotherapy",FALSE,"2","84.Leuprolide;","84.Leuprolide;84.Leuprolide;"
"3020","49.123.889.1","Solid Tumor","Genitourinary Oncology","Prostate cancer, BRCA-mutated",49,"Metastatic castration-resistant",123,"Olaparib monotherapy",TRUE,"Cont.","1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;","1.Olaparib;1.Olaparib;"
"3021","49.123.890.1","Solid Tumor","Genitourinary Oncology","Prostate cancer, BRCA-mutated",49,"Metastatic castration-resistant",123,"Rucaparib monotherapy",TRUE,"Cont.","1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;","1.Rucaparib;1.Rucaparib;"
"3022","5.127.325.1","Solid Tumor","Breast Oncology","Breast cancer, triple negative",5,"Metastatic disease, first-line therapy",127,"Carboplatin & Gemcitabine (GCb)",TRUE,"Cont.","14.Carboplatin;0.Gemcitabine;7.Carboplatin;0.Gemcitabine;14.Carboplatin;0.Gemcitabine;7.Carboplatin;0.Gemcitabine;","14.Carboplatin;0.Gemcitabine;7.Carboplatin;0.Gemcitabine;"
"3023","5.127.326.1","Solid Tumor","Breast Oncology","Breast cancer, triple negative",5,"Metastatic disease, first-line therapy",127,"Carboplatin & Gemcitabine (GCb) & Pembrolizumab",TRUE,"Cont.","14.Carboplatin;0.Gemcitabine;0.Pembrolizumab;7.Carboplatin;0.Gemcitabine;14.Carboplatin;0.Gemcitabine;0.Pembrolizumab;7.Carboplatin;0.Gemcitabine;","14.Carboplatin;0.Gemcitabine;0.Pembrolizumab;7.Carboplatin;0.Gemcitabine;"
"3024","5.127.327.1","Solid Tumor","Breast Oncology","Breast cancer, triple negative",5,"Metastatic disease, first-line therapy",127,"Cisplatin & Docetaxel (DC)",TRUE,"Cont.","21.Cisplatin;0.Docetaxel;21.Cisplatin;0.Docetaxel;","21.Cisplatin;0.Docetaxel;"
"3025","5.127.328.1","Solid Tumor","Breast Oncology","Breast cancer, triple negative",5,"Metastatic disease, first-line therapy",127,"Cisplatin & Gemcitabine (GC)",TRUE,"Cont.","14.Cisplatin;0.Gemcitabine;7.Gemcitabine;14.Cisplatin;0.Gemcitabine;7.Gemcitabine;","14.Cisplatin;0.Gemcitabine;7.Gemcitabine;"
"3026","5.127.329.1","Solid Tumor","Breast Oncology","Breast cancer, triple negative",5,"Metastatic disease, first-line therapy",127,"Docetaxel monotherapy",FALSE,"6","21.Docetaxel;21.Docetaxel;","21.Docetaxel;21.Docetaxel;"
"3027","5.127.330.1","Solid Tumor","Breast Oncology","Breast cancer, triple negative",5,"Metastatic disease, first-line therapy",127,"FAC",TRUE,"Cont.","15.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;15.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;","15.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Doxorubicin;0.Fluorouracil;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;"
"3028","5.127.331.1","Solid Tumor","Breast Oncology","Breast cancer, triple negative",5,"Metastatic disease, first-line therapy",127,"Paclitaxel monotherapy",TRUE,"Cont.","14.Paclitaxel;7.Paclitaxel;7.Paclitaxel;14.Paclitaxel;7.Paclitaxel;7.Paclitaxel;","14.Paclitaxel;7.Paclitaxel;7.Paclitaxel;"
"3029","5.127.332.1","Solid Tumor","Breast Oncology","Breast cancer, triple negative",5,"Metastatic disease, first-line therapy",127,"Paclitaxel & Pembrolizumab",TRUE,"Cont.","7.Paclitaxel;0.Pembrolizumab;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;0.Pembrolizumab;7.Paclitaxel;7.Paclitaxel;","7.Paclitaxel;0.Pembrolizumab;7.Paclitaxel;7.Paclitaxel;"
"3030","5.127.333.1","Solid Tumor","Breast Oncology","Breast cancer, triple negative",5,"Metastatic disease, first-line therapy",127,"nab-Paclitaxel & Atezolizumab",TRUE,"Cont.","14.Atezolizumab;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;14.Atezolizumab;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;","14.Atezolizumab;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;"
"3031","5.127.334.1","Solid Tumor","Breast Oncology","Breast cancer, triple negative",5,"Metastatic disease, first-line therapy",127,"nab-Paclitaxel & Pembrolizumab",TRUE,"Cont.","14.Paclitaxel;0.nanoparticlealbumin-bound;0.Pembrolizumab;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;14.Paclitaxel;0.nanoparticlealbumin-bound;0.Pembrolizumab;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;","14.Paclitaxel;0.nanoparticlealbumin-bound;0.Pembrolizumab;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;"
"3032","5.133.335.1","Solid Tumor","Breast Oncology","Breast cancer, triple negative",5,"Metastatic disease, subsequent lines of therapy",133,"Capecitabine monotherapy",TRUE,"Cont.","8.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"3033","5.133.336.1","Solid Tumor","Breast Oncology","Breast cancer, triple negative",5,"Metastatic disease, subsequent lines of therapy",133,"Enzalutamide monotherapy",TRUE,"Cont.","1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;1.Enzalutamide;","1.Enzalutamide;1.Enzalutamide;"
"3034","5.133.337.1","Solid Tumor","Breast Oncology","Breast cancer, triple negative",5,"Metastatic disease, subsequent lines of therapy",133,"Sacituzumab govitecan monotherapy",TRUE,"Cont.","14.Sacituzumanb;7.Sacituzumanb;14.Sacituzumanb;7.Sacituzumanb;","14.Sacituzumanb;7.Sacituzumanb;"
"3035","5.147.305.1","Solid Tumor","Breast Oncology","Breast cancer, triple negative",5,"Neoadjuvant chemotherapy",147,"ddAC & Atezolizumab",FALSE,"4","14.Atezolizumab;0.Cyclophosphamide;0.Doxorubicin;14.Atezolizumab;0.Cyclophosphamide;0.Doxorubicin;","14.Atezolizumab;0.Cyclophosphamide;0.Doxorubicin;"
"3036","5.147.306.1","Solid Tumor","Breast Oncology","Breast cancer, triple negative",5,"Neoadjuvant chemotherapy",147,"AC & Pembrolizumab",FALSE,"4","21.Cyclophosphamide;0.Doxorubicin;0.Pembrolizumab;21.Cyclophosphamide;0.Doxorubicin;0.Pembrolizumab;","21.Cyclophosphamide;0.Doxorubicin;0.Pembrolizumab;"
"3037","5.147.307.1","Solid Tumor","Breast Oncology","Breast cancer, triple negative",5,"Neoadjuvant chemotherapy",147,"Carboplatin & Docetaxel",FALSE,"6","21.Carboplatin;0.Docetaxel;21.Carboplatin;0.Docetaxel;","21.Carboplatin;0.Docetaxel;"
"3038","5.147.308.1","Solid Tumor","Breast Oncology","Breast cancer, triple negative",5,"Neoadjuvant chemotherapy",147,"Carboplatin & Paclitaxel (CP)",FALSE,"4","7.Carboplatin;0.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Paclitaxel;7.Paclitaxel;","7.Carboplatin;0.Paclitaxel;7.Paclitaxel;7.Paclitaxel;"
"3039","5.147.309.1","Solid Tumor","Breast Oncology","Breast cancer, triple negative",5,"Neoadjuvant chemotherapy",147,"Carboplatin & Paclitaxel (CP) & Pembrolizumab",FALSE,"4","7.Carboplatin;0.Paclitaxel;0.Pembrolizumab;7.Paclitaxel;7.Paclitaxel;7.Carboplatin;0.Paclitaxel;0.Pembrolizumab;7.Paclitaxel;7.Paclitaxel;","7.Carboplatin;0.Paclitaxel;0.Pembrolizumab;7.Paclitaxel;7.Paclitaxel;"
"3040","5.147.309.2","Solid Tumor","Breast Oncology","Breast cancer, triple negative",5,"Neoadjuvant chemotherapy",147,"Carboplatin & Paclitaxel (CP) & Pembrolizumab",FALSE,"4","7.Carboplatin;0.Paclitaxel;0.Pembrolizumab;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;0.Pembrolizumab;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;","7.Carboplatin;0.Paclitaxel;0.Pembrolizumab;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;"
"3041","5.147.310.1","Solid Tumor","Breast Oncology","Breast cancer, triple negative",5,"Neoadjuvant chemotherapy",147,"Carboplatin & nab-Paclitaxel",FALSE,"4","14.Carboplatin;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Carboplatin;0.Paclitaxel;0.nanoparticlealbumin-bound;14.Carboplatin;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Carboplatin;0.Paclitaxel;0.nanoparticlealbumin-bound;","14.Carboplatin;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Carboplatin;0.Paclitaxel;0.nanoparticlealbumin-bound;"
"3042","5.147.311.1","Solid Tumor","Breast Oncology","Breast cancer, triple negative",5,"Neoadjuvant chemotherapy",147,"Cisplatin monotherapy",FALSE,"4","21.Cisplatin;21.Cisplatin;","21.Cisplatin;21.Cisplatin;"
"3043","5.147.312.1","Solid Tumor","Breast Oncology","Breast cancer, triple negative",5,"Neoadjuvant chemotherapy",147,"Cisplatin & Bevacizumab",FALSE,"4","21.Bevacizumab;0.Cisplatin;21.Bevacizumab;0.Cisplatin;","21.Bevacizumab;0.Cisplatin;"
"3044","5.147.313.1","Solid Tumor","Breast Oncology","Breast cancer, triple negative",5,"Neoadjuvant chemotherapy",147,"Docetaxel & Bevacizumab",FALSE,"4","21.Bevacizumab;0.Bevacizumab;0.Docetaxel;0.Docetaxel;21.Bevacizumab;0.Bevacizumab;0.Docetaxel;0.Docetaxel;","21.Bevacizumab;0.Bevacizumab;0.Docetaxel;0.Docetaxel;"
"3045","5.147.314.1","Solid Tumor","Breast Oncology","Breast cancer, triple negative",5,"Neoadjuvant chemotherapy",147,"Cyclophosphamide & Epirubicin (EC) & Bevacizumab",FALSE,"4","21.Bevacizumab;0.Cyclophosphamide;0.Epirubicin;21.Bevacizumab;0.Cyclophosphamide;0.Epirubicin;","21.Bevacizumab;0.Cyclophosphamide;0.Epirubicin;"
"3046","5.147.315.1","Solid Tumor","Breast Oncology","Breast cancer, triple negative",5,"Neoadjuvant chemotherapy",147,"Cyclophosphamide & Epirubicin (EC) & Pembrolizumab",FALSE,"4","21.Cyclophosphamide;0.Epirubicin;0.Pembrolizumab;21.Cyclophosphamide;0.Epirubicin;0.Pembrolizumab;","21.Cyclophosphamide;0.Epirubicin;0.Pembrolizumab;"
"3047","5.147.316.1","Solid Tumor","Breast Oncology","Breast cancer, triple negative",5,"Neoadjuvant chemotherapy",147,"nab-Paclitaxel & Atezolizumab",FALSE,"6","7.Atezolizumab;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Atezolizumab;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;","7.Atezolizumab;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;"
"3048","5.147.317.2","Solid Tumor","Breast Oncology","Breast cancer, triple negative",5,"Neoadjuvant chemotherapy",147,"Paclitaxel monotherapy, weekly",FALSE,"3","7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;","7.Paclitaxel;7.Paclitaxel;"
"3049","5.2.322.1","Solid Tumor","Breast Oncology","Breast cancer, triple negative",5,"Adjuvant chemotherapy",2,"Carboplatin & Paclitaxel (CP)",FALSE,"6","7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;","7.Carboplatin;0.Paclitaxel;"
"3050","5.2.323.1","Solid Tumor","Breast Oncology","Breast cancer, triple negative",5,"Adjuvant chemotherapy",2,"CMF",FALSE,"6","21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;7.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;7.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;","21.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;7.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;"
"3051","5.2.323.2","Solid Tumor","Breast Oncology","Breast cancer, triple negative",5,"Adjuvant chemotherapy",2,"CMF",FALSE,"6","15.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;15.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;","15.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;0.Fluorouracil;0.Methotrexate;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;"
"3052","5.2.324.1","Solid Tumor","Breast Oncology","Breast cancer, triple negative",5,"Adjuvant chemotherapy",2,"Pembrolizumab monotherapy",TRUE,"Cont.","21.Pembrolizumab;21.Pembrolizumab;","21.Pembrolizumab;21.Pembrolizumab;"
"3053","5.3.318.1","Solid Tumor","Breast Oncology","Breast cancer, triple negative",5,"Adjuvant chemotherapy, sequential protocols",3,"D-FEC",FALSE,"3","21.Cyclophosphamide;0.Docetaxel;0.Epirubicin;0.Fluorouracil;21.Cyclophosphamide;0.Docetaxel;0.Epirubicin;0.Fluorouracil;","21.Cyclophosphamide;0.Docetaxel;0.Epirubicin;0.Fluorouracil;"
"3054","5.3.319.1","Solid Tumor","Breast Oncology","Breast cancer, triple negative",5,"Adjuvant chemotherapy, sequential protocols",3,"TX-CEX",NA,NA,"0.Capecitabine;0.Docetaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;15.Capecitabine;0.Docetaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;15.Capecitabine;0.Docetaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;15.Capecitabine;0.Cyclophosphamide;0.Epirubicin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;15.Capecitabine;0.Cyclophosphamide;0.Epirubicin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;15.Capecitabine;0.Cyclophosphamide;0.Epirubicin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","0.Capecitabine;0.Docetaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;15.Capecitabine;0.Docetaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;15.Capecitabine;0.Docetaxel;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;15.Capecitabine;0.Cyclophosphamide;0.Epirubicin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;15.Capecitabine;0.Cyclophosphamide;0.Epirubicin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;15.Capecitabine;0.Cyclophosphamide;0.Epirubicin;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"3055","5.3.320.1","Solid Tumor","Breast Oncology","Breast cancer, triple negative",5,"Adjuvant chemotherapy, sequential protocols",3,"T-AC",NA,NA,"0.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;","0.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;"
"3056","5.3.321.1","Solid Tumor","Breast Oncology","Breast cancer, triple negative",5,"Adjuvant chemotherapy, sequential protocols",3,"T-EC",NA,NA,"0.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;","0.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;"
"3057","50.125.892.1","Solid Tumor","Genitourinary Oncology","Renal cell carcinoma",50,"Metastatic disease, first-line",125,"Atezolizumab & Bevacizumab",TRUE,"Cont.","21.Atezolizumab;0.Bevacizumab;21.Atezolizumab;0.Bevacizumab;","21.Atezolizumab;0.Bevacizumab;"
"3058","50.125.893.1","Solid Tumor","Genitourinary Oncology","Renal cell carcinoma",50,"Metastatic disease, first-line",125,"Axitinib monotherapy",TRUE,"Cont.","1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;","1.Axitinib;1.Axitinib;"
"3059","50.125.894.1","Solid Tumor","Genitourinary Oncology","Renal cell carcinoma",50,"Metastatic disease, first-line",125,"Axitinib & Avelumab",TRUE,"Cont.","1.Avelumab;0.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Avelumab;0.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;","1.Avelumab;0.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;"
"3060","50.125.895.1","Solid Tumor","Genitourinary Oncology","Renal cell carcinoma",50,"Metastatic disease, first-line",125,"Axitinib & Pembrolizumab",TRUE,"Cont.","1.Axitinib;0.Pembrolizumab;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;0.Pembrolizumab;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;","1.Axitinib;0.Pembrolizumab;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;1.Axitinib;"
"3061","50.125.896.1","Solid Tumor","Genitourinary Oncology","Renal cell carcinoma",50,"Metastatic disease, first-line",125,"Bevacizumab monotherapy",TRUE,"Cont.","14.Bevacizumab;14.Bevacizumab;","14.Bevacizumab;14.Bevacizumab;"
"3062","50.125.897.1","Solid Tumor","Genitourinary Oncology","Renal cell carcinoma",50,"Metastatic disease, first-line",125,"Bevacizumab & Interferon alfa-2a",TRUE,"Cont.","3.Bevacizumab;0.Interferonalfa-2a;2.Interferonalfa-2a;2.Interferonalfa-2a;3.Interferonalfa-2a;2.Interferonalfa-2a;2.Interferonalfa-2a;3.Bevacizumab;0.Interferonalfa-2a;2.Interferonalfa-2a;2.Interferonalfa-2a;3.Interferonalfa-2a;2.Interferonalfa-2a;2.Interferonalfa-2a;","3.Bevacizumab;0.Interferonalfa-2a;2.Interferonalfa-2a;2.Interferonalfa-2a;3.Interferonalfa-2a;2.Interferonalfa-2a;2.Interferonalfa-2a;"
"3063","50.125.898.1","Solid Tumor","Genitourinary Oncology","Renal cell carcinoma",50,"Metastatic disease, first-line",125,"Cabozantinib, Ipilimumab & Nivolumab",TRUE,"Cont.","1.Cabozantinib;0.Ipilimumab;0.Nivolumab;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;0.Ipilimumab;0.Nivolumab;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;","1.Cabozantinib;0.Ipilimumab;0.Nivolumab;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;"
"3064","50.125.898.2","Solid Tumor","Genitourinary Oncology","Renal cell carcinoma",50,"Metastatic disease, first-line",125,"Cabozantinib, Ipilimumab & Nivolumab",TRUE,"Cont.","1.Cabozantinib;0.Ipilimumab;0.Nivolumab;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;0.Ipilimumab;0.Nivolumab;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;","1.Cabozantinib;0.Ipilimumab;0.Nivolumab;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;"
"3065","50.125.899.1","Solid Tumor","Genitourinary Oncology","Renal cell carcinoma",50,"Metastatic disease, first-line",125,"Cabozantinib & Nivolumab",TRUE,"Cont.","1.Cabozantinib;0.Nivolumab;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;0.Nivolumab;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;","1.Cabozantinib;0.Nivolumab;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;"
"3066","50.125.899.2","Solid Tumor","Genitourinary Oncology","Renal cell carcinoma",50,"Metastatic disease, first-line",125,"Cabozantinib & Nivolumab",TRUE,"Cont.","15.Cabozantinib;0.Nivolumab;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;15.Cabozantinib;0.Nivolumab;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;","15.Cabozantinib;0.Nivolumab;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;"
"3067","50.125.900.1","Solid Tumor","Genitourinary Oncology","Renal cell carcinoma",50,"Metastatic disease, first-line",125,"Erlotinib & Bevacizumab",TRUE,"Cont.","1.Bevacizumab;0.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Bevacizumab;0.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;","1.Bevacizumab;0.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;"
"3068","50.125.901.1","Solid Tumor","Genitourinary Oncology","Renal cell carcinoma",50,"Metastatic disease, first-line",125,"Everolimus monotherapy",TRUE,"Cont.","1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;","1.Everolimus;1.Everolimus;"
"3069","50.125.902.1","Solid Tumor","Genitourinary Oncology","Renal cell carcinoma",50,"Metastatic disease, first-line",125,"Everolimus & Lenvatinib",TRUE,"Cont.","1.Everolimus;0.Lenvatinib;1.Everolimus;0.Lenvatinib;1.Everolimus;0.Lenvatinib;1.Everolimus;0.Lenvatinib;1.Everolimus;0.Lenvatinib;1.Everolimus;0.Lenvatinib;1.Everolimus;0.Lenvatinib;1.Everolimus;0.Lenvatinib;1.Everolimus;0.Lenvatinib;1.Everolimus;0.Lenvatinib;1.Everolimus;0.Lenvatinib;1.Everolimus;0.Lenvatinib;1.Everolimus;0.Lenvatinib;1.Everolimus;0.Lenvatinib;1.Everolimus;0.Lenvatinib;1.Everolimus;0.Lenvatinib;1.Everolimus;0.Lenvatinib;1.Everolimus;0.Lenvatinib;1.Everolimus;0.Lenvatinib;1.Everolimus;0.Lenvatinib;1.Everolimus;0.Lenvatinib;1.Everolimus;0.Lenvatinib;1.Everolimus;0.Lenvatinib;1.Everolimus;0.Lenvatinib;1.Everolimus;0.Lenvatinib;1.Everolimus;0.Lenvatinib;1.Everolimus;0.Lenvatinib;1.Everolimus;0.Lenvatinib;1.Everolimus;0.Lenvatinib;1.Everolimus;0.Lenvatinib;1.Everolimus;0.Lenvatinib;1.Everolimus;0.Lenvatinib;1.Everolimus;0.Lenvatinib;1.Everolimus;0.Lenvatinib;1.Everolimus;0.Lenvatinib;1.Everolimus;0.Lenvatinib;1.Everolimus;0.Lenvatinib;1.Everolimus;0.Lenvatinib;1.Everolimus;0.Lenvatinib;1.Everolimus;0.Lenvatinib;1.Everolimus;0.Lenvatinib;1.Everolimus;0.Lenvatinib;","1.Everolimus;0.Lenvatinib;"
"3070","50.125.903.1","Solid Tumor","Genitourinary Oncology","Renal cell carcinoma",50,"Metastatic disease, first-line",125,"Gemcitabine & Sunitinib",TRUE,"Cont.","8.Gemcitabine;0.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Gemcitabine;0.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;8.Gemcitabine;0.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Gemcitabine;0.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;","8.Gemcitabine;0.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Gemcitabine;0.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;"
"3071","50.125.903.2","Solid Tumor","Genitourinary Oncology","Renal cell carcinoma",50,"Metastatic disease, first-line",125,"Gemcitabine & Sunitinib",TRUE,"Cont.","7.Gemcitabine;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Gemcitabine;0.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;7.Gemcitabine;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Gemcitabine;0.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;","7.Gemcitabine;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Gemcitabine;0.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;"
"3072","50.125.904.1","Solid Tumor","Genitourinary Oncology","Renal cell carcinoma",50,"Metastatic disease, first-line",125,"High-dose Interleukin-2",TRUE,"Cont.","10.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;10.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;10.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;10.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;","10.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;"
"3073","50.125.904.2","Solid Tumor","Genitourinary Oncology","Renal cell carcinoma",50,"Metastatic disease, first-line",125,"High-dose Interleukin-2",TRUE,"Cont.","52.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;52.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;","52.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;"
"3074","50.125.904.3","Solid Tumor","Genitourinary Oncology","Renal cell carcinoma",50,"Metastatic disease, first-line",125,"High-dose Interleukin-2",TRUE,"Cont.","53.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;53.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;","53.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;1.IL-2-Aldesleukin;"
"3075","50.125.904.4","Solid Tumor","Genitourinary Oncology","Renal cell carcinoma",50,"Metastatic disease, first-line",125,"High-dose Interleukin-2",TRUE,"Cont.","35.IL-2-Aldesleukin;7.IL-2-Aldesleukin;7.IL-2-Aldesleukin;7.IL-2-Aldesleukin;35.IL-2-Aldesleukin;7.IL-2-Aldesleukin;7.IL-2-Aldesleukin;7.IL-2-Aldesleukin;","35.IL-2-Aldesleukin;7.IL-2-Aldesleukin;7.IL-2-Aldesleukin;7.IL-2-Aldesleukin;"
"3076","50.125.905.1","Solid Tumor","Genitourinary Oncology","Renal cell carcinoma",50,"Metastatic disease, first-line",125,"Interferon alfa-2a monotherapy",TRUE,"Cont.","2.Interferonalfa-2a;1.Interferonalfa-2a;2.Interferonalfa-2a;1.Interferonalfa-2a;1.Interferonalfa-2a;2.Interferonalfa-2a;1.Interferonalfa-2a;2.Interferonalfa-2a;1.Interferonalfa-2a;1.Interferonalfa-2a;","2.Interferonalfa-2a;1.Interferonalfa-2a;2.Interferonalfa-2a;1.Interferonalfa-2a;1.Interferonalfa-2a;"
"3077","50.125.905.2","Solid Tumor","Genitourinary Oncology","Renal cell carcinoma",50,"Metastatic disease, first-line",125,"Interferon alfa-2a monotherapy",TRUE,"Cont.","1.Interferonalfa-2a;0.Interferonalfa-2a;1.Interferonalfa-2a;1.Interferonalfa-2a;0.Interferonalfa-2a;1.Interferonalfa-2a;1.Interferonalfa-2a;0.Interferonalfa-2a;1.Interferonalfa-2a;1.Interferonalfa-2a;1.Interferonalfa-2a;0.Interferonalfa-2a;1.Interferonalfa-2a;1.Interferonalfa-2a;0.Interferonalfa-2a;1.Interferonalfa-2a;1.Interferonalfa-2a;0.Interferonalfa-2a;1.Interferonalfa-2a;1.Interferonalfa-2a;","1.Interferonalfa-2a;0.Interferonalfa-2a;1.Interferonalfa-2a;1.Interferonalfa-2a;0.Interferonalfa-2a;1.Interferonalfa-2a;1.Interferonalfa-2a;0.Interferonalfa-2a;1.Interferonalfa-2a;1.Interferonalfa-2a;"
"3078","50.125.906.1","Solid Tumor","Genitourinary Oncology","Renal cell carcinoma",50,"Metastatic disease, first-line",125,"Ipilimumab & Nivolumab",FALSE,"4","21.Ipilimumab;0.Nivolumab;21.Ipilimumab;0.Nivolumab;","21.Ipilimumab;0.Nivolumab;"
"3079","50.125.906.2","Solid Tumor","Genitourinary Oncology","Renal cell carcinoma",50,"Metastatic disease, first-line",125,"Ipilimumab & Nivolumab",TRUE,"Cont.","14.Ipilimumab;0.Nivolumab;14.Ipilimumab;0.Nivolumab;","14.Ipilimumab;0.Nivolumab;"
"3080","50.125.906.3","Solid Tumor","Genitourinary Oncology","Renal cell carcinoma",50,"Metastatic disease, first-line",125,"Ipilimumab & Nivolumab",TRUE,"Cont.","28.Ipilimumab;0.Nivolumab;28.Ipilimumab;0.Nivolumab;","28.Ipilimumab;0.Nivolumab;"
"3081","50.125.907.1","Solid Tumor","Genitourinary Oncology","Renal cell carcinoma",50,"Metastatic disease, first-line",125,"Lenvatinib & Pembrolizumab",TRUE,"Cont.","1.Lenvatinib;0.Pembrolizumab;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;0.Pembrolizumab;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;","1.Lenvatinib;0.Pembrolizumab;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;"
"3082","50.125.907.2","Solid Tumor","Genitourinary Oncology","Renal cell carcinoma",50,"Metastatic disease, first-line",125,"Lenvatinib & Pembrolizumab",TRUE,"Cont.","1.Lenvatinib;0.Pembrolizumab;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;0.Pembrolizumab;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;","1.Lenvatinib;0.Pembrolizumab;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;"
"3083","50.125.908.1","Solid Tumor","Genitourinary Oncology","Renal cell carcinoma",50,"Metastatic disease, first-line",125,"Pazopanib monotherapy",TRUE,"Cont.","1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;","1.Pazopanib;1.Pazopanib;"
"3084","50.125.909.1","Solid Tumor","Genitourinary Oncology","Renal cell carcinoma",50,"Metastatic disease, first-line",125,"Regorafenib monotherapy",TRUE,"Cont.","8.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;8.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;","8.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;"
"3085","50.125.910.1","Solid Tumor","Genitourinary Oncology","Renal cell carcinoma",50,"Metastatic disease, first-line",125,"Sorafenib monotherapy",TRUE,"Cont.","1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;","1.Sorafenib;1.Sorafenib;"
"3086","50.125.911.1","Solid Tumor","Genitourinary Oncology","Renal cell carcinoma",50,"Metastatic disease, first-line",125,"Sunitinib monotherapy",TRUE,"Cont.","15.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;15.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;","15.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;"
"3087","50.125.911.2","Solid Tumor","Genitourinary Oncology","Renal cell carcinoma",50,"Metastatic disease, first-line",125,"Sunitinib monotherapy",TRUE,"Cont.","15.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;15.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;","15.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;"
"3088","50.125.912.1","Solid Tumor","Genitourinary Oncology","Renal cell carcinoma",50,"Metastatic disease, first-line",125,"Temsirolimus monotherapy",TRUE,"Cont.","7.Temsirolimus;7.Temsirolimus;","7.Temsirolimus;7.Temsirolimus;"
"3089","50.125.913.1","Solid Tumor","Genitourinary Oncology","Renal cell carcinoma",50,"Metastatic disease, first-line",125,"Tivozanib monotherapy",TRUE,"Cont.","8.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;8.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;","8.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;1.Tivozanib;"
"3090","50.130.914.1","Solid Tumor","Genitourinary Oncology","Renal cell carcinoma",50,"Metastatic disease, second-line",130,"Lenvatinib monotherapy",TRUE,"Cont.","1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;","1.Lenvatinib;1.Lenvatinib;"
"3091","50.130.915.1","Solid Tumor","Genitourinary Oncology","Renal cell carcinoma",50,"Metastatic disease, second-line",130,"Nivolumab monotherapy",TRUE,"Cont.","21.Nivolumab;21.Nivolumab;","21.Nivolumab;21.Nivolumab;"
"3092","50.4.891.1","Solid Tumor","Genitourinary Oncology","Renal cell carcinoma",50,"Adjuvant therapy",4,"Sunitinib monotherapy",TRUE,"Cont.","15.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;15.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;","15.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;"
"3093","51.4.916.1","Solid Tumor","Genitourinary Oncology","Clear cell renal cell carcinoma",51,"Adjuvant therapy",4,"Pembrolizumab monotherapy",TRUE,"Cont.","42.Pembrolizumab;42.Pembrolizumab;","42.Pembrolizumab;42.Pembrolizumab;"
"3094","53.125.917.1","Solid Tumor","Genitourinary Oncology","Papillary renal cell carcinoma",53,"Metastatic disease, first-line",125,"Erlotinib monotherapy",TRUE,"Cont.","1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;","1.Erlotinib;1.Erlotinib;"
"3095","54.125.918.1","Solid Tumor","Genitourinary Oncology","Sarcomatoid renal cell carcinoma",54,"Metastatic disease, first-line",125,"Doxorubicin & Gemcitabine",TRUE,"Cont.","14.Doxorubicin;0.Gemcitabine;14.Doxorubicin;0.Gemcitabine;","14.Doxorubicin;0.Gemcitabine;"
"3096","55.125.920.1","Solid Tumor","Genitourinary Oncology","Renal cell carcinoma, VHL-associated",55,"Metastatic disease, first-line",125,"Belzutifan monotherapy",TRUE,"Cont.","1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;1.Belzutifan;","1.Belzutifan;1.Belzutifan;"
"3097","56.184.930.1","Solid Tumor","Genitourinary Oncology","Testicular cancer",56,"Relapsed or refractory, salvage therapy",184,"Carboplatin & Etoposide (CE), then auto HSCT",FALSE,"1","0.Carboplatin;0.Etoposide;1.Carboplatin;0.Etoposide;1.Carboplatin;0.Etoposide;","0.Carboplatin;0.Etoposide;1.Carboplatin;0.Etoposide;1.Carboplatin;0.Etoposide;"
"3098","56.184.931.1","Solid Tumor","Genitourinary Oncology","Testicular cancer",56,"Relapsed or refractory, salvage therapy",184,"Cisplatin & Epirubicin",TRUE,"Cont.","17.Cisplatin;0.Epirubicin;1.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;17.Cisplatin;0.Epirubicin;1.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;","17.Cisplatin;0.Epirubicin;1.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;"
"3099","56.184.932.1","Solid Tumor","Genitourinary Oncology","Testicular cancer",56,"Relapsed or refractory, salvage therapy",184,"GIP",FALSE,"4","17.Cisplatin;0.Ifosfamide;1.Cisplatin;0.Ifosfamide;1.Cisplatin;0.Ifosfamide;1.Cisplatin;0.Ifosfamide;1.Cisplatin;0.Ifosfamide;17.Cisplatin;0.Ifosfamide;1.Cisplatin;0.Ifosfamide;1.Cisplatin;0.Ifosfamide;1.Cisplatin;0.Ifosfamide;1.Cisplatin;0.Ifosfamide;","17.Cisplatin;0.Ifosfamide;1.Cisplatin;0.Ifosfamide;1.Cisplatin;0.Ifosfamide;1.Cisplatin;0.Ifosfamide;1.Cisplatin;0.Ifosfamide;"
"3100","56.184.933.1","Solid Tumor","Genitourinary Oncology","Testicular cancer",56,"Relapsed or refractory, salvage therapy",184,"Ifosfamide & Paclitaxel",FALSE,"2","12.Ifosfamide;1.Ifosfamide;1.Ifosfamide;","12.Ifosfamide;1.Ifosfamide;1.Ifosfamide;"
"3101","56.184.934.1","Solid Tumor","Genitourinary Oncology","Testicular cancer",56,"Relapsed or refractory, salvage therapy",184,"TIP",FALSE,"4","16.Paclitaxel;1.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;16.Paclitaxel;1.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;","16.Paclitaxel;1.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;"
"3102","56.184.935.1","Solid Tumor","Genitourinary Oncology","Testicular cancer",56,"Relapsed or refractory, salvage therapy",184,"VeIP",FALSE,"4","17.Cisplatin;0.Vinblastine;1.Cisplatin;0.Vinblastine;1.Cisplatin;1.Cisplatin;1.Cisplatin;17.Cisplatin;0.Vinblastine;1.Cisplatin;0.Vinblastine;1.Cisplatin;1.Cisplatin;1.Cisplatin;","17.Cisplatin;0.Vinblastine;1.Cisplatin;0.Vinblastine;1.Cisplatin;1.Cisplatin;1.Cisplatin;"
"3103","56.193.936.1","Solid Tumor","Genitourinary Oncology","Testicular cancer",56,"Subsequent lines of therapy",193,"Etoposide monotherapy",TRUE,"Cont.","1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;","1.Etoposide;1.Etoposide;"
"3104","56.193.937.1","Solid Tumor","Genitourinary Oncology","Testicular cancer",56,"Subsequent lines of therapy",193,"GemOx",TRUE,"Cont.","14.Gemcitabine;0.Oxaliplatin;7.Gemcitabine;14.Gemcitabine;0.Oxaliplatin;7.Gemcitabine;","14.Gemcitabine;0.Oxaliplatin;7.Gemcitabine;"
"3105","56.193.938.1","Solid Tumor","Genitourinary Oncology","Testicular cancer",56,"Subsequent lines of therapy",193,"Gemcitabine, Oxaliplatin, Paclitaxel",TRUE,"Cont.","14.Gemcitabine;0.Oxaliplatin;0.Paclitaxel;7.Gemcitabine;0.Paclitaxel;14.Gemcitabine;0.Oxaliplatin;0.Paclitaxel;7.Gemcitabine;0.Paclitaxel;","14.Gemcitabine;0.Oxaliplatin;0.Paclitaxel;7.Gemcitabine;0.Paclitaxel;"
"3106","56.193.939.1","Solid Tumor","Genitourinary Oncology","Testicular cancer",56,"Subsequent lines of therapy",193,"Gemcitabine & Paclitaxel",TRUE,"Cont.","14.Gemcitabine;0.Paclitaxel;7.Gemcitabine;0.Paclitaxel;7.Gemcitabine;0.Paclitaxel;14.Gemcitabine;0.Paclitaxel;7.Gemcitabine;0.Paclitaxel;7.Gemcitabine;0.Paclitaxel;","14.Gemcitabine;0.Paclitaxel;7.Gemcitabine;0.Paclitaxel;7.Gemcitabine;0.Paclitaxel;"
"3107","56.193.940.1","Solid Tumor","Genitourinary Oncology","Testicular cancer",56,"Subsequent lines of therapy",193,"Oxaliplatin & Bevacizumab",TRUE,"Cont.","14.Bevacizumab;0.Oxaliplatin;14.Bevacizumab;0.Oxaliplatin;","14.Bevacizumab;0.Oxaliplatin;"
"3108","56.193.941.1","Solid Tumor","Genitourinary Oncology","Testicular cancer",56,"Subsequent lines of therapy",193,"Sunitinib monotherapy",TRUE,"Cont.","1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;","1.Sunitinib;1.Sunitinib;"
"3109","56.208.922.1","Solid Tumor","Genitourinary Oncology","Testicular cancer",56,"Upfront therapy for disseminated disease",208,"BEP",FALSE,"4","7.Bleomycin;0.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;3.Bleomycin;7.Bleomycin;7.Bleomycin;0.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;3.Bleomycin;7.Bleomycin;","7.Bleomycin;0.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;3.Bleomycin;7.Bleomycin;"
"3110","56.208.923.1","Solid Tumor","Genitourinary Oncology","Testicular cancer",56,"Upfront therapy for disseminated disease",208,"Accelerated BEP",FALSE,"4","10.Bleomycin;0.Cisplatin;0.Etoposide;1.Bleomycin;0.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;10.Bleomycin;0.Cisplatin;0.Etoposide;1.Bleomycin;0.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;","10.Bleomycin;0.Cisplatin;0.Etoposide;1.Bleomycin;0.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;"
"3111","56.208.924.1","Solid Tumor","Genitourinary Oncology","Testicular cancer",56,"Upfront therapy for disseminated disease",208,"Bleomycin & Vincristine (BO)",FALSE,"1","0.Bleomycin;0.Vincristine;7.Bleomycin;0.Vincristine;","0.Bleomycin;0.Vincristine;7.Bleomycin;0.Vincristine;"
"3112","56.208.925.1","Solid Tumor","Genitourinary Oncology","Testicular cancer",56,"Upfront therapy for disseminated disease",208,"C-BOP",FALSE,"2","2.Bleomycin;0.Cisplatin;0.Vincristine;1.Cisplatin;6.Bleomycin;0.Carboplatin;0.Cisplatin;0.Vincristine;1.Bleomycin;1.Bleomycin;1.Bleomycin;1.Bleomycin;1.Bleomycin;","2.Bleomycin;0.Cisplatin;0.Vincristine;1.Cisplatin;6.Bleomycin;0.Carboplatin;0.Cisplatin;0.Vincristine;1.Bleomycin;1.Bleomycin;1.Bleomycin;1.Bleomycin;1.Bleomycin;"
"3113","56.208.926.1","Solid Tumor","Genitourinary Oncology","Testicular cancer",56,"Upfront therapy for disseminated disease",208,"Cisplatin & Etoposide (EP)",FALSE,"4","17.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;17.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;","17.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;"
"3114","56.208.927.1","Solid Tumor","Genitourinary Oncology","Testicular cancer",56,"Upfront therapy for disseminated disease",208,"M-TIP",FALSE,"4","16.Methotrexate;0.Paclitaxel;1.Cisplatin;0.Ifosfamide;1.Cisplatin;0.Ifosfamide;1.Cisplatin;0.Ifosfamide;1.Cisplatin;0.Ifosfamide;1.Cisplatin;0.Ifosfamide;16.Methotrexate;0.Paclitaxel;1.Cisplatin;0.Ifosfamide;1.Cisplatin;0.Ifosfamide;1.Cisplatin;0.Ifosfamide;1.Cisplatin;0.Ifosfamide;1.Cisplatin;0.Ifosfamide;","16.Methotrexate;0.Paclitaxel;1.Cisplatin;0.Ifosfamide;1.Cisplatin;0.Ifosfamide;1.Cisplatin;0.Ifosfamide;1.Cisplatin;0.Ifosfamide;1.Cisplatin;0.Ifosfamide;"
"3115","56.208.928.1","Solid Tumor","Genitourinary Oncology","Testicular cancer",56,"Upfront therapy for disseminated disease",208,"PVeBV",TRUE,"Cont.","7.Bleomycin;0.Cisplatin;0.Etoposide;0.Vinblastine;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;3.Bleomycin;7.Bleomycin;7.Bleomycin;0.Cisplatin;0.Etoposide;0.Vinblastine;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;3.Bleomycin;7.Bleomycin;","7.Bleomycin;0.Cisplatin;0.Etoposide;0.Vinblastine;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;3.Bleomycin;7.Bleomycin;"
"3116","56.208.929.1","Solid Tumor","Genitourinary Oncology","Testicular cancer",56,"Upfront therapy for disseminated disease",208,"VIP",FALSE,"4","17.Cisplatin;0.Etoposide;0.Ifosfamide;1.Cisplatin;0.Etoposide;0.Ifosfamide;1.Cisplatin;0.Etoposide;0.Ifosfamide;1.Cisplatin;0.Etoposide;0.Ifosfamide;1.Cisplatin;0.Etoposide;0.Ifosfamide;17.Cisplatin;0.Etoposide;0.Ifosfamide;1.Cisplatin;0.Etoposide;0.Ifosfamide;1.Cisplatin;0.Etoposide;0.Ifosfamide;1.Cisplatin;0.Etoposide;0.Ifosfamide;1.Cisplatin;0.Etoposide;0.Ifosfamide;","17.Cisplatin;0.Etoposide;0.Ifosfamide;1.Cisplatin;0.Etoposide;0.Ifosfamide;1.Cisplatin;0.Etoposide;0.Ifosfamide;1.Cisplatin;0.Etoposide;0.Ifosfamide;1.Cisplatin;0.Etoposide;0.Ifosfamide;"
"3117","56.208.930.1","Solid Tumor","Genitourinary Oncology","Testicular cancer",56,"Upfront therapy for disseminated disease",208,"Carboplatin & Etoposide (CE), then auto HSCT",FALSE,"1","0.0;","0.0;0.0;"
"3118","56.208.932.1","Solid Tumor","Genitourinary Oncology","Testicular cancer",56,"Upfront therapy for disseminated disease",208,"GIP",FALSE,"4","17.Gemcitabine;1.Gemcitabine;1.Gemcitabine;1.Gemcitabine;1.Gemcitabine;17.Gemcitabine;1.Gemcitabine;1.Gemcitabine;1.Gemcitabine;1.Gemcitabine;","17.Gemcitabine;1.Gemcitabine;1.Gemcitabine;1.Gemcitabine;1.Gemcitabine;"
"3119","56.208.933.1","Solid Tumor","Genitourinary Oncology","Testicular cancer",56,"Upfront therapy for disseminated disease",208,"Ifosfamide & Paclitaxel",FALSE,"2","13.Paclitaxel;1.Paclitaxel;","13.Paclitaxel;1.Paclitaxel;"
"3120","56.208.934.1","Solid Tumor","Genitourinary Oncology","Testicular cancer",56,"Upfront therapy for disseminated disease",208,"TIP",FALSE,"4","17.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;17.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;","17.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;"
"3121","56.208.935.1","Solid Tumor","Genitourinary Oncology","Testicular cancer",56,"Upfront therapy for disseminated disease",208,"VeIP",FALSE,"4","17.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;17.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;","17.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;"
"3122","56.41.936.1","Solid Tumor","Genitourinary Oncology","Testicular cancer",56,"Consolidation after salvage therapy",41,"Etoposide monotherapy",FALSE,"3","8.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;8.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;","8.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;"
"3123","56.6.921.1","Solid Tumor","Genitourinary Oncology","Testicular cancer",56,"Adjuvant therapy for resectable disease",6,"BEP",TRUE,"Cont.","1.Bleomycin;0.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;3.Bleomycin;7.Bleomycin;1.Bleomycin;0.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;3.Bleomycin;7.Bleomycin;","1.Bleomycin;0.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;3.Bleomycin;7.Bleomycin;"
"3124","56.6.922.1","Solid Tumor","Genitourinary Oncology","Testicular cancer",56,"Adjuvant therapy for resectable disease",6,"Carboplatin monotherapy",FALSE,"1","0.Carboplatin;","0.Carboplatin;0.Carboplatin;"
"3125","56.6.922.2","Solid Tumor","Genitourinary Oncology","Testicular cancer",56,"Adjuvant therapy for resectable disease",6,"Carboplatin monotherapy",FALSE,"2","21.Carboplatin;","21.Carboplatin;21.Carboplatin;"
"3126","57.4.942.1","Solid Tumor","Genitourinary Oncology","Upper tract urothelial carcinoma",57,"Adjuvant therapy",4,"Pirarubicin monotherapy",FALSE,"1","0.Pirarubicin;","0.Pirarubicin;0.Pirarubicin;"
"3127","57.53.943.1","Solid Tumor","Genitourinary Oncology","Upper tract urothelial carcinoma",57,"Definitive therapy",53,"UGN-101 (mitomycin-containing reverse thermal gel) monotherapy",FALSE,"6","7.UGN-101;7.UGN-101;","7.UGN-101;7.UGN-101;"
"3128","58.147.944.1","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Neoadjuvant chemotherapy",147,"Cisplatin & Paclitaxel",FALSE,"3","10.Cisplatin;0.Paclitaxel;10.Cisplatin;0.Paclitaxel;","10.Cisplatin;0.Paclitaxel;"
"3129","58.159.955.1","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Persistent, recurrent, or metastatic disease, first-line therapy",159,"Carboplatin monotherapy",TRUE,"Cont.","28.Carboplatin;28.Carboplatin;","28.Carboplatin;28.Carboplatin;"
"3130","58.159.956.1","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Persistent, recurrent, or metastatic disease, first-line therapy",159,"Carboplatin & Docetaxel",TRUE,"Cont.","21.Carboplatin;0.Docetaxel;21.Carboplatin;0.Docetaxel;","21.Carboplatin;0.Docetaxel;"
"3131","58.159.957.1","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Persistent, recurrent, or metastatic disease, first-line therapy",159,"Carboplatin & Paclitaxel (CP)",TRUE,"Cont.","21.Carboplatin;0.Paclitaxel;21.Carboplatin;0.Paclitaxel;","21.Carboplatin;0.Paclitaxel;"
"3132","58.159.958.1","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Persistent, recurrent, or metastatic disease, first-line therapy",159,"Carboplatin & Paclitaxel (CP) & Bevacizumab",TRUE,"Cont.","21.Bevacizumab;0.Carboplatin;0.Paclitaxel;21.Bevacizumab;0.Carboplatin;0.Paclitaxel;","21.Bevacizumab;0.Carboplatin;0.Paclitaxel;"
"3133","58.159.959.1","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Persistent, recurrent, or metastatic disease, first-line therapy",159,"Carboplatin & Paclitaxel (CP), Bevacizumab, Pembrolizumab",TRUE,"Cont.","21.Bevacizumab;0.Carboplatin;0.Paclitaxel;0.Pembrolizumab;21.Bevacizumab;0.Carboplatin;0.Paclitaxel;0.Pembrolizumab;","21.Bevacizumab;0.Carboplatin;0.Paclitaxel;0.Pembrolizumab;"
"3134","58.159.960.1","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Persistent, recurrent, or metastatic disease, first-line therapy",159,"Carboplatin & Paclitaxel (CP) & Pembrolizumab",TRUE,"Cont.","21.Carboplatin;0.Paclitaxel;0.Pembrolizumab;21.Carboplatin;0.Paclitaxel;0.Pembrolizumab;","21.Carboplatin;0.Paclitaxel;0.Pembrolizumab;"
"3135","58.159.961.1","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Persistent, recurrent, or metastatic disease, first-line therapy",159,"Cisplatin monotherapy",TRUE,"Cont.","21.Cisplatin;21.Cisplatin;","21.Cisplatin;21.Cisplatin;"
"3136","58.159.962.1","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Persistent, recurrent, or metastatic disease, first-line therapy",159,"Cisplatin & Ifosfamide",TRUE,"Cont.","21.Cisplatin;0.Ifosfamide;21.Cisplatin;0.Ifosfamide;","21.Cisplatin;0.Ifosfamide;"
"3137","58.159.963.1","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Persistent, recurrent, or metastatic disease, first-line therapy",159,"Cisplatin & Mitomycin",FALSE,"9","28.Cisplatin;0.Mitomycin;28.Cisplatin;0.Mitomycin;","28.Cisplatin;0.Mitomycin;"
"3138","58.159.964.1","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Persistent, recurrent, or metastatic disease, first-line therapy",159,"Cisplatin & Paclitaxel",TRUE,"Cont.","20.Paclitaxel;1.Cisplatin;20.Paclitaxel;1.Cisplatin;","20.Paclitaxel;1.Cisplatin;"
"3139","58.159.964.2","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Persistent, recurrent, or metastatic disease, first-line therapy",159,"Cisplatin & Paclitaxel",TRUE,"Cont.","21.Cisplatin;0.Paclitaxel;21.Cisplatin;0.Paclitaxel;","21.Cisplatin;0.Paclitaxel;"
"3140","58.159.965.1","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Persistent, recurrent, or metastatic disease, first-line therapy",159,"Cisplatin, Paclitaxel, Bevacizumab",TRUE,"Cont.","21.Bevacizumab;0.Cisplatin;0.Paclitaxel;21.Bevacizumab;0.Cisplatin;0.Paclitaxel;","21.Bevacizumab;0.Cisplatin;0.Paclitaxel;"
"3141","58.159.966.1","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Persistent, recurrent, or metastatic disease, first-line therapy",159,"Cisplatin, Paclitaxel, Bevacizumab, Pembrolizumab",TRUE,"Cont.","21.Bevacizumab;0.Cisplatin;0.Paclitaxel;0.Pembrolizumab;21.Bevacizumab;0.Cisplatin;0.Paclitaxel;0.Pembrolizumab;","21.Bevacizumab;0.Cisplatin;0.Paclitaxel;0.Pembrolizumab;"
"3142","58.159.967.1","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Persistent, recurrent, or metastatic disease, first-line therapy",159,"Cisplatin & Topotecan",TRUE,"Cont.","21.Cisplatin;0.Topotecan;21.Cisplatin;0.Topotecan;","21.Cisplatin;0.Topotecan;"
"3143","58.159.968.1","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Persistent, recurrent, or metastatic disease, first-line therapy",159,"Cisplatin & Vinorelbine (CVb)",TRUE,"Cont.","14.Cisplatin;0.Vinorelbine;7.Vinorelbine;14.Cisplatin;0.Vinorelbine;7.Vinorelbine;","14.Cisplatin;0.Vinorelbine;7.Vinorelbine;"
"3144","58.159.969.1","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Persistent, recurrent, or metastatic disease, first-line therapy",159,"Ifosfamide monotherapy",TRUE,"Cont.","17.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;17.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;","17.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;"
"3145","58.159.970.1","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Persistent, recurrent, or metastatic disease, first-line therapy",159,"Paclitaxel monotherapy",TRUE,"Cont.","21.Paclitaxel;21.Paclitaxel;","21.Paclitaxel;21.Paclitaxel;"
"3146","58.159.971.1","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Persistent, recurrent, or metastatic disease, first-line therapy",159,"Paclitaxel & Topotecan",TRUE,"Cont.","19.Paclitaxel;0.Topotecan;1.Topotecan;1.Topotecan;19.Paclitaxel;0.Topotecan;1.Topotecan;1.Topotecan;","19.Paclitaxel;0.Topotecan;1.Topotecan;1.Topotecan;"
"3147","58.159.972.1","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Persistent, recurrent, or metastatic disease, first-line therapy",159,"Paclitaxel, Topotecan, Bevacizumab",TRUE,"Cont.","19.Bevacizumab;0.Paclitaxel;0.Topotecan;1.Topotecan;1.Topotecan;19.Bevacizumab;0.Paclitaxel;0.Topotecan;1.Topotecan;1.Topotecan;","19.Bevacizumab;0.Paclitaxel;0.Topotecan;1.Topotecan;1.Topotecan;"
"3148","58.159.973.1","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Persistent, recurrent, or metastatic disease, first-line therapy",159,"Topotecan monotherapy",TRUE,"Cont.","24.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;24.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;","24.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;"
"3149","58.159.973.2","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Persistent, recurrent, or metastatic disease, first-line therapy",159,"Topotecan monotherapy",TRUE,"Cont.","17.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;17.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;","17.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;"
"3150","58.159.974.1","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Persistent, recurrent, or metastatic disease, first-line therapy",159,"Vinorelbine monotherapy",TRUE,"Cont.","7.Vinorelbine;7.Vinorelbine;","7.Vinorelbine;7.Vinorelbine;"
"3151","58.159.974.2","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Persistent, recurrent, or metastatic disease, first-line therapy",159,"Vinorelbine monotherapy",TRUE,"Cont.","14.Vinorelbine;7.Vinorelbine;14.Vinorelbine;7.Vinorelbine;","14.Vinorelbine;7.Vinorelbine;"
"3152","58.26.975.1","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Advanced or metastatic disease, subsequent lines of therapy",26,"Bevacizumab monotherapy",TRUE,"Cont.","21.Bevacizumab;21.Bevacizumab;","21.Bevacizumab;21.Bevacizumab;"
"3153","58.26.976.1","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Advanced or metastatic disease, subsequent lines of therapy",26,"Cemiplimab monotherapy",TRUE,"Cont.","21.Cemiplimab;21.Cemiplimab;","21.Cemiplimab;21.Cemiplimab;"
"3154","58.26.977.1","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Advanced or metastatic disease, subsequent lines of therapy",26,"Docetaxel monotherapy",TRUE,"Cont.","14.Docetaxel;7.Docetaxel;7.Docetaxel;14.Docetaxel;7.Docetaxel;7.Docetaxel;","14.Docetaxel;7.Docetaxel;7.Docetaxel;"
"3155","58.26.977.2","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Advanced or metastatic disease, subsequent lines of therapy",26,"Docetaxel monotherapy",TRUE,"Cont.","21.Docetaxel;21.Docetaxel;","21.Docetaxel;21.Docetaxel;"
"3156","58.26.978.1","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Advanced or metastatic disease, subsequent lines of therapy",26,"FULV",FALSE,"2","24.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","24.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"3157","58.26.978.2","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Advanced or metastatic disease, subsequent lines of therapy",26,"FULV",TRUE,"Cont.","31.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;31.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","31.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"3158","58.26.979.1","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Advanced or metastatic disease, subsequent lines of therapy",26,"Gemcitabine monotherapy",TRUE,"Cont.","14.Gemcitabine;7.Gemcitabine;7.Gemcitabine;14.Gemcitabine;7.Gemcitabine;7.Gemcitabine;","14.Gemcitabine;7.Gemcitabine;7.Gemcitabine;"
"3159","58.26.979.2","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Advanced or metastatic disease, subsequent lines of therapy",26,"Gemcitabine monotherapy",TRUE,"Cont.","14.Gemcitabine;7.Gemcitabine;14.Gemcitabine;7.Gemcitabine;","14.Gemcitabine;7.Gemcitabine;"
"3160","58.26.980.1","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Advanced or metastatic disease, subsequent lines of therapy",26,"Irinotecan monotherapy",TRUE,"Cont.","21.Irinotecan;7.Irinotecan;7.Irinotecan;7.Irinotecan;21.Irinotecan;7.Irinotecan;7.Irinotecan;7.Irinotecan;","21.Irinotecan;7.Irinotecan;7.Irinotecan;7.Irinotecan;"
"3161","58.26.981.1","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Advanced or metastatic disease, subsequent lines of therapy",26,"Pembrolizumab monotherapy",TRUE,"Cont.","21.Pembrolizumab;21.Pembrolizumab;","21.Pembrolizumab;21.Pembrolizumab;"
"3162","58.26.982.1","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Advanced or metastatic disease, subsequent lines of therapy",26,"Pemetrexed monotherapy",TRUE,"Cont.","21.Pemetrexed;21.Pemetrexed;","21.Pemetrexed;21.Pemetrexed;"
"3163","58.26.983.1","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Advanced or metastatic disease, subsequent lines of therapy",26,"Tisotumab vedotin monotherapy",TRUE,"Cont.","21.Tisotumabvedotin;21.Tisotumabvedotin;","21.Tisotumabvedotin;21.Tisotumabvedotin;"
"3164","58.4.953.1","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Adjuvant therapy",4,"Carboplatin & Ifosfamide",FALSE,"4","19.Carboplatin;0.Ifosfamide;1.Ifosfamide;1.Ifosfamide;19.Carboplatin;0.Ifosfamide;1.Ifosfamide;1.Ifosfamide;","19.Carboplatin;0.Ifosfamide;1.Ifosfamide;1.Ifosfamide;"
"3165","58.4.954.1","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Adjuvant therapy",4,"Cisplatin & Gemcitabine (GC)",TRUE,"Cont.","14.Cisplatin;0.Gemcitabine;7.Gemcitabine;14.Cisplatin;0.Gemcitabine;7.Gemcitabine;","14.Cisplatin;0.Gemcitabine;7.Gemcitabine;"
"3166","58.54.945.1","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Definitive therapy for locally advanced disease",54,"Carboplatin & RT",FALSE,"5","7.Carboplatin;7.Carboplatin;","7.Carboplatin;7.Carboplatin;"
"3167","58.54.945.2","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Definitive therapy for locally advanced disease",54,"Carboplatin & RT",FALSE,"6","7.Carboplatin;7.Carboplatin;","7.Carboplatin;7.Carboplatin;"
"3168","58.54.946.1","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Definitive therapy for locally advanced disease",54,"Cisplatin & RT",FALSE,"5","7.Cisplatin;7.Cisplatin;","7.Cisplatin;7.Cisplatin;"
"3169","58.54.946.2","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Definitive therapy for locally advanced disease",54,"Cisplatin & RT",FALSE,"6","7.Cisplatin;0.Cisplatin;7.Cisplatin;0.Cisplatin;","7.Cisplatin;0.Cisplatin;"
"3170","58.54.947.1","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Definitive therapy for locally advanced disease",54,"Cisplatin & Fluorouracil (CF) & RT",FALSE,"4","21.Cisplatin;0.Fluorouracil;21.Cisplatin;0.Fluorouracil;","21.Cisplatin;0.Fluorouracil;"
"3171","58.54.947.2","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Definitive therapy for locally advanced disease",54,"Cisplatin & Fluorouracil (CF) & RT",FALSE,"4","17.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;17.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","17.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"3172","58.54.947.3","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Definitive therapy for locally advanced disease",54,"Cisplatin & Fluorouracil (CF) & RT",FALSE,"3","21.Cisplatin;0.Fluorouracil;21.Cisplatin;0.Fluorouracil;","21.Cisplatin;0.Fluorouracil;"
"3173","58.54.947.4","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Definitive therapy for locally advanced disease",54,"Cisplatin & Fluorouracil (CF) & RT",FALSE,"3","17.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;17.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","17.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"3174","58.54.948.1","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Definitive therapy for locally advanced disease",54,"Cisplatin & Fluorouracil (CF) & RT",FALSE,"4","4.Cisplatin;0.Fluorouracil;0.Hydroxyurea;3.Hydroxyurea;4.Hydroxyurea;3.Hydroxyurea;4.Hydroxyurea;3.Hydroxyurea;4.Cisplatin;0.Fluorouracil;0.Hydroxyurea;3.Hydroxyurea;4.Hydroxyurea;3.Hydroxyurea;4.Hydroxyurea;3.Hydroxyurea;","4.Cisplatin;0.Fluorouracil;0.Hydroxyurea;3.Hydroxyurea;4.Hydroxyurea;3.Hydroxyurea;4.Hydroxyurea;3.Hydroxyurea;"
"3175","58.54.948.2","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Definitive therapy for locally advanced disease",54,"Cisplatin & Fluorouracil (CF) & RT",FALSE,"4","4.Cisplatin;0.Fluorouracil;0.Hydroxyurea;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;0.Hydroxyurea;1.Fluorouracil;3.Hydroxyurea;3.Hydroxyurea;4.Hydroxyurea;3.Hydroxyurea;4.Cisplatin;0.Fluorouracil;0.Hydroxyurea;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;0.Hydroxyurea;1.Fluorouracil;3.Hydroxyurea;3.Hydroxyurea;4.Hydroxyurea;3.Hydroxyurea;","4.Cisplatin;0.Fluorouracil;0.Hydroxyurea;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;0.Hydroxyurea;1.Fluorouracil;3.Hydroxyurea;3.Hydroxyurea;4.Hydroxyurea;3.Hydroxyurea;"
"3176","58.54.949.1","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Definitive therapy for locally advanced disease",54,"Cisplatin & Gemcitabine (GC) & RT",FALSE,"1","0.Cisplatin;0.Gemcitabine;7.Cisplatin;0.Gemcitabine;7.Cisplatin;0.Gemcitabine;7.Cisplatin;0.Gemcitabine;7.Cisplatin;0.Gemcitabine;7.Cisplatin;0.Gemcitabine;","0.Cisplatin;0.Gemcitabine;7.Cisplatin;0.Gemcitabine;7.Cisplatin;0.Gemcitabine;7.Cisplatin;0.Gemcitabine;7.Cisplatin;0.Gemcitabine;7.Cisplatin;0.Gemcitabine;"
"3177","58.54.950.1","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Definitive therapy for locally advanced disease",54,"Fluorouracil & RT",FALSE,"6","7.Fluorouracil;7.Fluorouracil;","7.Fluorouracil;7.Fluorouracil;"
"3178","58.54.950.2","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Definitive therapy for locally advanced disease",54,"Fluorouracil & RT",FALSE,"6","2.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;2.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","2.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"3179","58.54.951.1","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Definitive therapy for locally advanced disease",54,"Hydroxyurea & RT",FALSE,"6","4.Hydroxyurea;3.Hydroxyurea;4.Hydroxyurea;3.Hydroxyurea;","4.Hydroxyurea;3.Hydroxyurea;"
"3180","58.54.952.1","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Definitive therapy for locally advanced disease",54,"Nedaplatin & RT",FALSE,"5","7.Nedaplatin;7.Nedaplatin;","7.Nedaplatin;7.Nedaplatin;"
"3181","58.54.952.2","Solid Tumor","Gynecologic Oncology","Cervical cancer",58,"Definitive therapy for locally advanced disease",54,"Nedaplatin & RT",FALSE,"6","7.Nedaplatin;7.Nedaplatin;","7.Nedaplatin;7.Nedaplatin;"
"3182","59.155.987.1","Solid Tumor","Gynecologic Oncology","Endometrial cancer",59,"Non-endocrine therapy for advanced, recurrent, or metastatic disease",155,"Carboplatin & Paclitaxel (CP) & Trastuzumab",TRUE,"Cont.","21.Carboplatin;0.Paclitaxel;0.Trastuzumab;21.Carboplatin;0.Paclitaxel;0.Trastuzumab;","21.Carboplatin;0.Paclitaxel;0.Trastuzumab;"
"3183","59.155.988.1","Solid Tumor","Gynecologic Oncology","Endometrial cancer",59,"Non-endocrine therapy for advanced, recurrent, or metastatic disease",155,"Carboplatin & Pegylated liposomal doxorubicin",TRUE,"Cont.","28.Carboplatin;0.Pegylatedliposomaldoxorubicin;28.Carboplatin;0.Pegylatedliposomaldoxorubicin;","28.Carboplatin;0.Pegylatedliposomaldoxorubicin;"
"3184","59.155.989.1","Solid Tumor","Gynecologic Oncology","Endometrial cancer",59,"Non-endocrine therapy for advanced, recurrent, or metastatic disease",155,"Cisplatin, Doxorubicin, Paclitaxel",FALSE,"7","20.Cisplatin;0.Doxorubicin;1.Paclitaxel;20.Cisplatin;0.Doxorubicin;1.Paclitaxel;","20.Cisplatin;0.Doxorubicin;1.Paclitaxel;"
"3185","59.155.990.1","Solid Tumor","Gynecologic Oncology","Endometrial cancer",59,"Non-endocrine therapy for advanced, recurrent, or metastatic disease",155,"Dactinomycin monotherapy",TRUE,"Cont.","28.Dactinomycin;28.Dactinomycin;","28.Dactinomycin;28.Dactinomycin;"
"3186","59.155.991.1","Solid Tumor","Gynecologic Oncology","Endometrial cancer",59,"Non-endocrine therapy for advanced, recurrent, or metastatic disease",155,"Dostarlimab monotherapy",FALSE,"4","21.Dostarlimab;21.Dostarlimab;","21.Dostarlimab;21.Dostarlimab;"
"3187","59.155.991.2","Solid Tumor","Gynecologic Oncology","Endometrial cancer",59,"Non-endocrine therapy for advanced, recurrent, or metastatic disease",155,"Dostarlimab monotherapy",TRUE,"Cont.","42.Dostarlimab;42.Dostarlimab;","42.Dostarlimab;42.Dostarlimab;"
"3188","59.155.992.1","Solid Tumor","Gynecologic Oncology","Endometrial cancer",59,"Non-endocrine therapy for advanced, recurrent, or metastatic disease",155,"Doxorubicin monotherapy",TRUE,"Cont.","28.Doxorubicin;28.Doxorubicin;","28.Doxorubicin;28.Doxorubicin;"
"3189","59.155.992.2","Solid Tumor","Gynecologic Oncology","Endometrial cancer",59,"Non-endocrine therapy for advanced, recurrent, or metastatic disease",155,"Doxorubicin monotherapy",TRUE,"Cont.","21.Doxorubicin;21.Doxorubicin;","21.Doxorubicin;21.Doxorubicin;"
"3190","59.155.993.1","Solid Tumor","Gynecologic Oncology","Endometrial cancer",59,"Non-endocrine therapy for advanced, recurrent, or metastatic disease",155,"Ifosfamide monotherapy",FALSE,"8","19.Ifosfamide;1.Ifosfamide;1.Ifosfamide;19.Ifosfamide;1.Ifosfamide;1.Ifosfamide;","19.Ifosfamide;1.Ifosfamide;1.Ifosfamide;"
"3191","59.155.994.1","Solid Tumor","Gynecologic Oncology","Endometrial cancer",59,"Non-endocrine therapy for advanced, recurrent, or metastatic disease",155,"Ifosfamide & Paclitaxel",TRUE,"Cont.","19.Ifosfamide;0.Paclitaxel;1.Ifosfamide;1.Ifosfamide;19.Ifosfamide;0.Paclitaxel;1.Ifosfamide;1.Ifosfamide;","19.Ifosfamide;0.Paclitaxel;1.Ifosfamide;1.Ifosfamide;"
"3192","59.155.995.1","Solid Tumor","Gynecologic Oncology","Endometrial cancer",59,"Non-endocrine therapy for advanced, recurrent, or metastatic disease",155,"Lenvatinib & Pembrolizumab",TRUE,"Cont.","1.Lenvatinib;0.Pembrolizumab;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;0.Pembrolizumab;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;","1.Lenvatinib;0.Pembrolizumab;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;1.Lenvatinib;"
"3193","59.155.996.1","Solid Tumor","Gynecologic Oncology","Endometrial cancer",59,"Non-endocrine therapy for advanced, recurrent, or metastatic disease",155,"Paclitaxel monotherapy",TRUE,"Cont.","14.Paclitaxel;7.Paclitaxel;7.Paclitaxel;14.Paclitaxel;7.Paclitaxel;7.Paclitaxel;","14.Paclitaxel;7.Paclitaxel;7.Paclitaxel;"
"3194","59.155.997.1","Solid Tumor","Gynecologic Oncology","Endometrial cancer",59,"Non-endocrine therapy for advanced, recurrent, or metastatic disease",155,"Pembrolizumab monotherapy",TRUE,"Cont.","14.Pembrolizumab;14.Pembrolizumab;","14.Pembrolizumab;14.Pembrolizumab;"
"3195","59.155.998.1","Solid Tumor","Gynecologic Oncology","Endometrial cancer",59,"Non-endocrine therapy for advanced, recurrent, or metastatic disease",155,"Temsirolimus monotherapy",TRUE,"Cont.","7.Temsirolimus;7.Temsirolimus;7.Temsirolimus;7.Temsirolimus;7.Temsirolimus;7.Temsirolimus;7.Temsirolimus;7.Temsirolimus;","7.Temsirolimus;7.Temsirolimus;"
"3196","59.4.984.1","Solid Tumor","Gynecologic Oncology","Endometrial cancer",59,"Adjuvant therapy",4,"CIM",FALSE,"3","18.Cisplatin;0.Ifosfamide;1.Cisplatin;0.Ifosfamide;1.Cisplatin;0.Ifosfamide;1.Cisplatin;0.Ifosfamide;18.Cisplatin;0.Ifosfamide;1.Cisplatin;0.Ifosfamide;1.Cisplatin;0.Ifosfamide;1.Cisplatin;0.Ifosfamide;","18.Cisplatin;0.Ifosfamide;1.Cisplatin;0.Ifosfamide;1.Cisplatin;0.Ifosfamide;1.Cisplatin;0.Ifosfamide;"
"3197","59.4.985.1","Solid Tumor","Gynecologic Oncology","Endometrial cancer",59,"Adjuvant therapy",4,"Cisplatin & Doxorubicin",FALSE,"6","21.Cisplatin;0.Doxorubicin;21.Cisplatin;0.Doxorubicin;","21.Cisplatin;0.Doxorubicin;"
"3198","59.4.985.2","Solid Tumor","Gynecologic Oncology","Endometrial cancer",59,"Adjuvant therapy",4,"Cisplatin & Doxorubicin",TRUE,"Cont.","21.Cisplatin;0.Doxorubicin;21.Cisplatin;0.Doxorubicin;","21.Cisplatin;0.Doxorubicin;"
"3199","59.4.986.1","Solid Tumor","Gynecologic Oncology","Endometrial cancer",59,"Adjuvant therapy",4,"Cisplatin & RT",FALSE,"2","21.Cisplatin;","21.Cisplatin;21.Cisplatin;"
"3200","59.59.1000.1","Solid Tumor","Gynecologic Oncology","Endometrial cancer",59,"Endocrine therapy for advanced, recurrent, or metastatic disease",59,"Medroxyprogesterone monotherapy",TRUE,"Cont.","1.Medroxyprogesterone;1.Medroxyprogesterone;1.Medroxyprogesterone;1.Medroxyprogesterone;1.Medroxyprogesterone;1.Medroxyprogesterone;1.Medroxyprogesterone;1.Medroxyprogesterone;1.Medroxyprogesterone;1.Medroxyprogesterone;1.Medroxyprogesterone;1.Medroxyprogesterone;1.Medroxyprogesterone;1.Medroxyprogesterone;1.Medroxyprogesterone;1.Medroxyprogesterone;1.Medroxyprogesterone;1.Medroxyprogesterone;1.Medroxyprogesterone;1.Medroxyprogesterone;1.Medroxyprogesterone;1.Medroxyprogesterone;1.Medroxyprogesterone;1.Medroxyprogesterone;1.Medroxyprogesterone;1.Medroxyprogesterone;1.Medroxyprogesterone;1.Medroxyprogesterone;1.Medroxyprogesterone;1.Medroxyprogesterone;1.Medroxyprogesterone;1.Medroxyprogesterone;1.Medroxyprogesterone;1.Medroxyprogesterone;1.Medroxyprogesterone;1.Medroxyprogesterone;1.Medroxyprogesterone;1.Medroxyprogesterone;1.Medroxyprogesterone;1.Medroxyprogesterone;1.Medroxyprogesterone;1.Medroxyprogesterone;","1.Medroxyprogesterone;1.Medroxyprogesterone;"
"3201","59.59.1001.1","Solid Tumor","Gynecologic Oncology","Endometrial cancer",59,"Endocrine therapy for advanced, recurrent, or metastatic disease",59,"Medroxyprogesterone & Tamoxifen",TRUE,"Cont.","1.Medroxyprogesterone;0.Tamoxifen;1.Medroxyprogesterone;0.Tamoxifen;1.Medroxyprogesterone;0.Tamoxifen;1.Medroxyprogesterone;0.Tamoxifen;1.Medroxyprogesterone;0.Tamoxifen;1.Medroxyprogesterone;0.Tamoxifen;1.Medroxyprogesterone;0.Tamoxifen;1.Medroxyprogesterone;0.Tamoxifen;1.Medroxyprogesterone;0.Tamoxifen;1.Medroxyprogesterone;0.Tamoxifen;1.Medroxyprogesterone;0.Tamoxifen;1.Medroxyprogesterone;0.Tamoxifen;1.Medroxyprogesterone;0.Tamoxifen;1.Medroxyprogesterone;0.Tamoxifen;1.Medroxyprogesterone;0.Tamoxifen;1.Medroxyprogesterone;0.Tamoxifen;1.Medroxyprogesterone;0.Tamoxifen;1.Medroxyprogesterone;0.Tamoxifen;1.Medroxyprogesterone;0.Tamoxifen;1.Medroxyprogesterone;0.Tamoxifen;1.Medroxyprogesterone;0.Tamoxifen;1.Medroxyprogesterone;0.Tamoxifen;1.Medroxyprogesterone;0.Tamoxifen;1.Medroxyprogesterone;0.Tamoxifen;1.Medroxyprogesterone;0.Tamoxifen;1.Medroxyprogesterone;0.Tamoxifen;1.Medroxyprogesterone;0.Tamoxifen;1.Medroxyprogesterone;0.Tamoxifen;1.Medroxyprogesterone;0.Tamoxifen;1.Medroxyprogesterone;0.Tamoxifen;1.Medroxyprogesterone;0.Tamoxifen;1.Medroxyprogesterone;0.Tamoxifen;1.Medroxyprogesterone;0.Tamoxifen;1.Medroxyprogesterone;0.Tamoxifen;1.Medroxyprogesterone;0.Tamoxifen;1.Medroxyprogesterone;0.Tamoxifen;1.Medroxyprogesterone;0.Tamoxifen;1.Medroxyprogesterone;0.Tamoxifen;1.Medroxyprogesterone;0.Tamoxifen;1.Medroxyprogesterone;0.Tamoxifen;1.Medroxyprogesterone;0.Tamoxifen;1.Medroxyprogesterone;0.Tamoxifen;","1.Medroxyprogesterone;0.Tamoxifen;"
"3202","59.59.1002.1","Solid Tumor","Gynecologic Oncology","Endometrial cancer",59,"Endocrine therapy for advanced, recurrent, or metastatic disease",59,"Megestrol monotherapy",TRUE,"Cont.","1.Megestrol;1.Megestrol;1.Megestrol;1.Megestrol;1.Megestrol;1.Megestrol;1.Megestrol;1.Megestrol;1.Megestrol;1.Megestrol;1.Megestrol;1.Megestrol;1.Megestrol;1.Megestrol;1.Megestrol;1.Megestrol;1.Megestrol;1.Megestrol;1.Megestrol;1.Megestrol;1.Megestrol;1.Megestrol;1.Megestrol;1.Megestrol;1.Megestrol;1.Megestrol;1.Megestrol;1.Megestrol;1.Megestrol;1.Megestrol;1.Megestrol;1.Megestrol;1.Megestrol;1.Megestrol;1.Megestrol;1.Megestrol;1.Megestrol;1.Megestrol;1.Megestrol;1.Megestrol;1.Megestrol;1.Megestrol;","1.Megestrol;1.Megestrol;"
"3203","59.59.1003.1","Solid Tumor","Gynecologic Oncology","Endometrial cancer",59,"Endocrine therapy for advanced, recurrent, or metastatic disease",59,"Megestrol & Tamoxifen",TRUE,"Cont.","1.Megestrol;0.Tamoxifen;1.Megestrol;0.Tamoxifen;1.Megestrol;0.Tamoxifen;1.Megestrol;0.Tamoxifen;1.Megestrol;0.Tamoxifen;1.Megestrol;0.Tamoxifen;1.Megestrol;0.Tamoxifen;1.Megestrol;0.Tamoxifen;1.Megestrol;0.Tamoxifen;1.Megestrol;0.Tamoxifen;1.Megestrol;0.Tamoxifen;1.Megestrol;0.Tamoxifen;1.Megestrol;0.Tamoxifen;1.Megestrol;0.Tamoxifen;1.Megestrol;0.Tamoxifen;1.Megestrol;0.Tamoxifen;1.Megestrol;0.Tamoxifen;1.Megestrol;0.Tamoxifen;1.Megestrol;0.Tamoxifen;1.Megestrol;0.Tamoxifen;1.Megestrol;0.Tamoxifen;1.Megestrol;0.Tamoxifen;1.Megestrol;0.Tamoxifen;1.Megestrol;0.Tamoxifen;1.Megestrol;0.Tamoxifen;1.Megestrol;0.Tamoxifen;1.Megestrol;0.Tamoxifen;1.Megestrol;0.Tamoxifen;1.Megestrol;0.Tamoxifen;1.Megestrol;0.Tamoxifen;1.Megestrol;0.Tamoxifen;1.Megestrol;0.Tamoxifen;1.Megestrol;0.Tamoxifen;1.Megestrol;0.Tamoxifen;1.Megestrol;0.Tamoxifen;1.Megestrol;0.Tamoxifen;1.Megestrol;0.Tamoxifen;1.Megestrol;0.Tamoxifen;1.Megestrol;0.Tamoxifen;1.Megestrol;0.Tamoxifen;1.Megestrol;0.Tamoxifen;1.Megestrol;0.Tamoxifen;","1.Megestrol;0.Tamoxifen;"
"3204","59.59.999.1","Solid Tumor","Gynecologic Oncology","Endometrial cancer",59,"Endocrine therapy for advanced, recurrent, or metastatic disease",59,"Anastrozole monotherapy",TRUE,"Cont.","1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;1.Anastrozole;","1.Anastrozole;1.Anastrozole;"
"3205","6.26.339.1","Solid Tumor","Breast Oncology","Breast cancer, BRCA-mutated",6,"Advanced or metastatic disease, subsequent lines of therapy",26,"Carboplatin monotherapy",FALSE,"6","21.Carboplatin;21.Carboplatin;","21.Carboplatin;21.Carboplatin;"
"3206","6.26.339.2","Solid Tumor","Breast Oncology","Breast cancer, BRCA-mutated",6,"Advanced or metastatic disease, subsequent lines of therapy",26,"Carboplatin monotherapy",FALSE,"7","21.Carboplatin;21.Carboplatin;","21.Carboplatin;21.Carboplatin;"
"3207","6.26.339.3","Solid Tumor","Breast Oncology","Breast cancer, BRCA-mutated",6,"Advanced or metastatic disease, subsequent lines of therapy",26,"Carboplatin monotherapy",FALSE,"8","21.Carboplatin;21.Carboplatin;","21.Carboplatin;21.Carboplatin;"
"3208","6.26.340.1","Solid Tumor","Breast Oncology","Breast cancer, BRCA-mutated",6,"Advanced or metastatic disease, subsequent lines of therapy",26,"Carboplatin & Paclitaxel (CP)",TRUE,"Cont.","7.Carboplatin;0.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Paclitaxel;7.Paclitaxel;","7.Carboplatin;0.Paclitaxel;7.Paclitaxel;7.Paclitaxel;"
"3209","6.26.341.1","Solid Tumor","Breast Oncology","Breast cancer, BRCA-mutated",6,"Advanced or metastatic disease, subsequent lines of therapy",26,"Talazoparib monotherapy",TRUE,"Cont.","1.Talazoparib;1.Talazoparib;1.Talazoparib;1.Talazoparib;1.Talazoparib;1.Talazoparib;1.Talazoparib;1.Talazoparib;1.Talazoparib;1.Talazoparib;1.Talazoparib;1.Talazoparib;1.Talazoparib;1.Talazoparib;","1.Talazoparib;1.Talazoparib;"
"3210","6.4.338.1","Solid Tumor","Breast Oncology","Breast cancer, BRCA-mutated",6,"Adjuvant therapy",4,"Olaparib monotherapy",TRUE,"Cont.","1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;","1.Olaparib;1.Olaparib;"
"3211","60.111.1004.1","Solid Tumor","Gynecologic Oncology","Gestational trophoblastic neoplasia",60,"Low-risk disease, all lines of therapy",111,"Dactinomycin monotherapy",TRUE,"Cont.","14.Dactinomycin;14.Dactinomycin;","14.Dactinomycin;14.Dactinomycin;"
"3212","60.111.1005.1","Solid Tumor","Gynecologic Oncology","Gestational trophoblastic neoplasia",60,"Low-risk disease, all lines of therapy",111,"EMA-CO",TRUE,"Cont.","7.Dactinomycin;0.Etoposide;0.Methotrexate;1.Dactinomycin;0.Etoposide;6.Cyclophosphamide;0.Vincristine;7.Dactinomycin;0.Etoposide;0.Methotrexate;1.Dactinomycin;0.Etoposide;6.Cyclophosphamide;0.Vincristine;","7.Dactinomycin;0.Etoposide;0.Methotrexate;1.Dactinomycin;0.Etoposide;6.Cyclophosphamide;0.Vincristine;"
"3213","60.111.1006.1","Solid Tumor","Gynecologic Oncology","Gestational trophoblastic neoplasia",60,"Low-risk disease, all lines of therapy",111,"Mercaptopurine & Methotrexate",TRUE,"Cont.","1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;0.Methotrexate;1.Mercaptopurine;0.Methotrexate;","1.Mercaptopurine;0.Methotrexate;"
"3214","60.111.1007.1","Solid Tumor","Gynecologic Oncology","Gestational trophoblastic neoplasia",60,"Low-risk disease, all lines of therapy",111,"Methotrexate monotherapy",TRUE,"Cont.","7.Methotrexate;7.Methotrexate;","7.Methotrexate;7.Methotrexate;"
"3215","61.170.1008.1","Solid Tumor","Gynecologic Oncology","Low-grade serous ovarian cancer",61,"Relapsed or recurrent disease",170,"Letrozole monotherapy",TRUE,"Cont.","1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;1.Letrozole;","1.Letrozole;1.Letrozole;"
"3216","61.170.1009.1","Solid Tumor","Gynecologic Oncology","Low-grade serous ovarian cancer",61,"Relapsed or recurrent disease",170,"Pegylated liposomal doxorubicin monotherapy",TRUE,"Cont.","28.Pegylatedliposomaldoxorubicin;28.Pegylatedliposomaldoxorubicin;","28.Pegylatedliposomaldoxorubicin;28.Pegylatedliposomaldoxorubicin;"
"3217","61.170.1010.1","Solid Tumor","Gynecologic Oncology","Low-grade serous ovarian cancer",61,"Relapsed or recurrent disease",170,"Selumetinib monotherapy",TRUE,"Cont.","1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;1.Selumetinib;","1.Selumetinib;1.Selumetinib;"
"3218","61.170.1011.1","Solid Tumor","Gynecologic Oncology","Low-grade serous ovarian cancer",61,"Relapsed or recurrent disease",170,"Tamoxifen monotherapy",TRUE,"Cont.","1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;1.Tamoxifen;","1.Tamoxifen;1.Tamoxifen;"
"3219","61.170.1012.1","Solid Tumor","Gynecologic Oncology","Low-grade serous ovarian cancer",61,"Relapsed or recurrent disease",170,"Topotecan monotherapy",TRUE,"Cont.","14.Topotecan;7.Topotecan;7.Topotecan;14.Topotecan;7.Topotecan;7.Topotecan;","14.Topotecan;7.Topotecan;7.Topotecan;"
"3220","61.170.1013.1","Solid Tumor","Gynecologic Oncology","Low-grade serous ovarian cancer",61,"Relapsed or recurrent disease",170,"Trametinib monotherapy",TRUE,"Cont.","1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;1.Trametinib;","1.Trametinib;1.Trametinib;"
"3221","62.114.1019.1","Solid Tumor","Gynecologic Oncology","Ovarian cancer",62,"Maintenance after first-line therapy",114,"Altretamine monotherapy",FALSE,"6","15.Altretamine;1.Altretamine;1.Altretamine;1.Altretamine;1.Altretamine;1.Altretamine;1.Altretamine;1.Altretamine;1.Altretamine;1.Altretamine;1.Altretamine;1.Altretamine;1.Altretamine;1.Altretamine;15.Altretamine;1.Altretamine;1.Altretamine;1.Altretamine;1.Altretamine;1.Altretamine;1.Altretamine;1.Altretamine;1.Altretamine;1.Altretamine;1.Altretamine;1.Altretamine;1.Altretamine;1.Altretamine;","15.Altretamine;1.Altretamine;1.Altretamine;1.Altretamine;1.Altretamine;1.Altretamine;1.Altretamine;1.Altretamine;1.Altretamine;1.Altretamine;1.Altretamine;1.Altretamine;1.Altretamine;1.Altretamine;"
"3222","62.114.1020.1","Solid Tumor","Gynecologic Oncology","Ovarian cancer",62,"Maintenance after first-line therapy",114,"Niraparib monotherapy",TRUE,"Cont.","1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;1.Niraparib;","1.Niraparib;1.Niraparib;"
"3223","62.114.1021.1","Solid Tumor","Gynecologic Oncology","Ovarian cancer",62,"Maintenance after first-line therapy",114,"Olaparib & Bevacizumab",TRUE,"Cont.","1.Bevacizumab;0.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Bevacizumab;0.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;","1.Bevacizumab;0.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;"
"3224","62.114.1022.1","Solid Tumor","Gynecologic Oncology","Ovarian cancer",62,"Maintenance after first-line therapy",114,"Paclitaxel monotherapy",TRUE,"Cont.","28.Paclitaxel;28.Paclitaxel;","28.Paclitaxel;28.Paclitaxel;"
"3225","62.114.1023.1","Solid Tumor","Gynecologic Oncology","Ovarian cancer",62,"Maintenance after first-line therapy",114,"Pazopanib monotherapy",TRUE,"Cont.","1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;","1.Pazopanib;1.Pazopanib;"
"3226","62.114.1024.1","Solid Tumor","Gynecologic Oncology","Ovarian cancer",62,"Maintenance after first-line therapy",114,"Rucaparib monotherapy",TRUE,"Cont.","1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;1.Rucaparib;","1.Rucaparib;1.Rucaparib;"
"3227","62.116.1032.1","Solid Tumor","Gynecologic Oncology","Ovarian cancer",62,"Maintenance after second-line therapy for platinum-sensitive disease",116,"Olaparib monotherapy",TRUE,"Cont.","1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;","1.Olaparib;1.Olaparib;"
"3228","62.171.1033.1","Solid Tumor","Gynecologic Oncology","Ovarian cancer",62,"Relapsed or recurrent disease, platinum-resistant",171,"Gemcitabine & Pegylated liposomal doxorubicin",TRUE,"Cont.","14.Gemcitabine;0.Pegylatedliposomaldoxorubicin;7.Gemcitabine;14.Gemcitabine;0.Pegylatedliposomaldoxorubicin;7.Gemcitabine;","14.Gemcitabine;0.Pegylatedliposomaldoxorubicin;7.Gemcitabine;"
"3229","62.171.1034.1","Solid Tumor","Gynecologic Oncology","Ovarian cancer",62,"Relapsed or recurrent disease, platinum-resistant",171,"Mirvetuximab soravtansine monotherapy",TRUE,"Cont.","21.Mirvetuximabsoravtansine;21.Mirvetuximabsoravtansine;","21.Mirvetuximabsoravtansine;21.Mirvetuximabsoravtansine;"
"3230","62.171.1035.1","Solid Tumor","Gynecologic Oncology","Ovarian cancer",62,"Relapsed or recurrent disease, platinum-resistant",171,"Paclitaxel monotherapy",TRUE,"Cont.","7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;","7.Paclitaxel;7.Paclitaxel;"
"3231","62.171.1036.1","Solid Tumor","Gynecologic Oncology","Ovarian cancer",62,"Relapsed or recurrent disease, platinum-resistant",171,"Paclitaxel & Bevacizumab",TRUE,"Cont.","7.Bevacizumab;0.Paclitaxel;7.Paclitaxel;7.Bevacizumab;0.Paclitaxel;7.Paclitaxel;7.Bevacizumab;0.Paclitaxel;7.Paclitaxel;7.Bevacizumab;0.Paclitaxel;7.Paclitaxel;","7.Bevacizumab;0.Paclitaxel;7.Paclitaxel;"
"3232","62.171.1037.1","Solid Tumor","Gynecologic Oncology","Ovarian cancer",62,"Relapsed or recurrent disease, platinum-resistant",171,"Paclitaxel & Pazopanib",TRUE,"Cont.","1.Paclitaxel;0.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Paclitaxel;0.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Paclitaxel;0.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Paclitaxel;0.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Paclitaxel;0.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Paclitaxel;0.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;","1.Paclitaxel;0.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;"
"3233","62.171.1038.1","Solid Tumor","Gynecologic Oncology","Ovarian cancer",62,"Relapsed or recurrent disease, platinum-resistant",171,"Pegylated liposomal doxorubicin & Bevacizumab",TRUE,"Cont.","14.Bevacizumab;0.Pegylatedliposomaldoxorubicin;14.Bevacizumab;14.Bevacizumab;0.Pegylatedliposomaldoxorubicin;14.Bevacizumab;","14.Bevacizumab;0.Pegylatedliposomaldoxorubicin;14.Bevacizumab;"
"3234","62.171.1039.1","Solid Tumor","Gynecologic Oncology","Ovarian cancer",62,"Relapsed or recurrent disease, platinum-resistant",171,"Pegylated liposomal doxorubicin & Trabectedin",TRUE,"Cont.","21.Pegylatedliposomaldoxorubicin;0.Trabectedin;21.Pegylatedliposomaldoxorubicin;0.Trabectedin;","21.Pegylatedliposomaldoxorubicin;0.Trabectedin;"
"3235","62.171.1040.1","Solid Tumor","Gynecologic Oncology","Ovarian cancer",62,"Relapsed or recurrent disease, platinum-resistant",171,"Topotecan & Bevacizumab",TRUE,"Cont.","14.Bevacizumab;0.Topotecan;7.Topotecan;7.Bevacizumab;0.Topotecan;14.Bevacizumab;0.Topotecan;7.Topotecan;7.Bevacizumab;0.Topotecan;","14.Bevacizumab;0.Topotecan;7.Topotecan;7.Bevacizumab;0.Topotecan;"
"3236","62.171.1040.2","Solid Tumor","Gynecologic Oncology","Ovarian cancer",62,"Relapsed or recurrent disease, platinum-resistant",171,"Topotecan & Bevacizumab",TRUE,"Cont.","17.Bevacizumab;0.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;17.Bevacizumab;0.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;","17.Bevacizumab;0.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;"
"3237","62.171.1041.1","Solid Tumor","Gynecologic Oncology","Ovarian cancer",62,"Relapsed or recurrent disease, platinum-resistant",171,"Trabectedin monotherapy",TRUE,"Cont.","14.Trabectedin;7.Trabectedin;7.Trabectedin;14.Trabectedin;7.Trabectedin;7.Trabectedin;","14.Trabectedin;7.Trabectedin;7.Trabectedin;"
"3238","62.171.1042.1","Solid Tumor","Gynecologic Oncology","Ovarian cancer",62,"Relapsed or recurrent disease, platinum-resistant",171,"Treosulfan monotherapy",TRUE,"Cont.","28.Treosulfan;28.Treosulfan;","28.Treosulfan;28.Treosulfan;"
"3239","62.171.1043.1","Solid Tumor","Gynecologic Oncology","Ovarian cancer",62,"Relapsed or recurrent disease, platinum-resistant",171,"Vinorelbine monotherapy",TRUE,"Cont.","14.Vinorelbine;7.Vinorelbine;14.Vinorelbine;7.Vinorelbine;","14.Vinorelbine;7.Vinorelbine;"
"3240","62.191.1025.1","Solid Tumor","Gynecologic Oncology","Ovarian cancer",62,"Second-line therapy for relapsed or recurrent disease, platinum-sensitive",191,"Carboplatin & Docetaxel",FALSE,"6","14.Carboplatin;0.Docetaxel;7.Carboplatin;0.Docetaxel;7.Carboplatin;0.Docetaxel;14.Carboplatin;0.Docetaxel;7.Carboplatin;0.Docetaxel;7.Carboplatin;0.Docetaxel;","14.Carboplatin;0.Docetaxel;7.Carboplatin;0.Docetaxel;7.Carboplatin;0.Docetaxel;"
"3241","62.191.1026.1","Solid Tumor","Gynecologic Oncology","Ovarian cancer",62,"Second-line therapy for relapsed or recurrent disease, platinum-sensitive",191,"Carboplatin, Pegylated liposomal doxorubicin, Bevacizumab",TRUE,"Cont.","14.Bevacizumab;0.Carboplatin;0.Pegylatedliposomaldoxorubicin;14.Bevacizumab;14.Bevacizumab;0.Carboplatin;0.Pegylatedliposomaldoxorubicin;14.Bevacizumab;","14.Bevacizumab;0.Carboplatin;0.Pegylatedliposomaldoxorubicin;14.Bevacizumab;"
"3242","62.191.1027.1","Solid Tumor","Gynecologic Oncology","Ovarian cancer",62,"Second-line therapy for relapsed or recurrent disease, platinum-sensitive",191,"Carboplatin & Gemcitabine (GCb) & Bevacizumab",TRUE,"Cont.","14.Bevacizumab;0.Carboplatin;0.Gemcitabine;7.Gemcitabine;14.Bevacizumab;0.Carboplatin;0.Gemcitabine;7.Gemcitabine;","14.Bevacizumab;0.Carboplatin;0.Gemcitabine;7.Gemcitabine;"
"3243","62.191.1028.1","Solid Tumor","Gynecologic Oncology","Ovarian cancer",62,"Second-line therapy for relapsed or recurrent disease, platinum-sensitive",191,"Carboplatin & Paclitaxel (CP) & Olaparib",TRUE,"Cont.","12.Carboplatin;0.Olaparib;0.Paclitaxel;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;12.Carboplatin;0.Olaparib;0.Paclitaxel;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;","12.Carboplatin;0.Olaparib;0.Paclitaxel;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;"
"3244","62.191.1028.2","Solid Tumor","Gynecologic Oncology","Ovarian cancer",62,"Second-line therapy for relapsed or recurrent disease, platinum-sensitive",191,"Carboplatin & Paclitaxel (CP) & Olaparib",TRUE,"Cont.","1.Carboplatin;0.Olaparib;0.Paclitaxel;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Carboplatin;0.Olaparib;0.Paclitaxel;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;","1.Carboplatin;0.Olaparib;0.Paclitaxel;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;1.Olaparib;"
"3245","62.191.1029.1","Solid Tumor","Gynecologic Oncology","Ovarian cancer",62,"Second-line therapy for relapsed or recurrent disease, platinum-sensitive",191,"Cisplatin & Gemcitabine (GC)",TRUE,"Cont.","14.Cisplatin;0.Gemcitabine;7.Cisplatin;0.Gemcitabine;14.Cisplatin;0.Gemcitabine;7.Cisplatin;0.Gemcitabine;","14.Cisplatin;0.Gemcitabine;7.Cisplatin;0.Gemcitabine;"
"3246","62.191.1030.1","Solid Tumor","Gynecologic Oncology","Ovarian cancer",62,"Second-line therapy for relapsed or recurrent disease, platinum-sensitive",191,"Etoposide monotherapy",TRUE,"Cont.","8.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;8.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;","8.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;"
"3247","62.191.1031.1","Solid Tumor","Gynecologic Oncology","Ovarian cancer",62,"Second-line therapy for relapsed or recurrent disease, platinum-sensitive",191,"nab-Paclitaxel monotherapy",TRUE,"Cont.","21.Paclitaxel;0.nanoparticlealbumin-bound;21.Paclitaxel;0.nanoparticlealbumin-bound;","21.Paclitaxel;0.nanoparticlealbumin-bound;"
"3248","62.5.1014.1","Solid Tumor","Gynecologic Oncology","Ovarian cancer",62,"Adjuvant therapy for early stage disease",5,"Carboplatin monotherapy",TRUE,"Cont.","21.Carboplatin;21.Carboplatin;","21.Carboplatin;21.Carboplatin;"
"3249","62.64.1015.1","Solid Tumor","Gynecologic Oncology","Ovarian cancer",62,"First-line chemotherapy for advanced stage disease",64,"Carboplatin & Pegylated liposomal doxorubicin",TRUE,"Cont.","21.Carboplatin;0.Pegylatedliposomaldoxorubicin;21.Carboplatin;0.Pegylatedliposomaldoxorubicin;","21.Carboplatin;0.Pegylatedliposomaldoxorubicin;"
"3250","62.64.1016.1","Solid Tumor","Gynecologic Oncology","Ovarian cancer",62,"First-line chemotherapy for advanced stage disease",64,"Carboplatin & Gemcitabine (GCb)",TRUE,"Cont.","14.Carboplatin;0.Gemcitabine;7.Gemcitabine;14.Carboplatin;0.Gemcitabine;7.Gemcitabine;","14.Carboplatin;0.Gemcitabine;7.Gemcitabine;"
"3251","62.64.1017.1","Solid Tumor","Gynecologic Oncology","Ovarian cancer",62,"First-line chemotherapy for advanced stage disease",64,"Carboplatin & Paclitaxel (CP)",TRUE,"Cont.","7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;","7.Carboplatin;0.Paclitaxel;"
"3252","62.64.1017.2","Solid Tumor","Gynecologic Oncology","Ovarian cancer",62,"First-line chemotherapy for advanced stage disease",64,"Carboplatin & Paclitaxel (CP)",TRUE,"Cont.","7.Carboplatin;0.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Paclitaxel;7.Paclitaxel;","7.Carboplatin;0.Paclitaxel;7.Paclitaxel;7.Paclitaxel;"
"3253","62.64.1018.1","Solid Tumor","Gynecologic Oncology","Ovarian cancer",62,"First-line chemotherapy for advanced stage disease",64,"Carboplatin & Paclitaxel (CP) & Nintedanib",TRUE,"Cont.","1.Carboplatin;0.Paclitaxel;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Carboplatin;0.Paclitaxel;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;","1.Carboplatin;0.Paclitaxel;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;"
"3254","64.153.1044.1","Solid Tumor","Gynecologic Oncology","Vulvar cancer",64,"Neoadjuvant therapy",153,"Cisplatin & RT",FALSE,"1","0.Cisplatin;7.Cisplatin;7.Cisplatin;7.Cisplatin;7.Cisplatin;7.Cisplatin;7.Cisplatin;","0.Cisplatin;7.Cisplatin;7.Cisplatin;7.Cisplatin;7.Cisplatin;7.Cisplatin;7.Cisplatin;"
"3255","65.101.1048.1","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Locally advanced disease, definitive therapy",101,"Carboplatin & RT",FALSE,"1","0.Carboplatin;7.Carboplatin;7.Carboplatin;7.Carboplatin;7.Carboplatin;7.Carboplatin;7.Carboplatin;","0.Carboplatin;7.Carboplatin;7.Carboplatin;7.Carboplatin;7.Carboplatin;7.Carboplatin;7.Carboplatin;"
"3256","65.101.1049.1","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Locally advanced disease, definitive therapy",101,"Carboplatin, Fluorouracil, RT",FALSE,"3","18.Carboplatin;0.Fluorouracil;1.Carboplatin;1.Carboplatin;1.Carboplatin;18.Carboplatin;0.Fluorouracil;1.Carboplatin;1.Carboplatin;1.Carboplatin;","18.Carboplatin;0.Fluorouracil;1.Carboplatin;1.Carboplatin;1.Carboplatin;"
"3257","65.101.1049.2","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Locally advanced disease, definitive therapy",101,"Carboplatin, Fluorouracil, RT",FALSE,"3","17.Carboplatin;0.Fluorouracil;1.Carboplatin;0.Fluorouracil;1.Carboplatin;0.Fluorouracil;1.Carboplatin;0.Fluorouracil;1.Fluorouracil;17.Carboplatin;0.Fluorouracil;1.Carboplatin;0.Fluorouracil;1.Carboplatin;0.Fluorouracil;1.Carboplatin;0.Fluorouracil;1.Fluorouracil;","17.Carboplatin;0.Fluorouracil;1.Carboplatin;0.Fluorouracil;1.Carboplatin;0.Fluorouracil;1.Carboplatin;0.Fluorouracil;1.Fluorouracil;"
"3258","65.101.1050.1","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Locally advanced disease, definitive therapy",101,"Carboplatin, Fluorouracil, Cetuximab, RT",FALSE,"1","0.Carboplatin;0.Fluorouracil;1.Carboplatin;1.Carboplatin;1.Carboplatin;3.Cetuximab;7.Cetuximab;","0.Carboplatin;0.Fluorouracil;1.Carboplatin;1.Carboplatin;1.Carboplatin;3.Cetuximab;7.Cetuximab;"
"3259","65.101.1050.2","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Locally advanced disease, definitive therapy",101,"Carboplatin, Fluorouracil, Cetuximab, RT",FALSE,"1","0.Carboplatin;0.Fluorouracil;1.Carboplatin;0.Fluorouracil;1.Carboplatin;0.Fluorouracil;1.Carboplatin;0.Fluorouracil;1.Fluorouracil;2.Cetuximab;7.Cetuximab;","0.Carboplatin;0.Fluorouracil;1.Carboplatin;0.Fluorouracil;1.Carboplatin;0.Fluorouracil;1.Carboplatin;0.Fluorouracil;1.Fluorouracil;2.Cetuximab;7.Cetuximab;"
"3260","65.101.1050.3","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Locally advanced disease, definitive therapy",101,"Carboplatin, Fluorouracil, Cetuximab, RT",FALSE,"2","7.Carboplatin;0.Cetuximab;0.Fluorouracil;1.Carboplatin;1.Carboplatin;1.Carboplatin;4.Cetuximab;7.Cetuximab;","7.Carboplatin;0.Cetuximab;0.Fluorouracil;1.Carboplatin;1.Carboplatin;1.Carboplatin;4.Cetuximab;7.Cetuximab;"
"3261","65.101.1050.4","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Locally advanced disease, definitive therapy",101,"Carboplatin, Fluorouracil, Cetuximab, RT",FALSE,"2","7.Carboplatin;0.Cetuximab;0.Fluorouracil;1.Carboplatin;0.Fluorouracil;1.Carboplatin;0.Fluorouracil;1.Carboplatin;0.Fluorouracil;1.Fluorouracil;3.Cetuximab;7.Cetuximab;","7.Carboplatin;0.Cetuximab;0.Fluorouracil;1.Carboplatin;0.Fluorouracil;1.Carboplatin;0.Fluorouracil;1.Carboplatin;0.Fluorouracil;1.Fluorouracil;3.Cetuximab;7.Cetuximab;"
"3262","65.101.1051.1","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Locally advanced disease, definitive therapy",101,"Carboplatin & Paclitaxel (CP) & RT",FALSE,"1","0.Carboplatin;0.Paclitaxexl;7.Carboplatin;0.Paclitaxexl;7.Carboplatin;0.Paclitaxexl;7.Carboplatin;0.Paclitaxexl;7.Carboplatin;0.Paclitaxexl;7.Carboplatin;0.Paclitaxexl;","0.Carboplatin;0.Paclitaxexl;7.Carboplatin;0.Paclitaxexl;7.Carboplatin;0.Paclitaxexl;7.Carboplatin;0.Paclitaxexl;7.Carboplatin;0.Paclitaxexl;7.Carboplatin;0.Paclitaxexl;"
"3263","65.101.1052.1","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Locally advanced disease, definitive therapy",101,"Cisplatin & Fluorouracil (CF) & RT",FALSE,"2","31.Cisplatin;0.Fluorouracil;1.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;","31.Cisplatin;0.Fluorouracil;1.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;"
"3264","65.101.1052.2","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Locally advanced disease, definitive therapy",101,"Cisplatin & Fluorouracil (CF) & RT",FALSE,"2","30.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Fluorouracil;","30.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Fluorouracil;"
"3265","65.101.1052.3","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Locally advanced disease, definitive therapy",101,"Cisplatin & Fluorouracil (CF) & RT",FALSE,"7","10.Cisplatin;0.Fluorouracil;1.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;10.Cisplatin;0.Fluorouracil;1.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;","10.Cisplatin;0.Fluorouracil;1.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;"
"3266","65.101.1052.4","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Locally advanced disease, definitive therapy",101,"Cisplatin & Fluorouracil (CF) & RT",FALSE,"7","9.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Fluorouracil;9.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Fluorouracil;","9.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Fluorouracil;"
"3267","65.101.1052.5","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Locally advanced disease, definitive therapy",101,"Cisplatin & Fluorouracil (CF) & RT",FALSE,"2","32.Cisplatin;0.Fluorouracil;1.Cisplatin;1.Cisplatin;1.Cisplatin;","32.Cisplatin;0.Fluorouracil;1.Cisplatin;1.Cisplatin;1.Cisplatin;"
"3268","65.101.1052.6","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Locally advanced disease, definitive therapy",101,"Cisplatin & Fluorouracil (CF) & RT",FALSE,"2","1.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;20.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;","1.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;20.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;"
"3269","65.101.1053.1","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Locally advanced disease, definitive therapy",101,"Cisplatin & RT",FALSE,"7","3.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;3.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;","3.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;1.Cisplatin;"
"3270","65.101.1053.2","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Locally advanced disease, definitive therapy",101,"Cisplatin & RT",FALSE,"1","0.Cisplatin;7.Cisplatin;7.Cisplatin;7.Cisplatin;7.Cisplatin;7.Cisplatin;7.Cisplatin;","0.Cisplatin;7.Cisplatin;7.Cisplatin;7.Cisplatin;7.Cisplatin;7.Cisplatin;7.Cisplatin;"
"3271","65.101.1053.3","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Locally advanced disease, definitive therapy",101,"Cisplatin & RT",FALSE,"7","7.Cisplatin;7.Cisplatin;","7.Cisplatin;7.Cisplatin;"
"3272","65.101.1053.4","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Locally advanced disease, definitive therapy",101,"Cisplatin & RT",TRUE,"Cont.","21.Cisplatin;21.Cisplatin;","21.Cisplatin;21.Cisplatin;"
"3273","65.101.1054.1","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Locally advanced disease, definitive therapy",101,"Cisplatin, Paclitaxel, RT",FALSE,"7","6.Paclitaxexl;1.Cisplatin;6.Paclitaxexl;1.Cisplatin;","6.Paclitaxexl;1.Cisplatin;"
"3274","65.101.1055.1","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Locally advanced disease, definitive therapy",101,"Docetaxel, Fluorouracil, Hydroxyurea, RT",FALSE,"5","9.Docetaxel;0.Fluorouracil;0.Hydroxyurea;1.Fluorouracil;0.Hydroxyurea;1.Fluorouracil;0.Hydroxyurea;1.Fluorouracil;0.Hydroxyurea;1.Fluorouracil;0.Hydroxyurea;1.Fluorouracil;0.Hydroxyurea;9.Docetaxel;0.Fluorouracil;0.Hydroxyurea;1.Fluorouracil;0.Hydroxyurea;1.Fluorouracil;0.Hydroxyurea;1.Fluorouracil;0.Hydroxyurea;1.Fluorouracil;0.Hydroxyurea;1.Fluorouracil;0.Hydroxyurea;","9.Docetaxel;0.Fluorouracil;0.Hydroxyurea;1.Fluorouracil;0.Hydroxyurea;1.Fluorouracil;0.Hydroxyurea;1.Fluorouracil;0.Hydroxyurea;1.Fluorouracil;0.Hydroxyurea;1.Fluorouracil;0.Hydroxyurea;"
"3275","65.101.1056.1","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Locally advanced disease, definitive therapy",101,"Fluorouracil, Hydroxyurea, RT",FALSE,"7","9.Fluorouracil;0.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;9.Fluorouracil;0.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;","9.Fluorouracil;0.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;"
"3276","65.101.1056.2","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Locally advanced disease, definitive therapy",101,"Fluorouracil, Hydroxyurea, RT",FALSE,"7","9.Fluorouracil;0.Hydroxyurea;1.Fluorouracil;0.Hydroxyurea;1.Fluorouracil;0.Hydroxyurea;1.Fluorouracil;0.Hydroxyurea;1.Fluorouracil;0.Hydroxyurea;1.Fluorouracil;0.Hydroxyurea;9.Fluorouracil;0.Hydroxyurea;1.Fluorouracil;0.Hydroxyurea;1.Fluorouracil;0.Hydroxyurea;1.Fluorouracil;0.Hydroxyurea;1.Fluorouracil;0.Hydroxyurea;1.Fluorouracil;0.Hydroxyurea;","9.Fluorouracil;0.Hydroxyurea;1.Fluorouracil;0.Hydroxyurea;1.Fluorouracil;0.Hydroxyurea;1.Fluorouracil;0.Hydroxyurea;1.Fluorouracil;0.Hydroxyurea;1.Fluorouracil;0.Hydroxyurea;"
"3277","65.101.1057.1","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Locally advanced disease, definitive therapy",101,"Fluorouracil, Mitomycin, RT",FALSE,"1","0.Fluorouracil;4.Mitomycin;31.Mitomycin;","0.Fluorouracil;4.Mitomycin;31.Mitomycin;"
"3278","65.101.1057.2","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Locally advanced disease, definitive therapy",101,"Fluorouracil, Mitomycin, RT",FALSE,"1","0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;0.Mitomycin;1.Fluorouracil;30.Mitomycin;","0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;0.Mitomycin;1.Fluorouracil;30.Mitomycin;"
"3279","65.101.1058.1","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Locally advanced disease, definitive therapy",101,"Fluorouracil & RT",FALSE,"1","0.Fluorouracil;","0.Fluorouracil;0.Fluorouracil;"
"3280","65.101.1058.2","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Locally advanced disease, definitive therapy",101,"Fluorouracil & RT",FALSE,"1","0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"3281","65.101.1059.1","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Locally advanced disease, definitive therapy",101,"Paclitaxel & RT",FALSE,"1","0.Paclitaxexl;7.Paclitaxexl;7.Paclitaxexl;7.Paclitaxexl;7.Paclitaxexl;7.Paclitaxexl;6.Paclitaxexl;","0.Paclitaxexl;7.Paclitaxexl;7.Paclitaxexl;7.Paclitaxexl;7.Paclitaxexl;7.Paclitaxexl;6.Paclitaxexl;"
"3282","65.102.1045.1","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Locally advanced disease, induction",102,"Cisplatin & Fluorouracil (CF)",TRUE,"Cont.","21.Cisplatin;0.Fluorouracil;21.Cisplatin;0.Fluorouracil;","21.Cisplatin;0.Fluorouracil;"
"3283","65.102.1045.2","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Locally advanced disease, induction",102,"Cisplatin & Fluorouracil (CF)",TRUE,"Cont.","17.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;17.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","17.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"3284","65.102.1045.3","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Locally advanced disease, induction",102,"Cisplatin & Fluorouracil (CF)",TRUE,"Cont.","16.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;16.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","16.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"3285","65.102.1046.1","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Locally advanced disease, induction",102,"PCF",TRUE,"Cont.","20.Fluorouracil;0.Paclitaxexl;1.Cisplatin;20.Fluorouracil;0.Paclitaxexl;1.Cisplatin;","20.Fluorouracil;0.Paclitaxexl;1.Cisplatin;"
"3286","65.102.1046.2","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Locally advanced disease, induction",102,"PCF",TRUE,"Cont.","16.Fluorouracil;0.Paclitaxexl;1.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;16.Fluorouracil;0.Paclitaxexl;1.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","16.Fluorouracil;0.Paclitaxexl;1.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"3287","65.102.1047.1","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Locally advanced disease, induction",102,"DCF",TRUE,"Cont.","21.Cisplatin;0.Docetaxel;0.Fluorouracil;21.Cisplatin;0.Docetaxel;0.Fluorouracil;","21.Cisplatin;0.Docetaxel;0.Fluorouracil;"
"3288","65.102.1047.2","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Locally advanced disease, induction",102,"DCF",TRUE,"Cont.","16.Cisplatin;0.Docetaxel;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;16.Cisplatin;0.Docetaxel;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","16.Cisplatin;0.Docetaxel;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"3289","65.102.1047.3","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Locally advanced disease, induction",102,"DCF",TRUE,"Cont.","17.Cisplatin;0.Docetaxel;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;17.Cisplatin;0.Docetaxel;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","17.Cisplatin;0.Docetaxel;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"3290","65.166.1063.1","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Recurrent or metastatic disease, first-line therapy",166,"Carboplatin & Docetaxel",TRUE,"Cont.","21.Carboplatin;0.Docetaxel;21.Carboplatin;0.Docetaxel;","21.Carboplatin;0.Docetaxel;"
"3291","65.166.1064.1","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Recurrent or metastatic disease, first-line therapy",166,"Carboplatin & Fluorouracil",TRUE,"Cont.","21.Carboplatin;0.Fluorouracil;21.Carboplatin;0.Fluorouracil;","21.Carboplatin;0.Fluorouracil;"
"3292","65.166.1064.2","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Recurrent or metastatic disease, first-line therapy",166,"Carboplatin & Fluorouracil",TRUE,"Cont.","17.Carboplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;17.Carboplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","17.Carboplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"3293","65.166.1064.3","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Recurrent or metastatic disease, first-line therapy",166,"Carboplatin & Fluorouracil",TRUE,"Cont.","28.Carboplatin;0.Fluorouracil;28.Carboplatin;0.Fluorouracil;","28.Carboplatin;0.Fluorouracil;"
"3294","65.166.1064.4","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Recurrent or metastatic disease, first-line therapy",166,"Carboplatin & Fluorouracil",TRUE,"Cont.","24.Carboplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;24.Carboplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","24.Carboplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"3295","65.166.1065.1","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Recurrent or metastatic disease, first-line therapy",166,"Carboplatin, Fluorouracil, Cetuximab",TRUE,"Cont.","7.Carboplatin;0.Cetuximab;0.Fluorouracil;7.Cetuximab;7.Cetuximab;7.Carboplatin;0.Cetuximab;0.Fluorouracil;7.Cetuximab;7.Cetuximab;","7.Carboplatin;0.Cetuximab;0.Fluorouracil;7.Cetuximab;7.Cetuximab;"
"3296","65.166.1065.2","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Recurrent or metastatic disease, first-line therapy",166,"Carboplatin, Fluorouracil, Cetuximab",TRUE,"Cont.","7.Carboplatin;0.Cetuximab;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;3.Cetuximab;7.Cetuximab;7.Carboplatin;0.Cetuximab;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;3.Cetuximab;7.Cetuximab;","7.Carboplatin;0.Cetuximab;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;3.Cetuximab;7.Cetuximab;"
"3297","65.166.1066.1","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Recurrent or metastatic disease, first-line therapy",166,"Carboplatin, Fluorouracil, Pembrolizumab",TRUE,"Cont.","21.Carboplatin;0.Fluorouracil;0.Pembrolizumab;21.Carboplatin;0.Fluorouracil;0.Pembrolizumab;","21.Carboplatin;0.Fluorouracil;0.Pembrolizumab;"
"3298","65.166.1066.2","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Recurrent or metastatic disease, first-line therapy",166,"Carboplatin, Fluorouracil, Pembrolizumab",TRUE,"Cont.","17.Carboplatin;0.Fluorouracil;0.Pembrolizumab;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;17.Carboplatin;0.Fluorouracil;0.Pembrolizumab;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","17.Carboplatin;0.Fluorouracil;0.Pembrolizumab;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"3299","65.166.1067.1","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Recurrent or metastatic disease, first-line therapy",166,"Cisplatin monotherapy",TRUE,"Cont.","21.Cisplatin;7.Cisplatin;21.Cisplatin;7.Cisplatin;","21.Cisplatin;7.Cisplatin;"
"3300","65.166.1067.2","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Recurrent or metastatic disease, first-line therapy",166,"Cisplatin monotherapy",TRUE,"Cont.","21.Cisplatin;21.Cisplatin;","21.Cisplatin;21.Cisplatin;"
"3301","65.166.1068.1","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Recurrent or metastatic disease, first-line therapy",166,"Cisplatin & Docetaxel (DC)",TRUE,"Cont.","21.Cisplatin;0.Docetaxel;21.Cisplatin;0.Docetaxel;","21.Cisplatin;0.Docetaxel;"
"3302","65.166.1069.1","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Recurrent or metastatic disease, first-line therapy",166,"Cisplatin & Fluorouracil (CF) & Cetuximab",TRUE,"Cont.","7.Cetuximab;0.Cisplatin;0.Fluorouracil;7.Cetuximab;7.Cetuximab;7.Cetuximab;0.Cisplatin;0.Fluorouracil;7.Cetuximab;7.Cetuximab;","7.Cetuximab;0.Cisplatin;0.Fluorouracil;7.Cetuximab;7.Cetuximab;"
"3303","65.166.1069.2","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Recurrent or metastatic disease, first-line therapy",166,"Cisplatin & Fluorouracil (CF) & Cetuximab",TRUE,"Cont.","7.Cetuximab;0.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;3.Cetuximab;7.Cetuximab;7.Cetuximab;0.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;3.Cetuximab;7.Cetuximab;","7.Cetuximab;0.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;3.Cetuximab;7.Cetuximab;"
"3304","65.166.1070.1","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Recurrent or metastatic disease, first-line therapy",166,"Cisplatin & Fluorouracil (CF) & Panitumumab",TRUE,"Cont.","21.Cisplatin;0.Fluorouracil;0.Panitumumab;21.Cisplatin;0.Fluorouracil;0.Panitumumab;","21.Cisplatin;0.Fluorouracil;0.Panitumumab;"
"3305","65.166.1070.2","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Recurrent or metastatic disease, first-line therapy",166,"Cisplatin & Fluorouracil (CF) & Panitumumab",TRUE,"Cont.","17.Cisplatin;0.Fluorouracil;0.Panitumumab;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;17.Cisplatin;0.Fluorouracil;0.Panitumumab;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","17.Cisplatin;0.Fluorouracil;0.Panitumumab;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"3306","65.166.1071.1","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Recurrent or metastatic disease, first-line therapy",166,"Cisplatin & Fluorouracil (CF) & Pembrolizumab",TRUE,"Cont.","21.Cisplatin;0.Fluorouracil;0.Pembrolizumab;21.Cisplatin;0.Fluorouracil;0.Pembrolizumab;","21.Cisplatin;0.Fluorouracil;0.Pembrolizumab;"
"3307","65.166.1071.2","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Recurrent or metastatic disease, first-line therapy",166,"Cisplatin & Fluorouracil (CF) & Pembrolizumab",TRUE,"Cont.","17.Cisplatin;0.Fluorouracil;0.Pembrolizumab;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;17.Cisplatin;0.Fluorouracil;0.Pembrolizumab;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","17.Cisplatin;0.Fluorouracil;0.Pembrolizumab;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"3308","65.166.1071.3","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Recurrent or metastatic disease, first-line therapy",166,"Cisplatin & Fluorouracil (CF) & Pembrolizumab",TRUE,"Cont.","16.Fluorouracil;0.Pembrolizumab;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;16.Fluorouracil;0.Pembrolizumab;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","16.Fluorouracil;0.Pembrolizumab;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"3309","65.166.1072.1","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Recurrent or metastatic disease, first-line therapy",166,"Cisplatin & Paclitaxel",TRUE,"Cont.","21.Cisplatin;0.Paclitaxexl;21.Cisplatin;0.Paclitaxexl;","21.Cisplatin;0.Paclitaxexl;"
"3310","65.166.1073.1","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Recurrent or metastatic disease, first-line therapy",166,"Fluorouracil monotherapy",TRUE,"Cont.","21.Fluorouracil;21.Fluorouracil;","21.Fluorouracil;21.Fluorouracil;"
"3311","65.166.1073.2","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Recurrent or metastatic disease, first-line therapy",166,"Fluorouracil monotherapy",TRUE,"Cont.","17.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;17.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","17.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"3312","65.166.1074.1","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Recurrent or metastatic disease, first-line therapy",166,"Methotrexate monotherapy",TRUE,"Cont.","7.Methotrexate;7.Methotrexate;7.Methotrexate;7.Methotrexate;7.Methotrexate;7.Methotrexate;7.Methotrexate;7.Methotrexate;","7.Methotrexate;7.Methotrexate;"
"3313","65.166.1075.1","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Recurrent or metastatic disease, first-line therapy",166,"Pembrolizumab monotherapy",TRUE,"Cont.","21.Pembrolizumab;21.Pembrolizumab;","21.Pembrolizumab;21.Pembrolizumab;"
"3314","65.167.1076.1","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Recurrent or metastatic disease, subsequent lines of therapy",167,"Afatinib monotherapy",TRUE,"Cont.","1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;","1.Afatinib;1.Afatinib;"
"3315","65.167.1077.1","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Recurrent or metastatic disease, subsequent lines of therapy",167,"Cetuximab monotherapy",TRUE,"Cont.","1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;1.Cetuximab;","1.Cetuximab;1.Cetuximab;"
"3316","65.167.1078.1","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Recurrent or metastatic disease, subsequent lines of therapy",167,"Docetaxel monotherapy",TRUE,"Cont.","7.Docetaxel;7.Docetaxel;7.Docetaxel;7.Docetaxel;7.Docetaxel;7.Docetaxel;7.Docetaxel;7.Docetaxel;","7.Docetaxel;7.Docetaxel;"
"3317","65.167.1078.2","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Recurrent or metastatic disease, subsequent lines of therapy",167,"Docetaxel monotherapy",TRUE,"Cont.","14.Docetaxel;7.Docetaxel;7.Docetaxel;14.Docetaxel;7.Docetaxel;7.Docetaxel;","14.Docetaxel;7.Docetaxel;7.Docetaxel;"
"3318","65.167.1079.1","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Recurrent or metastatic disease, subsequent lines of therapy",167,"Nivolumab monotherapy",TRUE,"Cont.","14.Nivolumab;14.Nivolumab;","14.Nivolumab;14.Nivolumab;"
"3319","65.167.1080.1","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Recurrent or metastatic disease, subsequent lines of therapy",167,"Paclitaxel monotherapy",TRUE,"Cont.","7.Paclitaxexl;7.Paclitaxexl;7.Paclitaxexl;7.Paclitaxexl;7.Paclitaxexl;7.Paclitaxexl;7.Paclitaxexl;7.Paclitaxexl;","7.Paclitaxexl;7.Paclitaxexl;"
"3320","65.167.1081.1","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Recurrent or metastatic disease, subsequent lines of therapy",167,"Pembrolizumab monotherapy",TRUE,"Cont.","14.Pembrolizumab;14.Pembrolizumab;","14.Pembrolizumab;14.Pembrolizumab;"
"3321","65.4.1060.1","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Adjuvant therapy",4,"Cisplatin, Cetuximab, RT",FALSE,"1","0.Cetuximab;0.Cisplatin;7.Cetuximab;0.Cisplatin;7.Cetuximab;0.Cisplatin;7.Cetuximab;0.Cisplatin;7.Cetuximab;0.Cisplatin;7.Cetuximab;0.Cisplatin;","0.Cetuximab;0.Cisplatin;7.Cetuximab;0.Cisplatin;7.Cetuximab;0.Cisplatin;7.Cetuximab;0.Cisplatin;7.Cetuximab;0.Cisplatin;7.Cetuximab;0.Cisplatin;"
"3322","65.4.1061.1","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Adjuvant therapy",4,"Docetaxel, Cetuximab, RT",FALSE,"1","0.Cetuximab;0.Docetaxel;7.Cetuximab;0.Docetaxel;7.Cetuximab;0.Docetaxel;7.Cetuximab;0.Docetaxel;7.Cetuximab;0.Docetaxel;7.Cetuximab;0.Docetaxel;","0.Cetuximab;0.Docetaxel;7.Cetuximab;0.Docetaxel;7.Cetuximab;0.Docetaxel;7.Cetuximab;0.Docetaxel;7.Cetuximab;0.Docetaxel;7.Cetuximab;0.Docetaxel;"
"3323","65.4.1062.1","Solid Tumor","Head & Neck Oncology","Head and neck cancer",65,"Adjuvant therapy",4,"Tegafur & Uracil",TRUE,"Cont.","1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;","1.Tegafuranduracil;1.Tegafuranduracil;"
"3324","66.100.1085.1","Solid Tumor","Head & Neck Oncology","Nasopharyngeal carcinoma",66,"Locally advanced disease, definitive chemoradiotherapy",100,"Carboplatin & RT",FALSE,"1","0.Carboplatin;7.Carboplatin;7.Carboplatin;7.Carboplatin;7.Carboplatin;7.Carboplatin;","0.Carboplatin;7.Carboplatin;7.Carboplatin;7.Carboplatin;7.Carboplatin;7.Carboplatin;"
"3325","66.100.1086.1","Solid Tumor","Head & Neck Oncology","Nasopharyngeal carcinoma",66,"Locally advanced disease, definitive chemoradiotherapy",100,"Oxaliplatin & RT",FALSE,"1","0.Oxaliplatin;7.Oxaliplatin;7.Oxaliplatin;7.Oxaliplatin;7.Oxaliplatin;7.Oxaliplatin;","0.Oxaliplatin;7.Oxaliplatin;7.Oxaliplatin;7.Oxaliplatin;7.Oxaliplatin;7.Oxaliplatin;"
"3326","66.102.1082.1","Solid Tumor","Head & Neck Oncology","Nasopharyngeal carcinoma",66,"Locally advanced disease, induction",102,"Cisplatin & Epirubicin",TRUE,"Cont.","28.Cisplatin;0.Epirubicin;28.Cisplatin;0.Epirubicin;","28.Cisplatin;0.Epirubicin;"
"3327","66.102.1083.1","Solid Tumor","Head & Neck Oncology","Nasopharyngeal carcinoma",66,"Locally advanced disease, induction",102,"Cisplatin & Gemcitabine (GC)",TRUE,"Cont.","14.Cisplatin;0.Gemcitabine;7.Gemcitabine;14.Cisplatin;0.Gemcitabine;7.Gemcitabine;","14.Cisplatin;0.Gemcitabine;7.Gemcitabine;"
"3328","66.102.1084.1","Solid Tumor","Head & Neck Oncology","Nasopharyngeal carcinoma",66,"Locally advanced disease, induction",102,"TPC",FALSE,"2","8.Capecitabine;0.Cisplatin;0.Paclitaxexl;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Capecitabine;0.Cisplatin;0.Paclitaxexl;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"3329","66.165.1089.1","Solid Tumor","Head & Neck Oncology","Nasopharyngeal carcinoma",66,"Recurrent or metastatic disease",165,"Cisplatin & Gemcitabine (GC) & Camrelizumab",TRUE,"Cont.","14.Camrelizumab;0.Cisplatin;0.Gemcitabine;7.Gemcitabine;14.Camrelizumab;0.Cisplatin;0.Gemcitabine;7.Gemcitabine;","14.Camrelizumab;0.Cisplatin;0.Gemcitabine;7.Gemcitabine;"
"3330","66.165.1090.1","Solid Tumor","Head & Neck Oncology","Nasopharyngeal carcinoma",66,"Recurrent or metastatic disease",165,"Cisplatin & Gemcitabine (GC) & Toripalimab",TRUE,"Cont.","14.Cisplatin;0.Gemcitabine;0.Toripalimab;7.Gemcitabine;14.Cisplatin;0.Gemcitabine;0.Toripalimab;7.Gemcitabine;","14.Cisplatin;0.Gemcitabine;0.Toripalimab;7.Gemcitabine;"
"3331","66.165.1091.1","Solid Tumor","Head & Neck Oncology","Nasopharyngeal carcinoma",66,"Recurrent or metastatic disease",165,"Gemcitabine monotherapy",TRUE,"Cont.","14.Gemcitabine;7.Gemcitabine;7.Gemcitabine;14.Gemcitabine;7.Gemcitabine;7.Gemcitabine;","14.Gemcitabine;7.Gemcitabine;7.Gemcitabine;"
"3332","66.165.1092.1","Solid Tumor","Head & Neck Oncology","Nasopharyngeal carcinoma",66,"Recurrent or metastatic disease",165,"Toripalimab monotherapy",TRUE,"Cont.","14.Toripalimab;14.Toripalimab;","14.Toripalimab;14.Toripalimab;"
"3333","66.4.1087.1","Solid Tumor","Head & Neck Oncology","Nasopharyngeal carcinoma",66,"Adjuvant therapy",4,"Capecitabine monotherapy",TRUE,"Cont.","8.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;"
"3334","66.4.1088.1","Solid Tumor","Head & Neck Oncology","Nasopharyngeal carcinoma",66,"Adjuvant therapy",4,"Cisplatin & Fluorouracil (CF) & RT",FALSE,"3","28.Cisplatin;0.Fluorouracil;28.Cisplatin;0.Fluorouracil;","28.Cisplatin;0.Fluorouracil;"
"3335","66.4.1088.2","Solid Tumor","Head & Neck Oncology","Nasopharyngeal carcinoma",66,"Adjuvant therapy",4,"Cisplatin & Fluorouracil (CF) & RT",FALSE,"3","23.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;23.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;","23.Cisplatin;0.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;1.Fluorouracil;"
"3336","68.26.1093.1","Solid Tumor","Mesothelioma","Malignant peritoneal mesothelioma",68,"Advanced or metastatic disease, subsequent lines of therapy",26,"Atezolizumab & Bevacizumab",TRUE,"Cont.","21.Atezolizumab;0.Bevacizumab;21.Atezolizumab;0.Bevacizumab;","21.Atezolizumab;0.Bevacizumab;"
"3337","69.20.1094.1","Solid Tumor","Mesothelioma","Malignant pleural mesothelioma",69,"Advanced or metastatic disease, first-line therapy",20,"Carboplatin & Pemetrexed",TRUE,"Cont.","21.Carboplatin;0.Pemetrexed;21.Carboplatin;0.Pemetrexed;","21.Carboplatin;0.Pemetrexed;"
"3338","69.20.1095.1","Solid Tumor","Mesothelioma","Malignant pleural mesothelioma",69,"Advanced or metastatic disease, first-line therapy",20,"Carboplatin, Pemetrexed, Bevacizumab",TRUE,"Cont.","21.Bevacizumab;0.Carboplatin;0.Pemetrexed;21.Bevacizumab;0.Carboplatin;0.Pemetrexed;","21.Bevacizumab;0.Carboplatin;0.Pemetrexed;"
"3339","69.20.1096.1","Solid Tumor","Mesothelioma","Malignant pleural mesothelioma",69,"Advanced or metastatic disease, first-line therapy",20,"Cisplatin monotherapy",TRUE,"Cont.","21.Cisplatin;21.Cisplatin;","21.Cisplatin;21.Cisplatin;"
"3340","69.20.1097.1","Solid Tumor","Mesothelioma","Malignant pleural mesothelioma",69,"Advanced or metastatic disease, first-line therapy",20,"Cisplatin & Gemcitabine (GC)",TRUE,"Cont.","14.Cisplatin;0.Gemcitabine;7.Gemcitabine;14.Cisplatin;0.Gemcitabine;7.Gemcitabine;","14.Cisplatin;0.Gemcitabine;7.Gemcitabine;"
"3341","69.20.1097.2","Solid Tumor","Mesothelioma","Malignant pleural mesothelioma",69,"Advanced or metastatic disease, first-line therapy",20,"Cisplatin & Gemcitabine (GC)",TRUE,"Cont.","7.Cisplatin;0.Gemcitabine;7.Gemcitabine;7.Gemcitabine;7.Cisplatin;0.Gemcitabine;7.Gemcitabine;7.Gemcitabine;","7.Cisplatin;0.Gemcitabine;7.Gemcitabine;7.Gemcitabine;"
"3342","69.20.1098.1","Solid Tumor","Mesothelioma","Malignant pleural mesothelioma",69,"Advanced or metastatic disease, first-line therapy",20,"Cisplatin & Pemetrexed",TRUE,"Cont.","21.Cisplatin;0.Pemetrexed;21.Cisplatin;0.Pemetrexed;","21.Cisplatin;0.Pemetrexed;"
"3343","69.20.1099.1","Solid Tumor","Mesothelioma","Malignant pleural mesothelioma",69,"Advanced or metastatic disease, first-line therapy",20,"Cisplatin & Raltitrexed",TRUE,"Cont.","21.Cisplatin;0.Raltitrexed;21.Cisplatin;0.Raltitrexed;","21.Cisplatin;0.Raltitrexed;"
"3344","69.20.1100.1","Solid Tumor","Mesothelioma","Malignant pleural mesothelioma",69,"Advanced or metastatic disease, first-line therapy",20,"Cisplatin, Pemetrexed, Bevacizumab",TRUE,"Cont.","21.Bevacizumab;0.Cisplatin;0.Pemetrexed;21.Bevacizumab;0.Cisplatin;0.Pemetrexed;","21.Bevacizumab;0.Cisplatin;0.Pemetrexed;"
"3345","69.20.1101.1","Solid Tumor","Mesothelioma","Malignant pleural mesothelioma",69,"Advanced or metastatic disease, first-line therapy",20,"Cisplatin, Pemetrexed, TTFields",TRUE,"Cont.","1.Cisplatin;0.NovoTTF-100Asystem;0.Pemetrexed;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.Cisplatin;0.NovoTTF-100Asystem;0.Pemetrexed;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;","1.Cisplatin;0.NovoTTF-100Asystem;0.Pemetrexed;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;"
"3346","69.20.1102.1","Solid Tumor","Mesothelioma","Malignant pleural mesothelioma",69,"Advanced or metastatic disease, first-line therapy",20,"Ipilimumab & Nivolumab",TRUE,"Cont.","14.Ipilimumab;0.Nivolumab;14.Nivolumab;14.Nivolumab;14.Ipilimumab;0.Nivolumab;14.Nivolumab;14.Nivolumab;","14.Ipilimumab;0.Nivolumab;14.Nivolumab;14.Nivolumab;"
"3347","69.20.1103.1","Solid Tumor","Mesothelioma","Malignant pleural mesothelioma",69,"Advanced or metastatic disease, first-line therapy",20,"Pemetrexed monotherapy",TRUE,"Cont.","21.Pemetrexed;21.Pemetrexed;","21.Pemetrexed;21.Pemetrexed;"
"3348","69.20.1104.1","Solid Tumor","Mesothelioma","Malignant pleural mesothelioma",69,"Advanced or metastatic disease, first-line therapy",20,"Vinorelbine monotherapy",FALSE,"2","14.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;","14.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;"
"3349","69.26.1105.1","Solid Tumor","Mesothelioma","Malignant pleural mesothelioma",69,"Advanced or metastatic disease, subsequent lines of therapy",26,"Doxorubicin monotherapy",TRUE,"Cont.","21.Doxorubicin;21.Doxorubicin;","21.Doxorubicin;21.Doxorubicin;"
"3350","69.26.1106.1","Solid Tumor","Mesothelioma","Malignant pleural mesothelioma",69,"Advanced or metastatic disease, subsequent lines of therapy",26,"Gemcitabine monotherapy",TRUE,"Cont.","14.Gemcitabine;7.Gemcitabine;14.Gemcitabine;7.Gemcitabine;","14.Gemcitabine;7.Gemcitabine;"
"3351","69.26.1106.2","Solid Tumor","Mesothelioma","Malignant pleural mesothelioma",69,"Advanced or metastatic disease, subsequent lines of therapy",26,"Gemcitabine monotherapy",TRUE,"Cont.","14.Gemcitabine;7.Gemcitabine;7.Gemcitabine;14.Gemcitabine;7.Gemcitabine;7.Gemcitabine;","14.Gemcitabine;7.Gemcitabine;7.Gemcitabine;"
"3352","69.26.1107.1","Solid Tumor","Mesothelioma","Malignant pleural mesothelioma",69,"Advanced or metastatic disease, subsequent lines of therapy",26,"Gemcitabine & Vinorelbine",TRUE,"Cont.","14.Gemcitabine;0.Vinorelbine;7.Gemcitabine;0.Vinorelbine;14.Gemcitabine;0.Vinorelbine;7.Gemcitabine;0.Vinorelbine;","14.Gemcitabine;0.Vinorelbine;7.Gemcitabine;0.Vinorelbine;"
"3353","69.26.1108.1","Solid Tumor","Mesothelioma","Malignant pleural mesothelioma",69,"Advanced or metastatic disease, subsequent lines of therapy",26,"Nivolumab monotherapy",TRUE,"Cont.","14.Nivolumab;14.Nivolumab;","14.Nivolumab;14.Nivolumab;"
"3354","69.26.1109.1","Solid Tumor","Mesothelioma","Malignant pleural mesothelioma",69,"Advanced or metastatic disease, subsequent lines of therapy",26,"Vinorelbine monotherapy",TRUE,"Cont.","14.Vinorelbine;7.Vinorelbine;14.Vinorelbine;7.Vinorelbine;","14.Vinorelbine;7.Vinorelbine;"
"3355","69.26.1109.2","Solid Tumor","Mesothelioma","Malignant pleural mesothelioma",69,"Advanced or metastatic disease, subsequent lines of therapy",26,"Vinorelbine monotherapy",TRUE,"Cont.","7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;","7.Vinorelbine;7.Vinorelbine;"
"3356","7.15.342.1","Solid Tumor","Breast Oncology","Breast cancer, PIK3CA-mutated",7,"Advanced or metastatic disease, all lines of therapy",15,"Alpelisib & Fulvestrant",TRUE,"Cont.","1.Alpelisib;0.Fulvestrant;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;0.Fulvestrant;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;0.Fulvestrant;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;0.Fulvestrant;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;","1.Alpelisib;0.Fulvestrant;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;"
"3357","7.15.342.2","Solid Tumor","Breast Oncology","Breast cancer, PIK3CA-mutated",7,"Advanced or metastatic disease, all lines of therapy",15,"Alpelisib & Fulvestrant",TRUE,"Cont.","1.Alpelisib;0.Fulvestrant;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;0.Fulvestrant;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;","1.Alpelisib;0.Fulvestrant;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;1.Alpelisib;"
"3358","70.164.1117.1","Solid Tumor","Neuro-Oncology","Anaplastic glioma",70,"Recurrent disease, salvage therapy",164,"Bevacizumab monotherapy",TRUE,"Cont.","14.Bevacizumab;14.Bevacizumab;","14.Bevacizumab;14.Bevacizumab;"
"3359","70.164.1118.1","Solid Tumor","Neuro-Oncology","Anaplastic glioma",70,"Recurrent disease, salvage therapy",164,"Carboplatin & Bevacizumab",TRUE,"Cont.","14.Bevacizumab;0.Carboplatin;14.Bevacizumab;0.Carboplatin;","14.Bevacizumab;0.Carboplatin;"
"3360","70.164.1118.2","Solid Tumor","Neuro-Oncology","Anaplastic glioma",70,"Recurrent disease, salvage therapy",164,"Carboplatin & Bevacizumab",TRUE,"Cont.","28.Bevacizumab;0.Carboplatin;28.Bevacizumab;0.Carboplatin;","28.Bevacizumab;0.Carboplatin;"
"3361","70.164.1119.1","Solid Tumor","Neuro-Oncology","Anaplastic glioma",70,"Recurrent disease, salvage therapy",164,"Cyclophosphamide monotherapy",TRUE,"Cont.","27.Cyclophosphamide;1.Cyclophosphamide;27.Cyclophosphamide;1.Cyclophosphamide;","27.Cyclophosphamide;1.Cyclophosphamide;"
"3362","70.164.1120.1","Solid Tumor","Neuro-Oncology","Anaplastic glioma",70,"Recurrent disease, salvage therapy",164,"Etoposide monotherapy",TRUE,"Cont.","1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;","1.Etoposide;1.Etoposide;"
"3363","70.164.1121.1","Solid Tumor","Neuro-Oncology","Anaplastic glioma",70,"Recurrent disease, salvage therapy",164,"Irinotecan monotherapy",TRUE,"Cont.","21.Irinotecan;7.Irinotecan;7.Irinotecan;7.Irinotecan;21.Irinotecan;7.Irinotecan;7.Irinotecan;7.Irinotecan;","21.Irinotecan;7.Irinotecan;7.Irinotecan;7.Irinotecan;"
"3364","70.164.1121.2","Solid Tumor","Neuro-Oncology","Anaplastic glioma",70,"Recurrent disease, salvage therapy",164,"Irinotecan monotherapy",TRUE,"Cont.","21.Irinotecan;21.Irinotecan;","21.Irinotecan;21.Irinotecan;"
"3365","70.164.1122.1","Solid Tumor","Neuro-Oncology","Anaplastic glioma",70,"Recurrent disease, salvage therapy",164,"Irinotecan & Bevacizumab",TRUE,"Cont.","14.Bevacizumab;0.Irinotecan;14.Bevacizumab;0.Irinotecan;","14.Bevacizumab;0.Irinotecan;"
"3366","70.164.1123.1","Solid Tumor","Neuro-Oncology","Anaplastic glioma",70,"Recurrent disease, salvage therapy",164,"Temozolomide monotherapy",TRUE,"Cont.","24.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;24.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;","24.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;"
"3367","70.4.1110.1","Solid Tumor","Neuro-Oncology","Anaplastic glioma",70,"Adjuvant therapy",4,"Carmustine monotherapy",TRUE,"Cont.","42.Carmustine;42.Carmustine;","42.Carmustine;42.Carmustine;"
"3368","70.4.1111.1","Solid Tumor","Neuro-Oncology","Anaplastic glioma",70,"Adjuvant therapy",4,"PCV",TRUE,"Cont.","14.Lomustine;7.Procarbazine;0.Vincristine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;8.Vincristine;14.Lomustine;7.Procarbazine;0.Vincristine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;8.Vincristine;","14.Lomustine;7.Procarbazine;0.Vincristine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;8.Vincristine;"
"3369","70.4.1111.2","Solid Tumor","Neuro-Oncology","Anaplastic glioma",70,"Adjuvant therapy",4,"PCV",TRUE,"Cont.","21.Lomustine;7.Procarbazine;0.Vincristine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;8.Vincristine;21.Lomustine;7.Procarbazine;0.Vincristine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;8.Vincristine;","21.Lomustine;7.Procarbazine;0.Vincristine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;8.Vincristine;"
"3370","70.4.1111.3","Solid Tumor","Neuro-Oncology","Anaplastic glioma",70,"Adjuvant therapy",4,"PCV",TRUE,"Cont.","28.Lomustine;7.Procarbazine;0.Vincristine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;8.Vincristine;28.Lomustine;7.Procarbazine;0.Vincristine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;8.Vincristine;","28.Lomustine;7.Procarbazine;0.Vincristine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;8.Vincristine;"
"3371","70.4.1112.1","Solid Tumor","Neuro-Oncology","Anaplastic glioma",70,"Adjuvant therapy",4,"RT, then Carmustine",TRUE,"Cont.","54.Carmustine;1.Carmustine;1.Carmustine;54.Carmustine;1.Carmustine;1.Carmustine;","54.Carmustine;1.Carmustine;1.Carmustine;"
"3372","70.4.1113.1","Solid Tumor","Neuro-Oncology","Anaplastic glioma",70,"Adjuvant therapy",4,"RT, then Temozolomide",TRUE,"Cont.","24.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;24.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;","24.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;"
"3373","70.4.1114.1","Solid Tumor","Neuro-Oncology","Anaplastic glioma",70,"Adjuvant therapy",4,"Temozolomide monotherapy",TRUE,"Cont.","8.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;8.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;","8.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;"
"3374","70.4.1115.1","Solid Tumor","Neuro-Oncology","Anaplastic glioma",70,"Adjuvant therapy",4,"Temozolomide, then Temozolomide & RT, then Temozolomide",NA,NA,"0.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;24.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;24.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;24.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;43.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;24.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;24.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;24.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;","0.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;24.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;24.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;24.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;43.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;24.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;24.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;24.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;"
"3375","70.4.1116.1","Solid Tumor","Neuro-Oncology","Anaplastic glioma",70,"Adjuvant therapy",4,"Temozolomide & RT",TRUE,"Cont.","1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;","1.Temozolomide;1.Temozolomide;"
"3376","71.10.1124.1","Solid Tumor","Neuro-Oncology","Glioblastoma",71,"Adjuvant therapy, standard patients",10,"Bevacizumab & RT",TRUE,"Cont.","28.Bevacizumab;28.Bevacizumab;","28.Bevacizumab;28.Bevacizumab;"
"3377","71.10.1125.1","Solid Tumor","Neuro-Oncology","Glioblastoma",71,"Adjuvant therapy, standard patients",10,"Lomustine, Temozolomide, RT",TRUE,"Cont.","37.Lomustine;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;37.Lomustine;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;","37.Lomustine;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;"
"3378","71.10.1126.1","Solid Tumor","Neuro-Oncology","Glioblastoma",71,"Adjuvant therapy, standard patients",10,"Nimustine & RT",TRUE,"Cont.","28.Nimustine;28.Nimustine;","28.Nimustine;28.Nimustine;"
"3379","71.114.1128.1","Solid Tumor","Neuro-Oncology","Glioblastoma",71,"Maintenance after first-line therapy",114,"Temozolomide & NovoTTF-100A",TRUE,"Cont.","1.NovoTTF-100Asystem;0.Temozolomide;1.NovoTTF-100Asystem;0.Temozolomide;1.NovoTTF-100Asystem;0.Temozolomide;1.NovoTTF-100Asystem;0.Temozolomide;1.NovoTTF-100Asystem;0.Temozolomide;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;0.Temozolomide;1.NovoTTF-100Asystem;0.Temozolomide;1.NovoTTF-100Asystem;0.Temozolomide;1.NovoTTF-100Asystem;0.Temozolomide;1.NovoTTF-100Asystem;0.Temozolomide;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;","1.NovoTTF-100Asystem;0.Temozolomide;1.NovoTTF-100Asystem;0.Temozolomide;1.NovoTTF-100Asystem;0.Temozolomide;1.NovoTTF-100Asystem;0.Temozolomide;1.NovoTTF-100Asystem;0.Temozolomide;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;1.NovoTTF-100Asystem;"
"3380","71.162.1134.1","Solid Tumor","Neuro-Oncology","Glioblastoma",71,"Recurrent disease, non-curative therapy, non-randomized or retrospective data",162,"Irinotecan & Bevacizumab",TRUE,"Cont.","14.Bevacizumab;0.Irinotecan;7.Irinotecan;14.Bevacizumab;0.Irinotecan;7.Irinotecan;14.Bevacizumab;0.Irinotecan;7.Irinotecan;14.Bevacizumab;0.Irinotecan;7.Irinotecan;","14.Bevacizumab;0.Irinotecan;7.Irinotecan;"
"3381","71.162.1135.1","Solid Tumor","Neuro-Oncology","Glioblastoma",71,"Recurrent disease, non-curative therapy, non-randomized or retrospective data",162,"Procarbazine monotherapy",TRUE,"Cont.","29.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;29.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;","29.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;"
"3382","71.162.1136.1","Solid Tumor","Neuro-Oncology","Glioblastoma",71,"Recurrent disease, non-curative therapy, non-randomized or retrospective data",162,"Temozolomide monotherapy",TRUE,"Cont.","1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;","1.Temozolomide;1.Temozolomide;"
"3383","71.163.1129.1","Solid Tumor","Neuro-Oncology","Glioblastoma",71,"Recurrent disease, non-curative therapy, randomized data",163,"Carmustine monotherapy",TRUE,"Cont.","56.Carmustine;56.Carmustine;","56.Carmustine;56.Carmustine;"
"3384","71.163.1130.1","Solid Tumor","Neuro-Oncology","Glioblastoma",71,"Recurrent disease, non-curative therapy, randomized data",163,"Hydroxyurea monotherapy",TRUE,"Cont.","1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;1.Hydroxyurea;","1.Hydroxyurea;1.Hydroxyurea;"
"3385","71.163.1131.1","Solid Tumor","Neuro-Oncology","Glioblastoma",71,"Recurrent disease, non-curative therapy, randomized data",163,"Hydroxyurea & Imatinib",TRUE,"Cont.","1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;1.Hydroxyurea;0.Imatinib;","1.Hydroxyurea;0.Imatinib;"
"3386","71.163.1132.1","Solid Tumor","Neuro-Oncology","Glioblastoma",71,"Recurrent disease, non-curative therapy, randomized data",163,"Lomustine monotherapy",TRUE,"Cont.","42.Lomustine;42.Lomustine;","42.Lomustine;42.Lomustine;"
"3387","71.163.1133.1","Solid Tumor","Neuro-Oncology","Glioblastoma",71,"Recurrent disease, non-curative therapy, randomized data",163,"Lomustine & Bevacizumab",TRUE,"Cont.","21.Bevacizumab;0.Lomustine;21.Bevacizumab;21.Bevacizumab;0.Lomustine;21.Bevacizumab;","21.Bevacizumab;0.Lomustine;21.Bevacizumab;"
"3388","71.163.1133.2","Solid Tumor","Neuro-Oncology","Glioblastoma",71,"Recurrent disease, non-curative therapy, randomized data",163,"Lomustine & Bevacizumab",TRUE,"Cont.","42.Bevacizumab;0.Lomustine;42.Bevacizumab;0.Lomustine;","42.Bevacizumab;0.Lomustine;"
"3389","71.7.1127.1","Solid Tumor","Neuro-Oncology","Glioblastoma",71,"Adjuvant therapy, elderly or poor performance status patients",7,"Temozolomide & low-dose RT",TRUE,"Cont.","1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;","1.Temozolomide;1.Temozolomide;"
"3390","72.168.1137.1","Solid Tumor","Neuro-Oncology","Low-grade glioma",72,"Recurrent or progressive, non-curative therapy",168,"Carboplatin monotherapy",TRUE,"Cont.","28.Carboplatin;28.Carboplatin;","28.Carboplatin;28.Carboplatin;"
"3391","72.168.1138.1","Solid Tumor","Neuro-Oncology","Low-grade glioma",72,"Recurrent or progressive, non-curative therapy",168,"Carboplatin & Teniposide",TRUE,"Cont.","26.Carboplatin;0.Teniposide;1.Teniposide;1.Teniposide;26.Carboplatin;0.Teniposide;1.Teniposide;1.Teniposide;","26.Carboplatin;0.Teniposide;1.Teniposide;1.Teniposide;"
"3392","72.168.1139.1","Solid Tumor","Neuro-Oncology","Low-grade glioma",72,"Recurrent or progressive, non-curative therapy",168,"Temozolomide monotherapy",TRUE,"Cont.","29.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;29.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;","29.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;"
"3393","74.31.1140.1","Solid Tumor","Neuro-Oncology","Subependymal giant cell astrocytoma",74,"All lines of therapy",31,"Everolimus monotherapy",TRUE,"Cont.","1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;","1.Everolimus;1.Everolimus;"
"3394","76.36.1141.1","Solid Tumor","Neuro-Oncology","CNS leukemia",76,"CNS prophylaxis, local therapy",36,"IT Cytarabine & Methotrexate",TRUE,"Cont.","16.Methotrexate;5.Cytarabine;16.Methotrexate;5.Cytarabine;","16.Methotrexate;5.Cytarabine;"
"3395","76.36.1142.1","Solid Tumor","Neuro-Oncology","CNS leukemia",76,"CNS prophylaxis, local therapy",36,"IT Cytarabine & WBRT",TRUE,"Cont.","7.Cytarabine;7.Cytarabine;7.Cytarabine;7.Cytarabine;7.Cytarabine;7.Cytarabine;7.Cytarabine;7.Cytarabine;","7.Cytarabine;7.Cytarabine;"
"3396","76.36.1142.2","Solid Tumor","Neuro-Oncology","CNS leukemia",76,"CNS prophylaxis, local therapy",36,"IT Cytarabine & WBRT",TRUE,"Cont.","112.Cytarabine;112.Cytarabine;","112.Cytarabine;112.Cytarabine;"
"3397","76.36.1143.1","Solid Tumor","Neuro-Oncology","CNS leukemia",76,"CNS prophylaxis, local therapy",36,"IT Methotrexate monotherapy",TRUE,"Cont.","28.Methotrexate;28.Methotrexate;","28.Methotrexate;28.Methotrexate;"
"3398","76.36.1143.2","Solid Tumor","Neuro-Oncology","CNS leukemia",76,"CNS prophylaxis, local therapy",36,"IT Methotrexate monotherapy",TRUE,"Cont.","7.Methotrexate;7.Methotrexate;7.Methotrexate;7.Methotrexate;7.Methotrexate;7.Methotrexate;7.Methotrexate;7.Methotrexate;","7.Methotrexate;7.Methotrexate;"
"3399","76.36.1144.1","Solid Tumor","Neuro-Oncology","CNS leukemia",76,"CNS prophylaxis, local therapy",36,"IT Methotrexate & WBRT",FALSE,"6","7.Methotrexate;7.Methotrexate;","7.Methotrexate;7.Methotrexate;"
"3400","76.37.1145.1","Solid Tumor","Neuro-Oncology","CNS leukemia",76,"CNS prophylaxis, systemic therapy",37,"Mercaptopurine & WBRT",TRUE,"Cont.","1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;1.Mercaptopurine;","1.Mercaptopurine;1.Mercaptopurine;"
"3401","76.38.1146.1","Solid Tumor","Neuro-Oncology","CNS leukemia",76,"CNS treatment, local therapy",38,"IT Cytarabine & Methotrexate",TRUE,"Cont.","7.Cytarabine;0.Methotrexate;7.Cytarabine;0.Methotrexate;","7.Cytarabine;0.Methotrexate;"
"3402","76.38.1146.2","Solid Tumor","Neuro-Oncology","CNS leukemia",76,"CNS treatment, local therapy",38,"IT Cytarabine & Methotrexate",TRUE,"Cont.","15.Methotrexate;6.Cytarabine;15.Methotrexate;6.Cytarabine;","15.Methotrexate;6.Cytarabine;"
"3403","76.38.1147.1","Solid Tumor","Neuro-Oncology","CNS leukemia",76,"CNS treatment, local therapy",38,"IT Methotrexate monotherapy",TRUE,"Cont.","7.Methotrexate;7.Methotrexate;","7.Methotrexate;7.Methotrexate;"
"3404","77.184.1179.1","Solid Tumor","Neuro-Oncology","CNS lymphoma",77,"Relapsed or refractory, salvage therapy",184,"CYVE",FALSE,"1","0.Cytarabine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;","0.Cytarabine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;"
"3405","77.184.1179.2","Solid Tumor","Neuro-Oncology","CNS lymphoma",77,"Relapsed or refractory, salvage therapy",184,"CYVE",FALSE,"1","0.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;","0.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;"
"3406","77.184.1180.1","Solid Tumor","Neuro-Oncology","CNS lymphoma",77,"Relapsed or refractory, salvage therapy",184,"Ifosfamide & Methotrexate",TRUE,"Cont.","17.Methotrexate;2.Ifosfamide;1.Ifosfamide;1.Ifosfamide;17.Methotrexate;2.Ifosfamide;1.Ifosfamide;1.Ifosfamide;","17.Methotrexate;2.Ifosfamide;1.Ifosfamide;1.Ifosfamide;"
"3407","77.184.1180.2","Solid Tumor","Neuro-Oncology","CNS lymphoma",77,"Relapsed or refractory, salvage therapy",184,"Ifosfamide & Methotrexate",TRUE,"Cont.","24.Methotrexate;2.Ifosfamide;1.Ifosfamide;1.Ifosfamide;24.Methotrexate;2.Ifosfamide;1.Ifosfamide;1.Ifosfamide;","24.Methotrexate;2.Ifosfamide;1.Ifosfamide;1.Ifosfamide;"
"3408","77.186.1181.1","Solid Tumor","Neuro-Oncology","CNS lymphoma",77,"Relapsed or refractory, subsequent lines of therapy",186,"Rituximab monotherapy",TRUE,"Cont.","7.Rituximab;7.Rituximab;7.Rituximab;7.Rituximab;7.Rituximab;7.Rituximab;7.Rituximab;7.Rituximab;","7.Rituximab;7.Rituximab;"
"3409","77.186.1182.1","Solid Tumor","Neuro-Oncology","CNS lymphoma",77,"Relapsed or refractory, subsequent lines of therapy",186,"Temsirolimus monotherapy",TRUE,"Cont.","7.Temsirolimus;7.Temsirolimus;7.Temsirolimus;7.Temsirolimus;7.Temsirolimus;7.Temsirolimus;7.Temsirolimus;7.Temsirolimus;","7.Temsirolimus;7.Temsirolimus;"
"3410","77.186.1183.1","Solid Tumor","Neuro-Oncology","CNS lymphoma",77,"Relapsed or refractory, subsequent lines of therapy",186,"Topotecan monotherapy",TRUE,"Cont.","17.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;17.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;","17.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;"
"3411","77.213.1157.1","Solid Tumor","Neuro-Oncology","CNS lymphoma",77,"Upfront therapy, non-randomized or retrospective data",213,"Lomustine, Methotrexate, Procarbazine",FALSE,"3","16.Lomustine;0.Methotrexate;0.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;5.Methotrexate;15.Methotrexate;16.Lomustine;0.Methotrexate;0.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;5.Methotrexate;15.Methotrexate;","16.Lomustine;0.Methotrexate;0.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;5.Methotrexate;15.Methotrexate;"
"3412","77.213.1158.1","Solid Tumor","Neuro-Oncology","CNS lymphoma",77,"Upfront therapy, non-randomized or retrospective data",213,"Methotrexate, then Cytarabine",NA,NA,"0.Methotrexate;14.Methotrexate;14.Methotrexate;14.Methotrexate;14.Methotrexate;14.Cytarabine;1.Cytarabine;27.Cytarabine;1.Cytarabine;","0.Methotrexate;14.Methotrexate;14.Methotrexate;14.Methotrexate;14.Methotrexate;14.Cytarabine;1.Cytarabine;27.Cytarabine;1.Cytarabine;"
"3413","77.213.1159.1","Solid Tumor","Neuro-Oncology","CNS lymphoma",77,"Upfront therapy, non-randomized or retrospective data",213,"Methotrexate, then Cytarabine & Thiotepa",NA,NA,"0.Methotrexate;29.Cytarabine;1.Cytarabine;0.Thiotepa;","0.Methotrexate;29.Cytarabine;1.Cytarabine;0.Thiotepa;"
"3414","77.213.1159.2","Solid Tumor","Neuro-Oncology","CNS lymphoma",77,"Upfront therapy, non-randomized or retrospective data",213,"Methotrexate, then Cytarabine & Thiotepa",NA,NA,"0.Methotrexate;10.Methotrexate;11.Cytarabine;1.Cytarabine;0.Thiotepa;20.Cytarabine;1.Cytarabine;0.Thiotepa;","0.Methotrexate;10.Methotrexate;11.Cytarabine;1.Cytarabine;0.Thiotepa;20.Cytarabine;1.Cytarabine;0.Thiotepa;"
"3415","77.213.1159.3","Solid Tumor","Neuro-Oncology","CNS lymphoma",77,"Upfront therapy, non-randomized or retrospective data",213,"Methotrexate, then Cytarabine & Thiotepa",NA,NA,"0.Methotrexate;10.Methotrexate;10.Methotrexate;11.Cytarabine;1.Cytarabine;0.Thiotepa;20.Cytarabine;1.Cytarabine;0.Thiotepa;","0.Methotrexate;10.Methotrexate;10.Methotrexate;11.Cytarabine;1.Cytarabine;0.Thiotepa;20.Cytarabine;1.Cytarabine;0.Thiotepa;"
"3416","77.213.1159.4","Solid Tumor","Neuro-Oncology","CNS lymphoma",77,"Upfront therapy, non-randomized or retrospective data",213,"Methotrexate, then Cytarabine & Thiotepa",NA,NA,"0.Methotrexate;10.Methotrexate;10.Methotrexate;10.Methotrexate;11.Cytarabine;1.Cytarabine;0.Thiotepa;20.Cytarabine;1.Cytarabine;0.Thiotepa;","0.Methotrexate;10.Methotrexate;10.Methotrexate;10.Methotrexate;11.Cytarabine;1.Cytarabine;0.Thiotepa;20.Cytarabine;1.Cytarabine;0.Thiotepa;"
"3417","77.213.1160.1","Solid Tumor","Neuro-Oncology","CNS lymphoma",77,"Upfront therapy, non-randomized or retrospective data",213,"Methotrexate & Rituximab",TRUE,"Cont.","7.Methotrexate;7.Rituximab;7.Methotrexate;7.Rituximab;","7.Methotrexate;7.Rituximab;"
"3418","77.213.1161.1","Solid Tumor","Neuro-Oncology","CNS lymphoma",77,"Upfront therapy, non-randomized or retrospective data",213,"MPV",FALSE,"5","7.Methotrexate;0.Procarbazine;0.Vincristine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Methotrexate;7.Methotrexate;0.Procarbazine;0.Vincristine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Methotrexate;","7.Methotrexate;0.Procarbazine;0.Vincristine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Methotrexate;"
"3419","77.213.1162.1","Solid Tumor","Neuro-Oncology","CNS lymphoma",77,"Upfront therapy, non-randomized or retrospective data",213,"MT-R",NA,NA,"0.Rituximab;4.Methotrexate;14.Methotrexate;14.Methotrexate;14.Methotrexate;14.Methotrexate;","0.Rituximab;4.Methotrexate;14.Methotrexate;14.Methotrexate;14.Methotrexate;14.Methotrexate;"
"3420","77.213.1162.2","Solid Tumor","Neuro-Oncology","CNS lymphoma",77,"Upfront therapy, non-randomized or retrospective data",213,"MT-R",NA,NA,"0.Methotrexate;0.Rituximab;14.Methotrexate;0.Rituximab;14.Methotrexate;0.Rituximab;14.Methotrexate;0.Rituximab;14.Methotrexate;0.Rituximab;14.Methotrexate;0.Rituximab;14.Methotrexate;0.Rituximab;","0.Methotrexate;0.Rituximab;14.Methotrexate;0.Rituximab;14.Methotrexate;0.Rituximab;14.Methotrexate;0.Rituximab;14.Methotrexate;0.Rituximab;14.Methotrexate;0.Rituximab;14.Methotrexate;0.Rituximab;"
"3421","77.213.1163.1","Solid Tumor","Neuro-Oncology","CNS lymphoma",77,"Upfront therapy, non-randomized or retrospective data",213,"MVBP",TRUE,"Cont.","7.Methotrexate;1.Etoposide;1.Carmustine;12.Methotrexate;7.Methotrexate;1.Etoposide;1.Carmustine;12.Methotrexate;","7.Methotrexate;1.Etoposide;1.Carmustine;12.Methotrexate;"
"3422","77.213.1164.1","Solid Tumor","Neuro-Oncology","CNS lymphoma",77,"Upfront therapy, non-randomized or retrospective data",213,"Nordic Regimen, older patients",NA,NA,"0.Methotrexate;0.Rituximab;1.Cytarabineliposomal;0.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;17.Methotrexate;1.Cyclophosphamide;0.Cytarabineliposomal;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;16.Cytarabine;0.Vindesine;1.Cytarabine;20.Methotrexate;1.Cytarabineliposomal;20.Methotrexate;1.Cyclophosphamide;0.Cytarabineliposomal;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;16.Cytarabine;0.Vindesine;1.Cytarabine;","0.Methotrexate;0.Rituximab;1.Cytarabineliposomal;0.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;17.Methotrexate;1.Cyclophosphamide;0.Cytarabineliposomal;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;16.Cytarabine;0.Vindesine;1.Cytarabine;20.Methotrexate;1.Cytarabineliposomal;20.Methotrexate;1.Cyclophosphamide;0.Cytarabineliposomal;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;1.Cyclophosphamide;16.Cytarabine;0.Vindesine;1.Cytarabine;"
"3423","77.213.1165.1","Solid Tumor","Neuro-Oncology","CNS lymphoma",77,"Upfront therapy, non-randomized or retrospective data",213,"Nordic Regimen, younger patients",NA,NA,"0.Methotrexate;0.Rituximab;0.Vincristine;1.Cyclophosphamide;0.Cytarabineliposomal;0.Ifosfamide;1.Cyclophosphamide;0.Ifosfamide;1.Cyclophosphamide;0.Ifosfamide;1.Cyclophosphamide;0.Ifosfamide;17.Methotrexate;1.Cytarabineliposomal;20.Cytarabine;0.Vindesine;1.Cytarabine;20.Methotrexate;0.Vincristine;1.Cyclophosphamide;0.Cytarabineliposomal;0.Ifosfamide;1.Cyclophosphamide;0.Ifosfamide;1.Cyclophosphamide;0.Ifosfamide;1.Cyclophosphamide;0.Ifosfamide;17.Methotrexate;1.Cytarabineliposomal;20.Cytarabine;0.Vindesine;1.Cytarabine;","0.Methotrexate;0.Rituximab;0.Vincristine;1.Cyclophosphamide;0.Cytarabineliposomal;0.Ifosfamide;1.Cyclophosphamide;0.Ifosfamide;1.Cyclophosphamide;0.Ifosfamide;1.Cyclophosphamide;0.Ifosfamide;17.Methotrexate;1.Cytarabineliposomal;20.Cytarabine;0.Vindesine;1.Cytarabine;20.Methotrexate;0.Vincristine;1.Cyclophosphamide;0.Cytarabineliposomal;0.Ifosfamide;1.Cyclophosphamide;0.Ifosfamide;1.Cyclophosphamide;0.Ifosfamide;1.Cyclophosphamide;0.Ifosfamide;17.Methotrexate;1.Cytarabineliposomal;20.Cytarabine;0.Vindesine;1.Cytarabine;"
"3424","77.213.1166.1","Solid Tumor","Neuro-Oncology","CNS lymphoma",77,"Upfront therapy, non-randomized or retrospective data",213,"R-MCP (CCNU)",TRUE,"Cont.","14.Rituximab;7.Rituximab;1.Lomustine;0.Methotrexate;0.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;4.Rituximab;1.Methotrexate;13.Rituximab;1.Methotrexate;14.Rituximab;7.Rituximab;1.Lomustine;0.Methotrexate;0.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;4.Rituximab;1.Methotrexate;13.Rituximab;1.Methotrexate;","14.Rituximab;7.Rituximab;1.Lomustine;0.Methotrexate;0.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;4.Rituximab;1.Methotrexate;13.Rituximab;1.Methotrexate;"
"3425","77.213.1167.1","Solid Tumor","Neuro-Oncology","CNS lymphoma",77,"Upfront therapy, non-randomized or retrospective data",213,"R-MP",NA,NA,"0.Rituximab;50.Rituximab;1.Methotrexate;0.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;36.Rituximab;1.Methotrexate;0.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;","0.Rituximab;50.Rituximab;1.Methotrexate;0.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;36.Rituximab;1.Methotrexate;0.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;"
"3426","77.213.1168.1","Solid Tumor","Neuro-Oncology","CNS lymphoma",77,"Upfront therapy, non-randomized or retrospective data",213,"R-MPV",TRUE,"Cont.","7.Procarbazine;0.Rituximab;1.Methotrexate;0.Procarbazine;0.Vincristine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Methotrexate;7.Procarbazine;0.Rituximab;1.Methotrexate;0.Procarbazine;0.Vincristine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Methotrexate;","7.Procarbazine;0.Rituximab;1.Methotrexate;0.Procarbazine;0.Vincristine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Methotrexate;"
"3427","77.214.1152.1","Solid Tumor","Neuro-Oncology","CNS lymphoma",77,"Upfront therapy, randomized data",214,"Cytarabine & Methotrexate (CYM)",FALSE,"4","19.Methotrexate;1.Cytarabine;1.Cytarabine;19.Methotrexate;1.Cytarabine;1.Cytarabine;","19.Methotrexate;1.Cytarabine;1.Cytarabine;"
"3428","77.214.1153.1","Solid Tumor","Neuro-Oncology","CNS lymphoma",77,"Upfront therapy, randomized data",214,"Cytarabine, Methotrexate, Rituximab",FALSE,"4","13.Rituximab;5.Rituximab;1.Methotrexate;1.Cytarabine;1.Cytarabine;13.Rituximab;5.Rituximab;1.Methotrexate;1.Cytarabine;1.Cytarabine;","13.Rituximab;5.Rituximab;1.Methotrexate;1.Cytarabine;1.Cytarabine;"
"3429","77.214.1154.1","Solid Tumor","Neuro-Oncology","CNS lymphoma",77,"Upfront therapy, randomized data",214,"MATRix",FALSE,"4","12.Rituximab;5.Rituximab;1.Methotrexate;1.Cytarabine;1.Cytarabine;1.Thiotepa;12.Rituximab;5.Rituximab;1.Methotrexate;1.Cytarabine;1.Cytarabine;1.Thiotepa;","12.Rituximab;5.Rituximab;1.Methotrexate;1.Cytarabine;1.Cytarabine;1.Thiotepa;"
"3430","77.214.1155.1","Solid Tumor","Neuro-Oncology","CNS lymphoma",77,"Upfront therapy, randomized data",214,"MBVP",FALSE,"2","14.Methotrexate;1.Teniposide;1.Teniposide;1.Carmustine;11.Methotrexate;","14.Methotrexate;1.Teniposide;1.Teniposide;1.Carmustine;11.Methotrexate;"
"3431","77.214.1156.1","Solid Tumor","Neuro-Oncology","CNS lymphoma",77,"Upfront therapy, randomized data",214,"Methotrexate monotherapy",FALSE,"4","21.Methotrexate;21.Methotrexate;","21.Methotrexate;21.Methotrexate;"
"3432","77.214.1156.2","Solid Tumor","Neuro-Oncology","CNS lymphoma",77,"Upfront therapy, randomized data",214,"Methotrexate monotherapy",FALSE,"4","14.Methotrexate;14.Methotrexate;","14.Methotrexate;14.Methotrexate;"
"3433","77.214.1156.3","Solid Tumor","Neuro-Oncology","CNS lymphoma",77,"Upfront therapy, randomized data",214,"Methotrexate monotherapy",FALSE,"1","0.Methotrexate;9.Methotrexate;","0.Methotrexate;9.Methotrexate;"
"3434","77.37.1148.1","Solid Tumor","Neuro-Oncology","CNS lymphoma",77,"CNS prophylaxis, systemic therapy",37,"High-dose Cytarabine monotherapy (HiDAC)",FALSE,"1","0.Cytarabine;1.Cytarabine;","0.Cytarabine;1.Cytarabine;"
"3435","77.37.1149.1","Solid Tumor","Neuro-Oncology","CNS lymphoma",77,"CNS prophylaxis, systemic therapy",37,"Methotrexate monotherapy",FALSE,"1","0.Methotrexate;1.Methotrexate;","0.Methotrexate;1.Methotrexate;"
"3436","77.38.1150.1","Solid Tumor","Neuro-Oncology","CNS lymphoma",77,"CNS treatment, local therapy",38,"IT Cytarabine monotherapy",FALSE,"1","0.Cytarabine;3.Cytarabine;4.Cytarabine;3.Cytarabine;4.Cytarabine;3.Cytarabine;4.Cytarabine;3.Cytarabine;","0.Cytarabine;3.Cytarabine;4.Cytarabine;3.Cytarabine;4.Cytarabine;3.Cytarabine;4.Cytarabine;3.Cytarabine;"
"3437","77.38.1151.1","Solid Tumor","Neuro-Oncology","CNS lymphoma",77,"CNS treatment, local therapy",38,"IT Cytarabine liposomal monotherapy",FALSE,"2","14.Cytarabineliposomal;","14.Cytarabineliposomal;14.Cytarabineliposomal;"
"3438","77.48.1169.1","Solid Tumor","Neuro-Oncology","CNS lymphoma",77,"Consolidation and/or maintenance after upfront therapy",48,"BCNU/TT, then auto HSCT",FALSE,"1","0.Carmustine;1.Thiotepa;1.Thiotepa;9.Granulocytecolony-stimulatingfactor;","0.Carmustine;1.Thiotepa;1.Thiotepa;9.Granulocytecolony-stimulatingfactor;"
"3439","77.48.1169.2","Solid Tumor","Neuro-Oncology","CNS lymphoma",77,"Consolidation and/or maintenance after upfront therapy",48,"BCNU/TT, then auto HSCT",FALSE,"1","0.Carmustine;1.Thiotepa;1.Thiotepa;","0.Carmustine;1.Thiotepa;1.Thiotepa;"
"3440","77.48.1170.1","Solid Tumor","Neuro-Oncology","CNS lymphoma",77,"Consolidation and/or maintenance after upfront therapy",48,"BEAM, then auto HSCT",FALSE,"1","0.Carmustine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Melphalan;","0.Carmustine;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Melphalan;"
"3441","77.48.1171.1","Solid Tumor","Neuro-Oncology","CNS lymphoma",77,"Consolidation and/or maintenance after upfront therapy",48,"Bu/TT, then auto HSCT",FALSE,"1","0.Bisulfan;1.Bisulfan;1.Bisulfan;1.Bisulfan;1.Thiotepa;1.Thiotepa;","0.Bisulfan;1.Bisulfan;1.Bisulfan;1.Bisulfan;1.Thiotepa;1.Thiotepa;"
"3442","77.48.1172.1","Solid Tumor","Neuro-Oncology","CNS lymphoma",77,"Consolidation and/or maintenance after upfront therapy",48,"Bu/TT/Cy, then auto HSCT",FALSE,"1","0.Thiotepa;1.Thiotepa;1.Thiotepa;1.Busulfan;1.Busulfan;1.Busulfan;1.Cyclophosphamide;1.Cyclophosphamide;","0.Thiotepa;1.Thiotepa;1.Thiotepa;1.Busulfan;1.Busulfan;1.Busulfan;1.Cyclophosphamide;1.Cyclophosphamide;"
"3443","77.48.1173.1","Solid Tumor","Neuro-Oncology","CNS lymphoma",77,"Consolidation and/or maintenance after upfront therapy",48,"High-dose Cytarabine monotherapy (HiDAC)",FALSE,"2","20.Cytarabine;1.Cytarabine;","20.Cytarabine;1.Cytarabine;"
"3444","77.48.1174.1","Solid Tumor","Neuro-Oncology","CNS lymphoma",77,"Consolidation and/or maintenance after upfront therapy",48,"CYVE",FALSE,"1","0.Cytarabine;0.Etoposide;1.Cytarabine;1.Cytarabine;1.Cytarabine;","0.Cytarabine;0.Etoposide;1.Cytarabine;1.Cytarabine;1.Cytarabine;"
"3445","77.48.1174.2","Solid Tumor","Neuro-Oncology","CNS lymphoma",77,"Consolidation and/or maintenance after upfront therapy",48,"CYVE",FALSE,"1","0.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;","0.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;1.Cytarabine;0.Etoposide;"
"3446","77.48.1175.1","Solid Tumor","Neuro-Oncology","CNS lymphoma",77,"Consolidation and/or maintenance after upfront therapy",48,"Lomustine, Methotrexate, Procarbazine",FALSE,"5","36.Lomustine;0.Methotrexate;0.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;36.Lomustine;0.Methotrexate;0.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;","36.Lomustine;0.Methotrexate;0.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;"
"3447","77.48.1176.1","Solid Tumor","Neuro-Oncology","CNS lymphoma",77,"Consolidation and/or maintenance after upfront therapy",48,"Methotrexate monotherapy",TRUE,"Cont.","28.Methotrexate;28.Methotrexate;","28.Methotrexate;28.Methotrexate;"
"3448","77.48.1177.1","Solid Tumor","Neuro-Oncology","CNS lymphoma",77,"Consolidation and/or maintenance after upfront therapy",48,"Procarbazine monotherapy",FALSE,"6","24.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;24.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;","24.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;1.Procarbazine;"
"3449","77.48.1178.1","Solid Tumor","Neuro-Oncology","CNS lymphoma",77,"Consolidation and/or maintenance after upfront therapy",48,"Temozolomide monotherapy",TRUE,"Cont.","3.Temozolomide;0.Temozolomide;1.Temozolomide;0.Temozolomide;1.Temozolomide;0.Temozolomide;1.Temozolomide;0.Temozolomide;1.Temozolomide;0.Temozolomide;3.Temozolomide;0.Temozolomide;1.Temozolomide;0.Temozolomide;1.Temozolomide;0.Temozolomide;1.Temozolomide;0.Temozolomide;1.Temozolomide;0.Temozolomide;","3.Temozolomide;0.Temozolomide;1.Temozolomide;0.Temozolomide;1.Temozolomide;0.Temozolomide;1.Temozolomide;0.Temozolomide;1.Temozolomide;0.Temozolomide;"
"3450","78.31.1184.1","Solid Tumor","Neuro-Oncology","CNS melanoma",78,"All lines of therapy",31,"Dabrafenib monotherapy",TRUE,"Cont.","1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;1.Dabrafenib;","1.Dabrafenib;1.Dabrafenib;"
"3451","78.31.1185.1","Solid Tumor","Neuro-Oncology","CNS melanoma",78,"All lines of therapy",31,"Dabrafenib & Trametinib",TRUE,"Cont.","1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;","1.Dabrafenib;0.Trametinib;"
"3452","78.31.1186.1","Solid Tumor","Neuro-Oncology","CNS melanoma",78,"All lines of therapy",31,"Fotemustine monotherapy",TRUE,"Cont.","1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;1.Fotemustine;","1.Fotemustine;1.Fotemustine;"
"3453","78.31.1187.1","Solid Tumor","Neuro-Oncology","CNS melanoma",78,"All lines of therapy",31,"Ipilimumab & Nivolumab",TRUE,"Cont.","21.Ipilimumab;0.Nivolumab;21.Ipilimumab;0.Nivolumab;","21.Ipilimumab;0.Nivolumab;"
"3454","78.31.1188.1","Solid Tumor","Neuro-Oncology","CNS melanoma",78,"All lines of therapy",31,"Nivolumab monotherapy",TRUE,"Cont.","14.Nivolumab;14.Nivolumab;","14.Nivolumab;14.Nivolumab;"
"3455","78.31.1189.1","Solid Tumor","Neuro-Oncology","CNS melanoma",78,"All lines of therapy",31,"Vemurafenib monotherapy",TRUE,"Cont.","1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;1.Vemurafenib;","1.Vemurafenib;1.Vemurafenib;"
"3456","8.147.343.1","Solid Tumor","Dermatologic Oncology","Cutaneous BCC",8,"Neoadjuvant chemotherapy",147,"Bleomycin & Cisplatin",FALSE,"3","18.Bleomycin;0.Cisplatin;1.Bleomycin;0.Cisplatin;1.Bleomycin;0.Cisplatin;1.Bleomycin;0.Cisplatin;18.Bleomycin;0.Cisplatin;1.Bleomycin;0.Cisplatin;1.Bleomycin;0.Cisplatin;1.Bleomycin;0.Cisplatin;","18.Bleomycin;0.Cisplatin;1.Bleomycin;0.Cisplatin;1.Bleomycin;0.Cisplatin;1.Bleomycin;0.Cisplatin;"
"3457","8.15.344.1","Solid Tumor","Dermatologic Oncology","Cutaneous BCC",8,"Advanced or metastatic disease, all lines of therapy",15,"Cemiplimab monotherapy",TRUE,"Cont.","21.Cemiplimab;21.Cemiplimab;","21.Cemiplimab;21.Cemiplimab;"
"3458","8.15.345.1","Solid Tumor","Dermatologic Oncology","Cutaneous BCC",8,"Advanced or metastatic disease, all lines of therapy",15,"Cisplatin & Doxorubicin",TRUE,"Cont.","21.Cisplatin;0.Doxorubicin;21.Cisplatin;0.Doxorubicin;","21.Cisplatin;0.Doxorubicin;"
"3459","8.15.346.1","Solid Tumor","Dermatologic Oncology","Cutaneous BCC",8,"Advanced or metastatic disease, all lines of therapy",15,"Cisplatin & Paclitaxel",TRUE,"Cont.","21.Cisplatin;0.Paclitaxel;21.Cisplatin;0.Paclitaxel;","21.Cisplatin;0.Paclitaxel;"
"3460","8.15.347.1","Solid Tumor","Dermatologic Oncology","Cutaneous BCC",8,"Advanced or metastatic disease, all lines of therapy",15,"Sonidegib monotherapy",TRUE,"Cont.","1.Sonidegib;1.Sonidegib;1.Sonidegib;1.Sonidegib;1.Sonidegib;1.Sonidegib;1.Sonidegib;1.Sonidegib;1.Sonidegib;1.Sonidegib;1.Sonidegib;1.Sonidegib;1.Sonidegib;1.Sonidegib;","1.Sonidegib;1.Sonidegib;"
"3461","8.15.348.1","Solid Tumor","Dermatologic Oncology","Cutaneous BCC",8,"Advanced or metastatic disease, all lines of therapy",15,"Vismodegib monotherapy",TRUE,"Cont.","1.Vismodegib;1.Vismodegib;1.Vismodegib;1.Vismodegib;1.Vismodegib;1.Vismodegib;1.Vismodegib;1.Vismodegib;1.Vismodegib;1.Vismodegib;1.Vismodegib;1.Vismodegib;1.Vismodegib;1.Vismodegib;","1.Vismodegib;1.Vismodegib;"
"3462","80.31.1190.1","Solid Tumor","Sarcoma","Desmoid tumor",80,"All lines of therapy",31,"Imatinib monotherapy",TRUE,"Cont.","1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;1.Imatinib;","1.Imatinib;1.Imatinib;"
"3463","80.31.1191.1","Solid Tumor","Sarcoma","Desmoid tumor",80,"All lines of therapy",31,"Methotrexate & Vinblastine",TRUE,"Cont.","7.Methotrexate;0.Vinblastine;7.Methotrexate;0.Vinblastine;","7.Methotrexate;0.Vinblastine;"
"3464","80.31.1191.2","Solid Tumor","Sarcoma","Desmoid tumor",80,"All lines of therapy",31,"Methotrexate & Vinblastine",TRUE,"Cont.","14.Methotrexate;0.Vinblastine;14.Methotrexate;0.Vinblastine;","14.Methotrexate;0.Vinblastine;"
"3465","80.31.1192.1","Solid Tumor","Sarcoma","Desmoid tumor",80,"All lines of therapy",31,"Pazopanib monotherapy",TRUE,"Cont.","1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;1.Pazopanib;","1.Pazopanib;1.Pazopanib;"
"3466","80.31.1193.1","Solid Tumor","Sarcoma","Desmoid tumor",80,"All lines of therapy",31,"Pegylated liposomal doxorubicin monotherapy",TRUE,"Cont.","28.Pegylatedliposomaldoxorubicin;28.Pegylatedliposomaldoxorubicin;","28.Pegylatedliposomaldoxorubicin;28.Pegylatedliposomaldoxorubicin;"
"3467","80.31.1194.1","Solid Tumor","Sarcoma","Desmoid tumor",80,"All lines of therapy",31,"Sorafenib monotherapy",TRUE,"Cont.","1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;","1.Sorafenib;1.Sorafenib;"
"3468","81.31.1195.1","Solid Tumor","Sarcoma","Epithelioid sarcoma",81,"All lines of therapy",31,"Tazemetostat monotherapy",TRUE,"Cont.","1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;1.Tazemetostat;","1.Tazemetostat;1.Tazemetostat;"
"3469","82.153.1196.1","Solid Tumor","Sarcoma","Ewing sarcoma",82,"Neoadjuvant therapy",153,"EVAIA",FALSE,"4","17.Dactinomycin;0.Etoposide;0.Ifosfamide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Ifosfamide;1.Dactinomycin;0.Etoposide;0.Ifosfamide;1.Doxorubicin;1.Dactinomycin;17.Dactinomycin;0.Etoposide;0.Ifosfamide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Ifosfamide;1.Dactinomycin;0.Etoposide;0.Ifosfamide;1.Doxorubicin;1.Dactinomycin;","17.Dactinomycin;0.Etoposide;0.Ifosfamide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Ifosfamide;1.Dactinomycin;0.Etoposide;0.Ifosfamide;1.Doxorubicin;1.Dactinomycin;"
"3470","82.153.1197.1","Solid Tumor","Sarcoma","Ewing sarcoma",82,"Neoadjuvant therapy",153,"VACA",TRUE,"Cont.","21.Cyclophosphamide;0.Dactinomycin;0.Doxorubicin;0.Vincristine;21.Cyclophosphamide;0.Dactinomycin;0.Doxorubicin;0.Vincristine;","21.Cyclophosphamide;0.Dactinomycin;0.Doxorubicin;0.Vincristine;"
"3471","82.153.1197.2","Solid Tumor","Sarcoma","Ewing sarcoma",82,"Neoadjuvant therapy",153,"VACA",FALSE,"1","0.Doxorubicin;0.Vincristine;1.Doxorubicin;6.Vincristine;7.Vincristine;7.Cyclophosphamide;0.Dactinomycin;0.Vincristine;1.Cyclophosphamide;0.Dactinomycin;1.Cyclophosphamide;0.Dactinomycin;19.Cyclophosphamide;0.Doxorubicin;1.Doxorubicin;","0.Doxorubicin;0.Vincristine;1.Doxorubicin;6.Vincristine;7.Vincristine;7.Cyclophosphamide;0.Dactinomycin;0.Vincristine;1.Cyclophosphamide;0.Dactinomycin;1.Cyclophosphamide;0.Dactinomycin;19.Cyclophosphamide;0.Doxorubicin;1.Doxorubicin;"
"3472","82.153.1198.1","Solid Tumor","Sarcoma","Ewing sarcoma",82,"Neoadjuvant therapy",153,"VACA/IE",NA,NA,"0.Cyclophosphamide;0.Dactinomycin;0.Doxorubicin;0.Vincristine;21.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Dactinomycin;0.Doxorubicin;0.Vincristine;21.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Dactinomycin;0.Doxorubicin;0.Vincristine;21.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Dactinomycin;0.Doxorubicin;0.Vincristine;21.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Dactinomycin;0.Doxorubicin;0.Vincristine;","0.Cyclophosphamide;0.Dactinomycin;0.Doxorubicin;0.Vincristine;21.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Dactinomycin;0.Doxorubicin;0.Vincristine;21.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Dactinomycin;0.Doxorubicin;0.Vincristine;21.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Dactinomycin;0.Doxorubicin;0.Vincristine;21.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Dactinomycin;0.Doxorubicin;0.Vincristine;"
"3473","82.153.1198.2","Solid Tumor","Sarcoma","Ewing sarcoma",82,"Neoadjuvant therapy",153,"VACA/IE",NA,NA,"0.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Dactinomycin;0.Doxorubicin;0.Vincristine;21.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Dactinomycin;0.Doxorubicin;0.Vincristine;21.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Dactinomycin;0.Doxorubicin;0.Vincristine;21.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Dactinomycin;0.Doxorubicin;0.Vincristine;21.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;","0.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Dactinomycin;0.Doxorubicin;0.Vincristine;21.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Dactinomycin;0.Doxorubicin;0.Vincristine;21.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Dactinomycin;0.Doxorubicin;0.Vincristine;21.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Dactinomycin;0.Doxorubicin;0.Vincristine;21.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;"
"3474","82.153.1199.1","Solid Tumor","Sarcoma","Ewing sarcoma",82,"Neoadjuvant therapy",153,"VAIA",FALSE,"4","17.Dactinomycin;0.Ifosfamide;0.Vincristine;1.Doxorubicin;0.Ifosfamide;1.Dactinomycin;0.Ifosfamide;1.Doxorubicin;1.Dactinomycin;17.Dactinomycin;0.Ifosfamide;0.Vincristine;1.Doxorubicin;0.Ifosfamide;1.Dactinomycin;0.Ifosfamide;1.Doxorubicin;1.Dactinomycin;","17.Dactinomycin;0.Ifosfamide;0.Vincristine;1.Doxorubicin;0.Ifosfamide;1.Dactinomycin;0.Ifosfamide;1.Doxorubicin;1.Dactinomycin;"
"3475","82.153.1199.2","Solid Tumor","Sarcoma","Ewing sarcoma",82,"Neoadjuvant therapy",153,"VAIA",FALSE,"1","0.Doxorubicin;0.Ifosfamide;0.Vincristine;1.Doxorubicin;0.Ifosfamide;6.Vincristine;7.Vincristine;7.Dactinomycin;0.Ifosfamide;0.Vincristine;1.Dactinomycin;0.Ifosfamide;1.Dactinomycin;19.Doxorubicin;0.Ifosfamide;1.Doxorubicin;0.Ifosfamide;","0.Doxorubicin;0.Ifosfamide;0.Vincristine;1.Doxorubicin;0.Ifosfamide;6.Vincristine;7.Vincristine;7.Dactinomycin;0.Ifosfamide;0.Vincristine;1.Dactinomycin;0.Ifosfamide;1.Dactinomycin;19.Doxorubicin;0.Ifosfamide;1.Doxorubicin;0.Ifosfamide;"
"3476","82.153.1200.1","Solid Tumor","Sarcoma","Ewing sarcoma",82,"Neoadjuvant therapy",153,"VDC/IE",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Doxorubicin;13.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;10.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Doxorubicin;13.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;10.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Doxorubicin;13.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;","0.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Doxorubicin;13.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;10.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Doxorubicin;13.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;10.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Doxorubicin;13.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;"
"3477","82.153.1200.2","Solid Tumor","Sarcoma","Ewing sarcoma",82,"Neoadjuvant therapy",153,"VDC/IE",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Doxorubicin;13.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;10.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Doxorubicin;13.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;10.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Doxorubicin;13.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;","0.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Doxorubicin;13.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;10.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Doxorubicin;13.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;10.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Doxorubicin;13.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;"
"3478","82.153.1200.3","Solid Tumor","Sarcoma","Ewing sarcoma",82,"Neoadjuvant therapy",153,"VDC/IE",NA,NA,"0.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Doxorubicin;13.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;10.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Doxorubicin;13.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;","0.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Doxorubicin;13.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;10.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Doxorubicin;13.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;"
"3479","82.153.1201.1","Solid Tumor","Sarcoma","Ewing sarcoma",82,"Neoadjuvant therapy",153,"VIDE",FALSE,"6","19.Doxorubicin;0.Etoposide;0.Ifosfamide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Ifosfamide;1.Doxorubicin;0.Etoposide;0.Ifosfamide;19.Doxorubicin;0.Etoposide;0.Ifosfamide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Ifosfamide;1.Doxorubicin;0.Etoposide;0.Ifosfamide;","19.Doxorubicin;0.Etoposide;0.Ifosfamide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Ifosfamide;1.Doxorubicin;0.Etoposide;0.Ifosfamide;"
"3480","82.175.1207.1","Solid Tumor","Sarcoma","Ewing sarcoma",82,"Relapsed or refractory or metastatic",175,"Cyclophosphamide & Topotecan",TRUE,"Cont.","17.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;17.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;","17.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;"
"3481","82.175.1207.2","Solid Tumor","Sarcoma","Ewing sarcoma",82,"Relapsed or refractory or metastatic",175,"Cyclophosphamide & Topotecan",TRUE,"Cont.","21.Cyclophosphamide;0.Topotecan;21.Cyclophosphamide;0.Topotecan;","21.Cyclophosphamide;0.Topotecan;"
"3482","82.175.1207.3","Solid Tumor","Sarcoma","Ewing sarcoma",82,"Relapsed or refractory or metastatic",175,"Cyclophosphamide & Topotecan",TRUE,"Cont.","18.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Topotecan;18.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Topotecan;","18.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Topotecan;"
"3483","82.175.1208.1","Solid Tumor","Sarcoma","Ewing sarcoma",82,"Relapsed or refractory or metastatic",175,"Docetaxel & Gemcitabine",TRUE,"Cont.","14.Gemcitabine;7.Docetaxel;0.Gemcitabine;14.Gemcitabine;7.Docetaxel;0.Gemcitabine;","14.Gemcitabine;7.Docetaxel;0.Gemcitabine;"
"3484","82.175.1209.1","Solid Tumor","Sarcoma","Ewing sarcoma",82,"Relapsed or refractory or metastatic",175,"ICE",TRUE,"Cont.","17.Carboplatin;0.Etoposide;0.Ifosfamide;1.Carboplatin;0.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Carboplatin;0.Etoposide;0.Ifosfamide;1.Carboplatin;0.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;","17.Carboplatin;0.Etoposide;0.Ifosfamide;1.Carboplatin;0.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;"
"3485","82.175.1210.1","Solid Tumor","Sarcoma","Ewing sarcoma",82,"Relapsed or refractory or metastatic",175,"IE",FALSE,"12","17.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;","17.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;"
"3486","82.175.1211.1","Solid Tumor","Sarcoma","Ewing sarcoma",82,"Relapsed or refractory or metastatic",175,"Irinotecan & Temozolomide",TRUE,"Cont.","17.Irinotecan;0.Temozolomide;1.Irinotecan;0.Temozolomide;1.Irinotecan;0.Temozolomide;1.Irinotecan;0.Temozolomide;1.Irinotecan;0.Temozolomide;3.Irinotecan;1.Irinotecan;1.Irinotecan;1.Irinotecan;1.Irinotecan;17.Irinotecan;0.Temozolomide;1.Irinotecan;0.Temozolomide;1.Irinotecan;0.Temozolomide;1.Irinotecan;0.Temozolomide;1.Irinotecan;0.Temozolomide;3.Irinotecan;1.Irinotecan;1.Irinotecan;1.Irinotecan;1.Irinotecan;","17.Irinotecan;0.Temozolomide;1.Irinotecan;0.Temozolomide;1.Irinotecan;0.Temozolomide;1.Irinotecan;0.Temozolomide;1.Irinotecan;0.Temozolomide;3.Irinotecan;1.Irinotecan;1.Irinotecan;1.Irinotecan;1.Irinotecan;"
"3487","82.175.1212.1","Solid Tumor","Sarcoma","Ewing sarcoma",82,"Relapsed or refractory or metastatic",175,"TC, then IE, VDoxoC, VEC",NA,NA,"0.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;17.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;17.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Cyclophosphamide;20.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Cyclophosphamide;20.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Cyclophosphamide;","0.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;17.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;17.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Cyclophosphamide;20.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Cyclophosphamide;20.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Cyclophosphamide;"
"3488","82.175.1212.2","Solid Tumor","Sarcoma","Ewing sarcoma",82,"Relapsed or refractory or metastatic",175,"TC, then IE, VDoxoC, VEC",NA,NA,"0.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;17.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;17.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;1.Doxorubicin;19.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;1.Doxorubicin;19.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;1.Doxorubicin;","0.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;17.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;1.Cyclophosphamide;0.Topotecan;17.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;1.Doxorubicin;19.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;1.Doxorubicin;19.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Cyclophosphamide;0.Doxorubicin;1.Doxorubicin;"
"3489","82.175.1213.1","Solid Tumor","Sarcoma","Ewing sarcoma",82,"Relapsed or refractory or metastatic",175,"VAdCA",TRUE,"Cont.","21.Cyclophosphamide;0.Dactinomycin;0.Doxorubicin;0.Vincristine;21.Cyclophosphamide;0.Dactinomycin;0.Doxorubicin;0.Vincristine;","21.Cyclophosphamide;0.Dactinomycin;0.Doxorubicin;0.Vincristine;"
"3490","82.175.1214.1","Solid Tumor","Sarcoma","Ewing sarcoma",82,"Relapsed or refractory or metastatic",175,"VAdCA/IE",NA,NA,"0.Cyclophosphamide;0.Dactinomycin;0.Doxorubicin;0.Vincristine;21.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Dactinomycin;0.Doxorubicin;0.Vincristine;21.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Dactinomycin;0.Doxorubicin;0.Vincristine;21.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Dactinomycin;0.Doxorubicin;0.Vincristine;21.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Dactinomycin;0.Doxorubicin;0.Vincristine;","0.Cyclophosphamide;0.Dactinomycin;0.Doxorubicin;0.Vincristine;21.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Dactinomycin;0.Doxorubicin;0.Vincristine;21.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Dactinomycin;0.Doxorubicin;0.Vincristine;21.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Dactinomycin;0.Doxorubicin;0.Vincristine;21.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Dactinomycin;0.Doxorubicin;0.Vincristine;"
"3491","82.175.1214.2","Solid Tumor","Sarcoma","Ewing sarcoma",82,"Relapsed or refractory or metastatic",175,"VAdCA/IE",NA,NA,"0.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Dactinomycin;0.Doxorubicin;0.Vincristine;21.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Dactinomycin;0.Doxorubicin;0.Vincristine;21.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Dactinomycin;0.Doxorubicin;0.Vincristine;21.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Dactinomycin;0.Doxorubicin;0.Vincristine;21.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;","0.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Dactinomycin;0.Doxorubicin;0.Vincristine;21.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Dactinomycin;0.Doxorubicin;0.Vincristine;21.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Dactinomycin;0.Doxorubicin;0.Vincristine;21.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;17.Cyclophosphamide;0.Dactinomycin;0.Doxorubicin;0.Vincristine;21.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;"
"3492","82.175.1215.1","Solid Tumor","Sarcoma","Ewing sarcoma",82,"Relapsed or refractory or metastatic",175,"VIDE",TRUE,"Cont.","19.Doxorubicin;0.Etoposide;0.Ifosfamide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Ifosfamide;1.Doxorubicin;0.Etoposide;0.Ifosfamide;19.Doxorubicin;0.Etoposide;0.Ifosfamide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Ifosfamide;1.Doxorubicin;0.Etoposide;0.Ifosfamide;","19.Doxorubicin;0.Etoposide;0.Ifosfamide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Ifosfamide;1.Doxorubicin;0.Etoposide;0.Ifosfamide;"
"3493","82.4.1202.1","Solid Tumor","Sarcoma","Ewing sarcoma",82,"Adjuvant therapy",4,"Busulfan & Melphalan, then auto HSCT",FALSE,"1","0.Busulfan;1.Busulfan;1.Busulfan;1.Busulfan;1.Melphalan;","0.Busulfan;1.Busulfan;1.Busulfan;1.Busulfan;1.Melphalan;"
"3494","82.4.1203.1","Solid Tumor","Sarcoma","Ewing sarcoma",82,"Adjuvant therapy",4,"EVAIA",TRUE,"Cont.","17.Dactinomycin;0.Etoposide;0.Ifosfamide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Ifosfamide;1.Dactinomycin;0.Etoposide;0.Ifosfamide;1.Doxorubicin;1.Dactinomycin;17.Dactinomycin;0.Etoposide;0.Ifosfamide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Ifosfamide;1.Dactinomycin;0.Etoposide;0.Ifosfamide;1.Doxorubicin;1.Dactinomycin;","17.Dactinomycin;0.Etoposide;0.Ifosfamide;0.Vincristine;1.Doxorubicin;0.Etoposide;0.Ifosfamide;1.Dactinomycin;0.Etoposide;0.Ifosfamide;1.Doxorubicin;1.Dactinomycin;"
"3495","82.4.1204.1","Solid Tumor","Sarcoma","Ewing sarcoma",82,"Adjuvant therapy",4,"VACA",TRUE,"Cont.","17.Cyclophosphamide;0.Dactinomycin;0.Vincristine;1.Doxorubicin;1.Dactinomycin;1.Doxorubicin;1.Dactinomycin;17.Cyclophosphamide;0.Dactinomycin;0.Vincristine;1.Doxorubicin;1.Dactinomycin;1.Doxorubicin;1.Dactinomycin;","17.Cyclophosphamide;0.Dactinomycin;0.Vincristine;1.Doxorubicin;1.Dactinomycin;1.Doxorubicin;1.Dactinomycin;"
"3496","82.4.1204.2","Solid Tumor","Sarcoma","Ewing sarcoma",82,"Adjuvant therapy",4,"VACA",TRUE,"Cont.","20.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Doxorubicin;6.Vincristine;7.Vincristine;7.Cyclophosphamide;0.Dactinomycin;0.Vincristine;1.Cyclophosphamide;0.Dactinomycin;1.Cyclophosphamide;0.Dactinomycin;19.Cyclophosphamide;0.Doxorubicin;1.Doxorubicin;20.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Doxorubicin;6.Vincristine;7.Vincristine;7.Cyclophosphamide;0.Dactinomycin;0.Vincristine;1.Cyclophosphamide;0.Dactinomycin;1.Cyclophosphamide;0.Dactinomycin;19.Cyclophosphamide;0.Doxorubicin;1.Doxorubicin;","20.Cyclophosphamide;0.Doxorubicin;0.Vincristine;1.Doxorubicin;6.Vincristine;7.Vincristine;7.Cyclophosphamide;0.Dactinomycin;0.Vincristine;1.Cyclophosphamide;0.Dactinomycin;1.Cyclophosphamide;0.Dactinomycin;19.Cyclophosphamide;0.Doxorubicin;1.Doxorubicin;"
"3497","82.4.1205.1","Solid Tumor","Sarcoma","Ewing sarcoma",82,"Adjuvant therapy",4,"VAI",TRUE,"Cont.","20.Dactinomycin;0.Ifosfamide;0.Vincristine;1.Dactinomycin;0.Ifosfamide;20.Dactinomycin;0.Ifosfamide;0.Vincristine;1.Dactinomycin;0.Ifosfamide;","20.Dactinomycin;0.Ifosfamide;0.Vincristine;1.Dactinomycin;0.Ifosfamide;"
"3498","82.4.1206.1","Solid Tumor","Sarcoma","Ewing sarcoma",82,"Adjuvant therapy",4,"VAIA",TRUE,"Cont.","17.Dactinomycin;0.Ifosfamide;0.Vincristine;1.Doxorubicin;0.Ifosfamide;1.Dactinomycin;0.Ifosfamide;1.Doxorubicin;1.Dactinomycin;17.Dactinomycin;0.Ifosfamide;0.Vincristine;1.Doxorubicin;0.Ifosfamide;1.Dactinomycin;0.Ifosfamide;1.Doxorubicin;1.Dactinomycin;","17.Dactinomycin;0.Ifosfamide;0.Vincristine;1.Doxorubicin;0.Ifosfamide;1.Dactinomycin;0.Ifosfamide;1.Doxorubicin;1.Dactinomycin;"
"3499","82.4.1206.2","Solid Tumor","Sarcoma","Ewing sarcoma",82,"Adjuvant therapy",4,"VAIA",TRUE,"Cont.","20.Doxorubicin;0.Ifosfamide;0.Vincristine;1.Doxorubicin;0.Ifosfamide;6.Vincristine;7.Vincristine;7.Dactinomycin;0.Ifosfamide;0.Vincristine;1.Dactinomycin;0.Ifosfamide;1.Dactinomycin;19.Doxorubicin;0.Ifosfamide;1.Doxorubicin;0.Ifosfamide;20.Doxorubicin;0.Ifosfamide;0.Vincristine;1.Doxorubicin;0.Ifosfamide;6.Vincristine;7.Vincristine;7.Dactinomycin;0.Ifosfamide;0.Vincristine;1.Dactinomycin;0.Ifosfamide;1.Dactinomycin;19.Doxorubicin;0.Ifosfamide;1.Doxorubicin;0.Ifosfamide;","20.Doxorubicin;0.Ifosfamide;0.Vincristine;1.Doxorubicin;0.Ifosfamide;6.Vincristine;7.Vincristine;7.Dactinomycin;0.Ifosfamide;0.Vincristine;1.Dactinomycin;0.Ifosfamide;1.Dactinomycin;19.Doxorubicin;0.Ifosfamide;1.Doxorubicin;0.Ifosfamide;"
"3500","83.19.1226.1","Solid Tumor","Sarcoma","Leiomyosarcoma",83,"Advanced or metastatic disease, first-line",19,"Doxorubicin monotherapy",TRUE,"Cont.","21.Doxorubicin;21.Doxorubicin;","21.Doxorubicin;21.Doxorubicin;"
"3501","83.19.1227.1","Solid Tumor","Sarcoma","Leiomyosarcoma",83,"Advanced or metastatic disease, first-line",19,"Doxorubicin & Trabectedin",TRUE,"Cont.","21.Doxorubicin;0.Trabectedin;21.Doxorubicin;0.Trabectedin;","21.Doxorubicin;0.Trabectedin;"
"3502","83.26.1228.1","Solid Tumor","Sarcoma","Leiomyosarcoma",83,"Advanced or metastatic disease, subsequent lines of therapy",26,"Dacarbazine monotherapy",TRUE,"Cont.","21.Dacarbazine;21.Dacarbazine;","21.Dacarbazine;21.Dacarbazine;"
"3503","83.26.1229.1","Solid Tumor","Sarcoma","Leiomyosarcoma",83,"Advanced or metastatic disease, subsequent lines of therapy",26,"Dacarbazine & Gemcitabine",TRUE,"Cont.","14.Dacarbazine;0.Gemcitabine;14.Dacarbazine;0.Gemcitabine;","14.Dacarbazine;0.Gemcitabine;"
"3504","83.26.1230.1","Solid Tumor","Sarcoma","Leiomyosarcoma",83,"Advanced or metastatic disease, subsequent lines of therapy",26,"Eribulin monotherapy",TRUE,"Cont.","14.Eribulin;7.Eribulin;14.Eribulin;7.Eribulin;","14.Eribulin;7.Eribulin;"
"3505","83.26.1231.1","Solid Tumor","Sarcoma","Leiomyosarcoma",83,"Advanced or metastatic disease, subsequent lines of therapy",26,"Regorafenib monotherapy",TRUE,"Cont.","8.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;8.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;","8.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;1.Regorafenib;"
"3506","83.26.1232.1","Solid Tumor","Sarcoma","Leiomyosarcoma",83,"Advanced or metastatic disease, subsequent lines of therapy",26,"Trabectedin monotherapy",TRUE,"Cont.","21.Trabectedin;21.Trabectedin;","21.Trabectedin;21.Trabectedin;"
"3507","83.31.1216.1","Solid Tumor","Sarcoma","Kaposi sarcoma",83,"All lines of therapy",31,"ABV (Vincristine)",TRUE,"Cont.","14.Bleomycin;0.Doxorubicin;0.Vincristine;14.Bleomycin;0.Doxorubicin;0.Vincristine;","14.Bleomycin;0.Doxorubicin;0.Vincristine;"
"3508","83.31.1217.1","Solid Tumor","Sarcoma","Kaposi sarcoma",83,"All lines of therapy",31,"Alitretinoin monotherapy",TRUE,"Cont.","1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;1.Alitretinoin;","1.Alitretinoin;1.Alitretinoin;"
"3509","83.31.1218.1","Solid Tumor","Sarcoma","Kaposi sarcoma",83,"All lines of therapy",31,"Bevacizumab monotherapy",TRUE,"Cont.","21.Bevacizumab;21.Bevacizumab;","21.Bevacizumab;21.Bevacizumab;"
"3510","83.31.1219.1","Solid Tumor","Sarcoma","Kaposi sarcoma",83,"All lines of therapy",31,"Daunorubicin liposomal monotherapy",TRUE,"Cont.","14.Daunorubicinliposomal;14.Daunorubicinliposomal;","14.Daunorubicinliposomal;14.Daunorubicinliposomal;"
"3511","83.31.1220.1","Solid Tumor","Sarcoma","Kaposi sarcoma",83,"All lines of therapy",31,"Etoposide monotherapy",TRUE,"Cont.","8.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;8.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;","8.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;"
"3512","83.31.1221.1","Solid Tumor","Sarcoma","Kaposi sarcoma",83,"All lines of therapy",31,"Interferon alfa-2a monotherapy",TRUE,"Cont.","2.Interferonalfa-2a;1.Interferonalfa-2a;2.Interferonalfa-2a;1.Interferonalfa-2a;1.Interferonalfa-2a;2.Interferonalfa-2a;1.Interferonalfa-2a;2.Interferonalfa-2a;1.Interferonalfa-2a;1.Interferonalfa-2a;","2.Interferonalfa-2a;1.Interferonalfa-2a;2.Interferonalfa-2a;1.Interferonalfa-2a;1.Interferonalfa-2a;"
"3513","83.31.1221.2","Solid Tumor","Sarcoma","Kaposi sarcoma",83,"All lines of therapy",31,"Interferon alfa-2a monotherapy",TRUE,"Cont.","3.Interferonalfa-2a;2.Interferonalfa-2a;2.Interferonalfa-2a;3.Interferonalfa-2a;2.Interferonalfa-2a;2.Interferonalfa-2a;","3.Interferonalfa-2a;2.Interferonalfa-2a;2.Interferonalfa-2a;"
"3514","83.31.1221.3","Solid Tumor","Sarcoma","Kaposi sarcoma",83,"All lines of therapy",31,"Interferon alfa-2a monotherapy",TRUE,"Cont.","1.Interferonalfa-2a;1.Interferonalfa-2a;1.Interferonalfa-2a;1.Interferonalfa-2a;1.Interferonalfa-2a;1.Interferonalfa-2a;1.Interferonalfa-2a;1.Interferonalfa-2a;1.Interferonalfa-2a;1.Interferonalfa-2a;1.Interferonalfa-2a;1.Interferonalfa-2a;1.Interferonalfa-2a;1.Interferonalfa-2a;","1.Interferonalfa-2a;1.Interferonalfa-2a;"
"3515","83.31.1222.1","Solid Tumor","Sarcoma","Kaposi sarcoma",83,"All lines of therapy",31,"Interferon alfa-2b monotherapy",TRUE,"Cont.","2.Interferonalfa-2b;1.Interferonalfa-2b;2.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;2.Interferonalfa-2b;1.Interferonalfa-2b;2.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;","2.Interferonalfa-2b;1.Interferonalfa-2b;2.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;"
"3516","83.31.1222.2","Solid Tumor","Sarcoma","Kaposi sarcoma",83,"All lines of therapy",31,"Interferon alfa-2b monotherapy",TRUE,"Cont.","3.Interferonalfa-2b;2.Interferonalfa-2b;2.Interferonalfa-2b;3.Interferonalfa-2b;2.Interferonalfa-2b;2.Interferonalfa-2b;","3.Interferonalfa-2b;2.Interferonalfa-2b;2.Interferonalfa-2b;"
"3517","83.31.1222.3","Solid Tumor","Sarcoma","Kaposi sarcoma",83,"All lines of therapy",31,"Interferon alfa-2b monotherapy",TRUE,"Cont.","1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;1.Interferonalfa-2b;","1.Interferonalfa-2b;1.Interferonalfa-2b;"
"3518","83.31.1223.1","Solid Tumor","Sarcoma","Kaposi sarcoma",83,"All lines of therapy",31,"Paclitaxel monotherapy",TRUE,"Cont.","21.Paclitaxel;21.Paclitaxel;","21.Paclitaxel;21.Paclitaxel;"
"3519","83.31.1224.1","Solid Tumor","Sarcoma","Kaposi sarcoma",83,"All lines of therapy",31,"Pegylated liposomal doxorubicin monotherapy",TRUE,"Cont.","14.Pegylatedliposomaldoxorubicin;14.Pegylatedliposomaldoxorubicin;","14.Pegylatedliposomaldoxorubicin;14.Pegylatedliposomaldoxorubicin;"
"3520","83.31.1224.2","Solid Tumor","Sarcoma","Kaposi sarcoma",83,"All lines of therapy",31,"Pegylated liposomal doxorubicin monotherapy",TRUE,"Cont.","21.Pegylatedliposomaldoxorubicin;21.Pegylatedliposomaldoxorubicin;","21.Pegylatedliposomaldoxorubicin;21.Pegylatedliposomaldoxorubicin;"
"3521","83.31.1225.1","Solid Tumor","Sarcoma","Kaposi sarcoma",83,"All lines of therapy",31,"Pomalidomide monotherapy",TRUE,"Cont.","8.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;8.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;","8.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;1.Pomalidomide;"
"3522","85.140.1236.1","Solid Tumor","Sarcoma","Gastrointestinal stromal tumor",85,"Metastatic or unresectable disease, fourth-line",140,"Avapritinib monotherapy",TRUE,"Cont.","1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;1.Avapritinib;","1.Avapritinib;1.Avapritinib;"
"3523","85.140.1237.1","Solid Tumor","Sarcoma","Gastrointestinal stromal tumor",85,"Metastatic or unresectable disease, fourth-line",140,"Pimitespib monotherapy",TRUE,"Cont.","3.Pimitespib;1.Pimitespib;1.Pimitespib;1.Pimitespib;1.Pimitespib;3.Pimitespib;1.Pimitespib;1.Pimitespib;1.Pimitespib;1.Pimitespib;3.Pimitespib;1.Pimitespib;1.Pimitespib;1.Pimitespib;1.Pimitespib;3.Pimitespib;1.Pimitespib;1.Pimitespib;1.Pimitespib;1.Pimitespib;3.Pimitespib;1.Pimitespib;1.Pimitespib;1.Pimitespib;1.Pimitespib;3.Pimitespib;1.Pimitespib;1.Pimitespib;1.Pimitespib;1.Pimitespib;","3.Pimitespib;1.Pimitespib;1.Pimitespib;1.Pimitespib;1.Pimitespib;"
"3524","85.140.1238.1","Solid Tumor","Sarcoma","Gastrointestinal stromal tumor",85,"Metastatic or unresectable disease, fourth-line",140,"Ripretinib monotherapy",TRUE,"Cont.","1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;1.Ripretinib;","1.Ripretinib;1.Ripretinib;"
"3525","85.141.1233.1","Solid Tumor","Sarcoma","Gastrointestinal stromal tumor",85,"Metastatic or unresectable disease, second-line",141,"Linsitinib monotherapy",TRUE,"Cont.","1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;1.Linsitinib;","1.Linsitinib;1.Linsitinib;"
"3526","85.141.1234.1","Solid Tumor","Sarcoma","Gastrointestinal stromal tumor",85,"Metastatic or unresectable disease, second-line",141,"Sunitinib monotherapy",TRUE,"Cont.","15.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;15.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;","15.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;"
"3527","85.143.1235.1","Solid Tumor","Sarcoma","Gastrointestinal stromal tumor",85,"Metastatic or unresectable disease, third-line",143,"Cabozantinib monotherapy",TRUE,"Cont.","1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;","1.Cabozantinib;1.Cabozantinib;"
"3528","86.153.1239.1","Solid Tumor","Sarcoma","Osteosarcoma",86,"Neoadjuvant therapy",153,"Cisplatin & Doxorubicin",TRUE,"Cont.","19.Cisplatin;0.Doxorubicin;1.Doxorubicin;1.Doxorubicin;19.Cisplatin;0.Doxorubicin;1.Doxorubicin;1.Doxorubicin;","19.Cisplatin;0.Doxorubicin;1.Doxorubicin;1.Doxorubicin;"
"3529","86.153.1240.1","Solid Tumor","Sarcoma","Osteosarcoma",86,"Neoadjuvant therapy",153,"Cisplatin, Epirubicin, Ifosfamide",FALSE,"3","18.Cisplatin;0.Epirubicin;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;18.Cisplatin;0.Epirubicin;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;","18.Cisplatin;0.Epirubicin;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;"
"3530","86.153.1241.1","Solid Tumor","Sarcoma","Osteosarcoma",86,"Neoadjuvant therapy",153,"MA",NA,NA,"0.Methotrexate;7.Methotrexate;7.Methotrexate;7.Doxorubicin;NA.Methotrexate;NA.Methotrexate;NA.Doxorubicin;","0.Methotrexate;7.Methotrexate;7.Methotrexate;7.Doxorubicin;NA.Methotrexate;NA.Methotrexate;NA.Doxorubicin;"
"3531","86.153.1242.1","Solid Tumor","Sarcoma","Osteosarcoma",86,"Neoadjuvant therapy",153,"MAP",FALSE,"2","9.Methotrexate;10.Cisplatin;0.Doxorubicin;1.Doxorubicin;1.Doxorubicin;","9.Methotrexate;10.Cisplatin;0.Doxorubicin;1.Doxorubicin;1.Doxorubicin;"
"3532","86.153.1242.2","Solid Tumor","Sarcoma","Osteosarcoma",86,"Neoadjuvant therapy",153,"MAP",FALSE,"2","9.Methotrexate;10.Cisplatin;0.Doxorubicin;1.Cisplatin;0.Doxorubicin;1.Doxorubicin;","9.Methotrexate;10.Cisplatin;0.Doxorubicin;1.Cisplatin;0.Doxorubicin;1.Doxorubicin;"
"3533","86.153.1242.3","Solid Tumor","Sarcoma","Osteosarcoma",86,"Neoadjuvant therapy",153,"MAP",FALSE,"2","19.Methotrexate;6.Cisplatin;2.Doxorubicin;","19.Methotrexate;6.Cisplatin;2.Doxorubicin;"
"3534","86.153.1242.4","Solid Tumor","Sarcoma","Osteosarcoma",86,"Neoadjuvant therapy",153,"MAP",FALSE,"2","18.Methotrexate;6.Cisplatin;1.Cisplatin;1.Cisplatin;0.Doxorubicin;1.Cisplatin;","18.Methotrexate;6.Cisplatin;1.Cisplatin;1.Cisplatin;0.Doxorubicin;1.Cisplatin;"
"3535","86.153.1242.5","Solid Tumor","Sarcoma","Osteosarcoma",86,"Neoadjuvant therapy",153,"MAP",FALSE,"2","7.Doxorubicin;1.Doxorubicin;1.Cisplatin;19.Methotrexate;7.Methotrexate;","7.Doxorubicin;1.Doxorubicin;1.Cisplatin;19.Methotrexate;7.Methotrexate;"
"3536","86.153.1242.6","Solid Tumor","Sarcoma","Osteosarcoma",86,"Neoadjuvant therapy",153,"MAP",NA,NA,"0.Doxorubicin;1.Doxorubicin;20.Methotrexate;35.Methotrexate;56.Methotrexate;56.Methotrexate;","0.Doxorubicin;1.Doxorubicin;20.Methotrexate;35.Methotrexate;56.Methotrexate;56.Methotrexate;"
"3537","86.153.1243.1","Solid Tumor","Sarcoma","Osteosarcoma",86,"Neoadjuvant therapy",153,"MAPI",FALSE,"2","14.Methotrexate;7.Cisplatin;2.Doxorubicin;19.Ifosfamide;","14.Methotrexate;7.Cisplatin;2.Doxorubicin;19.Ifosfamide;"
"3538","86.153.1243.2","Solid Tumor","Sarcoma","Osteosarcoma",86,"Neoadjuvant therapy",153,"MAPI",FALSE,"2","9.Methotrexate;7.Cisplatin;1.Cisplatin;1.Cisplatin;0.Doxorubicin;1.Doxorubicin;18.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;","9.Methotrexate;7.Cisplatin;1.Cisplatin;1.Cisplatin;0.Doxorubicin;1.Doxorubicin;18.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;"
"3539","86.153.1244.1","Solid Tumor","Sarcoma","Osteosarcoma",86,"Neoadjuvant therapy",153,"M-EI",NA,NA,"0.Methotrexate;7.Methotrexate;7.Methotrexate;7.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;NA.Methotrexate;NA.Methotrexate;NA.Etoposide;NA.Ifosfamide;NA.Etoposide;NA.Ifosfamide;NA.Etoposide;NA.Ifosfamide;NA.Etoposide;NA.Ifosfamide;","0.Methotrexate;7.Methotrexate;7.Methotrexate;7.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;NA.Methotrexate;NA.Methotrexate;NA.Etoposide;NA.Ifosfamide;NA.Etoposide;NA.Ifosfamide;NA.Etoposide;NA.Ifosfamide;NA.Etoposide;NA.Ifosfamide;"
"3540","86.153.1250.1","Solid Tumor","Sarcoma","Osteosarcoma",86,"Neoadjuvant therapy",153,"MAPI",FALSE,"3","21.Doxorubicin;35.Methotrexate;7.Cisplatin;21.Doxorubicin;35.Methotrexate;7.Cisplatin;","21.Doxorubicin;35.Methotrexate;7.Cisplatin;"
"3541","86.190.1253.1","Solid Tumor","Sarcoma","Osteosarcoma",86,"Relapsed, refractory, or metastatic, subsequent lines",190,"Cyclophosphamide & Etoposide",TRUE,"Cont.","18.Cyclophosphamide;1.Etoposide;1.Etoposide;1.Etoposide;18.Cyclophosphamide;1.Etoposide;1.Etoposide;1.Etoposide;","18.Cyclophosphamide;1.Etoposide;1.Etoposide;1.Etoposide;"
"3542","86.190.1254.1","Solid Tumor","Sarcoma","Osteosarcoma",86,"Relapsed, refractory, or metastatic, subsequent lines",190,"Gemcitabine monotherapy",TRUE,"Cont.","7.Gemcitabine;7.Gemcitabine;7.Gemcitabine;7.Gemcitabine;7.Gemcitabine;7.Gemcitabine;7.Gemcitabine;7.Gemcitabine;","7.Gemcitabine;7.Gemcitabine;"
"3543","86.190.1254.2","Solid Tumor","Sarcoma","Osteosarcoma",86,"Relapsed, refractory, or metastatic, subsequent lines",190,"Gemcitabine monotherapy",TRUE,"Cont.","14.Gemcitabine;7.Gemcitabine;7.Gemcitabine;14.Gemcitabine;7.Gemcitabine;7.Gemcitabine;","14.Gemcitabine;7.Gemcitabine;7.Gemcitabine;"
"3544","86.190.1255.1","Solid Tumor","Sarcoma","Osteosarcoma",86,"Relapsed, refractory, or metastatic, subsequent lines",190,"Samarium-153 with stem cell support",TRUE,"Cont.","14.Samarium-153;14.Samarium-153;","14.Samarium-153;14.Samarium-153;"
"3545","86.4.1245.1","Solid Tumor","Sarcoma","Osteosarcoma",86,"Adjuvant therapy",4,"Cisplatin & Doxorubicin",TRUE,"Cont.","19.Doxorubicin;1.Doxorubicin;1.Cisplatin;19.Doxorubicin;1.Doxorubicin;1.Cisplatin;","19.Doxorubicin;1.Doxorubicin;1.Cisplatin;"
"3546","86.4.1246.1","Solid Tumor","Sarcoma","Osteosarcoma",86,"Adjuvant therapy",4,"Cisplatin, Epirubicin, Ifosfamide",FALSE,"3","25.Cisplatin;0.Epirubicin;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;25.Cisplatin;0.Epirubicin;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;","25.Cisplatin;0.Epirubicin;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;"
"3547","86.4.1247.1","Solid Tumor","Sarcoma","Osteosarcoma",86,"Adjuvant therapy",4,"IE",TRUE,"Cont.","18.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;18.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;","18.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;"
"3548","86.4.1248.1","Solid Tumor","Sarcoma","Osteosarcoma",86,"Adjuvant therapy",4,"MA",NA,NA,"0.Methotrexate;28.Methotrexate;28.Methotrexate;28.Methotrexate;","0.Methotrexate;28.Methotrexate;28.Methotrexate;28.Methotrexate;"
"3549","86.4.1249.1","Solid Tumor","Sarcoma","Osteosarcoma",86,"Adjuvant therapy",4,"MAP",FALSE,"3","22.Doxorubicin;1.Doxorubicin;19.Methotrexate;6.Cisplatin;22.Doxorubicin;1.Doxorubicin;19.Methotrexate;6.Cisplatin;","22.Doxorubicin;1.Doxorubicin;19.Methotrexate;6.Cisplatin;"
"3550","86.4.1249.2","Solid Tumor","Sarcoma","Osteosarcoma",86,"Adjuvant therapy",4,"MAP",FALSE,"3","20.Doxorubicin;1.Doxorubicin;19.Methotrexate;6.Cisplatin;1.Cisplatin;1.Cisplatin;20.Doxorubicin;1.Doxorubicin;19.Methotrexate;6.Cisplatin;1.Cisplatin;1.Cisplatin;","20.Doxorubicin;1.Doxorubicin;19.Methotrexate;6.Cisplatin;1.Cisplatin;1.Cisplatin;"
"3551","86.4.1249.3","Solid Tumor","Sarcoma","Osteosarcoma",86,"Adjuvant therapy",4,"MAP",FALSE,"2","7.Doxorubicin;1.Doxorubicin;1.Cisplatin;19.Methotrexate;7.Methotrexate;","7.Doxorubicin;1.Doxorubicin;1.Cisplatin;19.Methotrexate;7.Methotrexate;"
"3552","86.4.1249.4","Solid Tumor","Sarcoma","Osteosarcoma",86,"Adjuvant therapy",4,"MAP",FALSE,"2","7.Cisplatin;0.Doxorubicin;1.Cisplatin;0.Doxorubicin;20.Methotrexate;7.Methotrexate;","7.Cisplatin;0.Doxorubicin;1.Cisplatin;0.Doxorubicin;20.Methotrexate;7.Methotrexate;"
"3553","86.4.1250.1","Solid Tumor","Sarcoma","Osteosarcoma",86,"Adjuvant therapy",4,"MAPI",FALSE,"3","63.Ifosfamide;63.Ifosfamide;","63.Ifosfamide;63.Ifosfamide;"
"3554","86.4.1250.2","Solid Tumor","Sarcoma","Osteosarcoma",86,"Adjuvant therapy",4,"MAPI",FALSE,"3","19.Doxorubicin;21.Ifosfamide;14.Methotrexate;7.Cisplatin;1.Cisplatin;1.Cisplatin;19.Doxorubicin;21.Ifosfamide;14.Methotrexate;7.Cisplatin;1.Cisplatin;1.Cisplatin;","19.Doxorubicin;21.Ifosfamide;14.Methotrexate;7.Cisplatin;1.Cisplatin;1.Cisplatin;"
"3555","86.4.1251.1","Solid Tumor","Sarcoma","Osteosarcoma",86,"Adjuvant therapy",4,"MAPIE",NA,NA,"0.Doxorubicin;1.Doxorubicin;68.Doxorubicin;1.Doxorubicin;68.Doxorubicin;1.Doxorubicin;68.Doxorubicin;1.Doxorubicin;","0.Doxorubicin;1.Doxorubicin;68.Doxorubicin;1.Doxorubicin;68.Doxorubicin;1.Doxorubicin;68.Doxorubicin;1.Doxorubicin;"
"3556","86.4.1251.2","Solid Tumor","Sarcoma","Osteosarcoma",86,"Adjuvant therapy",4,"MAPIE",NA,NA,"0.Doxorubicin;1.Doxorubicin;68.Doxorubicin;1.Doxorubicin;68.Doxorubicin;1.Doxorubicin;68.Doxorubicin;1.Doxorubicin;","0.Doxorubicin;1.Doxorubicin;68.Doxorubicin;1.Doxorubicin;68.Doxorubicin;1.Doxorubicin;68.Doxorubicin;1.Doxorubicin;"
"3557","86.4.1252.1","Solid Tumor","Sarcoma","Osteosarcoma",86,"Adjuvant therapy",4,"M-EI",NA,NA,"0.Methotrexate;28.Methotrexate;28.Methotrexate;28.Methotrexate;","0.Methotrexate;28.Methotrexate;28.Methotrexate;28.Methotrexate;"
"3558","87.31.1256.1","Solid Tumor","Sarcoma","PEComa",87,"All lines of therapy",31,"nab-Sirolimus monotherapy",TRUE,"Cont.","14.Sirolimusprotein-boundparticles;7.Sirolimusprotein-boundparticles;14.Sirolimusprotein-boundparticles;7.Sirolimusprotein-boundparticles;","14.Sirolimusprotein-boundparticles;7.Sirolimusprotein-boundparticles;"
"3559","88.31.1257.1","Solid Tumor","Sarcoma","Rhabdomyosarcoma",88,"All lines of therapy",31,"VA",TRUE,"Cont.","7.Dactinomycin;0.Vincristine;7.Vincristine;7.Vincristine;7.Dactinomycin;0.Vincristine;7.Vincristine;7.Vincristine;","7.Dactinomycin;0.Vincristine;7.Vincristine;7.Vincristine;"
"3560","88.31.1258.1","Solid Tumor","Sarcoma","Rhabdomyosarcoma",88,"All lines of therapy",31,"VAC",TRUE,"Cont.","7.Cyclophosphamide;0.Dactinomycin;0.Vincristine;7.Vincristine;7.Vincristine;7.Cyclophosphamide;0.Dactinomycin;0.Vincristine;7.Vincristine;7.Vincristine;","7.Cyclophosphamide;0.Dactinomycin;0.Vincristine;7.Vincristine;7.Vincristine;"
"3561","88.31.1259.1","Solid Tumor","Sarcoma","Rhabdomyosarcoma",88,"All lines of therapy",31,"VIE",TRUE,"Cont.","7.Etoposide;0.Ifosfamide;0.Vincristine;7.Vincristine;7.Vincristine;7.Etoposide;0.Ifosfamide;0.Vincristine;7.Vincristine;7.Vincristine;","7.Etoposide;0.Ifosfamide;0.Vincristine;7.Vincristine;7.Vincristine;"
"3562","89.103.1267.1","Solid Tumor","Sarcoma","Soft tissue sarcoma",89,"Locally advanced or metastatic disease, combination regimens",103,"Doxorubicin & Ifosfamide",TRUE,"Cont.","21.Doxorubicin;0.Ifosfamide;21.Doxorubicin;0.Ifosfamide;","21.Doxorubicin;0.Ifosfamide;"
"3563","89.103.1267.2","Solid Tumor","Sarcoma","Soft tissue sarcoma",89,"Locally advanced or metastatic disease, combination regimens",103,"Doxorubicin & Ifosfamide",TRUE,"Cont.","17.Doxorubicin;0.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;17.Doxorubicin;0.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;","17.Doxorubicin;0.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;"
"3564","89.103.1267.3","Solid Tumor","Sarcoma","Soft tissue sarcoma",89,"Locally advanced or metastatic disease, combination regimens",103,"Doxorubicin & Ifosfamide",TRUE,"Cont.","17.Doxorubicin;0.Ifosfamide;1.Doxorubicin;0.Ifosfamide;1.Doxorubicin;0.Ifosfamide;1.Doxorubicin;0.Ifosfamide;1.Ifosfamide;17.Doxorubicin;0.Ifosfamide;1.Doxorubicin;0.Ifosfamide;1.Doxorubicin;0.Ifosfamide;1.Doxorubicin;0.Ifosfamide;1.Ifosfamide;","17.Doxorubicin;0.Ifosfamide;1.Doxorubicin;0.Ifosfamide;1.Doxorubicin;0.Ifosfamide;1.Doxorubicin;0.Ifosfamide;1.Ifosfamide;"
"3565","89.103.1268.2","Solid Tumor","Sarcoma","Soft tissue sarcoma",89,"Locally advanced or metastatic disease, combination regimens",103,"Doxorubicin, Ifosfamide, RT",TRUE,"Cont.","19.Ifosfamide;1.Ifosfamide;1.Ifosfamide;19.Ifosfamide;1.Ifosfamide;1.Ifosfamide;","19.Ifosfamide;1.Ifosfamide;1.Ifosfamide;"
"3566","89.103.1269.1","Solid Tumor","Sarcoma","Soft tissue sarcoma",89,"Locally advanced or metastatic disease, combination regimens",103,"Epirubicin & Ifosfamide",TRUE,"Cont.","20.Ifosfamide;1.Epirubicin;20.Ifosfamide;1.Epirubicin;","20.Ifosfamide;1.Epirubicin;"
"3567","89.103.1269.2","Solid Tumor","Sarcoma","Soft tissue sarcoma",89,"Locally advanced or metastatic disease, combination regimens",103,"Epirubicin & Ifosfamide",TRUE,"Cont.","16.Ifosfamide;1.Epirubicin;0.Ifosfamide;1.Epirubicin;0.Ifosfamide;1.Epirubicin;0.Ifosfamide;1.Ifosfamide;1.Ifosfamide;16.Ifosfamide;1.Epirubicin;0.Ifosfamide;1.Epirubicin;0.Ifosfamide;1.Epirubicin;0.Ifosfamide;1.Ifosfamide;1.Ifosfamide;","16.Ifosfamide;1.Epirubicin;0.Ifosfamide;1.Epirubicin;0.Ifosfamide;1.Epirubicin;0.Ifosfamide;1.Ifosfamide;1.Ifosfamide;"
"3568","89.103.1270.1","Solid Tumor","Sarcoma","Soft tissue sarcoma",89,"Locally advanced or metastatic disease, combination regimens",103,"Gemcitabine & Vinorelbine",TRUE,"Cont.","14.Gemcitabine;0.Vinorelbine;7.Gemcitabine;0.Vinorelbine;14.Gemcitabine;0.Vinorelbine;7.Gemcitabine;0.Vinorelbine;","14.Gemcitabine;0.Vinorelbine;7.Gemcitabine;0.Vinorelbine;"
"3569","89.103.1271.1","Solid Tumor","Sarcoma","Soft tissue sarcoma",89,"Locally advanced or metastatic disease, combination regimens",103,"MAID",TRUE,"Cont.","19.Dacarbazine;1.Dacarbazine;1.Dacarbazine;19.Dacarbazine;1.Dacarbazine;1.Dacarbazine;","19.Dacarbazine;1.Dacarbazine;1.Dacarbazine;"
"3570","89.109.1262.1","Solid Tumor","Sarcoma","Soft tissue sarcoma",89,"Locally advanced or metastatic disease, single-agent regimens",109,"Cisplatin monotherapy",TRUE,"Cont.","21.Cisplatin;21.Cisplatin;","21.Cisplatin;21.Cisplatin;"
"3571","89.109.1263.1","Solid Tumor","Sarcoma","Soft tissue sarcoma",89,"Locally advanced or metastatic disease, single-agent regimens",109,"Epirubicin monotherapy",TRUE,"Cont.","21.Epirubicin;21.Epirubicin;","21.Epirubicin;21.Epirubicin;"
"3572","89.109.1264.1","Solid Tumor","Sarcoma","Soft tissue sarcoma",89,"Locally advanced or metastatic disease, single-agent regimens",109,"Ifosfamide monotherapy",TRUE,"Cont.","19.Ifosfamide;1.Ifosfamide;1.Ifosfamide;19.Ifosfamide;1.Ifosfamide;1.Ifosfamide;","19.Ifosfamide;1.Ifosfamide;1.Ifosfamide;"
"3573","89.109.1265.1","Solid Tumor","Sarcoma","Soft tissue sarcoma",89,"Locally advanced or metastatic disease, single-agent regimens",109,"Temozolomide monotherapy",TRUE,"Cont.","22.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;22.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;","22.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;"
"3574","89.109.1266.1","Solid Tumor","Sarcoma","Soft tissue sarcoma",89,"Locally advanced or metastatic disease, single-agent regimens",109,"Trabectedin monotherapy",TRUE,"Cont.","20.Trabectedin;1.Trabectedin;20.Trabectedin;1.Trabectedin;","20.Trabectedin;1.Trabectedin;"
"3575","89.109.1267.4","Solid Tumor","Sarcoma","Soft tissue sarcoma",89,"Locally advanced or metastatic disease, single-agent regimens",109,"Doxorubicin & Ifosfamide",TRUE,"Cont.","18.Doxorubicin;0.Ifosfamide;1.Doxorubicin;0.Ifosfamide;1.Doxorubicin;0.Ifosfamide;1.Doxorubicin;0.Ifosfamide;18.Doxorubicin;0.Ifosfamide;1.Doxorubicin;0.Ifosfamide;1.Doxorubicin;0.Ifosfamide;1.Doxorubicin;0.Ifosfamide;","18.Doxorubicin;0.Ifosfamide;1.Doxorubicin;0.Ifosfamide;1.Doxorubicin;0.Ifosfamide;1.Doxorubicin;0.Ifosfamide;"
"3576","89.109.1268.1","Solid Tumor","Sarcoma","Soft tissue sarcoma",89,"Locally advanced or metastatic disease, single-agent regimens",109,"Doxorubicin, Ifosfamide, RT",TRUE,"Cont.","19.Doxorubicin;0.Ifosfamide;1.Ifosfamide;1.Ifosfamide;19.Doxorubicin;0.Ifosfamide;1.Ifosfamide;1.Ifosfamide;","19.Doxorubicin;0.Ifosfamide;1.Ifosfamide;1.Ifosfamide;"
"3577","89.109.1268.2","Solid Tumor","Sarcoma","Soft tissue sarcoma",89,"Locally advanced or metastatic disease, single-agent regimens",109,"Doxorubicin, Ifosfamide, RT",TRUE,"Cont.","19.Doxorubicin;1.Doxorubicin;1.Doxorubicin;19.Doxorubicin;1.Doxorubicin;1.Doxorubicin;","19.Doxorubicin;1.Doxorubicin;1.Doxorubicin;"
"3578","89.109.1271.1","Solid Tumor","Sarcoma","Soft tissue sarcoma",89,"Locally advanced or metastatic disease, single-agent regimens",109,"MAID",TRUE,"Cont.","19.Doxorubicin;0.Ifosfamide;1.Doxorubicin;0.Ifosfamide;1.Doxorubicin;0.Ifosfamide;19.Doxorubicin;0.Ifosfamide;1.Doxorubicin;0.Ifosfamide;1.Doxorubicin;0.Ifosfamide;","19.Doxorubicin;0.Ifosfamide;1.Doxorubicin;0.Ifosfamide;1.Doxorubicin;0.Ifosfamide;"
"3579","89.153.1260.1","Solid Tumor","Sarcoma","Soft tissue sarcoma",89,"Neoadjuvant therapy",153,"Epirubicin & Ifosfamide",FALSE,"3","19.Epirubicin;0.Ifosfamide;1.Epirubicin;0.Ifosfamide;1.Ifosfamide;19.Epirubicin;0.Ifosfamide;1.Epirubicin;0.Ifosfamide;1.Ifosfamide;","19.Epirubicin;0.Ifosfamide;1.Epirubicin;0.Ifosfamide;1.Ifosfamide;"
"3580","89.153.1261.1","Solid Tumor","Sarcoma","Soft tissue sarcoma",89,"Neoadjuvant therapy",153,"EIA",FALSE,"4","18.Doxorubicin;0.Epirubicin;0.Ifosfamide;1.Epirubicin;0.Ifosfamide;1.Epirubicin;0.Ifosfamide;1.Epirubicin;0.Ifosfamide;18.Doxorubicin;0.Epirubicin;0.Ifosfamide;1.Epirubicin;0.Ifosfamide;1.Epirubicin;0.Ifosfamide;1.Epirubicin;0.Ifosfamide;","18.Doxorubicin;0.Epirubicin;0.Ifosfamide;1.Epirubicin;0.Ifosfamide;1.Epirubicin;0.Ifosfamide;1.Epirubicin;0.Ifosfamide;"
"3581","9.15.349.1","Solid Tumor","Dermatologic Oncology","Cutaneous SCC",9,"Advanced or metastatic disease, all lines of therapy",15,"Cemiplimab monotherapy",TRUE,"Cont.","14.Cemiplimab;14.Cemiplimab;","14.Cemiplimab;14.Cemiplimab;"
"3582","9.15.350.1","Solid Tumor","Dermatologic Oncology","Cutaneous SCC",9,"Advanced or metastatic disease, all lines of therapy",15,"Cetuximab monotherapy",TRUE,"Cont.","7.Cetuximab;7.Cetuximab;","7.Cetuximab;7.Cetuximab;"
"3583","9.15.350.2","Solid Tumor","Dermatologic Oncology","Cutaneous SCC",9,"Advanced or metastatic disease, all lines of therapy",15,"Cetuximab monotherapy",TRUE,"Cont.","147.Cetuximab;7.Cetuximab;7.Cetuximab;7.Cetuximab;147.Cetuximab;7.Cetuximab;7.Cetuximab;7.Cetuximab;","147.Cetuximab;7.Cetuximab;7.Cetuximab;7.Cetuximab;"
"3584","9.15.351.1","Solid Tumor","Dermatologic Oncology","Cutaneous SCC",9,"Advanced or metastatic disease, all lines of therapy",15,"Cisplatin, Interferon alfa-2a, Isotretinoin",TRUE,"Cont.","1.Cisplatin;0.Interferonalfa-2a;0.Isotretinoin;1.Isotretinoin;1.Interferonalfa-2a;0.Isotretinoin;1.Isotretinoin;1.Interferonalfa-2a;0.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Cisplatin;0.Interferonalfa-2a;0.Isotretinoin;1.Isotretinoin;1.Interferonalfa-2a;0.Isotretinoin;1.Isotretinoin;1.Interferonalfa-2a;0.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Cisplatin;0.Interferonalfa-2a;0.Isotretinoin;1.Isotretinoin;1.Interferonalfa-2a;0.Isotretinoin;1.Isotretinoin;1.Interferonalfa-2a;0.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Cisplatin;0.Interferonalfa-2a;0.Isotretinoin;1.Isotretinoin;1.Interferonalfa-2a;0.Isotretinoin;1.Isotretinoin;1.Interferonalfa-2a;0.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Cisplatin;0.Interferonalfa-2a;0.Isotretinoin;1.Isotretinoin;1.Interferonalfa-2a;0.Isotretinoin;1.Isotretinoin;1.Interferonalfa-2a;0.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Cisplatin;0.Interferonalfa-2a;0.Isotretinoin;1.Isotretinoin;1.Interferonalfa-2a;0.Isotretinoin;1.Isotretinoin;1.Interferonalfa-2a;0.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Cisplatin;0.Interferonalfa-2a;0.Isotretinoin;1.Isotretinoin;1.Interferonalfa-2a;0.Isotretinoin;1.Isotretinoin;1.Interferonalfa-2a;0.Isotretinoin;1.Isotretinoin;1.Isotretinoin;1.Cisplatin;0.Interferonalfa-2a;0.Isotretinoin;1.Isotretinoin;1.Interferonalfa-2a;0.Isotretinoin;1.Isotretinoin;1.Interferonalfa-2a;0.Isotretinoin;1.Isotretinoin;1.Isotretinoin;","1.Cisplatin;0.Interferonalfa-2a;0.Isotretinoin;1.Isotretinoin;1.Interferonalfa-2a;0.Isotretinoin;1.Isotretinoin;1.Interferonalfa-2a;0.Isotretinoin;1.Isotretinoin;1.Isotretinoin;"
"3585","9.15.352.1","Solid Tumor","Dermatologic Oncology","Cutaneous SCC",9,"Advanced or metastatic disease, all lines of therapy",15,"Pembrolizumab monotherapy",TRUE,"Cont.","21.Pembrolizumab;21.Pembrolizumab;","21.Pembrolizumab;21.Pembrolizumab;"
"3586","90.31.1272.1","Solid Tumor","Sarcoma","Tenosynovial giant cell tumor",90,"All lines of therapy",31,"Pexidartnib monotherapy",TRUE,"Cont.","1.Pexidartinib;1.Pexidartinib;1.Pexidartinib;1.Pexidartinib;1.Pexidartinib;1.Pexidartinib;1.Pexidartinib;1.Pexidartinib;1.Pexidartinib;1.Pexidartinib;1.Pexidartinib;1.Pexidartinib;1.Pexidartinib;1.Pexidartinib;1.Pexidartinib;1.Pexidartinib;1.Pexidartinib;1.Pexidartinib;1.Pexidartinib;1.Pexidartinib;1.Pexidartinib;1.Pexidartinib;1.Pexidartinib;1.Pexidartinib;1.Pexidartinib;1.Pexidartinib;1.Pexidartinib;1.Pexidartinib;","1.Pexidartinib;1.Pexidartinib;"
"3587","91.32.1273.1","Solid Tumor","Sarcoma","Vascular sarcoma",91,"Angiosarcoma, all lines of therapy",32,"Paclitaxel monotherapy",FALSE,"6","14.Paclitaxel;7.Paclitaxel;7.Paclitaxel;14.Paclitaxel;7.Paclitaxel;7.Paclitaxel;","14.Paclitaxel;7.Paclitaxel;7.Paclitaxel;"
"3588","92.114.1334.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Maintenance after first-line therapy",114,"Bevacizumab monotherapy",TRUE,"Cont.","21.Bevacizumab;21.Bevacizumab;","21.Bevacizumab;21.Bevacizumab;"
"3589","92.114.1335.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Maintenance after first-line therapy",114,"Ipilimumab monotherapy",TRUE,"Cont.","84.Ipilimumab;84.Ipilimumab;","84.Ipilimumab;84.Ipilimumab;"
"3590","92.153.1274.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Neoadjuvant therapy",153,"Carboplatin & Paclitaxel (CP)",TRUE,"Cont.","21.Carboplatin;0.Paclitaxel;21.Carboplatin;0.Paclitaxel;","21.Carboplatin;0.Paclitaxel;"
"3591","92.153.1275.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Neoadjuvant therapy",153,"Carboplatin & Paclitaxel (CP) & Nivolumab",TRUE,"Cont.","21.Carboplatin;0.Nivolumab;0.Paclitaxel;21.Carboplatin;0.Nivolumab;0.Paclitaxel;","21.Carboplatin;0.Nivolumab;0.Paclitaxel;"
"3592","92.153.1276.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Neoadjuvant therapy",153,"Cisplatin & Docetaxel (DC)",FALSE,"3","21.Cisplatin;0.Docetaxel;21.Cisplatin;0.Docetaxel;","21.Cisplatin;0.Docetaxel;"
"3593","92.153.1277.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Neoadjuvant therapy",153,"Cisplatin & Docetaxel (DC) & Durvalumab",NA,NA,"0.Cisplatin;0.Docetaxel;0.Durvalumab;21.Cisplatin;0.Docetaxel;0.Durvalumab;21.Cisplatin;0.Docetaxel;0.Durvalumab;21.Cisplatin;0.Docetaxel;0.Durvalumab;14.Cisplatin;0.Docetaxel;0.Durvalumab;","0.Cisplatin;0.Docetaxel;0.Durvalumab;21.Cisplatin;0.Docetaxel;0.Durvalumab;21.Cisplatin;0.Docetaxel;0.Durvalumab;21.Cisplatin;0.Docetaxel;0.Durvalumab;14.Cisplatin;0.Docetaxel;0.Durvalumab;"
"3594","92.153.1278.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Neoadjuvant therapy",153,"Cisplatin & Docetaxel (DC) & Nivolumab",FALSE,"3","21.Cisplatin;0.Docetaxel;0.Nivolumab;21.Cisplatin;0.Docetaxel;0.Nivolumab;","21.Cisplatin;0.Docetaxel;0.Nivolumab;"
"3595","92.153.1279.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Neoadjuvant therapy",153,"Cisplatin & Etoposide (EP)",TRUE,"Cont.","21.Cisplatin;0.Etoposide;21.Cisplatin;0.Etoposide;","21.Cisplatin;0.Etoposide;"
"3596","92.153.1280.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Neoadjuvant therapy",153,"Cisplatin & Gemcitabine (GC)",TRUE,"Cont.","14.Cisplatin;0.Gemcitabine;7.Gemcitabine;14.Cisplatin;0.Gemcitabine;7.Gemcitabine;","14.Cisplatin;0.Gemcitabine;7.Gemcitabine;"
"3597","92.153.1281.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Neoadjuvant therapy",153,"Cisplatin & Vinorelbine (CVb)",FALSE,"3","14.Cisplatin;0.Vinorelbine;7.Vinorelbine;14.Cisplatin;0.Vinorelbine;7.Vinorelbine;","14.Cisplatin;0.Vinorelbine;7.Vinorelbine;"
"3598","92.153.1282.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Neoadjuvant therapy",153,"Cisplatin & Vinorelbine (CVb) & Nivolumab",FALSE,"3","14.Cisplatin;0.Nivolumab;0.Vinorelbine;7.Vinorelbine;14.Cisplatin;0.Nivolumab;0.Vinorelbine;7.Vinorelbine;","14.Cisplatin;0.Nivolumab;0.Vinorelbine;7.Vinorelbine;"
"3599","92.19.1302.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",19,"Carboplatin & Docetaxel",TRUE,"Cont.","21.Carboplatin;0.Docetaxel;21.Carboplatin;0.Docetaxel;","21.Carboplatin;0.Docetaxel;"
"3600","92.19.1303.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",19,"Carboplatin & Etoposide (CE)",TRUE,"Cont.","19.Carboplatin;0.Etoposide;1.Etoposide;1.Etoposide;19.Carboplatin;0.Etoposide;1.Etoposide;1.Etoposide;","19.Carboplatin;0.Etoposide;1.Etoposide;1.Etoposide;"
"3601","92.19.1303.2","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",19,"Carboplatin & Etoposide (CE)",TRUE,"Cont.","26.Carboplatin;0.Etoposide;1.Etoposide;1.Etoposide;26.Carboplatin;0.Etoposide;1.Etoposide;1.Etoposide;","26.Carboplatin;0.Etoposide;1.Etoposide;1.Etoposide;"
"3602","92.19.1304.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",19,"Carboplatin & Gemcitabine (GCb)",TRUE,"Cont.","14.Carboplatin;0.Gemcitabine;7.Gemcitabine;14.Carboplatin;0.Gemcitabine;7.Gemcitabine;","14.Carboplatin;0.Gemcitabine;7.Gemcitabine;"
"3603","92.19.1304.2","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",19,"Carboplatin & Gemcitabine (GCb)",TRUE,"Cont.","14.Carboplatin;0.Gemcitabine;7.Gemcitabine;7.Gemcitabine;14.Carboplatin;0.Gemcitabine;7.Gemcitabine;7.Gemcitabine;","14.Carboplatin;0.Gemcitabine;7.Gemcitabine;7.Gemcitabine;"
"3604","92.19.1305.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",19,"Carboplatin & nab-Paclitaxel",FALSE,"6","7.Carboplatin;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Carboplatin;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;","7.Carboplatin;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;"
"3605","92.19.1306.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",19,"Carboplatin & Paclitaxel (CP) & Bevacizumab",TRUE,"Cont.","21.Bevacizumab;0.Carboplatin;0.Paclitaxel;21.Bevacizumab;0.Carboplatin;0.Paclitaxel;","21.Bevacizumab;0.Carboplatin;0.Paclitaxel;"
"3606","92.19.1307.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",19,"Carboplatin & Paclitaxel (CP) & Cemiplimab",TRUE,"Cont.","21.Carboplatin;0.Cemiplimab;0.Paclitaxel;21.Carboplatin;0.Cemiplimab;0.Paclitaxel;","21.Carboplatin;0.Cemiplimab;0.Paclitaxel;"
"3607","92.19.1308.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",19,"Carboplatin & Paclitaxel (CP) & Ipilimumab",TRUE,"Cont.","21.Carboplatin;0.Ipilimumab;0.Paclitaxel;21.Carboplatin;0.Ipilimumab;0.Paclitaxel;","21.Carboplatin;0.Ipilimumab;0.Paclitaxel;"
"3608","92.19.1309.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",19,"Carboplatin & Pemetrexed",TRUE,"Cont.","21.Carboplatin;0.Pemetrexed;21.Carboplatin;0.Pemetrexed;","21.Carboplatin;0.Pemetrexed;"
"3609","92.19.1310.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",19,"Carboplatin & Vinorelbine",TRUE,"Cont.","14.Carboplatin;0.Vinorelbine;7.Vinorelbine;14.Carboplatin;0.Vinorelbine;7.Vinorelbine;","14.Carboplatin;0.Vinorelbine;7.Vinorelbine;"
"3610","92.19.1311.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",19,"Cemiplimab monotherapy",TRUE,"Cont.","21.Cemiplimab;21.Cemiplimab;","21.Cemiplimab;21.Cemiplimab;"
"3611","92.19.1312.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",19,"Cisplatin & Etoposide (EP)",TRUE,"Cont.","14.Cisplatin;3.Etoposide;2.Etoposide;2.Etoposide;14.Cisplatin;3.Etoposide;2.Etoposide;2.Etoposide;","14.Cisplatin;3.Etoposide;2.Etoposide;2.Etoposide;"
"3612","92.19.1312.2","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",19,"Cisplatin & Etoposide (EP)",TRUE,"Cont.","19.Cisplatin;0.Etoposide;1.Etoposide;1.Etoposide;19.Cisplatin;0.Etoposide;1.Etoposide;1.Etoposide;","19.Cisplatin;0.Etoposide;1.Etoposide;1.Etoposide;"
"3613","92.19.1312.3","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",19,"Cisplatin & Etoposide (EP)",TRUE,"Cont.","19.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;19.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;","19.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;"
"3614","92.19.1313.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",19,"Cisplatin & Gemcitabine (GC)",TRUE,"Cont.","14.Gemcitabine;1.Cisplatin;6.Gemcitabine;14.Gemcitabine;1.Cisplatin;6.Gemcitabine;","14.Gemcitabine;1.Cisplatin;6.Gemcitabine;"
"3615","92.19.1313.2","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",19,"Cisplatin & Gemcitabine (GC)",TRUE,"Cont.","14.Cisplatin;0.Gemcitabine;7.Gemcitabine;7.Gemcitabine;14.Cisplatin;0.Gemcitabine;7.Gemcitabine;7.Gemcitabine;","14.Cisplatin;0.Gemcitabine;7.Gemcitabine;7.Gemcitabine;"
"3616","92.19.1313.3","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",19,"Cisplatin & Gemcitabine (GC)",TRUE,"Cont.","21.Cisplatin;0.Gemcitabine;7.Gemcitabine;21.Cisplatin;0.Gemcitabine;7.Gemcitabine;","21.Cisplatin;0.Gemcitabine;7.Gemcitabine;"
"3617","92.19.1314.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",19,"Cisplatin & Gemcitabine (GC) & Cetuximab",TRUE,"Cont.","7.Cetuximab;0.Cisplatin;0.Gemcitabine;7.Cetuximab;0.Gemcitabine;7.Cetuximab;7.Cetuximab;0.Cisplatin;0.Gemcitabine;7.Cetuximab;0.Gemcitabine;7.Cetuximab;","7.Cetuximab;0.Cisplatin;0.Gemcitabine;7.Cetuximab;0.Gemcitabine;7.Cetuximab;"
"3618","92.19.1315.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",19,"Cisplatin & Irinotecan (IC)",TRUE,"Cont.","14.Cisplatin;0.Irinotecan;7.Irinotecan;7.Irinotecan;14.Cisplatin;0.Irinotecan;7.Irinotecan;7.Irinotecan;","14.Cisplatin;0.Irinotecan;7.Irinotecan;7.Irinotecan;"
"3619","92.19.1316.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",19,"Cisplatin & Paclitaxel",TRUE,"Cont.","21.Cisplatin;0.Paclitaxel;21.Cisplatin;0.Paclitaxel;","21.Cisplatin;0.Paclitaxel;"
"3620","92.19.1317.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",19,"Cisplatin, Paclitaxel, Cemiplimab",TRUE,"Cont.","21.Cemiplimab;0.Cisplatin;0.Paclitaxel;21.Cemiplimab;0.Cisplatin;0.Paclitaxel;","21.Cemiplimab;0.Cisplatin;0.Paclitaxel;"
"3621","92.19.1318.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",19,"Cisplatin & Vinorelbine (CVb)",TRUE,"Cont.","14.Vinorelbine;7.Cisplatin;0.Vinorelbine;14.Vinorelbine;7.Cisplatin;0.Vinorelbine;","14.Vinorelbine;7.Cisplatin;0.Vinorelbine;"
"3622","92.19.1318.2","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",19,"Cisplatin & Vinorelbine (CVb)",TRUE,"Cont.","7.Cisplatin;0.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Cisplatin;0.Vinorelbine;7.Vinorelbine;7.Vinorelbine;","7.Cisplatin;0.Vinorelbine;7.Vinorelbine;7.Vinorelbine;"
"3623","92.19.1318.3","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",19,"Cisplatin & Vinorelbine (CVb)",TRUE,"Cont.","7.Cisplatin;0.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Cisplatin;0.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;","7.Cisplatin;0.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;"
"3624","92.19.1318.4","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",19,"Cisplatin & Vinorelbine (CVb)",TRUE,"Cont.","7.Cisplatin;0.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Cisplatin;0.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;","7.Cisplatin;0.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;"
"3625","92.19.1319.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",19,"Cisplatin, Vinorelbine, Cetuximab",TRUE,"Cont.","7.Cetuximab;0.Cisplatin;0.Vinorelbine;7.Cetuximab;0.Vinorelbine;7.Cetuximab;7.Cetuximab;0.Cisplatin;0.Vinorelbine;7.Cetuximab;0.Vinorelbine;7.Cetuximab;","7.Cetuximab;0.Cisplatin;0.Vinorelbine;7.Cetuximab;0.Vinorelbine;7.Cetuximab;"
"3626","92.19.1320.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",19,"Docetaxel & Vinorelbine",TRUE,"Cont.","14.Docetaxel;0.Vinorelbine;14.Docetaxel;0.Vinorelbine;","14.Docetaxel;0.Vinorelbine;"
"3627","92.19.1321.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",19,"Durvalumab & Tremelimumab",TRUE,"Cont.","28.Durvalumab;0.Tremelimumab;28.Durvalumab;0.Tremelimumab;","28.Durvalumab;0.Tremelimumab;"
"3628","92.19.1322.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",19,"Gemcitabine & Paclitaxel",TRUE,"Cont.","14.Gemcitabine;0.Paclitaxel;7.Gemcitabine;0.Paclitaxel;14.Gemcitabine;0.Paclitaxel;7.Gemcitabine;0.Paclitaxel;","14.Gemcitabine;0.Paclitaxel;7.Gemcitabine;0.Paclitaxel;"
"3629","92.19.1322.2","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",19,"Gemcitabine & Paclitaxel",TRUE,"Cont.","14.Gemcitabine;0.Paclitaxel;7.Gemcitabine;14.Gemcitabine;0.Paclitaxel;7.Gemcitabine;","14.Gemcitabine;0.Paclitaxel;7.Gemcitabine;"
"3630","92.19.1323.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",19,"Gemcitabine & Vinorelbine",TRUE,"Cont.","14.Gemcitabine;0.Vinorelbine;7.Gemcitabine;0.Vinorelbine;14.Gemcitabine;0.Vinorelbine;7.Gemcitabine;0.Vinorelbine;","14.Gemcitabine;0.Vinorelbine;7.Gemcitabine;0.Vinorelbine;"
"3631","92.19.1323.2","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",19,"Gemcitabine & Vinorelbine",TRUE,"Cont.","14.Gemcitabine;0.Vinorelbine;7.Gemcitabine;0.Vinorelbine;7.Gemcitabine;0.Vinorelbine;14.Gemcitabine;0.Vinorelbine;7.Gemcitabine;0.Vinorelbine;7.Gemcitabine;0.Vinorelbine;","14.Gemcitabine;0.Vinorelbine;7.Gemcitabine;0.Vinorelbine;7.Gemcitabine;0.Vinorelbine;"
"3632","92.19.1324.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",19,"Ipilimumab & Nivolumab",TRUE,"Cont.","14.Ipilimumab;0.Nivolumab;14.Nivolumab;14.Nivolumab;14.Ipilimumab;0.Nivolumab;14.Nivolumab;14.Nivolumab;","14.Ipilimumab;0.Nivolumab;14.Nivolumab;14.Nivolumab;"
"3633","92.19.1325.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",19,"Nivolumab monotherapy",TRUE,"Cont.","14.Nivolumab;14.Nivolumab;","14.Nivolumab;14.Nivolumab;"
"3634","92.19.1326.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",19,"PCG (Carboplatin)",TRUE,"Cont.","14.Carboplatin;0.Gemcitabine;0.Paclitaxel;7.Gemcitabine;14.Carboplatin;0.Gemcitabine;0.Paclitaxel;7.Gemcitabine;","14.Carboplatin;0.Gemcitabine;0.Paclitaxel;7.Gemcitabine;"
"3635","92.21.1327.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line, elderly or poor performance status",21,"Carboplatin & Paclitaxel (CP)",TRUE,"Cont.","14.Carboplatin;0.Paclitaxel;7.Paclitaxel;7.Paclitaxel;14.Carboplatin;0.Paclitaxel;7.Paclitaxel;7.Paclitaxel;","14.Carboplatin;0.Paclitaxel;7.Paclitaxel;7.Paclitaxel;"
"3636","92.21.1328.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line, elderly or poor performance status",21,"Carboplatin, Pemetrexed, Bevacizumab",TRUE,"Cont.","21.Bevacizumab;0.Carboplatin;0.Pemetrexed;21.Bevacizumab;0.Carboplatin;0.Pemetrexed;","21.Bevacizumab;0.Carboplatin;0.Pemetrexed;"
"3637","92.21.1329.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line, elderly or poor performance status",21,"Docetaxel monotherapy",TRUE,"Cont.","14.Docetaxel;7.Docetaxel;7.Docetaxel;14.Docetaxel;7.Docetaxel;7.Docetaxel;","14.Docetaxel;7.Docetaxel;7.Docetaxel;"
"3638","92.21.1329.2","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line, elderly or poor performance status",21,"Docetaxel monotherapy",TRUE,"Cont.","14.Docetaxel;7.Docetaxel;14.Docetaxel;7.Docetaxel;","14.Docetaxel;7.Docetaxel;"
"3639","92.21.1329.3","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line, elderly or poor performance status",21,"Docetaxel monotherapy",TRUE,"Cont.","21.Docetaxel;21.Docetaxel;","21.Docetaxel;21.Docetaxel;"
"3640","92.21.1330.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line, elderly or poor performance status",21,"Gemcitabine monotherapy",TRUE,"Cont.","14.Gemcitabine;7.Gemcitabine;7.Gemcitabine;14.Gemcitabine;7.Gemcitabine;7.Gemcitabine;","14.Gemcitabine;7.Gemcitabine;7.Gemcitabine;"
"3641","92.21.1330.2","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line, elderly or poor performance status",21,"Gemcitabine monotherapy",TRUE,"Cont.","14.Gemcitabine;7.Gemcitabine;14.Gemcitabine;7.Gemcitabine;","14.Gemcitabine;7.Gemcitabine;"
"3642","92.21.1331.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line, elderly or poor performance status",21,"Pemetrexed monotherapy",TRUE,"Cont.","21.Pemetrexed;21.Pemetrexed;","21.Pemetrexed;21.Pemetrexed;"
"3643","92.21.1332.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line, elderly or poor performance status",21,"Pemetrexed & Bevacizumab",TRUE,"Cont.","21.Bevacizumab;0.Pemetrexed;21.Bevacizumab;0.Pemetrexed;","21.Bevacizumab;0.Pemetrexed;"
"3644","92.21.1333.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line, elderly or poor performance status",21,"Vinorelbine monotherapy",TRUE,"Cont.","14.Vinorelbine;7.Vinorelbine;14.Vinorelbine;7.Vinorelbine;","14.Vinorelbine;7.Vinorelbine;"
"3645","92.23.1336.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, second-line",23,"Cabozantinib monotherapy",TRUE,"Cont.","1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;","1.Cabozantinib;1.Cabozantinib;"
"3646","92.23.1337.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, second-line",23,"Docetaxel monotherapy",TRUE,"Cont.","14.Docetaxel;14.Docetaxel;14.Docetaxel;14.Docetaxel;","14.Docetaxel;14.Docetaxel;"
"3647","92.23.1338.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, second-line",23,"Docetaxel & Ramucirumab",TRUE,"Cont.","21.Docetaxel;0.Ramucirumab;21.Docetaxel;0.Ramucirumab;","21.Docetaxel;0.Ramucirumab;"
"3648","92.23.1339.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, second-line",23,"Docetaxel & Vandetanib",TRUE,"Cont.","1.Docetaxel;0.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Docetaxel;0.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;","1.Docetaxel;0.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;"
"3649","92.23.1340.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, second-line",23,"Gefitinib monotherapy",TRUE,"Cont.","1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;","1.Gefitinib;1.Gefitinib;"
"3650","92.26.1342.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, subsequent lines of therapy",26,"Afatinib monotherapy",TRUE,"Cont.","1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;","1.Afatinib;1.Afatinib;"
"3651","92.26.1343.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, subsequent lines of therapy",26,"Afatinib & Paclitaxel",TRUE,"Cont.","1.Afatinib;0.Paclitaxel;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;0.Paclitaxel;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;0.Paclitaxel;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;0.Paclitaxel;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;0.Paclitaxel;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;0.Paclitaxel;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;0.Paclitaxel;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;0.Paclitaxel;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;","1.Afatinib;0.Paclitaxel;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;"
"3652","92.26.1344.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, subsequent lines of therapy",26,"Amrubicin monotherapy",TRUE,"Cont.","19.Amrubicin;1.Amrubicin;1.Amrubicin;19.Amrubicin;1.Amrubicin;1.Amrubicin;","19.Amrubicin;1.Amrubicin;1.Amrubicin;"
"3653","92.26.1345.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, subsequent lines of therapy",26,"Docetaxel & Nintedanib",TRUE,"Cont.","1.Docetaxel;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Docetaxel;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;","1.Docetaxel;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;"
"3654","92.26.1346.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, subsequent lines of therapy",26,"Docetaxel & Nivolumab",TRUE,"Cont.","28.Docetaxel;0.Nivolumab;28.Docetaxel;0.Nivolumab;","28.Docetaxel;0.Nivolumab;"
"3655","92.26.1347.2","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, subsequent lines of therapy",26,"Gemcitabine monotherapy",TRUE,"Cont.","14.Gemcitabine;7.Gemcitabine;7.Gemcitabine;14.Gemcitabine;7.Gemcitabine;7.Gemcitabine;","14.Gemcitabine;7.Gemcitabine;7.Gemcitabine;"
"3656","92.26.1348.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, subsequent lines of therapy",26,"Icotinib monotherapy",TRUE,"Cont.","1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;","1.Icotinib;1.Icotinib;"
"3657","92.26.1349.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, subsequent lines of therapy",26,"nab-Paclitaxel monotherapy",TRUE,"Cont.","7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;","7.Paclitaxel;0.nanoparticlealbumin-bound;"
"3658","92.26.1350.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, subsequent lines of therapy",26,"S-1 monotherapy",TRUE,"Cont.","15.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;15.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;","15.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;"
"3659","92.26.1351.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, subsequent lines of therapy",26,"Tislelizumab monotherapy",TRUE,"Cont.","21.Tislelizumab;21.Tislelizumab;","21.Tislelizumab;21.Tislelizumab;"
"3660","92.26.1352.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, subsequent lines of therapy",26,"Vinorelbine monotherapy",TRUE,"Cont.","7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;","7.Vinorelbine;7.Vinorelbine;"
"3661","92.27.1341.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, third-line",27,"Cabozantinib & Erlotinib",TRUE,"Cont.","1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;","1.Cabozantinib;0.Erlotinib;"
"3662","92.4.1283.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Adjuvant therapy",4,"Atezolizumab monotherapy",TRUE,"Cont.","14.Atezolizumab;14.Atezolizumab;","14.Atezolizumab;14.Atezolizumab;"
"3663","92.4.1283.2","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Adjuvant therapy",4,"Atezolizumab monotherapy",TRUE,"Cont.","21.Atezolizumab;21.Atezolizumab;","21.Atezolizumab;21.Atezolizumab;"
"3664","92.4.1283.3","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Adjuvant therapy",4,"Atezolizumab monotherapy",TRUE,"Cont.","28.Atezolizumab;28.Atezolizumab;","28.Atezolizumab;28.Atezolizumab;"
"3665","92.4.1284.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Adjuvant therapy",4,"Cisplatin & Pemetrexed",TRUE,"Cont.","21.Cisplatin;0.Pemetrexed;21.Cisplatin;0.Pemetrexed;","21.Cisplatin;0.Pemetrexed;"
"3666","92.4.1285.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Adjuvant therapy",4,"Cisplatin & Vinblastine",FALSE,"1","0.Cisplatin;0.Vinblastine;7.Vinblastine;7.Vinblastine;7.Cisplatin;0.Vinblastine;7.Vinblastine;14.Cisplatin;0.Vinblastine;14.Vinblastine;7.Cisplatin;","0.Cisplatin;0.Vinblastine;7.Vinblastine;7.Vinblastine;7.Cisplatin;0.Vinblastine;7.Vinblastine;14.Cisplatin;0.Vinblastine;14.Vinblastine;7.Cisplatin;"
"3667","92.4.1286.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Adjuvant therapy",4,"Cisplatin & Vindesine",FALSE,"1","0.Cisplatin;0.Vindesine;7.Vindesine;7.Vindesine;7.Cisplatin;0.Vindesine;7.Vindesine;14.Cisplatin;0.Vindesine;14.Vindesine;7.Cisplatin;","0.Cisplatin;0.Vindesine;7.Vindesine;7.Vindesine;7.Cisplatin;0.Vindesine;7.Vindesine;14.Cisplatin;0.Vindesine;14.Vindesine;7.Cisplatin;"
"3668","92.4.1287.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Adjuvant therapy",4,"Cisplatin & Vinorelbine (CVb)",TRUE,"Cont.","7.Cisplatin;0.Vinorelbine;7.Cisplatin;0.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Cisplatin;0.Vinorelbine;7.Cisplatin;0.Vinorelbine;7.Vinorelbine;7.Vinorelbine;","7.Cisplatin;0.Vinorelbine;7.Cisplatin;0.Vinorelbine;7.Vinorelbine;7.Vinorelbine;"
"3669","92.4.1287.2","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Adjuvant therapy",4,"Cisplatin & Vinorelbine (CVb)",TRUE,"Cont.","14.Cisplatin;0.Vinorelbine;7.Vinorelbine;14.Cisplatin;0.Vinorelbine;7.Vinorelbine;","14.Cisplatin;0.Vinorelbine;7.Vinorelbine;"
"3670","92.4.1287.3","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Adjuvant therapy",4,"Cisplatin & Vinorelbine (CVb)",FALSE,"4","7.Cisplatin;0.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Cisplatin;0.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;","7.Cisplatin;0.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;"
"3671","92.4.1288.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Adjuvant therapy",4,"Pembrolizumab monotherapy",TRUE,"Cont.","21.Pembrolizumab;21.Pembrolizumab;","21.Pembrolizumab;21.Pembrolizumab;"
"3672","92.4.1289.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Adjuvant therapy",4,"Tegafur & uracil monotherapy",TRUE,"Cont.","1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;","1.Tegafuranduracil;1.Tegafuranduracil;"
"3673","92.50.1300.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Consolidation or maintenance after definitive therapy for inoperable disease",50,"Durvalumab monotherapy",TRUE,"Cont.","14.Durvalumab;14.Durvalumab;","14.Durvalumab;14.Durvalumab;"
"3674","92.50.1301.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Consolidation or maintenance after definitive therapy for inoperable disease",50,"Sugemalimab monotherapy",TRUE,"Cont.","21.Sugemalimab;21.Sugemalimab;","21.Sugemalimab;21.Sugemalimab;"
"3675","92.54.1291.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Definitive therapy for locally advanced disease",54,"Carboplatin & Paclitaxel (CP) & RT",FALSE,"1","0.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;","0.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;"
"3676","92.54.1291.2","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Definitive therapy for locally advanced disease",54,"Carboplatin & Paclitaxel (CP) & RT",FALSE,"2","7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;","7.Carboplatin;0.Paclitaxel;"
"3677","92.54.1291.3","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Definitive therapy for locally advanced disease",54,"Carboplatin & Paclitaxel (CP) & RT",FALSE,"1","0.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;","0.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;"
"3678","92.54.1292.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Definitive therapy for locally advanced disease",54,"Carboplatin, Vinorelbine, RT",FALSE,"4","14.Carboplatin;0.Vinorelbine;7.Vinorelbine;14.Carboplatin;0.Vinorelbine;7.Vinorelbine;","14.Carboplatin;0.Vinorelbine;7.Vinorelbine;"
"3679","92.54.1293.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Definitive therapy for locally advanced disease",54,"Carboplatin & RT",FALSE,"1","0.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;3.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;3.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;3.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;","0.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;3.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;3.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;3.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;"
"3680","92.54.1294.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Definitive therapy for locally advanced disease",54,"Cisplatin & RT",FALSE,"2","2.Cisplatin;1.Cisplatin;2.Cisplatin;1.Cisplatin;1.Cisplatin;","2.Cisplatin;1.Cisplatin;2.Cisplatin;1.Cisplatin;1.Cisplatin;"
"3681","92.54.1294.2","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Definitive therapy for locally advanced disease",54,"Cisplatin & RT",FALSE,"3","21.Cisplatin;21.Cisplatin;","21.Cisplatin;21.Cisplatin;"
"3682","92.54.1295.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Definitive therapy for locally advanced disease",54,"Cisplatin, Docetaxel, RT",FALSE,"1","0.Cisplatin;0.Docetaxel;7.Cisplatin;0.Docetaxel;7.Cisplatin;0.Docetaxel;7.Cisplatin;0.Docetaxel;7.Cisplatin;0.Docetaxel;7.Cisplatin;0.Docetaxel;","0.Cisplatin;0.Docetaxel;7.Cisplatin;0.Docetaxel;7.Cisplatin;0.Docetaxel;7.Cisplatin;0.Docetaxel;7.Cisplatin;0.Docetaxel;7.Cisplatin;0.Docetaxel;"
"3683","92.54.1295.2","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Definitive therapy for locally advanced disease",54,"Cisplatin, Docetaxel, RT",FALSE,"2","21.Cisplatin;0.Docetaxel;7.Cisplatin;0.Docetaxel;","21.Cisplatin;0.Docetaxel;7.Cisplatin;0.Docetaxel;"
"3684","92.54.1296.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Definitive therapy for locally advanced disease",54,"Cisplatin, Etoposide, RT",FALSE,"2","21.Cisplatin;0.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;3.Cisplatin;","21.Cisplatin;0.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;3.Cisplatin;"
"3685","92.54.1296.2","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Definitive therapy for locally advanced disease",54,"Cisplatin, Etoposide, RT",FALSE,"2","24.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;","24.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;"
"3686","92.54.1296.3","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Definitive therapy for locally advanced disease",54,"Cisplatin, Etoposide, RT",FALSE,"2","17.Cisplatin;0.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;3.Cisplatin;0.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;","17.Cisplatin;0.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;3.Cisplatin;0.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;"
"3687","92.54.1297.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Definitive therapy for locally advanced disease",54,"Cisplatin, Pemetrexed, RT",FALSE,"3","21.Cisplatin;0.Pemetrexed;21.Cisplatin;0.Pemetrexed;","21.Cisplatin;0.Pemetrexed;"
"3688","92.54.1298.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Definitive therapy for locally advanced disease",54,"Cisplatin, Vinblastine, RT",FALSE,"1","0.Cisplatin;0.Vinblastine;7.Vinblastine;7.Vinblastine;7.Vinblastine;7.Cisplatin;0.Vinblastine;","0.Cisplatin;0.Vinblastine;7.Vinblastine;7.Vinblastine;7.Vinblastine;7.Cisplatin;0.Vinblastine;"
"3689","92.54.1299.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Definitive therapy for locally advanced disease",54,"Cisplatin, Vinorelbine, RT",FALSE,"1","0.Cisplatin;0.Vinorelbine;7.Cisplatin;0.Vinorelbine;","0.Cisplatin;0.Vinorelbine;7.Cisplatin;0.Vinorelbine;"
"3690","92.90.1290.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Induction chemotherapy for locally advanced disease",90,"Cisplatin & Vinblastine",FALSE,"1","0.Cisplatin;0.Vinblastine;7.Vinblastine;7.Vinblastine;7.Vinblastine;7.Cisplatin;0.Vinblastine;","0.Cisplatin;0.Vinblastine;7.Vinblastine;7.Vinblastine;7.Vinblastine;7.Cisplatin;0.Vinblastine;"
"3691","93.153.1353.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, nonsquamous",93,"Neoadjuvant therapy",153,"Cisplatin, Pemetrexed, Nivolumab",FALSE,"3","21.Cisplatin;0.Nivolumab;0.Pemetrexed;21.Cisplatin;0.Nivolumab;0.Pemetrexed;","21.Cisplatin;0.Nivolumab;0.Pemetrexed;"
"3692","93.19.1354.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, nonsquamous",93,"Advanced or metastatic disease, first-line",19,"ABCP",TRUE,"Cont.","21.Atezolizumab;0.Bevacizumab;0.Carboplatin;0.Paclitaxel;21.Atezolizumab;0.Bevacizumab;0.Carboplatin;0.Paclitaxel;","21.Atezolizumab;0.Bevacizumab;0.Carboplatin;0.Paclitaxel;"
"3693","93.19.1355.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, nonsquamous",93,"Advanced or metastatic disease, first-line",19,"Carboplatin & Gemcitabine (GCb)",TRUE,"Cont.","28.Carboplatin;0.Gemcitabine;28.Carboplatin;0.Gemcitabine;","28.Carboplatin;0.Gemcitabine;"
"3694","93.19.1356.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, nonsquamous",93,"Advanced or metastatic disease, first-line",19,"Carboplatin, nab-Paclitaxel, Atezolizumab",TRUE,"Cont.","7.Atezolizumab;0.Carboplatin;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Atezolizumab;0.Carboplatin;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;","7.Atezolizumab;0.Carboplatin;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;"
"3695","93.19.1357.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, nonsquamous",93,"Advanced or metastatic disease, first-line",19,"Carboplatin & Paclitaxel (CP), Bevacizumab, Nivolumab",TRUE,"Cont.","21.Bevacizumab;0.Carboplatin;0.Nivolumab;0.Paclitaxel;21.Bevacizumab;0.Carboplatin;0.Nivolumab;0.Paclitaxel;","21.Bevacizumab;0.Carboplatin;0.Nivolumab;0.Paclitaxel;"
"3696","93.19.1358.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, nonsquamous",93,"Advanced or metastatic disease, first-line",19,"Carboplatin, Pemetrexed, Atezolizumab",TRUE,"Cont.","21.Atezolizumab;0.Carboplatin;0.Pemetrexed;21.Atezolizumab;0.Carboplatin;0.Pemetrexed;","21.Atezolizumab;0.Carboplatin;0.Pemetrexed;"
"3697","93.19.1359.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, nonsquamous",93,"Advanced or metastatic disease, first-line",19,"Carboplatin, Pemetrexed, Cemiplimab",TRUE,"Cont.","21.Carboplatin;0.Cemiplimab;0.Pemetrexed;21.Carboplatin;0.Cemiplimab;0.Pemetrexed;","21.Carboplatin;0.Cemiplimab;0.Pemetrexed;"
"3698","93.19.1360.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, nonsquamous",93,"Advanced or metastatic disease, first-line",19,"Carboplatin, Pemetrexed, Ipilimumab, Nivolumab",TRUE,"Cont.","21.Carboplatin;0.Ipilimumab;0.Nivolumab;0.Pemetrexed;21.Carboplatin;0.Ipilimumab;0.Nivolumab;0.Pemetrexed;","21.Carboplatin;0.Ipilimumab;0.Nivolumab;0.Pemetrexed;"
"3699","93.19.1361.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, nonsquamous",93,"Advanced or metastatic disease, first-line",19,"Carboplatin, Pemetrexed, Pembrolizumab",TRUE,"Cont.","21.Carboplatin;0.Pembrolizumab;0.Pemetrexed;21.Carboplatin;0.Pembrolizumab;0.Pemetrexed;","21.Carboplatin;0.Pembrolizumab;0.Pemetrexed;"
"3700","93.19.1362.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, nonsquamous",93,"Advanced or metastatic disease, first-line",19,"Carboplatin, Pemetrexed, Sintilimab",TRUE,"Cont.","21.Carboplatin;0.Pemetrexed;0.Sintilimab;21.Carboplatin;0.Pemetrexed;0.Sintilimab;","21.Carboplatin;0.Pemetrexed;0.Sintilimab;"
"3701","93.19.1363.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, nonsquamous",93,"Advanced or metastatic disease, first-line",19,"Carboplatin, Pemetrexed, Sugemalimab",TRUE,"Cont.","21.Carboplatin;0.Pemetrexed;0.Sugemalimab;21.Carboplatin;0.Pemetrexed;0.Sugemalimab;","21.Carboplatin;0.Pemetrexed;0.Sugemalimab;"
"3702","93.19.1364.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, nonsquamous",93,"Advanced or metastatic disease, first-line",19,"Carboplatin, Pemetrexed, Tislelizumab",TRUE,"Cont.","21.Carboplatin;0.Pemetrexed;0.Tislelizumab;21.Carboplatin;0.Pemetrexed;0.Tislelizumab;","21.Carboplatin;0.Pemetrexed;0.Tislelizumab;"
"3703","93.19.1365.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, nonsquamous",93,"Advanced or metastatic disease, first-line",19,"Cisplatin & Gemcitabine (GC) & Bevacizumab",TRUE,"Cont.","14.Bevacizumab;0.Cisplatin;0.Gemcitabine;7.Gemcitabine;14.Bevacizumab;0.Cisplatin;0.Gemcitabine;7.Gemcitabine;","14.Bevacizumab;0.Cisplatin;0.Gemcitabine;7.Gemcitabine;"
"3704","93.19.1366.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, nonsquamous",93,"Advanced or metastatic disease, first-line",19,"Cisplatin, Pemetrexed, Atezolizumab",TRUE,"Cont.","21.Atezolizumab;0.Cisplatin;0.Pemetrexed;21.Atezolizumab;0.Cisplatin;0.Pemetrexed;","21.Atezolizumab;0.Cisplatin;0.Pemetrexed;"
"3705","93.19.1367.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, nonsquamous",93,"Advanced or metastatic disease, first-line",19,"Cisplatin, Pemetrexed, Bevacizumab",TRUE,"Cont.","21.Bevacizumab;0.Cisplatin;0.Pemetrexed;21.Bevacizumab;0.Cisplatin;0.Pemetrexed;","21.Bevacizumab;0.Cisplatin;0.Pemetrexed;"
"3706","93.19.1368.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, nonsquamous",93,"Advanced or metastatic disease, first-line",19,"Cisplatin, Pemetrexed, Cemiplimab",TRUE,"Cont.","21.Cemiplimab;0.Cisplatin;0.Pemetrexed;21.Cemiplimab;0.Cisplatin;0.Pemetrexed;","21.Cemiplimab;0.Cisplatin;0.Pemetrexed;"
"3707","93.19.1369.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, nonsquamous",93,"Advanced or metastatic disease, first-line",19,"Cisplatin, Pemetrexed, Ipilimumab, Nivolumab",TRUE,"Cont.","21.Cisplatin;0.Ipilimumab;0.Nivolumab;0.Pemetrexed;21.Cisplatin;0.Ipilimumab;0.Nivolumab;0.Pemetrexed;","21.Cisplatin;0.Ipilimumab;0.Nivolumab;0.Pemetrexed;"
"3708","93.19.1370.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, nonsquamous",93,"Advanced or metastatic disease, first-line",19,"Cisplatin, Pemetrexed, Pembrolizumab",TRUE,"Cont.","21.Cisplatin;0.Pembrolizumab;0.Pemetrexed;21.Cisplatin;0.Pembrolizumab;0.Pemetrexed;","21.Cisplatin;0.Pembrolizumab;0.Pemetrexed;"
"3709","93.19.1371.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, nonsquamous",93,"Advanced or metastatic disease, first-line",19,"Cisplatin, Pemetrexed, Sintilimab",TRUE,"Cont.","21.Cisplatin;0.Pemetrexed;0.Sintilimab;21.Cisplatin;0.Pemetrexed;0.Sintilimab;","21.Cisplatin;0.Pemetrexed;0.Sintilimab;"
"3710","93.19.1372.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, nonsquamous",93,"Advanced or metastatic disease, first-line",19,"Cisplatin, Pemetrexed, Tislelizumab",TRUE,"Cont.","21.Cisplatin;0.Pemetrexed;0.Tislelizumab;21.Cisplatin;0.Pemetrexed;0.Tislelizumab;","21.Cisplatin;0.Pemetrexed;0.Tislelizumab;"
"3711","93.26.1373.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, nonsquamous",93,"Advanced or metastatic disease, subsequent lines of therapy",26,"Nintedanib & Pemetrexed",TRUE,"Cont.","1.Pemetrexed;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Pemetrexed;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;","1.Pemetrexed;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;"
"3712","93.26.1374.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, nonsquamous",93,"Advanced or metastatic disease, subsequent lines of therapy",26,"Sorafenib monotherapy",TRUE,"Cont.","1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;","1.Sorafenib;1.Sorafenib;"
"3713","94.153.1375.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, squamous",94,"Neoadjuvant therapy",153,"Cisplatin & Gemcitabine (GC) & Nivolumab",FALSE,"3","14.Cisplatin;0.Gemcitabine;0.Nivolumab;7.Gemcitabine;14.Cisplatin;0.Gemcitabine;0.Nivolumab;7.Gemcitabine;","14.Cisplatin;0.Gemcitabine;0.Nivolumab;7.Gemcitabine;"
"3714","94.4.1376.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, squamous",94,"Adjuvant therapy",4,"Carboplatin, nab-Paclitaxel, Pembrolizumab",TRUE,"Cont.","7.Carboplatin;0.Paclitaxel;0.nanoparticlealbumin-bound;0.Pembrolizumab;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Carboplatin;0.Paclitaxel;0.nanoparticlealbumin-bound;0.Pembrolizumab;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;","7.Carboplatin;0.Paclitaxel;0.nanoparticlealbumin-bound;0.Pembrolizumab;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;"
"3715","94.4.1377.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, squamous",94,"Adjuvant therapy",4,"Carboplatin & nab-Paclitaxel (CnP) & Tislelizumab",TRUE,"Cont.","7.Carboplatin;0.Paclitaxel;0.nanoparticlealbumin-bound;0.Tislelizumab;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Carboplatin;0.Paclitaxel;0.nanoparticlealbumin-bound;0.Tislelizumab;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;","7.Carboplatin;0.Paclitaxel;0.nanoparticlealbumin-bound;0.Tislelizumab;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;"
"3716","94.4.1378.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, squamous",94,"Adjuvant therapy",4,"Carboplatin & Paclitaxel (CP) & Camrelizumab",TRUE,"Cont.","21.Camrelizumab;0.Carboplatin;0.Paclitaxel;21.Camrelizumab;0.Carboplatin;0.Paclitaxel;","21.Camrelizumab;0.Carboplatin;0.Paclitaxel;"
"3717","94.4.1379.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, squamous",94,"Adjuvant therapy",4,"Carboplatin & Paclitaxel (CP) & Ipilimumab, Nivolumab",TRUE,"Cont.","21.Carboplatin;0.Ipilimumab;0.Nivolumab;0.Paclitaxel;21.Carboplatin;0.Ipilimumab;0.Nivolumab;0.Paclitaxel;","21.Carboplatin;0.Ipilimumab;0.Nivolumab;0.Paclitaxel;"
"3718","94.4.1380.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, squamous",94,"Adjuvant therapy",4,"Carboplatin & Paclitaxel (CP) & Pembrolizumab",TRUE,"Cont.","21.Carboplatin;0.Paclitaxel;0.Pembrolizumab;21.Carboplatin;0.Paclitaxel;0.Pembrolizumab;","21.Carboplatin;0.Paclitaxel;0.Pembrolizumab;"
"3719","94.4.1381.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, squamous",94,"Adjuvant therapy",4,"Carboplatin & Paclitaxel (CP) & Sugemalimab",TRUE,"Cont.","21.Carboplatin;0.Paclitaxel;0.Sugemalimab;21.Carboplatin;0.Paclitaxel;0.Sugemalimab;","21.Carboplatin;0.Paclitaxel;0.Sugemalimab;"
"3720","94.4.1382.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, squamous",94,"Adjuvant therapy",4,"Carboplatin & Paclitaxel (CP) & Tislelizumab",TRUE,"Cont.","21.Carboplatin;0.Paclitaxel;0.Tislelizumab;21.Carboplatin;0.Paclitaxel;0.Tislelizumab;","21.Carboplatin;0.Paclitaxel;0.Tislelizumab;"
"3721","94.4.1383.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, squamous",94,"Adjuvant therapy",4,"Cisplatin & Gemcitabine (GC) & Necitumumab",TRUE,"Cont.","14.Cisplatin;0.Gemcitabine;0.Necitumumab;7.Gemcitabine;0.Necitumumab;14.Cisplatin;0.Gemcitabine;0.Necitumumab;7.Gemcitabine;0.Necitumumab;","14.Cisplatin;0.Gemcitabine;0.Necitumumab;7.Gemcitabine;0.Necitumumab;"
"3722","94.4.1384.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, squamous",94,"Adjuvant therapy",4,"Docetaxel & Nedaplatin",TRUE,"Cont.","21.Docetaxel;0.Nedaplatin;21.Docetaxel;0.Nedaplatin;","21.Docetaxel;0.Nedaplatin;"
"3723","94.4.1385.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, squamous",94,"Adjuvant therapy",4,"Sintilimab monotherapy",TRUE,"Cont.","21.Sintilimab;21.Sintilimab;","21.Sintilimab;21.Sintilimab;"
"3724","95.14.1386.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, ALK-positive",95,"Advanced or metastatic disease, ALK inhibitor-naive",14,"Alectinib monotherapy",TRUE,"Cont.","1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;","1.Alectinib;1.Alectinib;"
"3725","95.14.1387.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, ALK-positive",95,"Advanced or metastatic disease, ALK inhibitor-naive",14,"Brigatinib monotherapy",TRUE,"Cont.","1.Brigatinib;1.Brigatinib;1.Brigatinib;1.Brigatinib;1.Brigatinib;1.Brigatinib;1.Brigatinib;1.Brigatinib;1.Brigatinib;1.Brigatinib;1.Brigatinib;1.Brigatinib;1.Brigatinib;1.Brigatinib;","1.Brigatinib;1.Brigatinib;"
"3726","95.14.1388.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, ALK-positive",95,"Advanced or metastatic disease, ALK inhibitor-naive",14,"Ceritinib monotherapy",TRUE,"Cont.","1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;","1.Ceritinib;1.Ceritinib;"
"3727","95.14.1389.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, ALK-positive",95,"Advanced or metastatic disease, ALK inhibitor-naive",14,"Crizotinib monotherapy",TRUE,"Cont.","1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;","1.Crizotinib;1.Crizotinib;"
"3728","95.14.1390.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, ALK-positive",95,"Advanced or metastatic disease, ALK inhibitor-naive",14,"Lorlatinib monotherapy",TRUE,"Cont.","1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;","1.Lorlatinib;1.Lorlatinib;"
"3729","96.19.1391.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, BRAF-mutated",96,"Advanced or metastatic disease, first-line",19,"Dabrafenib & Trametinib",TRUE,"Cont.","1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;1.Dabrafenib;0.Trametinib;","1.Dabrafenib;0.Trametinib;"
"3730","97.153.1392.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, EGFR-mutated",97,"Neoadjuvant therapy",153,"Osimertinib monotherapy",TRUE,"Cont.","1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;","1.Osimertinib;1.Osimertinib;"
"3731","97.17.1406.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, EGFR-mutated",97,"Advanced or metastatic disease, EGFR inhibitor-exposed",17,"Afatinib & Bevacizumab",TRUE,"Cont.","1.Afatinib;0.Bevacizumab;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;0.Bevacizumab;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;","1.Afatinib;0.Bevacizumab;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;"
"3732","97.17.1407.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, EGFR-mutated",97,"Advanced or metastatic disease, EGFR inhibitor-exposed",17,"Afatinib & Cetuximab",TRUE,"Cont.","1.Afatinib;0.Cetuximab;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;0.Cetuximab;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;","1.Afatinib;0.Cetuximab;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;"
"3733","97.17.1408.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, EGFR-mutated",97,"Advanced or metastatic disease, EGFR inhibitor-exposed",17,"Docetaxel & Bevacizumab",TRUE,"Cont.","21.Bevacizumab;0.Docetaxel;21.Bevacizumab;0.Docetaxel;","21.Bevacizumab;0.Docetaxel;"
"3734","97.18.1395.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, EGFR-mutated",97,"Advanced or metastatic disease, EGFR inhibitor-naive",18,"Apatinib & Gefitinib",TRUE,"Cont.","1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;","1.Apatinib;0.Gefitinib;"
"3735","97.18.1396.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, EGFR-mutated",97,"Advanced or metastatic disease, EGFR inhibitor-naive",18,"Aumolertinib monotherapy",TRUE,"Cont.","1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;","1.Aumolertinib;1.Aumolertinib;"
"3736","97.18.1397.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, EGFR-mutated",97,"Advanced or metastatic disease, EGFR inhibitor-naive",18,"Carboplatin & Gemcitabine/Erlotinib",FALSE,"4","1.Carboplatin;0.Gemcitabine;7.Gemcitabine;7.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Carboplatin;0.Gemcitabine;7.Gemcitabine;7.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;","1.Carboplatin;0.Gemcitabine;7.Gemcitabine;7.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;"
"3737","97.18.1398.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, EGFR-mutated",97,"Advanced or metastatic disease, EGFR inhibitor-naive",18,"Cisplatin & Gemcitabine/Erlotinib",FALSE,"4","1.Cisplatin;0.Gemcitabine;7.Gemcitabine;7.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Cisplatin;0.Gemcitabine;7.Gemcitabine;7.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;","1.Cisplatin;0.Gemcitabine;7.Gemcitabine;7.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;"
"3738","97.18.1399.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, EGFR-mutated",97,"Advanced or metastatic disease, EGFR inhibitor-naive",18,"Dacomitinib monotherapy",TRUE,"Cont.","1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;","1.Dacomitinib;1.Dacomitinib;"
"3739","97.18.1400.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, EGFR-mutated",97,"Advanced or metastatic disease, EGFR inhibitor-naive",18,"Erlotinib monotherapy",TRUE,"Cont.","1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;","1.Erlotinib;1.Erlotinib;"
"3740","97.18.1401.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, EGFR-mutated",97,"Advanced or metastatic disease, EGFR inhibitor-naive",18,"Erlotinib & Bevacizumab",TRUE,"Cont.","1.Bevacizumab;0.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Bevacizumab;0.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;","1.Bevacizumab;0.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;"
"3741","97.18.1402.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, EGFR-mutated",97,"Advanced or metastatic disease, EGFR inhibitor-naive",18,"Erlotinib & Ramucirumab",TRUE,"Cont.","1.Erlotinib;0.Ramucirumab;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;0.Ramucirumab;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;","1.Erlotinib;0.Ramucirumab;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;"
"3742","97.18.1403.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, EGFR-mutated",97,"Advanced or metastatic disease, EGFR inhibitor-naive",18,"Furmonertinib monotherapy",TRUE,"Cont.","1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;","1.Furmonertinib;1.Furmonertinib;"
"3743","97.18.1404.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, EGFR-mutated",97,"Advanced or metastatic disease, EGFR inhibitor-naive",18,"GCP",TRUE,"Cont.","1.Carboplatin;0.Gefitinib;0.Pemetrexed;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Carboplatin;0.Gefitinib;0.Pemetrexed;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;","1.Carboplatin;0.Gefitinib;0.Pemetrexed;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;"
"3744","97.18.1405.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, EGFR-mutated",97,"Advanced or metastatic disease, EGFR inhibitor-naive",18,"Gefitinib & Pemetrexed",TRUE,"Cont.","1.Gefitinib;0.Pemetrexed;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;0.Pemetrexed;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;","1.Gefitinib;0.Pemetrexed;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;"
"3745","97.22.1393.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, EGFR-mutated",97,"Advanced or metastatic disease, platinum-exposed",22,"Amivantamab monotherapy",TRUE,"Cont.","7.Amivantamab;7.Amivantamab;","7.Amivantamab;7.Amivantamab;"
"3746","97.22.1393.2","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, EGFR-mutated",97,"Advanced or metastatic disease, platinum-exposed",22,"Amivantamab monotherapy",TRUE,"Cont.","14.Amivantamab;14.Amivantamab;","14.Amivantamab;14.Amivantamab;"
"3747","97.22.1394.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, EGFR-mutated",97,"Advanced or metastatic disease, platinum-exposed",22,"Mobocertinib monotherapy",TRUE,"Cont.","1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;","1.Mobocertinib;1.Mobocertinib;"
"3748","98.124.1409.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, HER2-mutated",98,"Metastatic disease, all lines of therapy",124,"Trastuzumab deruxtecan monotherapy",TRUE,"Cont.","21.Trastuzumabderuxtecan;21.Trastuzumabderuxtecan;","21.Trastuzumabderuxtecan;21.Trastuzumabderuxtecan;"
"3749","99.26.1410.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, KRAS-mutated",99,"Advanced or metastatic disease, subsequent lines of therapy",26,"Adagrasib monotherapy",TRUE,"Cont.","1.Adagrasib;1.Adagrasib;1.Adagrasib;1.Adagrasib;1.Adagrasib;1.Adagrasib;1.Adagrasib;1.Adagrasib;1.Adagrasib;1.Adagrasib;1.Adagrasib;1.Adagrasib;1.Adagrasib;1.Adagrasib;","1.Adagrasib;1.Adagrasib;"
"3750","99.26.1411.1","Solid Tumor","Thoraic Oncology","Non-small cell lung cancer, KRAS-mutated",99,"Advanced or metastatic disease, subsequent lines of therapy",26,"Sotorasib monotherapy",TRUE,"Cont.","1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;","1.Sotorasib;1.Sotorasib;"
